[{"Node1":"Cleft Palate, Isolated, And Mental Retardation","Edge_Type":"disease_to_mechanism","Node2":"interleukin 1 receptor antagonist","Weight":1,"Paper_List":"22370044","Original_Text":"PMID:22370044; Original text:The interleukin-1 receptor antagonist tandem repeats polymorphism was marginally associated with an elevated risk of CP in overall populations (22 versus LL (L means the long alleles): OR=1.47, 95% CI 1.00-2.18, p=0.05), and the association was consistently significant in severe CP subgroup (OR=4.02, 95% CI 1.84-8.80, p<0.0005)."},{"Node1":"Cleft Palate, Isolated, And Mental Retardation","Edge_Type":"disease_to_mechanism","Node2":"orosomucoid 1","Weight":1,"Paper_List":"22370044","Original_Text":"PMID:22370044; Original text:Further stratified analysis restricted to Hardy-Weinberg equilibrium studies showed evidence for an increased risk with CP in Asians (2 allele versus L allele: OR=1.82, 95% CI 1.31-2.54, p<0.0005), however, a decreased risk with AgP in Caucasians (L2 versus LL: OR=0.50, 95% CI 0.32-0.78, p=0.002)."},{"Node1":"Levofloxacin","Edge_Type":"chemical_to_disease","Node2":"Periodontal Pocket","Weight":1,"Paper_List":"24574052","Original_Text":"PMID:24574052; Original text:There was a reduction in the percentage of sites positive for periodontopathic bacteria over the duration of the study in both groups, and a statistically-significant reduction in the number of sites positive for A. actinomycetemcomitans in the systemic levofloxacin group (P < 0.001)."},{"Node1":"Levofloxacin","Edge_Type":"chemical_to_disease","Node2":"Periodontitis","Weight":1,"Paper_List":"24574052","Original_Text":"PMID:24574052; Original text:Levofloxacin was found to significantly improve the clinical and microbiological parameters in chronic periodontitis individuals."},{"Node1":"Yolk color","Edge_Type":"mechanism_to_antibody","Node2":"Anti-eggless","Weight":3,"Paper_List":"17928726|17928726|17928726","Original_Text":"PMID:17928726; Original text:The Anti-P. gingivalis egg yolk antibody group had a significant reduction in probing depth.|PMID:17928726; Original text:BOP significantly decreased in the Anti-P. gingivalis egg yolk antibody group compared to the control group at week 4.|PMID:17928726; Original text:The levels of P. gingivalis significantly increased in the control group at week 4, whereas the reduction in the levels of P. gingivalis was sustained in the Anti-P. gingivalis egg yolk antibody group."},{"Node1":"Yolk color","Edge_Type":"mechanism_to_anatomy","Node2":"Egg Yolk","Weight":3,"Paper_List":"17928726|17928726|17928726","Original_Text":"PMID:17928726; Original text:The Anti-P. gingivalis egg yolk antibody group had a significant reduction in probing depth.|PMID:17928726; Original text:BOP significantly decreased in the Anti-P. gingivalis egg yolk antibody group compared to the control group at week 4.|PMID:17928726; Original text:The levels of P. gingivalis significantly increased in the control group at week 4, whereas the reduction in the levels of P. gingivalis was sustained in the Anti-P. gingivalis egg yolk antibody group."},{"Node1":"Anti-eggless","Edge_Type":"antibody_to_anatomy","Node2":"Egg Yolk","Weight":3,"Paper_List":"17928726|17928726|17928726","Original_Text":"PMID:17928726; Original text:The Anti-P. gingivalis egg yolk antibody group had a significant reduction in probing depth.|PMID:17928726; Original text:BOP significantly decreased in the Anti-P. gingivalis egg yolk antibody group compared to the control group at week 4.|PMID:17928726; Original text:The levels of P. gingivalis significantly increased in the control group at week 4, whereas the reduction in the levels of P. gingivalis was sustained in the Anti-P. gingivalis egg yolk antibody group."},{"Node1":"collagen","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"20813541","Original_Text":"PMID:20813541; Original text:In group L the density of gingival collagen fibers (66±19%) was significantly increased (p<0.02) when compared to controls (35±21%)."},{"Node1":"Antigen-Presenting Cells","Edge_Type":"anatomy","Node2":"Langerhans Cells","Weight":1,"Paper_List":"20813541","Original_Text":"PMID:20813541; Original text:Concerning the antigen-presenting cells, the photodynamic therapy had differential effects depending on the drug delivery system; the number of macrophages was significantly decreased (p<0.05) in group L while the number of Langerhans cells was significantly decreased in group N (p<0.02)."},{"Node1":"Antigen-Presenting Cells","Edge_Type":"anatomy","Node2":"Cells","Weight":1,"Paper_List":"20813541","Original_Text":"PMID:20813541; Original text:Concerning the antigen-presenting cells, the photodynamic therapy had differential effects depending on the drug delivery system; the number of macrophages was significantly decreased (p<0.05) in group L while the number of Langerhans cells was significantly decreased in group N (p<0.02)."},{"Node1":"Antigen-Presenting Cells","Edge_Type":"anatomy","Node2":"Macrophages","Weight":1,"Paper_List":"20813541","Original_Text":"PMID:20813541; Original text:Concerning the antigen-presenting cells, the photodynamic therapy had differential effects depending on the drug delivery system; the number of macrophages was significantly decreased (p<0.05) in group L while the number of Langerhans cells was significantly decreased in group N (p<0.02)."},{"Node1":"Cells","Edge_Type":"anatomy","Node2":"Langerhans Cells","Weight":1,"Paper_List":"20813541","Original_Text":"PMID:20813541; Original text:Concerning the antigen-presenting cells, the photodynamic therapy had differential effects depending on the drug delivery system; the number of macrophages was significantly decreased (p<0.05) in group L while the number of Langerhans cells was significantly decreased in group N (p<0.02)."},{"Node1":"Langerhans Cells","Edge_Type":"anatomy","Node2":"Macrophages","Weight":1,"Paper_List":"20813541","Original_Text":"PMID:20813541; Original text:Concerning the antigen-presenting cells, the photodynamic therapy had differential effects depending on the drug delivery system; the number of macrophages was significantly decreased (p<0.05) in group L while the number of Langerhans cells was significantly decreased in group N (p<0.02)."},{"Node1":"Cells","Edge_Type":"anatomy","Node2":"Macrophages","Weight":1,"Paper_List":"20813541","Original_Text":"PMID:20813541; Original text:Concerning the antigen-presenting cells, the photodynamic therapy had differential effects depending on the drug delivery system; the number of macrophages was significantly decreased (p<0.05) in group L while the number of Langerhans cells was significantly decreased in group N (p<0.02)."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"interleukin 13","Weight":1,"Paper_List":"29415708","Original_Text":"PMID:29415708; Original text:The meta-analysis results indicated that the CC vs TT model, CT vs TT model and TT vs CT + CC model (CC VS TT: OR = 0.615, 95% CI = 0.395-0.957; CT vs TT: OR = 0.518, 95% CI = 0.323-0.830; and TT vs CT + CC: OR = 1.739, 95% CI = 1.130-2.676) were significant in five IL-13 -1112 gene polymorphism and periodontitis susceptibility models."},{"Node1":"Aggressive Periodontitis","Edge_Type":"disease_to_anatomy","Node2":"Coronary Vessels","Weight":2,"Paper_List":"25466412|25466412","Original_Text":"PMID:25466412; Original text:In-depth genotyping of 46 published coronary artery disease risk loci of genome-wide significance in the worldwide largest case-control sample of the severe early-onset phenotype aggressive periodontitis (the severe early-onset phenotype aggressive periodontitis) with the Illumina Immunochip (600 German the severe early-onset phenotype aggressive periodontitis cases, 1448 controls) and the Affymetrix 500K array set (283 German the severe early-onset phenotype aggressive periodontitis cases and 972 controls) highlighted ANRIL as the major risk gene and revealed further associations with the severe early-onset phenotype aggressive periodontitis for the gene PLASMINOGEN (PLG; rs4252120: P=5.9×10(-5); odds ratio, 1.27; 95% confidence interval, 1.3-1.4 [adjusted for smoking and sex]; 818 cases; 5309 controls).|PMID:25466412; Original text:Subsequent combined analyses of several genome-wide data sets of coronary artery disease and the severe early-onset phenotype aggressive periodontitis suggested TGFBRAP1 to be associated with the severe early-onset phenotype aggressive periodontitis (rs2679895: P=0.0016; odds ratio, 1.27 [95% confidence interval, 1.1-1.5]; 703 cases; 2.143 controls) and coronary artery disease (P=0.0003; odds ratio, 0.84 [95% confidence interval, 0.8-0.9]; n=4117 cases; 5824 controls)."},{"Node1":"Blood Platelets","Edge_Type":"anatomy","Node2":"Gingiva","Weight":4,"Paper_List":"17076775|17076775|33842996|33842996","Original_Text":"PMID:17076775; Original text:Compared with pre-operative values, the gingival crevice fluid volume and platelet activating factor levels were significantly decreased at postoperative weeks 6, 12 and 24 in both groups (p < 0.01).|PMID:17076775; Original text:There were also significant differences in gingival crevice fluid volume and platelet activating factor levels at all time points up to 24 wks in both groups (p < 0.01).|PMID:33842996; Original text:open flap debridement+AA/platelet-rich fibrin demonstrated significant gingival recession depth reduction of 0.90 ± 0.50 mm and 0.80 ± 0.71 mm at 3 and 6 months, while open flap debridement+platelet-rich fibrin showed gingival recession depth reduction of 0.10 ± 0.77 mm at 3 months, with an gingival recession depth-increase of 0.20 ± 0.82 mm at 6 months (p < 0.05).|PMID:33842996; Original text:open flap debridement+AA/platelet-rich fibrin and open flap debridement+platelet-rich fibrin demonstrated significant radiographic linear defect depth reduction (2.29 ± 0.61 mm and 1.63 ± 0.46 mm; p < 0.05) and gingival recession depthBD-increase (14.61 ± 5.39% and 12.58 ± 5.03%; p > 0.05)."},{"Node1":"platelet activating factor receptor S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":2,"Paper_List":"17076775|17076775","Original_Text":"PMID:17076775; Original text:Compared with pre-operative values, the gingival crevice fluid volume and platelet activating factor levels were significantly decreased at postoperative weeks 6, 12 and 24 in both groups (p < 0.01).|PMID:17076775; Original text:There were also significant differences in gingival crevice fluid volume and platelet activating factor levels at all time points up to 24 wks in both groups (p < 0.01)."},{"Node1":"platelet activating factor receptor S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Blood Platelets","Weight":2,"Paper_List":"17076775|17076775","Original_Text":"PMID:17076775; Original text:Compared with pre-operative values, the gingival crevice fluid volume and platelet activating factor levels were significantly decreased at postoperative weeks 6, 12 and 24 in both groups (p < 0.01).|PMID:17076775; Original text:There were also significant differences in gingival crevice fluid volume and platelet activating factor levels at all time points up to 24 wks in both groups (p < 0.01)."},{"Node1":"Alveolar Bone Loss","Edge_Type":"disease_to_anatomy","Node2":"Alveolar Process","Weight":4,"Paper_List":"20862420|17563512|33673616|30230662","Original_Text":"PMID:20862420; Original text:There were no statistically significant differences in insertion torque and alveolar bone loss between postextraction sites and healed sites.|PMID:17563512; Original text:The radiographic assessment showed no statistical significant difference in mesial and distal alveolar bone loss at the different intervals of the follow-up period, except at the 12-month period, where immediately loaded implants showed a decrease in the amount of alveolar bone loss mesially and distally compared to delayed loaded implants.|PMID:33673616; Original text:Neither radiography nor μCT revealed any significant effects of melatonin on alveolar bone loss.|PMID:30230662; Original text:Alveolar bone loss could be significantly prevented and regenerated by applying specialized pro-resolving lipid mediators, when compared to the control group."},{"Node1":"Diabetes Mellitus","Edge_Type":"disease","Node2":"Periodontitis","Weight":3,"Paper_List":"24354651|26114433|32652980","Original_Text":"PMID:24354651; Original text:Routine prophylaxes every 3 months significantly improve periodontal health and prevent progression of chronic periodontitis in both poorly controlled and well-controlled patients with 2 diabetes mellitus.|PMID:26114433; Original text:After adjustment for gender, hyperlipidemia, hypertension and diabetes mellitus, severe treated periodontitis was associated with a mildly but significantly increased risk of the long-term major adverse cardiovascular events among older patients > 60 years of age (incidence rate ratio, 1.26; 95% confidence interval, 1.08-1.46).|PMID:32652980; Original text:The Adjusted 2 diabetes mellitus prevalence was significantly higher in periodontitis patients (OR = 4.04, p = 0.000), and vice versa (OR = 1.58, p = 0.000)."},{"Node1":"Diabetes Mellitus","Edge_Type":"disease","Node2":"Periodontal Cyst","Weight":1,"Paper_List":"24354651","Original_Text":"PMID:24354651; Original text:Routine prophylaxes every 3 months significantly improve periodontal health and prevent progression of chronic periodontitis in both poorly controlled and well-controlled patients with 2 diabetes mellitus."},{"Node1":"Periodontal Cyst","Edge_Type":"disease","Node2":"Periodontitis","Weight":12,"Paper_List":"24354651|33397446|23705535|7767709|31694985|21698987|26184762|27027257|29211309|16623181|30624092|24970858","Original_Text":"PMID:24354651; Original text:Routine prophylaxes every 3 months significantly improve periodontal health and prevent progression of chronic periodontitis in both poorly controlled and well-controlled patients with 2 diabetes mellitus.|PMID:33397446; Original text:Administration of vitamin C as an adjunct to non-surgical periodontal therapy did not result in clinically significant improvements in pocket probing depths at 3 months in periodontitis patients.|PMID:23705535; Original text:The systemic use of systemic satranidazole, when used as an adjunct to non-surgical periodontal therapy in subjects with periodontitis, achieves significantly better clinical and microbiological results than scaling and root planing alone.|PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells.|PMID:31694985; Original text:Available human studies showed that there is limited evidence that traumatic occlusion is associated with periodontitis and to support the implementation of occlusal adjustment to significantly improve the periodontal condition in patients with periodontitis.|PMID:21698987; Original text:The dentin hypersensitivity observed after periodontal treatment was significantly reduced in periodontitis patients who used the DenShield system for 6 months.|PMID:26184762; Original text:However, comparable periodontal parameters were reported when antimicrobial photodynamic therapy as an adjunct to SRP was compared to SRP alone in the treatment of aggressive periodontitis in one study.|PMID:27027257; Original text:Evidence for significant differences between periodontal health and chronic periodontitis was observed for a few cytokines and one chemokine.|PMID:29211309; Original text:Thirteen of the experimentally induced periodontitis (81%) and 2 of the acute/chronified periodontal defect (29%) studies presented significantly better results in terms of alveolar bone level/amount in favor of statins.|PMID:16623181; Original text:We conclude that a full-mouth disinfection approach significantly improves periodontal status and metabolic control in type 1 diabetes patients with periodontitis.|PMID:30624092; Original text:leukocyte-platelet-rich fibrin combined with open flap debridement significantly increases growth factors levels and thus, it enhances the periodontal healing on chronic periodontitis patients.|PMID:24970858; Original text:In this randomized controlled trial, aspirin-triggered docosahexaenoic acid supplementation significantly improved periodontal outcomes in people with periodontitis, indicating its potential therapeutic efficacy (clinicaltrials.gov NCT01976806)."},{"Node1":"interleukin 6 cytokine family signal transducer","Edge_Type":"mechanism","Node2":"proline rich 4","Weight":5,"Paper_List":"26946202|31292965|19405832|20889139|20889139","Original_Text":"PMID:26946202; Original text:A clear decrease in DAS28 score and ESR was recorded, while other parameters such as CRP, IL-6 and TNFα showed a nonsignificant tendency to decrease as a result of treatment.|PMID:31292965; Original text:In the control group, serum high-sensitive CRP, IFN-γ, IL-12p70, and IL-6 were significantly increased one day after treatment, but subsequently decreased below the original numerical value.|PMID:19405832; Original text:Periodontal treatment significantly reduced the blood levels of fibrinogen, CRP, and IL-6 in the test group.|PMID:20889139; Original text:The serum adiponectin levels at baseline had decreased tendency with significant difference between each two groups, while CRP, TNF-α, and IL-6 levels had increased tendency with significant difference between each two groups among NC, impaired glucose tolerance, DM1 and DM2 groups (all P<0.01).|PMID:20889139; Original text:At 3 months after periodontal intervention, the serum adiponectin levels were increased than those without periodontal intervention (all P<0.01), while CRP, IL-6 and TNF-α significantly decreased (all P<0.05) in both impaired glucose tolerance and DM1 groups."},{"Node1":"Dentition","Edge_Type":"anatomy","Node2":"Periodontal Ligament","Weight":1,"Paper_List":"25186780","Original_Text":"PMID:25186780; Original text:Overall, periodontal therapy was found to be effective in improving the clinical outcomes of both primary and permanent dentitions."},{"Node1":"Tetracycline","Edge_Type":"chemical_to_disease","Node2":"Hemorrhage","Weight":1,"Paper_List":"8841900","Original_Text":"PMID:8841900; Original text:Improvements in probing depth, probing attachment level and bleeding on probing were significantly better in the group treated with adjunctive tetracycline, at 3 months post-treatment."},{"Node1":"Docosahexaenoic Acids","Edge_Type":"chemical","Node2":"docosapentaenoic acid","Weight":1,"Paper_List":"23721647","Original_Text":"PMID:23721647; Original text:In the placebo group, all serum long chain-polyunsaturated fatty acids levels reduced significantly (docosahexaenoic acid, Docosapentaenoic acid and AA, p = 0.004; eicosapetaenoic acid, p = 0.008)."},{"Node1":"Eicosapentaenoic Acid","Edge_Type":"chemical","Node2":"docosapentaenoic acid","Weight":1,"Paper_List":"23721647","Original_Text":"PMID:23721647; Original text:In the placebo group, all serum long chain-polyunsaturated fatty acids levels reduced significantly (docosahexaenoic acid, Docosapentaenoic acid and AA, p = 0.004; eicosapetaenoic acid, p = 0.008)."},{"Node1":"Docosahexaenoic Acids","Edge_Type":"chemical","Node2":"Eicosapentaenoic Acid","Weight":2,"Paper_List":"23721647|23721647","Original_Text":"PMID:23721647; Original text:In the placebo group, all serum long chain-polyunsaturated fatty acids levels reduced significantly (docosahexaenoic acid, Docosapentaenoic acid and AA, p = 0.004; eicosapetaenoic acid, p = 0.008).|PMID:23721647; Original text:Moreover, a significant decrease in the ratios AA/eicosapetaenoic acid and AA/docosahexaenoic acid (p = 0.005) was observed in the test group."},{"Node1":"Alveolar Bone Loss","Edge_Type":"disease_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"9846802","Original_Text":"PMID:9846802; Original text:Conversely, test sites exhibited a statistically significant greater increase in gingival recession (+1.9 versus +1.2; p<0.05) and alveolar crest resorption (-1.1 versus -0.3, p<0.01) in comparison to controls."},{"Node1":"Gingiva","Edge_Type":"anatomy","Node2":"Gingival Crevicular Fluid","Weight":80,"Paper_List":"18027183|20582610|34689450|22779219|18713481|16512758|29574763|29574763|30143550|21614479|22248223|20535518|27619532|23373793|7752836|7752836|28394081|28394081|17199546|17199546|17199546|17199546|16896836|16896836|8777275|32436173|34618843|11846190|11846190|21702323|21702323|21702323|26093363|26323451|15025222|15025222|30348440|30348440|21488873|18315429|18315429|15857076|25814780|25814780|26547514|18412719|27363844|11168739|11168739|7623251|26932392|26385382|26418666|22835005|22835005|24970858|20860592|20860592|25741580|9706855|18672990|23097216|15562917|15562917|15562917|15562917|24844029|8884648|22571226|18062117|18062117|22288485|787013|2177499|21121958|21121958|21121958|16441729|28406122|29577710","Original_Text":"PMID:18027183; Original text:Significant reduction in total bacterial count in gingival crevicular fluid was observed before and postdevice insertion, as well as between control and treatment groups.|PMID:20582610; Original text:Gingival crevicular fluid volume was lower on the test side compared to the control side (p < 0.01).|PMID:34689450; Original text:In the participants' gingival crevicular fluid samples, interleukin-1β, resistin, and adiponectin levels were higher in Group 1 (P< 0.05).|PMID:22779219; Original text:gingival crevicular fluid b-glu levels at 24 hours were reduced following patch placement, significantly more so than with controls (17/22 vs. 3/14 sites, respectively; p = 0.002).|PMID:18713481; Original text:After 12 months the following significant changes could be observed: reduction of clinical probing depth (2.40 v. 2.20 mm; P < 0.001), reduction of gingival inflammation (gingival index 1.13 v. 0.9; P < 0.001), reduced concentrations of IL-1beta (4.63 v. 1.10 pg/ml per site; P < 0.001) as well as IL-6 (1.85 v. 0.34 pg/ml per site; P = 0.022) in gingival crevicular fluid.|PMID:16512758; Original text:When data were combined from all groups, significant reductions in gingival crevicular fluid crevicular prostaglandin E2 levels and number of microorganisms were noted at all time points.|PMID:29574763; Original text:Clinical parameters, gingival crevicular fluid volumes and the concentrations of interleukin-1β and interleukin-1ra in gingival crevicular fluid were measured at baseline and 1, 3 and 6 months after the treatments.|PMID:29574763; Original text:At baseline, no statistically significant difference in periodontal and gingival crevicular fluid parameters was found between the Test and Control groups.|PMID:30143550; Original text:Baseline and 24-month measurements included radiographic interproximal alveolar bone height, probing depths (probing depths), clinical attachment level (clinical attachment level), bleeding on probing (BOP), gingival crevicular fluid (GCF), and salivary interleukin (IL) - 1β, (24 month only).|PMID:21614479; Original text:Although levels of IL-1β and MMP-8 in gingival crevicular fluid after treatment were lower in the test side than the control side, there was not a statistically significant difference (p > 0.05).|PMID:22248223; Original text:Using an individual-based analysis, individuals in group 1 showed enhanced clinical outcome (P <0.05) over a period of 6 months compared with those in group 2. 0.5% clarithromycin was detected in gingival crevicular fluid until a period of 7 weeks after the local drug delivery.|PMID:20535518; Original text:However, levels of IL-1 β in gingival crevicular fluid were significantly lower after root planing+NDL treatment when compared to IL-1 β levels obtained by root planing alone after 4 weeks of treatment.|PMID:27619532; Original text:It remains debatable whether adjunctive antimicrobial photodynamic therapy or laser therapy is effective in the reduction of the gingival crevicular fluid inflammatory proteins in periodontal disease due to non-standard laser parameters and short follow up period.|PMID:23373793; Original text:Statistically significant differences between groups were found in relation to the gingival crevicular fluid volume 21 days after the surgical procedures (p=0.03) and test groupF-β concentration in the gingival crevicular fluid 45 days post-initial therapy (p=0.04), favoring the test group.|PMID:7752836; Original text:In the first 3-week period, significant reductions in gingival crevicular fluid flow, probing depth and attachment loss were found only at experimental sites.|PMID:7752836; Original text:After mechanical subgingival debridement, significant decreases in the plaque index, gingival crevicular fluid flow, probing depth and attachment loss were found both at experimental and control sites.|PMID:28394081; Original text:Gingival crevicular fluid PAI-1 levels decreased significantly in the SCp+root planing+sham and SCp+root planing+low-level laser therapy groups (P<.05), and gingival crevicular fluid tissue plasminogen activator levels decreased significantly in the Cp+root planing+sham, Cp+root planing+low-level laser therapy and SCp+root planing+low-level laser therapy groups (P<.05).|PMID:28394081; Original text:Gingival crevicular fluid TGF-β1 levels decreased significantly in all treatment groups (P<.05).|PMID:17199546; Original text:In group 3, gingival crevicular fluid PGE(2) and TBARS levels exhibited a statistically significant decrease (P <0.05) after the therapy.|PMID:17199546; Original text:Group 4 showed significant reductions (P <0.05) in gingival crevicular fluid PGE(2) levels after the therapy.|PMID:17199546; Original text:No statistically significant reductions were observed in group 4 with regard to gingival crevicular fluid TBARS levels.|PMID:17199546; Original text:When groups 1 and 3 were compared according to gingival crevicular fluid TBARS levels after the therapy, a more statistically significant reduction was observed in group 3 (P = 0.001).|PMID:16896836; Original text:The The plaque index, gingival index, PD, and gingival crevicular fluid IL-1 receptor antagonist decreased significantly (p<0.05) in meloxicam group at first month when comparing the initial levels.|PMID:16896836; Original text:While decrease of the The plaque index was statistically significant in control group (p<0.05), statistically significant changes were not determined in the other clinical parameters and gingival crevicular fluid cytokine levels (p>0.05).|PMID:8777275; Original text:The gingival crevicular fluid and tissue IL-1 beta activity were significantly correlated with clinical parameters (gingival index, depth and gingival crevicular fluid flow), as well as with the percentage of inflammatory infiltrate and tissue alterations.|PMID:32436173; Original text:There was a significant decrease in ADA in gingival crevicular fluid and significant increases in CAT and GSH levels after root planing (p < 0.05) in all four groups.|PMID:34618843; Original text:Subgroup analysis by sample type showed that subgingival plaque (Subgigival plaque), tissue and gingival crevicular fluid GCF were useful for EBV detection (P<0.001).|PMID:11846190; Original text:Both meloxicam and placebo groups showed statistically significant reductions in papilla bleeding index, Plaque index, and gingival crevicular fluid MMP-8 levels on day 10 compared to baseline (P<0.01).|PMID:11846190; Original text:The gingival crevicular fluid MMP-8 level on day 10 in the meloxicam group was similar to the clinically healthy control group (P>0.05), while it was significantly higher in the placebo group (P<0.01).|PMID:21702323; Original text:Analysis of variance showed that gingival crevicular fluid.pt scores differed between the three periodontal groups (p = 0.01).|PMID:21702323; Original text:Ad hoc Tukey HMean age test showed periodontally diseased subjects (gingivitis and periodontitis) had higher gingival crevicular fluid.pt scores than periodontally healthy subjects (p = 0.05).|PMID:21702323; Original text:Correlation analysis showed moderate significant associations between clinical periodontal measures and both gingival crevicular fluid.tx and gingival crevicular fluid.pt scores.|PMID:26093363; Original text:Periodontal treatment significantly reduced the gingival crevicular fluid levels of IL-1β, IL-10, IL-12p70 and IL-6 at 28 weeks' GA compared with controls, while levels of MCP-1, IL-8 and TNF-α exhibited a significant gestational age-dependent increase, but no treatment response.|PMID:26323451; Original text:Alpha-2-macroglobulin was significantly reduced in gingival crevicular fluid by root planing and root planing and local drug delivery after 90 days (p < 0.001).|PMID:15025222; Original text:The gingival crevicular fluid MMP-8 level in the a low-dose doxycycline group was significantly lower than that of the placebo group at 6 months (P < 0.05).|PMID:15025222; Original text:From baseline to 12 months, gingival crevicular fluid MMP-8 levels were significantly reduced in both groups (P < 0.0125).|PMID:30348440; Original text:Results of a separate meta-analysis of 6 case-control studies including a total of 153 healthy control participants and 189 patients with periodontitis indicated that serum and gingival crevicular fluid matrix metalloproteinase-9 levels were significantly higher in patients with periodontitis than in periodontally healthy control participants (SMD, 1.96; 95% CI, 0.76 to 3.16; P < .01).|PMID:30348440; Original text:The results of the meta-analysis revealed statistically significant differences in the matrix metalloproteinase-9 levels in serum and serum and gingival crevicular fluid between patients with periodontitis and periodontally healthy control participants.|PMID:21488873; Original text:Clinical attachment level, probing depth, bleeding on probing and gingival crevicular fluid volume showed no predictive utility [area under the curve (the curve) <0.6, p>0.05].|PMID:18315429; Original text:From baseline to 6 months, the gingival crevicular fluid extracellular matrix metalloproteinase inducer levels were reduced significantly in the subantimicrobial dose doxycycline group (P <0.025).|PMID:18315429; Original text:The gingival crevicular fluid extracellular matrix metalloproteinase inducer level in the subantimicrobial dose doxycycline group was significantly lower than that of the placebo group at 3 and 6 months (P <0.05).|PMID:15857076; Original text:Gingival crevicular fluid lactate dehydrogenase activity was significantly elevated in all sites of the the test tooth and CT, as compared to the AT, where lactate dehydrogenase activity remained at the baseline level throughout the study.|PMID:25814780; Original text:gingival crevicular fluid, salivary and gingival OPG profiles were significantly higher in control subjects compared to chronic periodontitis patients at baseline (P < 0.001).|PMID:25814780; Original text:Within chronic periodontitis group, OPG levels in gingival crevicular fluid, saliva, and gingival samples showed a significant increase at 3 and 6 months after open flap debridement (P < 0.001) compared to baseline.|PMID:26547514; Original text:Similarly, vascular endothelial growth factor concentration in gingival crevicular fluid was significantly higher in the ankaferd blood stopper/autogenous cortical bone graft group at postoperative weeks 2 and 4 compared to the autogenous cortical bone graft group (p < 0.01).|PMID:18412719; Original text:gingival crevicular fluid TGF-beta(1) levels of 3-month adjunctive subantimicrobial dose doxycycline group was significantly higher than baseline (P < 0.0125) and placebo group (P < 0.017) at 3 months.|PMID:27363844; Original text:The gingival crevicular fluid IL-33 concentration was significantly lower in the CP group than in the H and G groups (p < 0.001).|PMID:11168739; Original text:Previous clinical studies have shown that doxycycline administered orally, at doses below those needed for antimicrobial efficacy, to human subjects with adult periodontitis resulted in significantly reduced collagenase activity in gingival crevicular fluid (gingival crevicular fluid) and in extracts of inflamed gingival tissues.|PMID:11168739; Original text:From baseline to week 12 (part I), treatment with specially formulated subantimicrobial dose doxycycline capsules (20 mg) 2x daily (1 x every 12 h) for up to 12 weeks was shown to significantly reduce gingival crevicular fluid collagenase activity and to improve periodontal attachment, effects not seen in patients treated with placebo.|PMID:7623251; Original text:Nested ANOVA revealed that ketorolac and flurbiprofen groups had less bone loss (P < 0.01) and reduced gingival crevicular fluid PGE2 levels (P < 0.03) compared to placebo.|PMID:26932392; Original text:Meta-analysis showed that low-level laser therapy-mediated root planing demonstrated significant short-term benefits over root planing monotherapy in the improvement of the probing pocket depth (p = 0.0009 at 1 mo; p = 0.03 at 2 mo) and the level of interleukin-1β in the gingival crevicular fluid (p = 0.01 at 1 mo).|PMID:26385382; Original text:Anthropometric measures and the amounts of serum and gingival crevicular fluid biomarkers had weak positive correlations (0.242 ≤ r ≤ 0.340), and low-density lipoprotein in serum correlated with MMP-8 (r = 0.332) and IL-1β (r = 0.342) in the obese group.|PMID:26418666; Original text:Similarly, differences in the gingival crevicular fluid IL-1β levels between root planing + L and root planing alone were not statistically significant.|PMID:22835005; Original text:Although periodontal therapy during pregnancy successfully reduced periodontal inflammation and gingival crevicular fluid cytokine levels, it did not have a significant impact on serum biomarkers.|PMID:22835005; Original text:Periodontal therapy significantly reduced the levels of interleukin-1β and interleukin-8 in gingival crevicular fluid (p < 0.001).|PMID:24970858; Original text:Significant adjusted differences were found between docosahexaenoic acid and control for both gingival crevicular fluid high-sensitivity C-reactive protein (-5.3 ng/mL, standard error [SE] = 2.4, p = .03) and IL-1β (-20.1 pg/mL, SE = 8.2, p = .02) but not IL-6 (0.02 pg/mL, SE = 0.71, p = .98) or systemic high-sensitivity C-reactive protein (-1.19 mg/L, SE = 0.90, p = .20).|PMID:20860592; Original text:The test sites showed a greater reduction of interleukin-1β levels in gingival crevicular fluid at 1 wk than the control sites (p < 0.05).|PMID:20860592; Original text:A significant decrease in gingival crevicular fluid volume was observed in both groups at 1 wk (p < 0.001), with a further decrease at 1 mo in the test sites (p < 0.05).|PMID:25741580; Original text:Decreased Gingival crevicular fluid metalloproteinase-8 levels and increased TIMP-1 levels were found to be significant up to day 180 (P <0.05).|PMID:9706855; Original text:A statistically significant increase in gingival crevicular fluid prostaglandin E2 levels was noted at days 28 and 42 in the placebo group (P < 0.01), but not in the ketorolac group (P > 0.05), when compared to baseline, however.|PMID:18672990; Original text:ICTP showed a similar pattern of change during a 2-year subantimicrobial-dose doxycycline treatment, and the gingival crevicular fluid collagenase activity and ICTP were positively correlated at all time periods (P<0.001).|PMID:23097216; Original text:The mean concentration of CLM was detected in gingival crevicular fluid for up to 7 weeks, fulfilling the conditions for a controlled-release device.|PMID:15562917; Original text:In the Low-dose doxycycline group, gingival crevicular fluid Laminin-5 gamma2 chain fragment levels were significantly reduced at 3 months (P < 0.0125) and then slightly increased during the rest of the study period.|PMID:15562917; Original text:gingival crevicular fluid Laminin-5 gamma2 chain fragment levels in Low-dose doxycycline group were significantly lower than those of the placebo group during the study period (P < 0.05).|PMID:15562917; Original text:The present data indicate that Low-dose doxycycline therapy in combination with root planing therapy can reduce gingival crevicular fluid Laminin-5 gamma2 chain fragment levels and improve clinical periodontal parameters in patients with chronic periodontitis.|PMID:15562917; Original text:In the placebo group, gingival crevicular fluid 45 and 70 kDa Laminin-5 gamma2 chain fragments tended to decrease at 3 months compared to baseline, but did not reach significance; these levels continued to increase throughout the remainder of the study period.|PMID:24844029; Original text:Within the limits of the present study, one can conclude that MPM coverage of periodontal defects is associated with a significant initial increase in gingival crevicular fluid levels of bone morphogenetic protein-2, a factor that could improve the clinical outcomes of guided tissue regenerative surgery.|PMID:8884648; Original text:Gingival crevicular fluid (GCF) flow was significantly lower in the sonic brush group (P = 0.018).|PMID:22571226; Original text:Gingival crevicular fluid biomarkers were determined by immunofluorometric assay and ELISA.|PMID:18062117; Original text:In all groups, the reduction of gingival crevicular fluid matrix metalloproteinase-8 levels after therapy was statistically significant compared to baseline levels (P < 0.001).|PMID:18062117; Original text:When groups 1 and 3 and 2 and 4 were compared according to gingival crevicular fluid matrix metalloproteinase-8 levels after the therapy, no statistically significant differences were observed (P = 0.117 and P = 0.485, respectively).|PMID:22288485; Original text:Analysis of Tannerella forsythia and Pg amounts, as well as interleukin-10 and interleukin-1β gingival crevicular fluid concentrations failed to demonstrate a difference between the groups (P >0.05).|PMID:787013; Original text:Following both regimes there was significant reduction in Plaque Index, Gingival Index, crevicular fluid and depths of pockets.|PMID:2177499; Original text:Collagenase activity in the crevicular fluid of periodontal pockets of an additional group of subjects was also significantly reduced, as was the severity of inflammation at the same gingival sites.|PMID:21121958; Original text:periimplant sulcular fluidthe osmotic pressure positively correlated with the clinical parameters of implants (P<0.01 for Silness-Löe plaque index, Löe-Silness gingival index and Bthe osmotic pressure; P<0.05 for pocket depth and attachment level), and gingival crevicular fluidthe osmotic pressure positively correlated with the clinical parameters of teeth (P<0.01 for pocket depth; P<0.05 for Silness-Löe plaque index, Löe-Silness gingival index, Bthe osmotic pressure and attachment level).|PMID:21121958; Original text:It was a preliminary research that aimed to quantify periimplant sulcular fluidthe osmotic pressure and gingival crevicular fluidthe osmotic pressure as well as to evaluate their clinical significances around implants and teeth.|PMID:21121958; Original text:The results reveal that periimplant sulcular fluidthe osmotic pressure and gingival crevicular fluidthe osmotic pressure may be measured by osmometer, and their levels may be related with the clinical conditions of periimplant/periodontal soft tissues.|PMID:16441729; Original text:In addition, gingival crevicular fluid volume was significantly higher in aggressive periodontitis group compared with either LR or HR groups at each observation interval (p<0.001).|PMID:28406122; Original text:gingival crevicular fluid volume decreased significantly in the Groups M and M + L (P < 0.05) but there was no difference among the groups (P > 0.05).|PMID:29577710; Original text:In all the samples at baseline, the interleukin-1β concentration in gingival crevicular fluid and BOP rate were significantly higher at deep the periodontal pocket depth sites than at the shallow ones."},{"Node1":"myeloid-specific peroxidase","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"18335584","Original_Text":"PMID:18335584; Original text:Gingival index and total PISF myeloperoxidase levels exhibited significant correlations (p < .05)."},{"Node1":"Pain","Edge_Type":"disease","Node2":"Pain, Postoperative","Weight":7,"Paper_List":"18056100|29398090|25355775|28231975|16460241|34058250|27248848","Original_Text":"PMID:18056100; Original text:However, postoperative pain was significantly higher for osseous resection (P < .01) and gingivectomy (P < .05) procedures than for root planing and modified Widman flap procedures.|PMID:29398090; Original text:The linear regression analysis demonstrated that group variable had the most significant effect on postoperative pain at day 1 (P < .001) among the other variables (group, age, gender, tooth number, preoperative pain levels, and VAS scores of pain on percussion).|PMID:25355775; Original text:In multivariable modeling, baseline factors predicting severe postoperative pain included current pain intensity (odds ratio [OR], 1.15; 95% confidence interval [CI], 1.07 to 1.25; P = 0.0003), number of days in the past week that the subject was kept from their usual activities due to pain (OR, 1.32; 95% CI, 1.13 to 1.55; P = 0.0005), pain made worse by stress (OR, 2.55; 95% CI, 1.22 to 5.35; P = 0.0130), and a diagnosis of symptomatic apical periodontitis (OR, 1.63; 95% CI, 1.01 to 2.64; P = 0.0452).|PMID:28231975; Original text:A significant difference was noted in postoperative pain in the first 2 days; the foraminal enlargement group experienced more pain than the conventional Nforaminal enlargement group (P < .05).|PMID:16460241; Original text:Patient satisfaction with esthetics, root sensitivity, and postoperative pain was also evaluated.|PMID:34058250; Original text:No significant difference in postoperative pain was found.|PMID:27248848; Original text:Regression analysis revealed a significant association of mean postoperative pain at 24 h with the irrigant protocol (P = 0.017) and preoperative pain (P = 0.000)."},{"Node1":"Vitamin C","Edge_Type":"nutrient_to_chemical","Node2":"Ascorbic Acid","Weight":3,"Paper_List":"33397446|30039526|20569170","Original_Text":"PMID:33397446; Original text:Administration of vitamin C as an adjunct to non-surgical periodontal therapy did not result in clinically significant improvements in pocket probing depths at 3 months in periodontitis patients.|PMID:30039526; Original text:In reference to vitamin C for pain relief, there were no statistically significant differences between the study groups.|PMID:20569170; Original text:However, the adjunctive dose of vitamin C did not offer additional effect (P >0.05)."},{"Node1":"Vitamin C","Edge_Type":"nutrient_to_disease","Node2":"Periodontal Cyst","Weight":1,"Paper_List":"33397446","Original_Text":"PMID:33397446; Original text:Administration of vitamin C as an adjunct to non-surgical periodontal therapy did not result in clinically significant improvements in pocket probing depths at 3 months in periodontitis patients."},{"Node1":"Vitamin C","Edge_Type":"nutrient_to_disease","Node2":"Periodontitis","Weight":1,"Paper_List":"33397446","Original_Text":"PMID:33397446; Original text:Administration of vitamin C as an adjunct to non-surgical periodontal therapy did not result in clinically significant improvements in pocket probing depths at 3 months in periodontitis patients."},{"Node1":"Ascorbic Acid","Edge_Type":"chemical_to_disease","Node2":"Periodontal Cyst","Weight":1,"Paper_List":"33397446","Original_Text":"PMID:33397446; Original text:Administration of vitamin C as an adjunct to non-surgical periodontal therapy did not result in clinically significant improvements in pocket probing depths at 3 months in periodontitis patients."},{"Node1":"Ascorbic Acid","Edge_Type":"chemical_to_disease","Node2":"Periodontitis","Weight":1,"Paper_List":"33397446","Original_Text":"PMID:33397446; Original text:Administration of vitamin C as an adjunct to non-surgical periodontal therapy did not result in clinically significant improvements in pocket probing depths at 3 months in periodontitis patients."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"high mobility group box 1","Weight":1,"Paper_List":"27917624","Original_Text":"PMID:27917624; Original text:In addition, there was a significant positive correlation between high-mobility group protein B1 and smyeloid cells concentration in chronic periodontitis group (p<0.05)."},{"Node1":"HMG-box containing 4","Edge_Type":"mechanism_to_anatomy","Node2":"Cells","Weight":1,"Paper_List":"27917624","Original_Text":"PMID:27917624; Original text:We also found significant positive correlation between PD (Pocket depth) and the concentration of high-mobility group protein B1 (p<0.001) and smyeloid cells (p<0.015)."},{"Node1":"high mobility group box 1","Edge_Type":"mechanism_to_anatomy","Node2":"Cells","Weight":1,"Paper_List":"27917624","Original_Text":"PMID:27917624; Original text:The concentration of high-mobility group protein B1 (p<0.001) and smyeloid cells (p<0.017), was significantly higher in chronic periodontitis group."},{"Node1":"Creatinine","Edge_Type":"chemical","Node2":"Urea","Weight":1,"Paper_List":"25933364","Original_Text":"PMID:25933364; Original text:Significant improvements were found (p < 0.05) in interleukin-6, ferritin, albumin, creatinine, blood urea nitrogen, and transferrin after therapy."},{"Node1":"Nitrogen","Edge_Type":"chemical","Node2":"Urea","Weight":1,"Paper_List":"25933364","Original_Text":"PMID:25933364; Original text:Significant improvements were found (p < 0.05) in interleukin-6, ferritin, albumin, creatinine, blood urea nitrogen, and transferrin after therapy."},{"Node1":"Creatinine","Edge_Type":"chemical","Node2":"Nitrogen","Weight":1,"Paper_List":"25933364","Original_Text":"PMID:25933364; Original text:Significant improvements were found (p < 0.05) in interleukin-6, ferritin, albumin, creatinine, blood urea nitrogen, and transferrin after therapy."},{"Node1":"Ferritin","Edge_Type":"mechanism","Node2":"Transferrin 3","Weight":1,"Paper_List":"25933364","Original_Text":"PMID:25933364; Original text:Significant improvements were found (p < 0.05) in interleukin-6, ferritin, albumin, creatinine, blood urea nitrogen, and transferrin after therapy."},{"Node1":"Transferrin 3","Edge_Type":"mechanism","Node2":"interleukin 6 L homeolog","Weight":1,"Paper_List":"25933364","Original_Text":"PMID:25933364; Original text:Significant improvements were found (p < 0.05) in interleukin-6, ferritin, albumin, creatinine, blood urea nitrogen, and transferrin after therapy."},{"Node1":"Transferrin 3","Edge_Type":"mechanism","Node2":"albumin","Weight":1,"Paper_List":"25933364","Original_Text":"PMID:25933364; Original text:Significant improvements were found (p < 0.05) in interleukin-6, ferritin, albumin, creatinine, blood urea nitrogen, and transferrin after therapy."},{"Node1":"Ferritin","Edge_Type":"mechanism","Node2":"interleukin 6 L homeolog","Weight":1,"Paper_List":"25933364","Original_Text":"PMID:25933364; Original text:Significant improvements were found (p < 0.05) in interleukin-6, ferritin, albumin, creatinine, blood urea nitrogen, and transferrin after therapy."},{"Node1":"Ferritin","Edge_Type":"mechanism","Node2":"albumin","Weight":1,"Paper_List":"25933364","Original_Text":"PMID:25933364; Original text:Significant improvements were found (p < 0.05) in interleukin-6, ferritin, albumin, creatinine, blood urea nitrogen, and transferrin after therapy."},{"Node1":"albumin","Edge_Type":"mechanism","Node2":"interleukin 6 L homeolog","Weight":1,"Paper_List":"25933364","Original_Text":"PMID:25933364; Original text:Significant improvements were found (p < 0.05) in interleukin-6, ferritin, albumin, creatinine, blood urea nitrogen, and transferrin after therapy."},{"Node1":"Urea","Edge_Type":"chemical_to_mechanism","Node2":"Transferrin 3","Weight":1,"Paper_List":"25933364","Original_Text":"PMID:25933364; Original text:Significant improvements were found (p < 0.05) in interleukin-6, ferritin, albumin, creatinine, blood urea nitrogen, and transferrin after therapy."},{"Node1":"Urea","Edge_Type":"chemical_to_mechanism","Node2":"Ferritin","Weight":1,"Paper_List":"25933364","Original_Text":"PMID:25933364; Original text:Significant improvements were found (p < 0.05) in interleukin-6, ferritin, albumin, creatinine, blood urea nitrogen, and transferrin after therapy."},{"Node1":"Urea","Edge_Type":"chemical_to_mechanism","Node2":"interleukin 6 L homeolog","Weight":1,"Paper_List":"25933364","Original_Text":"PMID:25933364; Original text:Significant improvements were found (p < 0.05) in interleukin-6, ferritin, albumin, creatinine, blood urea nitrogen, and transferrin after therapy."},{"Node1":"Urea","Edge_Type":"chemical_to_mechanism","Node2":"albumin","Weight":1,"Paper_List":"25933364","Original_Text":"PMID:25933364; Original text:Significant improvements were found (p < 0.05) in interleukin-6, ferritin, albumin, creatinine, blood urea nitrogen, and transferrin after therapy."},{"Node1":"Creatinine","Edge_Type":"chemical_to_mechanism","Node2":"Transferrin 3","Weight":1,"Paper_List":"25933364","Original_Text":"PMID:25933364; Original text:Significant improvements were found (p < 0.05) in interleukin-6, ferritin, albumin, creatinine, blood urea nitrogen, and transferrin after therapy."},{"Node1":"Creatinine","Edge_Type":"chemical_to_mechanism","Node2":"Ferritin","Weight":1,"Paper_List":"25933364","Original_Text":"PMID:25933364; Original text:Significant improvements were found (p < 0.05) in interleukin-6, ferritin, albumin, creatinine, blood urea nitrogen, and transferrin after therapy."},{"Node1":"Creatinine","Edge_Type":"chemical_to_mechanism","Node2":"interleukin 6 L homeolog","Weight":1,"Paper_List":"25933364","Original_Text":"PMID:25933364; Original text:Significant improvements were found (p < 0.05) in interleukin-6, ferritin, albumin, creatinine, blood urea nitrogen, and transferrin after therapy."},{"Node1":"Creatinine","Edge_Type":"chemical_to_mechanism","Node2":"albumin","Weight":1,"Paper_List":"25933364","Original_Text":"PMID:25933364; Original text:Significant improvements were found (p < 0.05) in interleukin-6, ferritin, albumin, creatinine, blood urea nitrogen, and transferrin after therapy."},{"Node1":"Nitrogen","Edge_Type":"chemical_to_mechanism","Node2":"Transferrin 3","Weight":1,"Paper_List":"25933364","Original_Text":"PMID:25933364; Original text:Significant improvements were found (p < 0.05) in interleukin-6, ferritin, albumin, creatinine, blood urea nitrogen, and transferrin after therapy."},{"Node1":"Nitrogen","Edge_Type":"chemical_to_mechanism","Node2":"Ferritin","Weight":1,"Paper_List":"25933364","Original_Text":"PMID:25933364; Original text:Significant improvements were found (p < 0.05) in interleukin-6, ferritin, albumin, creatinine, blood urea nitrogen, and transferrin after therapy."},{"Node1":"Nitrogen","Edge_Type":"chemical_to_mechanism","Node2":"interleukin 6 L homeolog","Weight":1,"Paper_List":"25933364","Original_Text":"PMID:25933364; Original text:Significant improvements were found (p < 0.05) in interleukin-6, ferritin, albumin, creatinine, blood urea nitrogen, and transferrin after therapy."},{"Node1":"Nitrogen","Edge_Type":"chemical_to_mechanism","Node2":"albumin","Weight":1,"Paper_List":"25933364","Original_Text":"PMID:25933364; Original text:Significant improvements were found (p < 0.05) in interleukin-6, ferritin, albumin, creatinine, blood urea nitrogen, and transferrin after therapy."},{"Node1":"Urea","Edge_Type":"chemical_to_anatomy","Node2":"Blood","Weight":1,"Paper_List":"25933364","Original_Text":"PMID:25933364; Original text:Significant improvements were found (p < 0.05) in interleukin-6, ferritin, albumin, creatinine, blood urea nitrogen, and transferrin after therapy."},{"Node1":"Creatinine","Edge_Type":"chemical_to_anatomy","Node2":"Blood","Weight":1,"Paper_List":"25933364","Original_Text":"PMID:25933364; Original text:Significant improvements were found (p < 0.05) in interleukin-6, ferritin, albumin, creatinine, blood urea nitrogen, and transferrin after therapy."},{"Node1":"Nitrogen","Edge_Type":"chemical_to_anatomy","Node2":"Blood","Weight":1,"Paper_List":"25933364","Original_Text":"PMID:25933364; Original text:Significant improvements were found (p < 0.05) in interleukin-6, ferritin, albumin, creatinine, blood urea nitrogen, and transferrin after therapy."},{"Node1":"Transferrin 3","Edge_Type":"mechanism_to_anatomy","Node2":"Blood","Weight":1,"Paper_List":"25933364","Original_Text":"PMID:25933364; Original text:Significant improvements were found (p < 0.05) in interleukin-6, ferritin, albumin, creatinine, blood urea nitrogen, and transferrin after therapy."},{"Node1":"Ferritin","Edge_Type":"mechanism_to_anatomy","Node2":"Blood","Weight":1,"Paper_List":"25933364","Original_Text":"PMID:25933364; Original text:Significant improvements were found (p < 0.05) in interleukin-6, ferritin, albumin, creatinine, blood urea nitrogen, and transferrin after therapy."},{"Node1":"interleukin 6 L homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Blood","Weight":1,"Paper_List":"25933364","Original_Text":"PMID:25933364; Original text:Significant improvements were found (p < 0.05) in interleukin-6, ferritin, albumin, creatinine, blood urea nitrogen, and transferrin after therapy."},{"Node1":"albumin","Edge_Type":"mechanism_to_anatomy","Node2":"Blood","Weight":1,"Paper_List":"25933364","Original_Text":"PMID:25933364; Original text:Significant improvements were found (p < 0.05) in interleukin-6, ferritin, albumin, creatinine, blood urea nitrogen, and transferrin after therapy."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_anatomy","Node2":"Bone and Bones","Weight":2,"Paper_List":"24059744|20348487","Original_Text":"PMID:24059744; Original text:In both groups, significant (P <0.01) PD reduction (post-surgical systemic doxycycline: 3.7 ± 2.2 mm; placebo: 3.4 ± 1.7 mm), CAL-V gain (post-surgical systemic doxycycline: 2.7 ± 1.9 mm; placebo: 3.0 ± 1.9 mm), and bone fill (post-surgical systemic doxycycline: 1.6 ± 2.7 mm; placebo: 1.8 ± 3.0 mm) were observed 24 months after surgery.|PMID:20348487; Original text:We previously demonstrated that subantimicrobial-dose-doxycycline (SDD) treatment of post-menopausal osteopenic women significantly reduced periodontal disease progression, and biomarkers of collagen destruction and bone resorption locally in periodontal pockets, in a double-blind placebo-controlled clinical trial."},{"Node1":"Necrosis","Edge_Type":"disease","Node2":"Neoplasms","Weight":6,"Paper_List":"34689450|19228095|19228095|24331774|20932155|18018468","Original_Text":"PMID:34689450; Original text:In the participants' serum samples, tumor necrosis factor-α (TNF-α) and leptin levels were lower, whereas adiponectin levels were significantly higher in Group 3 than in the obese groups (P< 0.05).|PMID:19228095; Original text:Non-surgical periodontal treatment with photodynamic therapy or root planing led to statistically significant reductions in tumor necrosis factor-alpha level 30 days following treatment.|PMID:19228095; Original text:There were similar levels of tumor necrosis factor-alpha and nuclear factor-kappa B ligand at the different time points in both groups, with no statistically significant differences.|PMID:24331774; Original text:Generalized linear model revealed that changes of serum adiponectin and tumor necrosis factor-α and change of BOP correlated significantly with the reduction of Glycated hemoglobin at 6 months after periodontal treatments.|PMID:20932155; Original text:Decrease in interleukin-6 in the adjunctive subantimicrobial-dose doxycycline group was significantly higher compared to the placebo group at 6 and 9 months in deep pockets (P <0.05), whereas tumor necrosis factor-α was significantly reduced in moderately deep pockets (P <0.05).|PMID:18018468; Original text:The circulating levels of tumor necrosis factor-alpha decreased statistically significantly in the group"},{"Node1":"leptin S homeolog","Edge_Type":"mechanism","Node2":"tumor necrosis factor S homeolog","Weight":1,"Paper_List":"34689450","Original_Text":"PMID:34689450; Original text:In the participants' serum samples, tumor necrosis factor-α (TNF-α) and leptin levels were lower, whereas adiponectin levels were significantly higher in Group 3 than in the obese groups (P< 0.05)."},{"Node1":"adiponectin, C1Q and collagen domain containing S homeolog","Edge_Type":"mechanism","Node2":"leptin S homeolog","Weight":1,"Paper_List":"34689450","Original_Text":"PMID:34689450; Original text:In the participants' serum samples, tumor necrosis factor-α (TNF-α) and leptin levels were lower, whereas adiponectin levels were significantly higher in Group 3 than in the obese groups (P< 0.05)."},{"Node1":"adiponectin, C1Q and collagen domain containing S homeolog","Edge_Type":"mechanism","Node2":"tumor necrosis factor S homeolog","Weight":2,"Paper_List":"34689450|24331774","Original_Text":"PMID:34689450; Original text:In the participants' serum samples, tumor necrosis factor-α (TNF-α) and leptin levels were lower, whereas adiponectin levels were significantly higher in Group 3 than in the obese groups (P< 0.05).|PMID:24331774; Original text:Generalized linear model revealed that changes of serum adiponectin and tumor necrosis factor-α and change of BOP correlated significantly with the reduction of Glycated hemoglobin at 6 months after periodontal treatments."},{"Node1":"Neoplasms","Edge_Type":"disease_to_mechanism","Node2":"leptin S homeolog","Weight":1,"Paper_List":"34689450","Original_Text":"PMID:34689450; Original text:In the participants' serum samples, tumor necrosis factor-α (TNF-α) and leptin levels were lower, whereas adiponectin levels were significantly higher in Group 3 than in the obese groups (P< 0.05)."},{"Node1":"Neoplasms","Edge_Type":"disease_to_mechanism","Node2":"tumor necrosis factor S homeolog","Weight":3,"Paper_List":"34689450|24331774|20932155","Original_Text":"PMID:34689450; Original text:In the participants' serum samples, tumor necrosis factor-α (TNF-α) and leptin levels were lower, whereas adiponectin levels were significantly higher in Group 3 than in the obese groups (P< 0.05).|PMID:24331774; Original text:Generalized linear model revealed that changes of serum adiponectin and tumor necrosis factor-α and change of BOP correlated significantly with the reduction of Glycated hemoglobin at 6 months after periodontal treatments.|PMID:20932155; Original text:Decrease in interleukin-6 in the adjunctive subantimicrobial-dose doxycycline group was significantly higher compared to the placebo group at 6 and 9 months in deep pockets (P <0.05), whereas tumor necrosis factor-α was significantly reduced in moderately deep pockets (P <0.05)."},{"Node1":"Neoplasms","Edge_Type":"disease_to_mechanism","Node2":"adiponectin, C1Q and collagen domain containing S homeolog","Weight":2,"Paper_List":"34689450|24331774","Original_Text":"PMID:34689450; Original text:In the participants' serum samples, tumor necrosis factor-α (TNF-α) and leptin levels were lower, whereas adiponectin levels were significantly higher in Group 3 than in the obese groups (P< 0.05).|PMID:24331774; Original text:Generalized linear model revealed that changes of serum adiponectin and tumor necrosis factor-α and change of BOP correlated significantly with the reduction of Glycated hemoglobin at 6 months after periodontal treatments."},{"Node1":"Necrosis","Edge_Type":"disease_to_mechanism","Node2":"leptin S homeolog","Weight":1,"Paper_List":"34689450","Original_Text":"PMID:34689450; Original text:In the participants' serum samples, tumor necrosis factor-α (TNF-α) and leptin levels were lower, whereas adiponectin levels were significantly higher in Group 3 than in the obese groups (P< 0.05)."},{"Node1":"Necrosis","Edge_Type":"disease_to_mechanism","Node2":"tumor necrosis factor S homeolog","Weight":3,"Paper_List":"34689450|24331774|20932155","Original_Text":"PMID:34689450; Original text:In the participants' serum samples, tumor necrosis factor-α (TNF-α) and leptin levels were lower, whereas adiponectin levels were significantly higher in Group 3 than in the obese groups (P< 0.05).|PMID:24331774; Original text:Generalized linear model revealed that changes of serum adiponectin and tumor necrosis factor-α and change of BOP correlated significantly with the reduction of Glycated hemoglobin at 6 months after periodontal treatments.|PMID:20932155; Original text:Decrease in interleukin-6 in the adjunctive subantimicrobial-dose doxycycline group was significantly higher compared to the placebo group at 6 and 9 months in deep pockets (P <0.05), whereas tumor necrosis factor-α was significantly reduced in moderately deep pockets (P <0.05)."},{"Node1":"Necrosis","Edge_Type":"disease_to_mechanism","Node2":"adiponectin, C1Q and collagen domain containing S homeolog","Weight":2,"Paper_List":"34689450|24331774","Original_Text":"PMID:34689450; Original text:In the participants' serum samples, tumor necrosis factor-α (TNF-α) and leptin levels were lower, whereas adiponectin levels were significantly higher in Group 3 than in the obese groups (P< 0.05).|PMID:24331774; Original text:Generalized linear model revealed that changes of serum adiponectin and tumor necrosis factor-α and change of BOP correlated significantly with the reduction of Glycated hemoglobin at 6 months after periodontal treatments."},{"Node1":"interleukin 1 beta","Edge_Type":"mechanism","Node2":"resistin, gene 1","Weight":2,"Paper_List":"34689450|34689450","Original_Text":"PMID:34689450; Original text:In the participants' saliva samples, interleukin-1β, TNF-α, and resistin levels were lowest in Group 3, but adiponectin was lowest in Group 2 (P< 0.05).|PMID:34689450; Original text:In the participants' gingival crevicular fluid samples, interleukin-1β, resistin, and adiponectin levels were higher in Group 1 (P< 0.05)."},{"Node1":"adiponectin, C1Q and collagen domain containing S homeolog","Edge_Type":"mechanism","Node2":"resistin, gene 1","Weight":2,"Paper_List":"34689450|34689450","Original_Text":"PMID:34689450; Original text:In the participants' saliva samples, interleukin-1β, TNF-α, and resistin levels were lowest in Group 3, but adiponectin was lowest in Group 2 (P< 0.05).|PMID:34689450; Original text:In the participants' gingival crevicular fluid samples, interleukin-1β, resistin, and adiponectin levels were higher in Group 1 (P< 0.05)."},{"Node1":"adiponectin, C1Q and collagen domain containing S homeolog","Edge_Type":"mechanism","Node2":"interleukin 1 beta","Weight":2,"Paper_List":"34689450|34689450","Original_Text":"PMID:34689450; Original text:In the participants' saliva samples, interleukin-1β, TNF-α, and resistin levels were lowest in Group 3, but adiponectin was lowest in Group 2 (P< 0.05).|PMID:34689450; Original text:In the participants' gingival crevicular fluid samples, interleukin-1β, resistin, and adiponectin levels were higher in Group 1 (P< 0.05)."},{"Node1":"resistin, gene 1","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"34689450","Original_Text":"PMID:34689450; Original text:In the participants' gingival crevicular fluid samples, interleukin-1β, resistin, and adiponectin levels were higher in Group 1 (P< 0.05)."},{"Node1":"resistin, gene 1","Edge_Type":"mechanism_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"34689450","Original_Text":"PMID:34689450; Original text:In the participants' gingival crevicular fluid samples, interleukin-1β, resistin, and adiponectin levels were higher in Group 1 (P< 0.05)."},{"Node1":"interleukin 1 beta","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":8,"Paper_List":"34689450|29574763|15613075|26932392|22835005|20860592|22288485|29577710","Original_Text":"PMID:34689450; Original text:In the participants' gingival crevicular fluid samples, interleukin-1β, resistin, and adiponectin levels were higher in Group 1 (P< 0.05).|PMID:29574763; Original text:Clinical parameters, gingival crevicular fluid volumes and the concentrations of interleukin-1β and interleukin-1ra in gingival crevicular fluid were measured at baseline and 1, 3 and 6 months after the treatments.|PMID:15613075; Original text:In this 18-week clinical trial, the results suggested that scaling/root planing with adjunctive subgingival administration of minocycline ointment has a significantly better and prolonged effect compared to scaling/root planing alone on the reduction of probing depth, clinical attachment loss, gingival index, and interleukin-1beta content, but not on bleeding on probing.|PMID:26932392; Original text:Meta-analysis showed that low-level laser therapy-mediated root planing demonstrated significant short-term benefits over root planing monotherapy in the improvement of the probing pocket depth (p = 0.0009 at 1 mo; p = 0.03 at 2 mo) and the level of interleukin-1β in the gingival crevicular fluid (p = 0.01 at 1 mo).|PMID:22835005; Original text:Periodontal therapy significantly reduced the levels of interleukin-1β and interleukin-8 in gingival crevicular fluid (p < 0.001).|PMID:20860592; Original text:The test sites showed a greater reduction of interleukin-1β levels in gingival crevicular fluid at 1 wk than the control sites (p < 0.05).|PMID:22288485; Original text:Analysis of Tannerella forsythia and Pg amounts, as well as interleukin-10 and interleukin-1β gingival crevicular fluid concentrations failed to demonstrate a difference between the groups (P >0.05).|PMID:29577710; Original text:In all the samples at baseline, the interleukin-1β concentration in gingival crevicular fluid and BOP rate were significantly higher at deep the periodontal pocket depth sites than at the shallow ones."},{"Node1":"interleukin 1 beta","Edge_Type":"mechanism_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":7,"Paper_List":"34689450|29574763|26932392|22835005|20860592|22288485|29577710","Original_Text":"PMID:34689450; Original text:In the participants' gingival crevicular fluid samples, interleukin-1β, resistin, and adiponectin levels were higher in Group 1 (P< 0.05).|PMID:29574763; Original text:Clinical parameters, gingival crevicular fluid volumes and the concentrations of interleukin-1β and interleukin-1ra in gingival crevicular fluid were measured at baseline and 1, 3 and 6 months after the treatments.|PMID:26932392; Original text:Meta-analysis showed that low-level laser therapy-mediated root planing demonstrated significant short-term benefits over root planing monotherapy in the improvement of the probing pocket depth (p = 0.0009 at 1 mo; p = 0.03 at 2 mo) and the level of interleukin-1β in the gingival crevicular fluid (p = 0.01 at 1 mo).|PMID:22835005; Original text:Periodontal therapy significantly reduced the levels of interleukin-1β and interleukin-8 in gingival crevicular fluid (p < 0.001).|PMID:20860592; Original text:The test sites showed a greater reduction of interleukin-1β levels in gingival crevicular fluid at 1 wk than the control sites (p < 0.05).|PMID:22288485; Original text:Analysis of Tannerella forsythia and Pg amounts, as well as interleukin-10 and interleukin-1β gingival crevicular fluid concentrations failed to demonstrate a difference between the groups (P >0.05).|PMID:29577710; Original text:In all the samples at baseline, the interleukin-1β concentration in gingival crevicular fluid and BOP rate were significantly higher at deep the periodontal pocket depth sites than at the shallow ones."},{"Node1":"adiponectin, C1Q and collagen domain containing S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"34689450","Original_Text":"PMID:34689450; Original text:In the participants' gingival crevicular fluid samples, interleukin-1β, resistin, and adiponectin levels were higher in Group 1 (P< 0.05)."},{"Node1":"adiponectin, C1Q and collagen domain containing S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"34689450","Original_Text":"PMID:34689450; Original text:In the participants' gingival crevicular fluid samples, interleukin-1β, resistin, and adiponectin levels were higher in Group 1 (P< 0.05)."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_mechanism","Node2":"matrix metallopeptidase 8","Weight":3,"Paper_List":"20370419|22621750|15025222","Original_Text":"PMID:20370419; Original text:Between groups there was a statistically significant decrease in PD, gingival index, and GCF levels of matrix metalloproteinase-8 favoring the group receiving subantimicrobial dose doxycycline adjunctive to root planing|PMID:22621750; Original text:crevicular fluid matrix metalloproteinase-8 levels were significantly reduced only in root planing + short-term adjunctive subantimicrobial dose doxycycline group (P < 0.01).|PMID:15025222; Original text:The gingival crevicular fluid MMP-8 level in the a low-dose doxycycline group was significantly lower than that of the placebo group at 6 months (P < 0.05)."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_anatomy","Node2":"Gingiva","Weight":17,"Paper_List":"20370419|17590156|15025222|15025222|18315429|18315429|18315429|25316464|18412719|11168739|11168739|18672990|20932155|15562917|15562917|15562917|15562917","Original_Text":"PMID:20370419; Original text:Between groups there was a statistically significant decrease in PD, gingival index, and GCF levels of matrix metalloproteinase-8 favoring the group receiving subantimicrobial dose doxycycline adjunctive to root planing|PMID:17590156; Original text:Between groups, there were statistically significant greater improvements in pocket depth (pocket depth), gingival index (gingival index), APO-A and high-density lipoprotein, favouring the group receiving sub-antimicrobial dose doxycycline adjunctive to root planing (p < 0.05).|PMID:15025222; Original text:The a low-dose doxycycline group showed a significantly greater reduction in mean PD scores at 9 and 12 months and in mean gingival index scores at all time points than the placebo group (P < 0.05).|PMID:15025222; Original text:The gingival crevicular fluid MMP-8 level in the a low-dose doxycycline group was significantly lower than that of the placebo group at 6 months (P < 0.05).|PMID:18315429; Original text:The subantimicrobial dose doxycycline group showed a significantly greater reduction in mean PD scores at 6 months and in mean gingival index scores at 3 and 6 months than the placebo group (P <0.05).|PMID:18315429; Original text:From baseline to 6 months, the gingival crevicular fluid extracellular matrix metalloproteinase inducer levels were reduced significantly in the subantimicrobial dose doxycycline group (P <0.025).|PMID:18315429; Original text:The gingival crevicular fluid extracellular matrix metalloproteinase inducer level in the subantimicrobial dose doxycycline group was significantly lower than that of the placebo group at 3 and 6 months (P <0.05).|PMID:25316464; Original text:The the treatment group showed a significant improvement in gingival index scores compared with the control group (p&lt;0.05) by the end of the first and 6 months after the administration of doxycycline.|PMID:18412719; Original text:gingival crevicular fluid TGF-beta(1) levels of 3-month adjunctive subantimicrobial dose doxycycline group was significantly higher than baseline (P < 0.0125) and placebo group (P < 0.017) at 3 months.|PMID:11168739; Original text:Previous clinical studies have shown that doxycycline administered orally, at doses below those needed for antimicrobial efficacy, to human subjects with adult periodontitis resulted in significantly reduced collagenase activity in gingival crevicular fluid (gingival crevicular fluid) and in extracts of inflamed gingival tissues.|PMID:11168739; Original text:From baseline to week 12 (part I), treatment with specially formulated subantimicrobial dose doxycycline capsules (20 mg) 2x daily (1 x every 12 h) for up to 12 weeks was shown to significantly reduce gingival crevicular fluid collagenase activity and to improve periodontal attachment, effects not seen in patients treated with placebo.|PMID:18672990; Original text:ICTP showed a similar pattern of change during a 2-year subantimicrobial-dose doxycycline treatment, and the gingival crevicular fluid collagenase activity and ICTP were positively correlated at all time periods (P<0.001).|PMID:20932155; Original text:Significant improvements were observed in all clinical parameters in both groups over 12 months (P <0.0125), whereas the adjunctive subantimicrobial-dose doxycycline group showed significantly better reduction in gingival index, probing depth, and gain in clinical attachment compared to the placebo group (P <0.05).|PMID:15562917; Original text:Low-dose doxycycline group showed a significantly greater reduction in the mean PD scores at 9 and 12 months and in the mean gingival index scores at all time points than the placebo group (P < 0.05).|PMID:15562917; Original text:In the Low-dose doxycycline group, gingival crevicular fluid Laminin-5 gamma2 chain fragment levels were significantly reduced at 3 months (P < 0.0125) and then slightly increased during the rest of the study period.|PMID:15562917; Original text:gingival crevicular fluid Laminin-5 gamma2 chain fragment levels in Low-dose doxycycline group were significantly lower than those of the placebo group during the study period (P < 0.05).|PMID:15562917; Original text:The present data indicate that Low-dose doxycycline therapy in combination with root planing therapy can reduce gingival crevicular fluid Laminin-5 gamma2 chain fragment levels and improve clinical periodontal parameters in patients with chronic periodontitis."},{"Node1":"matrix metallopeptidase 8","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":6,"Paper_List":"20370419|21614479|11846190|15025222|18062117|18062117","Original_Text":"PMID:20370419; Original text:Between groups there was a statistically significant decrease in PD, gingival index, and GCF levels of matrix metalloproteinase-8 favoring the group receiving subantimicrobial dose doxycycline adjunctive to root planing|PMID:21614479; Original text:Although levels of IL-1β and MMP-8 in gingival crevicular fluid after treatment were lower in the test side than the control side, there was not a statistically significant difference (p > 0.05).|PMID:11846190; Original text:The gingival crevicular fluid MMP-8 level on day 10 in the meloxicam group was similar to the clinically healthy control group (P>0.05), while it was significantly higher in the placebo group (P<0.01).|PMID:15025222; Original text:The gingival crevicular fluid MMP-8 level in the a low-dose doxycycline group was significantly lower than that of the placebo group at 6 months (P < 0.05).|PMID:18062117; Original text:In all groups, the reduction of gingival crevicular fluid matrix metalloproteinase-8 levels after therapy was statistically significant compared to baseline levels (P < 0.001).|PMID:18062117; Original text:When groups 1 and 3 and 2 and 4 were compared according to gingival crevicular fluid matrix metalloproteinase-8 levels after the therapy, no statistically significant differences were observed (P = 0.117 and P = 0.485, respectively)."},{"Node1":"collagenase 3-like","Edge_Type":"mechanism","Node2":"high","Weight":2,"Paper_List":"20370419|17590156","Original_Text":"PMID:20370419; Original text:Statistically significant differences in plaque index, gingival index (gingival index), probing depth (PD), GCF volumes, GCF matrix metalloproteinase levels, and serum levels of high-sensitivity C-reactive protein between pre-treatment and post-treatment were noted in both groups.|PMID:17590156; Original text:There were statistically significant improvements for all clinical parameters, GCF volumes, GCF matrix metalloproteinases and serum levels of high-sensitivity C-reactive protein, apolipoprotein-A (APO-A), high-density lipoprotein (high-density lipoprotein) and lipoprotein-a between pre- and post-treatment in both groups."},{"Node1":"high","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":3,"Paper_List":"20370419|17590156|24970858","Original_Text":"PMID:20370419; Original text:Statistically significant differences in plaque index, gingival index (gingival index), probing depth (PD), GCF volumes, GCF matrix metalloproteinase levels, and serum levels of high-sensitivity C-reactive protein between pre-treatment and post-treatment were noted in both groups.|PMID:17590156; Original text:Between groups, there were statistically significant greater improvements in pocket depth (pocket depth), gingival index (gingival index), APO-A and high-density lipoprotein, favouring the group receiving sub-antimicrobial dose doxycycline adjunctive to root planing (p < 0.05).|PMID:24970858; Original text:Significant adjusted differences were found between docosahexaenoic acid and control for both gingival crevicular fluid high-sensitivity C-reactive protein (-5.3 ng/mL, standard error [SE] = 2.4, p = .03) and IL-1β (-20.1 pg/mL, SE = 8.2, p = .02) but not IL-6 (0.02 pg/mL, SE = 0.71, p = .98) or systemic high-sensitivity C-reactive protein (-1.19 mg/L, SE = 0.90, p = .20)."},{"Node1":"collagenase 3-like","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"20370419","Original_Text":"PMID:20370419; Original text:Statistically significant differences in plaque index, gingival index (gingival index), probing depth (PD), GCF volumes, GCF matrix metalloproteinase levels, and serum levels of high-sensitivity C-reactive protein between pre-treatment and post-treatment were noted in both groups."},{"Node1":"Gingiva","Edge_Type":"anatomy","Node2":"Heterografts","Weight":1,"Paper_List":"11990445","Original_Text":"PMID:11990445; Original text:The most significant results were that gingival recession was greater for the group treated with derivative alone (0.8 +/- 0.8 mm) compared to derivative + a bovine-derived xenograft (0.3 +/- 0.6 mm)"},{"Node1":"Bone and Bones","Edge_Type":"anatomy","Node2":"Heterografts","Weight":2,"Paper_List":"11990445|22177808","Original_Text":"PMID:11990445; Original text:(P = 0.04) and bone fill was greater for derivative + a bovine-derived xenograft (4.0 +/- 0.8 mm) compared to derivative alone (3.1 +/- 1.0 mm)|PMID:22177808; Original text:Grafting of osseous defects distal to mandibular second molars with an anorganic xenograft plus a membrane predictably resulted in a significant reduction in the probing pocket depth, clinical attachment level gain, and bone fill, which suggests that grafting the extraction sites with an anorganic xenograft plus a membrane could prevent periodontal disease in the future."},{"Node1":"Androgen-Insensitivity Syndrome","Edge_Type":"disease_to_anatomy","Node2":"Mandible","Weight":1,"Paper_List":"14696659","Original_Text":"PMID:14696659; Original text:The 2 systems did not show statistically significant differences in occurrences of postprosthetic postprosthetic integration deficiency and functional deficiency; 5-year occurrence-free postprosthetic system lifetime probabilities were estimated as 42.5% with mandibular overdentures-2 intramobile cylinder and 42.8% with TPS, for postprosthetic integration deficiency; and as 82.6% with mandibular overdentures-2 intramobile cylinder and 87.2% with TPS, for functional deficiency."},{"Node1":"Arthritis, Rheumatoid","Edge_Type":"disease_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"34246253","Original_Text":"PMID:34246253; Original text:As the primary results, the change of PD was not statistically significant and in the secondary results changes of plaque index, gingival index, attachment loss and BOP were also not statistically significant in rheumatoid arthritis patients with periodontitis compared to non-rheumatoid arthritis periodontitis patients."},{"Node1":"Azithromycin","Edge_Type":"chemical_to_disease","Node2":"Bacteremia","Weight":1,"Paper_List":"20572765","Original_Text":"PMID:20572765; Original text:Significant reduction of the incidence of bacteremia was shown in the azithromycin group only (P <0.01)."},{"Node1":"Glucose","Edge_Type":"chemical","Node2":"N(6)-carboxymethyllysine","Weight":2,"Paper_List":"27468795|27468795","Original_Text":"PMID:27468795; Original text:Likewise, plasma glucose and serum N€-(carboxymethyl) lysine levels were significantly reduced in the propolis group, but not in the placebo group.|PMID:27468795; Original text:A 6-month regimen of 400 mg propolis once daily is a potentially viable adjunct to root planing that significantly reduces levels of hemoglobinA1c, plasma glucose, and serum N€-(carboxymethyl) lysine, and improves periodontal therapy outcome in people with 2 diabetes mellitus and chronic periodontitis."},{"Node1":"N(6)-carboxymethyllysine","Edge_Type":"chemical_to_anatomy","Node2":"Plasma","Weight":2,"Paper_List":"27468795|27468795","Original_Text":"PMID:27468795; Original text:Likewise, plasma glucose and serum N€-(carboxymethyl) lysine levels were significantly reduced in the propolis group, but not in the placebo group.|PMID:27468795; Original text:A 6-month regimen of 400 mg propolis once daily is a potentially viable adjunct to root planing that significantly reduces levels of hemoglobinA1c, plasma glucose, and serum N€-(carboxymethyl) lysine, and improves periodontal therapy outcome in people with 2 diabetes mellitus and chronic periodontitis."},{"Node1":"Glucose","Edge_Type":"chemical_to_anatomy","Node2":"Plasma","Weight":4,"Paper_List":"27468795|27468795|16120115|21859323","Original_Text":"PMID:27468795; Original text:Likewise, plasma glucose and serum N€-(carboxymethyl) lysine levels were significantly reduced in the propolis group, but not in the placebo group.|PMID:27468795; Original text:A 6-month regimen of 400 mg propolis once daily is a potentially viable adjunct to root planing that significantly reduces levels of hemoglobinA1c, plasma glucose, and serum N€-(carboxymethyl) lysine, and improves periodontal therapy outcome in people with 2 diabetes mellitus and chronic periodontitis.|PMID:16120115; Original text:In the control group, no significant changes in clinical periodontal parameters, plasma glucose and glycated hemoglobin levels were observed, except for significant increase in attachment loss (P < 0.05).|PMID:21859323; Original text:Although glycated hemoglobin declined significantly in treatment group 2 (P <0.05), the intergroup difference for glycated hemoglobin, plasma glucose, TNF-α, and lipid profiles was not statistically significant after therapy (P >0.05)."},{"Node1":"Chronic Periodontitis","Edge_Type":"disease","Node2":"Diabetes Mellitus","Weight":1,"Paper_List":"27468795","Original_Text":"PMID:27468795; Original text:A 6-month regimen of 400 mg propolis once daily is a potentially viable adjunct to root planing that significantly reduces levels of hemoglobinA1c, plasma glucose, and serum N€-(carboxymethyl) lysine, and improves periodontal therapy outcome in people with 2 diabetes mellitus and chronic periodontitis."},{"Node1":"N(6)-carboxymethyllysine","Edge_Type":"chemical_to_disease","Node2":"Diabetes Mellitus","Weight":1,"Paper_List":"27468795","Original_Text":"PMID:27468795; Original text:A 6-month regimen of 400 mg propolis once daily is a potentially viable adjunct to root planing that significantly reduces levels of hemoglobinA1c, plasma glucose, and serum N€-(carboxymethyl) lysine, and improves periodontal therapy outcome in people with 2 diabetes mellitus and chronic periodontitis."},{"Node1":"N(6)-carboxymethyllysine","Edge_Type":"chemical_to_disease","Node2":"Chronic Periodontitis","Weight":1,"Paper_List":"27468795","Original_Text":"PMID:27468795; Original text:A 6-month regimen of 400 mg propolis once daily is a potentially viable adjunct to root planing that significantly reduces levels of hemoglobinA1c, plasma glucose, and serum N€-(carboxymethyl) lysine, and improves periodontal therapy outcome in people with 2 diabetes mellitus and chronic periodontitis."},{"Node1":"Glucose","Edge_Type":"chemical_to_disease","Node2":"Diabetes Mellitus","Weight":2,"Paper_List":"27468795|24934646","Original_Text":"PMID:27468795; Original text:A 6-month regimen of 400 mg propolis once daily is a potentially viable adjunct to root planing that significantly reduces levels of hemoglobinA1c, plasma glucose, and serum N€-(carboxymethyl) lysine, and improves periodontal therapy outcome in people with 2 diabetes mellitus and chronic periodontitis.|PMID:24934646; Original text:Participants were assessed at baseline and 3 month follow up for glycosylated hemoglobin (significantly lower glycosylated hemoglobin), fasting plasma glucose (plasma glucose), body mass index (Bmotivational interviewing), periodontal status, knowledge, attitude and practice of oral health and diabetes mellitus."},{"Node1":"Glucose","Edge_Type":"chemical_to_disease","Node2":"Chronic Periodontitis","Weight":1,"Paper_List":"27468795","Original_Text":"PMID:27468795; Original text:A 6-month regimen of 400 mg propolis once daily is a potentially viable adjunct to root planing that significantly reduces levels of hemoglobinA1c, plasma glucose, and serum N€-(carboxymethyl) lysine, and improves periodontal therapy outcome in people with 2 diabetes mellitus and chronic periodontitis."},{"Node1":"N(6)-carboxymethyllysine","Edge_Type":"chemical_to_mechanism","Node2":"Hemoglobin","Weight":1,"Paper_List":"27468795","Original_Text":"PMID:27468795; Original text:A 6-month regimen of 400 mg propolis once daily is a potentially viable adjunct to root planing that significantly reduces levels of hemoglobinA1c, plasma glucose, and serum N€-(carboxymethyl) lysine, and improves periodontal therapy outcome in people with 2 diabetes mellitus and chronic periodontitis."},{"Node1":"Glucose","Edge_Type":"chemical_to_mechanism","Node2":"Hemoglobin","Weight":5,"Paper_List":"27468795|16120115|16120115|21859323|34197339","Original_Text":"PMID:27468795; Original text:A 6-month regimen of 400 mg propolis once daily is a potentially viable adjunct to root planing that significantly reduces levels of hemoglobinA1c, plasma glucose, and serum N€-(carboxymethyl) lysine, and improves periodontal therapy outcome in people with 2 diabetes mellitus and chronic periodontitis.|PMID:16120115; Original text:Clinical periodontal parameters, fasting plasma glucose (plasma glucose), and glycated hemoglobin levels were measures at baseline and 3 months.|PMID:16120115; Original text:In the control group, no significant changes in clinical periodontal parameters, plasma glucose and glycated hemoglobin levels were observed, except for significant increase in attachment loss (P < 0.05).|PMID:21859323; Original text:Although glycated hemoglobin declined significantly in treatment group 2 (P <0.05), the intergroup difference for glycated hemoglobin, plasma glucose, TNF-α, and lipid profiles was not statistically significant after therapy (P >0.05).|PMID:34197339; Original text:Both groups showed significant clinical and laboratory improvements during the study from baseline to 1 year with reductions in total cholesterol (total cholesterol), triglycerides, glucose, glycated hemoglobin (glycated hemoglobin), uric acid and C-reactive protein (uric acid and C-reactive protein)."},{"Node1":"Diabetes Mellitus","Edge_Type":"disease_to_mechanism","Node2":"Hemoglobin","Weight":1,"Paper_List":"27468795","Original_Text":"PMID:27468795; Original text:A 6-month regimen of 400 mg propolis once daily is a potentially viable adjunct to root planing that significantly reduces levels of hemoglobinA1c, plasma glucose, and serum N€-(carboxymethyl) lysine, and improves periodontal therapy outcome in people with 2 diabetes mellitus and chronic periodontitis."},{"Node1":"Chronic Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"Hemoglobin","Weight":1,"Paper_List":"27468795","Original_Text":"PMID:27468795; Original text:A 6-month regimen of 400 mg propolis once daily is a potentially viable adjunct to root planing that significantly reduces levels of hemoglobinA1c, plasma glucose, and serum N€-(carboxymethyl) lysine, and improves periodontal therapy outcome in people with 2 diabetes mellitus and chronic periodontitis."},{"Node1":"Arthritis, Rheumatoid","Edge_Type":"disease_to_anatomy","Node2":"Salivary Glands","Weight":2,"Paper_List":"29683364|29683364","Original_Text":"PMID:29683364; Original text:Serum salivary and serum matrix metalloproteinase-8 (p < .001; p < .001) and interleukin-6 (p < .001; p = .002) were significantly higher in Crheumatoid arthritis vs. other study groups during the study.|PMID:29683364; Original text:Salivary salivary and serum matrix metalloproteinase-8 (p = .010) and interleukin-6 (p = .010) were significantly higher in Erheumatoid arthritis vs. other study groups at baseline."},{"Node1":"Bacteremia","Edge_Type":"disease_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"22092606","Original_Text":"PMID:22092606; Original text:None of five studies on bacteraemia following dental flossing and chewing revealed a statistically significant association between oral hygiene, gingival or periodontal status and the development of bacteraemia."},{"Node1":"Hemoglobin","Edge_Type":"mechanism_to_anatomy","Node2":"Plasma","Weight":3,"Paper_List":"27468795|16120115|21859323","Original_Text":"PMID:27468795; Original text:A 6-month regimen of 400 mg propolis once daily is a potentially viable adjunct to root planing that significantly reduces levels of hemoglobinA1c, plasma glucose, and serum N€-(carboxymethyl) lysine, and improves periodontal therapy outcome in people with 2 diabetes mellitus and chronic periodontitis.|PMID:16120115; Original text:In the control group, no significant changes in clinical periodontal parameters, plasma glucose and glycated hemoglobin levels were observed, except for significant increase in attachment loss (P < 0.05).|PMID:21859323; Original text:Although glycated hemoglobin declined significantly in treatment group 2 (P <0.05), the intergroup difference for glycated hemoglobin, plasma glucose, TNF-α, and lipid profiles was not statistically significant after therapy (P >0.05)."},{"Node1":"Bacteremia","Edge_Type":"disease_to_anatomy","Node2":"Stem Cells","Weight":1,"Paper_List":"25950231","Original_Text":"PMID:25950231; Original text:With an average of 3.0 [1; 5] colony forming units, significantly less bacteria and bacteraemia were found in the test group compared to the controls (12.2 [1; 46]) (p = 0.003)."},{"Node1":"Fluorides","Edge_Type":"chemical","Node2":"Triclosan","Weight":1,"Paper_List":"15002887","Original_Text":"PMID:15002887; Original text:Subjects using the triclosan/copolymer/fluoride dentifrice exhibited significantly improved oral hygiene conditions, gingival health, and periodontal status compared with those using the standard fluoride dentifrice over the 24-month maintenance interval."},{"Node1":"Fluorides","Edge_Type":"chemical_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"15002887","Original_Text":"PMID:15002887; Original text:Subjects using the triclosan/copolymer/fluoride dentifrice exhibited significantly improved oral hygiene conditions, gingival health, and periodontal status compared with those using the standard fluoride dentifrice over the 24-month maintenance interval."},{"Node1":"Triclosan","Edge_Type":"chemical_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"15002887","Original_Text":"PMID:15002887; Original text:Subjects using the triclosan/copolymer/fluoride dentifrice exhibited significantly improved oral hygiene conditions, gingival health, and periodontal status compared with those using the standard fluoride dentifrice over the 24-month maintenance interval."},{"Node1":"Doxycycline","Edge_Type":"chemical","Node2":"Elyzol Dentalgel","Weight":1,"Paper_List":"12296782","Original_Text":"PMID:12296782; Original text:Furthermore, when sites treated with Atridox were compared with sites treated with Elyzol, a significant difference in mean PAL gain (0.3 mm) was observed."},{"Node1":"Aggregatibacter Actinomycetemcomitans","Edge_Type":"bacteria","Node2":"Porphyromonas Gingivalis (Organism)","Weight":5,"Paper_List":"34545592|23705535|32865464|29327449|30207437","Original_Text":"PMID:34545592; Original text:Most studies (61%) reported that the serum IgG antibody responses were elevated in coronary heart disease patients than in controls.|PMID:23705535; Original text:These subjects also showed significant reductions in the number of certain periodontopathogens, such as Tannerella forsythia, Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans.|PMID:32865464; Original text: mm after 12 months of follow-up.|PMID:29327449; Original text:Evaluation using clinical parameters showed better results in low-level laser therapy group.|PMID:30207437; Original text:Among the microrganisms evaluated Porphyromonas gengivalis (OR [95% CI] 2.93"},{"Node1":"Porphyromonas Gingivalis (Organism)","Edge_Type":"bacteria_to_disease","Node2":"Coronary Disease","Weight":1,"Paper_List":"34545592","Original_Text":"PMID:34545592; Original text:Most studies (61%) reported that the serum IgG antibody responses were elevated in coronary heart disease patients than in controls."},{"Node1":"Aggregatibacter Actinomycetemcomitans","Edge_Type":"bacteria_to_disease","Node2":"Coronary Disease","Weight":1,"Paper_List":"34545592","Original_Text":"PMID:34545592; Original text:Most studies (61%) reported that the serum IgG antibody responses were elevated in coronary heart disease patients than in controls."},{"Node1":"Porphyromonas Gingivalis (Organism)","Edge_Type":"bacteria_to_mechanism","Node2":"immunoglobulin heavy chain (S107 family)","Weight":2,"Paper_List":"34545592|17470016","Original_Text":"PMID:34545592; Original text:Most studies (61%) reported that the serum IgG antibody responses were elevated in coronary heart disease patients than in controls.|PMID:17470016; Original text:Maternal anti-Porphyromonas gingivalis IgG was significantly lower in the preterm group compared to the term group (P = 0.028)."},{"Node1":"Aggregatibacter Actinomycetemcomitans","Edge_Type":"bacteria_to_mechanism","Node2":"immunoglobulin heavy chain (S107 family)","Weight":1,"Paper_List":"34545592","Original_Text":"PMID:34545592; Original text:Most studies (61%) reported that the serum IgG antibody responses were elevated in coronary heart disease patients than in controls."},{"Node1":"Porphyromonas Gingivalis (Organism)","Edge_Type":"bacteria_to_antibody","Node2":"Anti-immunoglobulin kappa chain variable 9-120","Weight":1,"Paper_List":"34545592","Original_Text":"PMID:34545592; Original text:Most studies (61%) reported that the serum IgG antibody responses were elevated in coronary heart disease patients than in controls."},{"Node1":"Aggregatibacter Actinomycetemcomitans","Edge_Type":"bacteria_to_antibody","Node2":"Anti-immunoglobulin kappa chain variable 9-120","Weight":1,"Paper_List":"34545592","Original_Text":"PMID:34545592; Original text:Most studies (61%) reported that the serum IgG antibody responses were elevated in coronary heart disease patients than in controls."},{"Node1":"Coronary Disease","Edge_Type":"disease_to_mechanism","Node2":"immunoglobulin heavy chain (S107 family)","Weight":1,"Paper_List":"34545592","Original_Text":"PMID:34545592; Original text:Most studies (61%) reported that the serum IgG antibody responses were elevated in coronary heart disease patients than in controls."},{"Node1":"Coronary Disease","Edge_Type":"disease_to_antibody","Node2":"Anti-immunoglobulin kappa chain variable 9-120","Weight":1,"Paper_List":"34545592","Original_Text":"PMID:34545592; Original text:Most studies (61%) reported that the serum IgG antibody responses were elevated in coronary heart disease patients than in controls."},{"Node1":"immunoglobulin heavy chain (S107 family)","Edge_Type":"mechanism_to_antibody","Node2":"Anti-immunoglobulin kappa chain variable 9-120","Weight":1,"Paper_List":"34545592","Original_Text":"PMID:34545592; Original text:Most studies (61%) reported that the serum IgG antibody responses were elevated in coronary heart disease patients than in controls."},{"Node1":"Ketorolac","Edge_Type":"chemical_to_disease","Node2":"Pain","Weight":1,"Paper_List":"21419286","Original_Text":"PMID:21419286; Original text:IN ketorolac alone or with endodontic treatment showed significantly better pain relief compared with IN placebo spray alone or with endodontic treatment at 30 minutes after the first or second intranasal dose and at 4 hours after the first intranasal dose (P = .03)."},{"Node1":"Periodontitis","Edge_Type":"disease","Node2":"Renal Insufficiency, Chronic","Weight":1,"Paper_List":"29777531","Original_Text":"PMID:29777531; Original text:Most of them investigated a non-directional association of periodontitis with chronic kidney disease, including 7 case-control studies and 38 cross-sectional studies; 24 studies had statistical analysis on the non-directional association and 75% of them reported significant results, which were supported further by the meta-analysis (random: odds ratio ="},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"polyphemus","Weight":6,"Paper_List":"23527212|29514641|29514641|32831974|31577700|30647799","Original_Text":"PMID:23527212; Original text:The pooled results showed significant association between periodontitis susceptibility and MMP-1 g.-1607dupG polymorphism in homozygote (2G/2G versus 1G/1G, Odds ratio = 1.50, 95%|PMID:29514641; Original text:In the total analyses, COX2 -765G/C polymorphism had nonsignificant association on periodontitis risk in all models.|PMID:29514641; Original text:This meta-analysis indicated that COX2 -765G/C polymorphism had significantly affect on periodontitis risk among Chinese individuals, which should be confirmed by other ethnic groups.|PMID:32831974; Original text:Significant association was found between periodontitis and TLR-2 rs1898830 polymorphism under the allelic model (A allele vs. G allele: p = 0.014, OR = 1.208, 95% CI: 1.039-1.406), recessive model (GG vs. GA+AA: p = 0.028, OR = 0.755, 95% CI: 0.588-0.970), and codominant model (GG VS.|PMID:31577700; Original text:The overall analyses verified that the IL-10 rs1800872 polymorphism was significantly associated with an increased risk of periodontitis in the allelic model, homozygote model, dominant model, and recessive model (A vs C: An odds ratio = 1.28, 95%a 95% confidence interval = 1.11-1.49, P = .00, I = 56.87%; AA vs CC: An odds ratio = 2.06, 95%a 95% confidence interval = 1.32-3.23, P = .00, I = 73.3%; AA + AC vs CC: An odds ratio = 1.42, 95%a 95% confidence interval = 1.03-1.96, P = .03, I = 76.2%; AA vs AC + CC: An odds ratio = 1.78, 95%a 95% confidence interval = 1.26-2.56, P = .00, I = 76.7%).|PMID:30647799; Original text:The subgroup analysis stratified by ethnicity showed a weak association between the IL-1β polymorphism (IL-1β polymorphism) and chronic periodontitis in the Caucasian population (recessive model, OR = 1.34, 95% CI = 1.017-1.758, P = 0.037)."},{"Node1":"Prevotella Intermedia","Edge_Type":"bacteria","Node2":"Treponema Denticola (Organism)","Weight":6,"Paper_List":"31111123|15642054|24617449|29327449|26313005|26313005","Original_Text":"PMID:31111123; Original text:However, the use of InGaAsP followed by subgingival debridement and the adjunctive use of an Er,Cr:YSGG laser, yielded statistically significantly higher clinical (PD, CAL, bleeding on probing, number of sites with PD ≥ 5 mm, PD ≥ 6 mm, PD ≥ 7 mm) and microbiologic (Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia, Prevotella intermedia, Peptostreptococcus micros, Fusobacterium nucleatum) improvements (P < .05) compared to subgingival debridement alone.|PMID:15642054; Original text:The levels of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Tannerella forsythensis (Bacteroides forsythus) remained unchanged in untreated sites while levels of Prevetolla intermedia and Treponema denticola tended to decrease as compared with controls but did not reach significance.|PMID:24617449; Original text:A statistically significant improvement in gingival index and gingival bleeding index was seen for the test group after 2 weeks and 1 month of antimicrobial photodynamic therapy (p < 0.01), whereas the improvement in gingival index and gingival bleeding index at 3 months and in plaque index at 2 weeks after antimicrobial photodynamic therapy was less (p < 0.05).|PMID:29327449; Original text:Evaluation using clinical parameters showed better results in low-level laser therapy group.|PMID:26313005; Original text:The mere presence of Pg, even in low amount, was significantly associated with severe periodontitis, while the amount of Aggregatibacter actinomycetemcomitans, Treponema denticola, and Prevotella intermedia had to reach the critical thresholds to be significantly associated with disease.|PMID:26313005; Original text:Compared to individuals with low levels of both Treponema denticola and Prevotella intermedia, high colonization by either Treponema denticola or Prevotella intermedia alone significantly increased the odds of having severe periodontitis by 2.5 (95%CI 1.7-3.5) folds."},{"Node1":"Fusobacterium Nucleatum","Edge_Type":"bacteria","Node2":"Treponema Denticola (Organism)","Weight":1,"Paper_List":"31111123","Original_Text":"PMID:31111123; Original text:However, the use of InGaAsP followed by subgingival debridement and the adjunctive use of an Er,Cr:YSGG laser, yielded statistically significantly higher clinical (PD, CAL, bleeding on probing, number of sites with PD ≥ 5 mm, PD ≥ 6 mm, PD ≥ 7 mm) and microbiologic (Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia, Prevotella intermedia, Peptostreptococcus micros, Fusobacterium nucleatum) improvements (P < .05) compared to subgingival debridement alone."},{"Node1":"Porphyromonas Gingivalis (Organism)","Edge_Type":"bacteria","Node2":"Treponema Denticola (Organism)","Weight":10,"Paper_List":"31111123|19207889|23121460|15642054|24617449|18302679|22105837|29327449|18727657|29589156","Original_Text":"PMID:31111123; Original text:However, the use of InGaAsP followed by subgingival debridement and the adjunctive use of an Er,Cr:YSGG laser, yielded statistically significantly higher clinical (PD, CAL, bleeding on probing, number of sites with PD ≥ 5 mm, PD ≥ 6 mm, PD ≥ 7 mm) and microbiologic (Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia, Prevotella intermedia, Peptostreptococcus micros, Fusobacterium nucleatum) improvements (P < .05) compared to subgingival debridement alone.|PMID:19207889; Original text:Three months after treatment, a numerical decrease was observed for P. gingivalis, T. forsythia and T. denticola in both groups, which was statistically significant only for P. gingivalis (p<0.05).|PMID:23121460; Original text:For deep pockets (depth ≥7), reductions were similar in the boric acid irrigation and ) SRP + saline irrigationHX groups (P >0.05).|PMID:15642054; Original text:The levels of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Tannerella forsythensis (Bacteroides forsythus) remained unchanged in untreated sites while levels of Prevetolla intermedia and Treponema denticola tended to decrease as compared with controls but did not reach significance.|PMID:24617449; Original text:A statistically significant improvement in gingival index and gingival bleeding index was seen for the test group after 2 weeks and 1 month of antimicrobial photodynamic therapy (p < 0.01), whereas the improvement in gingival index and gingival bleeding index at 3 months and in plaque index at 2 weeks after antimicrobial photodynamic therapy was less (p < 0.05).|PMID:18302679; Original text:The counts and number of sites positive for P. gingivalis, T. forsythia and T. denticola significantly decreased in the test group after treatment, compared with those in the control group.|PMID:22105837; Original text:All three treatments resulted in a significant clinical improvement.|PMID:29327449; Original text:Evaluation using clinical parameters showed better results in low-level laser therapy group.|PMID:18727657; Original text:These subjects showed significant reductions in the mean counts and proportions of periodontal pathogens such as Tannerella forsythia, Porphyromonas gingivalis and Treponema denticola, and the greatest increase in proportions of host-compatible species.|PMID:29589156; Original text:At all time-points, levels of inflammatory markers in GCF were higher in arthritis-severe chronic periodontitis than in severe chronic periodontitis patients."},{"Node1":"Peptostreptococcus Micros (Organism)","Edge_Type":"bacteria","Node2":"Treponema Denticola (Organism)","Weight":1,"Paper_List":"31111123","Original_Text":"PMID:31111123; Original text:However, the use of InGaAsP followed by subgingival debridement and the adjunctive use of an Er,Cr:YSGG laser, yielded statistically significantly higher clinical (PD, CAL, bleeding on probing, number of sites with PD ≥ 5 mm, PD ≥ 6 mm, PD ≥ 7 mm) and microbiologic (Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia, Prevotella intermedia, Peptostreptococcus micros, Fusobacterium nucleatum) improvements (P < .05) compared to subgingival debridement alone."},{"Node1":"Tannerella Forsythia","Edge_Type":"bacteria","Node2":"Treponema Denticola (Organism)","Weight":11,"Paper_List":"31111123|19207889|19207889|23121460|22220822|18302679|25056413|26355881|22105837|18727657|29589156","Original_Text":"PMID:31111123; Original text:However, the use of InGaAsP followed by subgingival debridement and the adjunctive use of an Er,Cr:YSGG laser, yielded statistically significantly higher clinical (PD, CAL, bleeding on probing, number of sites with PD ≥ 5 mm, PD ≥ 6 mm, PD ≥ 7 mm) and microbiologic (Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia, Prevotella intermedia, Peptostreptococcus micros, Fusobacterium nucleatum) improvements (P < .05) compared to subgingival debridement alone.|PMID:19207889; Original text:Three months after treatment, a numerical decrease was observed for P. gingivalis, T. forsythia and T. denticola in both groups, which was statistically significant only for P. gingivalis (p<0.05).|PMID:19207889; Original text:Inter-group differences were observed at 6 months for T. forsythia and T. denticola (p<0.05), favouring root planing.|PMID:23121460; Original text:For deep pockets (depth ≥7), reductions were similar in the boric acid irrigation and ) SRP + saline irrigationHX groups (P >0.05).|PMID:22220822; Original text:The most beneficial changes were observed in the test group which showed significantly greater improvements in probing depth and clinical attachment level and a lower prevalence of Aggregatibacter actinomycetemcomitans, Treponema denticola, and Tannerella forsythia compared to the control one (p < 0.05).|PMID:18302679; Original text:The counts and number of sites positive for P. gingivalis, T. forsythia and T. denticola significantly decreased in the test group after treatment, compared with those in the control group.|PMID:25056413; Original text:However, it resulted in a higher reduction of BOP at 3 and 12 months comparing to US alone or hand instruments (antimicrobial photodynamic therapy from 25 to 13 and to 9%, US from 23 to 16 and to 12%, and hand instruments from 17 to 10 and to 9%, respectively).|PMID:26355881; Original text:At day 90, Baseline BOP, PD and Clinical attachment level reduction was higher in T (p<0.05).|PMID:22105837; Original text:All three treatments resulted in a significant clinical improvement.|PMID:18727657; Original text:These subjects showed significant reductions in the mean counts and proportions of periodontal pathogens such as Tannerella forsythia, Porphyromonas gingivalis and Treponema denticola, and the greatest increase in proportions of host-compatible species.|PMID:29589156; Original text:At all time-points, levels of inflammatory markers in GCF were higher in arthritis-severe chronic periodontitis than in severe chronic periodontitis patients."},{"Node1":"Fusobacterium Nucleatum","Edge_Type":"bacteria","Node2":"Prevotella Intermedia","Weight":3,"Paper_List":"31111123|20088984|23645178","Original_Text":"PMID:31111123; Original text:However, the use of InGaAsP followed by subgingival debridement and the adjunctive use of an Er,Cr:YSGG laser, yielded statistically significantly higher clinical (PD, CAL, bleeding on probing, number of sites with PD ≥ 5 mm, PD ≥ 6 mm, PD ≥ 7 mm) and microbiologic (Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia, Prevotella intermedia, Peptostreptococcus micros, Fusobacterium nucleatum) improvements (P < .05) compared to subgingival debridement alone.|PMID:20088984; Original text:The other clinical parameters did not show significant differences.|PMID:23645178; Original text:However, the bacterial loads of Fusobacterium nucleatum, Pg, and Prevotella intermedia were significantly reduced by root planing; the mean reduction of bacterial counts in saliva ranged from 52.2% to 62.5% (p<0.01), in supragingival plaque from 68.2% to 81.0% (p<0.05), and in subgingival plaque from 67.9% to 93.0% (p<0.01)."},{"Node1":"Porphyromonas Gingivalis (Organism)","Edge_Type":"bacteria","Node2":"Prevotella Intermedia","Weight":10,"Paper_List":"31111123|17470016|31292965|7853125|15642054|24617449|32865464|29327449|34145479|8396177","Original_Text":"PMID:31111123; Original text:However, the use of InGaAsP followed by subgingival debridement and the adjunctive use of an Er,Cr:YSGG laser, yielded statistically significantly higher clinical (PD, CAL, bleeding on probing, number of sites with PD ≥ 5 mm, PD ≥ 6 mm, PD ≥ 7 mm) and microbiologic (Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia, Prevotella intermedia, Peptostreptococcus micros, Fusobacterium nucleatum) improvements (P < .05) compared to subgingival debridement alone.|PMID:17470016; Original text:Postpartum, levels of P. gingivalis, Tannerella forsythia, Prevotella intermedia, and Prevotella nigrescens were statistically significantly higher in preterm births compared to term deliveries, adjusting for baseline levels.|PMID:31292965; Original text:Follow-up 6 weeks.|PMID:7853125; Original text:Abscess sites showed no P. gingivalis and the proportion of P. intermedia was significantly reduced 6 months after treatment.|PMID:15642054; Original text:The levels of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Tannerella forsythensis (Bacteroides forsythus) remained unchanged in untreated sites while levels of Prevetolla intermedia and Treponema denticola tended to decrease as compared with controls but did not reach significance.|PMID:24617449; Original text:A statistically significant improvement in gingival index and gingival bleeding index was seen for the test group after 2 weeks and 1 month of antimicrobial photodynamic therapy (p < 0.01), whereas the improvement in gingival index and gingival bleeding index at 3 months and in plaque index at 2 weeks after antimicrobial photodynamic therapy was less (p < 0.05).|PMID:32865464; Original text: mm after 12 months of follow-up.|PMID:29327449; Original text:Evaluation using clinical parameters showed better results in low-level laser therapy group.|PMID:34145479; Original text: mm; plaque index: 0.55 ± 0.23 vs. 0.73 ± 0.27) and 6-month follow-up (PD: 3.12 ± 0.63 vs. 4.0 ± 0.68 mm; plaque index: 0.49 ± 0.21 vs. 0.72 ± 0.28, respectively; P = 0.001 for PD and P = 0.021 for plaque index).|PMID:8396177; Original text:Subgingival minocycline ointment resulted in statistically significantly greater reduction of P. gingivalis at weeks 2, 4, 6, and 12; P. intermedia at weeks 2, 4, 6, and 12; and A. actinomycetemcomitans at weeks 6 and 12."},{"Node1":"Peptostreptococcus Micros (Organism)","Edge_Type":"bacteria","Node2":"Prevotella Intermedia","Weight":1,"Paper_List":"31111123","Original_Text":"PMID:31111123; Original text:However, the use of InGaAsP followed by subgingival debridement and the adjunctive use of an Er,Cr:YSGG laser, yielded statistically significantly higher clinical (PD, CAL, bleeding on probing, number of sites with PD ≥ 5 mm, PD ≥ 6 mm, PD ≥ 7 mm) and microbiologic (Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia, Prevotella intermedia, Peptostreptococcus micros, Fusobacterium nucleatum) improvements (P < .05) compared to subgingival debridement alone."},{"Node1":"Prevotella Intermedia","Edge_Type":"bacteria","Node2":"Tannerella Forsythia","Weight":4,"Paper_List":"31111123|17470016|32865464|17458082","Original_Text":"PMID:31111123; Original text:However, the use of InGaAsP followed by subgingival debridement and the adjunctive use of an Er,Cr:YSGG laser, yielded statistically significantly higher clinical (PD, CAL, bleeding on probing, number of sites with PD ≥ 5 mm, PD ≥ 6 mm, PD ≥ 7 mm) and microbiologic (Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia, Prevotella intermedia, Peptostreptococcus micros, Fusobacterium nucleatum) improvements (P < .05) compared to subgingival debridement alone.|PMID:17470016; Original text:Postpartum, levels of P. gingivalis, Tannerella forsythia, Prevotella intermedia, and Prevotella nigrescens were statistically significantly higher in preterm births compared to term deliveries, adjusting for baseline levels.|PMID:32865464; Original text: mm after 12 months of follow-up.|PMID:17458082; Original text:The mean pocket probing depth before treatment was 3.5 mm, which decreased significantly after treatment (3.2 mm)."},{"Node1":"Fusobacterium Nucleatum","Edge_Type":"bacteria","Node2":"Porphyromonas Gingivalis (Organism)","Weight":2,"Paper_List":"31111123|26932733","Original_Text":"PMID:31111123; Original text:However, the use of InGaAsP followed by subgingival debridement and the adjunctive use of an Er,Cr:YSGG laser, yielded statistically significantly higher clinical (PD, CAL, bleeding on probing, number of sites with PD ≥ 5 mm, PD ≥ 6 mm, PD ≥ 7 mm) and microbiologic (Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia, Prevotella intermedia, Peptostreptococcus micros, Fusobacterium nucleatum) improvements (P < .05) compared to subgingival debridement alone.|PMID:26932733; Original text:A significant difference in the geometric means for P. gingivalis (p = 0.01) was seen at years 1 and 4, and for F. nucleatum (p = 0.01) and in the total bacterial load (p = 0.03) at year 2; however, these differences were not statistically significant following a Bonferroni correction for multiple comparisons."},{"Node1":"Fusobacterium Nucleatum","Edge_Type":"bacteria","Node2":"Peptostreptococcus Micros (Organism)","Weight":1,"Paper_List":"31111123","Original_Text":"PMID:31111123; Original text:However, the use of InGaAsP followed by subgingival debridement and the adjunctive use of an Er,Cr:YSGG laser, yielded statistically significantly higher clinical (PD, CAL, bleeding on probing, number of sites with PD ≥ 5 mm, PD ≥ 6 mm, PD ≥ 7 mm) and microbiologic (Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia, Prevotella intermedia, Peptostreptococcus micros, Fusobacterium nucleatum) improvements (P < .05) compared to subgingival debridement alone."},{"Node1":"Fusobacterium Nucleatum","Edge_Type":"bacteria","Node2":"Tannerella Forsythia","Weight":1,"Paper_List":"31111123","Original_Text":"PMID:31111123; Original text:However, the use of InGaAsP followed by subgingival debridement and the adjunctive use of an Er,Cr:YSGG laser, yielded statistically significantly higher clinical (PD, CAL, bleeding on probing, number of sites with PD ≥ 5 mm, PD ≥ 6 mm, PD ≥ 7 mm) and microbiologic (Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia, Prevotella intermedia, Peptostreptococcus micros, Fusobacterium nucleatum) improvements (P < .05) compared to subgingival debridement alone."},{"Node1":"Peptostreptococcus Micros (Organism)","Edge_Type":"bacteria","Node2":"Porphyromonas Gingivalis (Organism)","Weight":1,"Paper_List":"31111123","Original_Text":"PMID:31111123; Original text:However, the use of InGaAsP followed by subgingival debridement and the adjunctive use of an Er,Cr:YSGG laser, yielded statistically significantly higher clinical (PD, CAL, bleeding on probing, number of sites with PD ≥ 5 mm, PD ≥ 6 mm, PD ≥ 7 mm) and microbiologic (Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia, Prevotella intermedia, Peptostreptococcus micros, Fusobacterium nucleatum) improvements (P < .05) compared to subgingival debridement alone."},{"Node1":"Porphyromonas Gingivalis (Organism)","Edge_Type":"bacteria","Node2":"Tannerella Forsythia","Weight":11,"Paper_List":"31111123|19207889|23121460|17470016|23705535|18302679|32865464|22105837|18727657|29589156|20214441","Original_Text":"PMID:31111123; Original text:However, the use of InGaAsP followed by subgingival debridement and the adjunctive use of an Er,Cr:YSGG laser, yielded statistically significantly higher clinical (PD, CAL, bleeding on probing, number of sites with PD ≥ 5 mm, PD ≥ 6 mm, PD ≥ 7 mm) and microbiologic (Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia, Prevotella intermedia, Peptostreptococcus micros, Fusobacterium nucleatum) improvements (P < .05) compared to subgingival debridement alone.|PMID:19207889; Original text:Three months after treatment, a numerical decrease was observed for P. gingivalis, T. forsythia and T. denticola in both groups, which was statistically significant only for P. gingivalis (p<0.05).|PMID:23121460; Original text:For deep pockets (depth ≥7), reductions were similar in the boric acid irrigation and ) SRP + saline irrigationHX groups (P >0.05).|PMID:17470016; Original text:Postpartum, levels of P. gingivalis, Tannerella forsythia, Prevotella intermedia, and Prevotella nigrescens were statistically significantly higher in preterm births compared to term deliveries, adjusting for baseline levels.|PMID:23705535; Original text:These subjects also showed significant reductions in the number of certain periodontopathogens, such as Tannerella forsythia, Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans.|PMID:18302679; Original text:The counts and number of sites positive for P. gingivalis, T. forsythia and T. denticola significantly decreased in the test group after treatment, compared with those in the control group.|PMID:32865464; Original text: mm after 12 months of follow-up.|PMID:22105837; Original text:All three treatments resulted in a significant clinical improvement.|PMID:18727657; Original text:These subjects showed significant reductions in the mean counts and proportions of periodontal pathogens such as Tannerella forsythia, Porphyromonas gingivalis and Treponema denticola, and the greatest increase in proportions of host-compatible species.|PMID:29589156; Original text:At all time-points, levels of inflammatory markers in GCF were higher in arthritis-severe chronic periodontitis than in severe chronic periodontitis patients.|PMID:20214441; Original text:P. gingivalis decreased significantly at 3 months (P <0.05), whereas T. forsythia was the only pathogen decreased below detection limits by the combination therapy with a significant difference compared to the control group (P <0.05)."},{"Node1":"Peptostreptococcus Micros (Organism)","Edge_Type":"bacteria","Node2":"Tannerella Forsythia","Weight":1,"Paper_List":"31111123","Original_Text":"PMID:31111123; Original text:However, the use of InGaAsP followed by subgingival debridement and the adjunctive use of an Er,Cr:YSGG laser, yielded statistically significantly higher clinical (PD, CAL, bleeding on probing, number of sites with PD ≥ 5 mm, PD ≥ 6 mm, PD ≥ 7 mm) and microbiologic (Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia, Prevotella intermedia, Peptostreptococcus micros, Fusobacterium nucleatum) improvements (P < .05) compared to subgingival debridement alone."},{"Node1":"Treponema Denticola (Organism)","Edge_Type":"bacteria_to_disease","Node2":"Hemorrhage","Weight":3,"Paper_List":"31111123|24617449|28321995","Original_Text":"PMID:31111123; Original text:However, the use of InGaAsP followed by subgingival debridement and the adjunctive use of an Er,Cr:YSGG laser, yielded statistically significantly higher clinical (PD, CAL, bleeding on probing, number of sites with PD ≥ 5 mm, PD ≥ 6 mm, PD ≥ 7 mm) and microbiologic (Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia, Prevotella intermedia, Peptostreptococcus micros, Fusobacterium nucleatum) improvements (P < .05) compared to subgingival debridement alone.|PMID:24617449; Original text:A statistically significant improvement in gingival index and gingival bleeding index was seen for the test group after 2 weeks and 1 month of antimicrobial photodynamic therapy (p < 0.01), whereas the improvement in gingival index and gingival bleeding index at 3 months and in plaque index at 2 weeks after antimicrobial photodynamic therapy was less (p < 0.05).|PMID:28321995; Original text:Clinical parameters, such as probing pocket depth, clinical attachment level, bleeding index, plaque index, and Treponema denticola, were significantly reduced in the MGA group compared to the placebo group from baseline to the third month."},{"Node1":"Prevotella Intermedia","Edge_Type":"bacteria_to_disease","Node2":"Hemorrhage","Weight":2,"Paper_List":"31111123|24617449","Original_Text":"PMID:31111123; Original text:However, the use of InGaAsP followed by subgingival debridement and the adjunctive use of an Er,Cr:YSGG laser, yielded statistically significantly higher clinical (PD, CAL, bleeding on probing, number of sites with PD ≥ 5 mm, PD ≥ 6 mm, PD ≥ 7 mm) and microbiologic (Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia, Prevotella intermedia, Peptostreptococcus micros, Fusobacterium nucleatum) improvements (P < .05) compared to subgingival debridement alone.|PMID:24617449; Original text:A statistically significant improvement in gingival index and gingival bleeding index was seen for the test group after 2 weeks and 1 month of antimicrobial photodynamic therapy (p < 0.01), whereas the improvement in gingival index and gingival bleeding index at 3 months and in plaque index at 2 weeks after antimicrobial photodynamic therapy was less (p < 0.05)."},{"Node1":"Fusobacterium Nucleatum","Edge_Type":"bacteria_to_disease","Node2":"Hemorrhage","Weight":1,"Paper_List":"31111123","Original_Text":"PMID:31111123; Original text:However, the use of InGaAsP followed by subgingival debridement and the adjunctive use of an Er,Cr:YSGG laser, yielded statistically significantly higher clinical (PD, CAL, bleeding on probing, number of sites with PD ≥ 5 mm, PD ≥ 6 mm, PD ≥ 7 mm) and microbiologic (Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia, Prevotella intermedia, Peptostreptococcus micros, Fusobacterium nucleatum) improvements (P < .05) compared to subgingival debridement alone."},{"Node1":"Porphyromonas Gingivalis (Organism)","Edge_Type":"bacteria_to_disease","Node2":"Hemorrhage","Weight":2,"Paper_List":"31111123|24617449","Original_Text":"PMID:31111123; Original text:However, the use of InGaAsP followed by subgingival debridement and the adjunctive use of an Er,Cr:YSGG laser, yielded statistically significantly higher clinical (PD, CAL, bleeding on probing, number of sites with PD ≥ 5 mm, PD ≥ 6 mm, PD ≥ 7 mm) and microbiologic (Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia, Prevotella intermedia, Peptostreptococcus micros, Fusobacterium nucleatum) improvements (P < .05) compared to subgingival debridement alone.|PMID:24617449; Original text:A statistically significant improvement in gingival index and gingival bleeding index was seen for the test group after 2 weeks and 1 month of antimicrobial photodynamic therapy (p < 0.01), whereas the improvement in gingival index and gingival bleeding index at 3 months and in plaque index at 2 weeks after antimicrobial photodynamic therapy was less (p < 0.05)."},{"Node1":"Peptostreptococcus Micros (Organism)","Edge_Type":"bacteria_to_disease","Node2":"Hemorrhage","Weight":1,"Paper_List":"31111123","Original_Text":"PMID:31111123; Original text:However, the use of InGaAsP followed by subgingival debridement and the adjunctive use of an Er,Cr:YSGG laser, yielded statistically significantly higher clinical (PD, CAL, bleeding on probing, number of sites with PD ≥ 5 mm, PD ≥ 6 mm, PD ≥ 7 mm) and microbiologic (Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia, Prevotella intermedia, Peptostreptococcus micros, Fusobacterium nucleatum) improvements (P < .05) compared to subgingival debridement alone."},{"Node1":"Tannerella Forsythia","Edge_Type":"bacteria_to_disease","Node2":"Hemorrhage","Weight":1,"Paper_List":"31111123","Original_Text":"PMID:31111123; Original text:However, the use of InGaAsP followed by subgingival debridement and the adjunctive use of an Er,Cr:YSGG laser, yielded statistically significantly higher clinical (PD, CAL, bleeding on probing, number of sites with PD ≥ 5 mm, PD ≥ 6 mm, PD ≥ 7 mm) and microbiologic (Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia, Prevotella intermedia, Peptostreptococcus micros, Fusobacterium nucleatum) improvements (P < .05) compared to subgingival debridement alone."},{"Node1":"High density lipoprotein cholesterol level QTL 6","Edge_Type":"mechanism","Node2":"component of oligomeric golgi complex 2","Weight":1,"Paper_List":"29558323","Original_Text":"PMID:29558323; Original text:[LDL-C], and high-density lipoprotein cholesterol"},{"Node1":"Cholesterol","Edge_Type":"chemical_to_mechanism","Node2":"component of oligomeric golgi complex 2","Weight":1,"Paper_List":"29558323","Original_Text":"PMID:29558323; Original text:[LDL-C], and high-density lipoprotein cholesterol"},{"Node1":"Cholesterol","Edge_Type":"chemical_to_mechanism","Node2":"High density lipoprotein cholesterol level QTL 6","Weight":3,"Paper_List":"29558323|21357860|26434651","Original_Text":"PMID:29558323; Original text:[LDL-C], and high-density lipoprotein cholesterol|PMID:21357860; Original text:A two-year subantimicrobial-dose-doxycycline regimen in postmenopausal women significantly reduced the serum inflammatory biomarkers SDD treatment reduced median high-sensitivity C-reactive protein and serum matrix metalloproteinase-9 and, among women more than five years postmenopausal, increased the high-density lipoprotein cholesterol level. subantimicrobial-dose-doxycycline significantly reduced the systemic inflammatory biomarkers SDD treatment reduced median high-sensitivity C-reactive protein and serum matrix metalloproteinase-9.|PMID:26434651; Original text:Two and 6 months after treatment, TRG levels were significantly lower in group 2 than in group 1 (P < 0.05), and the levels of high-density lipoprotein cholesterol were significantly higher (P < 0.05)."},{"Node1":"Membranes","Edge_Type":"anatomy","Node2":"Paranasal Sinuses","Weight":1,"Paper_List":"18436034","Original_Text":"PMID:18436034; Original text:Additional findings were seen significantly more frequently in cone-beam tomography compared with PA radiography including expansion of lesions into the maxillary sinus (p < 0.001), sinus membrane thickening (p < 0.001), and missed canals (p < 0.05)."},{"Node1":"Maxillary Sinus","Edge_Type":"anatomy","Node2":"Paranasal Sinuses","Weight":1,"Paper_List":"18436034","Original_Text":"PMID:18436034; Original text:Additional findings were seen significantly more frequently in cone-beam tomography compared with PA radiography including expansion of lesions into the maxillary sinus (p < 0.001), sinus membrane thickening (p < 0.001), and missed canals (p < 0.05)."},{"Node1":"Maxilla","Edge_Type":"anatomy","Node2":"Paranasal Sinuses","Weight":1,"Paper_List":"18436034","Original_Text":"PMID:18436034; Original text:Additional findings were seen significantly more frequently in cone-beam tomography compared with PA radiography including expansion of lesions into the maxillary sinus (p < 0.001), sinus membrane thickening (p < 0.001), and missed canals (p < 0.05)."},{"Node1":"Maxillary Sinus","Edge_Type":"anatomy","Node2":"Membranes","Weight":1,"Paper_List":"18436034","Original_Text":"PMID:18436034; Original text:Additional findings were seen significantly more frequently in cone-beam tomography compared with PA radiography including expansion of lesions into the maxillary sinus (p < 0.001), sinus membrane thickening (p < 0.001), and missed canals (p < 0.05)."},{"Node1":"Maxilla","Edge_Type":"anatomy","Node2":"Membranes","Weight":1,"Paper_List":"18436034","Original_Text":"PMID:18436034; Original text:Additional findings were seen significantly more frequently in cone-beam tomography compared with PA radiography including expansion of lesions into the maxillary sinus (p < 0.001), sinus membrane thickening (p < 0.001), and missed canals (p < 0.05)."},{"Node1":"Maxilla","Edge_Type":"anatomy","Node2":"Maxillary Sinus","Weight":1,"Paper_List":"18436034","Original_Text":"PMID:18436034; Original text:Additional findings were seen significantly more frequently in cone-beam tomography compared with PA radiography including expansion of lesions into the maxillary sinus (p < 0.001), sinus membrane thickening (p < 0.001), and missed canals (p < 0.05)."},{"Node1":"collagen type II alpha 1 chain","Edge_Type":"mechanism_to_anatomy","Node2":"Bone and Bones","Weight":1,"Paper_List":"1660056","Original_Text":"PMID:1660056; Original text:These spaces subsequently underwent mineralization, with deposition of bone apatite crystals followed by the peripheral deposition of a thin inner bone layer with a granular appearance and an outer normal bone layer of either woven bone, lamellar bone or bone with parallel calcified collagen fibrils."},{"Node1":"Gingiva","Edge_Type":"anatomy","Node2":"Mast Cells","Weight":2,"Paper_List":"29488617|29488617","Original_Text":"PMID:29488617; Original text:The results revealed that the expression of TLR4 in the gingival tissues and on mast cells in the gingival tissues of patients with chronic periodontitis were significantly higher, compared with those of the normal control group (P<0.05).|PMID:29488617; Original text:The expression levels of TLR4 in the gingival tissues and on mast cells in patients with advanced chronic periodontitis were significantly higher, compared with those in patients with mild chronic periodontitis (P<0.05)."},{"Node1":"Chronic Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"toll-like receptor 4 S homeolog","Weight":1,"Paper_List":"29488617","Original_Text":"PMID:29488617; Original text:The results revealed that the expression of TLR4 in the gingival tissues and on mast cells in the gingival tissues of patients with chronic periodontitis were significantly higher, compared with those of the normal control group (P<0.05)."},{"Node1":"Behcet Syndrome","Edge_Type":"disease_to_anatomy","Node2":"Tooth","Weight":1,"Paper_List":"19076988","Original_Text":"PMID:19076988; Original text:Periodontal indices, the number of oral ulcers and the daily frequency of tooth brushing were related to the severity scores of Behçet's disease (p < 0.001)."},{"Node1":"Bone Cysts","Edge_Type":"disease_to_anatomy","Node2":"Heterografts","Weight":1,"Paper_List":"15086616","Original_Text":"PMID:15086616; Original text:The results of the present study indicate that both collagen/chondroitin sulphate biomaterial and a bovine-derived hydroxyapatite xenograft grafting biomaterials have determined a clinically and statistically significant improvement in terms of clinical attachment level gain, pocket probing depth reduction and radiographic the defect gain when used for the treatment of deep intra-osseous defects."},{"Node1":"toll-like receptor 4 S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":2,"Paper_List":"29488617|29488617","Original_Text":"PMID:29488617; Original text:The results revealed that the expression of TLR4 in the gingival tissues and on mast cells in the gingival tissues of patients with chronic periodontitis were significantly higher, compared with those of the normal control group (P<0.05).|PMID:29488617; Original text:The expression levels of TLR4 in the gingival tissues and on mast cells in patients with advanced chronic periodontitis were significantly higher, compared with those in patients with mild chronic periodontitis (P<0.05)."},{"Node1":"toll-like receptor 4 S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Mast Cells","Weight":2,"Paper_List":"29488617|29488617","Original_Text":"PMID:29488617; Original text:The results revealed that the expression of TLR4 in the gingival tissues and on mast cells in the gingival tissues of patients with chronic periodontitis were significantly higher, compared with those of the normal control group (P<0.05).|PMID:29488617; Original text:The expression levels of TLR4 in the gingival tissues and on mast cells in patients with advanced chronic periodontitis were significantly higher, compared with those in patients with mild chronic periodontitis (P<0.05)."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"toll-like receptor 4 S homeolog","Weight":3,"Paper_List":"29488617|27603404|19426173","Original_Text":"PMID:29488617; Original text:The expression levels of TLR4 in the gingival tissues and on mast cells in patients with advanced chronic periodontitis were significantly higher, compared with those in patients with mild chronic periodontitis (P<0.05).|PMID:27603404; Original text:There was a significance between TLR4C>G (G) allele and chronic periodontitis in Asian, and its recessive model was also significant (for C vs G: odds ratio [OR] = 0.72, 95% confidence interval [CI] = 0.54-0.95,|PMID:19426173; Original text:In the pooled analysis, the TLR4 299Gly allele (TLR4+896 A>G) appeared to be a genetic risk factor for susceptibility to chronic periodontitis with a random effects and fixed effects odds ratio (fixed effects odds ratio) of 1.43 [95% confidence interval (1.43 [95% confidence interval):1.04-1.97; p=0.03]."},{"Node1":"Bone Diseases, Metabolic","Edge_Type":"disease_to_anatomy","Node2":"Bone and Bones","Weight":1,"Paper_List":"20348487","Original_Text":"PMID:20348487; Original text:We previously demonstrated that subantimicrobial-dose-doxycycline (SDD) treatment of post-menopausal osteopenic women significantly reduced periodontal disease progression, and biomarkers of collagen destruction and bone resorption locally in periodontal pockets, in a double-blind placebo-controlled clinical trial."},{"Node1":"Bone Diseases, Metabolic","Edge_Type":"disease_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"22151499","Original_Text":"PMID:22151499; Original text:Osteopenic women and women with normal Areal bone mineral density significantly differed in mean Gingival index (P = 0.02)."},{"Node1":"JIL-1 kinase","Edge_Type":"mechanism","Node2":"interleukin 6 cytokine family signal transducer","Weight":7,"Paper_List":"26754181|26093363|27027257|22126282|24970858|26251312|26434651","Original_Text":"PMID:26754181; Original text:Significant reductions were found in the total amounts of GCF levels of IL-1, IL-6, IL-8, intercellular adhesion molecule, and vascular cell adhesion molecule after treatment (P < 0.05).|PMID:26093363; Original text:Periodontal treatment significantly reduced the gingival crevicular fluid levels of IL-1β, IL-10, IL-12p70 and IL-6 at 28 weeks' GA compared with controls, while levels of MCP-1, IL-8 and TNF-α exhibited a significant gestational age-dependent increase, but no treatment response.|PMID:27027257; Original text:GCF levels of IL-1β, IL-6, IFN-γ and MCP-1/CCL2 were significantly higher in subjects diagnosed with chronic periodontitis than periodontally healthy subjects.|PMID:22126282; Original text:Significant reductions in crevicular fluid GM-CSF, IL-1β and the ratio IL-1β/IL-10 and increases in crevicular fluid IL-6 were detected after therapy.|PMID:24970858; Original text:Significant adjusted differences were found between docosahexaenoic acid and control for both gingival crevicular fluid high-sensitivity C-reactive protein (-5.3 ng/mL, standard error [SE] = 2.4, p = .03) and IL-1β (-20.1 pg/mL, SE = 8.2, p = .02) but not IL-6 (0.02 pg/mL, SE = 0.71, p = .98) or systemic high-sensitivity C-reactive protein (-1.19 mg/L, SE = 0.90, p = .20).|PMID:26251312; Original text:The levels of IL-1β, IL-6, IL-8 and TNF-α remained significantly lower in the test group compared to the placebo group.|PMID:26434651; Original text:Two and 6 months after therapy, the levels of TNF-α were significantly lower in group 2 than in group 1 (P < 0.05), as were the levels of IL-1β (P < 0.001) and IL-6 (P < 0.001)."},{"Node1":"interleukin 6 cytokine family signal transducer","Edge_Type":"mechanism","Node2":"vascular cell adhesion molecule 1b","Weight":1,"Paper_List":"26754181","Original_Text":"PMID:26754181; Original text:Significant reductions were found in the total amounts of GCF levels of IL-1, IL-6, IL-8, intercellular adhesion molecule, and vascular cell adhesion molecule after treatment (P < 0.05)."},{"Node1":"interleukin 6 cytokine family signal transducer","Edge_Type":"mechanism","Node2":"interleukin 8-like 2","Weight":5,"Paper_List":"26754181|21730256|26093363|28601733|26251312","Original_Text":"PMID:26754181; Original text:Significant reductions were found in the total amounts of GCF levels of IL-1, IL-6, IL-8, intercellular adhesion molecule, and vascular cell adhesion molecule after treatment (P < 0.05).|PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01).|PMID:26093363; Original text:Periodontal treatment significantly reduced the gingival crevicular fluid levels of IL-1β, IL-10, IL-12p70 and IL-6 at 28 weeks' GA compared with controls, while levels of MCP-1, IL-8 and TNF-α exhibited a significant gestational age-dependent increase, but no treatment response.|PMID:28601733; Original text:Both the groups showed significant reduction in all the clinical parameters scores and IL-6 and IL-8 levels after non-surgical periodontal therapy (root planing for group I/root planing+1.2% 1.2% simvastatin gel for group II) in contrast to baseline values.|PMID:26251312; Original text:The levels of IL-1β, IL-6, IL-8 and TNF-α remained significantly lower in the test group compared to the placebo group."},{"Node1":"SC:D0202","Edge_Type":"mechanism","Node2":"interleukin 6 cytokine family signal transducer","Weight":1,"Paper_List":"26754181","Original_Text":"PMID:26754181; Original text:Significant reductions were found in the total amounts of GCF levels of IL-1, IL-6, IL-8, intercellular adhesion molecule, and vascular cell adhesion molecule after treatment (P < 0.05)."},{"Node1":"JIL-1 kinase","Edge_Type":"mechanism","Node2":"vascular cell adhesion molecule 1b","Weight":1,"Paper_List":"26754181","Original_Text":"PMID:26754181; Original text:Significant reductions were found in the total amounts of GCF levels of IL-1, IL-6, IL-8, intercellular adhesion molecule, and vascular cell adhesion molecule after treatment (P < 0.05)."},{"Node1":"JIL-1 kinase","Edge_Type":"mechanism","Node2":"interleukin 8-like 2","Weight":3,"Paper_List":"26754181|26093363|26251312","Original_Text":"PMID:26754181; Original text:Significant reductions were found in the total amounts of GCF levels of IL-1, IL-6, IL-8, intercellular adhesion molecule, and vascular cell adhesion molecule after treatment (P < 0.05).|PMID:26093363; Original text:Periodontal treatment significantly reduced the gingival crevicular fluid levels of IL-1β, IL-10, IL-12p70 and IL-6 at 28 weeks' GA compared with controls, while levels of MCP-1, IL-8 and TNF-α exhibited a significant gestational age-dependent increase, but no treatment response.|PMID:26251312; Original text:The levels of IL-1β, IL-6, IL-8 and TNF-α remained significantly lower in the test group compared to the placebo group."},{"Node1":"JIL-1 kinase","Edge_Type":"mechanism","Node2":"SC:D0202","Weight":1,"Paper_List":"26754181","Original_Text":"PMID:26754181; Original text:Significant reductions were found in the total amounts of GCF levels of IL-1, IL-6, IL-8, intercellular adhesion molecule, and vascular cell adhesion molecule after treatment (P < 0.05)."},{"Node1":"interleukin 8-like 2","Edge_Type":"mechanism","Node2":"vascular cell adhesion molecule 1b","Weight":1,"Paper_List":"26754181","Original_Text":"PMID:26754181; Original text:Significant reductions were found in the total amounts of GCF levels of IL-1, IL-6, IL-8, intercellular adhesion molecule, and vascular cell adhesion molecule after treatment (P < 0.05)."},{"Node1":"SC:D0202","Edge_Type":"mechanism","Node2":"vascular cell adhesion molecule 1b","Weight":1,"Paper_List":"26754181","Original_Text":"PMID:26754181; Original text:Significant reductions were found in the total amounts of GCF levels of IL-1, IL-6, IL-8, intercellular adhesion molecule, and vascular cell adhesion molecule after treatment (P < 0.05)."},{"Node1":"SC:D0202","Edge_Type":"mechanism","Node2":"interleukin 8-like 2","Weight":1,"Paper_List":"26754181","Original_Text":"PMID:26754181; Original text:Significant reductions were found in the total amounts of GCF levels of IL-1, IL-6, IL-8, intercellular adhesion molecule, and vascular cell adhesion molecule after treatment (P < 0.05)."},{"Node1":"interleukin 6 cytokine family signal transducer","Edge_Type":"mechanism_to_anatomy","Node2":"Extracellular Fluid","Weight":1,"Paper_List":"26754181","Original_Text":"PMID:26754181; Original text:Significant reductions were found in the total amounts of GCF levels of IL-1, IL-6, IL-8, intercellular adhesion molecule, and vascular cell adhesion molecule after treatment (P < 0.05)."},{"Node1":"JIL-1 kinase","Edge_Type":"mechanism_to_anatomy","Node2":"Extracellular Fluid","Weight":1,"Paper_List":"26754181","Original_Text":"PMID:26754181; Original text:Significant reductions were found in the total amounts of GCF levels of IL-1, IL-6, IL-8, intercellular adhesion molecule, and vascular cell adhesion molecule after treatment (P < 0.05)."},{"Node1":"vascular cell adhesion molecule 1b","Edge_Type":"mechanism_to_anatomy","Node2":"Extracellular Fluid","Weight":1,"Paper_List":"26754181","Original_Text":"PMID:26754181; Original text:Significant reductions were found in the total amounts of GCF levels of IL-1, IL-6, IL-8, intercellular adhesion molecule, and vascular cell adhesion molecule after treatment (P < 0.05)."},{"Node1":"interleukin 8-like 2","Edge_Type":"mechanism_to_anatomy","Node2":"Extracellular Fluid","Weight":1,"Paper_List":"26754181","Original_Text":"PMID:26754181; Original text:Significant reductions were found in the total amounts of GCF levels of IL-1, IL-6, IL-8, intercellular adhesion molecule, and vascular cell adhesion molecule after treatment (P < 0.05)."},{"Node1":"SC:D0202","Edge_Type":"mechanism_to_anatomy","Node2":"Extracellular Fluid","Weight":1,"Paper_List":"26754181","Original_Text":"PMID:26754181; Original text:Significant reductions were found in the total amounts of GCF levels of IL-1, IL-6, IL-8, intercellular adhesion molecule, and vascular cell adhesion molecule after treatment (P < 0.05)."},{"Node1":"Cleft Palate, Isolated, And Mental Retardation","Edge_Type":"disease_to_mechanism","Node2":"tumor necrosis factor receptor superfamily, member a","Weight":1,"Paper_List":"24905365","Original_Text":"PMID:24905365; Original text:The TNF-α -308G/A AA genotype was associated with increased CP risk in Asians, non-smoking Asians and Caucasians, and this polymorphism was significantly associated with elevated risk of AgP in Asians and Caucasians."},{"Node1":"Bone Diseases, Metabolic","Edge_Type":"disease_to_anatomy","Node2":"Tissues","Weight":1,"Paper_List":"22151499","Original_Text":"PMID:22151499; Original text:Subjects with osteopenia and subjects with normal Areal bone mineral density did not differ in clinical attachment loss, which might suggest that the early diagnosis of reduced Areal bone mineral density, prior to the establishment of a significant negative impact on the periodontal tissues, might be important."},{"Node1":"Gingivitis","Edge_Type":"disease","Node2":"Periodontitis","Weight":7,"Paper_List":"22297597|29211279|33688007|17668970|10649937|25511061|10872948","Original_Text":"PMID:22297597; Original text:The mean Plasma glutathione peroxidase concentrations increased from health (14.01 ng/μl and 78.26 ng/ml) to gingivitis (22.86 ng/μl and 90.44 ng/ml) and then to periodontitis (29.89 ng/μl and 103.43 ng/ml), in GCF and serum respectively.|PMID:29211279; Original text:In all sampling times, polymerase chain reaction revealed higher blood bacterial levels than culture (p<0.0001), while gingivitis patients presented lower bacterial levels in blood than periodontitis patients (p<0.0001).|PMID:33688007; Original text:Thus, the microbiome-defined, transient gum SoH stage is a crucial link among gingivitis, periodontitis, and aging.|PMID:17668970; Original text:Supragingival plaque control resulted in significant changes in clinical parameters associated with gingivitis and periodontitis.|PMID:10649937; Original text:One-way ANOVA indicated that the rotary instrument was significantly more effective (P < 0.005) than the sonic brush in removing plaque and reducing gingivitis in treated adult periodontitis patients.|PMID:25511061; Original text:The post-treatment levels of the superoxide dismutase were statistically higher than the pre-treatment levels in periodontitis and gingivitis group.|PMID:10872948; Original text:After treatment there were substantial reductions of A fluorogenic matrix metalloproteinase substrate assay in gingivitis (approximately 51%; P <0.01) and severe periodontitis (approximately 45%; P <0.001), but not in stable periodontitis (13%; P >0.2)."},{"Node1":"Glutathionuria","Edge_Type":"disease","Node2":"Periodontitis","Weight":1,"Paper_List":"22297597","Original_Text":"PMID:22297597; Original text:The mean Plasma glutathione peroxidase concentrations increased from health (14.01 ng/μl and 78.26 ng/ml) to gingivitis (22.86 ng/μl and 90.44 ng/ml) and then to periodontitis (29.89 ng/μl and 103.43 ng/ml), in GCF and serum respectively."},{"Node1":"Gingivitis","Edge_Type":"disease","Node2":"Glutathionuria","Weight":1,"Paper_List":"22297597","Original_Text":"PMID:22297597; Original text:The mean Plasma glutathione peroxidase concentrations increased from health (14.01 ng/μl and 78.26 ng/ml) to gingivitis (22.86 ng/μl and 90.44 ng/ml) and then to periodontitis (29.89 ng/μl and 103.43 ng/ml), in GCF and serum respectively."},{"Node1":"Plasma","Edge_Type":"anatomy","Node2":"Platelet-Rich Plasma","Weight":15,"Paper_List":"22287494|22287494|19792848|19792848|18034853|11895286|18454658|18454658|23317096|23317096|22348695|15948682|22124042|21381872|19961374","Original_Text":"PMID:22287494; Original text:The median values of clinical attachment level decreased from 7.0 to 6.0 mm in the β-TCP group (p = 0.002), and 7.5 to 5.0 mm in the platelet-rich plasma/β-TCP group (p < 0.001).|PMID:22287494; Original text:After a 6-month healing period, both β-TCP and platelet-rich plasma/β-TCP were found effective in the treatment of three-walled intrabony defects and no additional statistically significant benefits were found with platelet-rich plasma.|PMID:19792848; Original text:In the platelet-rich plasma + an anorganic bovine bone mineral group, mean PD decreased from 8.6 +/- 1.8 mm to 3.4 +/-|PMID:19792848; Original text:clinical attachment level gains >or=3 mm were measured in 80% (12 of 15 defects) of cases treated with platelet-rich plasma + an anorganic bovine bone mineral and in 87% (13 of 15 defects) of cases treated with an anorganic bovine bone mineral alone.|PMID:18034853; Original text:Regenerative periodontal surgery utilizing a combination of an enamel matrix protein derivative (an enamel matrix protein derivative) and a natural bone mineral (a natural bone mineral) and platelet-rich plasma (platelet-rich plasma) has been shown to enhance the outcomes of regenerative surgery significantly.|PMID:11895286; Original text:Reentry surgeries revealed similar defect fill for both treatment groups (platelet-rich plasma/bovine porous bone mineral group: 4.82 +/- 1.34 mm on buccal and 4.74 +/- 1.30 mm on lingual sites; platelet-rich plasma/bovine porous bone mineral/guided tissue regeneration group: 4.96 +/-|PMID:18454658; Original text:Treatment with a combination of platelet-rich plasma and a demineralized freeze-dried bone allograft led to a significantly greater clinical improvement in intrabony periodontal defects compared to a demineralized freeze-dried bone allograft with saline.|PMID:18454658; Original text:No statistically significant differences were observed in the hard tissue response between the two treatment groups, which confirmed that platelet-rich plasma had no effect on hard tissue fill or gain in new hard tissue formation.|PMID:23317096; Original text:Relative vertical clinical attachment level gain was also greater in autologous platelet-rich fibrin (2.87 ± 0.85 mm) and autologous platelet-rich plasma (2.71 ± 1.04 mm) sites as compared to control site (1.37 ± 0.58|PMID:23317096; Original text:All clinical and radiographic parameters showed statistically significant improvement at both the test sites (autologous platelet-rich fibrin with OFD and autologous platelet-rich plasma with OFD) compared to those with OFD alone.|PMID:22348695; Original text:Furthermore, significantly greater percentage of mean bone fill was found in the autologous platelet-rich fibrin (55.41% ± 11.39%) and platelet-rich plasma (56.85% ± 14.01%) groups compared with the control (1.56% ± 15.12%) group.|PMID:15948682; Original text:Treatment with a combination of platelet-rich plasma and HA compared to HA with saline led to a significantly more favorable clinical improvement in intrabony periodontal defects.|PMID:22124042; Original text:When combined with platelet-rich plasma there is a significantly higher reduction in probing pocket depth, higher gain in attachment levels and higher amount of radio-density seen in the intrabony defects.|PMID:21381872; Original text:Albeit statistically insignificant, there is a preponderance of better clinical results with the addition of bovine anorganic bone mineral to platelet-rich plasma.|PMID:19961374; Original text:Both treatments achieved statistically significant and similar clinical attachment level gain (3.08 +/- 1.17 mm for Platelet-rich plasma + demineralized freeze-dried bone allograft and 3.08 +/- 0.95 mm for Platelet-rich plasma), probing depth, defect depth, and area surface reduction."},{"Node1":"Blood Platelets","Edge_Type":"anatomy","Node2":"Plasma","Weight":15,"Paper_List":"22287494|22287494|19792848|19792848|18034853|11895286|18454658|18454658|23317096|23317096|22348695|15948682|22124042|21381872|19961374","Original_Text":"PMID:22287494; Original text:The median values of clinical attachment level decreased from 7.0 to 6.0 mm in the β-TCP group (p = 0.002), and 7.5 to 5.0 mm in the platelet-rich plasma/β-TCP group (p < 0.001).|PMID:22287494; Original text:After a 6-month healing period, both β-TCP and platelet-rich plasma/β-TCP were found effective in the treatment of three-walled intrabony defects and no additional statistically significant benefits were found with platelet-rich plasma.|PMID:19792848; Original text:In the platelet-rich plasma + an anorganic bovine bone mineral group, mean PD decreased from 8.6 +/- 1.8 mm to 3.4 +/-|PMID:19792848; Original text:clinical attachment level gains >or=3 mm were measured in 80% (12 of 15 defects) of cases treated with platelet-rich plasma + an anorganic bovine bone mineral and in 87% (13 of 15 defects) of cases treated with an anorganic bovine bone mineral alone.|PMID:18034853; Original text:Regenerative periodontal surgery utilizing a combination of an enamel matrix protein derivative (an enamel matrix protein derivative) and a natural bone mineral (a natural bone mineral) and platelet-rich plasma (platelet-rich plasma) has been shown to enhance the outcomes of regenerative surgery significantly.|PMID:11895286; Original text:Reentry surgeries revealed similar defect fill for both treatment groups (platelet-rich plasma/bovine porous bone mineral group: 4.82 +/- 1.34 mm on buccal and 4.74 +/- 1.30 mm on lingual sites; platelet-rich plasma/bovine porous bone mineral/guided tissue regeneration group: 4.96 +/-|PMID:18454658; Original text:Treatment with a combination of platelet-rich plasma and a demineralized freeze-dried bone allograft led to a significantly greater clinical improvement in intrabony periodontal defects compared to a demineralized freeze-dried bone allograft with saline.|PMID:18454658; Original text:No statistically significant differences were observed in the hard tissue response between the two treatment groups, which confirmed that platelet-rich plasma had no effect on hard tissue fill or gain in new hard tissue formation.|PMID:23317096; Original text:Relative vertical clinical attachment level gain was also greater in autologous platelet-rich fibrin (2.87 ± 0.85 mm) and autologous platelet-rich plasma (2.71 ± 1.04 mm) sites as compared to control site (1.37 ± 0.58|PMID:23317096; Original text:All clinical and radiographic parameters showed statistically significant improvement at both the test sites (autologous platelet-rich fibrin with OFD and autologous platelet-rich plasma with OFD) compared to those with OFD alone.|PMID:22348695; Original text:Furthermore, significantly greater percentage of mean bone fill was found in the autologous platelet-rich fibrin (55.41% ± 11.39%) and platelet-rich plasma (56.85% ± 14.01%) groups compared with the control (1.56% ± 15.12%) group.|PMID:15948682; Original text:Treatment with a combination of platelet-rich plasma and HA compared to HA with saline led to a significantly more favorable clinical improvement in intrabony periodontal defects.|PMID:22124042; Original text:When combined with platelet-rich plasma there is a significantly higher reduction in probing pocket depth, higher gain in attachment levels and higher amount of radio-density seen in the intrabony defects.|PMID:21381872; Original text:Albeit statistically insignificant, there is a preponderance of better clinical results with the addition of bovine anorganic bone mineral to platelet-rich plasma.|PMID:19961374; Original text:Both treatments achieved statistically significant and similar clinical attachment level gain (3.08 +/- 1.17 mm for Platelet-rich plasma + demineralized freeze-dried bone allograft and 3.08 +/- 0.95 mm for Platelet-rich plasma), probing depth, defect depth, and area surface reduction."},{"Node1":"Blood Platelets","Edge_Type":"anatomy","Node2":"Platelet-Rich Plasma","Weight":17,"Paper_List":"22287494|22287494|19792848|19792848|18034853|27452270|11895286|18454658|18454658|23317096|23317096|22348695|15948682|27294433|22124042|21381872|19961374","Original_Text":"PMID:22287494; Original text:The median values of clinical attachment level decreased from 7.0 to 6.0 mm in the β-TCP group (p = 0.002), and 7.5 to 5.0 mm in the platelet-rich plasma/β-TCP group (p < 0.001).|PMID:22287494; Original text:After a 6-month healing period, both β-TCP and platelet-rich plasma/β-TCP were found effective in the treatment of three-walled intrabony defects and no additional statistically significant benefits were found with platelet-rich plasma.|PMID:19792848; Original text:In the platelet-rich plasma + an anorganic bovine bone mineral group, mean PD decreased from 8.6 +/- 1.8 mm to 3.4 +/-|PMID:19792848; Original text:clinical attachment level gains >or=3 mm were measured in 80% (12 of 15 defects) of cases treated with platelet-rich plasma + an anorganic bovine bone mineral and in 87% (13 of 15 defects) of cases treated with an anorganic bovine bone mineral alone.|PMID:18034853; Original text:Regenerative periodontal surgery utilizing a combination of an enamel matrix protein derivative (an enamel matrix protein derivative) and a natural bone mineral (a natural bone mineral) and platelet-rich plasma (platelet-rich plasma) has been shown to enhance the outcomes of regenerative surgery significantly.|PMID:27452270; Original text:open flap debridement with particularly rosuvastatin (1.2%) and platelet-rich fibrin results in significantly greater periodontal benefits compared with open flap debridement alone or with platelet-rich fibrin.|PMID:11895286; Original text:Reentry surgeries revealed similar defect fill for both treatment groups (platelet-rich plasma/bovine porous bone mineral group: 4.82 +/- 1.34 mm on buccal and 4.74 +/- 1.30 mm on lingual sites; platelet-rich plasma/bovine porous bone mineral/guided tissue regeneration group: 4.96 +/-|PMID:18454658; Original text:Treatment with a combination of platelet-rich plasma and a demineralized freeze-dried bone allograft led to a significantly greater clinical improvement in intrabony periodontal defects compared to a demineralized freeze-dried bone allograft with saline.|PMID:18454658; Original text:No statistically significant differences were observed in the hard tissue response between the two treatment groups, which confirmed that platelet-rich plasma had no effect on hard tissue fill or gain in new hard tissue formation.|PMID:23317096; Original text:Relative vertical clinical attachment level gain was also greater in autologous platelet-rich fibrin (2.87 ± 0.85 mm) and autologous platelet-rich plasma (2.71 ± 1.04 mm) sites as compared to control site (1.37 ± 0.58|PMID:23317096; Original text:All clinical and radiographic parameters showed statistically significant improvement at both the test sites (autologous platelet-rich fibrin with OFD and autologous platelet-rich plasma with OFD) compared to those with OFD alone.|PMID:22348695; Original text:Furthermore, significantly greater percentage of mean bone fill was found in the autologous platelet-rich fibrin (55.41% ± 11.39%) and platelet-rich plasma (56.85% ± 14.01%) groups compared with the control (1.56% ± 15.12%) group.|PMID:15948682; Original text:Treatment with a combination of platelet-rich plasma and HA compared to HA with saline led to a significantly more favorable clinical improvement in intrabony periodontal defects.|PMID:27294433; Original text:Platelet-rich fibrin + 1.2% atorvastatin and Platelet-rich fibrin alone showed significantly greater depth reduction and 4) relative clinical attachment level gain compared with open flap debridement alone at 9 months.|PMID:22124042; Original text:When combined with platelet-rich plasma there is a significantly higher reduction in probing pocket depth, higher gain in attachment levels and higher amount of radio-density seen in the intrabony defects.|PMID:21381872; Original text:Albeit statistically insignificant, there is a preponderance of better clinical results with the addition of bovine anorganic bone mineral to platelet-rich plasma.|PMID:19961374; Original text:Both treatments achieved statistically significant and similar clinical attachment level gain (3.08 +/- 1.17 mm for Platelet-rich plasma + demineralized freeze-dried bone allograft and 3.08 +/- 0.95 mm for Platelet-rich plasma), probing depth, defect depth, and area surface reduction."},{"Node1":"Bone Resorption","Edge_Type":"disease_to_anatomy","Node2":"Bone and Bones","Weight":1,"Paper_List":"20348487","Original_Text":"PMID:20348487; Original text:We previously demonstrated that subantimicrobial-dose-doxycycline (SDD) treatment of post-menopausal osteopenic women significantly reduced periodontal disease progression, and biomarkers of collagen destruction and bone resorption locally in periodontal pockets, in a double-blind placebo-controlled clinical trial."},{"Node1":"Plasma Cells","Edge_Type":"anatomy","Node2":"Tissues","Weight":1,"Paper_List":"1843466","Original_Text":"PMID:1843466; Original text:In the connective tissue, group a periimplant infection group showed a higher % of inflammatory infiltrate with significantly higher numbers of plasma cells and mononuclear cells than group a non-periimplant infection group."},{"Node1":"Plasma","Edge_Type":"anatomy","Node2":"Plasma Cells","Weight":1,"Paper_List":"1843466","Original_Text":"PMID:1843466; Original text:In the connective tissue, group a periimplant infection group showed a higher % of inflammatory infiltrate with significantly higher numbers of plasma cells and mononuclear cells than group a non-periimplant infection group."},{"Node1":"Connective Tissue","Edge_Type":"anatomy","Node2":"Plasma Cells","Weight":1,"Paper_List":"1843466","Original_Text":"PMID:1843466; Original text:In the connective tissue, group a periimplant infection group showed a higher % of inflammatory infiltrate with significantly higher numbers of plasma cells and mononuclear cells than group a non-periimplant infection group."},{"Node1":"Leukocytes, Mononuclear","Edge_Type":"anatomy","Node2":"Plasma Cells","Weight":1,"Paper_List":"1843466","Original_Text":"PMID:1843466; Original text:In the connective tissue, group a periimplant infection group showed a higher % of inflammatory infiltrate with significantly higher numbers of plasma cells and mononuclear cells than group a non-periimplant infection group."},{"Node1":"Plasma","Edge_Type":"anatomy","Node2":"Tissues","Weight":1,"Paper_List":"1843466","Original_Text":"PMID:1843466; Original text:In the connective tissue, group a periimplant infection group showed a higher % of inflammatory infiltrate with significantly higher numbers of plasma cells and mononuclear cells than group a non-periimplant infection group."},{"Node1":"Connective Tissue","Edge_Type":"anatomy","Node2":"Tissues","Weight":2,"Paper_List":"1843466|27435493","Original_Text":"PMID:1843466; Original text:In the connective tissue, group a periimplant infection group showed a higher % of inflammatory infiltrate with significantly higher numbers of plasma cells and mononuclear cells than group a non-periimplant infection group.|PMID:27435493; Original text:Postsurgery, a higher number of inflammatory cells and stronger expression of proinflammatory cytokines were observed in the epithelium and connective tissue of conventional osseous resective surgery gingival samples compared with fibre retention osseous resective surgery gingival samples (p < 0.001)."},{"Node1":"Leukocytes, Mononuclear","Edge_Type":"anatomy","Node2":"Tissues","Weight":1,"Paper_List":"1843466","Original_Text":"PMID:1843466; Original text:In the connective tissue, group a periimplant infection group showed a higher % of inflammatory infiltrate with significantly higher numbers of plasma cells and mononuclear cells than group a non-periimplant infection group."},{"Node1":"Connective Tissue","Edge_Type":"anatomy","Node2":"Plasma","Weight":1,"Paper_List":"1843466","Original_Text":"PMID:1843466; Original text:In the connective tissue, group a periimplant infection group showed a higher % of inflammatory infiltrate with significantly higher numbers of plasma cells and mononuclear cells than group a non-periimplant infection group."},{"Node1":"Leukocytes, Mononuclear","Edge_Type":"anatomy","Node2":"Plasma","Weight":1,"Paper_List":"1843466","Original_Text":"PMID:1843466; Original text:In the connective tissue, group a periimplant infection group showed a higher % of inflammatory infiltrate with significantly higher numbers of plasma cells and mononuclear cells than group a non-periimplant infection group."},{"Node1":"Connective Tissue","Edge_Type":"anatomy","Node2":"Leukocytes, Mononuclear","Weight":1,"Paper_List":"1843466","Original_Text":"PMID:1843466; Original text:In the connective tissue, group a periimplant infection group showed a higher % of inflammatory infiltrate with significantly higher numbers of plasma cells and mononuclear cells than group a non-periimplant infection group."},{"Node1":"Calculi","Edge_Type":"disease_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"22302453","Original_Text":"PMID:22302453; Original text:Compared to controls, women in the test group had significant reductions in the percentage of sites with plaque (48.5% vs. 10.3%, p < 0.001), gingival bleeding (23.3% vs. 2.5%, p < 0.001), calculus (21.3% vs. 4.1%, p < 0.001), bleeding on probing (38.1% vs. 2.6%, p < 0.001) and probing depth ≥3 mm (19.97% vs. −2.45%, p < 0.001)."},{"Node1":"Cardiovascular Diseases","Edge_Type":"disease_to_anatomy","Node2":"Myocardium","Weight":1,"Paper_List":"11216961","Original_Text":"PMID:11216961; Original text:In Cox proportional hazards regression analysis adjusted for age and treatment assignment, physicians who reported periodontal disease at baseline had slightly elevated, but statistically nonsignificant, relative risks (statistically nonsignificant, relative risks) of nonfatal myocardial infarction, (statistically nonsignificant, relative risks, 1.12; 95% confidence interval [CI], 0.92 to 1.36), nonfatal stroke (statistically nonsignificant, relative risks, 1.10; CI, 0.88 to 1.37) and cardiovascular death (statistically nonsignificant, relative risks, 1.20; CI, 0.97 to 1.49)."},{"Node1":"Chronic Periodontitis","Edge_Type":"disease_to_anatomy","Node2":"Body Fluids","Weight":2,"Paper_List":"25814780|25814780","Original_Text":"PMID:25814780; Original text:gingival crevicular fluid, salivary and gingival OPG profiles were significantly higher in control subjects compared to chronic periodontitis patients at baseline (P < 0.001).|PMID:25814780; Original text:Within chronic periodontitis group, OPG levels in gingival crevicular fluid, saliva, and gingival samples showed a significant increase at 3 and 6 months after open flap debridement (P < 0.001) compared to baseline."},{"Node1":"Chronic Periodontitis","Edge_Type":"disease_to_anatomy","Node2":"Gingiva","Weight":7,"Paper_List":"29488617|25814780|25814780|25811944|27498443|15562917|20151799","Original_Text":"PMID:29488617; Original text:The results revealed that the expression of TLR4 in the gingival tissues and on mast cells in the gingival tissues of patients with chronic periodontitis were significantly higher, compared with those of the normal control group (P<0.05).|PMID:25814780; Original text:gingival crevicular fluid, salivary and gingival OPG profiles were significantly higher in control subjects compared to chronic periodontitis patients at baseline (P < 0.001).|PMID:25814780; Original text:Within chronic periodontitis group, OPG levels in gingival crevicular fluid, saliva, and gingival samples showed a significant increase at 3 and 6 months after open flap debridement (P < 0.001) compared to baseline.|PMID:25811944; Original text:Gingival tissues from patients with chronic periodontitis and type 2 diabetes mellitus had a significant increase in visfatin and a decrease in leptin gene and protein expression (P <0.05) compared with both controls and patients with chronic periodontitis.|PMID:27498443; Original text:The conjunction of amoxicillin plus metronidazole or cefixime to the causal treatment of patients with chronic periodontitis led to statistically significant improvement in efficacy in relation to gingival index and BOP parameters, while cefixime was statistically significantly more efficient than the combination of amoxicillin and metronidazole for gingival index.|PMID:15562917; Original text:The present data indicate that Low-dose doxycycline therapy in combination with root planing therapy can reduce gingival crevicular fluid Laminin-5 gamma2 chain fragment levels and improve clinical periodontal parameters in patients with chronic periodontitis.|PMID:20151799; Original text:There was a greater decrease in gingival index and depth and more clinical attachment level gain with significant intrabony defect fill at sites treated with root planing plus locally delivered Simvastatin in patients with chronic periodontitis."},{"Node1":"Chronic Periodontitis","Edge_Type":"disease_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":3,"Paper_List":"25814780|25814780|15562917","Original_Text":"PMID:25814780; Original text:gingival crevicular fluid, salivary and gingival OPG profiles were significantly higher in control subjects compared to chronic periodontitis patients at baseline (P < 0.001).|PMID:25814780; Original text:Within chronic periodontitis group, OPG levels in gingival crevicular fluid, saliva, and gingival samples showed a significant increase at 3 and 6 months after open flap debridement (P < 0.001) compared to baseline.|PMID:15562917; Original text:The present data indicate that Low-dose doxycycline therapy in combination with root planing therapy can reduce gingival crevicular fluid Laminin-5 gamma2 chain fragment levels and improve clinical periodontal parameters in patients with chronic periodontitis."},{"Node1":"Hemoglobin","Edge_Type":"mechanism","Node2":"nejire","Weight":1,"Paper_List":"33796948","Original_Text":"PMID:33796948; Original text:Furthermore, glycosylated hemoglobin levels were reduced (p= 0.010) significantly in the intervention group while high-sensitivity C-reactive protein levels significantly increased in the control group (p= 0.04)."},{"Node1":"Peptostreptococcaceae","Edge_Type":"bacteria","Node2":"Prevotella Nigrescens","Weight":1,"Paper_List":"25308100","Original_Text":"PMID:25308100; Original text:The proportion of Prevotella nigrescens was significantly higher in peri-implantitis than in periodontitis, while the proportions of Peptostreptococcaceae sp."},{"Node1":"Desulfomicrobium Orale (Organism)","Edge_Type":"bacteria","Node2":"Prevotella Nigrescens","Weight":1,"Paper_List":"25308100","Original_Text":"PMID:25308100; Original text:The proportion of Prevotella nigrescens was significantly higher in peri-implantitis than in periodontitis, while the proportions of Peptostreptococcaceae sp."},{"Node1":"Desulfomicrobium Orale (Organism)","Edge_Type":"bacteria","Node2":"Peptostreptococcaceae","Weight":1,"Paper_List":"25308100","Original_Text":"PMID:25308100; Original text:The proportion of Prevotella nigrescens was significantly higher in peri-implantitis than in periodontitis, while the proportions of Peptostreptococcaceae sp."},{"Node1":"Peri-Implantitis","Edge_Type":"disease","Node2":"Periodontitis","Weight":4,"Paper_List":"25308100|25308100|25343317|25343317","Original_Text":"PMID:25308100; Original text:The proportion of Prevotella nigrescens was significantly higher in peri-implantitis than in periodontitis, while the proportions of Peptostreptococcaceae sp.|PMID:25308100; Original text:and Desulfomicrobium orale were significantly higher in periodontitis than in peri-implantitis.|PMID:25343317; Original text:Six of 10 studies reported statistically significantly higher MBL and prevalence of peri-implantitis among periodontitis patients.|PMID:25343317; Original text:Our meta-analysis did not find implant survival rates to be significantly lower among periodontitis patients (P = 0.99) but revealed a history of periodontitis to be significantly related to the higher prevalence of peri-implantitis (P < 0.001)."},{"Node1":"Prevotella Nigrescens","Edge_Type":"bacteria_to_disease","Node2":"Periodontitis","Weight":1,"Paper_List":"25308100","Original_Text":"PMID:25308100; Original text:The proportion of Prevotella nigrescens was significantly higher in peri-implantitis than in periodontitis, while the proportions of Peptostreptococcaceae sp."},{"Node1":"Prevotella Nigrescens","Edge_Type":"bacteria_to_disease","Node2":"Peri-Implantitis","Weight":1,"Paper_List":"25308100","Original_Text":"PMID:25308100; Original text:The proportion of Prevotella nigrescens was significantly higher in peri-implantitis than in periodontitis, while the proportions of Peptostreptococcaceae sp."},{"Node1":"Peptostreptococcaceae","Edge_Type":"bacteria_to_disease","Node2":"Periodontitis","Weight":1,"Paper_List":"25308100","Original_Text":"PMID:25308100; Original text:The proportion of Prevotella nigrescens was significantly higher in peri-implantitis than in periodontitis, while the proportions of Peptostreptococcaceae sp."},{"Node1":"Peptostreptococcaceae","Edge_Type":"bacteria_to_disease","Node2":"Peri-Implantitis","Weight":1,"Paper_List":"25308100","Original_Text":"PMID:25308100; Original text:The proportion of Prevotella nigrescens was significantly higher in peri-implantitis than in periodontitis, while the proportions of Peptostreptococcaceae sp."},{"Node1":"Desulfomicrobium Orale (Organism)","Edge_Type":"bacteria_to_disease","Node2":"Periodontitis","Weight":1,"Paper_List":"25308100","Original_Text":"PMID:25308100; Original text:The proportion of Prevotella nigrescens was significantly higher in peri-implantitis than in periodontitis, while the proportions of Peptostreptococcaceae sp."},{"Node1":"Desulfomicrobium Orale (Organism)","Edge_Type":"bacteria_to_disease","Node2":"Peri-Implantitis","Weight":1,"Paper_List":"25308100","Original_Text":"PMID:25308100; Original text:The proportion of Prevotella nigrescens was significantly higher in peri-implantitis than in periodontitis, while the proportions of Peptostreptococcaceae sp."},{"Node1":"Treponema Sp.","Edge_Type":"bacteria_to_disease","Node2":"Periodontitis","Weight":1,"Paper_List":"25308100","Original_Text":"PMID:25308100; Original text:and Desulfomicrobium orale were significantly higher in periodontitis than in peri-implantitis."},{"Node1":"Treponema Sp.","Edge_Type":"bacteria_to_disease","Node2":"Peri-Implantitis","Weight":1,"Paper_List":"25308100","Original_Text":"PMID:25308100; Original text:and Desulfomicrobium orale were significantly higher in periodontitis than in peri-implantitis."},{"Node1":"Lactobacillus Sp.","Edge_Type":"bacteria","Node2":"Streptococcus Mutans","Weight":1,"Paper_List":"24731062","Original_Text":"PMID:24731062; Original text:The F1000 SLactobacillus do not have an advantage over Avex Mx CB with respect to periodontal status and colonization of Streptococcus mutans and Lactobacillus."},{"Node1":"Nitrates","Edge_Type":"chemical","Node2":"Nitrites","Weight":1,"Paper_List":"17577323","Original_Text":"PMID:17577323; Original text:This was paralleled to a significant decrease of nitrite/nitrate, PGE(2), matrix metalloproteinase, and IFN-gamma levels in saliva samples."},{"Node1":"Nitrites","Edge_Type":"chemical","Node2":"Prostaglandins E","Weight":1,"Paper_List":"17577323","Original_Text":"PMID:17577323; Original text:This was paralleled to a significant decrease of nitrite/nitrate, PGE(2), matrix metalloproteinase, and IFN-gamma levels in saliva samples."},{"Node1":"Nitrates","Edge_Type":"chemical","Node2":"Prostaglandins E","Weight":1,"Paper_List":"17577323","Original_Text":"PMID:17577323; Original text:This was paralleled to a significant decrease of nitrite/nitrate, PGE(2), matrix metalloproteinase, and IFN-gamma levels in saliva samples."},{"Node1":"collagenase 3-like","Edge_Type":"mechanism","Node2":"interferon gamma","Weight":1,"Paper_List":"17577323","Original_Text":"PMID:17577323; Original text:This was paralleled to a significant decrease of nitrite/nitrate, PGE(2), matrix metalloproteinase, and IFN-gamma levels in saliva samples."},{"Node1":"Nitrites","Edge_Type":"chemical_to_mechanism","Node2":"interferon gamma","Weight":1,"Paper_List":"17577323","Original_Text":"PMID:17577323; Original text:This was paralleled to a significant decrease of nitrite/nitrate, PGE(2), matrix metalloproteinase, and IFN-gamma levels in saliva samples."},{"Node1":"Nitrites","Edge_Type":"chemical_to_mechanism","Node2":"collagenase 3-like","Weight":1,"Paper_List":"17577323","Original_Text":"PMID:17577323; Original text:This was paralleled to a significant decrease of nitrite/nitrate, PGE(2), matrix metalloproteinase, and IFN-gamma levels in saliva samples."},{"Node1":"Nitrates","Edge_Type":"chemical_to_mechanism","Node2":"interferon gamma","Weight":1,"Paper_List":"17577323","Original_Text":"PMID:17577323; Original text:This was paralleled to a significant decrease of nitrite/nitrate, PGE(2), matrix metalloproteinase, and IFN-gamma levels in saliva samples."},{"Node1":"Nitrates","Edge_Type":"chemical_to_mechanism","Node2":"collagenase 3-like","Weight":1,"Paper_List":"17577323","Original_Text":"PMID:17577323; Original text:This was paralleled to a significant decrease of nitrite/nitrate, PGE(2), matrix metalloproteinase, and IFN-gamma levels in saliva samples."},{"Node1":"Prostaglandins E","Edge_Type":"chemical_to_mechanism","Node2":"interferon gamma","Weight":1,"Paper_List":"17577323","Original_Text":"PMID:17577323; Original text:This was paralleled to a significant decrease of nitrite/nitrate, PGE(2), matrix metalloproteinase, and IFN-gamma levels in saliva samples."},{"Node1":"Prostaglandins E","Edge_Type":"chemical_to_mechanism","Node2":"collagenase 3-like","Weight":1,"Paper_List":"17577323","Original_Text":"PMID:17577323; Original text:This was paralleled to a significant decrease of nitrite/nitrate, PGE(2), matrix metalloproteinase, and IFN-gamma levels in saliva samples."},{"Node1":"Periodontal Diseases","Edge_Type":"disease","Node2":"Periodontitis","Weight":4,"Paper_List":"17577323|11887476|9696259|28631250","Original_Text":"PMID:17577323; Original text:Our findings give further insights into the knowledge of the molecular basis of periodontitis and have a potential clinical significance, giving the experimental ground for a new innovative, simple and efficacious therapeutical approach of periodontal disease.|PMID:11887476; Original text:In addition, the longitudinal studies that failed to show a significant association between periodontitis and cardiovascular disease used the least sensitive and crudest clinical measures of periodontal disease.|PMID:9696259; Original text:The reduction of P. gingivalis from treated periodontitis sites as detected by a significant decrease in BAPNA w/ gly-gly may prove to be a valuable marker for periodontal disease activity.|PMID:28631250; Original text:An effective mouthwash was developed for treatment of periodontitis and suppression of the indicator bacterium Aggregatibacter actinomycetemcomitans which is an obvious pathogen of periodontal disease."},{"Node1":"Calcium Hydroxide","Edge_Type":"chemical","Node2":"Lidocaine","Weight":1,"Paper_List":"32462277","Original_Text":"PMID:32462277; Original text:The calcium hydroxide mixed with lidocaine HCl group resulted in significantly less pain compared with the calcium hydroxide mixed with saline group during days 1 to 4 (p < 0.05)."},{"Node1":"Calcium Hydroxide","Edge_Type":"chemical_to_disease","Node2":"Pain","Weight":1,"Paper_List":"32462277","Original_Text":"PMID:32462277; Original text:The calcium hydroxide mixed with lidocaine HCl group resulted in significantly less pain compared with the calcium hydroxide mixed with saline group during days 1 to 4 (p < 0.05)."},{"Node1":"Lidocaine","Edge_Type":"chemical_to_disease","Node2":"Pain","Weight":4,"Paper_List":"32462277|17850608|17850608|24139250","Original_Text":"PMID:32462277; Original text:The calcium hydroxide mixed with lidocaine HCl group resulted in significantly less pain compared with the calcium hydroxide mixed with saline group during days 1 to 4 (p < 0.05).|PMID:17850608; Original text:The rescue anaesthetic, however, was associated with less intra-operative pain than the topical (2% lidocaine-TOP=-24.9 mm, p=0.005)|PMID:17850608; Original text:Among these 11, intra-operative pain scores did not differ significantly (TOP=38.6 mm, 2% lidocaine=28.4 mm, p=0.23).|PMID:24139250; Original text:The addition of a sodium bicarbonate buffer to 2% lidocaine with 1:100,000 epinephrine did not result in significantly decreased pain of infiltrations or significantly decreased pain of the incision and drainage procedure when compared with 2% lidocaine with 1:100,000 epinephrine in symptomatic patients with a diagnosis of pulpal necrosis and associated acute swelling."},{"Node1":"Diabetes Mellitus","Edge_Type":"disease","Node2":"Hypertension","Weight":1,"Paper_List":"26114433","Original_Text":"PMID:26114433; Original text:After adjustment for gender, hyperlipidemia, hypertension and diabetes mellitus, severe treated periodontitis was associated with a mildly but significantly increased risk of the long-term major adverse cardiovascular events among older patients > 60 years of age (incidence rate ratio, 1.26; 95% confidence interval, 1.08-1.46)."},{"Node1":"Diabetes Mellitus","Edge_Type":"disease","Node2":"Hyperlipidemias","Weight":1,"Paper_List":"26114433","Original_Text":"PMID:26114433; Original text:After adjustment for gender, hyperlipidemia, hypertension and diabetes mellitus, severe treated periodontitis was associated with a mildly but significantly increased risk of the long-term major adverse cardiovascular events among older patients > 60 years of age (incidence rate ratio, 1.26; 95% confidence interval, 1.08-1.46)."},{"Node1":"Hypertension","Edge_Type":"disease","Node2":"Periodontitis","Weight":1,"Paper_List":"26114433","Original_Text":"PMID:26114433; Original text:After adjustment for gender, hyperlipidemia, hypertension and diabetes mellitus, severe treated periodontitis was associated with a mildly but significantly increased risk of the long-term major adverse cardiovascular events among older patients > 60 years of age (incidence rate ratio, 1.26; 95% confidence interval, 1.08-1.46)."},{"Node1":"Hyperlipidemias","Edge_Type":"disease","Node2":"Periodontitis","Weight":1,"Paper_List":"26114433","Original_Text":"PMID:26114433; Original text:After adjustment for gender, hyperlipidemia, hypertension and diabetes mellitus, severe treated periodontitis was associated with a mildly but significantly increased risk of the long-term major adverse cardiovascular events among older patients > 60 years of age (incidence rate ratio, 1.26; 95% confidence interval, 1.08-1.46)."},{"Node1":"Hyperlipidemias","Edge_Type":"disease","Node2":"Hypertension","Weight":1,"Paper_List":"26114433","Original_Text":"PMID:26114433; Original text:After adjustment for gender, hyperlipidemia, hypertension and diabetes mellitus, severe treated periodontitis was associated with a mildly but significantly increased risk of the long-term major adverse cardiovascular events among older patients > 60 years of age (incidence rate ratio, 1.26; 95% confidence interval, 1.08-1.46)."},{"Node1":"interleukin 1 receptor antagonist","Edge_Type":"mechanism","Node2":"interleukin 6 cytokine family signal transducer","Weight":2,"Paper_List":"18713481|16022023","Original_Text":"PMID:18713481; Original text:After 12 months the following significant changes could be observed: reduction of clinical probing depth (2.40 v. 2.20 mm; P < 0.001), reduction of gingival inflammation (gingival index 1.13 v. 0.9; P < 0.001), reduced concentrations of IL-1beta (4.63 v. 1.10 pg/ml per site; P < 0.001) as well as IL-6 (1.85 v. 0.34 pg/ml per site; P = 0.022) in gingival crevicular fluid.|PMID:16022023; Original text:The test group also showed statistically greater reduction of IL-1beta at both 3 and 6 months and lower IL-6 concentration, which almost reached the level of significance at 6 months."},{"Node1":"interleukin 1 receptor antagonist","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"18713481","Original_Text":"PMID:18713481; Original text:After 12 months the following significant changes could be observed: reduction of clinical probing depth (2.40 v. 2.20 mm; P < 0.001), reduction of gingival inflammation (gingival index 1.13 v. 0.9; P < 0.001), reduced concentrations of IL-1beta (4.63 v. 1.10 pg/ml per site; P < 0.001) as well as IL-6 (1.85 v. 0.34 pg/ml per site; P = 0.022) in gingival crevicular fluid."},{"Node1":"interleukin 1 receptor antagonist","Edge_Type":"mechanism_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"18713481","Original_Text":"PMID:18713481; Original text:After 12 months the following significant changes could be observed: reduction of clinical probing depth (2.40 v. 2.20 mm; P < 0.001), reduction of gingival inflammation (gingival index 1.13 v. 0.9; P < 0.001), reduced concentrations of IL-1beta (4.63 v. 1.10 pg/ml per site; P < 0.001) as well as IL-6 (1.85 v. 0.34 pg/ml per site; P = 0.022) in gingival crevicular fluid."},{"Node1":"interleukin 6 cytokine family signal transducer","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":3,"Paper_List":"18713481|26093363|24970858","Original_Text":"PMID:18713481; Original text:After 12 months the following significant changes could be observed: reduction of clinical probing depth (2.40 v. 2.20 mm; P < 0.001), reduction of gingival inflammation (gingival index 1.13 v. 0.9; P < 0.001), reduced concentrations of IL-1beta (4.63 v. 1.10 pg/ml per site; P < 0.001) as well as IL-6 (1.85 v. 0.34 pg/ml per site; P = 0.022) in gingival crevicular fluid.|PMID:26093363; Original text:Periodontal treatment significantly reduced the gingival crevicular fluid levels of IL-1β, IL-10, IL-12p70 and IL-6 at 28 weeks' GA compared with controls, while levels of MCP-1, IL-8 and TNF-α exhibited a significant gestational age-dependent increase, but no treatment response.|PMID:24970858; Original text:Significant adjusted differences were found between docosahexaenoic acid and control for both gingival crevicular fluid high-sensitivity C-reactive protein (-5.3 ng/mL, standard error [SE] = 2.4, p = .03) and IL-1β (-20.1 pg/mL, SE = 8.2, p = .02) but not IL-6 (0.02 pg/mL, SE = 0.71, p = .98) or systemic high-sensitivity C-reactive protein (-1.19 mg/L, SE = 0.90, p = .20)."},{"Node1":"interleukin 6 cytokine family signal transducer","Edge_Type":"mechanism_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":4,"Paper_List":"18713481|26093363|22126282|24970858","Original_Text":"PMID:18713481; Original text:After 12 months the following significant changes could be observed: reduction of clinical probing depth (2.40 v. 2.20 mm; P < 0.001), reduction of gingival inflammation (gingival index 1.13 v. 0.9; P < 0.001), reduced concentrations of IL-1beta (4.63 v. 1.10 pg/ml per site; P < 0.001) as well as IL-6 (1.85 v. 0.34 pg/ml per site; P = 0.022) in gingival crevicular fluid.|PMID:26093363; Original text:Periodontal treatment significantly reduced the gingival crevicular fluid levels of IL-1β, IL-10, IL-12p70 and IL-6 at 28 weeks' GA compared with controls, while levels of MCP-1, IL-8 and TNF-α exhibited a significant gestational age-dependent increase, but no treatment response.|PMID:22126282; Original text:Significant reductions in crevicular fluid GM-CSF, IL-1β and the ratio IL-1β/IL-10 and increases in crevicular fluid IL-6 were detected after therapy.|PMID:24970858; Original text:Significant adjusted differences were found between docosahexaenoic acid and control for both gingival crevicular fluid high-sensitivity C-reactive protein (-5.3 ng/mL, standard error [SE] = 2.4, p = .03) and IL-1β (-20.1 pg/mL, SE = 8.2, p = .02) but not IL-6 (0.02 pg/mL, SE = 0.71, p = .98) or systemic high-sensitivity C-reactive protein (-1.19 mg/L, SE = 0.90, p = .20)."},{"Node1":"Sulfur","Edge_Type":"chemical","Node2":"methylmercaptan","Weight":1,"Paper_List":"18302621","Original_Text":"PMID:18302621; Original text:Significant correlations were observed between the organoleptic test score and hydrogen sulfide (hydrogen sulfide), methyl mercapton (methyl mercapton), tongue coating score and volatile sulfur compounds, which was also significantly correlated with bleeding on probing percentage and tongue coating score."},{"Node1":"Hydrogen Sulfide","Edge_Type":"chemical","Node2":"methylmercaptan","Weight":1,"Paper_List":"18302621","Original_Text":"PMID:18302621; Original text:Significant correlations were observed between the organoleptic test score and hydrogen sulfide (hydrogen sulfide), methyl mercapton (methyl mercapton), tongue coating score and volatile sulfur compounds, which was also significantly correlated with bleeding on probing percentage and tongue coating score."},{"Node1":"Hydrogen Sulfide","Edge_Type":"chemical","Node2":"Sulfur","Weight":1,"Paper_List":"18302621","Original_Text":"PMID:18302621; Original text:Significant correlations were observed between the organoleptic test score and hydrogen sulfide (hydrogen sulfide), methyl mercapton (methyl mercapton), tongue coating score and volatile sulfur compounds, which was also significantly correlated with bleeding on probing percentage and tongue coating score."},{"Node1":"methylmercaptan","Edge_Type":"chemical_to_disease","Node2":"Hemorrhage","Weight":1,"Paper_List":"18302621","Original_Text":"PMID:18302621; Original text:Significant correlations were observed between the organoleptic test score and hydrogen sulfide (hydrogen sulfide), methyl mercapton (methyl mercapton), tongue coating score and volatile sulfur compounds, which was also significantly correlated with bleeding on probing percentage and tongue coating score."},{"Node1":"Sulfur","Edge_Type":"chemical_to_disease","Node2":"Hemorrhage","Weight":1,"Paper_List":"18302621","Original_Text":"PMID:18302621; Original text:Significant correlations were observed between the organoleptic test score and hydrogen sulfide (hydrogen sulfide), methyl mercapton (methyl mercapton), tongue coating score and volatile sulfur compounds, which was also significantly correlated with bleeding on probing percentage and tongue coating score."},{"Node1":"Hydrogen Sulfide","Edge_Type":"chemical_to_disease","Node2":"Hemorrhage","Weight":1,"Paper_List":"18302621","Original_Text":"PMID:18302621; Original text:Significant correlations were observed between the organoleptic test score and hydrogen sulfide (hydrogen sulfide), methyl mercapton (methyl mercapton), tongue coating score and volatile sulfur compounds, which was also significantly correlated with bleeding on probing percentage and tongue coating score."},{"Node1":"Cetylpyridinium","Edge_Type":"chemical","Node2":"Chlorhexidine","Weight":5,"Paper_List":"18302621|15898930|15898930|15898930|15811057","Original_Text":"PMID:18302621; Original text:Nonsurgical periodontal treatment and oral hygiene instruction/chlorhexidine + cetyl pyridinium gargling maintained a significantly lower level of malodor compared with baseline.|PMID:15898930; Original text:Even though the initial volatile sulfide compounds values were not high (+/-90 ppb with only 18 patients revealing more than 100 ppb), significant (P <0.05) reductions could be achieved in the chlorhexidine and chlorhexidine + cetyl pyridinium chloride group, and to a lower extent in the placebo group (P = 0.10).|PMID:15898930; Original text:Tongue scraping resulted in a significant reduction (P < or =0.05) of the tongue coating up to month 6 in the placebo and chlorhexidine + cetyl pyridinium chloride group, but not in the chlorhexidine group (confusion due to staining).|PMID:15898930; Original text:The chlorhexidine and chlorhexidine + cetyl pyridinium chloride group showed, in comparison to baseline, significant (P <0.001) reductions in the number of anaerobic species in the supragingival plaque, in the saliva, and on the anterior part of the tongue.|PMID:15811057; Original text:The subjective ratings were slightly in favour of the new Chlorhexidine-CHX 0.05%+ cetyl pyridinium chloride formulation when compared with the other Chlorhexidine-alcohol formulation, especially for taste of the product (p<0.05), but less impressive for the staining of teeth and tongue."},{"Node1":"Spirochetes","Edge_Type":"bacteria_to_chemical","Node2":"Dinoprostone","Weight":1,"Paper_List":"16512758","Original_Text":"PMID:16512758; Original text:When data were combined from all groups, significant reductions in gingival crevicular fluid crevicular prostaglandin E2 levels and number of microorganisms were noted at all time points."},{"Node1":"Spirochetes","Edge_Type":"bacteria_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"16512758","Original_Text":"PMID:16512758; Original text:When data were combined from all groups, significant reductions in gingival crevicular fluid crevicular prostaglandin E2 levels and number of microorganisms were noted at all time points."},{"Node1":"Spirochetes","Edge_Type":"bacteria_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"16512758","Original_Text":"PMID:16512758; Original text:When data were combined from all groups, significant reductions in gingival crevicular fluid crevicular prostaglandin E2 levels and number of microorganisms were noted at all time points."},{"Node1":"Dinoprostone","Edge_Type":"chemical_to_anatomy","Node2":"Gingiva","Weight":5,"Paper_List":"16512758|17199546|10703660|12593597|9706855","Original_Text":"PMID:16512758; Original text:When data were combined from all groups, significant reductions in gingival crevicular fluid crevicular prostaglandin E2 levels and number of microorganisms were noted at all time points.|PMID:17199546; Original text:In group 3, gingival crevicular fluid PGE(2) and TBARS levels exhibited a statistically significant decrease (P <0.05) after the therapy.|PMID:10703660; Original text:Oral irrigation plus routine oral hygiene resulted in a significant reduction in pocket depths, BOP, gingival index and plaque index, as well as interleukin-1 beta levels by 7 days and prostaglandin-E2 levels by 14 days, relative to routine oral hygiene or no oral hygiene.|PMID:12593597; Original text:In the non-selective COX-1/COX-2 inhibitor group, the gingival tissue prostaglandinE2 levels exhibited a significant decrease (P < 0.05).|PMID:9706855; Original text:A statistically significant increase in gingival crevicular fluid prostaglandin E2 levels was noted at days 28 and 42 in the placebo group (P < 0.01), but not in the ketorolac group (P > 0.05), when compared to baseline, however."},{"Node1":"Dinoprostone","Edge_Type":"chemical_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":3,"Paper_List":"16512758|17199546|9706855","Original_Text":"PMID:16512758; Original text:When data were combined from all groups, significant reductions in gingival crevicular fluid crevicular prostaglandin E2 levels and number of microorganisms were noted at all time points.|PMID:17199546; Original text:In group 3, gingival crevicular fluid PGE(2) and TBARS levels exhibited a statistically significant decrease (P <0.05) after the therapy.|PMID:9706855; Original text:A statistically significant increase in gingival crevicular fluid prostaglandin E2 levels was noted at days 28 and 42 in the placebo group (P < 0.01), but not in the ketorolac group (P > 0.05), when compared to baseline, however."},{"Node1":"Arthritis, Rheumatoid","Edge_Type":"disease_to_mechanism","Node2":"immunoglobulin heavy chain (S107 family)","Weight":3,"Paper_List":"16369381|33641208|33641208","Original_Text":"PMID:16369381; Original text:The IgG levels of P gingivalis, P intermedia, P melaninogenica, and B forsythus were found to be significantly higher in rheumatoid arthritis patients when compared with those of the controls.|PMID:33641208; Original text:The patients with a moderate to high rheumatoid arthritis disease activity showed significantly higher levels of probing depth (probing depth), clinical attachment level, anti-cyclic citrullinated peptide IgG, and anti-agalactosyl IgG titer and greater mean percentages of severe periodontitis than those with a low rheumatoid arthritis disease activity (p < .05 for all).|PMID:33641208; Original text:Both univariate and multivariate analyses revealed a significantly positive correlation between the probing depth and rheumatoid arthritis disease activity (p = .009 and p = .001), between the anti-agalactosyl IgG titer and rheumatoid arthritis disease activity (p = .002 and p < .001), and between the anti-agalactosyl IgG titer and probing depth (p < .001 for both)."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"interleukin 1 receptor antagonist","Weight":2,"Paper_List":"16022023|22348697","Original_Text":"PMID:16022023; Original text:The results indicate that adjunctive local delivery of extracts from C. asiatica in combination with P. granatum significantly improved clinical signs of chronic periodontitis and IL-1beta level in maintenance patients.|PMID:22348697; Original text:This review and meta-analysis show that IL1A and IL1B genetic variations are significant contributors to chronic periodontitis in whites."},{"Node1":"Infections","Edge_Type":"disease","Node2":"Pain","Weight":2,"Paper_List":"14611715|8340625","Original_Text":"PMID:14611715; Original text:For the outcomes \"absence of infection\"and \"absence of pain\" the pooled odds ratios (\" the pooled odds ratios) were not statistically significant; for the outcome \"absence of pain and infection,\" 3 studies showed an equivalent treatment effect in both treatment and control groups.|PMID:8340625; Original text:There were no statistically significant differences between methods in relation to pain, facial swelling, sensory loss, infection, or periodontal pocket depth distal to the second molar, although 2% of third molars removed by chisel had lingual sensory disturbance at 7 days, as compared with 8% where burs had been used."},{"Node1":"Cardiovascular Diseases","Edge_Type":"disease","Node2":"Periodontitis","Weight":4,"Paper_List":"11887476|26932733|33810003|33940667","Original_Text":"PMID:11887476; Original text:In addition, the longitudinal studies that failed to show a significant association between periodontitis and cardiovascular disease used the least sensitive and crudest clinical measures of periodontal disease.|PMID:26932733; Original text:Within the limitations of the study, these data suggest that the use of triclosan/copolymer toothpaste significantly slowed the progression of periodontitis in patients with established cardiovascular disease but that it had little influence on key subgingival periodontopathic bacteria in these patients over the 5 years of the study.|PMID:33810003; Original text:metalloproteinase-9 concentrations in serum and saliva were statistically elevated in patients with cardiovascular disease (p < 0.01) and in patients with periodontitis plus cardiovascular disease (p < 0.001) compared to patients with periodontitis and healthy subjects.|PMID:33940667; Original text:In addition, (1) their blood high sensitivity C-reactive protein levels ranged from 0.94 to 12.6 mg/L with a mean of 3.41 mg/L, which is considered high risk for cardiovascular disease (cardiovascular disease) in spite of their statin therapy, and (2) the data demonstrated a positive correlation between severe periodontitis and elevated blood high sensitivity C-reactive protein levels (P< 0.05), consistent with systemic inflammation."},{"Node1":"Cardiovascular Diseases","Edge_Type":"disease","Node2":"Periodontal Diseases","Weight":2,"Paper_List":"11887476|11216961","Original_Text":"PMID:11887476; Original text:In addition, the longitudinal studies that failed to show a significant association between periodontitis and cardiovascular disease used the least sensitive and crudest clinical measures of periodontal disease.|PMID:11216961; Original text:In Cox proportional hazards regression analysis adjusted for age and treatment assignment, physicians who reported periodontal disease at baseline had slightly elevated, but statistically nonsignificant, relative risks (statistically nonsignificant, relative risks) of nonfatal myocardial infarction, (statistically nonsignificant, relative risks, 1.12; 95% confidence interval [CI], 0.92 to 1.36), nonfatal stroke (statistically nonsignificant, relative risks, 1.10; CI, 0.88 to 1.37) and cardiovascular death (statistically nonsignificant, relative risks, 1.20; CI, 0.97 to 1.49)."},{"Node1":"interleukin 1 beta","Edge_Type":"mechanism","Node2":"interleukin 17a/f3","Weight":1,"Paper_List":"29574763","Original_Text":"PMID:29574763; Original text:Clinical parameters, gingival crevicular fluid volumes and the concentrations of interleukin-1β and interleukin-1ra in gingival crevicular fluid were measured at baseline and 1, 3 and 6 months after the treatments."},{"Node1":"interleukin 17a/f3","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"29574763","Original_Text":"PMID:29574763; Original text:Clinical parameters, gingival crevicular fluid volumes and the concentrations of interleukin-1β and interleukin-1ra in gingival crevicular fluid were measured at baseline and 1, 3 and 6 months after the treatments."},{"Node1":"interleukin 17a/f3","Edge_Type":"mechanism_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"29574763","Original_Text":"PMID:29574763; Original text:Clinical parameters, gingival crevicular fluid volumes and the concentrations of interleukin-1β and interleukin-1ra in gingival crevicular fluid were measured at baseline and 1, 3 and 6 months after the treatments."},{"Node1":"Gingiva","Edge_Type":"anatomy","Node2":"Salivary Glands","Weight":3,"Paper_List":"30143550|23479592|25814780","Original_Text":"PMID:30143550; Original text:Baseline and 24-month measurements included radiographic interproximal alveolar bone height, probing depths (probing depths), clinical attachment level (clinical attachment level), bleeding on probing (BOP), gingival crevicular fluid (GCF), and salivary interleukin (IL) - 1β, (24 month only).|PMID:23479592; Original text:Test group (Test group) showed better results after therapy compared to the placebo group with reference to plaque index (P = .004), modified gingival index (P =.002), BOP (P = .021), salivary IL-1ß (P = .05), and uric acid levels (P = .02).|PMID:25814780; Original text:gingival crevicular fluid, salivary and gingival OPG profiles were significantly higher in control subjects compared to chronic periodontitis patients at baseline (P < 0.001)."},{"Node1":"Alveolar Process","Edge_Type":"anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"30143550","Original_Text":"PMID:30143550; Original text:Baseline and 24-month measurements included radiographic interproximal alveolar bone height, probing depths (probing depths), clinical attachment level (clinical attachment level), bleeding on probing (BOP), gingival crevicular fluid (GCF), and salivary interleukin (IL) - 1β, (24 month only)."},{"Node1":"Gingival Crevicular Fluid","Edge_Type":"anatomy","Node2":"Salivary Glands","Weight":2,"Paper_List":"30143550|25814780","Original_Text":"PMID:30143550; Original text:Baseline and 24-month measurements included radiographic interproximal alveolar bone height, probing depths (probing depths), clinical attachment level (clinical attachment level), bleeding on probing (BOP), gingival crevicular fluid (GCF), and salivary interleukin (IL) - 1β, (24 month only).|PMID:25814780; Original text:gingival crevicular fluid, salivary and gingival OPG profiles were significantly higher in control subjects compared to chronic periodontitis patients at baseline (P < 0.001)."},{"Node1":"Alveolar Process","Edge_Type":"anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"30143550","Original_Text":"PMID:30143550; Original text:Baseline and 24-month measurements included radiographic interproximal alveolar bone height, probing depths (probing depths), clinical attachment level (clinical attachment level), bleeding on probing (BOP), gingival crevicular fluid (GCF), and salivary interleukin (IL) - 1β, (24 month only)."},{"Node1":"Alveolar Process","Edge_Type":"anatomy","Node2":"Salivary Glands","Weight":1,"Paper_List":"30143550","Original_Text":"PMID:30143550; Original text:Baseline and 24-month measurements included radiographic interproximal alveolar bone height, probing depths (probing depths), clinical attachment level (clinical attachment level), bleeding on probing (BOP), gingival crevicular fluid (GCF), and salivary interleukin (IL) - 1β, (24 month only)."},{"Node1":"Hemorrhage","Edge_Type":"disease_to_mechanism","Node2":"deleted in malignant brain tumors 1 S homeolog","Weight":1,"Paper_List":"30143550","Original_Text":"PMID:30143550; Original text:Baseline and 24-month measurements included radiographic interproximal alveolar bone height, probing depths (probing depths), clinical attachment level (clinical attachment level), bleeding on probing (BOP), gingival crevicular fluid (GCF), and salivary interleukin (IL) - 1β, (24 month only)."},{"Node1":"Chronic Periodontitis","Edge_Type":"disease_to_anatomy","Node2":"Mast Cells","Weight":1,"Paper_List":"29488617","Original_Text":"PMID:29488617; Original text:The results revealed that the expression of TLR4 in the gingival tissues and on mast cells in the gingival tissues of patients with chronic periodontitis were significantly higher, compared with those of the normal control group (P<0.05)."},{"Node1":"Chronic Periodontitis","Edge_Type":"disease_to_anatomy","Node2":"Periodontal Ligament","Weight":2,"Paper_List":"27468795|24509697","Original_Text":"PMID:27468795; Original text:After therapy, periodontal parameters of chronic periodontitis were significantly improved in both groups.|PMID:24509697; Original text:Results obtained in this study indicate that application of oral treatment with tablets containing probiotic strain of L. reuteri induces in most patients with chronic periodontitis a significant reduction of pro-inflammatory cytokine response and improvement of clinical parameters (sulcus bleeding index, periodontal probing depth, clinical attachment level)."},{"Node1":"Chronic Periodontitis","Edge_Type":"disease_to_anatomy","Node2":"Plasma","Weight":1,"Paper_List":"27468795","Original_Text":"PMID:27468795; Original text:A 6-month regimen of 400 mg propolis once daily is a potentially viable adjunct to root planing that significantly reduces levels of hemoglobinA1c, plasma glucose, and serum N€-(carboxymethyl) lysine, and improves periodontal therapy outcome in people with 2 diabetes mellitus and chronic periodontitis."},{"Node1":"deleted in malignant brain tumors 1 S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"30143550","Original_Text":"PMID:30143550; Original text:Baseline and 24-month measurements included radiographic interproximal alveolar bone height, probing depths (probing depths), clinical attachment level (clinical attachment level), bleeding on probing (BOP), gingival crevicular fluid (GCF), and salivary interleukin (IL) - 1β, (24 month only)."},{"Node1":"deleted in malignant brain tumors 1 S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"30143550","Original_Text":"PMID:30143550; Original text:Baseline and 24-month measurements included radiographic interproximal alveolar bone height, probing depths (probing depths), clinical attachment level (clinical attachment level), bleeding on probing (BOP), gingival crevicular fluid (GCF), and salivary interleukin (IL) - 1β, (24 month only)."},{"Node1":"deleted in malignant brain tumors 1 S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Salivary Glands","Weight":1,"Paper_List":"30143550","Original_Text":"PMID:30143550; Original text:Baseline and 24-month measurements included radiographic interproximal alveolar bone height, probing depths (probing depths), clinical attachment level (clinical attachment level), bleeding on probing (BOP), gingival crevicular fluid (GCF), and salivary interleukin (IL) - 1β, (24 month only)."},{"Node1":"deleted in malignant brain tumors 1 S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Alveolar Process","Weight":1,"Paper_List":"30143550","Original_Text":"PMID:30143550; Original text:Baseline and 24-month measurements included radiographic interproximal alveolar bone height, probing depths (probing depths), clinical attachment level (clinical attachment level), bleeding on probing (BOP), gingival crevicular fluid (GCF), and salivary interleukin (IL) - 1β, (24 month only)."},{"Node1":"Pain","Edge_Type":"disease","Node2":"Periapical Periodontitis","Weight":3,"Paper_List":"25355775|26272704|29397215","Original_Text":"PMID:25355775; Original text:In multivariable modeling, baseline factors predicting severe postoperative pain included current pain intensity (odds ratio [OR], 1.15; 95% confidence interval [CI], 1.07 to 1.25; P = 0.0003), number of days in the past week that the subject was kept from their usual activities due to pain (OR, 1.32; 95% CI, 1.13 to 1.55; P = 0.0005), pain made worse by stress (OR, 2.55; 95% CI, 1.22 to 5.35; P = 0.0130), and a diagnosis of symptomatic apical periodontitis (OR, 1.63; 95% CI, 1.01 to 2.64; P = 0.0452).|PMID:26272704; Original text:Logistic regression analysis showed that teeth with apical periodontitis (OR = 0.35, 95% CI = 0.21-0.57, p < 0.01) and less pre-operative pain (OR = 1.10, 95% CI = 1.03-1.18, p < 0.01) had lower incidences of post-obturation pain after one day.|PMID:29397215; Original text:Preoperative pain and apical periodontitis were significantly different among arms (P < .05); however, it was not the case when the IPC group was excluded."},{"Node1":"Pain, Postoperative","Edge_Type":"disease","Node2":"Periapical Periodontitis","Weight":1,"Paper_List":"25355775","Original_Text":"PMID:25355775; Original text:In multivariable modeling, baseline factors predicting severe postoperative pain included current pain intensity (odds ratio [OR], 1.15; 95% confidence interval [CI], 1.07 to 1.25; P = 0.0003), number of days in the past week that the subject was kept from their usual activities due to pain (OR, 1.32; 95% CI, 1.13 to 1.55; P = 0.0005), pain made worse by stress (OR, 2.55; 95% CI, 1.22 to 5.35; P = 0.0130), and a diagnosis of symptomatic apical periodontitis (OR, 1.63; 95% CI, 1.01 to 2.64; P = 0.0452)."},{"Node1":"Gingiva","Edge_Type":"anatomy","Node2":"Tissues","Weight":5,"Paper_List":"19453849|7767709|34618843|22961538|27435493","Original_Text":"PMID:19453849; Original text:In all groups, there is a significant increase in the prevalence of soft tissue cleft and crater formation (P < 0.01), with increase in plaque index and (ii) gingival index scores at interdental soft tissue defect areas (P < 0.001), 3 months after the operations.|PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells.|PMID:34618843; Original text:Subgroup analysis by sample type showed that subgingival plaque (Subgigival plaque), tissue and gingival crevicular fluid GCF were useful for EBV detection (P<0.001).|PMID:22961538; Original text:A significantly more frequent presence of interdental contact point and interdental soft tissue crater, and narrower base of the interdental papilla were observed at sites with either the Early Wound-Healing Index > 1 or the Early Wound-Healing Index = 4 compared to sites with the Early Wound-Healing Index = 1.|PMID:27435493; Original text:Postsurgery, a higher number of inflammatory cells and stronger expression of proinflammatory cytokines were observed in the epithelium and connective tissue of conventional osseous resective surgery gingival samples compared with fibre retention osseous resective surgery gingival samples (p < 0.001)."},{"Node1":"Curcumin","Edge_Type":"chemical_to_disease","Node2":"Chronic Periodontitis","Weight":1,"Paper_List":"31597806","Original_Text":"PMID:31597806; Original text:The local application of curcumin gel when used in conjunction with root planing showed a significant improvement in periodontal parameters and has a beneficial effect in patients with chronic periodontitis."},{"Node1":"interleukin 4","Edge_Type":"mechanism","Node2":"interleukin 6 cytokine family signal transducer","Weight":1,"Paper_List":"21730256","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01)."},{"Node1":"interleukin 10","Edge_Type":"mechanism","Node2":"interleukin 6 cytokine family signal transducer","Weight":2,"Paper_List":"21730256|23788609","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01).|PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05)."},{"Node1":"interleukin 12B","Edge_Type":"mechanism","Node2":"interleukin 6 cytokine family signal transducer","Weight":2,"Paper_List":"21730256|23788609","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01).|PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05)."},{"Node1":"interleukin 6 cytokine family signal transducer","Edge_Type":"mechanism","Node2":"mast cell protease 1","Weight":4,"Paper_List":"21730256|26093363|23788609|27027257","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01).|PMID:26093363; Original text:Periodontal treatment significantly reduced the gingival crevicular fluid levels of IL-1β, IL-10, IL-12p70 and IL-6 at 28 weeks' GA compared with controls, while levels of MCP-1, IL-8 and TNF-α exhibited a significant gestational age-dependent increase, but no treatment response.|PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05).|PMID:27027257; Original text:GCF levels of IL-1β, IL-6, IFN-γ and MCP-1/CCL2 were significantly higher in subjects diagnosed with chronic periodontitis than periodontally healthy subjects."},{"Node1":"colony stimulating factor 2","Edge_Type":"mechanism","Node2":"interleukin 6 cytokine family signal transducer","Weight":1,"Paper_List":"21730256","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01)."},{"Node1":"interleukin 4 receptor","Edge_Type":"mechanism","Node2":"interleukin 6 cytokine family signal transducer","Weight":1,"Paper_List":"21730256","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01)."},{"Node1":"interleukin 6 cytokine family signal transducer","Edge_Type":"mechanism","Node2":"zinc finger protein 667","Weight":2,"Paper_List":"21730256|23788609","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01).|PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05)."},{"Node1":"interleukin 10","Edge_Type":"mechanism","Node2":"interleukin 4","Weight":1,"Paper_List":"21730256","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01)."},{"Node1":"interleukin 4","Edge_Type":"mechanism","Node2":"interleukin 8-like 2","Weight":1,"Paper_List":"21730256","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01)."},{"Node1":"interleukin 12B","Edge_Type":"mechanism","Node2":"interleukin 4","Weight":1,"Paper_List":"21730256","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01)."},{"Node1":"interleukin 4","Edge_Type":"mechanism","Node2":"mast cell protease 1","Weight":1,"Paper_List":"21730256","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01)."},{"Node1":"colony stimulating factor 2","Edge_Type":"mechanism","Node2":"interleukin 4","Weight":1,"Paper_List":"21730256","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01)."},{"Node1":"interleukin 4","Edge_Type":"mechanism","Node2":"interleukin 4 receptor","Weight":1,"Paper_List":"21730256","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01)."},{"Node1":"interleukin 4","Edge_Type":"mechanism","Node2":"zinc finger protein 667","Weight":1,"Paper_List":"21730256","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01)."},{"Node1":"interleukin 10","Edge_Type":"mechanism","Node2":"interleukin 8-like 2","Weight":1,"Paper_List":"21730256","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01)."},{"Node1":"interleukin 10","Edge_Type":"mechanism","Node2":"interleukin 12B","Weight":2,"Paper_List":"21730256|23788609","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01).|PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05)."},{"Node1":"interleukin 10","Edge_Type":"mechanism","Node2":"mast cell protease 1","Weight":2,"Paper_List":"21730256|23788609","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01).|PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05)."},{"Node1":"colony stimulating factor 2","Edge_Type":"mechanism","Node2":"interleukin 10","Weight":1,"Paper_List":"21730256","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01)."},{"Node1":"interleukin 10","Edge_Type":"mechanism","Node2":"interleukin 4 receptor","Weight":1,"Paper_List":"21730256","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01)."},{"Node1":"interleukin 10","Edge_Type":"mechanism","Node2":"zinc finger protein 667","Weight":2,"Paper_List":"21730256|23788609","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01).|PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05)."},{"Node1":"interleukin 12B","Edge_Type":"mechanism","Node2":"interleukin 8-like 2","Weight":1,"Paper_List":"21730256","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01)."},{"Node1":"interleukin 8-like 2","Edge_Type":"mechanism","Node2":"mast cell protease 1","Weight":2,"Paper_List":"21730256|26093363","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01).|PMID:26093363; Original text:Periodontal treatment significantly reduced the gingival crevicular fluid levels of IL-1β, IL-10, IL-12p70 and IL-6 at 28 weeks' GA compared with controls, while levels of MCP-1, IL-8 and TNF-α exhibited a significant gestational age-dependent increase, but no treatment response."},{"Node1":"colony stimulating factor 2","Edge_Type":"mechanism","Node2":"interleukin 8-like 2","Weight":1,"Paper_List":"21730256","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01)."},{"Node1":"interleukin 4 receptor","Edge_Type":"mechanism","Node2":"interleukin 8-like 2","Weight":1,"Paper_List":"21730256","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01)."},{"Node1":"interleukin 8-like 2","Edge_Type":"mechanism","Node2":"zinc finger protein 667","Weight":1,"Paper_List":"21730256","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01)."},{"Node1":"interleukin 12B","Edge_Type":"mechanism","Node2":"mast cell protease 1","Weight":2,"Paper_List":"21730256|23788609","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01).|PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05)."},{"Node1":"colony stimulating factor 2","Edge_Type":"mechanism","Node2":"interleukin 12B","Weight":1,"Paper_List":"21730256","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01)."},{"Node1":"interleukin 12B","Edge_Type":"mechanism","Node2":"interleukin 4 receptor","Weight":1,"Paper_List":"21730256","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01)."},{"Node1":"interleukin 12B","Edge_Type":"mechanism","Node2":"zinc finger protein 667","Weight":2,"Paper_List":"21730256|23788609","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01).|PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05)."},{"Node1":"colony stimulating factor 2","Edge_Type":"mechanism","Node2":"mast cell protease 1","Weight":1,"Paper_List":"21730256","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01)."},{"Node1":"interleukin 4 receptor","Edge_Type":"mechanism","Node2":"mast cell protease 1","Weight":1,"Paper_List":"21730256","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01)."},{"Node1":"mast cell protease 1","Edge_Type":"mechanism","Node2":"zinc finger protein 667","Weight":2,"Paper_List":"21730256|23788609","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01).|PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05)."},{"Node1":"colony stimulating factor 2","Edge_Type":"mechanism","Node2":"interleukin 4 receptor","Weight":1,"Paper_List":"21730256","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01)."},{"Node1":"colony stimulating factor 2","Edge_Type":"mechanism","Node2":"zinc finger protein 667","Weight":1,"Paper_List":"21730256","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01)."},{"Node1":"interleukin 4 receptor","Edge_Type":"mechanism","Node2":"zinc finger protein 667","Weight":1,"Paper_List":"21730256","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01)."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"interleukin 6 cytokine family signal transducer","Weight":2,"Paper_List":"21730256|32745291","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01).|PMID:32745291; Original text:Meta-analysis of Single nucleotide polymorphisms identified indicated allele T of CTLA4 rs5742909 (3 studies; 461 control, 369 periodontitis) and allele G of IL6 rs1800796 (18 studies; 2760 control, 2442 periodontitis) were significantly associated with periodontitis (OR"},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"interleukin 4","Weight":2,"Paper_List":"21730256|25029213","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01).|PMID:25029213; Original text:The meta-analysis showed that none of these interleukin-4 gene polymorphisms were significantly associated with periodontitis susceptibility in all study participants."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"interleukin 10","Weight":2,"Paper_List":"21730256|30348144","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01).|PMID:30348144; Original text:A significant association between polymorphism of IL10-1082 A > G polymorphism and the risk of chronic periodontitis in the non-Asian populations was observed only in the recessive model (odds ratio,1.42; 95% its 95%confidence interval:1.11, 1.8,I: 43%)."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"interleukin 8-like 2","Weight":1,"Paper_List":"21730256","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01)."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"interleukin 12B","Weight":1,"Paper_List":"21730256","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01)."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"mast cell protease 1","Weight":1,"Paper_List":"21730256","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01)."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"colony stimulating factor 2","Weight":1,"Paper_List":"21730256","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01)."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"interleukin 4 receptor","Weight":1,"Paper_List":"21730256","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01)."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"zinc finger protein 667","Weight":1,"Paper_List":"21730256","Original_Text":"PMID:21730256; Original text:Nine mediators were elevated in localized aggressive periodontitis diseased sites as compared with healthy sites (TNFα, INFγ, IL1β, IL2, IL6, IL10, Il12p40, GMCSF, and MIP1α, p < 0.001), while MCP1, IL4, and IL8 were elevated in healthy sites (p < 0.01)."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_disease","Node2":"Hemorrhage","Weight":2,"Paper_List":"18315426|15626316","Original_Text":"PMID:18315426; Original text:In moderate sites (baseline baseline probing depths 4 to 6 mm), adjunctive 40 mg doxycycline provided significant clinical benefits compared to placebo for mean clinical attachment level (all time points: P <0.05), baseline probing depths (3 months: P = 0.002; 6 and 9 months: P = 0.001), and bleeding on probing (BOP) (3 months: P <0.01; 6 months: P <0.02; 9 months: P <0.05).|PMID:15626316; Original text:Several investigations demonstrated that adjunctive subantimicrobial-dose doxycycline prescribed as an adjunct to conventional therapy provides a statistically significant improvement with respect to probing depth reduction, gain of clinical attachment, decreased bleeding on probing, and reduced incidence of disease progression in patients with chronic periodontitis."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_disease","Node2":"Periodontitis","Weight":7,"Paper_List":"18315426|8724709|12146536|11168739|11168739|15088884|14971246","Original_Text":"PMID:18315426; Original text:40 mg doxycycline used as an adjunct to root planing resulted in significantly greater clinical benefits than root planing alone in the treatment of periodontitis.|PMID:8724709; Original text:We propose: 1) that Specially-formulated low-dose doxycycline inhibits tissue destruction in the absence of either antimicrobial or significant anti-inflammatory efficacy; and 2) that long-term Specially-formulated low-dose doxycycline could be a useful adjunct to instrumentation therapy in the management of the adult periodontitis patient.|PMID:12146536; Original text:The supplementation of hygienist-delivered full mouth subgingival and supragingival debridement with a host-modulating agent, adjunctive subantimicrobial doxycycline, provides clinically and statistically significant benefits in the reduction of deep pockets in patients with severe, generalized periodontitis.|PMID:11168739; Original text:Previous clinical studies have shown that doxycycline administered orally, at doses below those needed for antimicrobial efficacy, to human subjects with adult periodontitis resulted in significantly reduced collagenase activity in gingival crevicular fluid (gingival crevicular fluid) and in extracts of inflamed gingival tissues.|PMID:11168739; Original text:Doxycycline administered at subantimicrobial doses led to improvements in disease parameters, with no apparent side effects, and appears to have significant potential as an oral adjunctive therapy in the long-term management of adult periodontitis.|PMID:15088884; Original text:Consistent with previous studies on animal models of chronic destructive disease (e.g., rheumatoid arthritis), the subantimicrobial dose doxycycline and NSAID ) low-dose flurbiprofen therapy synergistically suppressed MMP and other neutral proteinases in the gingiva of chronic periodontitis patients.|PMID:14971246; Original text:A meta-analysis done on the studies reporting changes in bone or clinical attachment levels and PD following administration of sub-antimicrobial doses of doxycycline (doxycycline) in conjunction with scaling and root planing (root planing) in patients with periodontitis showed a statistically significant beneficial adjunctive effect."},{"Node1":"Lunate Bone","Edge_Type":"anatomy","Node2":"Trapezoid Bone","Weight":1,"Paper_List":"7498042","Original_Text":"PMID:7498042; Original text:No statistically significant change was observed in pocket depth or attachment level between the trapezoidal and the semilunar flaps (p > 0.05)."},{"Node1":"Tannerella Forsythia","Edge_Type":"bacteria_to_chemical","Node2":"boric acid","Weight":1,"Paper_List":"23121460","Original_Text":"PMID:23121460; Original text:For deep pockets (depth ≥7), reductions were similar in the boric acid irrigation and ) SRP + saline irrigationHX groups (P >0.05)."},{"Node1":"Porphyromonas Gingivalis (Organism)","Edge_Type":"bacteria_to_chemical","Node2":"boric acid","Weight":1,"Paper_List":"23121460","Original_Text":"PMID:23121460; Original text:For deep pockets (depth ≥7), reductions were similar in the boric acid irrigation and ) SRP + saline irrigationHX groups (P >0.05)."},{"Node1":"Treponema Denticola (Organism)","Edge_Type":"bacteria_to_chemical","Node2":"boric acid","Weight":1,"Paper_List":"23121460","Original_Text":"PMID:23121460; Original text:For deep pockets (depth ≥7), reductions were similar in the boric acid irrigation and ) SRP + saline irrigationHX groups (P >0.05)."},{"Node1":"boric acid","Edge_Type":"chemical_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"23121460","Original_Text":"PMID:23121460; Original text:gingival index and plaque index scores were significantly lower in the boric acid irrigation and ) SRP + saline irrigationHX groups compared with the ) SRP + saline irrigation group at all time points after treatment (P <0.05)."},{"Node1":"Porphyromonas Gingivalis (Organism)","Edge_Type":"bacteria_to_antibody","Node2":"Anti-immunoglobulin heavy chain (S107 family)","Weight":1,"Paper_List":"17470016","Original_Text":"PMID:17470016; Original text:Maternal anti-Porphyromonas gingivalis IgG was significantly lower in the preterm group compared to the term group (P = 0.028)."},{"Node1":"immunoglobulin heavy chain (S107 family)","Edge_Type":"mechanism_to_antibody","Node2":"Anti-immunoglobulin heavy chain (S107 family)","Weight":1,"Paper_List":"17470016","Original_Text":"PMID:17470016; Original text:Maternal anti-Porphyromonas gingivalis IgG was significantly lower in the preterm group compared to the term group (P = 0.028)."},{"Node1":"Porphyromonas Gingivalis (Organism)","Edge_Type":"bacteria","Node2":"Prevotella Nigrescens","Weight":1,"Paper_List":"17470016","Original_Text":"PMID:17470016; Original text:Postpartum, levels of P. gingivalis, Tannerella forsythia, Prevotella intermedia, and Prevotella nigrescens were statistically significantly higher in preterm births compared to term deliveries, adjusting for baseline levels."},{"Node1":"Prevotella Nigrescens","Edge_Type":"bacteria","Node2":"Tannerella Forsythia","Weight":1,"Paper_List":"17470016","Original_Text":"PMID:17470016; Original text:Postpartum, levels of P. gingivalis, Tannerella forsythia, Prevotella intermedia, and Prevotella nigrescens were statistically significantly higher in preterm births compared to term deliveries, adjusting for baseline levels."},{"Node1":"Prevotella Intermedia","Edge_Type":"bacteria","Node2":"Prevotella Nigrescens","Weight":1,"Paper_List":"17470016","Original_Text":"PMID:17470016; Original text:Postpartum, levels of P. gingivalis, Tannerella forsythia, Prevotella intermedia, and Prevotella nigrescens were statistically significantly higher in preterm births compared to term deliveries, adjusting for baseline levels."},{"Node1":"Membranes","Edge_Type":"anatomy","Node2":"Tooth Components","Weight":1,"Paper_List":"9869347","Original_Text":"PMID:9869347; Original text:The present study demonstrated that: (i) guided tissue regeneration with bioresorbable barrier membranes resulted in a significant added benefit in comparison with access flap alone; (ii) the linear amounts of CAL gains were greater in deep than in shallow defects; (iii) CAL gains expressed as %s of the baseline depths of the intrabony component, were similar in shallow and deep defects; (iii) the regenerative procedure tested in the present study resulted in CAL gains equal to the depth of the intrabony component of the defect in some, but not in most of the instances."},{"Node1":"Blood Platelets","Edge_Type":"anatomy","Node2":"Platelet-Rich Fibrin","Weight":24,"Paper_List":"30882646|30882646|30882646|27452270|27452270|27452270|23317096|23317096|22348695|29023611|28820320|28820320|25654961|30624092|30624092|30624092|33842996|33842996|33842996|33842996|33842996|27966508|27966508|27294433","Original_Text":"PMID:30882646; Original text:Pooled data found that adjunctive platelet-rich fibrin exactly yielded a significantly superior probing depth reduction compared with open flap debridement alone (weighted mean difference, 1.01; 95% confidence interval 0.95-1.08; P < .00001).|PMID:30882646; Original text:Regarding the hard tissue radiographic parameters, including defect depth reduction and percentage of fill defects in bone, adjunctive platelet-rich fibrin yielded significantly superior results compared with open flap debridement alone.|PMID:30882646; Original text:Adjunctive use of platelet-rich fibrin with open flap debridement significantly improves fill defects when compared to open flap debridement alone.|PMID:27452270; Original text:Addition of 1.2% particularly rosuvastatin gel to platelet-rich fibrin resulted in significantly greater CAL gain and depth and IBD depth reductions over 9 months compared with other groups.|PMID:27452270; Original text:open flap debridement with particularly rosuvastatin (1.2%) and platelet-rich fibrin results in significantly greater periodontal benefits compared with open flap debridement alone or with platelet-rich fibrin.|PMID:27452270; Original text:platelet-rich fibrin placement significantly enhanced improvements in periodontal parameters compared with open flap debridement alone.|PMID:23317096; Original text:Relative vertical clinical attachment level gain was also greater in autologous platelet-rich fibrin (2.87 ± 0.85 mm) and autologous platelet-rich plasma (2.71 ± 1.04 mm) sites as compared to control site (1.37 ± 0.58|PMID:23317096; Original text:All clinical and radiographic parameters showed statistically significant improvement at both the test sites (autologous platelet-rich fibrin with OFD and autologous platelet-rich plasma with OFD) compared to those with OFD alone.|PMID:22348695; Original text:Furthermore, significantly greater percentage of mean bone fill was found in the autologous platelet-rich fibrin (55.41% ± 11.39%) and platelet-rich plasma (56.85% ± 14.01%) groups compared with the control (1.56% ± 15.12%) group.|PMID:29023611; Original text:Use of autologous platelet-rich fibrin significantly enhances the clinical and radiographic outcomes of open flap debridement in the treatment of periodontal intraosseous defects in patients affected by localized aggressive periodontitis.|PMID:28820320; Original text:Mean PD reduction and mean clinical attachment level gain were significantly greater in Platelet-rich fibrin compared with the control group.|PMID:28820320; Original text:Furthermore, a significantly greater percentage of mean bone defect change was found in the Platelet-rich fibrin group.|PMID:25654961; Original text:The Emdogain group presented with significantly greater percentage defect resolution (43.07% ± 12.21) than did the platelet-rich fibrin group (32.41% ± 14.61).|PMID:30624092; Original text:PD reduction and clinical attachment level gain were significantly higher in the open flap debridement + leukocyte-platelet-rich fibrin sites than in open flap debridement sites.|PMID:30624092; Original text:leukocyte-platelet-rich fibrin combined with open flap debridement significantly increases growth factors levels and thus, it enhances the periodontal healing on chronic periodontitis patients.|PMID:30624092; Original text:open flap debridement + leukocyte-platelet-rich fibrin group showed significantly increased bone morphogenetic protein-2 and insulin-like growth factor-1 at 2 weeks compared with baseline.|PMID:33842996; Original text:open flap debridement+AA/platelet-rich fibrin and open flap debridement+platelet-rich fibrin showed no differences regarding full-mouth bleeding scores or full-mouth plaque scores (p > 0.05).|PMID:33842996; Original text:open flap debridement+AA/platelet-rich fibrin and open flap debridement+platelet-rich fibrin demonstrated significant intragroup CAL gain and pocket depth reduction at 3 and 6 months (p < 0.001).|PMID:33842996; Original text:open flap debridement+AA/platelet-rich fibrin demonstrated significant gingival recession depth reduction of 0.90 ± 0.50 mm and 0.80 ± 0.71 mm at 3 and 6 months, while open flap debridement+platelet-rich fibrin showed gingival recession depth reduction of 0.10 ± 0.77 mm at 3 months, with an gingival recession depth-increase of 0.20 ± 0.82 mm at 6 months (p < 0.05).|PMID:33842996; Original text:open flap debridement+AA/platelet-rich fibrin and open flap debridement+platelet-rich fibrin demonstrated significant radiographic linear defect depth reduction (2.29 ± 0.61 mm and 1.63 ± 0.46 mm; p < 0.05) and gingival recession depthBD-increase (14.61 ± 5.39% and 12.58 ± 5.03%; p > 0.05).|PMID:33842996; Original text:platelet-rich fibrin, with or without AA, could significantly improve periodontal parameters.|PMID:27966508; Original text:Both platelet-rich fibrin and Both intraoral autogenous bone grafting sites produced a significant improvement from baseline to 9 months for all the parameters.|PMID:27966508; Original text:In addition, Both intraoral autogenous bone grafting showed significantly greater RBF (30.34%) as compared to platelet-rich fibrin (20.22%).|PMID:27294433; Original text:Platelet-rich fibrin + 1.2% atorvastatin and Platelet-rich fibrin alone showed significantly greater depth reduction and 4) relative clinical attachment level gain compared with open flap debridement alone at 9 months."},{"Node1":"Bone and Bones","Edge_Type":"anatomy","Node2":"Platelet-Rich Fibrin","Weight":1,"Paper_List":"30882646","Original_Text":"PMID:30882646; Original text:Regarding the hard tissue radiographic parameters, including defect depth reduction and percentage of fill defects in bone, adjunctive platelet-rich fibrin yielded significantly superior results compared with open flap debridement alone."},{"Node1":"Blood Platelets","Edge_Type":"anatomy","Node2":"Bone and Bones","Weight":1,"Paper_List":"30882646","Original_Text":"PMID:30882646; Original text:Regarding the hard tissue radiographic parameters, including defect depth reduction and percentage of fill defects in bone, adjunctive platelet-rich fibrin yielded significantly superior results compared with open flap debridement alone."},{"Node1":"Plateletcrit","Edge_Type":"mechanism_to_anatomy","Node2":"Bone and Bones","Weight":1,"Paper_List":"30882646","Original_Text":"PMID:30882646; Original text:Regarding the hard tissue radiographic parameters, including defect depth reduction and percentage of fill defects in bone, adjunctive platelet-rich fibrin yielded significantly superior results compared with open flap debridement alone."},{"Node1":"Plateletcrit","Edge_Type":"mechanism_to_anatomy","Node2":"Platelet-Rich Fibrin","Weight":14,"Paper_List":"30882646|30882646|27452270|27452270|27452270|29023611|28820320|28820320|25654961|33842996|33842996|27966508|27966508|27294433","Original_Text":"PMID:30882646; Original text:Regarding the hard tissue radiographic parameters, including defect depth reduction and percentage of fill defects in bone, adjunctive platelet-rich fibrin yielded significantly superior results compared with open flap debridement alone.|PMID:30882646; Original text:Adjunctive use of platelet-rich fibrin with open flap debridement significantly improves fill defects when compared to open flap debridement alone.|PMID:27452270; Original text:Addition of 1.2% particularly rosuvastatin gel to platelet-rich fibrin resulted in significantly greater CAL gain and depth and IBD depth reductions over 9 months compared with other groups.|PMID:27452270; Original text:open flap debridement with particularly rosuvastatin (1.2%) and platelet-rich fibrin results in significantly greater periodontal benefits compared with open flap debridement alone or with platelet-rich fibrin.|PMID:27452270; Original text:platelet-rich fibrin placement significantly enhanced improvements in periodontal parameters compared with open flap debridement alone.|PMID:29023611; Original text:Use of autologous platelet-rich fibrin significantly enhances the clinical and radiographic outcomes of open flap debridement in the treatment of periodontal intraosseous defects in patients affected by localized aggressive periodontitis.|PMID:28820320; Original text:Mean PD reduction and mean clinical attachment level gain were significantly greater in Platelet-rich fibrin compared with the control group.|PMID:28820320; Original text:Furthermore, a significantly greater percentage of mean bone defect change was found in the Platelet-rich fibrin group.|PMID:25654961; Original text:The Emdogain group presented with significantly greater percentage defect resolution (43.07% ± 12.21) than did the platelet-rich fibrin group (32.41% ± 14.61).|PMID:33842996; Original text:open flap debridement+AA/platelet-rich fibrin and open flap debridement+platelet-rich fibrin demonstrated significant intragroup CAL gain and pocket depth reduction at 3 and 6 months (p < 0.001).|PMID:33842996; Original text:platelet-rich fibrin, with or without AA, could significantly improve periodontal parameters.|PMID:27966508; Original text:Both platelet-rich fibrin and Both intraoral autogenous bone grafting sites produced a significant improvement from baseline to 9 months for all the parameters.|PMID:27966508; Original text:In addition, Both intraoral autogenous bone grafting showed significantly greater RBF (30.34%) as compared to platelet-rich fibrin (20.22%).|PMID:27294433; Original text:Platelet-rich fibrin + 1.2% atorvastatin and Platelet-rich fibrin alone showed significantly greater depth reduction and 4) relative clinical attachment level gain compared with open flap debridement alone at 9 months."},{"Node1":"Plateletcrit","Edge_Type":"mechanism_to_anatomy","Node2":"Blood Platelets","Weight":14,"Paper_List":"30882646|30882646|27452270|27452270|27452270|29023611|28820320|28820320|25654961|33842996|33842996|27966508|27966508|27294433","Original_Text":"PMID:30882646; Original text:Regarding the hard tissue radiographic parameters, including defect depth reduction and percentage of fill defects in bone, adjunctive platelet-rich fibrin yielded significantly superior results compared with open flap debridement alone.|PMID:30882646; Original text:Adjunctive use of platelet-rich fibrin with open flap debridement significantly improves fill defects when compared to open flap debridement alone.|PMID:27452270; Original text:Addition of 1.2% particularly rosuvastatin gel to platelet-rich fibrin resulted in significantly greater CAL gain and depth and IBD depth reductions over 9 months compared with other groups.|PMID:27452270; Original text:open flap debridement with particularly rosuvastatin (1.2%) and platelet-rich fibrin results in significantly greater periodontal benefits compared with open flap debridement alone or with platelet-rich fibrin.|PMID:27452270; Original text:platelet-rich fibrin placement significantly enhanced improvements in periodontal parameters compared with open flap debridement alone.|PMID:29023611; Original text:Use of autologous platelet-rich fibrin significantly enhances the clinical and radiographic outcomes of open flap debridement in the treatment of periodontal intraosseous defects in patients affected by localized aggressive periodontitis.|PMID:28820320; Original text:Mean PD reduction and mean clinical attachment level gain were significantly greater in Platelet-rich fibrin compared with the control group.|PMID:28820320; Original text:Furthermore, a significantly greater percentage of mean bone defect change was found in the Platelet-rich fibrin group.|PMID:25654961; Original text:The Emdogain group presented with significantly greater percentage defect resolution (43.07% ± 12.21) than did the platelet-rich fibrin group (32.41% ± 14.61).|PMID:33842996; Original text:open flap debridement+AA/platelet-rich fibrin and open flap debridement+platelet-rich fibrin demonstrated significant intragroup CAL gain and pocket depth reduction at 3 and 6 months (p < 0.001).|PMID:33842996; Original text:platelet-rich fibrin, with or without AA, could significantly improve periodontal parameters.|PMID:27966508; Original text:Both platelet-rich fibrin and Both intraoral autogenous bone grafting sites produced a significant improvement from baseline to 9 months for all the parameters.|PMID:27966508; Original text:In addition, Both intraoral autogenous bone grafting showed significantly greater RBF (30.34%) as compared to platelet-rich fibrin (20.22%).|PMID:27294433; Original text:Platelet-rich fibrin + 1.2% atorvastatin and Platelet-rich fibrin alone showed significantly greater depth reduction and 4) relative clinical attachment level gain compared with open flap debridement alone at 9 months."},{"Node1":"Periodontitis","Edge_Type":"disease","Node2":"Peripheral Arterial Disease","Weight":2,"Paper_List":"29980169|29980169","Original_Text":"PMID:29980169; Original text:The pooled analysis showed that there was a significant difference in the risk of periodontitis between both peripheral arterial disease patients and non-both peripheral arterial disease participants (RR = 1.70, 95% CI = 1.25-2.29, P = 0.01).|PMID:29980169; Original text:In conclusion, the results of this meta-analysis revealed a significant relationship between periodontitis and both peripheral arterial disease."},{"Node1":"cytidylyl-(3'-5')-cytidine","Edge_Type":"chemical_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"25197740","Original_Text":"PMID:25197740; Original text:Mechanical interdental plaque control using interdental brushes combined with the use of CPC gel significantly improved 6-month gingival and periodontal outcomes (SBI and PD) compared with mechanical cleaning with interdental brushes alone."},{"Node1":"Cholesterol","Edge_Type":"chemical_to_mechanism","Node2":"component of oligomeric golgi complex 1","Weight":1,"Paper_List":"17639748","Original_Text":"PMID:17639748; Original text:In the third month, there was a significant decrease in total and low density lipoprotein (total and low density lipoprotein) cholesterol levels of the treatment group compared with baseline values."},{"Node1":"Cholesterol","Edge_Type":"chemical_to_mechanism","Node2":"low-density lipoprotein receptor (ldl)","Weight":1,"Paper_List":"17639748","Original_Text":"PMID:17639748; Original text:The present study indicates that periodontitis causes changes in total and total and low density lipoprotein cholesterol levels and local periodontal treatment resulted in a significant decrease in these markers."},{"Node1":"Cortical Bone","Edge_Type":"anatomy","Node2":"Gingiva","Weight":3,"Paper_List":"17274711|26547514|26547514","Original_Text":"PMID:17274711; Original text:At 12 months, a significantly greater gingival recession increase in the derivative group (1.1 +/- 0.7 mm) compared to the derivative + autogenous cortical bone particulate group (0.3 +/- 0.8 mm) was observed (P <0.05).|PMID:26547514; Original text:Similarly, vascular endothelial growth factor concentration in gingival crevicular fluid was significantly higher in the ankaferd blood stopper/autogenous cortical bone graft group at postoperative weeks 2 and 4 compared to the autogenous cortical bone graft group (p < 0.01).|PMID:26547514; Original text:Intergroup comparisons showed that there was a significantly higher gain in clinical attachment level in the ankaferd blood stopper/autogenous cortical bone graft group compared to autogenous cortical bone graft group (p < 0.05) with significantly less clinical attachment level and gingival recession (p < 0.05)."},{"Node1":"Ibuprofen","Edge_Type":"chemical","Node2":"rofecoxib","Weight":3,"Paper_List":"12540224|12540224|12540224","Original_Text":"PMID:12540224; Original text:The purpose of this study was to determine if prophylactic rofecoxib would significantly reduce postendodontic pain, when compared with ibuprofen or placebo.|PMID:12540224; Original text:Results showed that at the 4- and 8-h periods, both rofecoxib and ibuprofen provided significantly better pain relief than placebo.|PMID:12540224; Original text:At the 12- and 24-h periods, rofecoxib demonstrated significantly better pain relief than both ibuprofen and placebo."},{"Node1":"rofecoxib","Edge_Type":"chemical_to_disease","Node2":"Pain","Weight":3,"Paper_List":"12540224|12540224|12540224","Original_Text":"PMID:12540224; Original text:The purpose of this study was to determine if prophylactic rofecoxib would significantly reduce postendodontic pain, when compared with ibuprofen or placebo.|PMID:12540224; Original text:Results showed that at the 4- and 8-h periods, both rofecoxib and ibuprofen provided significantly better pain relief than placebo.|PMID:12540224; Original text:At the 12- and 24-h periods, rofecoxib demonstrated significantly better pain relief than both ibuprofen and placebo."},{"Node1":"Ibuprofen","Edge_Type":"chemical_to_disease","Node2":"Pain","Weight":3,"Paper_List":"12540224|12540224|12540224","Original_Text":"PMID:12540224; Original text:The purpose of this study was to determine if prophylactic rofecoxib would significantly reduce postendodontic pain, when compared with ibuprofen or placebo.|PMID:12540224; Original text:Results showed that at the 4- and 8-h periods, both rofecoxib and ibuprofen provided significantly better pain relief than placebo.|PMID:12540224; Original text:At the 12- and 24-h periods, rofecoxib demonstrated significantly better pain relief than both ibuprofen and placebo."},{"Node1":"Aggregatibacter Actinomycetemcomitans","Edge_Type":"bacteria","Node2":"Treponema Denticola (Organism)","Weight":5,"Paper_List":"22220822|25056413|26355881|29327449|26313005","Original_Text":"PMID:22220822; Original text:The most beneficial changes were observed in the test group which showed significantly greater improvements in probing depth and clinical attachment level and a lower prevalence of Aggregatibacter actinomycetemcomitans, Treponema denticola, and Tannerella forsythia compared to the control one (p < 0.05).|PMID:25056413; Original text:However, it resulted in a higher reduction of BOP at 3 and 12 months comparing to US alone or hand instruments (antimicrobial photodynamic therapy from 25 to 13 and to 9%, US from 23 to 16 and to 12%, and hand instruments from 17 to 10 and to 9%, respectively).|PMID:26355881; Original text:At day 90, Baseline BOP, PD and Clinical attachment level reduction was higher in T (p<0.05).|PMID:29327449; Original text:Evaluation using clinical parameters showed better results in low-level laser therapy group.|PMID:26313005; Original text:The mere presence of Pg, even in low amount, was significantly associated with severe periodontitis, while the amount of Aggregatibacter actinomycetemcomitans, Treponema denticola, and Prevotella intermedia had to reach the critical thresholds to be significantly associated with disease."},{"Node1":"Aggregatibacter Actinomycetemcomitans","Edge_Type":"bacteria","Node2":"Tannerella Forsythia","Weight":7,"Paper_List":"22220822|23705535|25056413|32865464|26355881|32696031|32696031","Original_Text":"PMID:22220822; Original text:The most beneficial changes were observed in the test group which showed significantly greater improvements in probing depth and clinical attachment level and a lower prevalence of Aggregatibacter actinomycetemcomitans, Treponema denticola, and Tannerella forsythia compared to the control one (p < 0.05).|PMID:23705535; Original text:These subjects also showed significant reductions in the number of certain periodontopathogens, such as Tannerella forsythia, Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans.|PMID:25056413; Original text:However, it resulted in a higher reduction of BOP at 3 and 12 months comparing to US alone or hand instruments (antimicrobial photodynamic therapy from 25 to 13 and to 9%, US from 23 to 16 and to 12%, and hand instruments from 17 to 10 and to 9%, respectively).|PMID:32865464; Original text: mm after 12 months of follow-up.|PMID:26355881; Original text:At day 90, Baseline BOP, PD and Clinical attachment level reduction was higher in T (p<0.05).|PMID:32696031; Original text:The effects of the therapies on probing depth and clinical attachment level, including interactions with Aggregatibacter actinomycetemcomitans, Pg, or Tannerella forsythia at baseline, were explored using regression models.<br /> Results: At 6 months, all treatment groups showed improved clinical outcomes in patients harboring Aggregatibacter actinomycetemcomitans, Pg, or Tannerella forsythia at baseline compared to the patients who did not harbor these microorganisms at baseline.|PMID:32696031; Original text:Furthermore, the percentage of sites ≥ 6 mm was reduced in the test groups, compared to the control group; these periodontopathogens were not present in sites with probing depth ≥ 6 mm in the MXF group."},{"Node1":"Amoxicillin","Edge_Type":"chemical","Node2":"Metronidazole","Weight":24,"Paper_List":"22220822|11314884|17850607|26221918|21846460|21846460|24930639|26007680|27013640|11966932|12787214|26654350|20447259|17618330|26273264|31834660|26034931|22882646|27498443|27498443|27498443|21062335|14971252|22288485","Original_Text":"PMID:22220822; Original text:Systemic administration of metronidazole and amoxicillin as an adjunct to the One-Stage-Full-Mouth-Disinfection protocol therapy significantly improved clinical and microbiological outcomes in patients with generalized aggressive periodontitis patients over a 6-month period.|PMID:11314884; Original text:the testhis study has shown that systemic usage of metronidazole and amoxicillin, when used in conjunction with initial periodontal treatment in adult periodontitis patients, achieves significantly better clinical and microbiological results than initial periodontal treatment alone.|PMID:17850607; Original text:Finally, amoxicillin/metronidazole patients presented significantly more Clinical attachment level \"gain\", PD reduction and less remaining deep sites after 6 months.|PMID:26221918; Original text:This study showed that subjects taking metronidazole and amoxicillin at the initial phase of treatment exhibited statistically significantly greater reduction in pocket depth and gain in clinical attachment level in initially deep sites (PD≥7 mm) than subjects taking antibiotics after healing (p<0.05).|PMID:21846460; Original text:Values for a probing pocket depth and clinical attachment level were more improved in the antibiotic groups than in the root planing group, and more improved in the metronidazole and amoxicillin group than in the doxycycline group (p < 0.05).|PMID:21846460; Original text:Systemic use of metronidazole and amoxicillin or doxycycline was clinically superior to root planing for reducing a probing pocket depths ≥ 7 mm (p < 0.05).|PMID:24930639; Original text:The adjunctive use of metronidazole+ + amoxicillin significantly improved the clinical and microbiological outcomes of root planing in the treatment of type 2 diabetic subjects with chronic periodontitis.|PMID:26007680; Original text:Within the limits of the present study, it may be suggested that in patients with aggressive periodontitis, nonsurgical periodontal therapy in conjunction with adjunctive systemic administration of amoxicilin and metronidazole is more effective in reducing GCF MMP-8 levels compared to the adjunctive use of photodynamic therapy.|PMID:27013640; Original text:(P < 0.05) at 2 y posttreatment. systemic metronidazole + amoxicillin intake was the only significant predictor of subjects achieving the low risk at 2 y (odds ratio, 20.9; P = 0.0000).|PMID:11966932; Original text:The significant differences among treatment groups and the overall trend in the data, in line with other studies, support the considerable adjunctive benefits to root planing of amoxycillin and metronidazole combined in the treatment of advanced chronic periodontal disease.|PMID:12787214; Original text:This analysis showed a statistically significant additional benefit for spiramycin (pocket depth change) and amoxicillin/metronidazole (CAL change) in deep pockets.|PMID:26654350; Original text:Amoxicillin plus metronidazole did not significantly affect the resistance pattern of the The viridans group streptococci to penicillin or erythromycin.|PMID:20447259; Original text:Subjects with generalized aggressive periodontitis significantly benefit from the adjunctive use of metronidazole and amoxicillin.|PMID:17618330; Original text:The significant differences between treatment and placebo groups are in line with other studies and support the considerable adjunctive benefits of the combination of amoxicillin and metronidazole in the treatment of chronic periodontitis.|PMID:26273264; Original text:In the T group, significant increases in the The minimum inhibitory concentrations of chlorhexidine (p < 0.05) and amoxicillin (p < 0.01) were detected during the first 3 months; however, the MIC of metronidazole decreased at 12 months (p < 0.05).|PMID:31834660; Original text:The periodontal therapy periodontal treatment using a combination of metronidazole and amoxicillin significantly improved the metabolic outcome in addition to periodontal health in diabetic subjects with periodontitis periodontitis.|PMID:26034931; Original text:Systemic administration of moxifloxacin as an adjunct to non-surgical treatment significantly improves clinical outcomes and provides comparable clinical improvement with less adverse events to that of combination of amoxicillin and metronidazole in the treatment of generalized aggressive periodontitis.|PMID:22882646; Original text:Subjects receiving metronidazole plus amoxicillin exhibited the deepest reductions in mean probing depth (PD) and gain in clinical attachment between baseline and 1 year post-therapy in the full-mouth analysis and in initially intermediate (PD 4-6 mm) and deep (PD ≥ 7 mm) sites (p < 0.01).|PMID:27498443; Original text:The improvement in the control group of patients on the day 7 was 19% in BOP and 28% in gingival index; this improvement was statistically highly significant after the addition of amoxicillin plus metronodazole (71% in BOP and 77% in gingival index) or cefixime (62% in BOP and 82% in gingival index).|PMID:27498443; Original text:Compared to the combination of amoxicillin and metronidazole, cefixim was statistically significantly more effective for gingival index (p < 0.05), while for the other three clinical parameters their effects were equal.|PMID:27498443; Original text:The conjunction of amoxicillin plus metronidazole or cefixime to the causal treatment of patients with chronic periodontitis led to statistically significant improvement in efficacy in relation to gingival index and BOP parameters, while cefixime was statistically significantly more efficient than the combination of amoxicillin and metronidazole for gingival index.|PMID:21062335; Original text:Previously, we showed that systemic metronidazole and amoxicillin significantly improved the outcomes of non-surgical debridement in generalized aggressive periodontitis patients.|PMID:14971252; Original text:When examining the effects of individual or combinations of antibiotics, it was found that there were statistically significant improvements in mean attachment level change for tetracycline, metronidazole, and an effect of borderline statistical significance for the combination of amoxicillin plus metronidazole.|PMID:22288485; Original text:Amoxicillin/metronidazole used as an adjunct to the full-mouth ultrasonic debridement protocol added clinical and microbiologic benefits to GAgP treatment (P <0.05)."},{"Node1":"amelogenin X-linked","Edge_Type":"mechanism_to_anatomy","Node2":"Membranes","Weight":2,"Paper_List":"15212355|11846197","Original_Text":"PMID:15212355; Original text:All cases treated with guided tissue regeneration presented at least one surgical complication, mostly membrane exposure, while only 6% of enamel matrix proteins treated sites displayed complications (P < 0.0001).|PMID:11846197; Original text:The 1-year results indicated that: 1) all treatment modalities resulted in clinically significant improvements in clinical attachment levels (clinical attachment levels) and reduction in probing depth (probing depth); 2) a statistically significant treatment effect was demonstrated comparing the enamel matrix proteins test, the membrane control, and the flap control groups in terms of clinical attachment levels gains; 3) both the enamel matrix proteins test and the membrane control groups showed significant clinical attachment levels gains compared to the flap control group; 4) a statistically significantly greater amount of clinical attachment levels gain was demonstrated in guided tissue regeneration-treated compared to enamel matrix proteins-treated patients; 5) deeper residual probing depths but smaller increases in gingival recession were demonstrated following enamel matrix proteins therapy; and 6) smoking habits reduced the clinical outcomes of both regenerative procedures."},{"Node1":"Selenomonas","Edge_Type":"bacteria","Node2":"Spirochetes","Weight":1,"Paper_List":"1602034","Original_Text":"PMID:1602034; Original text:These clinical improvements in the metronidazole group were associated with significantly lower proportions of spirochetes, selenomonads, motile rods, and P. intermedius, and a significantly higher proportion of cocci in the plaques."},{"Node1":"Spirochetes","Edge_Type":"bacteria_to_chemical","Node2":"Metronidazole","Weight":1,"Paper_List":"1602034","Original_Text":"PMID:1602034; Original text:These clinical improvements in the metronidazole group were associated with significantly lower proportions of spirochetes, selenomonads, motile rods, and P. intermedius, and a significantly higher proportion of cocci in the plaques."},{"Node1":"Selenomonas","Edge_Type":"bacteria_to_chemical","Node2":"Metronidazole","Weight":1,"Paper_List":"1602034","Original_Text":"PMID:1602034; Original text:These clinical improvements in the metronidazole group were associated with significantly lower proportions of spirochetes, selenomonads, motile rods, and P. intermedius, and a significantly higher proportion of cocci in the plaques."},{"Node1":"Spirochetes","Edge_Type":"bacteria_to_anatomy","Node2":"Lunate Bone","Weight":1,"Paper_List":"1602034","Original_Text":"PMID:1602034; Original text:These clinical improvements in the metronidazole group were associated with significantly lower proportions of spirochetes, selenomonads, motile rods, and P. intermedius, and a significantly higher proportion of cocci in the plaques."},{"Node1":"Selenomonas","Edge_Type":"bacteria_to_anatomy","Node2":"Lunate Bone","Weight":1,"Paper_List":"1602034","Original_Text":"PMID:1602034; Original text:These clinical improvements in the metronidazole group were associated with significantly lower proportions of spirochetes, selenomonads, motile rods, and P. intermedius, and a significantly higher proportion of cocci in the plaques."},{"Node1":"Metronidazole","Edge_Type":"chemical_to_anatomy","Node2":"Lunate Bone","Weight":1,"Paper_List":"1602034","Original_Text":"PMID:1602034; Original text:These clinical improvements in the metronidazole group were associated with significantly lower proportions of spirochetes, selenomonads, motile rods, and P. intermedius, and a significantly higher proportion of cocci in the plaques."},{"Node1":"lactotransferrin","Edge_Type":"mechanism_to_anatomy","Node2":"Salivary Glands","Weight":1,"Paper_List":"18727656","Original_Text":"PMID:18727656; Original text:Salivary Lf level was also significantly decreased in the test group smokers."},{"Node1":"Actinobacillus Actinomycetemcomitans","Edge_Type":"bacteria","Node2":"Eikenella Corrodens (Organism)","Weight":1,"Paper_List":"15898936","Original_Text":"PMID:15898936; Original text:7 mm a significantly (P <0.05) higher frequency of 2 mm or more attachment gain (37.3% +/- 4.6%) and lower frequency of attachment loss (7.2% +/- 3.1%) compared to the 17 controls (8.2% +/- 3.9% and 19.1% +/- 13.1%, respectively)."},{"Node1":"Eikenella Corrodens (Organism)","Edge_Type":"bacteria","Node2":"Porphyromonas Gingivalis (Organism)","Weight":1,"Paper_List":"15898936","Original_Text":"PMID:15898936; Original text:7 mm a significantly (P <0.05) higher frequency of 2 mm or more attachment gain (37.3% +/- 4.6%) and lower frequency of attachment loss (7.2% +/- 3.1%) compared to the 17 controls (8.2% +/- 3.9% and 19.1% +/- 13.1%, respectively)."},{"Node1":"Actinobacillus Actinomycetemcomitans","Edge_Type":"bacteria","Node2":"Porphyromonas Gingivalis (Organism)","Weight":7,"Paper_List":"15898936|9477013|9650874|15642054|24617449|17618330|8396177","Original_Text":"PMID:15898936; Original text:7 mm a significantly (P <0.05) higher frequency of 2 mm or more attachment gain (37.3% +/- 4.6%) and lower frequency of attachment loss (7.2% +/- 3.1%) compared to the 17 controls (8.2% +/- 3.9% and 19.1% +/- 13.1%, respectively).|PMID:9477013; Original text:A. actinomycetemcomitans was detected in the oral cavity, i.e., subgingival plaque and/or mucous membranes, less frequently in chlorhexidine digluconate patients compared to controls at 9 and 12 months (p<0.01), whereas, the intraoral detection frequency of P. gingivalis was significantly reduced only 10 days following therapy (p<0.001).|PMID:9650874; Original text:In contrast, patients initially harboring P. gingivalis but not A. actinomycetemcomitans in the oral cavity showed a significantly higher incidence of attachment level loss following adjunctive antimicrobial therapy compared to scaling alone (p<0.05).|PMID:15642054; Original text:The levels of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Tannerella forsythensis (Bacteroides forsythus) remained unchanged in untreated sites while levels of Prevetolla intermedia and Treponema denticola tended to decrease as compared with controls but did not reach significance.|PMID:24617449; Original text:A statistically significant improvement in gingival index and gingival bleeding index was seen for the test group after 2 weeks and 1 month of antimicrobial photodynamic therapy (p < 0.01), whereas the improvement in gingival index and gingival bleeding index at 3 months and in plaque index at 2 weeks after antimicrobial photodynamic therapy was less (p < 0.05).|PMID:17618330; Original text:Parallel to the clinical changes, treatment significantly reduced the number of Actinobacillus actinomycetemcomitans (Actinobacillus actinomycetemcomitans), Porphyromonas gingivalis (Pg), and P. intermedia (P. intermedia) compared with baseline in the T group (P=0.003, 0.021 and 0.0001, respectively).|PMID:8396177; Original text:Subgingival minocycline ointment resulted in statistically significantly greater reduction of P. gingivalis at weeks 2, 4, 6, and 12; P. intermedia at weeks 2, 4, 6, and 12; and A. actinomycetemcomitans at weeks 6 and 12."},{"Node1":"JIL-1 kinase","Edge_Type":"mechanism","Node2":"matrix metallopeptidase 8","Weight":3,"Paper_List":"21614479|31543299|31543299","Original_Text":"PMID:21614479; Original text:Although levels of IL-1β and MMP-8 in gingival crevicular fluid after treatment were lower in the test side than the control side, there was not a statistically significant difference (p > 0.05).|PMID:31543299; Original text:Compared with controls, BOP was reduced more prominently, IL-1β and MMP-8 were significantly lower, and reductions in pocket depth and clinical attachment loss were slightly greater in the PTT group at 4-6 weeks (0.05-0.19 mm).|PMID:31543299; Original text:All examined teeth showed modest reductions in probing pocket depth (pocket depth), clinical attachment loss (clinical attachment loss), bleeding upon probing (BOP), and plaque score at 4-6 weeks and 6 months and significant reductions in IL-1β and MMP-8 at 6 months."},{"Node1":"JIL-1 kinase","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":5,"Paper_List":"21614479|20535518|26093363|24970858|31641967","Original_Text":"PMID:21614479; Original text:Although levels of IL-1β and MMP-8 in gingival crevicular fluid after treatment were lower in the test side than the control side, there was not a statistically significant difference (p > 0.05).|PMID:20535518; Original text:However, levels of IL-1 β in gingival crevicular fluid were significantly lower after root planing+NDL treatment when compared to IL-1 β levels obtained by root planing alone after 4 weeks of treatment.|PMID:26093363; Original text:Periodontal treatment significantly reduced the gingival crevicular fluid levels of IL-1β, IL-10, IL-12p70 and IL-6 at 28 weeks' GA compared with controls, while levels of MCP-1, IL-8 and TNF-α exhibited a significant gestational age-dependent increase, but no treatment response.|PMID:24970858; Original text:Significant adjusted differences were found between docosahexaenoic acid and control for both gingival crevicular fluid high-sensitivity C-reactive protein (-5.3 ng/mL, standard error [SE] = 2.4, p = .03) and IL-1β (-20.1 pg/mL, SE = 8.2, p = .02) but not IL-6 (0.02 pg/mL, SE = 0.71, p = .98) or systemic high-sensitivity C-reactive protein (-1.19 mg/L, SE = 0.90, p = .20).|PMID:31641967; Original text:Comparing the test and control quadrant after treatment, the test quadrant showed significant decrease in pocket depth at 1 month, 3 months, and 6 months; in gingival index at 3 months and 6 months; in clinical attachment level at month 6; in GCF at 1 week, 1 month, 3 months, and 6 months; and in IL-1β data at 3 months in comparison to the control quadrant."},{"Node1":"JIL-1 kinase","Edge_Type":"mechanism_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":5,"Paper_List":"21614479|20535518|26093363|22126282|24970858","Original_Text":"PMID:21614479; Original text:Although levels of IL-1β and MMP-8 in gingival crevicular fluid after treatment were lower in the test side than the control side, there was not a statistically significant difference (p > 0.05).|PMID:20535518; Original text:However, levels of IL-1 β in gingival crevicular fluid were significantly lower after root planing+NDL treatment when compared to IL-1 β levels obtained by root planing alone after 4 weeks of treatment.|PMID:26093363; Original text:Periodontal treatment significantly reduced the gingival crevicular fluid levels of IL-1β, IL-10, IL-12p70 and IL-6 at 28 weeks' GA compared with controls, while levels of MCP-1, IL-8 and TNF-α exhibited a significant gestational age-dependent increase, but no treatment response.|PMID:22126282; Original text:Significant reductions in crevicular fluid GM-CSF, IL-1β and the ratio IL-1β/IL-10 and increases in crevicular fluid IL-6 were detected after therapy.|PMID:24970858; Original text:Significant adjusted differences were found between docosahexaenoic acid and control for both gingival crevicular fluid high-sensitivity C-reactive protein (-5.3 ng/mL, standard error [SE] = 2.4, p = .03) and IL-1β (-20.1 pg/mL, SE = 8.2, p = .02) but not IL-6 (0.02 pg/mL, SE = 0.71, p = .98) or systemic high-sensitivity C-reactive protein (-1.19 mg/L, SE = 0.90, p = .20)."},{"Node1":"matrix metallopeptidase 8","Edge_Type":"mechanism_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":6,"Paper_List":"21614479|22621750|11846190|15025222|18062117|18062117","Original_Text":"PMID:21614479; Original text:Although levels of IL-1β and MMP-8 in gingival crevicular fluid after treatment were lower in the test side than the control side, there was not a statistically significant difference (p > 0.05).|PMID:22621750; Original text:crevicular fluid matrix metalloproteinase-8 levels were significantly reduced only in root planing + short-term adjunctive subantimicrobial dose doxycycline group (P < 0.01).|PMID:11846190; Original text:The gingival crevicular fluid MMP-8 level on day 10 in the meloxicam group was similar to the clinically healthy control group (P>0.05), while it was significantly higher in the placebo group (P<0.01).|PMID:15025222; Original text:The gingival crevicular fluid MMP-8 level in the a low-dose doxycycline group was significantly lower than that of the placebo group at 6 months (P < 0.05).|PMID:18062117; Original text:In all groups, the reduction of gingival crevicular fluid matrix metalloproteinase-8 levels after therapy was statistically significant compared to baseline levels (P < 0.001).|PMID:18062117; Original text:When groups 1 and 3 and 2 and 4 were compared according to gingival crevicular fluid matrix metalloproteinase-8 levels after the therapy, no statistically significant differences were observed (P = 0.117 and P = 0.485, respectively)."},{"Node1":"Simvastatin","Edge_Type":"chemical_to_anatomy","Node2":"Bone and Bones","Weight":2,"Paper_List":"22420871|23713634","Original_Text":"PMID:22420871; Original text:Furthermore, significantly greater mean percentage of bone fill was found in the Simvastatin group (32.64% ± 12.90%) compared to the placebo group (4.22% ± 9.75%) after 9 months.|PMID:23713634; Original text:Furthermore, significantly greater mean percentage of bone fill was found in the Simvastatin group (32.37 ± 10.23%) compared to the placebo (4.18 ± 5.39%)."},{"Node1":"Chronic Periodontitis","Edge_Type":"disease","Node2":"Hemorrhage","Weight":4,"Paper_List":"22420871|23713634|24509697|15626316","Original_Text":"PMID:22420871; Original text:There was a greater decrease in modified sulcus bleeding index and depth and more clinical attachment level gain with significant intrabony defect fill at sites treated with root planing plus locally delivered Simvastatin in patients with type 2 diabetes and chronic periodontitis.|PMID:23713634; Original text:There was a greater decrease in modified sulcus bleeding index and PD and more clinical attachment level gain with significant intrabony defect fill at sites treated with root planing plus locally delivered Simvastatin in smokers with chronic periodontitis.|PMID:24509697; Original text:Results obtained in this study indicate that application of oral treatment with tablets containing probiotic strain of L. reuteri induces in most patients with chronic periodontitis a significant reduction of pro-inflammatory cytokine response and improvement of clinical parameters (sulcus bleeding index, periodontal probing depth, clinical attachment level).|PMID:15626316; Original text:Several investigations demonstrated that adjunctive subantimicrobial-dose doxycycline prescribed as an adjunct to conventional therapy provides a statistically significant improvement with respect to probing depth reduction, gain of clinical attachment, decreased bleeding on probing, and reduced incidence of disease progression in patients with chronic periodontitis."},{"Node1":"Chronic Periodontitis","Edge_Type":"disease","Node2":"Diabetes Mellitus, Type 2","Weight":4,"Paper_List":"22420871|25811944|19656023|24655616","Original_Text":"PMID:22420871; Original text:There was a greater decrease in modified sulcus bleeding index and depth and more clinical attachment level gain with significant intrabony defect fill at sites treated with root planing plus locally delivered Simvastatin in patients with type 2 diabetes and chronic periodontitis.|PMID:25811944; Original text:Gingival tissues from patients with chronic periodontitis and type 2 diabetes mellitus had a significant increase in visfatin and a decrease in leptin gene and protein expression (P <0.05) compared with both controls and patients with chronic periodontitis.|PMID:19656023; Original text:root planing and PMSRP were equally effective in treating chronic periodontitis in subjects with type 2 diabetes, without significant improvements in the glycemic control at 3 and 6 months.|PMID:24655616; Original text:Individuals with type 2 diabetes mellitus (type 2 diabetes mellitus) and chronic periodontitis have significantly higher levels of interleukin-1 beta compared with systemically healthy individuals with chronic periodontitis."},{"Node1":"Diabetes Mellitus, Type 2","Edge_Type":"disease","Node2":"Hemorrhage","Weight":2,"Paper_List":"22420871|21804283","Original_Text":"PMID:22420871; Original text:There was a greater decrease in modified sulcus bleeding index and depth and more clinical attachment level gain with significant intrabony defect fill at sites treated with root planing plus locally delivered Simvastatin in patients with type 2 diabetes and chronic periodontitis.|PMID:21804283; Original text:The levels of clinical periodontal variables, the probing depth, attachment loss, bleeding index, and plaque index were improved significantly in type 2 diabetes mellitus-T group after 3 months compared to type 2 diabetes mellitus-NT group (all p<0.01)."},{"Node1":"Simvastatin","Edge_Type":"chemical_to_disease","Node2":"Chronic Periodontitis","Weight":3,"Paper_List":"22420871|23713634|20151799","Original_Text":"PMID:22420871; Original text:There was a greater decrease in modified sulcus bleeding index and depth and more clinical attachment level gain with significant intrabony defect fill at sites treated with root planing plus locally delivered Simvastatin in patients with type 2 diabetes and chronic periodontitis.|PMID:23713634; Original text:There was a greater decrease in modified sulcus bleeding index and PD and more clinical attachment level gain with significant intrabony defect fill at sites treated with root planing plus locally delivered Simvastatin in smokers with chronic periodontitis.|PMID:20151799; Original text:There was a greater decrease in gingival index and depth and more clinical attachment level gain with significant intrabony defect fill at sites treated with root planing plus locally delivered Simvastatin in patients with chronic periodontitis."},{"Node1":"Simvastatin","Edge_Type":"chemical_to_disease","Node2":"Hemorrhage","Weight":2,"Paper_List":"22420871|23713634","Original_Text":"PMID:22420871; Original text:There was a greater decrease in modified sulcus bleeding index and depth and more clinical attachment level gain with significant intrabony defect fill at sites treated with root planing plus locally delivered Simvastatin in patients with type 2 diabetes and chronic periodontitis.|PMID:23713634; Original text:There was a greater decrease in modified sulcus bleeding index and PD and more clinical attachment level gain with significant intrabony defect fill at sites treated with root planing plus locally delivered Simvastatin in smokers with chronic periodontitis."},{"Node1":"Simvastatin","Edge_Type":"chemical_to_disease","Node2":"Diabetes Mellitus, Type 2","Weight":1,"Paper_List":"22420871","Original_Text":"PMID:22420871; Original text:There was a greater decrease in modified sulcus bleeding index and depth and more clinical attachment level gain with significant intrabony defect fill at sites treated with root planing plus locally delivered Simvastatin in patients with type 2 diabetes and chronic periodontitis."},{"Node1":"Metronidazole","Edge_Type":"chemical_to_anatomy","Node2":"Gingiva","Weight":4,"Paper_List":"12710758|27498443|27498443|27498443","Original_Text":"PMID:12710758; Original text:There were no statistically significant differences in plaque index, gingival index, BOP, depth, or clinical attachment level between metronidazole gel and a placebo gel sites.|PMID:27498443; Original text:The improvement in the control group of patients on the day 7 was 19% in BOP and 28% in gingival index; this improvement was statistically highly significant after the addition of amoxicillin plus metronodazole (71% in BOP and 77% in gingival index) or cefixime (62% in BOP and 82% in gingival index).|PMID:27498443; Original text:Compared to the combination of amoxicillin and metronidazole, cefixim was statistically significantly more effective for gingival index (p < 0.05), while for the other three clinical parameters their effects were equal.|PMID:27498443; Original text:The conjunction of amoxicillin plus metronidazole or cefixime to the causal treatment of patients with chronic periodontitis led to statistically significant improvement in efficacy in relation to gingival index and BOP parameters, while cefixime was statistically significantly more efficient than the combination of amoxicillin and metronidazole for gingival index."},{"Node1":"Azithromycin","Edge_Type":"chemical_to_mechanism","Node2":"immunoglobulin heavy chain (S107 family)","Weight":1,"Paper_List":"31292965","Original_Text":"PMID:31292965; Original text:IgG titers for P gingivalis significantly decreased after root planing with systemically administered azithromycin, and the body temperature increased significantly after root planing without systemically administered azithromycin."},{"Node1":"Hemorrhage","Edge_Type":"disease","Node2":"Sleep Initiation and Maintenance Disorders","Weight":1,"Paper_List":"30298556","Original_Text":"PMID:30298556; Original text: months of therapy, whereas the measurements of pocket depth reduction (PD reduction), bleeding on probing (BOP %), and the changes in salivary TNF-α levels and Athens insomnia scale (insomnia scale) scores represented the secondary endpoints."},{"Node1":"Sleep Initiation and Maintenance Disorders","Edge_Type":"disease_to_mechanism","Node2":"saliva","Weight":1,"Paper_List":"30298556","Original_Text":"PMID:30298556; Original text: months of therapy, whereas the measurements of pocket depth reduction (PD reduction), bleeding on probing (BOP %), and the changes in salivary TNF-α levels and Athens insomnia scale (insomnia scale) scores represented the secondary endpoints."},{"Node1":"Hemorrhage","Edge_Type":"disease_to_mechanism","Node2":"saliva","Weight":1,"Paper_List":"30298556","Original_Text":"PMID:30298556; Original text: months of therapy, whereas the measurements of pocket depth reduction (PD reduction), bleeding on probing (BOP %), and the changes in salivary TNF-α levels and Athens insomnia scale (insomnia scale) scores represented the secondary endpoints."},{"Node1":"Chronic Periodontitis","Edge_Type":"disease_to_anatomy","Node2":"Salivary Glands","Weight":2,"Paper_List":"25814780|28177133","Original_Text":"PMID:25814780; Original text:gingival crevicular fluid, salivary and gingival OPG profiles were significantly higher in control subjects compared to chronic periodontitis patients at baseline (P < 0.001).|PMID:28177133; Original text:The results demonstrated that dietary supplementation with low-dose omega-3 omega-3 polyunsaturated fatty acids improves salivary TNF-α without any significant impact on clinical parameters in patients with chronic periodontitis, suggesting that the systemic benefits of dietary omega-3 omega-3 polyunsaturated fatty acids may not be translated to periodontal health."},{"Node1":"saliva","Edge_Type":"mechanism_to_anatomy","Node2":"Salivary Glands","Weight":4,"Paper_List":"30298556|23479592|29504999|28177133","Original_Text":"PMID:30298556; Original text: months of therapy, whereas the measurements of pocket depth reduction (PD reduction), bleeding on probing (BOP %), and the changes in salivary TNF-α levels and Athens insomnia scale (insomnia scale) scores represented the secondary endpoints.|PMID:23479592; Original text:Test group (Test group) showed better results after therapy compared to the placebo group with reference to plaque index (P = .004), modified gingival index (P =.002), BOP (P = .021), salivary IL-1ß (P = .05), and uric acid levels (P = .02).|PMID:29504999; Original text:Our meta-analysis showed that salivary the salivary matrix metalloproteinase-8 levels were significantly higher in periodontitis patients compared with healthy controls overall.|PMID:28177133; Original text:The results demonstrated that dietary supplementation with low-dose omega-3 omega-3 polyunsaturated fatty acids improves salivary TNF-α without any significant impact on clinical parameters in patients with chronic periodontitis, suggesting that the systemic benefits of dietary omega-3 omega-3 polyunsaturated fatty acids may not be translated to periodontal health."},{"Node1":"Confusion","Edge_Type":"disease_to_anatomy","Node2":"Tongue","Weight":1,"Paper_List":"15898930","Original_Text":"PMID:15898930; Original text:Tongue scraping resulted in a significant reduction (P < or =0.05) of the tongue coating up to month 6 in the placebo and chlorhexidine + cetyl pyridinium chloride group, but not in the chlorhexidine group (confusion due to staining)."},{"Node1":"interleukin 6 L homeolog","Edge_Type":"mechanism","Node2":"matrix metallopeptidase 8","Weight":2,"Paper_List":"29683364|29683364","Original_Text":"PMID:29683364; Original text:Serum salivary and serum matrix metalloproteinase-8 (p < .001; p < .001) and interleukin-6 (p < .001; p = .002) were significantly higher in Crheumatoid arthritis vs. other study groups during the study.|PMID:29683364; Original text:Salivary salivary and serum matrix metalloproteinase-8 (p = .010) and interleukin-6 (p = .010) were significantly higher in Erheumatoid arthritis vs. other study groups at baseline."},{"Node1":"Arthritis, Rheumatoid","Edge_Type":"disease_to_mechanism","Node2":"interleukin 6 L homeolog","Weight":2,"Paper_List":"29683364|29683364","Original_Text":"PMID:29683364; Original text:Serum salivary and serum matrix metalloproteinase-8 (p < .001; p < .001) and interleukin-6 (p < .001; p = .002) were significantly higher in Crheumatoid arthritis vs. other study groups during the study.|PMID:29683364; Original text:Salivary salivary and serum matrix metalloproteinase-8 (p = .010) and interleukin-6 (p = .010) were significantly higher in Erheumatoid arthritis vs. other study groups at baseline."},{"Node1":"Arthritis, Rheumatoid","Edge_Type":"disease_to_mechanism","Node2":"matrix metallopeptidase 8","Weight":2,"Paper_List":"29683364|29683364","Original_Text":"PMID:29683364; Original text:Serum salivary and serum matrix metalloproteinase-8 (p < .001; p < .001) and interleukin-6 (p < .001; p = .002) were significantly higher in Crheumatoid arthritis vs. other study groups during the study.|PMID:29683364; Original text:Salivary salivary and serum matrix metalloproteinase-8 (p = .010) and interleukin-6 (p = .010) were significantly higher in Erheumatoid arthritis vs. other study groups at baseline."},{"Node1":"Coronary Artery Disease","Edge_Type":"disease_to_anatomy","Node2":"Coronary Vessels","Weight":3,"Paper_List":"21357860|25466412|25466412","Original_Text":"PMID:21357860; Original text:More research is needed to determine whether subantimicrobial-dose-doxycycline has a role in managing the care of patients at risk of developing coronary artery disease.|PMID:25466412; Original text:In-depth genotyping of 46 published coronary artery disease risk loci of genome-wide significance in the worldwide largest case-control sample of the severe early-onset phenotype aggressive periodontitis (the severe early-onset phenotype aggressive periodontitis) with the Illumina Immunochip (600 German the severe early-onset phenotype aggressive periodontitis cases, 1448 controls) and the Affymetrix 500K array set (283 German the severe early-onset phenotype aggressive periodontitis cases and 972 controls) highlighted ANRIL as the major risk gene and revealed further associations with the severe early-onset phenotype aggressive periodontitis for the gene PLASMINOGEN (PLG; rs4252120: P=5.9×10(-5); odds ratio, 1.27; 95% confidence interval, 1.3-1.4 [adjusted for smoking and sex]; 818 cases; 5309 controls).|PMID:25466412; Original text:Subsequent combined analyses of several genome-wide data sets of coronary artery disease and the severe early-onset phenotype aggressive periodontitis suggested TGFBRAP1 to be associated with the severe early-onset phenotype aggressive periodontitis (rs2679895: P=0.0016; odds ratio, 1.27 [95% confidence interval, 1.1-1.5]; 703 cases; 2.143 controls) and coronary artery disease (P=0.0003; odds ratio, 0.84 [95% confidence interval, 0.8-0.9]; n=4117 cases; 5824 controls)."},{"Node1":"interleukin 6 L homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Salivary Glands","Weight":2,"Paper_List":"29683364|29683364","Original_Text":"PMID:29683364; Original text:Serum salivary and serum matrix metalloproteinase-8 (p < .001; p < .001) and interleukin-6 (p < .001; p = .002) were significantly higher in Crheumatoid arthritis vs. other study groups during the study.|PMID:29683364; Original text:Salivary salivary and serum matrix metalloproteinase-8 (p = .010) and interleukin-6 (p = .010) were significantly higher in Erheumatoid arthritis vs. other study groups at baseline."},{"Node1":"matrix metallopeptidase 8","Edge_Type":"mechanism_to_anatomy","Node2":"Salivary Glands","Weight":2,"Paper_List":"29683364|29683364","Original_Text":"PMID:29683364; Original text:Serum salivary and serum matrix metalloproteinase-8 (p < .001; p < .001) and interleukin-6 (p < .001; p = .002) were significantly higher in Crheumatoid arthritis vs. other study groups during the study.|PMID:29683364; Original text:Salivary salivary and serum matrix metalloproteinase-8 (p = .010) and interleukin-6 (p = .010) were significantly higher in Erheumatoid arthritis vs. other study groups at baseline."},{"Node1":"Periodontal Pocket","Edge_Type":"disease","Node2":"Periodontitis","Weight":1,"Paper_List":"26932733","Original_Text":"PMID:26932733; Original text:Within the limitations of the study, these data suggest that the use of triclosan/copolymer toothpaste significantly slowed the progression of periodontitis in patients with established cardiovascular disease but that it had little influence on key subgingival periodontopathic bacteria in these patients over the 5 years of the study."},{"Node1":"Cardiovascular Diseases","Edge_Type":"disease","Node2":"Periodontal Pocket","Weight":1,"Paper_List":"26932733","Original_Text":"PMID:26932733; Original text:Within the limitations of the study, these data suggest that the use of triclosan/copolymer toothpaste significantly slowed the progression of periodontitis in patients with established cardiovascular disease but that it had little influence on key subgingival periodontopathic bacteria in these patients over the 5 years of the study."},{"Node1":"Triclosan","Edge_Type":"chemical_to_disease","Node2":"Periodontal Pocket","Weight":1,"Paper_List":"26932733","Original_Text":"PMID:26932733; Original text:Within the limitations of the study, these data suggest that the use of triclosan/copolymer toothpaste significantly slowed the progression of periodontitis in patients with established cardiovascular disease but that it had little influence on key subgingival periodontopathic bacteria in these patients over the 5 years of the study."},{"Node1":"Triclosan","Edge_Type":"chemical_to_disease","Node2":"Periodontitis","Weight":1,"Paper_List":"26932733","Original_Text":"PMID:26932733; Original text:Within the limitations of the study, these data suggest that the use of triclosan/copolymer toothpaste significantly slowed the progression of periodontitis in patients with established cardiovascular disease but that it had little influence on key subgingival periodontopathic bacteria in these patients over the 5 years of the study."},{"Node1":"Triclosan","Edge_Type":"chemical_to_disease","Node2":"Cardiovascular Diseases","Weight":1,"Paper_List":"26932733","Original_Text":"PMID:26932733; Original text:Within the limitations of the study, these data suggest that the use of triclosan/copolymer toothpaste significantly slowed the progression of periodontitis in patients with established cardiovascular disease but that it had little influence on key subgingival periodontopathic bacteria in these patients over the 5 years of the study."},{"Node1":"planinin","Edge_Type":"chemical_to_mechanism","Node2":"JIL-1 kinase","Weight":1,"Paper_List":"20535518","Original_Text":"PMID:20535518; Original text:However, levels of IL-1 β in gingival crevicular fluid were significantly lower after root planing+NDL treatment when compared to IL-1 β levels obtained by root planing alone after 4 weeks of treatment."},{"Node1":"planinin","Edge_Type":"chemical_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"20535518","Original_Text":"PMID:20535518; Original text:However, levels of IL-1 β in gingival crevicular fluid were significantly lower after root planing+NDL treatment when compared to IL-1 β levels obtained by root planing alone after 4 weeks of treatment."},{"Node1":"planinin","Edge_Type":"chemical_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"20535518","Original_Text":"PMID:20535518; Original text:However, levels of IL-1 β in gingival crevicular fluid were significantly lower after root planing+NDL treatment when compared to IL-1 β levels obtained by root planing alone after 4 weeks of treatment."},{"Node1":"planinin","Edge_Type":"chemical_to_mechanism","Node2":"tumor necrosis factor receptor superfamily, member a","Weight":1,"Paper_List":"20535518","Original_Text":"PMID:20535518; Original text:Levels of TNF-α were significantly lower after the root planing+NDL treatment during post-therapy."},{"Node1":"Actinobacillus Actinomycetemcomitans","Edge_Type":"bacteria_to_chemical","Node2":"Doxycycline","Weight":1,"Paper_List":"15732860","Original_Text":"PMID:15732860; Original text:No statistically significant difference was found in the reduction of Actinobacillus actinomycetemcomitans in either the doxycycline or SRP group (P > 0.05)."},{"Node1":"Tannerella Forsythensis","Edge_Type":"bacteria_to_chemical","Node2":"Doxycycline","Weight":2,"Paper_List":"15732860|15732860","Original_Text":"PMID:15732860; Original text:The reduction in Tannerella forsythensis, Pg, and Tannerella forsythensis + Pg was statistically significant for doxycycline only (P = 0.016, 0.027, and 0.027, respectively).|PMID:15732860; Original text:The proportion of sites free of Tannerella forsythensis at 3 months was 53% for doxycycline and 9% for SRP (P = 0.02)."},{"Node1":"Membranes","Edge_Type":"anatomy","Node2":"Mucous Membrane","Weight":2,"Paper_List":"9477013|29202571","Original_Text":"PMID:9477013; Original text:A. actinomycetemcomitans was detected in the oral cavity, i.e., subgingival plaque and/or mucous membranes, less frequently in chlorhexidine digluconate patients compared to controls at 9 and 12 months (p<0.01), whereas, the intraoral detection frequency of P. gingivalis was significantly reduced only 10 days following therapy (p<0.001).|PMID:29202571; Original text:The emollient and restructuring action exerted on the mucous membranes by hyaluronic acid is of particular significance."},{"Node1":"Mouth","Edge_Type":"anatomy","Node2":"Mucous Membrane","Weight":1,"Paper_List":"9477013","Original_Text":"PMID:9477013; Original text:A. actinomycetemcomitans was detected in the oral cavity, i.e., subgingival plaque and/or mucous membranes, less frequently in chlorhexidine digluconate patients compared to controls at 9 and 12 months (p<0.01), whereas, the intraoral detection frequency of P. gingivalis was significantly reduced only 10 days following therapy (p<0.001)."},{"Node1":"Membranes","Edge_Type":"anatomy","Node2":"Mouth","Weight":1,"Paper_List":"9477013","Original_Text":"PMID:9477013; Original text:A. actinomycetemcomitans was detected in the oral cavity, i.e., subgingival plaque and/or mucous membranes, less frequently in chlorhexidine digluconate patients compared to controls at 9 and 12 months (p<0.01), whereas, the intraoral detection frequency of P. gingivalis was significantly reduced only 10 days following therapy (p<0.001)."},{"Node1":"Actinobacillus Actinomycetemcomitans","Edge_Type":"bacteria_to_chemical","Node2":"chlorhexidine gluconate","Weight":1,"Paper_List":"9477013","Original_Text":"PMID:9477013; Original text:A. actinomycetemcomitans was detected in the oral cavity, i.e., subgingival plaque and/or mucous membranes, less frequently in chlorhexidine digluconate patients compared to controls at 9 and 12 months (p<0.01), whereas, the intraoral detection frequency of P. gingivalis was significantly reduced only 10 days following therapy (p<0.001)."},{"Node1":"Porphyromonas Gingivalis (Organism)","Edge_Type":"bacteria_to_chemical","Node2":"chlorhexidine gluconate","Weight":1,"Paper_List":"9477013","Original_Text":"PMID:9477013; Original text:A. actinomycetemcomitans was detected in the oral cavity, i.e., subgingival plaque and/or mucous membranes, less frequently in chlorhexidine digluconate patients compared to controls at 9 and 12 months (p<0.01), whereas, the intraoral detection frequency of P. gingivalis was significantly reduced only 10 days following therapy (p<0.001)."},{"Node1":"Actinobacillus Actinomycetemcomitans","Edge_Type":"bacteria_to_anatomy","Node2":"Mucous Membrane","Weight":1,"Paper_List":"9477013","Original_Text":"PMID:9477013; Original text:A. actinomycetemcomitans was detected in the oral cavity, i.e., subgingival plaque and/or mucous membranes, less frequently in chlorhexidine digluconate patients compared to controls at 9 and 12 months (p<0.01), whereas, the intraoral detection frequency of P. gingivalis was significantly reduced only 10 days following therapy (p<0.001)."},{"Node1":"Actinobacillus Actinomycetemcomitans","Edge_Type":"bacteria_to_anatomy","Node2":"Membranes","Weight":1,"Paper_List":"9477013","Original_Text":"PMID:9477013; Original text:A. actinomycetemcomitans was detected in the oral cavity, i.e., subgingival plaque and/or mucous membranes, less frequently in chlorhexidine digluconate patients compared to controls at 9 and 12 months (p<0.01), whereas, the intraoral detection frequency of P. gingivalis was significantly reduced only 10 days following therapy (p<0.001)."},{"Node1":"Actinobacillus Actinomycetemcomitans","Edge_Type":"bacteria_to_anatomy","Node2":"Mouth","Weight":2,"Paper_List":"9477013|9650874","Original_Text":"PMID:9477013; Original text:A. actinomycetemcomitans was detected in the oral cavity, i.e., subgingival plaque and/or mucous membranes, less frequently in chlorhexidine digluconate patients compared to controls at 9 and 12 months (p<0.01), whereas, the intraoral detection frequency of P. gingivalis was significantly reduced only 10 days following therapy (p<0.001).|PMID:9650874; Original text:In contrast, patients initially harboring P. gingivalis but not A. actinomycetemcomitans in the oral cavity showed a significantly higher incidence of attachment level loss following adjunctive antimicrobial therapy compared to scaling alone (p<0.05)."},{"Node1":"Porphyromonas Gingivalis (Organism)","Edge_Type":"bacteria_to_anatomy","Node2":"Mucous Membrane","Weight":1,"Paper_List":"9477013","Original_Text":"PMID:9477013; Original text:A. actinomycetemcomitans was detected in the oral cavity, i.e., subgingival plaque and/or mucous membranes, less frequently in chlorhexidine digluconate patients compared to controls at 9 and 12 months (p<0.01), whereas, the intraoral detection frequency of P. gingivalis was significantly reduced only 10 days following therapy (p<0.001)."},{"Node1":"Porphyromonas Gingivalis (Organism)","Edge_Type":"bacteria_to_anatomy","Node2":"Membranes","Weight":1,"Paper_List":"9477013","Original_Text":"PMID:9477013; Original text:A. actinomycetemcomitans was detected in the oral cavity, i.e., subgingival plaque and/or mucous membranes, less frequently in chlorhexidine digluconate patients compared to controls at 9 and 12 months (p<0.01), whereas, the intraoral detection frequency of P. gingivalis was significantly reduced only 10 days following therapy (p<0.001)."},{"Node1":"Porphyromonas Gingivalis (Organism)","Edge_Type":"bacteria_to_anatomy","Node2":"Mouth","Weight":3,"Paper_List":"9477013|9650874|21861637","Original_Text":"PMID:9477013; Original text:A. actinomycetemcomitans was detected in the oral cavity, i.e., subgingival plaque and/or mucous membranes, less frequently in chlorhexidine digluconate patients compared to controls at 9 and 12 months (p<0.01), whereas, the intraoral detection frequency of P. gingivalis was significantly reduced only 10 days following therapy (p<0.001).|PMID:9650874; Original text:In contrast, patients initially harboring P. gingivalis but not A. actinomycetemcomitans in the oral cavity showed a significantly higher incidence of attachment level loss following adjunctive antimicrobial therapy compared to scaling alone (p<0.05).|PMID:21861637; Original text:Total P. gingivalis counts in the oral cavity were significantly reduced after full-mouth GPAP compared to coronal polishing at day 90 (P <0.05)."},{"Node1":"chlorhexidine gluconate","Edge_Type":"chemical_to_anatomy","Node2":"Mucous Membrane","Weight":1,"Paper_List":"9477013","Original_Text":"PMID:9477013; Original text:A. actinomycetemcomitans was detected in the oral cavity, i.e., subgingival plaque and/or mucous membranes, less frequently in chlorhexidine digluconate patients compared to controls at 9 and 12 months (p<0.01), whereas, the intraoral detection frequency of P. gingivalis was significantly reduced only 10 days following therapy (p<0.001)."},{"Node1":"chlorhexidine gluconate","Edge_Type":"chemical_to_anatomy","Node2":"Membranes","Weight":1,"Paper_List":"9477013","Original_Text":"PMID:9477013; Original text:A. actinomycetemcomitans was detected in the oral cavity, i.e., subgingival plaque and/or mucous membranes, less frequently in chlorhexidine digluconate patients compared to controls at 9 and 12 months (p<0.01), whereas, the intraoral detection frequency of P. gingivalis was significantly reduced only 10 days following therapy (p<0.001)."},{"Node1":"chlorhexidine gluconate","Edge_Type":"chemical_to_anatomy","Node2":"Mouth","Weight":1,"Paper_List":"9477013","Original_Text":"PMID:9477013; Original text:A. actinomycetemcomitans was detected in the oral cavity, i.e., subgingival plaque and/or mucous membranes, less frequently in chlorhexidine digluconate patients compared to controls at 9 and 12 months (p<0.01), whereas, the intraoral detection frequency of P. gingivalis was significantly reduced only 10 days following therapy (p<0.001)."},{"Node1":"Spirochaetes","Edge_Type":"bacteria_to_chemical","Node2":"Azithromycin","Weight":1,"Paper_List":"8951627","Original_Text":"PMID:8951627; Original text:Counts of spirochaetes were significantly reduced throughout the study in patients who received azithromycin compared to placebo."},{"Node1":"interleukin 1 beta","Edge_Type":"mechanism","Node2":"tumor necrosis factor receptor superfamily, member a","Weight":1,"Paper_List":"27619532","Original_Text":"PMID:27619532; Original text:Four antimicrobial photodynamic therapy studies showed significant reduction in interleukin-1β while one study showed significant reduction in TNF-α levels after antimicrobial photodynamic therapy application at follow-up."},{"Node1":"interleukin 6 L homeolog","Edge_Type":"mechanism","Node2":"tissue inhibitor of metalloproteinase-1 L homeolog","Weight":2,"Paper_List":"27619532|23161345","Original_Text":"PMID:27619532; Original text:One study showed significant reduction of IFN-γ, interleukin-8 and granulocyte colony-stimulating factor levels after antimicrobial photodynamic therapy at follow-up. interleukin-1β significantly reduced in 4 laser therapy studies, while one study showed significant decrease for interleukin-6 and TIMP-1 levels.|PMID:23161345; Original text:The total amount of IL-1β, interleukin-6, MMP-1, metalloproteinase-8, and TIMP-1 decreased (p < 0.05) and interleukin-8 increased after treatment in both diode laser and control groups (p < 0.05)."},{"Node1":"methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2 like","Edge_Type":"mechanism","Node2":"tissue inhibitor of metalloproteinase-1 L homeolog","Weight":2,"Paper_List":"27619532|23161345","Original_Text":"PMID:27619532; Original text:One study showed significant reduction of IFN-γ, interleukin-8 and granulocyte colony-stimulating factor levels after antimicrobial photodynamic therapy at follow-up. interleukin-1β significantly reduced in 4 laser therapy studies, while one study showed significant decrease for interleukin-6 and TIMP-1 levels.|PMID:23161345; Original text:The total amount of IL-1β, interleukin-6, MMP-1, metalloproteinase-8, and TIMP-1 decreased (p < 0.05) and interleukin-8 increased after treatment in both diode laser and control groups (p < 0.05)."},{"Node1":"interleukin 1 beta","Edge_Type":"mechanism","Node2":"tissue inhibitor of metalloproteinase-1 L homeolog","Weight":1,"Paper_List":"27619532","Original_Text":"PMID:27619532; Original text:One study showed significant reduction of IFN-γ, interleukin-8 and granulocyte colony-stimulating factor levels after antimicrobial photodynamic therapy at follow-up. interleukin-1β significantly reduced in 4 laser therapy studies, while one study showed significant decrease for interleukin-6 and TIMP-1 levels."},{"Node1":"colony stimulating factor 3 S homeolog","Edge_Type":"mechanism","Node2":"tissue inhibitor of metalloproteinase-1 L homeolog","Weight":1,"Paper_List":"27619532","Original_Text":"PMID:27619532; Original text:One study showed significant reduction of IFN-γ, interleukin-8 and granulocyte colony-stimulating factor levels after antimicrobial photodynamic therapy at follow-up. interleukin-1β significantly reduced in 4 laser therapy studies, while one study showed significant decrease for interleukin-6 and TIMP-1 levels."},{"Node1":"interleukin 6 L homeolog","Edge_Type":"mechanism","Node2":"methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2 like","Weight":2,"Paper_List":"27619532|23161345","Original_Text":"PMID:27619532; Original text:One study showed significant reduction of IFN-γ, interleukin-8 and granulocyte colony-stimulating factor levels after antimicrobial photodynamic therapy at follow-up. interleukin-1β significantly reduced in 4 laser therapy studies, while one study showed significant decrease for interleukin-6 and TIMP-1 levels.|PMID:23161345; Original text:The total amount of IL-1β, interleukin-6, MMP-1, metalloproteinase-8, and TIMP-1 decreased (p < 0.05) and interleukin-8 increased after treatment in both diode laser and control groups (p < 0.05)."},{"Node1":"interleukin 1 beta","Edge_Type":"mechanism","Node2":"interleukin 6 L homeolog","Weight":1,"Paper_List":"27619532","Original_Text":"PMID:27619532; Original text:One study showed significant reduction of IFN-γ, interleukin-8 and granulocyte colony-stimulating factor levels after antimicrobial photodynamic therapy at follow-up. interleukin-1β significantly reduced in 4 laser therapy studies, while one study showed significant decrease for interleukin-6 and TIMP-1 levels."},{"Node1":"colony stimulating factor 3 S homeolog","Edge_Type":"mechanism","Node2":"interleukin 6 L homeolog","Weight":1,"Paper_List":"27619532","Original_Text":"PMID:27619532; Original text:One study showed significant reduction of IFN-γ, interleukin-8 and granulocyte colony-stimulating factor levels after antimicrobial photodynamic therapy at follow-up. interleukin-1β significantly reduced in 4 laser therapy studies, while one study showed significant decrease for interleukin-6 and TIMP-1 levels."},{"Node1":"interleukin 1 beta","Edge_Type":"mechanism","Node2":"methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2 like","Weight":2,"Paper_List":"27619532|22835005","Original_Text":"PMID:27619532; Original text:One study showed significant reduction of IFN-γ, interleukin-8 and granulocyte colony-stimulating factor levels after antimicrobial photodynamic therapy at follow-up. interleukin-1β significantly reduced in 4 laser therapy studies, while one study showed significant decrease for interleukin-6 and TIMP-1 levels.|PMID:22835005; Original text:Periodontal therapy significantly reduced the levels of interleukin-1β and interleukin-8 in gingival crevicular fluid (p < 0.001)."},{"Node1":"colony stimulating factor 3 S homeolog","Edge_Type":"mechanism","Node2":"methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2 like","Weight":1,"Paper_List":"27619532","Original_Text":"PMID:27619532; Original text:One study showed significant reduction of IFN-γ, interleukin-8 and granulocyte colony-stimulating factor levels after antimicrobial photodynamic therapy at follow-up. interleukin-1β significantly reduced in 4 laser therapy studies, while one study showed significant decrease for interleukin-6 and TIMP-1 levels."},{"Node1":"colony stimulating factor 3 S homeolog","Edge_Type":"mechanism","Node2":"interleukin 1 beta","Weight":1,"Paper_List":"27619532","Original_Text":"PMID:27619532; Original text:One study showed significant reduction of IFN-γ, interleukin-8 and granulocyte colony-stimulating factor levels after antimicrobial photodynamic therapy at follow-up. interleukin-1β significantly reduced in 4 laser therapy studies, while one study showed significant decrease for interleukin-6 and TIMP-1 levels."},{"Node1":"tissue inhibitor of metalloproteinase-1 L homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Granulocytes","Weight":1,"Paper_List":"27619532","Original_Text":"PMID:27619532; Original text:One study showed significant reduction of IFN-γ, interleukin-8 and granulocyte colony-stimulating factor levels after antimicrobial photodynamic therapy at follow-up. interleukin-1β significantly reduced in 4 laser therapy studies, while one study showed significant decrease for interleukin-6 and TIMP-1 levels."},{"Node1":"interleukin 6 L homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Granulocytes","Weight":1,"Paper_List":"27619532","Original_Text":"PMID:27619532; Original text:One study showed significant reduction of IFN-γ, interleukin-8 and granulocyte colony-stimulating factor levels after antimicrobial photodynamic therapy at follow-up. interleukin-1β significantly reduced in 4 laser therapy studies, while one study showed significant decrease for interleukin-6 and TIMP-1 levels."},{"Node1":"methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2 like","Edge_Type":"mechanism_to_anatomy","Node2":"Granulocytes","Weight":1,"Paper_List":"27619532","Original_Text":"PMID:27619532; Original text:One study showed significant reduction of IFN-γ, interleukin-8 and granulocyte colony-stimulating factor levels after antimicrobial photodynamic therapy at follow-up. interleukin-1β significantly reduced in 4 laser therapy studies, while one study showed significant decrease for interleukin-6 and TIMP-1 levels."},{"Node1":"interleukin 1 beta","Edge_Type":"mechanism_to_anatomy","Node2":"Granulocytes","Weight":1,"Paper_List":"27619532","Original_Text":"PMID:27619532; Original text:One study showed significant reduction of IFN-γ, interleukin-8 and granulocyte colony-stimulating factor levels after antimicrobial photodynamic therapy at follow-up. interleukin-1β significantly reduced in 4 laser therapy studies, while one study showed significant decrease for interleukin-6 and TIMP-1 levels."},{"Node1":"colony stimulating factor 3 S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Granulocytes","Weight":3,"Paper_List":"27619532|22181685|22181685","Original_Text":"PMID:27619532; Original text:One study showed significant reduction of IFN-γ, interleukin-8 and granulocyte colony-stimulating factor levels after antimicrobial photodynamic therapy at follow-up. interleukin-1β significantly reduced in 4 laser therapy studies, while one study showed significant decrease for interleukin-6 and TIMP-1 levels.|PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment.|PMID:22181685; Original text:Except for granulocyte colony-stimulating factor, these differences remained significant throughout the observation period."},{"Node1":"collagenase 3-like","Edge_Type":"mechanism","Node2":"interleukin 2","Weight":1,"Paper_List":"26870843","Original_Text":"PMID:26870843; Original text:After 12 weeks, interleukin (IL)-8 and matrix metalloproteinase (MMP)-8 were significantly higher in the test group (p=0.023 and p=0.003, respectively)."},{"Node1":"Arthritis, Rheumatoid","Edge_Type":"disease","Node2":"Periodontitis","Weight":5,"Paper_List":"34246253|23945051|27977821|15088884|33641208","Original_Text":"PMID:34246253; Original text:As the primary results, the change of PD was not statistically significant and in the secondary results changes of plaque index, gingival index, attachment loss and BOP were also not statistically significant in rheumatoid arthritis patients with periodontitis compared to non-rheumatoid arthritis periodontitis patients.|PMID:23945051; Original text:A significant association has been shown to exist between periodontitis and Rheumatoid arthritis in observational studies.|PMID:27977821; Original text:This meta-analysis indicates that rheumatoid arthritis was significantly associated with increased overall risk of periodontitis.|PMID:15088884; Original text:Consistent with previous studies on animal models of chronic destructive disease (e.g., rheumatoid arthritis), the subantimicrobial dose doxycycline and NSAID ) low-dose flurbiprofen therapy synergistically suppressed MMP and other neutral proteinases in the gingiva of chronic periodontitis patients.|PMID:33641208; Original text:The patients with a moderate to high rheumatoid arthritis disease activity showed significantly higher levels of probing depth (probing depth), clinical attachment level, anti-cyclic citrullinated peptide IgG, and anti-agalactosyl IgG titer and greater mean percentages of severe periodontitis than those with a low rheumatoid arthritis disease activity (p < .05 for all)."},{"Node1":"Coronary Disease","Edge_Type":"disease_to_anatomy","Node2":"Blood","Weight":1,"Paper_List":"22966824","Original_Text":"PMID:22966824; Original text:In coronary heart disease patients with periodontitis, non-surgical mechanical periodontal therapy significantly reduced systemic levels of C-reactive protein, fibrinogen and white blood cells."},{"Node1":"Alendronate","Edge_Type":"chemical_to_anatomy","Node2":"Bone and Bones","Weight":3,"Paper_List":"21609254|21542734|22264208","Original_Text":"PMID:21609254; Original text:Furthermore, significantly greater mean percentage of bone fill was found in the 1% alendronate group (46.1% ± 9.48%) compared to the placebo group (2% ± 1.02%).|PMID:21542734; Original text:Furthermore, a significantly greater mean percentage of bone fill was found in the Alendronate group (40.4% ± 11.71%) than in the placebo group (2.5% ± 1.02%).|PMID:22264208; Original text:Furthermore, significantly greater mean percentage of bone fill was found in the Alendronate group (44.2% ± 11.78%) compared to the placebo group (2.8% ± 1.61%)."},{"Node1":"Alendronate","Edge_Type":"chemical_to_disease","Node2":"Aggressive Periodontitis","Weight":1,"Paper_List":"21609254","Original_Text":"PMID:21609254; Original text:The results of the present study show local delivery of 1% 1% alendronate stimulates a significant increase in PD reduction, CAL gain, and improved bone fill compared to placebo gel as an adjunct to scaling and root planing in patients with aggressive periodontitis."},{"Node1":"Coronary Disease","Edge_Type":"disease_to_anatomy","Node2":"Blood Cells","Weight":1,"Paper_List":"22966824","Original_Text":"PMID:22966824; Original text:In coronary heart disease patients with periodontitis, non-surgical mechanical periodontal therapy significantly reduced systemic levels of C-reactive protein, fibrinogen and white blood cells."},{"Node1":"immunoglobulin kappa chain variable 21 (V21)","Edge_Type":"mechanism_to_anatomy","Node2":"Erythrocytes","Weight":1,"Paper_List":"15811060","Original_Text":"PMID:15811060; Original text:erythrocyte sedimentation rate was significantly reduced for G2 after root planing although Rheumatoid factor did not show statistical reductions."},{"Node1":"Coronary Disease","Edge_Type":"disease_to_anatomy","Node2":"Leukocytes","Weight":1,"Paper_List":"22966824","Original_Text":"PMID:22966824; Original text:In coronary heart disease patients with periodontitis, non-surgical mechanical periodontal therapy significantly reduced systemic levels of C-reactive protein, fibrinogen and white blood cells."},{"Node1":"Allografts","Edge_Type":"anatomy","Node2":"Membranes","Weight":3,"Paper_List":"11195135|11759870|15068108","Original_Text":"PMID:11195135; Original text:The marginal tissue recession was reduced 0.4 +/- 0.7 mm in ePTFE membrane and demineralized, freeze-dried bone allografts group but increased 0.9 +/- 0.6 mm in ePTFE membrane only group.|PMID:11759870; Original text:The results of this 9-month reentry study comparing the use of porous and non-porous barrier membranes with a dried bone allografts graft indicate that there were no statistically significant differences between groups.|PMID:15068108; Original text:Therefore, the purpose of this clinical trial was to determine whether the addition of bone graft (i.e., demineralized freeze-dried bone allograft [DFDBA]) significantly affects the outcome of collagen membrane guided tissue regeneration-based root coverage procedures."},{"Node1":"Eosinophils","Edge_Type":"anatomy","Node2":"Neutrophils","Weight":1,"Paper_List":"34267006","Original_Text":"PMID:34267006; Original text:Moreover, a reduction was observed in neutrophils, monocytes, eosinophils post therapeutically in group II but the decrease was significant only for monocyte count."},{"Node1":"Eosinophils","Edge_Type":"anatomy","Node2":"Monocytes","Weight":1,"Paper_List":"34267006","Original_Text":"PMID:34267006; Original text:Moreover, a reduction was observed in neutrophils, monocytes, eosinophils post therapeutically in group II but the decrease was significant only for monocyte count."},{"Node1":"Monocytes","Edge_Type":"anatomy","Node2":"Neutrophils","Weight":1,"Paper_List":"34267006","Original_Text":"PMID:34267006; Original text:Moreover, a reduction was observed in neutrophils, monocytes, eosinophils post therapeutically in group II but the decrease was significant only for monocyte count."},{"Node1":"Chlorhexidine","Edge_Type":"chemical_to_anatomy","Node2":"Gingiva","Weight":3,"Paper_List":"2033528|18294229|11696921","Original_Text":"PMID:2033528; Original text:Adjunctive use of chlorhexidine with fixed prosthodontic procedures significantly reduced plaque levels and significantly improved gingival health compared with the control patients.|PMID:18294229; Original text:ultrasonic mechanical instrumentation either with or without additional chlorhexidine use determined a significant reduction of supragingival plaque and gingival inflammation as well as a significant reduction of subgingival bacterial pathogens.|PMID:11696921; Original text:There was an improvement in clinical parameters in all groups with a significantly greater decrease in gingival recession and bleeding in the chlorhexidine group."},{"Node1":"Glucose","Edge_Type":"chemical","Node2":"Vitamin D","Weight":1,"Paper_List":"33673568","Original_Text":"PMID:33673568; Original text:Third trimester (Third trimester) and 6-8 weeks postpartum (6-8 weeks postpartum) exploratory outcomes included periodontal health (% sites with bleeding on probing (BOP)), glucose, insulin, C-Reactive Protein, serum calcium and vitamin D."},{"Node1":"Calcium","Edge_Type":"chemical","Node2":"Glucose","Weight":1,"Paper_List":"33673568","Original_Text":"PMID:33673568; Original text:Third trimester (Third trimester) and 6-8 weeks postpartum (6-8 weeks postpartum) exploratory outcomes included periodontal health (% sites with bleeding on probing (BOP)), glucose, insulin, C-Reactive Protein, serum calcium and vitamin D."},{"Node1":"Calcium","Edge_Type":"chemical","Node2":"Vitamin D","Weight":1,"Paper_List":"33673568","Original_Text":"PMID:33673568; Original text:Third trimester (Third trimester) and 6-8 weeks postpartum (6-8 weeks postpartum) exploratory outcomes included periodontal health (% sites with bleeding on probing (BOP)), glucose, insulin, C-Reactive Protein, serum calcium and vitamin D."},{"Node1":"provisional ortholog of C-reactive protein L homeolog","Edge_Type":"mechanism","Node2":"provisional ortholog of insulin L homeolog","Weight":1,"Paper_List":"33673568","Original_Text":"PMID:33673568; Original text:Third trimester (Third trimester) and 6-8 weeks postpartum (6-8 weeks postpartum) exploratory outcomes included periodontal health (% sites with bleeding on probing (BOP)), glucose, insulin, C-Reactive Protein, serum calcium and vitamin D."},{"Node1":"Glucose","Edge_Type":"chemical_to_disease","Node2":"Hemorrhage","Weight":2,"Paper_List":"33673568|24934646","Original_Text":"PMID:33673568; Original text:Third trimester (Third trimester) and 6-8 weeks postpartum (6-8 weeks postpartum) exploratory outcomes included periodontal health (% sites with bleeding on probing (BOP)), glucose, insulin, C-Reactive Protein, serum calcium and vitamin D.|PMID:24934646; Original text:Participants in the intervention group had significantly lower glycosylated hemoglobin (significantly lower glycosylated hemoglobin), fasting plasma glucose (plasma glucose), plaque index score, gingival index score, pocket depth, clinical attachment level (clinical attachment level), and percentage of bleeding on probing (BOP) when compared to the control group."},{"Node1":"Vitamin D","Edge_Type":"chemical_to_disease","Node2":"Hemorrhage","Weight":1,"Paper_List":"33673568","Original_Text":"PMID:33673568; Original text:Third trimester (Third trimester) and 6-8 weeks postpartum (6-8 weeks postpartum) exploratory outcomes included periodontal health (% sites with bleeding on probing (BOP)), glucose, insulin, C-Reactive Protein, serum calcium and vitamin D."},{"Node1":"Calcium","Edge_Type":"chemical_to_disease","Node2":"Hemorrhage","Weight":1,"Paper_List":"33673568","Original_Text":"PMID:33673568; Original text:Third trimester (Third trimester) and 6-8 weeks postpartum (6-8 weeks postpartum) exploratory outcomes included periodontal health (% sites with bleeding on probing (BOP)), glucose, insulin, C-Reactive Protein, serum calcium and vitamin D."},{"Node1":"Glucose","Edge_Type":"chemical_to_mechanism","Node2":"provisional ortholog of insulin L homeolog","Weight":2,"Paper_List":"33673568|21804283","Original_Text":"PMID:33673568; Original text:Third trimester (Third trimester) and 6-8 weeks postpartum (6-8 weeks postpartum) exploratory outcomes included periodontal health (% sites with bleeding on probing (BOP)), glucose, insulin, C-Reactive Protein, serum calcium and vitamin D.|PMID:21804283; Original text:After 3 months, the serum levels of hsCRP, TNF-α, interleukin-6, fasting plasma glucose (plasma glucose), glycosylated hemoglobin (glycosylated hemoglobin), fasting insulin (insulin) and HOMA-adiponectin, insulin resistance index decreased, and adiponectin was significantly increased in type 2 diabetes mellitus-T group compared to those in the type 2 diabetes mellitus-NT group (p<0.05 or p<0.01)."},{"Node1":"Glucose","Edge_Type":"chemical_to_mechanism","Node2":"provisional ortholog of C-reactive protein L homeolog","Weight":2,"Paper_List":"33673568|34197339","Original_Text":"PMID:33673568; Original text:Third trimester (Third trimester) and 6-8 weeks postpartum (6-8 weeks postpartum) exploratory outcomes included periodontal health (% sites with bleeding on probing (BOP)), glucose, insulin, C-Reactive Protein, serum calcium and vitamin D.|PMID:34197339; Original text:Both groups showed significant clinical and laboratory improvements during the study from baseline to 1 year with reductions in total cholesterol (total cholesterol), triglycerides, glucose, glycated hemoglobin (glycated hemoglobin), uric acid and C-reactive protein (uric acid and C-reactive protein)."},{"Node1":"Vitamin D","Edge_Type":"chemical_to_mechanism","Node2":"provisional ortholog of insulin L homeolog","Weight":1,"Paper_List":"33673568","Original_Text":"PMID:33673568; Original text:Third trimester (Third trimester) and 6-8 weeks postpartum (6-8 weeks postpartum) exploratory outcomes included periodontal health (% sites with bleeding on probing (BOP)), glucose, insulin, C-Reactive Protein, serum calcium and vitamin D."},{"Node1":"Vitamin D","Edge_Type":"chemical_to_mechanism","Node2":"provisional ortholog of C-reactive protein L homeolog","Weight":1,"Paper_List":"33673568","Original_Text":"PMID:33673568; Original text:Third trimester (Third trimester) and 6-8 weeks postpartum (6-8 weeks postpartum) exploratory outcomes included periodontal health (% sites with bleeding on probing (BOP)), glucose, insulin, C-Reactive Protein, serum calcium and vitamin D."},{"Node1":"Calcium","Edge_Type":"chemical_to_mechanism","Node2":"provisional ortholog of insulin L homeolog","Weight":1,"Paper_List":"33673568","Original_Text":"PMID:33673568; Original text:Third trimester (Third trimester) and 6-8 weeks postpartum (6-8 weeks postpartum) exploratory outcomes included periodontal health (% sites with bleeding on probing (BOP)), glucose, insulin, C-Reactive Protein, serum calcium and vitamin D."},{"Node1":"Calcium","Edge_Type":"chemical_to_mechanism","Node2":"provisional ortholog of C-reactive protein L homeolog","Weight":1,"Paper_List":"33673568","Original_Text":"PMID:33673568; Original text:Third trimester (Third trimester) and 6-8 weeks postpartum (6-8 weeks postpartum) exploratory outcomes included periodontal health (% sites with bleeding on probing (BOP)), glucose, insulin, C-Reactive Protein, serum calcium and vitamin D."},{"Node1":"Hemorrhage","Edge_Type":"disease_to_mechanism","Node2":"provisional ortholog of insulin L homeolog","Weight":1,"Paper_List":"33673568","Original_Text":"PMID:33673568; Original text:Third trimester (Third trimester) and 6-8 weeks postpartum (6-8 weeks postpartum) exploratory outcomes included periodontal health (% sites with bleeding on probing (BOP)), glucose, insulin, C-Reactive Protein, serum calcium and vitamin D."},{"Node1":"Hemorrhage","Edge_Type":"disease_to_mechanism","Node2":"provisional ortholog of C-reactive protein L homeolog","Weight":1,"Paper_List":"33673568","Original_Text":"PMID:33673568; Original text:Third trimester (Third trimester) and 6-8 weeks postpartum (6-8 weeks postpartum) exploratory outcomes included periodontal health (% sites with bleeding on probing (BOP)), glucose, insulin, C-Reactive Protein, serum calcium and vitamin D."},{"Node1":"amelogenin X-linked","Edge_Type":"mechanism_to_anatomy","Node2":"Plasma","Weight":1,"Paper_List":"18034853","Original_Text":"PMID:18034853; Original text:Regenerative periodontal surgery utilizing a combination of an enamel matrix protein derivative (an enamel matrix protein derivative) and a natural bone mineral (a natural bone mineral) and platelet-rich plasma (platelet-rich plasma) has been shown to enhance the outcomes of regenerative surgery significantly."},{"Node1":"amelogenin X-linked","Edge_Type":"mechanism_to_anatomy","Node2":"Platelet-Rich Plasma","Weight":1,"Paper_List":"18034853","Original_Text":"PMID:18034853; Original text:Regenerative periodontal surgery utilizing a combination of an enamel matrix protein derivative (an enamel matrix protein derivative) and a natural bone mineral (a natural bone mineral) and platelet-rich plasma (platelet-rich plasma) has been shown to enhance the outcomes of regenerative surgery significantly."},{"Node1":"amelogenin X-linked","Edge_Type":"mechanism_to_anatomy","Node2":"Blood Platelets","Weight":1,"Paper_List":"18034853","Original_Text":"PMID:18034853; Original text:Regenerative periodontal surgery utilizing a combination of an enamel matrix protein derivative (an enamel matrix protein derivative) and a natural bone mineral (a natural bone mineral) and platelet-rich plasma (platelet-rich plasma) has been shown to enhance the outcomes of regenerative surgery significantly."},{"Node1":"satranidazole","Edge_Type":"chemical_to_disease","Node2":"Periodontal Cyst","Weight":1,"Paper_List":"23705535","Original_Text":"PMID:23705535; Original text:The systemic use of systemic satranidazole, when used as an adjunct to non-surgical periodontal therapy in subjects with periodontitis, achieves significantly better clinical and microbiological results than scaling and root planing alone."},{"Node1":"satranidazole","Edge_Type":"chemical_to_disease","Node2":"Periodontitis","Weight":1,"Paper_List":"23705535","Original_Text":"PMID:23705535; Original text:The systemic use of systemic satranidazole, when used as an adjunct to non-surgical periodontal therapy in subjects with periodontitis, achieves significantly better clinical and microbiological results than scaling and root planing alone."},{"Node1":"Gingiva","Edge_Type":"anatomy","Node2":"Periodontal Ligament","Weight":3,"Paper_List":"29807962|21594208|32428060","Original_Text":"PMID:29807962; Original text:An improvement of Plaque index, gingival index, papillary bleeding index, periodontal probing depth, and clinical attachment loss was observed at 6 and 12 weeks (p < 0.05) in both groups.|PMID:21594208; Original text:There was a significant reduction in plaque score, gingival score, periodontal pocket depth and total anaerobic colony count from baseline in both groups at all time intervals.|PMID:32428060; Original text:In both groups, periodontal therapy using the one-stage full-mouth disinfection protocol significantly improved clinical attachment level, PD, gingival index, and plaque index (p<0.05)."},{"Node1":"Dental Calculus","Edge_Type":"disease_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"26405803","Original_Text":"PMID:26405803; Original text:There were significant differences between the patients with stroke and subjects without in pack-years of smoking (p = 0.01), prevalence of gingival inflammation (gingival inflammation) (p = 0.03), and dental calculus (p = 0.017)."},{"Node1":"Infections","Edge_Type":"disease","Node2":"Voice Disorders","Weight":1,"Paper_List":"8340625","Original_Text":"PMID:8340625; Original text:There were no statistically significant differences between methods in relation to pain, facial swelling, sensory loss, infection, or periodontal pocket depth distal to the second molar, although 2% of third molars removed by chisel had lingual sensory disturbance at 7 days, as compared with 8% where burs had been used."},{"Node1":"Pain","Edge_Type":"disease","Node2":"Voice Disorders","Weight":1,"Paper_List":"8340625","Original_Text":"PMID:8340625; Original text:There were no statistically significant differences between methods in relation to pain, facial swelling, sensory loss, infection, or periodontal pocket depth distal to the second molar, although 2% of third molars removed by chisel had lingual sensory disturbance at 7 days, as compared with 8% where burs had been used."},{"Node1":"Molar","Edge_Type":"anatomy","Node2":"Molar, Third","Weight":1,"Paper_List":"8340625","Original_Text":"PMID:8340625; Original text:There were no statistically significant differences between methods in relation to pain, facial swelling, sensory loss, infection, or periodontal pocket depth distal to the second molar, although 2% of third molars removed by chisel had lingual sensory disturbance at 7 days, as compared with 8% where burs had been used."},{"Node1":"Molar","Edge_Type":"anatomy","Node2":"Sensilla","Weight":1,"Paper_List":"8340625","Original_Text":"PMID:8340625; Original text:There were no statistically significant differences between methods in relation to pain, facial swelling, sensory loss, infection, or periodontal pocket depth distal to the second molar, although 2% of third molars removed by chisel had lingual sensory disturbance at 7 days, as compared with 8% where burs had been used."},{"Node1":"Molar, Third","Edge_Type":"anatomy","Node2":"Sensilla","Weight":1,"Paper_List":"8340625","Original_Text":"PMID:8340625; Original text:There were no statistically significant differences between methods in relation to pain, facial swelling, sensory loss, infection, or periodontal pocket depth distal to the second molar, although 2% of third molars removed by chisel had lingual sensory disturbance at 7 days, as compared with 8% where burs had been used."},{"Node1":"Dentin Sensitivity","Edge_Type":"disease_to_anatomy","Node2":"Dentin","Weight":1,"Paper_List":"22976566","Original_Text":"PMID:22976566; Original text:However, there was a significant increase (P<0.05) in dentinal hypersensitivity following topical ozonated olive oil as an adjunct to scaling and root planing therapy."},{"Node1":"Diabetes Mellitus","Edge_Type":"disease_to_anatomy","Node2":"Periodontal Ligament","Weight":1,"Paper_List":"24934646","Original_Text":"PMID:24934646; Original text:Participants were assessed at baseline and 3 month follow up for glycosylated hemoglobin (significantly lower glycosylated hemoglobin), fasting plasma glucose (plasma glucose), body mass index (Bmotivational interviewing), periodontal status, knowledge, attitude and practice of oral health and diabetes mellitus."},{"Node1":"Diabetes Mellitus","Edge_Type":"disease_to_anatomy","Node2":"Plasma","Weight":1,"Paper_List":"27468795","Original_Text":"PMID:27468795; Original text:A 6-month regimen of 400 mg propolis once daily is a potentially viable adjunct to root planing that significantly reduces levels of hemoglobinA1c, plasma glucose, and serum N€-(carboxymethyl) lysine, and improves periodontal therapy outcome in people with 2 diabetes mellitus and chronic periodontitis."},{"Node1":"Diabetes Mellitus, Type 2","Edge_Type":"disease_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"25811944","Original_Text":"PMID:25811944; Original text:Gingival tissues from patients with chronic periodontitis and type 2 diabetes mellitus had a significant increase in visfatin and a decrease in leptin gene and protein expression (P <0.05) compared with both controls and patients with chronic periodontitis."},{"Node1":"Down Syndrome","Edge_Type":"disease_to_anatomy","Node2":"Neutrophils","Weight":1,"Paper_List":"16018747","Original_Text":"PMID:16018747; Original text:Neutrophil chemotaxis, phagocytic activity, and production of super-oxide anion were significantly decreased in the Down's syndrome patients."},{"Node1":"Drug Hypersensitivity","Edge_Type":"disease_to_anatomy","Node2":"Tooth","Weight":1,"Paper_List":"11128919","Original_Text":"PMID:11128919; Original text:Smokers were found to have a statistically significantly higher incidence of severe symptoms in root hypersensitivity, tooth pain, and swelling compared to non-smokers (n = 21)."},{"Node1":"Esophageal Neoplasms","Edge_Type":"disease_to_anatomy","Node2":"Prostate","Weight":1,"Paper_List":"33029095","Original_Text":"PMID:33029095; Original text:With statistical significance, participants with periodontitis might have enhanced risks of esophageal cancer (HR = 1.79, 95% CI: 1.15-2.79), prostate cancer (HR = 1.20, 95% CI: 1.09-1.31), hematological malignancy (HR = 1.19, 95% CI: 1.09-1.29), and melanoma of skin (HR = 1.21, 95% CI: 1.03-1.42), compared with those without periodontitis."},{"Node1":"Esophageal Neoplasms","Edge_Type":"disease_to_anatomy","Node2":"Skin","Weight":1,"Paper_List":"33029095","Original_Text":"PMID:33029095; Original text:With statistical significance, participants with periodontitis might have enhanced risks of esophageal cancer (HR = 1.79, 95% CI: 1.15-2.79), prostate cancer (HR = 1.20, 95% CI: 1.09-1.31), hematological malignancy (HR = 1.19, 95% CI: 1.09-1.29), and melanoma of skin (HR = 1.21, 95% CI: 1.03-1.42), compared with those without periodontitis."},{"Node1":"Fistula","Edge_Type":"disease_to_anatomy","Node2":"Dental Pulp Cavity","Weight":1,"Paper_List":"18524271","Original_Text":"PMID:18524271; Original text:Periapical radiolucency and fistula in pulpotomized teeth was significantly higher than in root canal therapy-treated teeth (P < 0.05)"},{"Node1":"Periodontitis","Edge_Type":"disease","Node2":"Premature Birth","Weight":2,"Paper_List":"33143275|26504910","Original_Text":"PMID:33143275; Original text:Statistically significant values were obtained regarding the risk of preterm birth in pregnant women with periodontitis (RR = 1.67 (1.17-2.38), 95% confidence interval (95% confidence interval)), and low birth weight (RR = 2.53 (1.61-3.98)|PMID:26504910; Original text:The computed the Risk Ratio for periodontitis was 1.61 for preterm birth evaluated in 16 studies (P < .001), 1.65 for low birthweight evaluated in 10 studies (P < .001), and 3.44 for preterm low birthweight evaluated in four studies."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_disease","Node2":"Chronic Periodontitis","Weight":3,"Paper_List":"11442739|15562917|15626316","Original_Text":"PMID:11442739; Original text:Subantimicrobial dose doxycycline (SDD 20 mg bid) plus scaling and root planing (root planing) significantly improved clinical attachment level (clinical attachment level) and reduced probing depth (PD) compared with placebo plus root planing in a double-blind, placebo-controlled, multicenter study of patients with adult periodontitis (adult periodontitis).|PMID:15562917; Original text:The present data indicate that Low-dose doxycycline therapy in combination with root planing therapy can reduce gingival crevicular fluid Laminin-5 gamma2 chain fragment levels and improve clinical periodontal parameters in patients with chronic periodontitis.|PMID:15626316; Original text:Several investigations demonstrated that adjunctive subantimicrobial-dose doxycycline prescribed as an adjunct to conventional therapy provides a statistically significant improvement with respect to probing depth reduction, gain of clinical attachment, decreased bleeding on probing, and reduced incidence of disease progression in patients with chronic periodontitis."},{"Node1":"IgM constant region","Edge_Type":"mechanism","Node2":"immunoglobulin heavy chain (S107 family)","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"Membranes","Edge_Type":"anatomy","Node2":"Tissues","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"Gonadotrophs","Edge_Type":"anatomy","Node2":"Tissues","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"Bacterial Outer Membrane","Edge_Type":"anatomy","Node2":"Tissues","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"Gonadotrophs","Edge_Type":"anatomy","Node2":"Membranes","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"Bacterial Outer Membrane","Edge_Type":"anatomy","Node2":"Membranes","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"Gingiva","Edge_Type":"anatomy","Node2":"Membranes","Weight":3,"Paper_List":"7767709|26009915|11846197","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells.|PMID:26009915; Original text:amnion membrane did not induce significant gingival recession and is suggested as a new barrier membrane in guided tissue regeneration treatment.|PMID:11846197; Original text:The 1-year results indicated that: 1) all treatment modalities resulted in clinically significant improvements in clinical attachment levels (clinical attachment levels) and reduction in probing depth (probing depth); 2) a statistically significant treatment effect was demonstrated comparing the enamel matrix proteins test, the membrane control, and the flap control groups in terms of clinical attachment levels gains; 3) both the enamel matrix proteins test and the membrane control groups showed significant clinical attachment levels gains compared to the flap control group; 4) a statistically significantly greater amount of clinical attachment levels gain was demonstrated in guided tissue regeneration-treated compared to enamel matrix proteins-treated patients; 5) deeper residual probing depths but smaller increases in gingival recession were demonstrated following enamel matrix proteins therapy; and 6) smoking habits reduced the clinical outcomes of both regenerative procedures."},{"Node1":"Bacterial Outer Membrane","Edge_Type":"anatomy","Node2":"Gonadotrophs","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"Gingiva","Edge_Type":"anatomy","Node2":"Gonadotrophs","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"Bacterial Outer Membrane","Edge_Type":"anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"Fusobacterium Nucleatum","Edge_Type":"bacteria_to_disease","Node2":"Periodontal Cyst","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"Fusobacterium Nucleatum","Edge_Type":"bacteria_to_disease","Node2":"Periodontitis","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"Fusobacterium Nucleatum","Edge_Type":"bacteria_to_mechanism","Node2":"immunoglobulin heavy chain (S107 family)","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"Fusobacterium Nucleatum","Edge_Type":"bacteria_to_mechanism","Node2":"IgM constant region","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"Fusobacterium Nucleatum","Edge_Type":"bacteria_to_anatomy","Node2":"Tissues","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"Fusobacterium Nucleatum","Edge_Type":"bacteria_to_anatomy","Node2":"Membranes","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"Fusobacterium Nucleatum","Edge_Type":"bacteria_to_anatomy","Node2":"Gonadotrophs","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"Fusobacterium Nucleatum","Edge_Type":"bacteria_to_anatomy","Node2":"Bacterial Outer Membrane","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"Fusobacterium Nucleatum","Edge_Type":"bacteria_to_anatomy","Node2":"Gingiva","Weight":2,"Paper_List":"7767709|23645178","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells.|PMID:23645178; Original text:Essential-oils mouthwash reduced Fusobacterium nucleatum levels in supragingival plaque by a mean of 53.2%, and reduced total bacterial loads in supra- and sub-gingival plaque (p<0.01)."},{"Node1":"Periodontal Cyst","Edge_Type":"disease_to_mechanism","Node2":"immunoglobulin heavy chain (S107 family)","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"Periodontal Cyst","Edge_Type":"disease_to_mechanism","Node2":"IgM constant region","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"immunoglobulin heavy chain (S107 family)","Weight":2,"Paper_List":"7767709|33641208","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells.|PMID:33641208; Original text:The patients with a moderate to high rheumatoid arthritis disease activity showed significantly higher levels of probing depth (probing depth), clinical attachment level, anti-cyclic citrullinated peptide IgG, and anti-agalactosyl IgG titer and greater mean percentages of severe periodontitis than those with a low rheumatoid arthritis disease activity (p < .05 for all)."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"IgM constant region","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"Gingival Recession","Edge_Type":"disease_to_anatomy","Node2":"Acellular Dermis","Weight":1,"Paper_List":"23593633","Original_Text":"PMID:23593633; Original text:The results of this study demonstrate that acellular dermal matrix allograft with a a coronally positioned flap is an effective procedure for the treatment of multiple gingival recessions."},{"Node1":"Gingival Recession","Edge_Type":"disease_to_anatomy","Node2":"Allografts","Weight":1,"Paper_List":"23593633","Original_Text":"PMID:23593633; Original text:The results of this study demonstrate that acellular dermal matrix allograft with a a coronally positioned flap is an effective procedure for the treatment of multiple gingival recessions."},{"Node1":"Gingival Recession","Edge_Type":"disease_to_anatomy","Node2":"Gingiva","Weight":11,"Paper_List":"18062108|26009915|23811645|34319670|25727403|23441791|17209788|27084855|23593633|7986629|11846197","Original_Text":"PMID:18062108; Original text:Both treatments resulted in decreases in PD, plaque index, gingival index, and BOP, increases in gingival recession, and gains in clinical attachment level.|PMID:26009915; Original text:amnion membrane did not induce significant gingival recession and is suggested as a new barrier membrane in guided tissue regeneration treatment.|PMID:23811645; Original text:The clinical parameters like plaque index, gingival index, probing pocket depth, clinical attachment level and gingival recession were recorded at baseline, 6 weeks, 3, 6 and 9 months.|PMID:34319670; Original text:Patients in the either Mini-Five Gracey Curettes (the MFC) group experienced lower gingival recession (lower gingival recession), especially in both thin (2 ± 0.4 mm vs 3.1 ± 0.5 mm; difference: -1.1; P < 0.001) and medium (1.6 ± 0.5 mm vs 2.6 ± 0.6; difference: -1 mm; P = 0.010) periodontal phenotypes.|PMID:25727403; Original text:glycine powder air polishing results in clinically significant improvement in plaque and gingival index scores and histologically causes less gingival erosion than air polishing or ultrasonic instrumentation, further supporting the safety of this debridement technique in periodontal maintenance therapy.|PMID:23441791; Original text:YSGG laser assisted pocket therapy compared with Traditional periodontal open flap debridement results in similar clinical attachment loss gains with less gingival recession and significant reductions in reduced pocket depth, Gingival Index and Sulcular Bleeding Index, and may be considered as an alternative to surgical therapy.|PMID:17209788; Original text:Compared to baseline, 18-month measurements showed a significant reduction in probing depth, gain in attachment level, and decrease in gingival recession for control and experimental groups.|PMID:27084855; Original text:PD, gingival recession, BOP nor other clinical parameters, though patients' subjective perception of postoperative discomfort was significantly smaller in the group receiving antibiotics.|PMID:23593633; Original text:The results of this study demonstrate that acellular dermal matrix allograft with a a coronally positioned flap is an effective procedure for the treatment of multiple gingival recessions.|PMID:7986629; Original text:In addition, an increase in gingival recession (P < 0.001) was accompanied by a reduction in mean probing depths (mean probing depths)|PMID:11846197; Original text:The 1-year results indicated that: 1) all treatment modalities resulted in clinically significant improvements in clinical attachment levels (clinical attachment levels) and reduction in probing depth (probing depth); 2) a statistically significant treatment effect was demonstrated comparing the enamel matrix proteins test, the membrane control, and the flap control groups in terms of clinical attachment levels gains; 3) both the enamel matrix proteins test and the membrane control groups showed significant clinical attachment levels gains compared to the flap control group; 4) a statistically significantly greater amount of clinical attachment levels gain was demonstrated in guided tissue regeneration-treated compared to enamel matrix proteins-treated patients; 5) deeper residual probing depths but smaller increases in gingival recession were demonstrated following enamel matrix proteins therapy; and 6) smoking habits reduced the clinical outcomes of both regenerative procedures."},{"Node1":"Gingival Recession","Edge_Type":"disease_to_anatomy","Node2":"Membranes","Weight":2,"Paper_List":"26009915|11846197","Original_Text":"PMID:26009915; Original text:amnion membrane did not induce significant gingival recession and is suggested as a new barrier membrane in guided tissue regeneration treatment.|PMID:11846197; Original text:The 1-year results indicated that: 1) all treatment modalities resulted in clinically significant improvements in clinical attachment levels (clinical attachment levels) and reduction in probing depth (probing depth); 2) a statistically significant treatment effect was demonstrated comparing the enamel matrix proteins test, the membrane control, and the flap control groups in terms of clinical attachment levels gains; 3) both the enamel matrix proteins test and the membrane control groups showed significant clinical attachment levels gains compared to the flap control group; 4) a statistically significantly greater amount of clinical attachment levels gain was demonstrated in guided tissue regeneration-treated compared to enamel matrix proteins-treated patients; 5) deeper residual probing depths but smaller increases in gingival recession were demonstrated following enamel matrix proteins therapy; and 6) smoking habits reduced the clinical outcomes of both regenerative procedures."},{"Node1":"Gingivitis","Edge_Type":"disease_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"2760247","Original_Text":"PMID:2760247; Original text:Gingivitis again developed in these quadrants, although when the results were compared to the equivalent data from the first investigation, significantly greater median values for probing pocket depths and gingival indices were found in the latter study."},{"Node1":"Gingivitis","Edge_Type":"disease_to_anatomy","Node2":"T-Lymphocytes, Regulatory","Weight":1,"Paper_List":"17668982","Original_Text":"PMID:17668982; Original text:Aspirin can have an affect on BOP in naturally occurring gingivitis patients."},{"Node1":"Halitosis","Edge_Type":"disease_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"25101909","Original_Text":"PMID:25101909; Original text:No statistically significant group × time interactions were found for plaque index, gingival index, pocket depth, bleeding on probing, and halitosis, which means three independent groups change like each other by time."},{"Node1":"Hematologic Neoplasms","Edge_Type":"disease_to_anatomy","Node2":"Prostate","Weight":1,"Paper_List":"33029095","Original_Text":"PMID:33029095; Original text:With statistical significance, participants with periodontitis might have enhanced risks of esophageal cancer (HR = 1.79, 95% CI: 1.15-2.79), prostate cancer (HR = 1.20, 95% CI: 1.09-1.31), hematological malignancy (HR = 1.19, 95% CI: 1.09-1.29), and melanoma of skin (HR = 1.21, 95% CI: 1.03-1.42), compared with those without periodontitis."},{"Node1":"Hematologic Neoplasms","Edge_Type":"disease_to_anatomy","Node2":"Skin","Weight":1,"Paper_List":"33029095","Original_Text":"PMID:33029095; Original text:With statistical significance, participants with periodontitis might have enhanced risks of esophageal cancer (HR = 1.79, 95% CI: 1.15-2.79), prostate cancer (HR = 1.20, 95% CI: 1.09-1.31), hematological malignancy (HR = 1.19, 95% CI: 1.09-1.29), and melanoma of skin (HR = 1.21, 95% CI: 1.03-1.42), compared with those without periodontitis."},{"Node1":"immunoglobulin heavy chain (S107 family)","Edge_Type":"mechanism_to_anatomy","Node2":"Tissues","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"immunoglobulin heavy chain (S107 family)","Edge_Type":"mechanism_to_anatomy","Node2":"Membranes","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"immunoglobulin heavy chain (S107 family)","Edge_Type":"mechanism_to_anatomy","Node2":"Gonadotrophs","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"immunoglobulin heavy chain (S107 family)","Edge_Type":"mechanism_to_anatomy","Node2":"Bacterial Outer Membrane","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"immunoglobulin heavy chain (S107 family)","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"IgM constant region","Edge_Type":"mechanism_to_anatomy","Node2":"Tissues","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"IgM constant region","Edge_Type":"mechanism_to_anatomy","Node2":"Membranes","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"IgM constant region","Edge_Type":"mechanism_to_anatomy","Node2":"Gonadotrophs","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"IgM constant region","Edge_Type":"mechanism_to_anatomy","Node2":"Bacterial Outer Membrane","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"IgM constant region","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"Rosuvastatin Calcium","Edge_Type":"chemical_to_mechanism","Node2":"Plateletcrit","Weight":2,"Paper_List":"27452270|27452270","Original_Text":"PMID:27452270; Original text:Addition of 1.2% particularly rosuvastatin gel to platelet-rich fibrin resulted in significantly greater CAL gain and depth and IBD depth reductions over 9 months compared with other groups.|PMID:27452270; Original text:open flap debridement with particularly rosuvastatin (1.2%) and platelet-rich fibrin results in significantly greater periodontal benefits compared with open flap debridement alone or with platelet-rich fibrin."},{"Node1":"Rosuvastatin Calcium","Edge_Type":"chemical_to_anatomy","Node2":"Platelet-Rich Fibrin","Weight":2,"Paper_List":"27452270|27452270","Original_Text":"PMID:27452270; Original text:Addition of 1.2% particularly rosuvastatin gel to platelet-rich fibrin resulted in significantly greater CAL gain and depth and IBD depth reductions over 9 months compared with other groups.|PMID:27452270; Original text:open flap debridement with particularly rosuvastatin (1.2%) and platelet-rich fibrin results in significantly greater periodontal benefits compared with open flap debridement alone or with platelet-rich fibrin."},{"Node1":"Rosuvastatin Calcium","Edge_Type":"chemical_to_anatomy","Node2":"Blood Platelets","Weight":2,"Paper_List":"27452270|27452270","Original_Text":"PMID:27452270; Original text:Addition of 1.2% particularly rosuvastatin gel to platelet-rich fibrin resulted in significantly greater CAL gain and depth and IBD depth reductions over 9 months compared with other groups.|PMID:27452270; Original text:open flap debridement with particularly rosuvastatin (1.2%) and platelet-rich fibrin results in significantly greater periodontal benefits compared with open flap debridement alone or with platelet-rich fibrin."},{"Node1":"Platelet-Rich Fibrin","Edge_Type":"anatomy","Node2":"Platelet-Rich Plasma","Weight":5,"Paper_List":"27452270|23317096|23317096|22348695|27294433","Original_Text":"PMID:27452270; Original text:open flap debridement with particularly rosuvastatin (1.2%) and platelet-rich fibrin results in significantly greater periodontal benefits compared with open flap debridement alone or with platelet-rich fibrin.|PMID:23317096; Original text:Relative vertical clinical attachment level gain was also greater in autologous platelet-rich fibrin (2.87 ± 0.85 mm) and autologous platelet-rich plasma (2.71 ± 1.04 mm) sites as compared to control site (1.37 ± 0.58|PMID:23317096; Original text:All clinical and radiographic parameters showed statistically significant improvement at both the test sites (autologous platelet-rich fibrin with OFD and autologous platelet-rich plasma with OFD) compared to those with OFD alone.|PMID:22348695; Original text:Furthermore, significantly greater percentage of mean bone fill was found in the autologous platelet-rich fibrin (55.41% ± 11.39%) and platelet-rich plasma (56.85% ± 14.01%) groups compared with the control (1.56% ± 15.12%) group.|PMID:27294433; Original text:Platelet-rich fibrin + 1.2% atorvastatin and Platelet-rich fibrin alone showed significantly greater depth reduction and 4) relative clinical attachment level gain compared with open flap debridement alone at 9 months."},{"Node1":"Rosuvastatin Calcium","Edge_Type":"chemical_to_anatomy","Node2":"Platelet-Rich Plasma","Weight":1,"Paper_List":"27452270","Original_Text":"PMID:27452270; Original text:open flap debridement with particularly rosuvastatin (1.2%) and platelet-rich fibrin results in significantly greater periodontal benefits compared with open flap debridement alone or with platelet-rich fibrin."},{"Node1":"Plateletcrit","Edge_Type":"mechanism_to_anatomy","Node2":"Platelet-Rich Plasma","Weight":2,"Paper_List":"27452270|27294433","Original_Text":"PMID:27452270; Original text:open flap debridement with particularly rosuvastatin (1.2%) and platelet-rich fibrin results in significantly greater periodontal benefits compared with open flap debridement alone or with platelet-rich fibrin.|PMID:27294433; Original text:Platelet-rich fibrin + 1.2% atorvastatin and Platelet-rich fibrin alone showed significantly greater depth reduction and 4) relative clinical attachment level gain compared with open flap debridement alone at 9 months."},{"Node1":"Vitamin C","Edge_Type":"nutrient_to_disease","Node2":"Pain","Weight":1,"Paper_List":"30039526","Original_Text":"PMID:30039526; Original text:In reference to vitamin C for pain relief, there were no statistically significant differences between the study groups."},{"Node1":"Ascorbic Acid","Edge_Type":"chemical_to_disease","Node2":"Pain","Weight":1,"Paper_List":"30039526","Original_Text":"PMID:30039526; Original text:In reference to vitamin C for pain relief, there were no statistically significant differences between the study groups."},{"Node1":"Superoxides","Edge_Type":"chemical_to_disease","Node2":"Chronic Periodontitis","Weight":2,"Paper_List":"23478273|23478273","Original_Text":"PMID:23478273; Original text:At baseline, patients with chronic periodontitis had higher mean Superoxide dismutase activity (2.73 ± 1.36) than the control subjects (1.12 ± 1.13) with p=0.00003 (p< 0.05).|PMID:23478273; Original text:Non-surgical periodontal therapy significantly improves the clinical parameters and restores previously increased Superoxide dismutase levels to normal in chronic periodontitis patients."},{"Node1":"Superoxides","Edge_Type":"chemical_to_mechanism","Node2":"superoxide dismutase","Weight":6,"Paper_List":"23478273|23478273|23478273|20415915|20415915|25511061","Original_Text":"PMID:23478273; Original text:At baseline, patients with chronic periodontitis had higher mean Superoxide dismutase activity (2.73 ± 1.36) than the control subjects (1.12 ± 1.13) with p=0.00003 (p< 0.05).|PMID:23478273; Original text:At 2 months post non-surgical periodontal therapy median Superoxide dismutase level (1.00) had come close to median Superoxide dismutase value of control group (0.85); p=0.99 (p> 0.05).|PMID:23478273; Original text:Non-surgical periodontal therapy significantly improves the clinical parameters and restores previously increased Superoxide dismutase levels to normal in chronic periodontitis patients.|PMID:20415915; Original text:The levels of total oxidative status and superoxide dismutase values were significantly higher in the chronic periodontitis group than in the control group (p < 0.05), but only Malondialdehyde in GCF.|PMID:20415915; Original text:Post-periodontal therapy, serum, saliva and GCF total oxidative status and superoxide dismutase levels significantly decreased compared to basal levels (p < 0.05), but only Malondialdehyde in GCF.|PMID:25511061; Original text:The post-treatment levels of the superoxide dismutase were statistically higher than the pre-treatment levels in periodontitis and gingivitis group."},{"Node1":"Chronic Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"superoxide dismutase","Weight":2,"Paper_List":"23478273|23478273","Original_Text":"PMID:23478273; Original text:At baseline, patients with chronic periodontitis had higher mean Superoxide dismutase activity (2.73 ± 1.36) than the control subjects (1.12 ± 1.13) with p=0.00003 (p< 0.05).|PMID:23478273; Original text:Non-surgical periodontal therapy significantly improves the clinical parameters and restores previously increased Superoxide dismutase levels to normal in chronic periodontitis patients."},{"Node1":"Moxifloxacin","Edge_Type":"chemical_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"32507863","Original_Text":"PMID:32507863; Original text:There was a significant reduction in the occurrence of gingival pockets ≥ 6 mm at 6 months in all treatment groups (P < .0001), favoring the moxifloxacin and Amoxifloxacin+ME groups."},{"Node1":"Calcium Sulfate","Edge_Type":"chemical","Node2":"Doxycycline","Weight":1,"Paper_List":"12449309","Original_Text":"PMID:12449309; Original text:Furthermore, the addition of either doxycycline or demineralized freeze-dried bone allograft to calcium sulfate significantly enhanced the clinical outcome more than did the calcium sulfate alone, and the addition of demineralized freeze-dried bone allograft was more effective in the treatment of Class II mandibular furcation defects than doxycycline."},{"Node1":"Allografts","Edge_Type":"anatomy","Node2":"Mandible","Weight":1,"Paper_List":"12449309","Original_Text":"PMID:12449309; Original text:Furthermore, the addition of either doxycycline or demineralized freeze-dried bone allograft to calcium sulfate significantly enhanced the clinical outcome more than did the calcium sulfate alone, and the addition of demineralized freeze-dried bone allograft was more effective in the treatment of Class II mandibular furcation defects than doxycycline."},{"Node1":"Calcium Sulfate","Edge_Type":"chemical_to_anatomy","Node2":"Allografts","Weight":1,"Paper_List":"12449309","Original_Text":"PMID:12449309; Original text:Furthermore, the addition of either doxycycline or demineralized freeze-dried bone allograft to calcium sulfate significantly enhanced the clinical outcome more than did the calcium sulfate alone, and the addition of demineralized freeze-dried bone allograft was more effective in the treatment of Class II mandibular furcation defects than doxycycline."},{"Node1":"Calcium Sulfate","Edge_Type":"chemical_to_anatomy","Node2":"Mandible","Weight":1,"Paper_List":"12449309","Original_Text":"PMID:12449309; Original text:Furthermore, the addition of either doxycycline or demineralized freeze-dried bone allograft to calcium sulfate significantly enhanced the clinical outcome more than did the calcium sulfate alone, and the addition of demineralized freeze-dried bone allograft was more effective in the treatment of Class II mandibular furcation defects than doxycycline."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_anatomy","Node2":"Allografts","Weight":1,"Paper_List":"12449309","Original_Text":"PMID:12449309; Original text:Furthermore, the addition of either doxycycline or demineralized freeze-dried bone allograft to calcium sulfate significantly enhanced the clinical outcome more than did the calcium sulfate alone, and the addition of demineralized freeze-dried bone allograft was more effective in the treatment of Class II mandibular furcation defects than doxycycline."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_anatomy","Node2":"Mandible","Weight":1,"Paper_List":"12449309","Original_Text":"PMID:12449309; Original text:Furthermore, the addition of either doxycycline or demineralized freeze-dried bone allograft to calcium sulfate significantly enhanced the clinical outcome more than did the calcium sulfate alone, and the addition of demineralized freeze-dried bone allograft was more effective in the treatment of Class II mandibular furcation defects than doxycycline."},{"Node1":"Hemorrhage","Edge_Type":"disease","Node2":"Osteoporosis","Weight":1,"Paper_List":"22151499","Original_Text":"PMID:22151499; Original text:Mean Gingival index, bleeding on probing, clinical attachment loss and recession were significantly greater for osteoporotic women than women with normal Areal bone mineral density (P = 0.002, P = 0.01, P = 0.04, respectively)."},{"Node1":"Hemorrhage","Edge_Type":"disease_to_anatomy","Node2":"Alveolar Process","Weight":1,"Paper_List":"30143550","Original_Text":"PMID:30143550; Original text:Baseline and 24-month measurements included radiographic interproximal alveolar bone height, probing depths (probing depths), clinical attachment level (clinical attachment level), bleeding on probing (BOP), gingival crevicular fluid (GCF), and salivary interleukin (IL) - 1β, (24 month only)."},{"Node1":"Hemorrhage","Edge_Type":"disease_to_anatomy","Node2":"Blood Platelets","Weight":1,"Paper_List":"33842996","Original_Text":"PMID:33842996; Original text:open flap debridement+AA/platelet-rich fibrin and open flap debridement+platelet-rich fibrin showed no differences regarding full-mouth bleeding scores or full-mouth plaque scores (p > 0.05)."},{"Node1":"Hemorrhage","Edge_Type":"disease_to_anatomy","Node2":"Bone and Bones","Weight":2,"Paper_List":"18454658|29802627","Original_Text":"PMID:18454658; Original text:Compared to baseline, the 12-month results indicated that both treatment modalities resulted in significant changes in all clinical parameters (gingival index, bleeding on probing, probing depth, clinical attachment level, and gingival recession; P <0.001) and radiographic parameters (hard tissue fill and bone depth reduction; P <0.001).|PMID:29802627; Original text:modified sulcus bleeding index, BP, pocket probing depth, and clinical attachment level were improved in all the groups, however mean reductions in pocket probing depth, clinical attachment level gain, and percentage of bone fill was found to be higher in RSV and MF groups than placebo group at all visits."},{"Node1":"Doxycycline","Edge_Type":"chemical","Node2":"Potassium","Weight":1,"Paper_List":"8393108","Original_Text":"PMID:8393108; Original text:The doxycycline group produced significant reduction in pocket depth only at 4 and 12 weeks (0.8 and 0.8 mm); the doxycycline + potassium group produced significant gain of 0.8 mm in probing attachment level at 4 and 12 weeks; and the doxycycline + potassium group in conjunction with root planing produced the most sustained reduction in pocket depth and gain in PAL."},{"Node1":"Chlorhexidine","Edge_Type":"chemical","Node2":"Sulfides","Weight":1,"Paper_List":"15898930","Original_Text":"PMID:15898930; Original text:Even though the initial volatile sulfide compounds values were not high (+/-90 ppb with only 18 patients revealing more than 100 ppb), significant (P <0.05) reductions could be achieved in the chlorhexidine and chlorhexidine + cetyl pyridinium chloride group, and to a lower extent in the placebo group (P = 0.10)."},{"Node1":"Cetylpyridinium","Edge_Type":"chemical","Node2":"Sulfides","Weight":1,"Paper_List":"15898930","Original_Text":"PMID:15898930; Original text:Even though the initial volatile sulfide compounds values were not high (+/-90 ppb with only 18 patients revealing more than 100 ppb), significant (P <0.05) reductions could be achieved in the chlorhexidine and chlorhexidine + cetyl pyridinium chloride group, and to a lower extent in the placebo group (P = 0.10)."},{"Node1":"Cetylpyridinium","Edge_Type":"chemical_to_disease","Node2":"Confusion","Weight":1,"Paper_List":"15898930","Original_Text":"PMID:15898930; Original text:Tongue scraping resulted in a significant reduction (P < or =0.05) of the tongue coating up to month 6 in the placebo and chlorhexidine + cetyl pyridinium chloride group, but not in the chlorhexidine group (confusion due to staining)."},{"Node1":"Chlorhexidine","Edge_Type":"chemical_to_disease","Node2":"Confusion","Weight":1,"Paper_List":"15898930","Original_Text":"PMID:15898930; Original text:Tongue scraping resulted in a significant reduction (P < or =0.05) of the tongue coating up to month 6 in the placebo and chlorhexidine + cetyl pyridinium chloride group, but not in the chlorhexidine group (confusion due to staining)."},{"Node1":"Cetylpyridinium","Edge_Type":"chemical_to_anatomy","Node2":"Tongue","Weight":2,"Paper_List":"15898930|15898930","Original_Text":"PMID:15898930; Original text:Tongue scraping resulted in a significant reduction (P < or =0.05) of the tongue coating up to month 6 in the placebo and chlorhexidine + cetyl pyridinium chloride group, but not in the chlorhexidine group (confusion due to staining).|PMID:15898930; Original text:The chlorhexidine and chlorhexidine + cetyl pyridinium chloride group showed, in comparison to baseline, significant (P <0.001) reductions in the number of anaerobic species in the supragingival plaque, in the saliva, and on the anterior part of the tongue."},{"Node1":"Chlorhexidine","Edge_Type":"chemical_to_anatomy","Node2":"Tongue","Weight":2,"Paper_List":"15898930|15898930","Original_Text":"PMID:15898930; Original text:Tongue scraping resulted in a significant reduction (P < or =0.05) of the tongue coating up to month 6 in the placebo and chlorhexidine + cetyl pyridinium chloride group, but not in the chlorhexidine group (confusion due to staining).|PMID:15898930; Original text:The chlorhexidine and chlorhexidine + cetyl pyridinium chloride group showed, in comparison to baseline, significant (P <0.001) reductions in the number of anaerobic species in the supragingival plaque, in the saliva, and on the anterior part of the tongue."},{"Node1":"Hemorrhage","Edge_Type":"disease_to_anatomy","Node2":"Gingiva","Weight":51,"Paper_List":"18027183|16022023|30143550|26977121|17639748|31463484|29807962|22151499|18194335|33331040|7752836|20429647|22302453|24617449|7990020|24415114|9759061|18454658|23756425|26369484|11846190|21073330|1569224|3925112|15948682|15016039|15613075|30709694|21488873|25101909|2778608|15088885|26965080|23992525|28392215|28392215|20302221|11696921|3290430|30095173|1430286|22126407|7823272|25040766|25040766|17470020|24934646|23003342|21121958|25044531|14643271","Original_Text":"PMID:18027183; Original text:Intergroup study revealed a significant (alpha < or = 0.01) change in the bleeding index, gingival index, plaque index, calculus criteria, and pocket depth.|PMID:16022023; Original text:The results showed significant improvement of probing pocket depth, attachment level, and gingival index at 3 and 6 months and of bleeding index at 6 months in the test group as compared to control.|PMID:30143550; Original text:Baseline and 24-month measurements included radiographic interproximal alveolar bone height, probing depths (probing depths), clinical attachment level (clinical attachment level), bleeding on probing (BOP), gingival crevicular fluid (GCF), and salivary interleukin (IL) - 1β, (24 month only).|PMID:26977121; Original text:Patients undergoing standardised fermented papaya gel treatment showed significant (P < 0.05), durable improvement of three major clinical indices of disease severity: reduced bleeding (day 7), plaque and gingival conditions (day 14), and consistent gingival pocket depth reduction (day 45).|PMID:17639748; Original text:Also, the reduction in bleeding on probing, pocket depth, attachment loss, plaque index and gingival index were statistically significant in the treatment group.|PMID:31463484; Original text:The test group showed significantly greater improvement in probing pocket depth, clinical attachment level, bleeding on probing, and Gingival Index, although Plaque Index scores were similar.|PMID:29807962; Original text:An improvement of Plaque index, gingival index, papillary bleeding index, periodontal probing depth, and clinical attachment loss was observed at 6 and 12 weeks (p < 0.05) in both groups.|PMID:22151499; Original text:Mean Gingival index, bleeding on probing, clinical attachment loss and recession were significantly greater for osteoporotic women than women with normal Areal bone mineral density (P = 0.002, P = 0.01, P = 0.04, respectively).|PMID:18194335; Original text:Patients in whom both the bleeding on probing and gingival index at 1 week had improved were significantly older in the inorganic polyphosphate group than in the control group (p < 0.05).|PMID:33331040; Original text:Significant improvements in modified gingival index (P = 0.0000), sulcus bleeding index (P = 0.0000), and plaque index (P = 0.0102) were also observed in 6 months.|PMID:7752836; Original text:However, significant improvements in the modified gingival index, bleeding on probing and peptidase activity derived from periodontopathic bacteria were observed only at experimental sites.|PMID:20429647; Original text:gingival bleeding index decreased for root planingL and increased for L, root planing, and C (P <0.05) 12 days postoperatively and decreased for root planingL and root planing (P <0.05) 3, 6, and 12 months after baseline; BOP and probing depth decreased for all treated groups (P <0.01) 3, 6, and 12 months after treatment.|PMID:22302453; Original text:Compared to controls, women in the test group had significant reductions in the percentage of sites with plaque (48.5% vs. 10.3%, p < 0.001), gingival bleeding (23.3% vs. 2.5%, p < 0.001), calculus (21.3% vs. 4.1%, p < 0.001), bleeding on probing (38.1% vs. 2.6%, p < 0.001) and probing depth ≥3 mm (19.97% vs. −2.45%, p < 0.001).|PMID:24617449; Original text:A statistically significant improvement in gingival index and gingival bleeding index was seen for the test group after 2 weeks and 1 month of antimicrobial photodynamic therapy (p < 0.01), whereas the improvement in gingival index and gingival bleeding index at 3 months and in plaque index at 2 weeks after antimicrobial photodynamic therapy was less (p < 0.05).|PMID:7990020; Original text:Plaque index, gingival sulcus bleeding index (gingival sulcus bleeding index), probing depth, and attachment level decreased significantly in all groups compared to the baseline values (P < 0.05).|PMID:24415114; Original text:p = 0.17), and SLEDAI (5.9 ± 4.2 vs. 6.3 ± 4.3, p = 0.73) as well as Periodontal disease parameters [bleeding gingival index (40.8 ± 31.0 vs. 40.7 ± 36.2 %, p = 0.89), depth (1.7 ± 1.8 vs. 1.5 ± |PMID:9759061; Original text:In both groups, after 4 weeks, the mean sulcular bleeding index, approximal plaque index, and gingival index scores had decreased significantly.|PMID:18454658; Original text:Compared to baseline, the 12-month results indicated that both treatment modalities resulted in significant changes in all clinical parameters (gingival index, bleeding on probing, probing depth, clinical attachment level, and gingival recession; P <0.001) and radiographic parameters (hard tissue fill and bone depth reduction; P <0.001).|PMID:23756425; Original text:The gingival index and gingival bleeding index showed a statistically significant reduction at two weeks, three months and six months (P<0.001) in both groups.|PMID:26369484; Original text:Improvements in gingival index and bleeding on probing were greater in the nondiabetic participants and the treated patients with good glycemic control than in the treated patients with poor glycemic control (P < 0.05).|PMID:11846190; Original text:Both meloxicam and placebo groups showed statistically significant reductions in papilla bleeding index, Plaque index, and gingival crevicular fluid MMP-8 levels on day 10 compared to baseline (P<0.01).|PMID:21073330; Original text:Periodontal therapy significantly decreased visible plaque index, bleeding gingival index, bleeding on probing, probing depth of 4 to 6 mm, probing depth|PMID:1569224; Original text:Within-group comparisons showed that the 0.2% chlorhexidine digluconate regime reduced A modified dichotomous plaque index, gingival bleeding index and pocket depths significantly but that the placebo group (the placebo group) only achieved a significant reduction in the pocket depths.|PMID:3925112; Original text:In both groups there was a significant decrease in plaque scores, gingival inflammation, gingival bleeding and probeable depths for all sites and for affected sites.|PMID:15948682; Original text:When compared to baseline, the 12-month results indicated that, while both treatment modalities resulted in significant changes in all clinical parameters (gingival index, bleeding on probing, probing depth, clinical attachment level, and intrabony defect fill; P <0.001), the test group exhibited statistically significant changes compared to the control sites in probing depth reduction: 4.7 +/- 1.6 mm versus 3.7 +/- 2.0 mm (P <0.05); clinical attachment gain: 3.4 +/- 1.7 mm versus 2.0 +/- 1.2 mm (P <0.001); and vertical relative attachment gain: 70.3% +/- 23.4% versus 45.5% +/- 29.4% (P <0.001).|PMID:15016039; Original text:There were significant reductions in PD, suppuration (suppuration), modified gingival index (modified gingival index) and plaque index (plaque index) in the remaining untreated quadrants in the Q-SRP group during the initial phase of treatment (p<0.05), while minimum changes in RALs and bleeding on probing (BOP) occurred.|PMID:15613075; Original text:In this 18-week clinical trial, the results suggested that scaling/root planing with adjunctive subgingival administration of minocycline ointment has a significantly better and prolonged effect compared to scaling/root planing alone on the reduction of probing depth, clinical attachment loss, gingival index, and interleukin-1beta content, but not on bleeding on probing.|PMID:30709694; Original text:At evaluation, all examined sites exhibited significantly reduced probing pocket depth (significantly reduced probing pocket depth), clinical attachment level (clinical attachment level), gingival bleeding index, plaque score, and visual analog scale.|PMID:21488873; Original text:Clinical attachment level, probing depth, bleeding on probing and gingival crevicular fluid volume showed no predictive utility [area under the curve (the curve) <0.6, p>0.05].|PMID:25101909; Original text:No statistically significant group × time interactions were found for plaque index, gingival index, pocket depth, bleeding on probing, and halitosis, which means three independent groups change like each other by time.|PMID:2778608; Original text:Both groups had significantly improved scores (P less than 0.01) for Gingival Index and bleeding tendency during the 12-month period, but no differences were found between the groups at any examination.|PMID:15088885; Original text:At 6 months, no difference was found between groups regarding plaque, bleeding reduction, gingival recession or PD (P > 0.05).|PMID:26965080; Original text:Probiotics significantly reduced bleeding-on-probing (SMD: -1.15; -1.68/-0.62) and gingival index (SMD: -0.86; -1.52/-0.20), but not plaque index (SMD: -0.other genus4; -0.89/0.21).|PMID:23992525; Original text:Compared to the control group, there were statistically significant reductions in extent of shallow pockets: PD ≥4 mm (mean difference -2.86, [95% CI -5.01 to -0.71], p = 0.009) and gingival bleeding (mean difference -0.25, [95% CI -0.43 to -0.08], p = 0.005) but not deeper pockets PD ≥5 mm|PMID:28392215; Original text:Participants of both programmes had a significant reduction in the percentages of sites with moderate to abundant dental plaque (p<0.001) and with gingival bleeding (p<0.05).|PMID:28392215; Original text:Those in the an advanced oral hygiene care programme had significantly less plaque and gingival bleeding than those in the a conventional oral hygiene care programme controlling for other factors at the end of the clinical trial period (both p<0.001) and the observational period (plaque: p<0.05, gingival bleeding: p<0.01).|PMID:20302221; Original text:All protocols (groups 1, 2, 3 and 4) induced a reduction of probing depths, plaque and gingival indices and bleeding on probing.|PMID:11696921; Original text:There was an improvement in clinical parameters in all groups with a significantly greater decrease in gingival recession and bleeding in the chlorhexidine group.|PMID:3290430; Original text:Clinical and microbiologic changes were monitored every two weeks using plaque and gingival indices, gingival fluid flow, probing depths, bleeding on probing and dark-field microscopic examination of the subgingival microbial flora.|PMID:30095173; Original text:Nevertheless, the statistically significant difference for the sulcus bleeding index score demonstrates that Photodynamic therapy may have additional effect on the reduction in gingival bleeding.|PMID:1430286; Original text:The majority of the sites demonstrated a significant improvement in gingival conditions and a reduction in bleeding.|PMID:22126407; Original text:Linear regression analysis demonstrated the following significant associations: (i) oral malodour from H(2)S and thickness of the tongue coating, (ii) oral malodour from CH(3)SH and periodontal pocket depth of 5 mm or more and the presence of gingival bleeding and (iii) oral malodour from (CH(3))(2)S and systemic disease, medications and thickness of the tongue coating.|PMID:7823272; Original text:No statistically significant differences were found between test and control sites regarding plaque, bleeding on probing, reduction in pocket depth, gain in bone height, or recession of the gingival margin.|PMID:25040766; Original text:At baseline and 3-mo visits, gingival bleeding was assessed within 30 s after probing to full pocket depth using an approximate force of 0.75 N.|PMID:25040766; Original text:Ninety-seven pockets showed depth increases of ≥ 2 mm after 3 mo: 60 (62%) of those pockets exhibited bleeding on probing at both the initial and the 3-mo visits; 24 (25%) bled at only one of the two visits; and 13 (13%) never demonstrated gingival bleeding (p < 0.001).|PMID:17470020; Original text:All of the clinical parameters, except mean gingival bleeding index, were significantly lower in the experimental group (P <0.05).|PMID:24934646; Original text:Participants in the intervention group had significantly lower glycosylated hemoglobin (significantly lower glycosylated hemoglobin), fasting plasma glucose (plasma glucose), plaque index score, gingival index score, pocket depth, clinical attachment level (clinical attachment level), and percentage of bleeding on probing (BOP) when compared to the control group.|PMID:23003342; Original text:In vivo efficacy studies showed a significant improvement (p <0.001) in clinical parameters such as gingival index, probing pocket depth, clinical attachment level, bleeding index and plaque index.|PMID:21121958; Original text:These parameters included Silness-Löe plaque index (Silness-Löe plaque index), Löe-Silness gingival index (Löe-Silness gingival index), bleeding on probing (Bthe osmotic pressure), probing pocket depth (pocket depth) and probing attachment level (attachment level).|PMID:25044531; Original text:The clinical variables evaluated were probing depth (depth), clinical attachment level (clinical attachment level), gingival index (gingival index), plaque index (plaque index), and percent bleeding on probing sites (%BOP), while microbiologic variables included percentage of subjects positive for A. actinomycetemcomitans at baseline, 3, 6, and 12 months.|PMID:14643271; Original text:mm (2.7% for non-acute myocardial infarction and 12.1% for acute myocardial infarction group, 95% CI: -2.8 to 0.01, P<0.05) but no difference in the extent of gingival bleeding was found between groups."},{"Node1":"Pituitary Gland, Anterior","Edge_Type":"anatomy","Node2":"Tongue","Weight":1,"Paper_List":"15898930","Original_Text":"PMID:15898930; Original text:The chlorhexidine and chlorhexidine + cetyl pyridinium chloride group showed, in comparison to baseline, significant (P <0.001) reductions in the number of anaerobic species in the supragingival plaque, in the saliva, and on the anterior part of the tongue."},{"Node1":"Pharynx","Edge_Type":"anatomy","Node2":"Tongue","Weight":1,"Paper_List":"15898930","Original_Text":"PMID:15898930; Original text:The chlorhexidine and chlorhexidine + cetyl pyridinium chloride group showed, in comparison to baseline, significant (P <0.001) reductions in the number of anaerobic species in the supragingival plaque, in the saliva, and on the anterior part of the tongue."},{"Node1":"Pharynx","Edge_Type":"anatomy","Node2":"Pituitary Gland, Anterior","Weight":1,"Paper_List":"15898930","Original_Text":"PMID:15898930; Original text:The chlorhexidine and chlorhexidine + cetyl pyridinium chloride group showed, in comparison to baseline, significant (P <0.001) reductions in the number of anaerobic species in the supragingival plaque, in the saliva, and on the anterior part of the tongue."},{"Node1":"Cetylpyridinium","Edge_Type":"chemical_to_anatomy","Node2":"Pituitary Gland, Anterior","Weight":1,"Paper_List":"15898930","Original_Text":"PMID:15898930; Original text:The chlorhexidine and chlorhexidine + cetyl pyridinium chloride group showed, in comparison to baseline, significant (P <0.001) reductions in the number of anaerobic species in the supragingival plaque, in the saliva, and on the anterior part of the tongue."},{"Node1":"Cetylpyridinium","Edge_Type":"chemical_to_anatomy","Node2":"Pharynx","Weight":1,"Paper_List":"15898930","Original_Text":"PMID:15898930; Original text:The chlorhexidine and chlorhexidine + cetyl pyridinium chloride group showed, in comparison to baseline, significant (P <0.001) reductions in the number of anaerobic species in the supragingival plaque, in the saliva, and on the anterior part of the tongue."},{"Node1":"Chlorhexidine","Edge_Type":"chemical_to_anatomy","Node2":"Pituitary Gland, Anterior","Weight":1,"Paper_List":"15898930","Original_Text":"PMID:15898930; Original text:The chlorhexidine and chlorhexidine + cetyl pyridinium chloride group showed, in comparison to baseline, significant (P <0.001) reductions in the number of anaerobic species in the supragingival plaque, in the saliva, and on the anterior part of the tongue."},{"Node1":"Chlorhexidine","Edge_Type":"chemical_to_anatomy","Node2":"Pharynx","Weight":1,"Paper_List":"15898930","Original_Text":"PMID:15898930; Original text:The chlorhexidine and chlorhexidine + cetyl pyridinium chloride group showed, in comparison to baseline, significant (P <0.001) reductions in the number of anaerobic species in the supragingival plaque, in the saliva, and on the anterior part of the tongue."},{"Node1":"Sulfides","Edge_Type":"chemical_to_anatomy","Node2":"Tongue","Weight":1,"Paper_List":"15898930","Original_Text":"PMID:15898930; Original text:The results of this study indicate that in patients with moderate periodontitis, initial periodontal therapy including tongue scraping did not have a significant effect on the microbial load of the tongue and had only a weak impact on the volatile sulfide compounds level, except when combined with a mouthrinse."},{"Node1":"Leg","Edge_Type":"anatomy","Node2":"Tongue","Weight":1,"Paper_List":"15898930","Original_Text":"PMID:15898930; Original text:For the posterior part of the tongue the microbial changes remained < or =0.3 log values (P >0.05)."},{"Node1":"Interleukin-17","Edge_Type":"mechanism","Node2":"interleukin 10 S homeolog","Weight":1,"Paper_List":"31785387","Original_Text":"PMID:31785387; Original text:Group-II was capable of increasing the levels of inflammatory interleukin-10 and reducing inflammatory interleukin-17 in GCF at both time periods compared to Group-I (p < 0.05)."},{"Node1":"Hematologic Neoplasms","Edge_Type":"disease","Node2":"Periodontal Diseases","Weight":2,"Paper_List":"31880294|31880294","Original_Text":"PMID:31880294; Original text:The pooled analysis revealed that periodontal disease was significantly associated with an increased risk of hematopoietic and lymphatic cancers (The summary relative risk = 1.17; 95% 95% confidence interval = 1.07-1.27; P = 0).|PMID:31880294; Original text:Stratified analysis showed the association of periodontal disease with hematopoietic and lymphatic cancers remained significant in the never smokers (The summary relative risk = 1.28; 95% 95% confidence interval = 1.07-1.54; P = 0.007), and in the American population (The summary relative risk = 1.17; 95% 95% confidence interval = 1.05-1.30; P = 0.003), respectively."},{"Node1":"distal membrane arm assembly component 2 like","Edge_Type":"mechanism","Node2":"vascular endothelial growth factor precursor","Weight":1,"Paper_List":"16846342","Original_Text":"PMID:16846342; Original text:Increased levels of vascular endothelial growth factor in the WF was observed for all surgical treatment groups with the 1.0 mg/mL rhplatelet-derived growth factor-BB group showing the most pronounced difference at 3 weeks in the AUC analysis versus control (p < 0.0001)."},{"Node1":"distal membrane arm assembly component 2 like","Edge_Type":"mechanism_to_anatomy","Node2":"Endothelium, Vascular","Weight":1,"Paper_List":"16846342","Original_Text":"PMID:16846342; Original text:Increased levels of vascular endothelial growth factor in the WF was observed for all surgical treatment groups with the 1.0 mg/mL rhplatelet-derived growth factor-BB group showing the most pronounced difference at 3 weeks in the AUC analysis versus control (p < 0.0001)."},{"Node1":"vascular endothelial growth factor precursor","Edge_Type":"mechanism_to_anatomy","Node2":"Endothelium, Vascular","Weight":3,"Paper_List":"16846342|26547514|18496484","Original_Text":"PMID:16846342; Original text:Increased levels of vascular endothelial growth factor in the WF was observed for all surgical treatment groups with the 1.0 mg/mL rhplatelet-derived growth factor-BB group showing the most pronounced difference at 3 weeks in the AUC analysis versus control (p < 0.0001).|PMID:26547514; Original text:Similarly, vascular endothelial growth factor concentration in gingival crevicular fluid was significantly higher in the ankaferd blood stopper/autogenous cortical bone graft group at postoperative weeks 2 and 4 compared to the autogenous cortical bone graft group (p < 0.01).|PMID:18496484; Original text:IL-1beta, vascular endothelial growth factor and PGE(2) levels were significantly lower in test compared to control group."},{"Node1":"Dinoprostone","Edge_Type":"chemical","Node2":"Nitric Oxide","Weight":1,"Paper_List":"31813866","Original_Text":"PMID:31813866; Original text:Results indicated that the levels of PGE2, TNF-α and nitric oxide in the groups of patients received gel treatment and mouthwash treatment was decreased to significant levels (p<0.001) as compared to the group of standard treatment."},{"Node1":"Polyphosphates","Edge_Type":"chemical_to_disease","Node2":"Hemorrhage","Weight":1,"Paper_List":"18194335","Original_Text":"PMID:18194335; Original text:Patients in whom both the bleeding on probing and gingival index at 1 week had improved were significantly older in the inorganic polyphosphate group than in the control group (p < 0.05)."},{"Node1":"Polyphosphates","Edge_Type":"chemical_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"18194335","Original_Text":"PMID:18194335; Original text:Patients in whom both the bleeding on probing and gingival index at 1 week had improved were significantly older in the inorganic polyphosphate group than in the control group (p < 0.05)."},{"Node1":"Behcet Syndrome","Edge_Type":"disease","Node2":"Ulcer","Weight":1,"Paper_List":"19076988","Original_Text":"PMID:19076988; Original text:Periodontal indices, the number of oral ulcers and the daily frequency of tooth brushing were related to the severity scores of Behçet's disease (p < 0.001)."},{"Node1":"Hemorrhage","Edge_Type":"disease_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":3,"Paper_List":"30143550|11846190|21488873","Original_Text":"PMID:30143550; Original text:Baseline and 24-month measurements included radiographic interproximal alveolar bone height, probing depths (probing depths), clinical attachment level (clinical attachment level), bleeding on probing (BOP), gingival crevicular fluid (GCF), and salivary interleukin (IL) - 1β, (24 month only).|PMID:11846190; Original text:Both meloxicam and placebo groups showed statistically significant reductions in papilla bleeding index, Plaque index, and gingival crevicular fluid MMP-8 levels on day 10 compared to baseline (P<0.01).|PMID:21488873; Original text:Clinical attachment level, probing depth, bleeding on probing and gingival crevicular fluid volume showed no predictive utility [area under the curve (the curve) <0.6, p>0.05]."},{"Node1":"Hemorrhage","Edge_Type":"disease_to_anatomy","Node2":"Myocardium","Weight":1,"Paper_List":"14643271","Original_Text":"PMID:14643271; Original text:mm (2.7% for non-acute myocardial infarction and 12.1% for acute myocardial infarction group, 95% CI: -2.8 to 0.01, P<0.05) but no difference in the extent of gingival bleeding was found between groups."},{"Node1":"Behcet Syndrome","Edge_Type":"disease","Node2":"Pain","Weight":1,"Paper_List":"19076988","Original_Text":"PMID:19076988; Original text:The results indicated that Behçet's disease patients treated with the Nd:YAG laser had less post-treatment pain and fewer functional complications and reported immediate relief of pain and faster healing (p < 0.001)."},{"Node1":"anterior polar opacity","Edge_Type":"mechanism","Node2":"high","Weight":2,"Paper_List":"17590156|17590156","Original_Text":"PMID:17590156; Original text:Between groups, there were statistically significant greater improvements in pocket depth (pocket depth), gingival index (gingival index), APO-A and high-density lipoprotein, favouring the group receiving sub-antimicrobial dose doxycycline adjunctive to root planing (p < 0.05).|PMID:17590156; Original text:There were statistically significant improvements for all clinical parameters, GCF volumes, GCF matrix metalloproteinases and serum levels of high-sensitivity C-reactive protein, apolipoprotein-A (APO-A), high-density lipoprotein (high-density lipoprotein) and lipoprotein-a between pre- and post-treatment in both groups."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_mechanism","Node2":"high","Weight":1,"Paper_List":"17590156","Original_Text":"PMID:17590156; Original text:Between groups, there were statistically significant greater improvements in pocket depth (pocket depth), gingival index (gingival index), APO-A and high-density lipoprotein, favouring the group receiving sub-antimicrobial dose doxycycline adjunctive to root planing (p < 0.05)."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_mechanism","Node2":"anterior polar opacity","Weight":1,"Paper_List":"17590156","Original_Text":"PMID:17590156; Original text:Between groups, there were statistically significant greater improvements in pocket depth (pocket depth), gingival index (gingival index), APO-A and high-density lipoprotein, favouring the group receiving sub-antimicrobial dose doxycycline adjunctive to root planing (p < 0.05)."},{"Node1":"anterior polar opacity","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"17590156","Original_Text":"PMID:17590156; Original text:Between groups, there were statistically significant greater improvements in pocket depth (pocket depth), gingival index (gingival index), APO-A and high-density lipoprotein, favouring the group receiving sub-antimicrobial dose doxycycline adjunctive to root planing (p < 0.05)."},{"Node1":"apovitellenin 1","Edge_Type":"mechanism","Node2":"high","Weight":1,"Paper_List":"17590156","Original_Text":"PMID:17590156; Original text:There were statistically significant improvements for all clinical parameters, GCF volumes, GCF matrix metalloproteinases and serum levels of high-sensitivity C-reactive protein, apolipoprotein-A (APO-A), high-density lipoprotein (high-density lipoprotein) and lipoprotein-a between pre- and post-treatment in both groups."},{"Node1":"anterior polar opacity","Edge_Type":"mechanism","Node2":"collagenase 3-like","Weight":1,"Paper_List":"17590156","Original_Text":"PMID:17590156; Original text:There were statistically significant improvements for all clinical parameters, GCF volumes, GCF matrix metalloproteinases and serum levels of high-sensitivity C-reactive protein, apolipoprotein-A (APO-A), high-density lipoprotein (high-density lipoprotein) and lipoprotein-a between pre- and post-treatment in both groups."},{"Node1":"anterior polar opacity","Edge_Type":"mechanism","Node2":"apovitellenin 1","Weight":1,"Paper_List":"17590156","Original_Text":"PMID:17590156; Original text:There were statistically significant improvements for all clinical parameters, GCF volumes, GCF matrix metalloproteinases and serum levels of high-sensitivity C-reactive protein, apolipoprotein-A (APO-A), high-density lipoprotein (high-density lipoprotein) and lipoprotein-a between pre- and post-treatment in both groups."},{"Node1":"apovitellenin 1","Edge_Type":"mechanism","Node2":"collagenase 3-like","Weight":1,"Paper_List":"17590156","Original_Text":"PMID:17590156; Original text:There were statistically significant improvements for all clinical parameters, GCF volumes, GCF matrix metalloproteinases and serum levels of high-sensitivity C-reactive protein, apolipoprotein-A (APO-A), high-density lipoprotein (high-density lipoprotein) and lipoprotein-a between pre- and post-treatment in both groups."},{"Node1":"Dementia","Edge_Type":"disease","Node2":"Periodontitis","Weight":2,"Paper_List":"34202071|34202071","Original_Text":"PMID:34202071; Original text:There was no statistical significance in the effect of periodontitis on dementia (the odds ratio = 1.59; 95%1.77 (95% confidence interval, 0.92-2.76).|PMID:34202071; Original text:The subgroup analysis revealed that moderate or severe periodontitis was significantly associated with dementia (the odds ratio = 2.13; 95%1.77 (95% confidence interval, 1.25-3.64)."},{"Node1":"Hemorrhage","Edge_Type":"disease","Node2":"Periodontal Pocket","Weight":1,"Paper_List":"7752836","Original_Text":"PMID:7752836; Original text:However, significant improvements in the modified gingival index, bleeding on probing and peptidase activity derived from periodontopathic bacteria were observed only at experimental sites."},{"Node1":"Periodontal Pocket","Edge_Type":"disease_to_mechanism","Node2":"OMA1 zinc metallopeptidase","Weight":1,"Paper_List":"7752836","Original_Text":"PMID:7752836; Original text:However, significant improvements in the modified gingival index, bleeding on probing and peptidase activity derived from periodontopathic bacteria were observed only at experimental sites."},{"Node1":"Hemorrhage","Edge_Type":"disease_to_mechanism","Node2":"OMA1 zinc metallopeptidase","Weight":1,"Paper_List":"7752836","Original_Text":"PMID:7752836; Original text:However, significant improvements in the modified gingival index, bleeding on probing and peptidase activity derived from periodontopathic bacteria were observed only at experimental sites."},{"Node1":"Hemorrhage","Edge_Type":"disease_to_anatomy","Node2":"Periodontal Ligament","Weight":3,"Paper_List":"29807962|24509697|24509697","Original_Text":"PMID:29807962; Original text:An improvement of Plaque index, gingival index, papillary bleeding index, periodontal probing depth, and clinical attachment loss was observed at 6 and 12 weeks (p < 0.05) in both groups.|PMID:24509697; Original text:Results obtained in this study indicate that application of oral treatment with tablets containing probiotic strain of L. reuteri induces in most patients with chronic periodontitis a significant reduction of pro-inflammatory cytokine response and improvement of clinical parameters (sulcus bleeding index, periodontal probing depth, clinical attachment level).|PMID:24509697; Original text:At individuals of Group 2 levels of studies, pro-inflammatory cytokines and clinical indices (sulcus bleeding index, periodontal probing depth, clinical attachment level) were significantly higher than in Group 1."},{"Node1":"OMA1 zinc metallopeptidase","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"7752836","Original_Text":"PMID:7752836; Original text:However, significant improvements in the modified gingival index, bleeding on probing and peptidase activity derived from periodontopathic bacteria were observed only at experimental sites."},{"Node1":"collagenase","Edge_Type":"mechanism","Node2":"serpin family A member 1","Weight":1,"Paper_List":"8724709","Original_Text":"PMID:8724709; Original text:However, attachment levels, probing depth, and GCF collagenase activity and alpha 1-PI degradation were all beneficially and significantly (P < 0.05) affected by the drug regimen."},{"Node1":"plasminogen","Edge_Type":"mechanism","Node2":"serpin family E member 2","Weight":1,"Paper_List":"28394081","Original_Text":"PMID:28394081; Original text:Gingival crevicular fluid PAI-1 levels decreased significantly in the SCp+root planing+sham and SCp+root planing+low-level laser therapy groups (P<.05), and gingival crevicular fluid tissue plasminogen activator levels decreased significantly in the Cp+root planing+sham, Cp+root planing+low-level laser therapy and SCp+root planing+low-level laser therapy groups (P<.05)."},{"Node1":"plasminogen","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"28394081","Original_Text":"PMID:28394081; Original text:Gingival crevicular fluid PAI-1 levels decreased significantly in the SCp+root planing+sham and SCp+root planing+low-level laser therapy groups (P<.05), and gingival crevicular fluid tissue plasminogen activator levels decreased significantly in the Cp+root planing+sham, Cp+root planing+low-level laser therapy and SCp+root planing+low-level laser therapy groups (P<.05)."},{"Node1":"plasminogen","Edge_Type":"mechanism_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"28394081","Original_Text":"PMID:28394081; Original text:Gingival crevicular fluid PAI-1 levels decreased significantly in the SCp+root planing+sham and SCp+root planing+low-level laser therapy groups (P<.05), and gingival crevicular fluid tissue plasminogen activator levels decreased significantly in the Cp+root planing+sham, Cp+root planing+low-level laser therapy and SCp+root planing+low-level laser therapy groups (P<.05)."},{"Node1":"serpin family E member 2","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"28394081","Original_Text":"PMID:28394081; Original text:Gingival crevicular fluid PAI-1 levels decreased significantly in the SCp+root planing+sham and SCp+root planing+low-level laser therapy groups (P<.05), and gingival crevicular fluid tissue plasminogen activator levels decreased significantly in the Cp+root planing+sham, Cp+root planing+low-level laser therapy and SCp+root planing+low-level laser therapy groups (P<.05)."},{"Node1":"serpin family E member 2","Edge_Type":"mechanism_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"28394081","Original_Text":"PMID:28394081; Original text:Gingival crevicular fluid PAI-1 levels decreased significantly in the SCp+root planing+sham and SCp+root planing+low-level laser therapy groups (P<.05), and gingival crevicular fluid tissue plasminogen activator levels decreased significantly in the Cp+root planing+sham, Cp+root planing+low-level laser therapy and SCp+root planing+low-level laser therapy groups (P<.05)."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_disease","Node2":"Diabetes Mellitus, Type 2","Weight":1,"Paper_List":"25041182","Original_Text":"PMID:25041182; Original text:Adjunctive systemic doxycycline does not seem to significantly enhance the effects of root planing in well-controlled diabetes type 2 patients."},{"Node1":"Aggressive Periodontitis","Edge_Type":"disease","Node2":"Cleft Palate, Isolated, And Mental Retardation","Weight":1,"Paper_List":"29027636","Original_Text":"PMID:29027636; Original text:Seven articles with 1540 participants composed the results in which the mutant allele in the rs2275913 polymorphism did not present significant association with the risk of CP or aggressive periodontitis (odds ratio 1.56, 95% CI 0.77, 3.15, P = 0.21; odds ratio 1.12, 95% CI 0.05, 23.44, P = 0.94, respectively) nor was the mutant allele in rs763780 associated with the risk of CP (odds ratio 1.19, 95% CI 0.80, 1.76, P = 0.39) or aggressive periodontitis (odds ratio 1.07, 95% CI 0.63, 1.84, P = 0.79)."},{"Node1":"Fc gamma receptor Ia","Edge_Type":"mechanism","Node2":"Rab geranylgeranyltransferase subunit alpha","Weight":1,"Paper_List":"14761117","Original_Text":"PMID:14761117; Original text:Given the diversity of the distribution of the Gm (23) allotypes and FcgammaR genotypes in different ethnic groups, it was our purpose to examine their clinical significance in periodontitis in Taiwan."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"Fc gamma receptor Ia","Weight":1,"Paper_List":"14761117","Original_Text":"PMID:14761117; Original text:Given the diversity of the distribution of the Gm (23) allotypes and FcgammaR genotypes in different ethnic groups, it was our purpose to examine their clinical significance in periodontitis in Taiwan."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"Rab geranylgeranyltransferase subunit alpha","Weight":1,"Paper_List":"14761117","Original_Text":"PMID:14761117; Original text:Given the diversity of the distribution of the Gm (23) allotypes and FcgammaR genotypes in different ethnic groups, it was our purpose to examine their clinical significance in periodontitis in Taiwan."},{"Node1":"Aggressive Periodontitis","Edge_Type":"disease","Node2":"Chronic Periodontitis","Weight":7,"Paper_List":"14761117|14761117|34394107|28013438|28013438|22763734|34479676","Original_Text":"PMID:14761117; Original text:The frequency of the R131 allele of the FcgammaR IIa polymorphisms was higher in generalized aggressive periodontitis than in chronic periodontitis when R/H allelic frequencies (p = 0.01) were examined by the chi2 test.|PMID:14761117; Original text:Although the R131 allele of FcgammaR IIa occurred more frequently in generalized aggressive periodontitis than in chronic periodontitis, its clinical significance could not be justified in this study.|PMID:34394107; Original text:Patients with aggressive periodontitis exhibited on average more than 50% higher levels of C-reactive protein (means [95% confidence interval [CI]]: 1.56 [1.15; 2.12], p=0.0039) than patients with chronic periodontitis.|PMID:28013438; Original text:The 3-year survival rate for chronic periodontitis and HP patients was 100 % while in aggressive periodontitis subjects, the respective value was 97.98 %; this difference being statistically significant.|PMID:28013438; Original text:A significant difference between the aggressive periodontitis and chronic periodontitis groups was identified (p < 0.05).|PMID:22763734; Original text:Nine case-control studies involving 841 periodontitis cases (644 chronic periodontitis and 197 aggressive periodontitis cases) and 748 controls were included.|PMID:34479676; Original text:Variant A of TNF-α (G-308A) was associated with increased aggressive periodontitis risk in the general population, especially in Asians, and this polymorphism was significantly associated with elevated risk of Chronic periodontitis in Asians and Caucasians."},{"Node1":"Aggressive Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"Fc gamma receptor and transporter","Weight":1,"Paper_List":"14761117","Original_Text":"PMID:14761117; Original text:The frequency of the R131 allele of the FcgammaR IIa polymorphisms was higher in generalized aggressive periodontitis than in chronic periodontitis when R/H allelic frequencies (p = 0.01) were examined by the chi2 test."},{"Node1":"Chronic Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"Fc gamma receptor and transporter","Weight":1,"Paper_List":"14761117","Original_Text":"PMID:14761117; Original text:The frequency of the R131 allele of the FcgammaR IIa polymorphisms was higher in generalized aggressive periodontitis than in chronic periodontitis when R/H allelic frequencies (p = 0.01) were examined by the chi2 test."},{"Node1":"Aggressive Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"Fc gamma receptor IIa","Weight":1,"Paper_List":"14761117","Original_Text":"PMID:14761117; Original text:Although the R131 allele of FcgammaR IIa occurred more frequently in generalized aggressive periodontitis than in chronic periodontitis, its clinical significance could not be justified in this study."},{"Node1":"Chronic Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"Fc gamma receptor IIa","Weight":1,"Paper_List":"14761117","Original_Text":"PMID:14761117; Original text:Although the R131 allele of FcgammaR IIa occurred more frequently in generalized aggressive periodontitis than in chronic periodontitis, its clinical significance could not be justified in this study."},{"Node1":"interleukin 1 alpha","Edge_Type":"mechanism","Node2":"interleukin 1 receptor antagonist","Weight":3,"Paper_List":"18673406|22348697|22348697","Original_Text":"PMID:18673406; Original text:Using random effect methods we found statistically significant association of IL-1A C[-889]T and IL-1B C[3953/4]T polymorphisms with chronic periodontal disease without any evidence of publication bias or significant statistical heterogeneity.|PMID:22348697; Original text:This review and meta-analysis show that IL1A and IL1B genetic variations are significant contributors to chronic periodontitis in whites.|PMID:22348697; Original text:The meta-analysis, based on 13 qualifying studies, found significant effects for the two individual gene variations (IL1A odds ratio [OR] = 1.48; IL1B OR = 1.54) and for a composite genotype that combines minor alleles at each locus (OR = 1.51)."},{"Node1":"Chronic Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"interleukin 1 receptor antagonist","Weight":1,"Paper_List":"18673406","Original_Text":"PMID:18673406; Original text:Using random effect methods we found statistically significant association of IL-1A C[-889]T and IL-1B C[3953/4]T polymorphisms with chronic periodontal disease without any evidence of publication bias or significant statistical heterogeneity."},{"Node1":"Chronic Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"interleukin 1 alpha","Weight":1,"Paper_List":"18673406","Original_Text":"PMID:18673406; Original text:Using random effect methods we found statistically significant association of IL-1A C[-889]T and IL-1B C[3953/4]T polymorphisms with chronic periodontal disease without any evidence of publication bias or significant statistical heterogeneity."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_mechanism","Node2":"stathmin 3","Weight":1,"Paper_List":"31834951","Original_Text":"PMID:31834951; Original text:After 6 months, local administration of 1.2% statin gels as adjuncts to non-surgical periodontal therapy significantly improved probing pocket depth reduction (1.83 mm) in infrabony defects and systemic administration of sub-antimicrobial dose doxycycline (sub-antimicrobial dose doxycycline) in addition to non-surgical periodontal therapy improved probing pocket depth reduction of deep pockets."},{"Node1":"WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2","Edge_Type":"mechanism","Node2":"pink","Weight":1,"Paper_List":"23701010","Original_Text":"PMID:23701010; Original text:(P = 0.02), serum levels of immunoglobulinG to P. gingivalis hemin binding protein (P. gingivalis hemin binding protein)35"},{"Node1":"nejire","Edge_Type":"mechanism","Node2":"pink","Weight":1,"Paper_List":"23701010","Original_Text":"PMID:23701010; Original text:(P = 0.02), serum levels of immunoglobulinG to P. gingivalis hemin binding protein (P. gingivalis hemin binding protein)35"},{"Node1":"WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2","Edge_Type":"mechanism","Node2":"nejire","Weight":1,"Paper_List":"23701010","Original_Text":"PMID:23701010; Original text:(P = 0.02), serum levels of immunoglobulinG to P. gingivalis hemin binding protein (P. gingivalis hemin binding protein)35"},{"Node1":"NADH:ubiquinone oxidoreductase subunit A2 L homeolog","Edge_Type":"mechanism","Node2":"provisional ortholog of C-reactive protein L homeolog","Weight":1,"Paper_List":"18701824","Original_Text":"PMID:18701824; Original text:Binary logistic regression analyses revealed a significant association between abscess or fistula formation as the outcome variable and the CD14 genotype and the concentrations of C-reactive protein and of neopterin as factors (p < 0.05)."},{"Node1":"Fistula","Edge_Type":"disease_to_mechanism","Node2":"NADH:ubiquinone oxidoreductase subunit A2 L homeolog","Weight":1,"Paper_List":"18701824","Original_Text":"PMID:18701824; Original text:Binary logistic regression analyses revealed a significant association between abscess or fistula formation as the outcome variable and the CD14 genotype and the concentrations of C-reactive protein and of neopterin as factors (p < 0.05)."},{"Node1":"Fistula","Edge_Type":"disease_to_mechanism","Node2":"provisional ortholog of C-reactive protein L homeolog","Weight":1,"Paper_List":"18701824","Original_Text":"PMID:18701824; Original text:Binary logistic regression analyses revealed a significant association between abscess or fistula formation as the outcome variable and the CD14 genotype and the concentrations of C-reactive protein and of neopterin as factors (p < 0.05)."},{"Node1":"Abscess","Edge_Type":"disease","Node2":"Fistula","Weight":2,"Paper_List":"18701824|18701824","Original_Text":"PMID:18701824; Original text:A significant negative association was found between the CD14-260 TT and abscess or fistula formation (p = 0.035, OR = 3.3) for the whole population.|PMID:18701824; Original text:For children who had 4 or more carious lesions at baseline, the significance increased (p = 0.005, OR = 4.8), suggesting that the CD14-260 TT genotype was protective for abscess or fistula formation as a consequence of dental caries."},{"Node1":"Abscess","Edge_Type":"disease_to_mechanism","Node2":"transthyretin","Weight":2,"Paper_List":"18701824|18701824","Original_Text":"PMID:18701824; Original text:A significant negative association was found between the CD14-260 TT and abscess or fistula formation (p = 0.035, OR = 3.3) for the whole population.|PMID:18701824; Original text:For children who had 4 or more carious lesions at baseline, the significance increased (p = 0.005, OR = 4.8), suggesting that the CD14-260 TT genotype was protective for abscess or fistula formation as a consequence of dental caries."},{"Node1":"Fistula","Edge_Type":"disease_to_mechanism","Node2":"transthyretin","Weight":2,"Paper_List":"18701824|18701824","Original_Text":"PMID:18701824; Original text:A significant negative association was found between the CD14-260 TT and abscess or fistula formation (p = 0.035, OR = 3.3) for the whole population.|PMID:18701824; Original text:For children who had 4 or more carious lesions at baseline, the significance increased (p = 0.005, OR = 4.8), suggesting that the CD14-260 TT genotype was protective for abscess or fistula formation as a consequence of dental caries."},{"Node1":"Abscess","Edge_Type":"disease","Node2":"Dental Caries","Weight":1,"Paper_List":"18701824","Original_Text":"PMID:18701824; Original text:For children who had 4 or more carious lesions at baseline, the significance increased (p = 0.005, OR = 4.8), suggesting that the CD14-260 TT genotype was protective for abscess or fistula formation as a consequence of dental caries."},{"Node1":"Dental Caries","Edge_Type":"disease","Node2":"Fistula","Weight":1,"Paper_List":"18701824","Original_Text":"PMID:18701824; Original text:For children who had 4 or more carious lesions at baseline, the significance increased (p = 0.005, OR = 4.8), suggesting that the CD14-260 TT genotype was protective for abscess or fistula formation as a consequence of dental caries."},{"Node1":"Dental Caries","Edge_Type":"disease_to_mechanism","Node2":"transthyretin","Weight":1,"Paper_List":"18701824","Original_Text":"PMID:18701824; Original text:For children who had 4 or more carious lesions at baseline, the significance increased (p = 0.005, OR = 4.8), suggesting that the CD14-260 TT genotype was protective for abscess or fistula formation as a consequence of dental caries."},{"Node1":"Anxiety Disorders","Edge_Type":"disease","Node2":"Pain","Weight":2,"Paper_List":"24771775|24771775","Original_Text":"PMID:24771775; Original text:Subjects who indicated some level of dental anxiety did express increased pain levels, but these levels were not statistically significant.|PMID:24771775; Original text:Subjects did not find the periodontal endoscope to elicit significant anxiety or pain during subgingival visualization."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"JIL-1 kinase","Weight":3,"Paper_List":"22348697|10703660|28559203","Original_Text":"PMID:22348697; Original text:Nineteen studies yielded significant associations between carriage of the minor IL-1 alleles and periodontitis.|PMID:10703660; Original text:Analysis of covariance was performed using SAS 6.12 and Proc Mixed with group and the periodontitis-related IL-1 genotype as the factors and the baseline levels as the covariate, with output being least squares means and least significant difference (LSD).|PMID:28559203; Original text:Considering the effects of adjunctive antimicrobial photodynamic therapy as compared to root planing on clinical signs of chronic periodontitis in type 2 diabetes mellitus and smokers, no difference could be observed for all evaluated parameters (PD: Z=-0.81, P=0.41; CAL: Z=-0.19, P=0.84) except IL-1β (Z=4.57, P<0.001)."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"interleukin 1 alpha","Weight":1,"Paper_List":"22348697","Original_Text":"PMID:22348697; Original text:This review and meta-analysis show that IL1A and IL1B genetic variations are significant contributors to chronic periodontitis in whites."},{"Node1":"Chlorhexidine","Edge_Type":"chemical_to_disease","Node2":"Hemorrhage","Weight":6,"Paper_List":"11199684|9839852|3479456|11696921|32690830|12747445","Original_Text":"PMID:11199684; Original text:Multicenter clinical trials have established that the adjunctive use of the subgingival controlled release of chlorhexidine, in the form of the PerioChip, significantly reduces pocket probing depth, improves probing attachment levels, and reduces bleeding on probing compared to scaling and root planing alone, for periods up to 9 months.|PMID:9839852; Original text:Chlorhexidine chip in conjunction with scaling and root planing, when compared to scaling and root planing alone, has shown significant improvement in probing pocket depth reduction, probing attachment level and bleeding on probing.|PMID:3479456; Original text:The results revealed that repeated professional irrigation of unscaled periodontal pockets with chlorhexidine or hydrogen peroxide resulted in a temporarily reduced frequency of bleeding sites, but not in any clinically significant changes in probing assessments.|PMID:11696921; Original text:There was an improvement in clinical parameters in all groups with a significantly greater decrease in gingival recession and bleeding in the chlorhexidine group.|PMID:32690830; Original text:The experimental group (2% curcumin gel) showed statistically significant improvements in periodontal [i.e., sulcus bleeding index (periodontal [i.e., sulcus bleeding index), probing pocket depth (pocket depth), and relative attachment level (relative attachment level)] and microbiologic parameters in the form of colony-forming units (colony-forming units) in comparison with control group (0.2% chlorhexidine gel).|PMID:12747445; Original text:Multicenter clinical trials have established that the adjunctive use of the subgingival controlled release of chlorhexidine, (CHX chip), significantly reduces probing depth (probing depth), improves clinical attachment levels, and reduces bleeding on probing compared to scaling and root planing (root planing) alone for periods of up to 9 months."},{"Node1":"Vitamin D","Edge_Type":"chemical","Node2":"Vitamins","Weight":1,"Paper_List":"21555774","Original_Text":"PMID:21555774; Original text:Placebo patients with baseline vitamin D deficiency [serum 25(OH)D, 16-19 ng/mL] had significantly less clinical attachment loss (significantly less clinical attachment loss) gain (-0.43 mm vs. 0.92 mm, p < 0.01) and probing depth (PPD) reduction (0.43 mm vs. 1.83 mm, p < 0.01) than vitamin-D-sufficient individuals."},{"Node1":"Vitamin D","Edge_Type":"chemical","Node2":"hydroxide ion","Weight":1,"Paper_List":"21555774","Original_Text":"PMID:21555774; Original text:Placebo patients with baseline vitamin D deficiency [serum 25(OH)D, 16-19 ng/mL] had significantly less clinical attachment loss (significantly less clinical attachment loss) gain (-0.43 mm vs. 0.92 mm, p < 0.01) and probing depth (PPD) reduction (0.43 mm vs. 1.83 mm, p < 0.01) than vitamin-D-sufficient individuals."},{"Node1":"Vitamins","Edge_Type":"chemical","Node2":"hydroxide ion","Weight":1,"Paper_List":"21555774","Original_Text":"PMID:21555774; Original text:Placebo patients with baseline vitamin D deficiency [serum 25(OH)D, 16-19 ng/mL] had significantly less clinical attachment loss (significantly less clinical attachment loss) gain (-0.43 mm vs. 0.92 mm, p < 0.01) and probing depth (PPD) reduction (0.43 mm vs. 1.83 mm, p < 0.01) than vitamin-D-sufficient individuals."},{"Node1":"Glucose","Edge_Type":"chemical_to_anatomy","Node2":"Gingiva","Weight":2,"Paper_List":"29265454|24934646","Original_Text":"PMID:29265454; Original text:Pocket depth, gingival index, and plaque index were assessed at baseline and after 3 and 6 months together with determinations of fasting plasma glucose, HbA1c, and bacterial counts.|PMID:24934646; Original text:Participants in the intervention group had significantly lower glycosylated hemoglobin (significantly lower glycosylated hemoglobin), fasting plasma glucose (plasma glucose), plaque index score, gingival index score, pocket depth, clinical attachment level (clinical attachment level), and percentage of bleeding on probing (BOP) when compared to the control group."},{"Node1":"Gingiva","Edge_Type":"anatomy","Node2":"Transplants","Weight":2,"Paper_List":"19431956|16274299","Original_Text":"PMID:19431956; Original text:The thickness of the gingival graft tissue influenced the dimensional changes in the height of the grafts in the recipient bed (p < 0.047).|PMID:16274299; Original text:There were four studies comparing acellular dermal matrix versus a connective tissue graft for root coverage procedures, two studies comparing acellular dermal matrix versus coronally advanced flap (coronally advanced flap) for root coverage procedures, and two studies comparing acellular dermal matrix to free gingival graft in augmentation of keratinized tissue."},{"Node1":"Metronidazole","Edge_Type":"chemical_to_anatomy","Node2":"Tooth","Weight":1,"Paper_List":"7987887","Original_Text":"PMID:7987887; Original text:Two previous double-blind studies have shown that 1 week of metronidazole, plus scaling and root planing, can significantly reduce the number of teeth per patient that require periodontal surgery, when compared to a positive-control treatment that consisted of 1 week of placebo treatment plus scaling and root planing."},{"Node1":"Periodontitis","Edge_Type":"disease","Node2":"Visceral Steatosis, Congenital","Weight":1,"Paper_List":"32530988","Original_Text":"PMID:32530988; Original text:Three studies reported the magnitude of association between nonalcoholic fatty liver disease and periodontitis that was diagnosed based on a clinical attachment level of ≥ 3 mm."},{"Node1":"Bacteroides Forsythus (Organism)","Edge_Type":"bacteria","Node2":"Pleomorphomonas Sp.","Weight":1,"Paper_List":"11314884","Original_Text":"PMID:11314884; Original text:At baseline, no statistically significant differences between groups were found for any of the clinical parameters."},{"Node1":"Bacteroides Forsythus (Organism)","Edge_Type":"bacteria","Node2":"Microseira","Weight":1,"Paper_List":"11314884","Original_Text":"PMID:11314884; Original text:Except for the plaque, there was a significantly larger change in the bleeding, probing pocket depth (the placebothe placeboD) and clinical attachment level (clinical attachment level) in the the test-group as compared to the the placebo-group after therapy."},{"Node1":"Bacteroides Forsythus (Organism)","Edge_Type":"bacteria_to_disease","Node2":"Hemorrhage","Weight":2,"Paper_List":"11314884|24617449","Original_Text":"PMID:11314884; Original text:Except for the plaque, there was a significantly larger change in the bleeding, probing pocket depth (the placebothe placeboD) and clinical attachment level (clinical attachment level) in the the test-group as compared to the the placebo-group after therapy.|PMID:24617449; Original text:A statistically significant improvement in gingival index and gingival bleeding index was seen for the test group after 2 weeks and 1 month of antimicrobial photodynamic therapy (p < 0.01), whereas the improvement in gingival index and gingival bleeding index at 3 months and in plaque index at 2 weeks after antimicrobial photodynamic therapy was less (p < 0.05)."},{"Node1":"Microseira","Edge_Type":"bacteria_to_disease","Node2":"Hemorrhage","Weight":1,"Paper_List":"11314884","Original_Text":"PMID:11314884; Original text:Except for the plaque, there was a significantly larger change in the bleeding, probing pocket depth (the placebothe placeboD) and clinical attachment level (clinical attachment level) in the the test-group as compared to the the placebo-group after therapy."},{"Node1":"ZMP:0000001088","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"17915999","Original_Text":"PMID:17915999; Original text:Compared to the control group, the test group had significantly better wound healing indices scores at 1 month, significantly less gingival index at 2 weeks, and sustained reductions of red-complex bacteria with trypsin-like enzyme activity at 3 months."},{"Node1":"homocysteine","Edge_Type":"nutrient_to_chemical","Node2":"Homocysteine","Weight":4,"Paper_List":"34204680|34204680|34204680|34204680","Original_Text":"PMID:34204680; Original text:the periodontal epithelial surface area showed to be significantly associated with homocysteine both for the crude and adjusted models (p < 0.01), but not the periodontal inflamed surface area (p > 0.05).|PMID:34204680; Original text:In the association of homocysteine with systolic blood pressure, the periodontal inflamed surface area significantly mediated 17.4% and the periodontal epithelial surface area 0.9%.|PMID:34204680; Original text:In the association of homocysteine with diastolic blood pressure, the periodontal inflamed surface area significantly mediated 16.3% and the periodontal epithelial surface area 47.2%.|PMID:34204680; Original text:Further, both the periodontal inflamed surface area and the periodontal epithelial surface area significantly mediated the association of homocysteine with systolic blood pressure and diastolic blood pressure."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"nejire","Weight":2,"Paper_List":"24896165|34394107","Original_Text":"PMID:24896165; Original text:Before therapy, in the periodontitis group, the ratio of subjects with high-sensitivity C-reactive protein <0.3 mg/dL was statistically lower than in the control group (P<0.0216).|PMID:34394107; Original text:These findings provide robust evidence that periodontitis is associated with systemic inflammation as measured by serum C-reactive protein levels."},{"Node1":"Streptococci Sp.","Edge_Type":"bacteria","Node2":"Streptococcus Mutans","Weight":1,"Paper_List":"28292338","Original_Text":"PMID:28292338; Original text:Both CH dressings provided a significant reduction in the number of microorganisms (anaerobic, aerobic, black-pigmented bacilli, streptococci and Streptococcus mutans) in a similar way (P>0.05)."},{"Node1":"Connective Tissue","Edge_Type":"anatomy","Node2":"Transplants","Weight":2,"Paper_List":"25039691|16274299","Original_Text":"PMID:25039691; Original text:For an increase in tissue width, a coronally advanced flap + a connective tissue graft significantly improved more than a coronally advanced flap alone.|PMID:16274299; Original text:There were four studies comparing acellular dermal matrix versus a connective tissue graft for root coverage procedures, two studies comparing acellular dermal matrix versus coronally advanced flap (coronally advanced flap) for root coverage procedures, and two studies comparing acellular dermal matrix to free gingival graft in augmentation of keratinized tissue."},{"Node1":"Titanium","Edge_Type":"chemical_to_anatomy","Node2":"Tissues","Weight":1,"Paper_List":"21054554","Original_Text":"PMID:21054554; Original text:Healthy clinical conditions were seen around both ZrO(2) and titanium abutments at all times, without significant differences in most clinical parameters of peri-implant soft tissue health."},{"Node1":"Prostaglandins E","Edge_Type":"chemical_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"17199546","Original_Text":"PMID:17199546; Original text:Group 4 showed significant reductions (P <0.05) in gingival crevicular fluid PGE(2) levels after the therapy."},{"Node1":"Prostaglandins E","Edge_Type":"chemical_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"17199546","Original_Text":"PMID:17199546; Original text:Group 4 showed significant reductions (P <0.05) in gingival crevicular fluid PGE(2) levels after the therapy."},{"Node1":"Thiobarbituric Acid Reactive Substances","Edge_Type":"chemical_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"17199546","Original_Text":"PMID:17199546; Original text:No statistically significant reductions were observed in group 4 with regard to gingival crevicular fluid TBARS levels."},{"Node1":"Thiobarbituric Acid Reactive Substances","Edge_Type":"chemical_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"17199546","Original_Text":"PMID:17199546; Original text:No statistically significant reductions were observed in group 4 with regard to gingival crevicular fluid TBARS levels."},{"Node1":"Calculi","Edge_Type":"disease","Node2":"Hemorrhage","Weight":1,"Paper_List":"22302453","Original_Text":"PMID:22302453; Original text:Compared to controls, women in the test group had significant reductions in the percentage of sites with plaque (48.5% vs. 10.3%, p < 0.001), gingival bleeding (23.3% vs. 2.5%, p < 0.001), calculus (21.3% vs. 4.1%, p < 0.001), bleeding on probing (38.1% vs. 2.6%, p < 0.001) and probing depth ≥3 mm (19.97% vs. −2.45%, p < 0.001)."},{"Node1":"Hemorrhage","Edge_Type":"disease_to_anatomy","Node2":"Platelet-Rich Fibrin","Weight":1,"Paper_List":"33842996","Original_Text":"PMID:33842996; Original text:open flap debridement+AA/platelet-rich fibrin and open flap debridement+platelet-rich fibrin showed no differences regarding full-mouth bleeding scores or full-mouth plaque scores (p > 0.05)."},{"Node1":"Iodine","Edge_Type":"chemical","Node2":"Povidone","Weight":4,"Paper_List":"12753370|12753370|19909406|19909406","Original_Text":"PMID:12753370; Original text:At 5 weeks post-treatment, subgingival irrigation with [polyvinylpyrrolidone-iodine complex together with scaling and root planing caused a 95% or greater reduction in total pathogen counts in 44% of pockets having >/= 6 mm depth whereas scaling and root planing alone, povidone-iodine irrigation alone and water irrigation alone caused 95% reduction of total pathogens only in 6-13% of similar study sites (P = 0.02).|PMID:12753370; Original text:Reduction in mean pocket depth was 1.8 mm for the [polyvinylpyrrolidone-iodine complex/scaling and root planing group, 1.6 mm for the scaling and root planing group, and 0.9 mm for the [polyvinylpyrrolidone-iodine complex and the saline monotherapy groups, with statistical significance reached for the scaling and root planing group vs. the [polyvinylpyrrolidone-iodine complex group (P = 0.04) and for the scaling and root planing group vs. the saline group (P = 0.02).|PMID:19909406; Original text:A small, but statistically significant additional beneficial effect of the adjunctive use of povidone-iodine with enhanced probing pocket depth reductions of 0.28 mm (95% confidence interval: 0.08 to 0.48, p = 0.007) was found.|PMID:19909406; Original text:The adjunctive use of povidone-iodine during scaling and root planing may increase the clinical pocket depth reduction, although the clinical significance is small to moderate."},{"Node1":"Bacteroides Forsythus (Organism)","Edge_Type":"bacteria","Node2":"Treponema Denticola (Organism)","Weight":2,"Paper_List":"15642054|24617449","Original_Text":"PMID:15642054; Original text:The levels of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Tannerella forsythensis (Bacteroides forsythus) remained unchanged in untreated sites while levels of Prevetolla intermedia and Treponema denticola tended to decrease as compared with controls but did not reach significance.|PMID:24617449; Original text:A statistically significant improvement in gingival index and gingival bleeding index was seen for the test group after 2 weeks and 1 month of antimicrobial photodynamic therapy (p < 0.01), whereas the improvement in gingival index and gingival bleeding index at 3 months and in plaque index at 2 weeks after antimicrobial photodynamic therapy was less (p < 0.05)."},{"Node1":"Bacteroides Forsythus (Organism)","Edge_Type":"bacteria","Node2":"Prevotella Intermedia","Weight":2,"Paper_List":"15642054|24617449","Original_Text":"PMID:15642054; Original text:The levels of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Tannerella forsythensis (Bacteroides forsythus) remained unchanged in untreated sites while levels of Prevetolla intermedia and Treponema denticola tended to decrease as compared with controls but did not reach significance.|PMID:24617449; Original text:A statistically significant improvement in gingival index and gingival bleeding index was seen for the test group after 2 weeks and 1 month of antimicrobial photodynamic therapy (p < 0.01), whereas the improvement in gingival index and gingival bleeding index at 3 months and in plaque index at 2 weeks after antimicrobial photodynamic therapy was less (p < 0.05)."},{"Node1":"Actinobacillus Actinomycetemcomitans","Edge_Type":"bacteria","Node2":"Bacteroides Forsythus (Organism)","Weight":3,"Paper_List":"15642054|24617449|15356501","Original_Text":"PMID:15642054; Original text:The levels of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Tannerella forsythensis (Bacteroides forsythus) remained unchanged in untreated sites while levels of Prevetolla intermedia and Treponema denticola tended to decrease as compared with controls but did not reach significance.|PMID:24617449; Original text:A statistically significant improvement in gingival index and gingival bleeding index was seen for the test group after 2 weeks and 1 month of antimicrobial photodynamic therapy (p < 0.01), whereas the improvement in gingival index and gingival bleeding index at 3 months and in plaque index at 2 weeks after antimicrobial photodynamic therapy was less (p < 0.05).|PMID:15356501; Original text:The improvement in periodontal health at 30 days was concomitant with a reduction of sites positive for A. actinomycetemcomitans and B. forsythus (P <.05)."},{"Node1":"Bacteroides Forsythus (Organism)","Edge_Type":"bacteria","Node2":"Porphyromonas Gingivalis (Organism)","Weight":2,"Paper_List":"15642054|24617449","Original_Text":"PMID:15642054; Original text:The levels of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Tannerella forsythensis (Bacteroides forsythus) remained unchanged in untreated sites while levels of Prevetolla intermedia and Treponema denticola tended to decrease as compared with controls but did not reach significance.|PMID:24617449; Original text:A statistically significant improvement in gingival index and gingival bleeding index was seen for the test group after 2 weeks and 1 month of antimicrobial photodynamic therapy (p < 0.01), whereas the improvement in gingival index and gingival bleeding index at 3 months and in plaque index at 2 weeks after antimicrobial photodynamic therapy was less (p < 0.05)."},{"Node1":"Bacteroides Forsythus (Organism)","Edge_Type":"bacteria","Node2":"Tannerella Forsythensis","Weight":2,"Paper_List":"15642054|24617449","Original_Text":"PMID:15642054; Original text:The levels of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Tannerella forsythensis (Bacteroides forsythus) remained unchanged in untreated sites while levels of Prevetolla intermedia and Treponema denticola tended to decrease as compared with controls but did not reach significance.|PMID:24617449; Original text:A statistically significant improvement in gingival index and gingival bleeding index was seen for the test group after 2 weeks and 1 month of antimicrobial photodynamic therapy (p < 0.01), whereas the improvement in gingival index and gingival bleeding index at 3 months and in plaque index at 2 weeks after antimicrobial photodynamic therapy was less (p < 0.05)."},{"Node1":"Actinobacillus Actinomycetemcomitans","Edge_Type":"bacteria","Node2":"Treponema Denticola (Organism)","Weight":2,"Paper_List":"15642054|24617449","Original_Text":"PMID:15642054; Original text:The levels of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Tannerella forsythensis (Bacteroides forsythus) remained unchanged in untreated sites while levels of Prevetolla intermedia and Treponema denticola tended to decrease as compared with controls but did not reach significance.|PMID:24617449; Original text:A statistically significant improvement in gingival index and gingival bleeding index was seen for the test group after 2 weeks and 1 month of antimicrobial photodynamic therapy (p < 0.01), whereas the improvement in gingival index and gingival bleeding index at 3 months and in plaque index at 2 weeks after antimicrobial photodynamic therapy was less (p < 0.05)."},{"Node1":"Tannerella Forsythensis","Edge_Type":"bacteria","Node2":"Treponema Denticola (Organism)","Weight":3,"Paper_List":"15642054|24617449|29327449","Original_Text":"PMID:15642054; Original text:The levels of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Tannerella forsythensis (Bacteroides forsythus) remained unchanged in untreated sites while levels of Prevetolla intermedia and Treponema denticola tended to decrease as compared with controls but did not reach significance.|PMID:24617449; Original text:A statistically significant improvement in gingival index and gingival bleeding index was seen for the test group after 2 weeks and 1 month of antimicrobial photodynamic therapy (p < 0.01), whereas the improvement in gingival index and gingival bleeding index at 3 months and in plaque index at 2 weeks after antimicrobial photodynamic therapy was less (p < 0.05).|PMID:29327449; Original text:Evaluation using clinical parameters showed better results in low-level laser therapy group."},{"Node1":"Actinobacillus Actinomycetemcomitans","Edge_Type":"bacteria","Node2":"Prevotella Intermedia","Weight":3,"Paper_List":"15642054|24617449|8396177","Original_Text":"PMID:15642054; Original text:The levels of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Tannerella forsythensis (Bacteroides forsythus) remained unchanged in untreated sites while levels of Prevetolla intermedia and Treponema denticola tended to decrease as compared with controls but did not reach significance.|PMID:24617449; Original text:A statistically significant improvement in gingival index and gingival bleeding index was seen for the test group after 2 weeks and 1 month of antimicrobial photodynamic therapy (p < 0.01), whereas the improvement in gingival index and gingival bleeding index at 3 months and in plaque index at 2 weeks after antimicrobial photodynamic therapy was less (p < 0.05).|PMID:8396177; Original text:Subgingival minocycline ointment resulted in statistically significantly greater reduction of P. gingivalis at weeks 2, 4, 6, and 12; P. intermedia at weeks 2, 4, 6, and 12; and A. actinomycetemcomitans at weeks 6 and 12."},{"Node1":"Prevotella Intermedia","Edge_Type":"bacteria","Node2":"Tannerella Forsythensis","Weight":3,"Paper_List":"15642054|24617449|29327449","Original_Text":"PMID:15642054; Original text:The levels of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Tannerella forsythensis (Bacteroides forsythus) remained unchanged in untreated sites while levels of Prevetolla intermedia and Treponema denticola tended to decrease as compared with controls but did not reach significance.|PMID:24617449; Original text:A statistically significant improvement in gingival index and gingival bleeding index was seen for the test group after 2 weeks and 1 month of antimicrobial photodynamic therapy (p < 0.01), whereas the improvement in gingival index and gingival bleeding index at 3 months and in plaque index at 2 weeks after antimicrobial photodynamic therapy was less (p < 0.05).|PMID:29327449; Original text:Evaluation using clinical parameters showed better results in low-level laser therapy group."},{"Node1":"Actinobacillus Actinomycetemcomitans","Edge_Type":"bacteria","Node2":"Tannerella Forsythensis","Weight":2,"Paper_List":"15642054|24617449","Original_Text":"PMID:15642054; Original text:The levels of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Tannerella forsythensis (Bacteroides forsythus) remained unchanged in untreated sites while levels of Prevetolla intermedia and Treponema denticola tended to decrease as compared with controls but did not reach significance.|PMID:24617449; Original text:A statistically significant improvement in gingival index and gingival bleeding index was seen for the test group after 2 weeks and 1 month of antimicrobial photodynamic therapy (p < 0.01), whereas the improvement in gingival index and gingival bleeding index at 3 months and in plaque index at 2 weeks after antimicrobial photodynamic therapy was less (p < 0.05)."},{"Node1":"Porphyromonas Gingivalis (Organism)","Edge_Type":"bacteria","Node2":"Tannerella Forsythensis","Weight":3,"Paper_List":"15642054|24617449|29327449","Original_Text":"PMID:15642054; Original text:The levels of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Tannerella forsythensis (Bacteroides forsythus) remained unchanged in untreated sites while levels of Prevetolla intermedia and Treponema denticola tended to decrease as compared with controls but did not reach significance.|PMID:24617449; Original text:A statistically significant improvement in gingival index and gingival bleeding index was seen for the test group after 2 weeks and 1 month of antimicrobial photodynamic therapy (p < 0.01), whereas the improvement in gingival index and gingival bleeding index at 3 months and in plaque index at 2 weeks after antimicrobial photodynamic therapy was less (p < 0.05).|PMID:29327449; Original text:Evaluation using clinical parameters showed better results in low-level laser therapy group."},{"Node1":"Actinobacillus Actinomycetemcomitans","Edge_Type":"bacteria_to_disease","Node2":"Hemorrhage","Weight":1,"Paper_List":"24617449","Original_Text":"PMID:24617449; Original text:A statistically significant improvement in gingival index and gingival bleeding index was seen for the test group after 2 weeks and 1 month of antimicrobial photodynamic therapy (p < 0.01), whereas the improvement in gingival index and gingival bleeding index at 3 months and in plaque index at 2 weeks after antimicrobial photodynamic therapy was less (p < 0.05)."},{"Node1":"Tannerella Forsythensis","Edge_Type":"bacteria_to_disease","Node2":"Hemorrhage","Weight":1,"Paper_List":"24617449","Original_Text":"PMID:24617449; Original text:A statistically significant improvement in gingival index and gingival bleeding index was seen for the test group after 2 weeks and 1 month of antimicrobial photodynamic therapy (p < 0.01), whereas the improvement in gingival index and gingival bleeding index at 3 months and in plaque index at 2 weeks after antimicrobial photodynamic therapy was less (p < 0.05)."},{"Node1":"Bacteroides Forsythus (Organism)","Edge_Type":"bacteria_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"24617449","Original_Text":"PMID:24617449; Original text:A statistically significant improvement in gingival index and gingival bleeding index was seen for the test group after 2 weeks and 1 month of antimicrobial photodynamic therapy (p < 0.01), whereas the improvement in gingival index and gingival bleeding index at 3 months and in plaque index at 2 weeks after antimicrobial photodynamic therapy was less (p < 0.05)."},{"Node1":"Treponema Denticola (Organism)","Edge_Type":"bacteria_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"24617449","Original_Text":"PMID:24617449; Original text:A statistically significant improvement in gingival index and gingival bleeding index was seen for the test group after 2 weeks and 1 month of antimicrobial photodynamic therapy (p < 0.01), whereas the improvement in gingival index and gingival bleeding index at 3 months and in plaque index at 2 weeks after antimicrobial photodynamic therapy was less (p < 0.05)."},{"Node1":"Prevotella Intermedia","Edge_Type":"bacteria_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"24617449","Original_Text":"PMID:24617449; Original text:A statistically significant improvement in gingival index and gingival bleeding index was seen for the test group after 2 weeks and 1 month of antimicrobial photodynamic therapy (p < 0.01), whereas the improvement in gingival index and gingival bleeding index at 3 months and in plaque index at 2 weeks after antimicrobial photodynamic therapy was less (p < 0.05)."},{"Node1":"Actinobacillus Actinomycetemcomitans","Edge_Type":"bacteria_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"24617449","Original_Text":"PMID:24617449; Original text:A statistically significant improvement in gingival index and gingival bleeding index was seen for the test group after 2 weeks and 1 month of antimicrobial photodynamic therapy (p < 0.01), whereas the improvement in gingival index and gingival bleeding index at 3 months and in plaque index at 2 weeks after antimicrobial photodynamic therapy was less (p < 0.05)."},{"Node1":"Porphyromonas Gingivalis (Organism)","Edge_Type":"bacteria_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"24617449","Original_Text":"PMID:24617449; Original text:A statistically significant improvement in gingival index and gingival bleeding index was seen for the test group after 2 weeks and 1 month of antimicrobial photodynamic therapy (p < 0.01), whereas the improvement in gingival index and gingival bleeding index at 3 months and in plaque index at 2 weeks after antimicrobial photodynamic therapy was less (p < 0.05)."},{"Node1":"Tannerella Forsythensis","Edge_Type":"bacteria_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"24617449","Original_Text":"PMID:24617449; Original text:A statistically significant improvement in gingival index and gingival bleeding index was seen for the test group after 2 weeks and 1 month of antimicrobial photodynamic therapy (p < 0.01), whereas the improvement in gingival index and gingival bleeding index at 3 months and in plaque index at 2 weeks after antimicrobial photodynamic therapy was less (p < 0.05)."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":11,"Paper_List":"22621750|15025222|18315429|18315429|18412719|11168739|11168739|18672990|15562917|15562917|15562917","Original_Text":"PMID:22621750; Original text:crevicular fluid matrix metalloproteinase-8 levels were significantly reduced only in root planing + short-term adjunctive subantimicrobial dose doxycycline group (P < 0.01).|PMID:15025222; Original text:The gingival crevicular fluid MMP-8 level in the a low-dose doxycycline group was significantly lower than that of the placebo group at 6 months (P < 0.05).|PMID:18315429; Original text:From baseline to 6 months, the gingival crevicular fluid extracellular matrix metalloproteinase inducer levels were reduced significantly in the subantimicrobial dose doxycycline group (P <0.025).|PMID:18315429; Original text:The gingival crevicular fluid extracellular matrix metalloproteinase inducer level in the subantimicrobial dose doxycycline group was significantly lower than that of the placebo group at 3 and 6 months (P <0.05).|PMID:18412719; Original text:gingival crevicular fluid TGF-beta(1) levels of 3-month adjunctive subantimicrobial dose doxycycline group was significantly higher than baseline (P < 0.0125) and placebo group (P < 0.017) at 3 months.|PMID:11168739; Original text:Previous clinical studies have shown that doxycycline administered orally, at doses below those needed for antimicrobial efficacy, to human subjects with adult periodontitis resulted in significantly reduced collagenase activity in gingival crevicular fluid (gingival crevicular fluid) and in extracts of inflamed gingival tissues.|PMID:11168739; Original text:From baseline to week 12 (part I), treatment with specially formulated subantimicrobial dose doxycycline capsules (20 mg) 2x daily (1 x every 12 h) for up to 12 weeks was shown to significantly reduce gingival crevicular fluid collagenase activity and to improve periodontal attachment, effects not seen in patients treated with placebo.|PMID:18672990; Original text:ICTP showed a similar pattern of change during a 2-year subantimicrobial-dose doxycycline treatment, and the gingival crevicular fluid collagenase activity and ICTP were positively correlated at all time periods (P<0.001).|PMID:15562917; Original text:In the Low-dose doxycycline group, gingival crevicular fluid Laminin-5 gamma2 chain fragment levels were significantly reduced at 3 months (P < 0.0125) and then slightly increased during the rest of the study period.|PMID:15562917; Original text:gingival crevicular fluid Laminin-5 gamma2 chain fragment levels in Low-dose doxycycline group were significantly lower than those of the placebo group during the study period (P < 0.05).|PMID:15562917; Original text:The present data indicate that Low-dose doxycycline therapy in combination with root planing therapy can reduce gingival crevicular fluid Laminin-5 gamma2 chain fragment levels and improve clinical periodontal parameters in patients with chronic periodontitis."},{"Node1":"Hemorrhage","Edge_Type":"disease_to_anatomy","Node2":"Salivary Glands","Weight":2,"Paper_List":"30143550|30298556","Original_Text":"PMID:30143550; Original text:Baseline and 24-month measurements included radiographic interproximal alveolar bone height, probing depths (probing depths), clinical attachment level (clinical attachment level), bleeding on probing (BOP), gingival crevicular fluid (GCF), and salivary interleukin (IL) - 1β, (24 month only).|PMID:30298556; Original text: months of therapy, whereas the measurements of pocket depth reduction (PD reduction), bleeding on probing (BOP %), and the changes in salivary TNF-α levels and Athens insomnia scale (insomnia scale) scores represented the secondary endpoints."},{"Node1":"Hemorrhage","Edge_Type":"disease_to_anatomy","Node2":"Stem Cells","Weight":1,"Paper_List":"32690830","Original_Text":"PMID:32690830; Original text:The experimental group (2% curcumin gel) showed statistically significant improvements in periodontal [i.e., sulcus bleeding index (periodontal [i.e., sulcus bleeding index), probing pocket depth (pocket depth), and relative attachment level (relative attachment level)] and microbiologic parameters in the form of colony-forming units (colony-forming units) in comparison with control group (0.2% chlorhexidine gel)."},{"Node1":"Meloxicam","Edge_Type":"chemical_to_mechanism","Node2":"neuropilin-1","Weight":1,"Paper_List":"16896836","Original_Text":"PMID:16896836; Original text:The The plaque index, gingival index, PD, and gingival crevicular fluid IL-1 receptor antagonist decreased significantly (p<0.05) in meloxicam group at first month when comparing the initial levels."},{"Node1":"Meloxicam","Edge_Type":"chemical_to_anatomy","Node2":"Gingiva","Weight":3,"Paper_List":"16896836|11846190|11846190","Original_Text":"PMID:16896836; Original text:The The plaque index, gingival index, PD, and gingival crevicular fluid IL-1 receptor antagonist decreased significantly (p<0.05) in meloxicam group at first month when comparing the initial levels.|PMID:11846190; Original text:Both meloxicam and placebo groups showed statistically significant reductions in papilla bleeding index, Plaque index, and gingival crevicular fluid MMP-8 levels on day 10 compared to baseline (P<0.01).|PMID:11846190; Original text:The gingival crevicular fluid MMP-8 level on day 10 in the meloxicam group was similar to the clinically healthy control group (P>0.05), while it was significantly higher in the placebo group (P<0.01)."},{"Node1":"Meloxicam","Edge_Type":"chemical_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":3,"Paper_List":"16896836|11846190|11846190","Original_Text":"PMID:16896836; Original text:The The plaque index, gingival index, PD, and gingival crevicular fluid IL-1 receptor antagonist decreased significantly (p<0.05) in meloxicam group at first month when comparing the initial levels.|PMID:11846190; Original text:Both meloxicam and placebo groups showed statistically significant reductions in papilla bleeding index, Plaque index, and gingival crevicular fluid MMP-8 levels on day 10 compared to baseline (P<0.01).|PMID:11846190; Original text:The gingival crevicular fluid MMP-8 level on day 10 in the meloxicam group was similar to the clinically healthy control group (P>0.05), while it was significantly higher in the placebo group (P<0.01)."},{"Node1":"neuropilin-1","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"16896836","Original_Text":"PMID:16896836; Original text:The The plaque index, gingival index, PD, and gingival crevicular fluid IL-1 receptor antagonist decreased significantly (p<0.05) in meloxicam group at first month when comparing the initial levels."},{"Node1":"neuropilin-1","Edge_Type":"mechanism_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"16896836","Original_Text":"PMID:16896836; Original text:The The plaque index, gingival index, PD, and gingival crevicular fluid IL-1 receptor antagonist decreased significantly (p<0.05) in meloxicam group at first month when comparing the initial levels."},{"Node1":"Hemorrhage","Edge_Type":"disease","Node2":"Periodontal Diseases","Weight":1,"Paper_List":"24415114","Original_Text":"PMID:24415114; Original text:p = 0.17), and SLEDAI (5.9 ± 4.2 vs. 6.3 ± 4.3, p = 0.73) as well as Periodontal disease parameters [bleeding gingival index (40.8 ± 31.0 vs. 40.7 ± 36.2 %, p = 0.89), depth (1.7 ± 1.8 vs. 1.5 ± "},{"Node1":"Hemorrhage","Edge_Type":"disease_to_anatomy","Node2":"Tissues","Weight":1,"Paper_List":"28902426","Original_Text":"PMID:28902426; Original text:Clinical examinations at 3 years after treatment revealed (i) improved peri-implant soft tissue health with a mean reduction in probing depth of 2.7 mm and a reduction in bleeding/suppuration on probing of 40% and (ii) stable peri-implant marginal bone levels (mean bone loss during follow-up: 0.04 mm)."},{"Node1":"Aspartic Acid","Edge_Type":"chemical_to_disease","Node2":"Periodontitis","Weight":1,"Paper_List":"11210069","Original_Text":"PMID:11210069; Original text:The percentage of sites exhibiting Aspartate aminotransferase > or = 800 microIU, Aspartate aminotransferase > or = 1,200 microIU, and BOP in the 41 periodontitis subjects was significantly (P<0.02) lower at 6 and 12 months compared to baseline."},{"Node1":"Aspartic Acid","Edge_Type":"chemical_to_mechanism","Node2":"aspartate aminotransferase","Weight":2,"Paper_List":"11210069|10960023","Original_Text":"PMID:11210069; Original text:The percentage of sites exhibiting Aspartate aminotransferase > or = 800 microIU, Aspartate aminotransferase > or = 1,200 microIU, and BOP in the 41 periodontitis subjects was significantly (P<0.02) lower at 6 and 12 months compared to baseline.|PMID:10960023; Original text:The mean Aspartate aminotransferase activity in 27 healthy implants was 0.26 +/-"},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"aspartate aminotransferase","Weight":1,"Paper_List":"11210069","Original_Text":"PMID:11210069; Original text:The percentage of sites exhibiting Aspartate aminotransferase > or = 800 microIU, Aspartate aminotransferase > or = 1,200 microIU, and BOP in the 41 periodontitis subjects was significantly (P<0.02) lower at 6 and 12 months compared to baseline."},{"Node1":"Periodontal Diseases","Edge_Type":"disease_to_mechanism","Node2":"collagenase 3-like","Weight":1,"Paper_List":"25166440","Original_Text":"PMID:25166440; Original text:Matrix metalloproteinases (Matrix metalloproteinases) and cytokines play a role of extracellular matrix degradation and remodelling, and are significantly involved in the course of periodontal disease."},{"Node1":"Hemorrhage","Edge_Type":"disease_to_anatomy","Node2":"Tongue","Weight":1,"Paper_List":"22126407","Original_Text":"PMID:22126407; Original text:Linear regression analysis demonstrated the following significant associations: (i) oral malodour from H(2)S and thickness of the tongue coating, (ii) oral malodour from CH(3)SH and periodontal pocket depth of 5 mm or more and the presence of gingival bleeding and (iii) oral malodour from (CH(3))(2)S and systemic disease, medications and thickness of the tongue coating."},{"Node1":"collagenase 3-like","Edge_Type":"mechanism_to_anatomy","Node2":"Extracellular Matrix","Weight":1,"Paper_List":"25166440","Original_Text":"PMID:25166440; Original text:Matrix metalloproteinases (Matrix metalloproteinases) and cytokines play a role of extracellular matrix degradation and remodelling, and are significantly involved in the course of periodontal disease."},{"Node1":"granulocyte-macrophage colony-stimulating factor","Edge_Type":"mechanism","Node2":"interleukin 6","Weight":1,"Paper_List":"26325644","Original_Text":"PMID:26325644; Original text:There was a significantly greater increase in the levels of granulocyte-macrophage colony-stimulating factor and interleukin 6 from baseline to 3 months in the healthy sites adjacent to residual pockets receiving surgical debridement (P < 0.05)."},{"Node1":"Granulocyte-Macrophage Progenitor Cells","Edge_Type":"anatomy","Node2":"Granulocytes","Weight":2,"Paper_List":"26325644|22181685","Original_Text":"PMID:26325644; Original text:There was a significantly greater increase in the levels of granulocyte-macrophage colony-stimulating factor and interleukin 6 from baseline to 3 months in the healthy sites adjacent to residual pockets receiving surgical debridement (P < 0.05).|PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"Granulocyte-Macrophage Progenitor Cells","Edge_Type":"anatomy","Node2":"Macrophages","Weight":2,"Paper_List":"26325644|22181685","Original_Text":"PMID:26325644; Original text:There was a significantly greater increase in the levels of granulocyte-macrophage colony-stimulating factor and interleukin 6 from baseline to 3 months in the healthy sites adjacent to residual pockets receiving surgical debridement (P < 0.05).|PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"Granulocytes","Edge_Type":"anatomy","Node2":"Macrophages","Weight":2,"Paper_List":"26325644|22181685","Original_Text":"PMID:26325644; Original text:There was a significantly greater increase in the levels of granulocyte-macrophage colony-stimulating factor and interleukin 6 from baseline to 3 months in the healthy sites adjacent to residual pockets receiving surgical debridement (P < 0.05).|PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"granulocyte-macrophage colony-stimulating factor","Edge_Type":"mechanism_to_anatomy","Node2":"Granulocyte-Macrophage Progenitor Cells","Weight":1,"Paper_List":"26325644","Original_Text":"PMID:26325644; Original text:There was a significantly greater increase in the levels of granulocyte-macrophage colony-stimulating factor and interleukin 6 from baseline to 3 months in the healthy sites adjacent to residual pockets receiving surgical debridement (P < 0.05)."},{"Node1":"granulocyte-macrophage colony-stimulating factor","Edge_Type":"mechanism_to_anatomy","Node2":"Granulocytes","Weight":1,"Paper_List":"26325644","Original_Text":"PMID:26325644; Original text:There was a significantly greater increase in the levels of granulocyte-macrophage colony-stimulating factor and interleukin 6 from baseline to 3 months in the healthy sites adjacent to residual pockets receiving surgical debridement (P < 0.05)."},{"Node1":"granulocyte-macrophage colony-stimulating factor","Edge_Type":"mechanism_to_anatomy","Node2":"Macrophages","Weight":1,"Paper_List":"26325644","Original_Text":"PMID:26325644; Original text:There was a significantly greater increase in the levels of granulocyte-macrophage colony-stimulating factor and interleukin 6 from baseline to 3 months in the healthy sites adjacent to residual pockets receiving surgical debridement (P < 0.05)."},{"Node1":"interleukin 6","Edge_Type":"mechanism_to_anatomy","Node2":"Granulocyte-Macrophage Progenitor Cells","Weight":1,"Paper_List":"26325644","Original_Text":"PMID:26325644; Original text:There was a significantly greater increase in the levels of granulocyte-macrophage colony-stimulating factor and interleukin 6 from baseline to 3 months in the healthy sites adjacent to residual pockets receiving surgical debridement (P < 0.05)."},{"Node1":"interleukin 6","Edge_Type":"mechanism_to_anatomy","Node2":"Granulocytes","Weight":1,"Paper_List":"26325644","Original_Text":"PMID:26325644; Original text:There was a significantly greater increase in the levels of granulocyte-macrophage colony-stimulating factor and interleukin 6 from baseline to 3 months in the healthy sites adjacent to residual pockets receiving surgical debridement (P < 0.05)."},{"Node1":"interleukin 6","Edge_Type":"mechanism_to_anatomy","Node2":"Macrophages","Weight":1,"Paper_List":"26325644","Original_Text":"PMID:26325644; Original text:There was a significantly greater increase in the levels of granulocyte-macrophage colony-stimulating factor and interleukin 6 from baseline to 3 months in the healthy sites adjacent to residual pockets receiving surgical debridement (P < 0.05)."},{"Node1":"C-C motif chemokine ligand 2","Edge_Type":"mechanism","Node2":"C-C motif chemokine ligand 3 like 3","Weight":1,"Paper_List":"26325644","Original_Text":"PMID:26325644; Original text:A significant decrease in the levels of monocyte chemoattractant protein-1 and macrophage inflammatory protein 1α occurred from baseline to 12 months in the residual pockets treated by surgical debridement (P < 0.05)."},{"Node1":"Macrophages","Edge_Type":"anatomy","Node2":"Monocytes","Weight":1,"Paper_List":"26325644","Original_Text":"PMID:26325644; Original text:A significant decrease in the levels of monocyte chemoattractant protein-1 and macrophage inflammatory protein 1α occurred from baseline to 12 months in the residual pockets treated by surgical debridement (P < 0.05)."},{"Node1":"C-C motif chemokine ligand 3 like 3","Edge_Type":"mechanism_to_anatomy","Node2":"Monocytes","Weight":1,"Paper_List":"26325644","Original_Text":"PMID:26325644; Original text:A significant decrease in the levels of monocyte chemoattractant protein-1 and macrophage inflammatory protein 1α occurred from baseline to 12 months in the residual pockets treated by surgical debridement (P < 0.05)."},{"Node1":"C-C motif chemokine ligand 3 like 3","Edge_Type":"mechanism_to_anatomy","Node2":"Macrophages","Weight":3,"Paper_List":"26325644|21480939|22181685","Original_Text":"PMID:26325644; Original text:A significant decrease in the levels of monocyte chemoattractant protein-1 and macrophage inflammatory protein 1α occurred from baseline to 12 months in the residual pockets treated by surgical debridement (P < 0.05).|PMID:21480939; Original text:OPG, MMP-8, and macrophage inflammatory protein-1α were significantly reduced in responders compared with non-responders (p=0.04, 0.01, 0.05, respectively).|PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"C-C motif chemokine ligand 2","Edge_Type":"mechanism_to_anatomy","Node2":"Monocytes","Weight":1,"Paper_List":"26325644","Original_Text":"PMID:26325644; Original text:A significant decrease in the levels of monocyte chemoattractant protein-1 and macrophage inflammatory protein 1α occurred from baseline to 12 months in the residual pockets treated by surgical debridement (P < 0.05)."},{"Node1":"C-C motif chemokine ligand 2","Edge_Type":"mechanism_to_anatomy","Node2":"Macrophages","Weight":1,"Paper_List":"26325644","Original_Text":"PMID:26325644; Original text:A significant decrease in the levels of monocyte chemoattractant protein-1 and macrophage inflammatory protein 1α occurred from baseline to 12 months in the residual pockets treated by surgical debridement (P < 0.05)."},{"Node1":"fibrinogen gamma chain","Edge_Type":"mechanism","Node2":"provisional ortholog of C-reactive protein L homeolog","Weight":1,"Paper_List":"22966824","Original_Text":"PMID:22966824; Original text:In coronary heart disease patients with periodontitis, non-surgical mechanical periodontal therapy significantly reduced systemic levels of C-reactive protein, fibrinogen and white blood cells."},{"Node1":"Blood Cells","Edge_Type":"anatomy","Node2":"Leukocytes","Weight":1,"Paper_List":"22966824","Original_Text":"PMID:22966824; Original text:In coronary heart disease patients with periodontitis, non-surgical mechanical periodontal therapy significantly reduced systemic levels of C-reactive protein, fibrinogen and white blood cells."},{"Node1":"Blood","Edge_Type":"anatomy","Node2":"Leukocytes","Weight":1,"Paper_List":"22966824","Original_Text":"PMID:22966824; Original text:In coronary heart disease patients with periodontitis, non-surgical mechanical periodontal therapy significantly reduced systemic levels of C-reactive protein, fibrinogen and white blood cells."},{"Node1":"Blood","Edge_Type":"anatomy","Node2":"Blood Cells","Weight":1,"Paper_List":"22966824","Original_Text":"PMID:22966824; Original text:In coronary heart disease patients with periodontitis, non-surgical mechanical periodontal therapy significantly reduced systemic levels of C-reactive protein, fibrinogen and white blood cells."},{"Node1":"Coronary Disease","Edge_Type":"disease_to_mechanism","Node2":"provisional ortholog of C-reactive protein L homeolog","Weight":1,"Paper_List":"22966824","Original_Text":"PMID:22966824; Original text:In coronary heart disease patients with periodontitis, non-surgical mechanical periodontal therapy significantly reduced systemic levels of C-reactive protein, fibrinogen and white blood cells."},{"Node1":"Coronary Disease","Edge_Type":"disease_to_mechanism","Node2":"fibrinogen gamma chain","Weight":1,"Paper_List":"22966824","Original_Text":"PMID:22966824; Original text:In coronary heart disease patients with periodontitis, non-surgical mechanical periodontal therapy significantly reduced systemic levels of C-reactive protein, fibrinogen and white blood cells."},{"Node1":"Hemorrhage","Edge_Type":"disease_to_anatomy","Node2":"Tooth","Weight":1,"Paper_List":"19426177","Original_Text":"PMID:19426177; Original text:Gestational age and birthweight were not associated with change from baseline in percentage of tooth sites with bleeding on probing or between those who did versus did not progress according to a published definition of disease progression (p>0.05)."},{"Node1":"Hypertension","Edge_Type":"disease_to_anatomy","Node2":"Placenta","Weight":1,"Paper_List":"23711357","Original_Text":"PMID:23711357; Original text:A significant increase was observed in the expression of TLR-2 in the placentas of patients with hypertensive disorders (p = 0.04)."},{"Node1":"Infarction","Edge_Type":"disease_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"14643271","Original_Text":"PMID:14643271; Original text:mm (2.7% for non-acute myocardial infarction and 12.1% for acute myocardial infarction group, 95% CI: -2.8 to 0.01, P<0.05) but no difference in the extent of gingival bleeding was found between groups."},{"Node1":"provisional ortholog of C-reactive protein L homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Leukocytes","Weight":1,"Paper_List":"22966824","Original_Text":"PMID:22966824; Original text:In coronary heart disease patients with periodontitis, non-surgical mechanical periodontal therapy significantly reduced systemic levels of C-reactive protein, fibrinogen and white blood cells."},{"Node1":"provisional ortholog of C-reactive protein L homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Blood Cells","Weight":1,"Paper_List":"22966824","Original_Text":"PMID:22966824; Original text:In coronary heart disease patients with periodontitis, non-surgical mechanical periodontal therapy significantly reduced systemic levels of C-reactive protein, fibrinogen and white blood cells."},{"Node1":"provisional ortholog of C-reactive protein L homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Blood","Weight":1,"Paper_List":"22966824","Original_Text":"PMID:22966824; Original text:In coronary heart disease patients with periodontitis, non-surgical mechanical periodontal therapy significantly reduced systemic levels of C-reactive protein, fibrinogen and white blood cells."},{"Node1":"fibrinogen gamma chain","Edge_Type":"mechanism_to_anatomy","Node2":"Leukocytes","Weight":1,"Paper_List":"22966824","Original_Text":"PMID:22966824; Original text:In coronary heart disease patients with periodontitis, non-surgical mechanical periodontal therapy significantly reduced systemic levels of C-reactive protein, fibrinogen and white blood cells."},{"Node1":"fibrinogen gamma chain","Edge_Type":"mechanism_to_anatomy","Node2":"Blood Cells","Weight":1,"Paper_List":"22966824","Original_Text":"PMID:22966824; Original text:In coronary heart disease patients with periodontitis, non-surgical mechanical periodontal therapy significantly reduced systemic levels of C-reactive protein, fibrinogen and white blood cells."},{"Node1":"fibrinogen gamma chain","Edge_Type":"mechanism_to_anatomy","Node2":"Blood","Weight":1,"Paper_List":"22966824","Original_Text":"PMID:22966824; Original text:In coronary heart disease patients with periodontitis, non-surgical mechanical periodontal therapy significantly reduced systemic levels of C-reactive protein, fibrinogen and white blood cells."},{"Node1":"Carbon Dioxide","Edge_Type":"chemical_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"9287068","Original_Text":"PMID:9287068; Original text:The results show significant differences between the carbon dioxide laser and reverse bevel incision with respect to sulcular (P < or = 0.025) and gingival (the gingival)"},{"Node1":"Melanoma","Edge_Type":"disease","Node2":"Periodontitis","Weight":1,"Paper_List":"33029095","Original_Text":"PMID:33029095; Original text:With statistical significance, participants with periodontitis might have enhanced risks of esophageal cancer (HR = 1.79, 95% CI: 1.15-2.79), prostate cancer (HR = 1.20, 95% CI: 1.09-1.31), hematological malignancy (HR = 1.19, 95% CI: 1.09-1.29), and melanoma of skin (HR = 1.21, 95% CI: 1.03-1.42), compared with those without periodontitis."},{"Node1":"Melanoma","Edge_Type":"disease","Node2":"Prostatic Neoplasms","Weight":1,"Paper_List":"33029095","Original_Text":"PMID:33029095; Original text:With statistical significance, participants with periodontitis might have enhanced risks of esophageal cancer (HR = 1.79, 95% CI: 1.15-2.79), prostate cancer (HR = 1.20, 95% CI: 1.09-1.31), hematological malignancy (HR = 1.19, 95% CI: 1.09-1.29), and melanoma of skin (HR = 1.21, 95% CI: 1.03-1.42), compared with those without periodontitis."},{"Node1":"Esophageal Neoplasms","Edge_Type":"disease","Node2":"Melanoma","Weight":1,"Paper_List":"33029095","Original_Text":"PMID:33029095; Original text:With statistical significance, participants with periodontitis might have enhanced risks of esophageal cancer (HR = 1.79, 95% CI: 1.15-2.79), prostate cancer (HR = 1.20, 95% CI: 1.09-1.31), hematological malignancy (HR = 1.19, 95% CI: 1.09-1.29), and melanoma of skin (HR = 1.21, 95% CI: 1.03-1.42), compared with those without periodontitis."},{"Node1":"Hematologic Neoplasms","Edge_Type":"disease","Node2":"Melanoma","Weight":1,"Paper_List":"33029095","Original_Text":"PMID:33029095; Original text:With statistical significance, participants with periodontitis might have enhanced risks of esophageal cancer (HR = 1.79, 95% CI: 1.15-2.79), prostate cancer (HR = 1.20, 95% CI: 1.09-1.31), hematological malignancy (HR = 1.19, 95% CI: 1.09-1.29), and melanoma of skin (HR = 1.21, 95% CI: 1.03-1.42), compared with those without periodontitis."},{"Node1":"Periodontitis","Edge_Type":"disease","Node2":"Prostatic Neoplasms","Weight":1,"Paper_List":"33029095","Original_Text":"PMID:33029095; Original text:With statistical significance, participants with periodontitis might have enhanced risks of esophageal cancer (HR = 1.79, 95% CI: 1.15-2.79), prostate cancer (HR = 1.20, 95% CI: 1.09-1.31), hematological malignancy (HR = 1.19, 95% CI: 1.09-1.29), and melanoma of skin (HR = 1.21, 95% CI: 1.03-1.42), compared with those without periodontitis."},{"Node1":"Esophageal Neoplasms","Edge_Type":"disease","Node2":"Periodontitis","Weight":1,"Paper_List":"33029095","Original_Text":"PMID:33029095; Original text:With statistical significance, participants with periodontitis might have enhanced risks of esophageal cancer (HR = 1.79, 95% CI: 1.15-2.79), prostate cancer (HR = 1.20, 95% CI: 1.09-1.31), hematological malignancy (HR = 1.19, 95% CI: 1.09-1.29), and melanoma of skin (HR = 1.21, 95% CI: 1.03-1.42), compared with those without periodontitis."},{"Node1":"Hematologic Neoplasms","Edge_Type":"disease","Node2":"Periodontitis","Weight":1,"Paper_List":"33029095","Original_Text":"PMID:33029095; Original text:With statistical significance, participants with periodontitis might have enhanced risks of esophageal cancer (HR = 1.79, 95% CI: 1.15-2.79), prostate cancer (HR = 1.20, 95% CI: 1.09-1.31), hematological malignancy (HR = 1.19, 95% CI: 1.09-1.29), and melanoma of skin (HR = 1.21, 95% CI: 1.03-1.42), compared with those without periodontitis."},{"Node1":"Esophageal Neoplasms","Edge_Type":"disease","Node2":"Prostatic Neoplasms","Weight":1,"Paper_List":"33029095","Original_Text":"PMID:33029095; Original text:With statistical significance, participants with periodontitis might have enhanced risks of esophageal cancer (HR = 1.79, 95% CI: 1.15-2.79), prostate cancer (HR = 1.20, 95% CI: 1.09-1.31), hematological malignancy (HR = 1.19, 95% CI: 1.09-1.29), and melanoma of skin (HR = 1.21, 95% CI: 1.03-1.42), compared with those without periodontitis."},{"Node1":"Hematologic Neoplasms","Edge_Type":"disease","Node2":"Prostatic Neoplasms","Weight":1,"Paper_List":"33029095","Original_Text":"PMID:33029095; Original text:With statistical significance, participants with periodontitis might have enhanced risks of esophageal cancer (HR = 1.79, 95% CI: 1.15-2.79), prostate cancer (HR = 1.20, 95% CI: 1.09-1.31), hematological malignancy (HR = 1.19, 95% CI: 1.09-1.29), and melanoma of skin (HR = 1.21, 95% CI: 1.03-1.42), compared with those without periodontitis."},{"Node1":"Esophageal Neoplasms","Edge_Type":"disease","Node2":"Hematologic Neoplasms","Weight":1,"Paper_List":"33029095","Original_Text":"PMID:33029095; Original text:With statistical significance, participants with periodontitis might have enhanced risks of esophageal cancer (HR = 1.79, 95% CI: 1.15-2.79), prostate cancer (HR = 1.20, 95% CI: 1.09-1.31), hematological malignancy (HR = 1.19, 95% CI: 1.09-1.29), and melanoma of skin (HR = 1.21, 95% CI: 1.03-1.42), compared with those without periodontitis."},{"Node1":"Prostate","Edge_Type":"anatomy","Node2":"Skin","Weight":1,"Paper_List":"33029095","Original_Text":"PMID:33029095; Original text:With statistical significance, participants with periodontitis might have enhanced risks of esophageal cancer (HR = 1.79, 95% CI: 1.15-2.79), prostate cancer (HR = 1.20, 95% CI: 1.09-1.31), hematological malignancy (HR = 1.19, 95% CI: 1.09-1.29), and melanoma of skin (HR = 1.21, 95% CI: 1.03-1.42), compared with those without periodontitis."},{"Node1":"Infarction","Edge_Type":"disease_to_anatomy","Node2":"Myocardium","Weight":2,"Paper_List":"14643271|14643271","Original_Text":"PMID:14643271; Original text:mm (2.7% for non-acute myocardial infarction and 12.1% for acute myocardial infarction group, 95% CI: -2.8 to 0.01, P<0.05) but no difference in the extent of gingival bleeding was found between groups.|PMID:14643271; Original text:The odds ratio of having acute myocardial infarction and periodontitis varied between 9.2:1 to 14.1:1 with the greatest odds ratio if bone loss exceeded 4mm at >/=50"},{"Node1":"Infections","Edge_Type":"disease_to_anatomy","Node2":"Connective Tissue","Weight":1,"Paper_List":"1843466","Original_Text":"PMID:1843466; Original text:In the connective tissue, group a periimplant infection group showed a higher % of inflammatory infiltrate with significantly higher numbers of plasma cells and mononuclear cells than group a non-periimplant infection group."},{"Node1":"Infections","Edge_Type":"disease_to_anatomy","Node2":"Epithelium","Weight":1,"Paper_List":"1843466","Original_Text":"PMID:1843466; Original text:With histometry, group a periimplant infection group showed significantly higher transmigration of inflammatory cells in the epithelium than group a non-periimplant infection group."},{"Node1":"Infections","Edge_Type":"disease_to_anatomy","Node2":"Leukocytes, Mononuclear","Weight":1,"Paper_List":"1843466","Original_Text":"PMID:1843466; Original text:In the connective tissue, group a periimplant infection group showed a higher % of inflammatory infiltrate with significantly higher numbers of plasma cells and mononuclear cells than group a non-periimplant infection group."},{"Node1":"Infections","Edge_Type":"disease_to_anatomy","Node2":"Molar","Weight":1,"Paper_List":"8340625","Original_Text":"PMID:8340625; Original text:There were no statistically significant differences between methods in relation to pain, facial swelling, sensory loss, infection, or periodontal pocket depth distal to the second molar, although 2% of third molars removed by chisel had lingual sensory disturbance at 7 days, as compared with 8% where burs had been used."},{"Node1":"Infections","Edge_Type":"disease_to_anatomy","Node2":"Molar, Third","Weight":1,"Paper_List":"8340625","Original_Text":"PMID:8340625; Original text:There were no statistically significant differences between methods in relation to pain, facial swelling, sensory loss, infection, or periodontal pocket depth distal to the second molar, although 2% of third molars removed by chisel had lingual sensory disturbance at 7 days, as compared with 8% where burs had been used."},{"Node1":"Infections","Edge_Type":"disease_to_anatomy","Node2":"Plasma","Weight":1,"Paper_List":"1843466","Original_Text":"PMID:1843466; Original text:In the connective tissue, group a periimplant infection group showed a higher % of inflammatory infiltrate with significantly higher numbers of plasma cells and mononuclear cells than group a non-periimplant infection group."},{"Node1":"Infections","Edge_Type":"disease_to_anatomy","Node2":"Plasma Cells","Weight":1,"Paper_List":"1843466","Original_Text":"PMID:1843466; Original text:In the connective tissue, group a periimplant infection group showed a higher % of inflammatory infiltrate with significantly higher numbers of plasma cells and mononuclear cells than group a non-periimplant infection group."},{"Node1":"Infections","Edge_Type":"disease_to_anatomy","Node2":"Sensilla","Weight":1,"Paper_List":"8340625","Original_Text":"PMID:8340625; Original text:There were no statistically significant differences between methods in relation to pain, facial swelling, sensory loss, infection, or periodontal pocket depth distal to the second molar, although 2% of third molars removed by chisel had lingual sensory disturbance at 7 days, as compared with 8% where burs had been used."},{"Node1":"Infections","Edge_Type":"disease_to_anatomy","Node2":"Tissues","Weight":1,"Paper_List":"1843466","Original_Text":"PMID:1843466; Original text:In the connective tissue, group a periimplant infection group showed a higher % of inflammatory infiltrate with significantly higher numbers of plasma cells and mononuclear cells than group a non-periimplant infection group."},{"Node1":"Testosterone","Edge_Type":"chemical_to_disease","Node2":"Periodontitis","Weight":1,"Paper_List":"27645514","Original_Text":"PMID:27645514; Original text:Within the limits of the evidence available, the relationship between low testosterone levels and chronic periodontitis remains debatable and further longitudinal studies and control trials are needed."},{"Node1":"Cholesterol","Edge_Type":"chemical_to_mechanism","Node2":"provisional ortholog of C-reactive protein L homeolog","Weight":2,"Paper_List":"33810003|34197339","Original_Text":"PMID:33810003; Original text:Multivariate regression analysis showed that c-reactive protein (c-reactive protein) was the only significant predictor for metalloproteinase-9 serum (p < 0.001), whereas c-reactive protein (p < 0.001) and total cholesterol (p = 0.029) were the statistically significant salivary metalloproteinase-9 predictors.|PMID:34197339; Original text:Both groups showed significant clinical and laboratory improvements during the study from baseline to 1 year with reductions in total cholesterol (total cholesterol), triglycerides, glucose, glycated hemoglobin (glycated hemoglobin), uric acid and C-reactive protein (uric acid and C-reactive protein)."},{"Node1":"Cholesterol","Edge_Type":"chemical_to_anatomy","Node2":"Salivary Glands","Weight":1,"Paper_List":"33810003","Original_Text":"PMID:33810003; Original text:Multivariate regression analysis showed that c-reactive protein (c-reactive protein) was the only significant predictor for metalloproteinase-9 serum (p < 0.001), whereas c-reactive protein (p < 0.001) and total cholesterol (p = 0.029) were the statistically significant salivary metalloproteinase-9 predictors."},{"Node1":"provisional ortholog of C-reactive protein L homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Salivary Glands","Weight":1,"Paper_List":"33810003","Original_Text":"PMID:33810003; Original text:Multivariate regression analysis showed that c-reactive protein (c-reactive protein) was the only significant predictor for metalloproteinase-9 serum (p < 0.001), whereas c-reactive protein (p < 0.001) and total cholesterol (p = 0.029) were the statistically significant salivary metalloproteinase-9 predictors."},{"Node1":"Cardiovascular Diseases","Edge_Type":"disease_to_mechanism","Node2":"matrix metallopeptidase 1","Weight":1,"Paper_List":"33810003","Original_Text":"PMID:33810003; Original text:metalloproteinase-9 concentrations in serum and saliva were statistically elevated in patients with cardiovascular disease (p < 0.01) and in patients with periodontitis plus cardiovascular disease (p < 0.001) compared to patients with periodontitis and healthy subjects."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"matrix metallopeptidase 1","Weight":3,"Paper_List":"33810003|29504999|15088884","Original_Text":"PMID:33810003; Original text:metalloproteinase-9 concentrations in serum and saliva were statistically elevated in patients with cardiovascular disease (p < 0.01) and in patients with periodontitis plus cardiovascular disease (p < 0.001) compared to patients with periodontitis and healthy subjects.|PMID:29504999; Original text:Our meta-analysis showed that salivary the salivary matrix metalloproteinase-8 levels were significantly higher in periodontitis patients compared with healthy controls overall.|PMID:15088884; Original text:Consistent with previous studies on animal models of chronic destructive disease (e.g., rheumatoid arthritis), the subantimicrobial dose doxycycline and NSAID ) low-dose flurbiprofen therapy synergistically suppressed MMP and other neutral proteinases in the gingiva of chronic periodontitis patients."},{"Node1":"Myocardial Infarction","Edge_Type":"disease","Node2":"Pancreatitis, Chronic","Weight":1,"Paper_List":"28645686","Original_Text":"PMID:28645686; Original text:A significant relationship was observed with atherothrombotic cardiovascular disease in 10 out of 10 studies addressing the degree of oral hygiene, in 14 of 17 that included loss of teeth, in 6 of 12 that analysed caries and in 11 of 15 that included chronic apical periodontitis."},{"Node1":"Inflammation","Edge_Type":"disease_to_anatomy","Node2":"Gingiva","Weight":17,"Paper_List":"12591005|3925112|9487838|2681675|22479786|34618684|30845920|18294229|33904994|25639826|15356501|22835005|26405803|26525126|787013|2177499|16441729","Original_Text":"PMID:12591005; Original text:Improvement in gingival inflammation was observed in subjects treated with borage oil (P<0.016), with a trend apparent in subjects treated with fish oil or a combination of polyunsaturated fatty acids.|PMID:3925112; Original text:In both groups there was a significant decrease in plaque scores, gingival inflammation, gingival bleeding and probeable depths for all sites and for affected sites.|PMID:9487838; Original text:Gingival inflammation also decreased in both groups over the 6-month period, but the A sonic electric toothbrush group showed significantly superior the Papillary Bleeding Score scores at 4 months (t-test; p = 0.002) and 6 months (p = 0.005).|PMID:2681675; Original text:Visible plaque (PlI greater than 2) in the CHx group was reduced by 99% over the placebo group at 6 weeks and at 4 weeks post-surgical, gingival inflammation scores were significantly lower in the CHx group (17% reduction over the placebo at 4 weeks, P less than 0.05).|PMID:22479786; Original text:Progression of gingival inflammation resulting from lack of dental hygiene was lowest in patients treated with the rinse rinse, and was significantly less marked than in patients treated with the water-only preparation.|PMID:34618684; Original text:ConclusionAMY-101 treatment resulted in a significant and sustainable reduction in gingival inflammation without adverse events and, we believe, merits further investigation for the treatment of periodontitis and other oral or peri-implant inflammatory conditions.|PMID:30845920; Original text:Within the study, carbazochrome showed a significant reduction in gingival inflammation compared with a placebo.|PMID:18294229; Original text:ultrasonic mechanical instrumentation either with or without additional chlorhexidine use determined a significant reduction of supragingival plaque and gingival inflammation as well as a significant reduction of subgingival bacterial pathogens.|PMID:33904994; Original text:However, meta-analysis showed that among individuals with periodontitis, significantly higher levels of gingival inflammation are observed in those with obesity (n of individuals=240) when compared to those who were not obese (n of individuals=574)|PMID:25639826; Original text:Re-chargeable power toothbrushes provide small but statistically significant additional reductions in gingival inflammation and plaque levels.|PMID:15356501; Original text:Periodontal pathogens associated with gingival inflammation during orthodontic treatment can be significantly reduced by orthodontic appliance removal and professional prophylaxis.|PMID:22835005; Original text:Although periodontal therapy during pregnancy successfully reduced periodontal inflammation and gingival crevicular fluid cytokine levels, it did not have a significant impact on serum biomarkers.|PMID:26405803; Original text:There were significant differences between the patients with stroke and subjects without in pack-years of smoking (p = 0.01), prevalence of gingival inflammation (gingival inflammation) (p = 0.03), and dental calculus (p = 0.017).|PMID:26525126; Original text:Overall, debridement discomfort was associated with not receiving LA, noncompliance with the pain control regimen allocated, longer treatment duration, greater gingival inflammation and a higher percentage sites with probing pocket depths≥5 mm (p<0.05).|PMID:787013; Original text:Retrospective comparisons of the initial depths of pockets with the final gingival status indicated that, when initial depths of pockets had been 3 mm or over, surgical treatment was more effective than non-surgical in reducing the final values of both depths of pockets and inflammation; this finding was statistically significant for some, but not all of the parameters.|PMID:2177499; Original text:Collagenase activity in the crevicular fluid of periodontal pockets of an additional group of subjects was also significantly reduced, as was the severity of inflammation at the same gingival sites.|PMID:16441729; Original text:These results suggest that susceptibility to gingival inflammation in response to de novo plaque accumulation may be related to susceptibility to periodontitis."},{"Node1":"Inflammation","Edge_Type":"disease_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":2,"Paper_List":"22835005|2177499","Original_Text":"PMID:22835005; Original text:Although periodontal therapy during pregnancy successfully reduced periodontal inflammation and gingival crevicular fluid cytokine levels, it did not have a significant impact on serum biomarkers.|PMID:2177499; Original text:Collagenase activity in the crevicular fluid of periodontal pockets of an additional group of subjects was also significantly reduced, as was the severity of inflammation at the same gingival sites."},{"Node1":"Bone and Bones","Edge_Type":"anatomy","Node2":"Gingiva","Weight":2,"Paper_List":"18454658|24844029","Original_Text":"PMID:18454658; Original text:Compared to baseline, the 12-month results indicated that both treatment modalities resulted in significant changes in all clinical parameters (gingival index, bleeding on probing, probing depth, clinical attachment level, and gingival recession; P <0.001) and radiographic parameters (hard tissue fill and bone depth reduction; P <0.001).|PMID:24844029; Original text:Within the limits of the present study, one can conclude that MPM coverage of periodontal defects is associated with a significant initial increase in gingival crevicular fluid levels of bone morphogenetic protein-2, a factor that could improve the clinical outcomes of guided tissue regenerative surgery."},{"Node1":"Inflammation","Edge_Type":"disease_to_anatomy","Node2":"Integumentary System","Weight":1,"Paper_List":"7823272","Original_Text":"PMID:7823272; Original text:During the first month of membrane implantation, no statistically significant differences between test and control surfaces were noted with respect to inflammation of the marginal gingiva."},{"Node1":"Allografts","Edge_Type":"anatomy","Node2":"Plasma","Weight":2,"Paper_List":"18454658|19961374","Original_Text":"PMID:18454658; Original text:Treatment with a combination of platelet-rich plasma and a demineralized freeze-dried bone allograft led to a significantly greater clinical improvement in intrabony periodontal defects compared to a demineralized freeze-dried bone allograft with saline.|PMID:19961374; Original text:Both treatments achieved statistically significant and similar clinical attachment level gain (3.08 +/- 1.17 mm for Platelet-rich plasma + demineralized freeze-dried bone allograft and 3.08 +/- 0.95 mm for Platelet-rich plasma), probing depth, defect depth, and area surface reduction."},{"Node1":"Allografts","Edge_Type":"anatomy","Node2":"Platelet-Rich Plasma","Weight":2,"Paper_List":"18454658|19961374","Original_Text":"PMID:18454658; Original text:Treatment with a combination of platelet-rich plasma and a demineralized freeze-dried bone allograft led to a significantly greater clinical improvement in intrabony periodontal defects compared to a demineralized freeze-dried bone allograft with saline.|PMID:19961374; Original text:Both treatments achieved statistically significant and similar clinical attachment level gain (3.08 +/- 1.17 mm for Platelet-rich plasma + demineralized freeze-dried bone allograft and 3.08 +/- 0.95 mm for Platelet-rich plasma), probing depth, defect depth, and area surface reduction."},{"Node1":"Allografts","Edge_Type":"anatomy","Node2":"Blood Platelets","Weight":2,"Paper_List":"18454658|19961374","Original_Text":"PMID:18454658; Original text:Treatment with a combination of platelet-rich plasma and a demineralized freeze-dried bone allograft led to a significantly greater clinical improvement in intrabony periodontal defects compared to a demineralized freeze-dried bone allograft with saline.|PMID:19961374; Original text:Both treatments achieved statistically significant and similar clinical attachment level gain (3.08 +/- 1.17 mm for Platelet-rich plasma + demineralized freeze-dried bone allograft and 3.08 +/- 0.95 mm for Platelet-rich plasma), probing depth, defect depth, and area surface reduction."},{"Node1":"Inflammation","Edge_Type":"disease_to_anatomy","Node2":"Membranes","Weight":2,"Paper_List":"7823272|10743863","Original_Text":"PMID:7823272; Original text:During the first month of membrane implantation, no statistically significant differences between test and control surfaces were noted with respect to inflammation of the marginal gingiva.|PMID:10743863; Original text:Npolylactic acid membranes treated sites showed less signs of post-surgical inflammation during the 1st 4 weeks of healing than did polylactic acid membranes treated sites (p<0.05)."},{"Node1":"Inflammation","Edge_Type":"disease_to_anatomy","Node2":"Tissues","Weight":1,"Paper_List":"20450373","Original_Text":"PMID:20450373; Original text:Many metabolites associated with inflammation, oxidative stress, tissue degradation, and bacterial metabolism were found to be significantly induced by the diseases."},{"Node1":"Melanoma","Edge_Type":"disease_to_anatomy","Node2":"Prostate","Weight":1,"Paper_List":"33029095","Original_Text":"PMID:33029095; Original text:With statistical significance, participants with periodontitis might have enhanced risks of esophageal cancer (HR = 1.79, 95% CI: 1.15-2.79), prostate cancer (HR = 1.20, 95% CI: 1.09-1.31), hematological malignancy (HR = 1.19, 95% CI: 1.09-1.29), and melanoma of skin (HR = 1.21, 95% CI: 1.03-1.42), compared with those without periodontitis."},{"Node1":"Melanoma","Edge_Type":"disease_to_anatomy","Node2":"Skin","Weight":1,"Paper_List":"33029095","Original_Text":"PMID:33029095; Original text:With statistical significance, participants with periodontitis might have enhanced risks of esophageal cancer (HR = 1.79, 95% CI: 1.15-2.79), prostate cancer (HR = 1.20, 95% CI: 1.09-1.31), hematological malignancy (HR = 1.19, 95% CI: 1.09-1.29), and melanoma of skin (HR = 1.21, 95% CI: 1.03-1.42), compared with those without periodontitis."},{"Node1":"Wnt family member 3A S homeolog","Edge_Type":"mechanism","Node2":"wingless-type MMTV integration site family member 9B L homeolog","Weight":1,"Paper_List":"31831777","Original_Text":"PMID:31831777; Original text:Haplotypes involving WNT3-WNT9B-WNT3A alleles were also significantly associated with apical periodontitis (P ≤ 0.003)."},{"Node1":"Wnt oncogene analog 5","Edge_Type":"mechanism","Node2":"wingless-type MMTV integration site family member 9B L homeolog","Weight":1,"Paper_List":"31831777","Original_Text":"PMID:31831777; Original text:Haplotypes involving WNT3-WNT9B-WNT3A alleles were also significantly associated with apical periodontitis (P ≤ 0.003)."},{"Node1":"Wnt family member 3A S homeolog","Edge_Type":"mechanism","Node2":"Wnt oncogene analog 5","Weight":2,"Paper_List":"31831777|31831777","Original_Text":"PMID:31831777; Original text:Haplotypes involving WNT3-WNT9B-WNT3A alleles were also significantly associated with apical periodontitis (P ≤ 0.003).|PMID:31831777; Original text:Expression of WNT3, WNT3A and WNT5A in apical periodontitis tissues was significantly higher than in control tissues, and inversely correlated with the expression of SERPINB1, COL1A1 and TIMP1 (P < 0.05)."},{"Node1":"Periapical Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"wingless-type MMTV integration site family member 9B L homeolog","Weight":1,"Paper_List":"31831777","Original_Text":"PMID:31831777; Original text:Haplotypes involving WNT3-WNT9B-WNT3A alleles were also significantly associated with apical periodontitis (P ≤ 0.003)."},{"Node1":"Periapical Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"Wnt family member 3A S homeolog","Weight":1,"Paper_List":"31831777","Original_Text":"PMID:31831777; Original text:Haplotypes involving WNT3-WNT9B-WNT3A alleles were also significantly associated with apical periodontitis (P ≤ 0.003)."},{"Node1":"Periapical Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"Wnt oncogene analog 5","Weight":1,"Paper_List":"31831777","Original_Text":"PMID:31831777; Original text:Haplotypes involving WNT3-WNT9B-WNT3A alleles were also significantly associated with apical periodontitis (P ≤ 0.003)."},{"Node1":"Wnt family member 3A S homeolog","Edge_Type":"mechanism","Node2":"Wnt family member 5A S homeolog","Weight":1,"Paper_List":"31831777","Original_Text":"PMID:31831777; Original text:Expression of WNT3, WNT3A and WNT5A in apical periodontitis tissues was significantly higher than in control tissues, and inversely correlated with the expression of SERPINB1, COL1A1 and TIMP1 (P < 0.05)."},{"Node1":"Wnt family member 5A S homeolog","Edge_Type":"mechanism","Node2":"collagen, type I, alpha 1 S homeolog","Weight":1,"Paper_List":"31831777","Original_Text":"PMID:31831777; Original text:Expression of WNT3, WNT3A and WNT5A in apical periodontitis tissues was significantly higher than in control tissues, and inversely correlated with the expression of SERPINB1, COL1A1 and TIMP1 (P < 0.05)."},{"Node1":"Wnt family member 5A S homeolog","Edge_Type":"mechanism","Node2":"serpin peptidase inhibitor, clade B (ovalbumin), member 1, like 1","Weight":1,"Paper_List":"31831777","Original_Text":"PMID:31831777; Original text:Expression of WNT3, WNT3A and WNT5A in apical periodontitis tissues was significantly higher than in control tissues, and inversely correlated with the expression of SERPINB1, COL1A1 and TIMP1 (P < 0.05)."},{"Node1":"Wnt family member 5A S homeolog","Edge_Type":"mechanism","Node2":"tissue inhibitor of metalloproteinase-1 S homeolog","Weight":1,"Paper_List":"31831777","Original_Text":"PMID:31831777; Original text:Expression of WNT3, WNT3A and WNT5A in apical periodontitis tissues was significantly higher than in control tissues, and inversely correlated with the expression of SERPINB1, COL1A1 and TIMP1 (P < 0.05)."},{"Node1":"Wnt family member 5A S homeolog","Edge_Type":"mechanism","Node2":"Wnt oncogene analog 5","Weight":1,"Paper_List":"31831777","Original_Text":"PMID:31831777; Original text:Expression of WNT3, WNT3A and WNT5A in apical periodontitis tissues was significantly higher than in control tissues, and inversely correlated with the expression of SERPINB1, COL1A1 and TIMP1 (P < 0.05)."},{"Node1":"Wnt family member 3A S homeolog","Edge_Type":"mechanism","Node2":"collagen, type I, alpha 1 S homeolog","Weight":1,"Paper_List":"31831777","Original_Text":"PMID:31831777; Original text:Expression of WNT3, WNT3A and WNT5A in apical periodontitis tissues was significantly higher than in control tissues, and inversely correlated with the expression of SERPINB1, COL1A1 and TIMP1 (P < 0.05)."},{"Node1":"Wnt family member 3A S homeolog","Edge_Type":"mechanism","Node2":"serpin peptidase inhibitor, clade B (ovalbumin), member 1, like 1","Weight":1,"Paper_List":"31831777","Original_Text":"PMID:31831777; Original text:Expression of WNT3, WNT3A and WNT5A in apical periodontitis tissues was significantly higher than in control tissues, and inversely correlated with the expression of SERPINB1, COL1A1 and TIMP1 (P < 0.05)."},{"Node1":"Wnt family member 3A S homeolog","Edge_Type":"mechanism","Node2":"tissue inhibitor of metalloproteinase-1 S homeolog","Weight":1,"Paper_List":"31831777","Original_Text":"PMID:31831777; Original text:Expression of WNT3, WNT3A and WNT5A in apical periodontitis tissues was significantly higher than in control tissues, and inversely correlated with the expression of SERPINB1, COL1A1 and TIMP1 (P < 0.05)."},{"Node1":"collagen, type I, alpha 1 S homeolog","Edge_Type":"mechanism","Node2":"serpin peptidase inhibitor, clade B (ovalbumin), member 1, like 1","Weight":1,"Paper_List":"31831777","Original_Text":"PMID:31831777; Original text:Expression of WNT3, WNT3A and WNT5A in apical periodontitis tissues was significantly higher than in control tissues, and inversely correlated with the expression of SERPINB1, COL1A1 and TIMP1 (P < 0.05)."},{"Node1":"collagen, type I, alpha 1 S homeolog","Edge_Type":"mechanism","Node2":"tissue inhibitor of metalloproteinase-1 S homeolog","Weight":1,"Paper_List":"31831777","Original_Text":"PMID:31831777; Original text:Expression of WNT3, WNT3A and WNT5A in apical periodontitis tissues was significantly higher than in control tissues, and inversely correlated with the expression of SERPINB1, COL1A1 and TIMP1 (P < 0.05)."},{"Node1":"Wnt oncogene analog 5","Edge_Type":"mechanism","Node2":"collagen, type I, alpha 1 S homeolog","Weight":1,"Paper_List":"31831777","Original_Text":"PMID:31831777; Original text:Expression of WNT3, WNT3A and WNT5A in apical periodontitis tissues was significantly higher than in control tissues, and inversely correlated with the expression of SERPINB1, COL1A1 and TIMP1 (P < 0.05)."},{"Node1":"serpin peptidase inhibitor, clade B (ovalbumin), member 1, like 1","Edge_Type":"mechanism","Node2":"tissue inhibitor of metalloproteinase-1 S homeolog","Weight":1,"Paper_List":"31831777","Original_Text":"PMID:31831777; Original text:Expression of WNT3, WNT3A and WNT5A in apical periodontitis tissues was significantly higher than in control tissues, and inversely correlated with the expression of SERPINB1, COL1A1 and TIMP1 (P < 0.05)."},{"Node1":"Wnt oncogene analog 5","Edge_Type":"mechanism","Node2":"serpin peptidase inhibitor, clade B (ovalbumin), member 1, like 1","Weight":1,"Paper_List":"31831777","Original_Text":"PMID:31831777; Original text:Expression of WNT3, WNT3A and WNT5A in apical periodontitis tissues was significantly higher than in control tissues, and inversely correlated with the expression of SERPINB1, COL1A1 and TIMP1 (P < 0.05)."},{"Node1":"Wnt oncogene analog 5","Edge_Type":"mechanism","Node2":"tissue inhibitor of metalloproteinase-1 S homeolog","Weight":1,"Paper_List":"31831777","Original_Text":"PMID:31831777; Original text:Expression of WNT3, WNT3A and WNT5A in apical periodontitis tissues was significantly higher than in control tissues, and inversely correlated with the expression of SERPINB1, COL1A1 and TIMP1 (P < 0.05)."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"Wnt family member 5A S homeolog","Weight":1,"Paper_List":"31831777","Original_Text":"PMID:31831777; Original text:Expression of WNT3, WNT3A and WNT5A in apical periodontitis tissues was significantly higher than in control tissues, and inversely correlated with the expression of SERPINB1, COL1A1 and TIMP1 (P < 0.05)."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"Wnt family member 3A S homeolog","Weight":1,"Paper_List":"31831777","Original_Text":"PMID:31831777; Original text:Expression of WNT3, WNT3A and WNT5A in apical periodontitis tissues was significantly higher than in control tissues, and inversely correlated with the expression of SERPINB1, COL1A1 and TIMP1 (P < 0.05)."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"collagen, type I, alpha 1 S homeolog","Weight":1,"Paper_List":"31831777","Original_Text":"PMID:31831777; Original text:Expression of WNT3, WNT3A and WNT5A in apical periodontitis tissues was significantly higher than in control tissues, and inversely correlated with the expression of SERPINB1, COL1A1 and TIMP1 (P < 0.05)."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"serpin peptidase inhibitor, clade B (ovalbumin), member 1, like 1","Weight":1,"Paper_List":"31831777","Original_Text":"PMID:31831777; Original text:Expression of WNT3, WNT3A and WNT5A in apical periodontitis tissues was significantly higher than in control tissues, and inversely correlated with the expression of SERPINB1, COL1A1 and TIMP1 (P < 0.05)."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"tissue inhibitor of metalloproteinase-1 S homeolog","Weight":1,"Paper_List":"31831777","Original_Text":"PMID:31831777; Original text:Expression of WNT3, WNT3A and WNT5A in apical periodontitis tissues was significantly higher than in control tissues, and inversely correlated with the expression of SERPINB1, COL1A1 and TIMP1 (P < 0.05)."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"Wnt oncogene analog 5","Weight":1,"Paper_List":"31831777","Original_Text":"PMID:31831777; Original text:Expression of WNT3, WNT3A and WNT5A in apical periodontitis tissues was significantly higher than in control tissues, and inversely correlated with the expression of SERPINB1, COL1A1 and TIMP1 (P < 0.05)."},{"Node1":"Wnt family member 5A S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Tissues","Weight":1,"Paper_List":"31831777","Original_Text":"PMID:31831777; Original text:Expression of WNT3, WNT3A and WNT5A in apical periodontitis tissues was significantly higher than in control tissues, and inversely correlated with the expression of SERPINB1, COL1A1 and TIMP1 (P < 0.05)."},{"Node1":"Wnt family member 3A S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Tissues","Weight":1,"Paper_List":"31831777","Original_Text":"PMID:31831777; Original text:Expression of WNT3, WNT3A and WNT5A in apical periodontitis tissues was significantly higher than in control tissues, and inversely correlated with the expression of SERPINB1, COL1A1 and TIMP1 (P < 0.05)."},{"Node1":"collagen, type I, alpha 1 S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Tissues","Weight":1,"Paper_List":"31831777","Original_Text":"PMID:31831777; Original text:Expression of WNT3, WNT3A and WNT5A in apical periodontitis tissues was significantly higher than in control tissues, and inversely correlated with the expression of SERPINB1, COL1A1 and TIMP1 (P < 0.05)."},{"Node1":"serpin peptidase inhibitor, clade B (ovalbumin), member 1, like 1","Edge_Type":"mechanism_to_anatomy","Node2":"Tissues","Weight":1,"Paper_List":"31831777","Original_Text":"PMID:31831777; Original text:Expression of WNT3, WNT3A and WNT5A in apical periodontitis tissues was significantly higher than in control tissues, and inversely correlated with the expression of SERPINB1, COL1A1 and TIMP1 (P < 0.05)."},{"Node1":"tissue inhibitor of metalloproteinase-1 S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Tissues","Weight":1,"Paper_List":"31831777","Original_Text":"PMID:31831777; Original text:Expression of WNT3, WNT3A and WNT5A in apical periodontitis tissues was significantly higher than in control tissues, and inversely correlated with the expression of SERPINB1, COL1A1 and TIMP1 (P < 0.05)."},{"Node1":"Wnt oncogene analog 5","Edge_Type":"mechanism_to_anatomy","Node2":"Tissues","Weight":1,"Paper_List":"31831777","Original_Text":"PMID:31831777; Original text:Expression of WNT3, WNT3A and WNT5A in apical periodontitis tissues was significantly higher than in control tissues, and inversely correlated with the expression of SERPINB1, COL1A1 and TIMP1 (P < 0.05)."},{"Node1":"Allografts","Edge_Type":"anatomy","Node2":"Dura Mater","Weight":2,"Paper_List":"2600748|2600748","Original_Text":"PMID:2600748; Original text:There was a significantly greater amount of probing pocket depth reduction and significantly shallower residual pockets when Freeze-dried dura mater allografts was used.|PMID:2600748; Original text:There were significant differences in the percent of defect resolution and the depth of the residual defect in favor of the Freeze-dried dura mater allografts treatment."},{"Node1":"Doxycycline","Edge_Type":"chemical","Node2":"Metronidazole","Weight":2,"Paper_List":"21846460|21846460","Original_Text":"PMID:21846460; Original text:Values for a probing pocket depth and clinical attachment level were more improved in the antibiotic groups than in the root planing group, and more improved in the metronidazole and amoxicillin group than in the doxycycline group (p < 0.05).|PMID:21846460; Original text:Systemic use of metronidazole and amoxicillin or doxycycline was clinically superior to root planing for reducing a probing pocket depths ≥ 7 mm (p < 0.05)."},{"Node1":"Amoxicillin","Edge_Type":"chemical","Node2":"Doxycycline","Weight":2,"Paper_List":"21846460|21846460","Original_Text":"PMID:21846460; Original text:Values for a probing pocket depth and clinical attachment level were more improved in the antibiotic groups than in the root planing group, and more improved in the metronidazole and amoxicillin group than in the doxycycline group (p < 0.05).|PMID:21846460; Original text:Systemic use of metronidazole and amoxicillin or doxycycline was clinically superior to root planing for reducing a probing pocket depths ≥ 7 mm (p < 0.05)."},{"Node1":"Plasma","Edge_Type":"anatomy","Node2":"Platelet-Rich Fibrin","Weight":3,"Paper_List":"23317096|23317096|22348695","Original_Text":"PMID:23317096; Original text:Relative vertical clinical attachment level gain was also greater in autologous platelet-rich fibrin (2.87 ± 0.85 mm) and autologous platelet-rich plasma (2.71 ± 1.04 mm) sites as compared to control site (1.37 ± 0.58|PMID:23317096; Original text:All clinical and radiographic parameters showed statistically significant improvement at both the test sites (autologous platelet-rich fibrin with OFD and autologous platelet-rich plasma with OFD) compared to those with OFD alone.|PMID:22348695; Original text:Furthermore, significantly greater percentage of mean bone fill was found in the autologous platelet-rich fibrin (55.41% ± 11.39%) and platelet-rich plasma (56.85% ± 14.01%) groups compared with the control (1.56% ± 15.12%) group."},{"Node1":"silk fibroin light chain","Edge_Type":"mechanism_to_anatomy","Node2":"Plasma","Weight":1,"Paper_List":"23317096","Original_Text":"PMID:23317096; Original text:Relative vertical clinical attachment level gain was also greater in autologous platelet-rich fibrin (2.87 ± 0.85 mm) and autologous platelet-rich plasma (2.71 ± 1.04 mm) sites as compared to control site (1.37 ± 0.58"},{"Node1":"silk fibroin light chain","Edge_Type":"mechanism_to_anatomy","Node2":"Platelet-Rich Fibrin","Weight":5,"Paper_List":"23317096|30624092|30624092|30624092|33842996","Original_Text":"PMID:23317096; Original text:Relative vertical clinical attachment level gain was also greater in autologous platelet-rich fibrin (2.87 ± 0.85 mm) and autologous platelet-rich plasma (2.71 ± 1.04 mm) sites as compared to control site (1.37 ± 0.58|PMID:30624092; Original text:PD reduction and clinical attachment level gain were significantly higher in the open flap debridement + leukocyte-platelet-rich fibrin sites than in open flap debridement sites.|PMID:30624092; Original text:leukocyte-platelet-rich fibrin combined with open flap debridement significantly increases growth factors levels and thus, it enhances the periodontal healing on chronic periodontitis patients.|PMID:30624092; Original text:open flap debridement + leukocyte-platelet-rich fibrin group showed significantly increased bone morphogenetic protein-2 and insulin-like growth factor-1 at 2 weeks compared with baseline.|PMID:33842996; Original text:open flap debridement+AA/platelet-rich fibrin and open flap debridement+platelet-rich fibrin demonstrated significant intragroup CAL gain and pocket depth reduction at 3 and 6 months (p < 0.001)."},{"Node1":"silk fibroin light chain","Edge_Type":"mechanism_to_anatomy","Node2":"Platelet-Rich Plasma","Weight":1,"Paper_List":"23317096","Original_Text":"PMID:23317096; Original text:Relative vertical clinical attachment level gain was also greater in autologous platelet-rich fibrin (2.87 ± 0.85 mm) and autologous platelet-rich plasma (2.71 ± 1.04 mm) sites as compared to control site (1.37 ± 0.58"},{"Node1":"silk fibroin light chain","Edge_Type":"mechanism_to_anatomy","Node2":"Blood Platelets","Weight":5,"Paper_List":"23317096|30624092|30624092|30624092|33842996","Original_Text":"PMID:23317096; Original text:Relative vertical clinical attachment level gain was also greater in autologous platelet-rich fibrin (2.87 ± 0.85 mm) and autologous platelet-rich plasma (2.71 ± 1.04 mm) sites as compared to control site (1.37 ± 0.58|PMID:30624092; Original text:PD reduction and clinical attachment level gain were significantly higher in the open flap debridement + leukocyte-platelet-rich fibrin sites than in open flap debridement sites.|PMID:30624092; Original text:leukocyte-platelet-rich fibrin combined with open flap debridement significantly increases growth factors levels and thus, it enhances the periodontal healing on chronic periodontitis patients.|PMID:30624092; Original text:open flap debridement + leukocyte-platelet-rich fibrin group showed significantly increased bone morphogenetic protein-2 and insulin-like growth factor-1 at 2 weeks compared with baseline.|PMID:33842996; Original text:open flap debridement+AA/platelet-rich fibrin and open flap debridement+platelet-rich fibrin demonstrated significant intragroup CAL gain and pocket depth reduction at 3 and 6 months (p < 0.001)."},{"Node1":"Iron","Edge_Type":"chemical_to_disease","Node2":"Periodontitis","Weight":1,"Paper_List":"26194850","Original_Text":"PMID:26194850; Original text:At the end of the intervention, the prevalence of caries was 56.7%, 69.1% and 63.3% (P = 0.004), and periodontitis 34.9%, 29.8% and 31.2% (P = 0.338) in the one daily iron-folic acid capsule, 18 micronutrients and lipid-based nutrient supplements groups, respectively."},{"Node1":"Acellular Dermis","Edge_Type":"anatomy","Node2":"Gingiva","Weight":2,"Paper_List":"16274299|23593633","Original_Text":"PMID:16274299; Original text:There were four studies comparing acellular dermal matrix versus a connective tissue graft for root coverage procedures, two studies comparing acellular dermal matrix versus coronally advanced flap (coronally advanced flap) for root coverage procedures, and two studies comparing acellular dermal matrix to free gingival graft in augmentation of keratinized tissue.|PMID:23593633; Original text:The results of this study demonstrate that acellular dermal matrix allograft with a a coronally positioned flap is an effective procedure for the treatment of multiple gingival recessions."},{"Node1":"Connective Tissue","Edge_Type":"anatomy","Node2":"Gingiva","Weight":2,"Paper_List":"16274299|27435493","Original_Text":"PMID:16274299; Original text:There were four studies comparing acellular dermal matrix versus a connective tissue graft for root coverage procedures, two studies comparing acellular dermal matrix versus coronally advanced flap (coronally advanced flap) for root coverage procedures, and two studies comparing acellular dermal matrix to free gingival graft in augmentation of keratinized tissue.|PMID:27435493; Original text:Postsurgery, a higher number of inflammatory cells and stronger expression of proinflammatory cytokines were observed in the epithelium and connective tissue of conventional osseous resective surgery gingival samples compared with fibre retention osseous resective surgery gingival samples (p < 0.001)."},{"Node1":"Acellular Dermis","Edge_Type":"anatomy","Node2":"Connective Tissue","Weight":1,"Paper_List":"16274299","Original_Text":"PMID:16274299; Original text:There were four studies comparing acellular dermal matrix versus a connective tissue graft for root coverage procedures, two studies comparing acellular dermal matrix versus coronally advanced flap (coronally advanced flap) for root coverage procedures, and two studies comparing acellular dermal matrix to free gingival graft in augmentation of keratinized tissue."},{"Node1":"Acellular Dermis","Edge_Type":"anatomy","Node2":"Transplants","Weight":1,"Paper_List":"16274299","Original_Text":"PMID:16274299; Original text:There were four studies comparing acellular dermal matrix versus a connective tissue graft for root coverage procedures, two studies comparing acellular dermal matrix versus coronally advanced flap (coronally advanced flap) for root coverage procedures, and two studies comparing acellular dermal matrix to free gingival graft in augmentation of keratinized tissue."},{"Node1":"interleukin 6 L homeolog","Edge_Type":"mechanism","Node2":"nejire","Weight":2,"Paper_List":"15086624|15086624","Original_Text":"PMID:15086624; Original text:These were accompanied with significant reductions in serum interleukin-6 and Serum C-reactive protein concentrations.|PMID:15086624; Original text:In a multivariate model, serum Serum C-reactive protein levels were significantly associated with the outcome of periodontal treatment after correcting for potential covariates (age, body mass index, gender, smoking) and polymorphisms in the interleukin-6 (-174 C/G) and IL-1A (-889) genes."},{"Node1":"interleukin 1 alpha","Edge_Type":"mechanism","Node2":"interleukin 6 L homeolog","Weight":1,"Paper_List":"15086624","Original_Text":"PMID:15086624; Original text:In a multivariate model, serum Serum C-reactive protein levels were significantly associated with the outcome of periodontal treatment after correcting for potential covariates (age, body mass index, gender, smoking) and polymorphisms in the interleukin-6 (-174 C/G) and IL-1A (-889) genes."},{"Node1":"interleukin 1 alpha","Edge_Type":"mechanism","Node2":"nejire","Weight":1,"Paper_List":"15086624","Original_Text":"PMID:15086624; Original text:In a multivariate model, serum Serum C-reactive protein levels were significantly associated with the outcome of periodontal treatment after correcting for potential covariates (age, body mass index, gender, smoking) and polymorphisms in the interleukin-6 (-174 C/G) and IL-1A (-889) genes."},{"Node1":"3-nitrotyrosine","Edge_Type":"chemical_to_anatomy","Node2":"Tissues","Weight":1,"Paper_List":"23147558","Original_Text":"PMID:23147558; Original text:Compared to baseline, at the completion of treatment, significant decreases in the levels of tissue nitric oxide synthase and 3-nitrotyrosine and serum NO(x) and 3-nitrotyrosine were observed in both groups."},{"Node1":"Porphyromonas Gingivalis (Organism)","Edge_Type":"bacteria_to_chemical","Node2":"Triclosan","Weight":1,"Paper_List":"12716333","Original_Text":"PMID:12716333; Original text:There was no effect of the triclosan/copolymer dentifrice in individuals without probing depths > or =3.5 mm at the previous examination."},{"Node1":"Azithromycin","Edge_Type":"chemical","Node2":"Metronidazole","Weight":2,"Paper_List":"18279183|17309596","Original_Text":"PMID:18279183; Original text:The significant reduction of red and orange complex species at 2 weeks in the subjects receiving root planing plus azithromycin or metronidazole may have contributed to a better clinical response in these treatment groups.|PMID:17309596; Original text:Sites with initial pocket depth > 6 mm showed significantly greater pocket depth reduction and greater attachment gain in subjects receiving metronidazole or azithromycin than subjects in the other groups."},{"Node1":"Arginine","Edge_Type":"chemical_to_disease","Node2":"Dentin Sensitivity","Weight":1,"Paper_List":"29178740","Original_Text":"PMID:29178740; Original text:The arginine-based approach provided significantly greater dentin hypersensitivity (significantly greater dentin hypersensitivity) relief after non-surgical periodontal treatment (non-surgical periodontal treatment) when compared to the control."},{"Node1":"Gingival Crevicular Fluid","Edge_Type":"anatomy","Node2":"Tissues","Weight":1,"Paper_List":"34618843","Original_Text":"PMID:34618843; Original text:Subgroup analysis by sample type showed that subgingival plaque (Subgigival plaque), tissue and gingival crevicular fluid GCF were useful for EBV detection (P<0.001)."},{"Node1":"matrix metallopeptidase 9 gene 1 S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Dental Pulp Cavity","Weight":1,"Paper_List":"30993696","Original_Text":"PMID:30993696; Original text:MMP-9/MMP-9/total protein levels in periapical fluid declined significantly (P < 0.001) after 1 week with no medication in the root canal, without significant difference between treatment groups (P > 0.05)."},{"Node1":"secreted phosphoprotein 1","Edge_Type":"mechanism","Node2":"tumor necrosis factor receptor superfamily member 11b S homeolog","Weight":1,"Paper_List":"24158337","Original_Text":"PMID:24158337; Original text:Transforming growth factors, osteoprotegerin, osteopontin, and parathyroid hormone presented an earlier release peak in group IM than in NL group (p < .05)."},{"Node1":"parathyroid hormone 1b","Edge_Type":"mechanism","Node2":"tumor necrosis factor receptor superfamily member 11b S homeolog","Weight":1,"Paper_List":"24158337","Original_Text":"PMID:24158337; Original text:Transforming growth factors, osteoprotegerin, osteopontin, and parathyroid hormone presented an earlier release peak in group IM than in NL group (p < .05)."},{"Node1":"RNA component of signal recognition particle 7SL1","Edge_Type":"mechanism","Node2":"tumor necrosis factor receptor superfamily member 11b S homeolog","Weight":1,"Paper_List":"24158337","Original_Text":"PMID:24158337; Original text:Transforming growth factors, osteoprotegerin, osteopontin, and parathyroid hormone presented an earlier release peak in group IM than in NL group (p < .05)."},{"Node1":"parathyroid hormone 1b","Edge_Type":"mechanism","Node2":"secreted phosphoprotein 1","Weight":1,"Paper_List":"24158337","Original_Text":"PMID:24158337; Original text:Transforming growth factors, osteoprotegerin, osteopontin, and parathyroid hormone presented an earlier release peak in group IM than in NL group (p < .05)."},{"Node1":"RNA component of signal recognition particle 7SL1","Edge_Type":"mechanism","Node2":"secreted phosphoprotein 1","Weight":1,"Paper_List":"24158337","Original_Text":"PMID:24158337; Original text:Transforming growth factors, osteoprotegerin, osteopontin, and parathyroid hormone presented an earlier release peak in group IM than in NL group (p < .05)."},{"Node1":"RNA component of signal recognition particle 7SL1","Edge_Type":"mechanism","Node2":"parathyroid hormone 1b","Weight":1,"Paper_List":"24158337","Original_Text":"PMID:24158337; Original text:Transforming growth factors, osteoprotegerin, osteopontin, and parathyroid hormone presented an earlier release peak in group IM than in NL group (p < .05)."},{"Node1":"tumor necrosis factor receptor superfamily member 11b S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Parathyroid Glands","Weight":1,"Paper_List":"24158337","Original_Text":"PMID:24158337; Original text:Transforming growth factors, osteoprotegerin, osteopontin, and parathyroid hormone presented an earlier release peak in group IM than in NL group (p < .05)."},{"Node1":"secreted phosphoprotein 1","Edge_Type":"mechanism_to_anatomy","Node2":"Parathyroid Glands","Weight":1,"Paper_List":"24158337","Original_Text":"PMID:24158337; Original text:Transforming growth factors, osteoprotegerin, osteopontin, and parathyroid hormone presented an earlier release peak in group IM than in NL group (p < .05)."},{"Node1":"parathyroid hormone 1b","Edge_Type":"mechanism_to_anatomy","Node2":"Parathyroid Glands","Weight":1,"Paper_List":"24158337","Original_Text":"PMID:24158337; Original text:Transforming growth factors, osteoprotegerin, osteopontin, and parathyroid hormone presented an earlier release peak in group IM than in NL group (p < .05)."},{"Node1":"RNA component of signal recognition particle 7SL1","Edge_Type":"mechanism_to_anatomy","Node2":"Parathyroid Glands","Weight":1,"Paper_List":"24158337","Original_Text":"PMID:24158337; Original text:Transforming growth factors, osteoprotegerin, osteopontin, and parathyroid hormone presented an earlier release peak in group IM than in NL group (p < .05)."},{"Node1":"Penicillins","Edge_Type":"chemical","Node2":"Stearates","Weight":1,"Paper_List":"3112672","Original_Text":"PMID:3112672; Original text:A 2.2% flare-up incidence was found, with no statistically significant differences for penicillin (0.0%), base (2.9%), and stearate (3.8%)."},{"Node1":"Fatty Acids, Unsaturated","Edge_Type":"chemical_to_disease","Node2":"Inflammation","Weight":1,"Paper_List":"12591005","Original_Text":"PMID:12591005; Original text:Improvement in gingival inflammation was observed in subjects treated with borage oil (P<0.016), with a trend apparent in subjects treated with fish oil or a combination of polyunsaturated fatty acids."},{"Node1":"Fatty Acids, Unsaturated","Edge_Type":"chemical_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"12591005","Original_Text":"PMID:12591005; Original text:Improvement in gingival inflammation was observed in subjects treated with borage oil (P<0.016), with a trend apparent in subjects treated with fish oil or a combination of polyunsaturated fatty acids."},{"Node1":"Mycetoma","Edge_Type":"disease_to_anatomy","Node2":"Plasma Cells","Weight":1,"Paper_List":"11811507","Original_Text":"PMID:11811507; Original text:Scaling and root planing resulted in a decrease of all cell phenotypes studied in individuals without Actinobacillus actinomycetemcomitans, whereas in subjects with Actinobacillus actinomycetemcomitans, the only significant decrease that was seen occurred in plasma cells."},{"Node1":"Meloxicam","Edge_Type":"chemical_to_disease","Node2":"Hemorrhage","Weight":1,"Paper_List":"11846190","Original_Text":"PMID:11846190; Original text:Both meloxicam and placebo groups showed statistically significant reductions in papilla bleeding index, Plaque index, and gingival crevicular fluid MMP-8 levels on day 10 compared to baseline (P<0.01)."},{"Node1":"Meloxicam","Edge_Type":"chemical_to_mechanism","Node2":"matrix metallopeptidase 8","Weight":1,"Paper_List":"11846190","Original_Text":"PMID:11846190; Original text:The gingival crevicular fluid MMP-8 level on day 10 in the meloxicam group was similar to the clinically healthy control group (P>0.05), while it was significantly higher in the placebo group (P<0.01)."},{"Node1":"Mucous Membrane","Edge_Type":"anatomy","Node2":"Synoviocytes","Weight":1,"Paper_List":"29202571","Original_Text":"PMID:29202571; Original text:The emollient and restructuring action exerted on the mucous membranes by hyaluronic acid is of particular significance."},{"Node1":"Membranes","Edge_Type":"anatomy","Node2":"Synoviocytes","Weight":1,"Paper_List":"29202571","Original_Text":"PMID:29202571; Original text:The emollient and restructuring action exerted on the mucous membranes by hyaluronic acid is of particular significance."},{"Node1":"Atorvastatin","Edge_Type":"chemical","Node2":"Cholesterol","Weight":1,"Paper_List":"20825523","Original_Text":"PMID:20825523; Original text:After comparing the figures of change, significant improvements were observed in cholesterol levels (Δ=-58.5 ± 37.6 versusΔ=5.4 ± 41.2 mg/dl, p<0.0002), low-density lipoprotein levels (Δ=-48.1 ± 31.7 versusΔ=1.9 ± 42.8 mg/dl, p<0.002), dental mobility (Δ=-0.17 ± 0.11 versusΔ=-0.06 ± 0.11%, p<0.04), and the distance from the crestal alveolar bone to the cemento-enamel junction (Δ=-0.75 ± 0.7 versusΔ=0.09 ± 0.4 mm, p<0.0006) in the atorvastatin group."},{"Node1":"Atorvastatin","Edge_Type":"chemical_to_mechanism","Node2":"transcription factor AP-2 alpha","Weight":1,"Paper_List":"20825523","Original_Text":"PMID:20825523; Original text:After comparing the figures of change, significant improvements were observed in cholesterol levels (Δ=-58.5 ± 37.6 versusΔ=5.4 ± 41.2 mg/dl, p<0.0002), low-density lipoprotein levels (Δ=-48.1 ± 31.7 versusΔ=1.9 ± 42.8 mg/dl, p<0.002), dental mobility (Δ=-0.17 ± 0.11 versusΔ=-0.06 ± 0.11%, p<0.04), and the distance from the crestal alveolar bone to the cemento-enamel junction (Δ=-0.75 ± 0.7 versusΔ=0.09 ± 0.4 mm, p<0.0006) in the atorvastatin group."},{"Node1":"Cholesterol","Edge_Type":"chemical_to_mechanism","Node2":"transcription factor AP-2 alpha","Weight":1,"Paper_List":"20825523","Original_Text":"PMID:20825523; Original text:After comparing the figures of change, significant improvements were observed in cholesterol levels (Δ=-58.5 ± 37.6 versusΔ=5.4 ± 41.2 mg/dl, p<0.0002), low-density lipoprotein levels (Δ=-48.1 ± 31.7 versusΔ=1.9 ± 42.8 mg/dl, p<0.002), dental mobility (Δ=-0.17 ± 0.11 versusΔ=-0.06 ± 0.11%, p<0.04), and the distance from the crestal alveolar bone to the cemento-enamel junction (Δ=-0.75 ± 0.7 versusΔ=0.09 ± 0.4 mm, p<0.0006) in the atorvastatin group."},{"Node1":"Atorvastatin","Edge_Type":"chemical_to_anatomy","Node2":"Alveolar Process","Weight":2,"Paper_List":"20825523|29211309","Original_Text":"PMID:20825523; Original text:After comparing the figures of change, significant improvements were observed in cholesterol levels (Δ=-58.5 ± 37.6 versusΔ=5.4 ± 41.2 mg/dl, p<0.0002), low-density lipoprotein levels (Δ=-48.1 ± 31.7 versusΔ=1.9 ± 42.8 mg/dl, p<0.002), dental mobility (Δ=-0.17 ± 0.11 versusΔ=-0.06 ± 0.11%, p<0.04), and the distance from the crestal alveolar bone to the cemento-enamel junction (Δ=-0.75 ± 0.7 versusΔ=0.09 ± 0.4 mm, p<0.0006) in the atorvastatin group.|PMID:29211309; Original text:Meta-analysis based on 14 experimentally induced periodontitis trials confirmed a significant benefit of local and systemic statin use (P < .001) in terms of alveolar bone level/amount; meta-regression revealed that statin type exhibited a significant effect (P = .014) in favor of atorvastatin."},{"Node1":"Cholesterol","Edge_Type":"chemical_to_anatomy","Node2":"Alveolar Process","Weight":1,"Paper_List":"20825523","Original_Text":"PMID:20825523; Original text:After comparing the figures of change, significant improvements were observed in cholesterol levels (Δ=-58.5 ± 37.6 versusΔ=5.4 ± 41.2 mg/dl, p<0.0002), low-density lipoprotein levels (Δ=-48.1 ± 31.7 versusΔ=1.9 ± 42.8 mg/dl, p<0.002), dental mobility (Δ=-0.17 ± 0.11 versusΔ=-0.06 ± 0.11%, p<0.04), and the distance from the crestal alveolar bone to the cemento-enamel junction (Δ=-0.75 ± 0.7 versusΔ=0.09 ± 0.4 mm, p<0.0006) in the atorvastatin group."},{"Node1":"transcription factor AP-2 alpha","Edge_Type":"mechanism_to_anatomy","Node2":"Alveolar Process","Weight":1,"Paper_List":"20825523","Original_Text":"PMID:20825523; Original text:After comparing the figures of change, significant improvements were observed in cholesterol levels (Δ=-58.5 ± 37.6 versusΔ=5.4 ± 41.2 mg/dl, p<0.0002), low-density lipoprotein levels (Δ=-48.1 ± 31.7 versusΔ=1.9 ± 42.8 mg/dl, p<0.002), dental mobility (Δ=-0.17 ± 0.11 versusΔ=-0.06 ± 0.11%, p<0.04), and the distance from the crestal alveolar bone to the cemento-enamel junction (Δ=-0.75 ± 0.7 versusΔ=0.09 ± 0.4 mm, p<0.0006) in the atorvastatin group."},{"Node1":"Dialister Pneumosintes (Organism)","Edge_Type":"bacteria_to_mechanism","Node2":"amelogenin X-linked","Weight":1,"Paper_List":"14974812","Original_Text":"PMID:14974812; Original text:Various clinical studies have demonstrated that applying commercially available enamel matrix proteins (commercially available enamel matrix proteins) on the instrumented root surface during access flap surgery promotes clinically significant gains of clinical attachment and bone in intrabony defects."},{"Node1":"Dialister Pneumosintes (Organism)","Edge_Type":"bacteria_to_anatomy","Node2":"Bone and Bones","Weight":1,"Paper_List":"14974812","Original_Text":"PMID:14974812; Original text:Various clinical studies have demonstrated that applying commercially available enamel matrix proteins (commercially available enamel matrix proteins) on the instrumented root surface during access flap surgery promotes clinically significant gains of clinical attachment and bone in intrabony defects."},{"Node1":"amelogenin X-linked","Edge_Type":"mechanism_to_anatomy","Node2":"Bone and Bones","Weight":1,"Paper_List":"14974812","Original_Text":"PMID:14974812; Original text:Various clinical studies have demonstrated that applying commercially available enamel matrix proteins (commercially available enamel matrix proteins) on the instrumented root surface during access flap surgery promotes clinically significant gains of clinical attachment and bone in intrabony defects."},{"Node1":"Dialister Pneumosintes (Organism)","Edge_Type":"bacteria_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"14974812","Original_Text":"PMID:14974812; Original text:Both techniques resulted in clinically and statistically significant improvements between baseline and 1 year, in terms of clinical attachment level (clinical attachment level) gain, probing depth (PD) reduction, and radiographic bone fill; however, the bovine porous bone mineral test treatment showed statistically significantly greater clinical attachment level (5.8 +/- 1.1 versus 4.9 +/- 1.0) and radiographic bone (DEPTH) level gains (5.3 +/- 1.1 versus 4.3 +/- 1.5), and less increase in gingival recession (0.4 +/- 0.6 versus 0.9 +/- 0.5) than the control surgical procedure."},{"Node1":"Dialister Pneumosintes (Organism)","Edge_Type":"bacteria_to_disease","Node2":"Chronic Periodontitis","Weight":1,"Paper_List":"17980633","Original_Text":"PMID:17980633; Original text:chronic periodontitis patients presented a significantly greater mean prevalence of this species in sites with periodontal health and periodontal infection (43.5+/-7.4% and 62.1+/-6.4%, respectively) than periodontal health subjects (29.4+/-7.9%) (Mann-Whitney; p<0.01)."},{"Node1":"Dialister Pneumosintes (Organism)","Edge_Type":"bacteria_to_disease","Node2":"Hemorrhage","Weight":1,"Paper_List":"17980633","Original_Text":"PMID:17980633; Original text:Moreover, significant associations between the prevalence of D. pneumosintes and pocket depth (p=0.001), attachment loss (p=0.001) and bleeding on probing (GLM, p=0.014) were observed after adjusting for age and gender."},{"Node1":"Tooth Loss","Edge_Type":"disease_to_mechanism","Node2":"JIL-1 kinase","Weight":1,"Paper_List":"31025366","Original_Text":"PMID:31025366; Original text:Older patients (n = 8 studies; OR: 1.05, 95% CI: 1.03-1.08/year), non-compliant ones (n = 11; 1.51, 1.06-2.16), diabetics (n = 7; 1.80, 1.26-2.57), those with IL-1-polymorphism (n = 3; 1.80; 1.29-2.52) and smokers (n = 15; 1.98, 1.58-2.48) had a significantly higher risk of tooth loss."},{"Node1":"JIL-1 kinase","Edge_Type":"mechanism_to_anatomy","Node2":"Tooth","Weight":1,"Paper_List":"31025366","Original_Text":"PMID:31025366; Original text:Older patients (n = 8 studies; OR: 1.05, 95% CI: 1.03-1.08/year), non-compliant ones (n = 11; 1.51, 1.06-2.16), diabetics (n = 7; 1.80, 1.26-2.57), those with IL-1-polymorphism (n = 3; 1.80; 1.29-2.52) and smokers (n = 15; 1.98, 1.58-2.48) had a significantly higher risk of tooth loss."},{"Node1":"Bone and Bones","Edge_Type":"anatomy","Node2":"Membranes","Weight":3,"Paper_List":"24171985|22177808|15068108","Original_Text":"PMID:24171985; Original text:Treatment with a combination of collagen membrane and bone graft led to a significantly more favorable clinical outcome in intrabony defects as compared to open flap debridement alone.|PMID:22177808; Original text:Grafting of osseous defects distal to mandibular second molars with an anorganic xenograft plus a membrane predictably resulted in a significant reduction in the probing pocket depth, clinical attachment level gain, and bone fill, which suggests that grafting the extraction sites with an anorganic xenograft plus a membrane could prevent periodontal disease in the future.|PMID:15068108; Original text:Therefore, the purpose of this clinical trial was to determine whether the addition of bone graft (i.e., demineralized freeze-dried bone allograft [DFDBA]) significantly affects the outcome of collagen membrane guided tissue regeneration-based root coverage procedures."},{"Node1":"collagen","Edge_Type":"mechanism_to_anatomy","Node2":"Bone and Bones","Weight":3,"Paper_List":"24171985|20348487|15068108","Original_Text":"PMID:24171985; Original text:Treatment with a combination of collagen membrane and bone graft led to a significantly more favorable clinical outcome in intrabony defects as compared to open flap debridement alone.|PMID:20348487; Original text:We previously demonstrated that subantimicrobial-dose-doxycycline (SDD) treatment of post-menopausal osteopenic women significantly reduced periodontal disease progression, and biomarkers of collagen destruction and bone resorption locally in periodontal pockets, in a double-blind placebo-controlled clinical trial.|PMID:15068108; Original text:Therefore, the purpose of this clinical trial was to determine whether the addition of bone graft (i.e., demineralized freeze-dried bone allograft [DFDBA]) significantly affects the outcome of collagen membrane guided tissue regeneration-based root coverage procedures."},{"Node1":"collagen","Edge_Type":"mechanism_to_anatomy","Node2":"Membranes","Weight":14,"Paper_List":"24171985|18834243|18834243|9205915|9205915|20932158|22639800|11575110|24835417|24835417|15068108|12702114|12702114|1430283","Original_Text":"PMID:24171985; Original text:Treatment with a combination of collagen membrane and bone graft led to a significantly more favorable clinical outcome in intrabony defects as compared to open flap debridement alone.|PMID:18834243; Original text:The collagen membrane and membrane groups had significantly smaller PD, clinical attachment level, and DBL values than subjects treated with only open flap debridement.|PMID:18834243; Original text:No significant differences were seen between collagen membrane and membrane.|PMID:9205915; Original text:PPD reduced very significantly in all groups (p < 0.01), the highest and lowest reductions in PPD being for the polytetrafluoroethylene membrane + hydroxyapatite-collagen alloplastic graft materials and conventional flap surgery group respectively.|PMID:9205915; Original text:Similarly attachment gain for all groups was very significant (p < 0.01) and the highest and lowest attachment gains were for the polytetrafluoroethylene membrane + hydroxyapatite-collagen alloplastic graft materials and conventional flap surgery group respectively.|PMID:20932158; Original text:guided tissue regeneration treatment of intrabony defects with the collagen membrane from bovine pericardium and adjunct implantation of the new bovine bone biomaterial may result in significant clinical improvements that can be maintained over a period of 3 years, and regeneration of cementum and periodontal ligament, but without bone formation.|PMID:22639800; Original text:Er:YAG laser (YAG laser) device, or (ii) plastic curets + cotton pellets + sterile saline (sterile saline) were augmented with a natural bone mineral and covered with a collagen membrane.|PMID:11575110; Original text:This study was designed to evaluate the clinical significance of antibiotic therapy combined with guided tissue regeneration (guided tissue regeneration) therapy with a collagen membrane.|PMID:24835417; Original text:No statistically significant difference (P = 0.62) was observed comparing the frequency of clinical attachment level gain ≥4 mm between protein derivative + deproteinized bovine bone mineral (60%) and collagen membrane + deproteinized bovine bone mineral (50%) or comparing the frequency of residual PD ≥6 mm between protein derivative + deproteinized bovine bone mineral (5%) and collagen membrane + deproteinized bovine bone mineral (15%) (P = 0.21).|PMID:24835417; Original text:The mean clinical attachment level gain at sites treated with protein derivative + deproteinized bovine bone mineral was not statistically significantly different (P = 0.82) compared with collagen membrane + deproteinized bovine bone mineral (3.8 ± 1.5 versus 3.7 ± 1.2 mm).|PMID:15068108; Original text:Therefore, the purpose of this clinical trial was to determine whether the addition of bone graft (i.e., demineralized freeze-dried bone allograft [DFDBA]) significantly affects the outcome of collagen membrane guided tissue regeneration-based root coverage procedures.|PMID:12702114; Original text:The BDX + collagen membrane treatment resulted in statistically higher PD reductions (p<or=0.05) and mean clinical attachment level gains (p<0.001) than the access flap surgery one.|PMID:12702114; Original text:At 1 year after therapy, the BDX + collagen membrane group showed a reduction in mean probing depth (PD) from 9.2+/-1.3 to 3.9+/-0.7 mm (p<0.001) and a change in mean clinical attachment level (mean clinical attachment level) from 10.2+/-1.5 to 6.2+/-0.5 mm (p<0.0001).|PMID:1430283; Original text:Reductions in pocket depth and attachment level were significantly (p less than 0.001) more pronounced at 6 months in the collagen membrane sites compared to the controls."},{"Node1":"Drug Hypersensitivity","Edge_Type":"disease","Node2":"Pain","Weight":1,"Paper_List":"11128919","Original_Text":"PMID:11128919; Original text:Smokers were found to have a statistically significantly higher incidence of severe symptoms in root hypersensitivity, tooth pain, and swelling compared to non-smokers (n = 21)."},{"Node1":"Mycetoma","Edge_Type":"disease_to_anatomy","Node2":"Tooth","Weight":1,"Paper_List":"10551154","Original_Text":"PMID:10551154; Original text:In patients harboring A. actinomycetemcomitans intraorally, the IgG4 antibody reactivity against the 110-kDa protein of A. actinomycetemcomitans was associated with significantly increased survival rates of teeth and of sites not exhibiting 2 mm or more of probing attachment loss."},{"Node1":"Titanium","Edge_Type":"chemical_to_anatomy","Node2":"Germ Cell Ribonucleoprotein Granules","Weight":3,"Paper_List":"22442781|22442781|26450511","Original_Text":"PMID:22442781; Original text:Change in radiographic defect height and percent fill of the peri-implant osseous defect significantly favored patients treated with Porous titanium granules.|PMID:22442781; Original text:Reconstruction with Porous titanium granules resulted in significantly better radiographic peri-implant defect fill compared with controls; however, the results do not necessarily imply reosseointegration or osseointegration of Porous titanium granules particles.|PMID:26450511; Original text:Reconstructive surgery using porous titanium granules resulted in significantly enhanced radiographic defect fill compared with the control group."},{"Node1":"Mandible","Edge_Type":"anatomy","Node2":"Molar, Third","Weight":1,"Paper_List":"12420253","Original_Text":"PMID:12420253; Original text:The distals of second molars and third molars in the mandible were affected more often than in the maxilla (25% vs 5%, P =.0001)."},{"Node1":"Uric Acid","Edge_Type":"chemical_to_mechanism","Node2":"saliva","Weight":1,"Paper_List":"23479592","Original_Text":"PMID:23479592; Original text:Test group (Test group) showed better results after therapy compared to the placebo group with reference to plaque index (P = .004), modified gingival index (P =.002), BOP (P = .021), salivary IL-1ß (P = .05), and uric acid levels (P = .02)."},{"Node1":"Uric Acid","Edge_Type":"chemical_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"23479592","Original_Text":"PMID:23479592; Original text:Test group (Test group) showed better results after therapy compared to the placebo group with reference to plaque index (P = .004), modified gingival index (P =.002), BOP (P = .021), salivary IL-1ß (P = .05), and uric acid levels (P = .02)."},{"Node1":"Uric Acid","Edge_Type":"chemical_to_anatomy","Node2":"Salivary Glands","Weight":2,"Paper_List":"23479592|34810387","Original_Text":"PMID:23479592; Original text:Test group (Test group) showed better results after therapy compared to the placebo group with reference to plaque index (P = .004), modified gingival index (P =.002), BOP (P = .021), salivary IL-1ß (P = .05), and uric acid levels (P = .02).|PMID:34810387; Original text:After treatment, a very highly significant increase (P ≤ 0.001) in the test group and significant (P ≤ 0.05) increase in the control group were observed in salivary uric acid levels."},{"Node1":"saliva","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"23479592","Original_Text":"PMID:23479592; Original text:Test group (Test group) showed better results after therapy compared to the placebo group with reference to plaque index (P = .004), modified gingival index (P =.002), BOP (P = .021), salivary IL-1ß (P = .05), and uric acid levels (P = .02)."},{"Node1":"Neisseria Mucosa","Edge_Type":"bacteria","Node2":"Streptococcus Sobrinus","Weight":1,"Paper_List":"21605286","Original_Text":"PMID:21605286; Original text:The quantity of the cariogenic bacteria Actinomyces spp."},{"Node1":"Neisseria Mucosa","Edge_Type":"bacteria","Node2":"Streptococcus Mutans","Weight":1,"Paper_List":"21605286","Original_Text":"PMID:21605286; Original text:The quantity of the cariogenic bacteria Actinomyces spp."},{"Node1":"Neisseria Mucosa","Edge_Type":"bacteria","Node2":"Propionibacterium Acnes","Weight":1,"Paper_List":"21605286","Original_Text":"PMID:21605286; Original text:The quantity of the cariogenic bacteria Actinomyces spp."},{"Node1":"Actinomyces Sp.","Edge_Type":"bacteria","Node2":"Neisseria Mucosa","Weight":1,"Paper_List":"21605286","Original_Text":"PMID:21605286; Original text:The quantity of the cariogenic bacteria Actinomyces spp."},{"Node1":"Neisseria Mucosa","Edge_Type":"bacteria","Node2":"Veillonella Parvula","Weight":1,"Paper_List":"21605286","Original_Text":"PMID:21605286; Original text:The quantity of the cariogenic bacteria Actinomyces spp."},{"Node1":"Neisseria Mucosa","Edge_Type":"bacteria","Node2":"Parvimonas Micra","Weight":1,"Paper_List":"21605286","Original_Text":"PMID:21605286; Original text:The quantity of the cariogenic bacteria Actinomyces spp."},{"Node1":"Streptococcus Mutans","Edge_Type":"bacteria","Node2":"Streptococcus Sobrinus","Weight":1,"Paper_List":"21605286","Original_Text":"PMID:21605286; Original text:The quantity of the cariogenic bacteria Actinomyces spp."},{"Node1":"Propionibacterium Acnes","Edge_Type":"bacteria","Node2":"Streptococcus Sobrinus","Weight":1,"Paper_List":"21605286","Original_Text":"PMID:21605286; Original text:The quantity of the cariogenic bacteria Actinomyces spp."},{"Node1":"Actinomyces Sp.","Edge_Type":"bacteria","Node2":"Streptococcus Sobrinus","Weight":1,"Paper_List":"21605286","Original_Text":"PMID:21605286; Original text:The quantity of the cariogenic bacteria Actinomyces spp."},{"Node1":"Streptococcus Sobrinus","Edge_Type":"bacteria","Node2":"Veillonella Parvula","Weight":1,"Paper_List":"21605286","Original_Text":"PMID:21605286; Original text:The quantity of the cariogenic bacteria Actinomyces spp."},{"Node1":"Parvimonas Micra","Edge_Type":"bacteria","Node2":"Streptococcus Sobrinus","Weight":1,"Paper_List":"21605286","Original_Text":"PMID:21605286; Original text:The quantity of the cariogenic bacteria Actinomyces spp."},{"Node1":"Propionibacterium Acnes","Edge_Type":"bacteria","Node2":"Streptococcus Mutans","Weight":1,"Paper_List":"21605286","Original_Text":"PMID:21605286; Original text:The quantity of the cariogenic bacteria Actinomyces spp."},{"Node1":"Actinomyces Sp.","Edge_Type":"bacteria","Node2":"Streptococcus Mutans","Weight":1,"Paper_List":"21605286","Original_Text":"PMID:21605286; Original text:The quantity of the cariogenic bacteria Actinomyces spp."},{"Node1":"Streptococcus Mutans","Edge_Type":"bacteria","Node2":"Veillonella Parvula","Weight":1,"Paper_List":"21605286","Original_Text":"PMID:21605286; Original text:The quantity of the cariogenic bacteria Actinomyces spp."},{"Node1":"Parvimonas Micra","Edge_Type":"bacteria","Node2":"Streptococcus Mutans","Weight":1,"Paper_List":"21605286","Original_Text":"PMID:21605286; Original text:The quantity of the cariogenic bacteria Actinomyces spp."},{"Node1":"Actinomyces Sp.","Edge_Type":"bacteria","Node2":"Propionibacterium Acnes","Weight":1,"Paper_List":"21605286","Original_Text":"PMID:21605286; Original text:The quantity of the cariogenic bacteria Actinomyces spp."},{"Node1":"Propionibacterium Acnes","Edge_Type":"bacteria","Node2":"Veillonella Parvula","Weight":1,"Paper_List":"21605286","Original_Text":"PMID:21605286; Original text:The quantity of the cariogenic bacteria Actinomyces spp."},{"Node1":"Parvimonas Micra","Edge_Type":"bacteria","Node2":"Propionibacterium Acnes","Weight":1,"Paper_List":"21605286","Original_Text":"PMID:21605286; Original text:The quantity of the cariogenic bacteria Actinomyces spp."},{"Node1":"Actinomyces Sp.","Edge_Type":"bacteria","Node2":"Veillonella Parvula","Weight":1,"Paper_List":"21605286","Original_Text":"PMID:21605286; Original text:The quantity of the cariogenic bacteria Actinomyces spp."},{"Node1":"Actinomyces Sp.","Edge_Type":"bacteria","Node2":"Parvimonas Micra","Weight":1,"Paper_List":"21605286","Original_Text":"PMID:21605286; Original text:The quantity of the cariogenic bacteria Actinomyces spp."},{"Node1":"Parvimonas Micra","Edge_Type":"bacteria","Node2":"Veillonella Parvula","Weight":1,"Paper_List":"21605286","Original_Text":"PMID:21605286; Original text:The quantity of the cariogenic bacteria Actinomyces spp."},{"Node1":"Diclofenac","Edge_Type":"chemical_to_disease","Node2":"Pain","Weight":1,"Paper_List":"20930354","Original_Text":"PMID:20930354; Original text:Spontaneous pain was significantly reduced by diclofenac mouthwash."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"interferon gamma","Weight":1,"Paper_List":"14761115","Original_Text":"PMID:14761115; Original text:These data indicate that sites with high GCF levels of IFN-gamma are at significantly greater risk for progression of periodontitis in HIV+ patients."},{"Node1":"Chorion","Edge_Type":"anatomy","Node2":"Membranes","Weight":4,"Paper_List":"30631986|30631986|23839254|31449576","Original_Text":"PMID:30631986; Original text:Radiographic assessment showed that mean baseline bone defect area for amnion chorion membrane group was 10.39 ± 3.86 mm, which significantly reduced to 5.21 ± 2.38 after 6 months.|PMID:30631986; Original text:Six months postoperatively, amnion chorion membrane showed 3.18 ± 0.85 mm, pocket depth reduction and 2.25 ± 0.75 mm clinical attachment level gain, while demineralized bone matrix putty revealed 3.45 ± 1.08 mm pocket depth reduction and 2.73 ± 0.85 mm clinical attachment level gain.|PMID:23839254; Original text:Radiographic findings from this study demonstrated significant bone gain and density in sites treated with chorionic membrane as compared to control sites.|PMID:31449576; Original text:Group I + chorion membrane led to significant improvement in all parameters, indicating additional benefits of combination therapy."},{"Node1":"Haversian System","Edge_Type":"anatomy","Node2":"Membranes","Weight":1,"Paper_List":"30631986","Original_Text":"PMID:30631986; Original text:Six months postoperatively, amnion chorion membrane showed 3.18 ± 0.85 mm, pocket depth reduction and 2.25 ± 0.75 mm clinical attachment level gain, while demineralized bone matrix putty revealed 3.45 ± 1.08 mm pocket depth reduction and 2.73 ± 0.85 mm clinical attachment level gain."},{"Node1":"Chorion","Edge_Type":"anatomy","Node2":"Haversian System","Weight":1,"Paper_List":"30631986","Original_Text":"PMID:30631986; Original text:Six months postoperatively, amnion chorion membrane showed 3.18 ± 0.85 mm, pocket depth reduction and 2.25 ± 0.75 mm clinical attachment level gain, while demineralized bone matrix putty revealed 3.45 ± 1.08 mm pocket depth reduction and 2.73 ± 0.85 mm clinical attachment level gain."},{"Node1":"Metronidazole","Edge_Type":"chemical_to_disease","Node2":"Periodontitis","Weight":7,"Paper_List":"2191111|15295949|20447259|17618330|26034931|21062335|28796888","Original_Text":"PMID:2191111; Original text:The difference is statistically significant and shows the supplementary effect of adjunctive metronidazole in non-surgical treatment of moderate and advanced periodontitis.|PMID:15295949; Original text:Our results demonstrated the effectiveness of metronidazole as an adjunct to SRP in the treatment of chronic adult periodontitis, but clinical significance and dissemination of antibiotics should be taken into account in the evaluation of metronidazole as an alternative to SRP.|PMID:20447259; Original text:Subjects with generalized aggressive periodontitis significantly benefit from the adjunctive use of metronidazole and amoxicillin.|PMID:17618330; Original text:The significant differences between treatment and placebo groups are in line with other studies and support the considerable adjunctive benefits of the combination of amoxicillin and metronidazole in the treatment of chronic periodontitis.|PMID:26034931; Original text:Systemic administration of moxifloxacin as an adjunct to non-surgical treatment significantly improves clinical outcomes and provides comparable clinical improvement with less adverse events to that of combination of amoxicillin and metronidazole in the treatment of generalized aggressive periodontitis.|PMID:21062335; Original text:Previously, we showed that systemic metronidazole and amoxicillin significantly improved the outcomes of non-surgical debridement in generalized aggressive periodontitis patients.|PMID:28796888; Original text:While single-level analyses showed statistically significant differences, they could not be confirmed with more appropriate analyses and were too small to recommend adjunctive metronidazole, with its risk of patient side effects and environmental consequences, for the treatment of patients with severe periodontitis."},{"Node1":"interleukin 1 beta","Edge_Type":"mechanism","Node2":"interleukin 10 S homeolog","Weight":4,"Paper_List":"21261621|24555751|25415245|22288485","Original_Text":"PMID:21261621; Original text:Furthermore, the experimental protocol was able to achieve a significant modulatory effect on the levels of interleukin-1β and interleukin-10 compared with control therapy.|PMID:24555751; Original text:Intergroup analyses showed reduced anti-inflammatory interleukin-10 and increased interferon-γ and anti-inflammatory interleukin-1β levels in the 2) photosensitizer protocol when compared with the other therapies during follow-ups (P <0.05).|PMID:25415245; Original text:The test group also demonstrated significantly less periodontal pathogens of red and orange complexes and a lower interleukin-1β/interleukin-10 ratio than the control group (P < 0.05).|PMID:22288485; Original text:Analysis of Tannerella forsythia and Pg amounts, as well as interleukin-10 and interleukin-1β gingival crevicular fluid concentrations failed to demonstrate a difference between the groups (P >0.05)."},{"Node1":"chlorhexidine gluconate","Edge_Type":"chemical_to_disease","Node2":"Hemorrhage","Weight":2,"Paper_List":"1569224|27409799","Original_Text":"PMID:1569224; Original text:Within-group comparisons showed that the 0.2% chlorhexidine digluconate regime reduced A modified dichotomous plaque index, gingival bleeding index and pocket depths significantly but that the placebo group (the placebo group) only achieved a significant reduction in the pocket depths.|PMID:27409799; Original text:The most significant improvements were found concerning plaque index in different chlorhexidine gluconate solution with root planing and different chlorhexidine gluconate gel with root planing groups over controls at one month recall, as well as concerning bleeding index and pocket depth in different chlorhexidine gluconate chip with root planing group over root planing alone at three-month recall."},{"Node1":"chlorhexidine gluconate","Edge_Type":"chemical_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"1569224","Original_Text":"PMID:1569224; Original text:Within-group comparisons showed that the 0.2% chlorhexidine digluconate regime reduced A modified dichotomous plaque index, gingival bleeding index and pocket depths significantly but that the placebo group (the placebo group) only achieved a significant reduction in the pocket depths."},{"Node1":"Meclofenamic Acid","Edge_Type":"chemical","Node2":"Sodium","Weight":1,"Paper_List":"1810525","Original_Text":"PMID:1810525; Original text:After initial testing, meclofenamate sodium was found to be significantly more effective than piroxicam-beta-cyclodextrin."},{"Node1":"Piroxicam","Edge_Type":"chemical","Node2":"Sodium","Weight":1,"Paper_List":"1810525","Original_Text":"PMID:1810525; Original text:After initial testing, meclofenamate sodium was found to be significantly more effective than piroxicam-beta-cyclodextrin."},{"Node1":"Sodium","Edge_Type":"chemical","Node2":"betadex","Weight":1,"Paper_List":"1810525","Original_Text":"PMID:1810525; Original text:After initial testing, meclofenamate sodium was found to be significantly more effective than piroxicam-beta-cyclodextrin."},{"Node1":"Meclofenamic Acid","Edge_Type":"chemical","Node2":"Piroxicam","Weight":1,"Paper_List":"1810525","Original_Text":"PMID:1810525; Original text:After initial testing, meclofenamate sodium was found to be significantly more effective than piroxicam-beta-cyclodextrin."},{"Node1":"Meclofenamic Acid","Edge_Type":"chemical","Node2":"betadex","Weight":1,"Paper_List":"1810525","Original_Text":"PMID:1810525; Original text:After initial testing, meclofenamate sodium was found to be significantly more effective than piroxicam-beta-cyclodextrin."},{"Node1":"Piroxicam","Edge_Type":"chemical","Node2":"betadex","Weight":1,"Paper_List":"1810525","Original_Text":"PMID:1810525; Original text:After initial testing, meclofenamate sodium was found to be significantly more effective than piroxicam-beta-cyclodextrin."},{"Node1":"Metronidazole","Edge_Type":"chemical_to_mechanism","Node2":"matrix metallopeptidase 8 S homeolog","Weight":1,"Paper_List":"26007680","Original_Text":"PMID:26007680; Original text:Within the limits of the present study, it may be suggested that in patients with aggressive periodontitis, nonsurgical periodontal therapy in conjunction with adjunctive systemic administration of amoxicilin and metronidazole is more effective in reducing GCF MMP-8 levels compared to the adjunctive use of photodynamic therapy."},{"Node1":"Amoxicillin","Edge_Type":"chemical_to_mechanism","Node2":"matrix metallopeptidase 8 S homeolog","Weight":1,"Paper_List":"26007680","Original_Text":"PMID:26007680; Original text:Within the limits of the present study, it may be suggested that in patients with aggressive periodontitis, nonsurgical periodontal therapy in conjunction with adjunctive systemic administration of amoxicilin and metronidazole is more effective in reducing GCF MMP-8 levels compared to the adjunctive use of photodynamic therapy."},{"Node1":"nejire","Edge_Type":"mechanism_to_anatomy","Node2":"Peripheral Blood Stem Cells","Weight":1,"Paper_List":"24974939","Original_Text":"PMID:24974939; Original text:Serum C-reactive protein levels, lipid levels and peripheral blood counts were obtained for all three groups."},{"Node1":"Indocyanine Green","Edge_Type":"chemical_to_disease","Node2":"Periodontitis","Weight":1,"Paper_List":"31939363","Original_Text":"PMID:31939363; Original text:Indocyanine Green can act as an alternative to other photosensitizers in photodynamic therapy as an adjunct to control group in the treatment of chronic periodontitis."},{"Node1":"Gingiva","Edge_Type":"anatomy","Node2":"Tooth","Weight":2,"Paper_List":"18298219|21121958","Original_Text":"PMID:18298219; Original text:The the pocket depths and the gingival index of teeth with brackets showed significantly lower values in comparison with teeth treated with bands (P = .0001).|PMID:21121958; Original text:periimplant sulcular fluidthe osmotic pressure positively correlated with the clinical parameters of implants (P<0.01 for Silness-Löe plaque index, Löe-Silness gingival index and Bthe osmotic pressure; P<0.05 for pocket depth and attachment level), and gingival crevicular fluidthe osmotic pressure positively correlated with the clinical parameters of teeth (P<0.01 for pocket depth; P<0.05 for Silness-Löe plaque index, Löe-Silness gingival index, Bthe osmotic pressure and attachment level)."},{"Node1":"Myocardial Infarction","Edge_Type":"disease_to_anatomy","Node2":"Myocardium","Weight":1,"Paper_List":"11216961","Original_Text":"PMID:11216961; Original text:In Cox proportional hazards regression analysis adjusted for age and treatment assignment, physicians who reported periodontal disease at baseline had slightly elevated, but statistically nonsignificant, relative risks (statistically nonsignificant, relative risks) of nonfatal myocardial infarction, (statistically nonsignificant, relative risks, 1.12; 95% confidence interval [CI], 0.92 to 1.36), nonfatal stroke (statistically nonsignificant, relative risks, 1.10; CI, 0.88 to 1.37) and cardiovascular death (statistically nonsignificant, relative risks, 1.20; CI, 0.97 to 1.49)."},{"Node1":"calcium ","Edge_Type":"nutrient_to_chemical","Node2":"Calcium Hydroxide","Weight":2,"Paper_List":"21956349|27452293","Original_Text":"PMID:21956349; Original text:The use of calcium hydroxide in the intermediary dressings allows the neutralization of acidic compounds, alkaline phosphatase activation creating a significant development of the antibacterial action.|PMID:27452293; Original text:Streptococci were significantly reduced in both groups, and E. faecalis was found in only 1 S2 sample and not in calcium hydroxide medication."},{"Node1":"calcium ","Edge_Type":"nutrient_to_mechanism","Node2":"Photophobe","Weight":1,"Paper_List":"21956349","Original_Text":"PMID:21956349; Original text:The use of calcium hydroxide in the intermediary dressings allows the neutralization of acidic compounds, alkaline phosphatase activation creating a significant development of the antibacterial action."},{"Node1":"Calcium Hydroxide","Edge_Type":"chemical_to_mechanism","Node2":"Photophobe","Weight":1,"Paper_List":"21956349","Original_Text":"PMID:21956349; Original text:The use of calcium hydroxide in the intermediary dressings allows the neutralization of acidic compounds, alkaline phosphatase activation creating a significant development of the antibacterial action."},{"Node1":"Durapatite","Edge_Type":"chemical","Node2":"polytetrafluoroethylene-silicone","Weight":2,"Paper_List":"9205915|9205915","Original_Text":"PMID:9205915; Original text:PPD reduced very significantly in all groups (p < 0.01), the highest and lowest reductions in PPD being for the polytetrafluoroethylene membrane + hydroxyapatite-collagen alloplastic graft materials and conventional flap surgery group respectively.|PMID:9205915; Original text:Similarly attachment gain for all groups was very significant (p < 0.01) and the highest and lowest attachment gains were for the polytetrafluoroethylene membrane + hydroxyapatite-collagen alloplastic graft materials and conventional flap surgery group respectively."},{"Node1":"Durapatite","Edge_Type":"chemical_to_mechanism","Node2":"collagen","Weight":3,"Paper_List":"9205915|9205915|15086616","Original_Text":"PMID:9205915; Original text:PPD reduced very significantly in all groups (p < 0.01), the highest and lowest reductions in PPD being for the polytetrafluoroethylene membrane + hydroxyapatite-collagen alloplastic graft materials and conventional flap surgery group respectively.|PMID:9205915; Original text:Similarly attachment gain for all groups was very significant (p < 0.01) and the highest and lowest attachment gains were for the polytetrafluoroethylene membrane + hydroxyapatite-collagen alloplastic graft materials and conventional flap surgery group respectively.|PMID:15086616; Original text:The results of the present study indicate that both collagen/chondroitin sulphate biomaterial and a bovine-derived hydroxyapatite xenograft grafting biomaterials have determined a clinically and statistically significant improvement in terms of clinical attachment level gain, pocket probing depth reduction and radiographic the defect gain when used for the treatment of deep intra-osseous defects."},{"Node1":"polytetrafluoroethylene-silicone","Edge_Type":"chemical_to_mechanism","Node2":"collagen","Weight":2,"Paper_List":"9205915|9205915","Original_Text":"PMID:9205915; Original text:PPD reduced very significantly in all groups (p < 0.01), the highest and lowest reductions in PPD being for the polytetrafluoroethylene membrane + hydroxyapatite-collagen alloplastic graft materials and conventional flap surgery group respectively.|PMID:9205915; Original text:Similarly attachment gain for all groups was very significant (p < 0.01) and the highest and lowest attachment gains were for the polytetrafluoroethylene membrane + hydroxyapatite-collagen alloplastic graft materials and conventional flap surgery group respectively."},{"Node1":"Durapatite","Edge_Type":"chemical_to_anatomy","Node2":"Membranes","Weight":2,"Paper_List":"9205915|9205915","Original_Text":"PMID:9205915; Original text:PPD reduced very significantly in all groups (p < 0.01), the highest and lowest reductions in PPD being for the polytetrafluoroethylene membrane + hydroxyapatite-collagen alloplastic graft materials and conventional flap surgery group respectively.|PMID:9205915; Original text:Similarly attachment gain for all groups was very significant (p < 0.01) and the highest and lowest attachment gains were for the polytetrafluoroethylene membrane + hydroxyapatite-collagen alloplastic graft materials and conventional flap surgery group respectively."},{"Node1":"polytetrafluoroethylene-silicone","Edge_Type":"chemical_to_anatomy","Node2":"Membranes","Weight":4,"Paper_List":"9205915|9205915|10743863|10743863","Original_Text":"PMID:9205915; Original text:PPD reduced very significantly in all groups (p < 0.01), the highest and lowest reductions in PPD being for the polytetrafluoroethylene membrane + hydroxyapatite-collagen alloplastic graft materials and conventional flap surgery group respectively.|PMID:9205915; Original text:Similarly attachment gain for all groups was very significant (p < 0.01) and the highest and lowest attachment gains were for the polytetrafluoroethylene membrane + hydroxyapatite-collagen alloplastic graft materials and conventional flap surgery group respectively.|PMID:10743863; Original text:The results of this study indicated that there was no clinically significant difference in treatment outcomes following GTR treatment of intrabony defects with citric acid ester softened polylactic acid membranes as compared to non-resorbable expanded polytetrafluoroethylene barriers.|PMID:10743863; Original text:Thus, no clinically significant difference in treatment outcomes was observed following GTR treatment of intrabony defects with citric acid ester softened polylactic acid membranes or non-resorbable expanded polytetrafluoroethylene barriers."},{"Node1":"Hemorrhage","Edge_Type":"disease","Node2":"Inflammation","Weight":2,"Paper_List":"3925112|22835005","Original_Text":"PMID:3925112; Original text:In both groups there was a significant decrease in plaque scores, gingival inflammation, gingival bleeding and probeable depths for all sites and for affected sites.|PMID:22835005; Original text:After treatment, a major reduction in periodontal inflammation was observed in the test group, with bleeding on probing decreasing from 49.62% of sites to 11.66% of sites (p < 0.001)."},{"Node1":"Periodontal Abscess","Edge_Type":"disease","Node2":"Periodontitis","Weight":1,"Paper_List":"29023611","Original_Text":"PMID:29023611; Original text:Use of autologous platelet-rich fibrin significantly enhances the clinical and radiographic outcomes of open flap debridement in the treatment of periodontal intraosseous defects in patients affected by localized aggressive periodontitis."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"Plateletcrit","Weight":1,"Paper_List":"29023611","Original_Text":"PMID:29023611; Original text:Use of autologous platelet-rich fibrin significantly enhances the clinical and radiographic outcomes of open flap debridement in the treatment of periodontal intraosseous defects in patients affected by localized aggressive periodontitis."},{"Node1":"Periodontal Abscess","Edge_Type":"disease_to_mechanism","Node2":"Plateletcrit","Weight":1,"Paper_List":"29023611","Original_Text":"PMID:29023611; Original text:Use of autologous platelet-rich fibrin significantly enhances the clinical and radiographic outcomes of open flap debridement in the treatment of periodontal intraosseous defects in patients affected by localized aggressive periodontitis."},{"Node1":"Myocardial Infarction","Edge_Type":"disease_to_anatomy","Node2":"Tooth","Weight":1,"Paper_List":"28645686","Original_Text":"PMID:28645686; Original text:A significant relationship was observed with atherothrombotic cardiovascular disease in 10 out of 10 studies addressing the degree of oral hygiene, in 14 of 17 that included loss of teeth, in 6 of 12 that analysed caries and in 11 of 15 that included chronic apical periodontitis."},{"Node1":"Obesity","Edge_Type":"disease_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"33904994","Original_Text":"PMID:33904994; Original text:However, meta-analysis showed that among individuals with periodontitis, significantly higher levels of gingival inflammation are observed in those with obesity (n of individuals=240) when compared to those who were not obese (n of individuals=574)"},{"Node1":"Orofaciodigital Syndromes","Edge_Type":"disease_to_anatomy","Node2":"Gonadotrophs","Weight":1,"Paper_List":"19192047","Original_Text":"PMID:19192047; Original text:Among the menopausal or postmenopausal women with mouth syndrome, the follicle stimulating hormone (FSH) level was significantly higher, but the estradiol level was significantly lower."},{"Node1":"Osteoporosis","Edge_Type":"disease_to_anatomy","Node2":"Bone and Bones","Weight":1,"Paper_List":"20348487","Original_Text":"PMID:20348487; Original text:In subsets of the study population, adjunctive SDD significantly reduced serum biomarkers of bone resorption (biomarkers of bone formation were unaffected), consistent with reduced risk of future systemic bone loss in these post-menopausal women not yet on anti-osteoporotic drugs."},{"Node1":"Osteoporosis","Edge_Type":"disease_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"22151499","Original_Text":"PMID:22151499; Original text:Mean Gingival index, bleeding on probing, clinical attachment loss and recession were significantly greater for osteoporotic women than women with normal Areal bone mineral density (P = 0.002, P = 0.01, P = 0.04, respectively)."},{"Node1":"Neoplasms","Edge_Type":"disease_to_mechanism","Node2":"tumor necrosis factor L homeolog","Weight":3,"Paper_List":"19228095|19228095|18018468","Original_Text":"PMID:19228095; Original text:Non-surgical periodontal treatment with photodynamic therapy or root planing led to statistically significant reductions in tumor necrosis factor-alpha level 30 days following treatment.|PMID:19228095; Original text:There were similar levels of tumor necrosis factor-alpha and nuclear factor-kappa B ligand at the different time points in both groups, with no statistically significant differences.|PMID:18018468; Original text:The circulating levels of tumor necrosis factor-alpha decreased statistically significantly in the group"},{"Node1":"Necrosis","Edge_Type":"disease_to_mechanism","Node2":"tumor necrosis factor L homeolog","Weight":3,"Paper_List":"19228095|19228095|18018468","Original_Text":"PMID:19228095; Original text:Non-surgical periodontal treatment with photodynamic therapy or root planing led to statistically significant reductions in tumor necrosis factor-alpha level 30 days following treatment.|PMID:19228095; Original text:There were similar levels of tumor necrosis factor-alpha and nuclear factor-kappa B ligand at the different time points in both groups, with no statistically significant differences.|PMID:18018468; Original text:The circulating levels of tumor necrosis factor-alpha decreased statistically significantly in the group"},{"Node1":"TNF superfamily member 11","Edge_Type":"mechanism","Node2":"tumor necrosis factor L homeolog","Weight":1,"Paper_List":"19228095","Original_Text":"PMID:19228095; Original text:There were similar levels of tumor necrosis factor-alpha and nuclear factor-kappa B ligand at the different time points in both groups, with no statistically significant differences."},{"Node1":"Neoplasms","Edge_Type":"disease_to_mechanism","Node2":"TNF superfamily member 11","Weight":1,"Paper_List":"19228095","Original_Text":"PMID:19228095; Original text:There were similar levels of tumor necrosis factor-alpha and nuclear factor-kappa B ligand at the different time points in both groups, with no statistically significant differences."},{"Node1":"Necrosis","Edge_Type":"disease_to_mechanism","Node2":"TNF superfamily member 11","Weight":1,"Paper_List":"19228095","Original_Text":"PMID:19228095; Original text:There were similar levels of tumor necrosis factor-alpha and nuclear factor-kappa B ligand at the different time points in both groups, with no statistically significant differences."},{"Node1":"polylevolactic acid","Edge_Type":"chemical","Node2":"polytetrafluoroethylene-silicone","Weight":4,"Paper_List":"9527556|9660331|10743863|10743863","Original_Text":"PMID:9527556; Original text:Two-sample t-either a PLA comparisons of PD and clinical attachment level measurements between barrier device covered sites at baseline (PD: expanded polytetrafluoroethylene, 2.32+/-0.51; polylactic acid, 2.59+/-0.74; clinical attachment level: expanded polytetrafluoroethylene, 2.71+/-0.66; polylactic acid, 2.59+/-0.65 mm), and at one year (PD: expanded polytetrafluoroethylene, 2.14+/-0.37; polylactic acid, 2.07+/-0.56; clinical attachment level: expanded polytetrafluoroethylene, 3.14+/-1.05; polylactic acid, 2.75+/-0.73 mm) were not statistically different (P > 0.05).|PMID:9660331; Original text:Treatment with both types of barriers produced significant changes from baseline for all parameters, except in the expanded polytetrafluoroethylene group for the amount of bony crest resorption (P = 0.055) and in the polylactic acid group for increased recession (P = 0.109).|PMID:10743863; Original text:The results of this study indicated that there was no clinically significant difference in treatment outcomes following GTR treatment of intrabony defects with citric acid ester softened polylactic acid membranes as compared to non-resorbable expanded polytetrafluoroethylene barriers.|PMID:10743863; Original text:Thus, no clinically significant difference in treatment outcomes was observed following GTR treatment of intrabony defects with citric acid ester softened polylactic acid membranes or non-resorbable expanded polytetrafluoroethylene barriers."},{"Node1":"Hemorrhage","Edge_Type":"disease_to_mechanism","Node2":"JIL-1 kinase","Weight":1,"Paper_List":"31543299","Original_Text":"PMID:31543299; Original text:All examined teeth showed modest reductions in probing pocket depth (pocket depth), clinical attachment loss (clinical attachment loss), bleeding upon probing (BOP), and plaque score at 4-6 weeks and 6 months and significant reductions in IL-1β and MMP-8 at 6 months."},{"Node1":"Hemorrhage","Edge_Type":"disease_to_mechanism","Node2":"matrix metallopeptidase 8","Weight":1,"Paper_List":"31543299","Original_Text":"PMID:31543299; Original text:All examined teeth showed modest reductions in probing pocket depth (pocket depth), clinical attachment loss (clinical attachment loss), bleeding upon probing (BOP), and plaque score at 4-6 weeks and 6 months and significant reductions in IL-1β and MMP-8 at 6 months."},{"Node1":"Dinoprostone","Edge_Type":"chemical_to_mechanism","Node2":"interleukin 1 beta L homeolog","Weight":1,"Paper_List":"10703660","Original_Text":"PMID:10703660; Original text:Oral irrigation plus routine oral hygiene resulted in a significant reduction in pocket depths, BOP, gingival index and plaque index, as well as interleukin-1 beta levels by 7 days and prostaglandin-E2 levels by 14 days, relative to routine oral hygiene or no oral hygiene."},{"Node1":"interleukin 1 beta L homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"10703660","Original_Text":"PMID:10703660; Original text:Oral irrigation plus routine oral hygiene resulted in a significant reduction in pocket depths, BOP, gingival index and plaque index, as well as interleukin-1 beta levels by 7 days and prostaglandin-E2 levels by 14 days, relative to routine oral hygiene or no oral hygiene."},{"Node1":"Malondialdehyde","Edge_Type":"chemical","Node2":"Nitric Oxide","Weight":1,"Paper_List":"25477703","Original_Text":"PMID:25477703; Original text:Our results showed that periodontitis patients had significantly lower levels of total antioxidant capacity (SMD = -2.02; 95% CI: -3.08, -0.96; P = 0.000) and higher levels of malondialdehyde (SMD = 0.99; 95% CI: 0.12, 1.86; P = 0.026) and nitric oxide (SMD = 4.98; 95% CI: 2.33, 7.63; P = 0.000) than periodontal healthy control."},{"Node1":"Mastocytosis, Systemic","Edge_Type":"disease","Node2":"Periodontitis","Weight":1,"Paper_List":"25477703","Original_Text":"PMID:25477703; Original text:In conclusion, our meta-analysis showed that chronic periodontitis is significantly associated with circulating levels of three oxidative stress biomarkers, indicating a role of chronic periodontitis in systemic diseases."},{"Node1":"interleukin 10 S homeolog","Edge_Type":"mechanism","Node2":"interleukin 6 cytokine family signal transducer","Weight":2,"Paper_List":"26093363|22126282","Original_Text":"PMID:26093363; Original text:Periodontal treatment significantly reduced the gingival crevicular fluid levels of IL-1β, IL-10, IL-12p70 and IL-6 at 28 weeks' GA compared with controls, while levels of MCP-1, IL-8 and TNF-α exhibited a significant gestational age-dependent increase, but no treatment response.|PMID:22126282; Original text:Significant reductions in crevicular fluid GM-CSF, IL-1β and the ratio IL-1β/IL-10 and increases in crevicular fluid IL-6 were detected after therapy."},{"Node1":"interleukin 6 cytokine family signal transducer","Edge_Type":"mechanism","Node2":"tumor necrosis factor receptor superfamily, member a","Weight":2,"Paper_List":"26093363|24111886","Original_Text":"PMID:26093363; Original text:Periodontal treatment significantly reduced the gingival crevicular fluid levels of IL-1β, IL-10, IL-12p70 and IL-6 at 28 weeks' GA compared with controls, while levels of MCP-1, IL-8 and TNF-α exhibited a significant gestational age-dependent increase, but no treatment response.|PMID:24111886; Original text:Meta-analyses demonstrated significant weighted mean difference (significant weighted mean difference) for hsCRP (-0.50 mg/l, 95% CI:-0.78; -0.22), IL-6 (-0.48 ng/l, 95% CI: -0.90; -0.06), TNF-α (-0.75 pg/ml, 95% CI: -1.34; -0.17), fibrinogen (-0.47 g/l, 95% CI: -0.76; -0.17), total cholesterol (-0.11 mmol/l, 95% CI: -0.21; -0.01) and HDL-C (0.04 mmol/l, 95% CI: 0.03; 0.06) favouring periodontal intervention."},{"Node1":"JIL-1 kinase","Edge_Type":"mechanism","Node2":"interleukin 10 S homeolog","Weight":2,"Paper_List":"26093363|22126282","Original_Text":"PMID:26093363; Original text:Periodontal treatment significantly reduced the gingival crevicular fluid levels of IL-1β, IL-10, IL-12p70 and IL-6 at 28 weeks' GA compared with controls, while levels of MCP-1, IL-8 and TNF-α exhibited a significant gestational age-dependent increase, but no treatment response.|PMID:22126282; Original text:Significant reductions in crevicular fluid GM-CSF, IL-1β and the ratio IL-1β/IL-10 and increases in crevicular fluid IL-6 were detected after therapy."},{"Node1":"interleukin 10 S homeolog","Edge_Type":"mechanism","Node2":"tumor necrosis factor receptor superfamily, member a","Weight":1,"Paper_List":"26093363","Original_Text":"PMID:26093363; Original text:Periodontal treatment significantly reduced the gingival crevicular fluid levels of IL-1β, IL-10, IL-12p70 and IL-6 at 28 weeks' GA compared with controls, while levels of MCP-1, IL-8 and TNF-α exhibited a significant gestational age-dependent increase, but no treatment response."},{"Node1":"interleukin 10 S homeolog","Edge_Type":"mechanism","Node2":"interleukin 8-like 2","Weight":1,"Paper_List":"26093363","Original_Text":"PMID:26093363; Original text:Periodontal treatment significantly reduced the gingival crevicular fluid levels of IL-1β, IL-10, IL-12p70 and IL-6 at 28 weeks' GA compared with controls, while levels of MCP-1, IL-8 and TNF-α exhibited a significant gestational age-dependent increase, but no treatment response."},{"Node1":"interleukin 10 S homeolog","Edge_Type":"mechanism","Node2":"mast cell protease 1","Weight":1,"Paper_List":"26093363","Original_Text":"PMID:26093363; Original text:Periodontal treatment significantly reduced the gingival crevicular fluid levels of IL-1β, IL-10, IL-12p70 and IL-6 at 28 weeks' GA compared with controls, while levels of MCP-1, IL-8 and TNF-α exhibited a significant gestational age-dependent increase, but no treatment response."},{"Node1":"JIL-1 kinase","Edge_Type":"mechanism","Node2":"tumor necrosis factor receptor superfamily, member a","Weight":1,"Paper_List":"26093363","Original_Text":"PMID:26093363; Original text:Periodontal treatment significantly reduced the gingival crevicular fluid levels of IL-1β, IL-10, IL-12p70 and IL-6 at 28 weeks' GA compared with controls, while levels of MCP-1, IL-8 and TNF-α exhibited a significant gestational age-dependent increase, but no treatment response."},{"Node1":"JIL-1 kinase","Edge_Type":"mechanism","Node2":"mast cell protease 1","Weight":2,"Paper_List":"26093363|27027257","Original_Text":"PMID:26093363; Original text:Periodontal treatment significantly reduced the gingival crevicular fluid levels of IL-1β, IL-10, IL-12p70 and IL-6 at 28 weeks' GA compared with controls, while levels of MCP-1, IL-8 and TNF-α exhibited a significant gestational age-dependent increase, but no treatment response.|PMID:27027257; Original text:GCF levels of IL-1β, IL-6, IFN-γ and MCP-1/CCL2 were significantly higher in subjects diagnosed with chronic periodontitis than periodontally healthy subjects."},{"Node1":"interleukin 8-like 2","Edge_Type":"mechanism","Node2":"tumor necrosis factor receptor superfamily, member a","Weight":1,"Paper_List":"26093363","Original_Text":"PMID:26093363; Original text:Periodontal treatment significantly reduced the gingival crevicular fluid levels of IL-1β, IL-10, IL-12p70 and IL-6 at 28 weeks' GA compared with controls, while levels of MCP-1, IL-8 and TNF-α exhibited a significant gestational age-dependent increase, but no treatment response."},{"Node1":"mast cell protease 1","Edge_Type":"mechanism","Node2":"tumor necrosis factor receptor superfamily, member a","Weight":1,"Paper_List":"26093363","Original_Text":"PMID:26093363; Original text:Periodontal treatment significantly reduced the gingival crevicular fluid levels of IL-1β, IL-10, IL-12p70 and IL-6 at 28 weeks' GA compared with controls, while levels of MCP-1, IL-8 and TNF-α exhibited a significant gestational age-dependent increase, but no treatment response."},{"Node1":"interleukin 10 S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":2,"Paper_List":"26093363|22288485","Original_Text":"PMID:26093363; Original text:Periodontal treatment significantly reduced the gingival crevicular fluid levels of IL-1β, IL-10, IL-12p70 and IL-6 at 28 weeks' GA compared with controls, while levels of MCP-1, IL-8 and TNF-α exhibited a significant gestational age-dependent increase, but no treatment response.|PMID:22288485; Original text:Analysis of Tannerella forsythia and Pg amounts, as well as interleukin-10 and interleukin-1β gingival crevicular fluid concentrations failed to demonstrate a difference between the groups (P >0.05)."},{"Node1":"interleukin 10 S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":3,"Paper_List":"26093363|22126282|22288485","Original_Text":"PMID:26093363; Original text:Periodontal treatment significantly reduced the gingival crevicular fluid levels of IL-1β, IL-10, IL-12p70 and IL-6 at 28 weeks' GA compared with controls, while levels of MCP-1, IL-8 and TNF-α exhibited a significant gestational age-dependent increase, but no treatment response.|PMID:22126282; Original text:Significant reductions in crevicular fluid GM-CSF, IL-1β and the ratio IL-1β/IL-10 and increases in crevicular fluid IL-6 were detected after therapy.|PMID:22288485; Original text:Analysis of Tannerella forsythia and Pg amounts, as well as interleukin-10 and interleukin-1β gingival crevicular fluid concentrations failed to demonstrate a difference between the groups (P >0.05)."},{"Node1":"tumor necrosis factor receptor superfamily, member a","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"26093363","Original_Text":"PMID:26093363; Original text:Periodontal treatment significantly reduced the gingival crevicular fluid levels of IL-1β, IL-10, IL-12p70 and IL-6 at 28 weeks' GA compared with controls, while levels of MCP-1, IL-8 and TNF-α exhibited a significant gestational age-dependent increase, but no treatment response."},{"Node1":"tumor necrosis factor receptor superfamily, member a","Edge_Type":"mechanism_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"26093363","Original_Text":"PMID:26093363; Original text:Periodontal treatment significantly reduced the gingival crevicular fluid levels of IL-1β, IL-10, IL-12p70 and IL-6 at 28 weeks' GA compared with controls, while levels of MCP-1, IL-8 and TNF-α exhibited a significant gestational age-dependent increase, but no treatment response."},{"Node1":"interleukin 8-like 2","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"26093363","Original_Text":"PMID:26093363; Original text:Periodontal treatment significantly reduced the gingival crevicular fluid levels of IL-1β, IL-10, IL-12p70 and IL-6 at 28 weeks' GA compared with controls, while levels of MCP-1, IL-8 and TNF-α exhibited a significant gestational age-dependent increase, but no treatment response."},{"Node1":"interleukin 8-like 2","Edge_Type":"mechanism_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"26093363","Original_Text":"PMID:26093363; Original text:Periodontal treatment significantly reduced the gingival crevicular fluid levels of IL-1β, IL-10, IL-12p70 and IL-6 at 28 weeks' GA compared with controls, while levels of MCP-1, IL-8 and TNF-α exhibited a significant gestational age-dependent increase, but no treatment response."},{"Node1":"mast cell protease 1","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"26093363","Original_Text":"PMID:26093363; Original text:Periodontal treatment significantly reduced the gingival crevicular fluid levels of IL-1β, IL-10, IL-12p70 and IL-6 at 28 weeks' GA compared with controls, while levels of MCP-1, IL-8 and TNF-α exhibited a significant gestational age-dependent increase, but no treatment response."},{"Node1":"mast cell protease 1","Edge_Type":"mechanism_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"26093363","Original_Text":"PMID:26093363; Original text:Periodontal treatment significantly reduced the gingival crevicular fluid levels of IL-1β, IL-10, IL-12p70 and IL-6 at 28 weeks' GA compared with controls, while levels of MCP-1, IL-8 and TNF-α exhibited a significant gestational age-dependent increase, but no treatment response."},{"Node1":"Tetracycline","Edge_Type":"chemical_to_disease","Node2":"Chronic Periodontitis","Weight":2,"Paper_List":"26323451|14971255","Original_Text":"PMID:26323451; Original text:Clinical and biochemical variables showed a more favorable outcome when root planing was combined with local drug delivery of tetracycline fibers in management of patients suffering from chronic periodontitis.|PMID:14971255; Original text:Evidence to date suggests that the use of citric acid, tetracycline, or ethylenediaminetetraacetic acid to modify the root surface provides no benefit of clinical significance to regeneration in patients with chronic periodontitis."},{"Node1":"pregnancy-zone protein L homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"26323451","Original_Text":"PMID:26323451; Original text:Alpha-2-macroglobulin was significantly reduced in gingival crevicular fluid by root planing and root planing and local drug delivery after 90 days (p < 0.001)."},{"Node1":"pregnancy-zone protein L homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"26323451","Original_Text":"PMID:26323451; Original text:Alpha-2-macroglobulin was significantly reduced in gingival crevicular fluid by root planing and root planing and local drug delivery after 90 days (p < 0.001)."},{"Node1":"Minocycline","Edge_Type":"chemical_to_disease","Node2":"Hemorrhage","Weight":2,"Paper_List":"15613075|12789964","Original_Text":"PMID:15613075; Original text:In this 18-week clinical trial, the results suggested that scaling/root planing with adjunctive subgingival administration of minocycline ointment has a significantly better and prolonged effect compared to scaling/root planing alone on the reduction of probing depth, clinical attachment loss, gingival index, and interleukin-1beta content, but not on bleeding on probing.|PMID:12789964; Original text:Similarly, significant improvements in clinical attachment level and percent bleeding on probing were observed among advanced periodontitis patients treated with SRP plus minocycline microspheres relative to controls."},{"Node1":"Minocycline","Edge_Type":"chemical_to_mechanism","Node2":"interleukin 1 beta","Weight":1,"Paper_List":"15613075","Original_Text":"PMID:15613075; Original text:In this 18-week clinical trial, the results suggested that scaling/root planing with adjunctive subgingival administration of minocycline ointment has a significantly better and prolonged effect compared to scaling/root planing alone on the reduction of probing depth, clinical attachment loss, gingival index, and interleukin-1beta content, but not on bleeding on probing."},{"Node1":"Minocycline","Edge_Type":"chemical_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"15613075","Original_Text":"PMID:15613075; Original text:In this 18-week clinical trial, the results suggested that scaling/root planing with adjunctive subgingival administration of minocycline ointment has a significantly better and prolonged effect compared to scaling/root planing alone on the reduction of probing depth, clinical attachment loss, gingival index, and interleukin-1beta content, but not on bleeding on probing."},{"Node1":"Hemorrhage","Edge_Type":"disease_to_mechanism","Node2":"interleukin 1 beta","Weight":1,"Paper_List":"15613075","Original_Text":"PMID:15613075; Original text:In this 18-week clinical trial, the results suggested that scaling/root planing with adjunctive subgingival administration of minocycline ointment has a significantly better and prolonged effect compared to scaling/root planing alone on the reduction of probing depth, clinical attachment loss, gingival index, and interleukin-1beta content, but not on bleeding on probing."},{"Node1":"Enterococcus Faecalis (Organism)","Edge_Type":"bacteria","Node2":"Streptococci Sp.","Weight":1,"Paper_List":"27452293","Original_Text":"PMID:27452293; Original text:Streptococci were significantly reduced in both groups, and E. faecalis was found in only 1 S2 sample and not in calcium hydroxide medication."},{"Node1":"Streptococci Sp.","Edge_Type":"bacteria_to_nutrient","Node2":"calcium ","Weight":1,"Paper_List":"27452293","Original_Text":"PMID:27452293; Original text:Streptococci were significantly reduced in both groups, and E. faecalis was found in only 1 S2 sample and not in calcium hydroxide medication."},{"Node1":"Enterococcus Faecalis (Organism)","Edge_Type":"bacteria_to_nutrient","Node2":"calcium ","Weight":1,"Paper_List":"27452293","Original_Text":"PMID:27452293; Original text:Streptococci were significantly reduced in both groups, and E. faecalis was found in only 1 S2 sample and not in calcium hydroxide medication."},{"Node1":"Streptococci Sp.","Edge_Type":"bacteria_to_chemical","Node2":"Calcium Hydroxide","Weight":1,"Paper_List":"27452293","Original_Text":"PMID:27452293; Original text:Streptococci were significantly reduced in both groups, and E. faecalis was found in only 1 S2 sample and not in calcium hydroxide medication."},{"Node1":"Enterococcus Faecalis (Organism)","Edge_Type":"bacteria_to_chemical","Node2":"Calcium Hydroxide","Weight":1,"Paper_List":"27452293","Original_Text":"PMID:27452293; Original text:Streptococci were significantly reduced in both groups, and E. faecalis was found in only 1 S2 sample and not in calcium hydroxide medication."},{"Node1":"Oxygen","Edge_Type":"chemical_to_anatomy","Node2":"Gingiva","Weight":2,"Paper_List":"12670118|11966926","Original_Text":"PMID:12670118; Original text:Highly significant differences in Gingival Indices (Gingival Indices), Sulcus Bleeding Indices (Sulcus Bleeding Indices), Probing Depth (Probing Depth), Attachment Loss (Attachment Loss), Plaque Index (Plaque Index), and gingival blood flow were seen in the Hyperbaric Oxygen, the Hyperbaric Oxygen + Scaling and the Scaling Groups compared to the Control Group (P < 0.01).|PMID:11966926; Original text:The test group had a statistically significant reduction for modified gingival index, plaque index, and BOP compared to controls (p<0.03) at 12 weeks and for Reactive Oxygen Species generation at 12 weeks (p<0.012)."},{"Node1":"Aspirin","Edge_Type":"chemical_to_disease","Node2":"Gingivitis","Weight":1,"Paper_List":"17668982","Original_Text":"PMID:17668982; Original text:Aspirin can have an affect on BOP in naturally occurring gingivitis patients."},{"Node1":"Aspirin","Edge_Type":"chemical_to_anatomy","Node2":"T-Lymphocytes, Regulatory","Weight":1,"Paper_List":"17668982","Original_Text":"PMID:17668982; Original text:Aspirin can have an affect on BOP in naturally occurring gingivitis patients."},{"Node1":"Pain","Edge_Type":"disease_to_anatomy","Node2":"Animal Scales","Weight":1,"Paper_List":"11495138","Original_Text":"PMID:11495138; Original text:Patients also assessed pain by using a 5-point verbal rating scale, from \"no pain\" to \"very severe pain."},{"Node1":"Superoxides","Edge_Type":"chemical_to_disease","Node2":"Down Syndrome","Weight":1,"Paper_List":"16018747","Original_Text":"PMID:16018747; Original text:Neutrophil chemotaxis, phagocytic activity, and production of super-oxide anion were significantly decreased in the Down's syndrome patients."},{"Node1":"Superoxides","Edge_Type":"chemical_to_anatomy","Node2":"Neutrophils","Weight":1,"Paper_List":"16018747","Original_Text":"PMID:16018747; Original text:Neutrophil chemotaxis, phagocytic activity, and production of super-oxide anion were significantly decreased in the Down's syndrome patients."},{"Node1":"Pain","Edge_Type":"disease_to_anatomy","Node2":"Cicatrix","Weight":1,"Paper_List":"20629549","Original_Text":"PMID:20629549; Original text:This prospective randomized study showed statistically significant differences between experimental and control groups regarding cicatrization, wound healing, and pain."},{"Node1":"Calcium Hydroxide","Edge_Type":"chemical_to_mechanism","Node2":"16S ribosomal RNA","Weight":1,"Paper_List":"31300248","Original_Text":"PMID:31300248; Original text:Canals that yielded 16S ribosomal RNA gene-based real-time quantitative polymerase chain reaction-negative results in calcium hydroxide medication had a higher healing rate (79%) than 16S ribosomal RNA gene-based real-time quantitative polymerase chain reaction-positive canals (45%, P < .05)."},{"Node1":"Pain","Edge_Type":"disease_to_anatomy","Node2":"Dental Pulp Cavity","Weight":1,"Paper_List":"20478447","Original_Text":"PMID:20478447; Original text:With regard to tooth-related factors, the following categories were significantly associated with higher healed rates: cases without preoperative pain or signs, cases with good density of root canal filling, and cases with absence or size < or = 5 mm of periapical lesion."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"cytotoxic T-lymphocyte associated protein 4","Weight":4,"Paper_List":"32745291|32745291|32745291|32745291","Original_Text":"PMID:32745291; Original text:Allele G of rs4553808 in promoter of CTLA4 was more frequently detected in periodontitis than controls (P < 0.005), but did not remain significant after age and gender adjustment.|PMID:32745291; Original text:Haplotype (Haplotype) in a block of three CTLA4 Single nucleotide polymorphisms (rs4553808, rs16840252, rs5742909) was significantly associated with periodontitis.|PMID:32745291; Original text:Meta-analysis of Single nucleotide polymorphisms identified indicated allele T of CTLA4 rs5742909 (3 studies; 461 control, 369 periodontitis) and allele G of IL6 rs1800796 (18 studies; 2760 control, 2442 periodontitis) were significantly associated with periodontitis (OR|PMID:32745291; Original text:Within limitations of this study, a haplotype of CTLA4 concerning Th2 cell regulation, may be associated with periodontitis in Chinese nonsmokers followed."},{"Node1":"cytotoxic T-lymphocyte associated protein 4","Edge_Type":"mechanism","Node2":"interleukin 6 cytokine family signal transducer","Weight":1,"Paper_List":"32745291","Original_Text":"PMID:32745291; Original text:Meta-analysis of Single nucleotide polymorphisms identified indicated allele T of CTLA4 rs5742909 (3 studies; 461 control, 369 periodontitis) and allele G of IL6 rs1800796 (18 studies; 2760 control, 2442 periodontitis) were significantly associated with periodontitis (OR"},{"Node1":"Pain","Edge_Type":"disease_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"26525126","Original_Text":"PMID:26525126; Original text:Overall, debridement discomfort was associated with not receiving LA, noncompliance with the pain control regimen allocated, longer treatment duration, greater gingival inflammation and a higher percentage sites with probing pocket depths≥5 mm (p<0.05)."},{"Node1":"cytotoxic T-lymphocyte associated protein 4","Edge_Type":"mechanism_to_anatomy","Node2":"Th2 Cells","Weight":1,"Paper_List":"32745291","Original_Text":"PMID:32745291; Original text:Within limitations of this study, a haplotype of CTLA4 concerning Th2 cell regulation, may be associated with periodontitis in Chinese nonsmokers followed."},{"Node1":"Hypersensitivity","Edge_Type":"disease","Node2":"Periodontitis","Weight":1,"Paper_List":"21698987","Original_Text":"PMID:21698987; Original text:The dentin hypersensitivity observed after periodontal treatment was significantly reduced in periodontitis patients who used the DenShield system for 6 months."},{"Node1":"Hypersensitivity","Edge_Type":"disease","Node2":"Periodontal Cyst","Weight":1,"Paper_List":"21698987","Original_Text":"PMID:21698987; Original text:The dentin hypersensitivity observed after periodontal treatment was significantly reduced in periodontitis patients who used the DenShield system for 6 months."},{"Node1":"Leucine-rich repeat-containing G protein-coupled receptor 1","Edge_Type":"mechanism","Node2":"follicle stimulating hormone subunit beta","Weight":1,"Paper_List":"19192047","Original_Text":"PMID:19192047; Original text:Among the menopausal or postmenopausal women with mouth syndrome, the follicle stimulating hormone (FSH) level was significantly higher, but the estradiol level was significantly lower."},{"Node1":"Estradiol","Edge_Type":"chemical_to_disease","Node2":"Orofaciodigital Syndromes","Weight":1,"Paper_List":"19192047","Original_Text":"PMID:19192047; Original text:Among the menopausal or postmenopausal women with mouth syndrome, the follicle stimulating hormone (FSH) level was significantly higher, but the estradiol level was significantly lower."},{"Node1":"Estradiol","Edge_Type":"chemical_to_mechanism","Node2":"follicle stimulating hormone subunit beta","Weight":1,"Paper_List":"19192047","Original_Text":"PMID:19192047; Original text:Among the menopausal or postmenopausal women with mouth syndrome, the follicle stimulating hormone (FSH) level was significantly higher, but the estradiol level was significantly lower."},{"Node1":"Estradiol","Edge_Type":"chemical_to_mechanism","Node2":"Leucine-rich repeat-containing G protein-coupled receptor 1","Weight":1,"Paper_List":"19192047","Original_Text":"PMID:19192047; Original text:Among the menopausal or postmenopausal women with mouth syndrome, the follicle stimulating hormone (FSH) level was significantly higher, but the estradiol level was significantly lower."},{"Node1":"Estradiol","Edge_Type":"chemical_to_anatomy","Node2":"Gonadotrophs","Weight":1,"Paper_List":"19192047","Original_Text":"PMID:19192047; Original text:Among the menopausal or postmenopausal women with mouth syndrome, the follicle stimulating hormone (FSH) level was significantly higher, but the estradiol level was significantly lower."},{"Node1":"Orofaciodigital Syndromes","Edge_Type":"disease_to_mechanism","Node2":"follicle stimulating hormone subunit beta","Weight":1,"Paper_List":"19192047","Original_Text":"PMID:19192047; Original text:Among the menopausal or postmenopausal women with mouth syndrome, the follicle stimulating hormone (FSH) level was significantly higher, but the estradiol level was significantly lower."},{"Node1":"Orofaciodigital Syndromes","Edge_Type":"disease_to_mechanism","Node2":"Leucine-rich repeat-containing G protein-coupled receptor 1","Weight":1,"Paper_List":"19192047","Original_Text":"PMID:19192047; Original text:Among the menopausal or postmenopausal women with mouth syndrome, the follicle stimulating hormone (FSH) level was significantly higher, but the estradiol level was significantly lower."},{"Node1":"Pain","Edge_Type":"disease_to_anatomy","Node2":"Molar","Weight":1,"Paper_List":"8340625","Original_Text":"PMID:8340625; Original text:There were no statistically significant differences between methods in relation to pain, facial swelling, sensory loss, infection, or periodontal pocket depth distal to the second molar, although 2% of third molars removed by chisel had lingual sensory disturbance at 7 days, as compared with 8% where burs had been used."},{"Node1":"follicle stimulating hormone subunit beta","Edge_Type":"mechanism_to_anatomy","Node2":"Gonadotrophs","Weight":1,"Paper_List":"19192047","Original_Text":"PMID:19192047; Original text:Among the menopausal or postmenopausal women with mouth syndrome, the follicle stimulating hormone (FSH) level was significantly higher, but the estradiol level was significantly lower."},{"Node1":"Leucine-rich repeat-containing G protein-coupled receptor 1","Edge_Type":"mechanism_to_anatomy","Node2":"Gonadotrophs","Weight":1,"Paper_List":"19192047","Original_Text":"PMID:19192047; Original text:Among the menopausal or postmenopausal women with mouth syndrome, the follicle stimulating hormone (FSH) level was significantly higher, but the estradiol level was significantly lower."},{"Node1":"Anxiety Disorders","Edge_Type":"disease","Node2":"Orofaciodigital Syndromes","Weight":1,"Paper_List":"19192047","Original_Text":"PMID:19192047; Original text:Patients with mouth syndrome significantly exhibited symptoms of somatization, and both the scores of anxiety, depression in patients with mouth syndrome were higher than those of the control group (P < 0.05)."},{"Node1":"Pain","Edge_Type":"disease_to_anatomy","Node2":"Molar, Third","Weight":1,"Paper_List":"8340625","Original_Text":"PMID:8340625; Original text:There were no statistically significant differences between methods in relation to pain, facial swelling, sensory loss, infection, or periodontal pocket depth distal to the second molar, although 2% of third molars removed by chisel had lingual sensory disturbance at 7 days, as compared with 8% where burs had been used."},{"Node1":"matrix metallopeptidase 9 gene 2 S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":2,"Paper_List":"30348440|30348440","Original_Text":"PMID:30348440; Original text:Results of a separate meta-analysis of 6 case-control studies including a total of 153 healthy control participants and 189 patients with periodontitis indicated that serum and gingival crevicular fluid matrix metalloproteinase-9 levels were significantly higher in patients with periodontitis than in periodontally healthy control participants (SMD, 1.96; 95% CI, 0.76 to 3.16; P < .01).|PMID:30348440; Original text:The results of the meta-analysis revealed statistically significant differences in the matrix metalloproteinase-9 levels in serum and serum and gingival crevicular fluid between patients with periodontitis and periodontally healthy control participants."},{"Node1":"matrix metallopeptidase 9 gene 2 S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":2,"Paper_List":"30348440|30348440","Original_Text":"PMID:30348440; Original text:Results of a separate meta-analysis of 6 case-control studies including a total of 153 healthy control participants and 189 patients with periodontitis indicated that serum and gingival crevicular fluid matrix metalloproteinase-9 levels were significantly higher in patients with periodontitis than in periodontally healthy control participants (SMD, 1.96; 95% CI, 0.76 to 3.16; P < .01).|PMID:30348440; Original text:The results of the meta-analysis revealed statistically significant differences in the matrix metalloproteinase-9 levels in serum and serum and gingival crevicular fluid between patients with periodontitis and periodontally healthy control participants."},{"Node1":"Obesity","Edge_Type":"disease","Node2":"Periodontitis","Weight":2,"Paper_List":"24897477|33904994","Original_Text":"PMID:24897477; Original text:The meta-analysis showed a significant association with obesity and periodontitis (OR = 1.30|PMID:33904994; Original text:However, meta-analysis showed that among individuals with periodontitis, significantly higher levels of gingival inflammation are observed in those with obesity (n of individuals=240) when compared to those who were not obese (n of individuals=574)"},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"Benzoylarginine Nitroanilide","Weight":1,"Paper_List":"9696259","Original_Text":"PMID:9696259; Original text:The reduction of P. gingivalis from treated periodontitis sites as detected by a significant decrease in BAPNA w/ gly-gly may prove to be a valuable marker for periodontal disease activity."},{"Node1":"Periodontal Diseases","Edge_Type":"disease_to_mechanism","Node2":"Benzoylarginine Nitroanilide","Weight":1,"Paper_List":"9696259","Original_Text":"PMID:9696259; Original text:The reduction of P. gingivalis from treated periodontitis sites as detected by a significant decrease in BAPNA w/ gly-gly may prove to be a valuable marker for periodontal disease activity."},{"Node1":"Azithromycin","Edge_Type":"chemical_to_disease","Node2":"Periodontitis","Weight":3,"Paper_List":"32873290|23082385|27223128","Original_Text":"PMID:32873290; Original text:Despite significant changes in numbers of A. actinomycetemcomitans, P. gingivalis and C. rectus, patients with periodontitis do not benefit from adjunctive systemic azithromycin in terms of number of persisting sites with pocket depth ≥ 5 mm and BOP.|PMID:23082385; Original text:The use of azithromycin as an adjunct to root planing in the treatment of AgP. 17 aggressive periodontitis did not result in significant radiographic bone level changes compared to placebo.|PMID:27223128; Original text:It may be concluded that dental plaque, tooth type, disease extent, baseline pocket depth, and use of azithromycin were significant predictors of the clinical response to treatment for aggressive periodontitis in young individuals."},{"Node1":"Pain","Edge_Type":"disease_to_anatomy","Node2":"Sensilla","Weight":1,"Paper_List":"8340625","Original_Text":"PMID:8340625; Original text:There were no statistically significant differences between methods in relation to pain, facial swelling, sensory loss, infection, or periodontal pocket depth distal to the second molar, although 2% of third molars removed by chisel had lingual sensory disturbance at 7 days, as compared with 8% where burs had been used."},{"Node1":"Periodontal Cyst","Edge_Type":"disease","Node2":"Periodontal Pocket","Weight":1,"Paper_List":"15324352","Original_Text":"PMID:15324352; Original text:Sites receiving Sc/Rp + doxycycline polymer and sites receiving Sc/Rp alone exhibited similar levels of periodontal pathogens at baseline and did not differ significantly in total viable counts and proportional recovery of periodontopathic bacteria post-treatment."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_disease","Node2":"Periodontal Pocket","Weight":1,"Paper_List":"15324352","Original_Text":"PMID:15324352; Original text:Sites receiving Sc/Rp + doxycycline polymer and sites receiving Sc/Rp alone exhibited similar levels of periodontal pathogens at baseline and did not differ significantly in total viable counts and proportional recovery of periodontopathic bacteria post-treatment."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_disease","Node2":"Periodontal Cyst","Weight":1,"Paper_List":"15324352","Original_Text":"PMID:15324352; Original text:Sites receiving Sc/Rp + doxycycline polymer and sites receiving Sc/Rp alone exhibited similar levels of periodontal pathogens at baseline and did not differ significantly in total viable counts and proportional recovery of periodontopathic bacteria post-treatment."},{"Node1":"Inflammation","Edge_Type":"disease","Node2":"Periodontitis","Weight":5,"Paper_List":"34394107|17458082|34618684|33904994|16441729","Original_Text":"PMID:34394107; Original text:These findings provide robust evidence that periodontitis is associated with systemic inflammation as measured by serum C-reactive protein levels.|PMID:17458082; Original text:Although the assessment of the activity of such enzymes as beta-glucuronidase, HEX, HEX A and HEX B in the saliva of aggressive periodontitis patients allows detection of periodontal inflammation, it cannot be used to determine the risk of its development and therefore has no practical significance.|PMID:34618684; Original text:ConclusionAMY-101 treatment resulted in a significant and sustainable reduction in gingival inflammation without adverse events and, we believe, merits further investigation for the treatment of periodontitis and other oral or peri-implant inflammatory conditions.|PMID:33904994; Original text:However, meta-analysis showed that among individuals with periodontitis, significantly higher levels of gingival inflammation are observed in those with obesity (n of individuals=240) when compared to those who were not obese (n of individuals=574)|PMID:16441729; Original text:These results suggest that susceptibility to gingival inflammation in response to de novo plaque accumulation may be related to susceptibility to periodontitis."},{"Node1":"Inflammation","Edge_Type":"disease_to_mechanism","Node2":"nejire","Weight":1,"Paper_List":"34394107","Original_Text":"PMID:34394107; Original text:These findings provide robust evidence that periodontitis is associated with systemic inflammation as measured by serum C-reactive protein levels."},{"Node1":"curcumin ","Edge_Type":"nutrient_to_chemical","Node2":"Curcumin","Weight":1,"Paper_List":"34331694","Original_Text":"PMID:34331694; Original text:Three of the five in vitro studies evaluated the effect of curcumin on mixed biofilm of periopathogens, which showed a significant inhibitory effect of curcumin on periodontal biofilms."},{"Node1":"Glucose","Edge_Type":"chemical_to_mechanism","Node2":"GLYcosylation related","Weight":3,"Paper_List":"33832490|21804283|24934646","Original_Text":"PMID:33832490; Original text:The fasting blood glucose, 2-h postprandial blood glucose and glycosylated hemoglobin in the combined group, root planing group, periodontal curettage group and cleansing group were significantly lower than those before treatment (P < 0.05).|PMID:21804283; Original text:After 3 months, the serum levels of hsCRP, TNF-α, interleukin-6, fasting plasma glucose (plasma glucose), glycosylated hemoglobin (glycosylated hemoglobin), fasting insulin (insulin) and HOMA-adiponectin, insulin resistance index decreased, and adiponectin was significantly increased in type 2 diabetes mellitus-T group compared to those in the type 2 diabetes mellitus-NT group (p<0.05 or p<0.01).|PMID:24934646; Original text:Participants were assessed at baseline and 3 month follow up for glycosylated hemoglobin (significantly lower glycosylated hemoglobin), fasting plasma glucose (plasma glucose), body mass index (Bmotivational interviewing), periodontal status, knowledge, attitude and practice of oral health and diabetes mellitus."},{"Node1":"Glucose","Edge_Type":"chemical_to_anatomy","Node2":"Periodontal Ligament","Weight":2,"Paper_List":"33832490|24934646","Original_Text":"PMID:33832490; Original text:The fasting blood glucose, 2-h postprandial blood glucose and glycosylated hemoglobin in the combined group, root planing group, periodontal curettage group and cleansing group were significantly lower than those before treatment (P < 0.05).|PMID:24934646; Original text:Participants were assessed at baseline and 3 month follow up for glycosylated hemoglobin (significantly lower glycosylated hemoglobin), fasting plasma glucose (plasma glucose), body mass index (Bmotivational interviewing), periodontal status, knowledge, attitude and practice of oral health and diabetes mellitus."},{"Node1":"GLYcosylation related","Edge_Type":"mechanism_to_anatomy","Node2":"Periodontal Ligament","Weight":2,"Paper_List":"33832490|24934646","Original_Text":"PMID:33832490; Original text:The fasting blood glucose, 2-h postprandial blood glucose and glycosylated hemoglobin in the combined group, root planing group, periodontal curettage group and cleansing group were significantly lower than those before treatment (P < 0.05).|PMID:24934646; Original text:Participants were assessed at baseline and 3 month follow up for glycosylated hemoglobin (significantly lower glycosylated hemoglobin), fasting plasma glucose (plasma glucose), body mass index (Bmotivational interviewing), periodontal status, knowledge, attitude and practice of oral health and diabetes mellitus."},{"Node1":"endothelin receptor type B","Edge_Type":"mechanism","Node2":"tumor necrosis factor receptor superfamily, member a","Weight":2,"Paper_List":"33832490|24111886","Original_Text":"PMID:33832490; Original text:The levels of TNF- α and hs-CRP in the combined group were lower than those in the root planing group, periodontal curettage group and cleansing group, and those in the root planing group and periodontal curettage group were significantly lower than those in the cleansing group (P< 0.05).|PMID:24111886; Original text:Meta-analyses demonstrated significant weighted mean difference (significant weighted mean difference) for hsCRP (-0.50 mg/l, 95% CI:-0.78; -0.22), IL-6 (-0.48 ng/l, 95% CI: -0.90; -0.06), TNF-α (-0.75 pg/ml, 95% CI: -1.34; -0.17), fibrinogen (-0.47 g/l, 95% CI: -0.76; -0.17), total cholesterol (-0.11 mmol/l, 95% CI: -0.21; -0.01) and HDL-C (0.04 mmol/l, 95% CI: 0.03; 0.06) favouring periodontal intervention."},{"Node1":"endothelin receptor type B","Edge_Type":"mechanism_to_anatomy","Node2":"Periodontal Ligament","Weight":1,"Paper_List":"33832490","Original_Text":"PMID:33832490; Original text:The levels of TNF- α and hs-CRP in the combined group were lower than those in the root planing group, periodontal curettage group and cleansing group, and those in the root planing group and periodontal curettage group were significantly lower than those in the cleansing group (P< 0.05)."},{"Node1":"tumor necrosis factor receptor superfamily, member a","Edge_Type":"mechanism_to_anatomy","Node2":"Periodontal Ligament","Weight":1,"Paper_List":"33832490","Original_Text":"PMID:33832490; Original text:The levels of TNF- α and hs-CRP in the combined group were lower than those in the root planing group, periodontal curettage group and cleansing group, and those in the root planing group and periodontal curettage group were significantly lower than those in the cleansing group (P< 0.05)."},{"Node1":"Cetylpyridinium","Edge_Type":"chemical_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"22479786","Original_Text":"PMID:22479786; Original text:When compared to the a cetylpyridinium chloride and an essential oils treatments, rinse was the only mouth rinse that was significantlybetter than the control, with respect to both the change in absolute The gingival index scores (p = .006) and to the percent increase in The gingival index scores (p = .012)."},{"Node1":"8-Hydroxy-2'-Deoxyguanosine","Edge_Type":"chemical_to_anatomy","Node2":"Salivary Glands","Weight":1,"Paper_List":"32065311","Original_Text":"PMID:32065311; Original text:Baseline salivary levels of 8-OHdG were significantly higher in smoking habit group (14.775 pg/mL)"},{"Node1":"Dinoprostone","Edge_Type":"chemical_to_disease","Node2":"Premature Birth","Weight":1,"Paper_List":"23805813","Original_Text":"PMID:23805813; Original text:The models revealed a significant relation between a specific polymorphism of prostaglandin E receptor 3 (a gene associated with inflammatory response) and both periodontal treatment failure (odds ratio 11.09, P <0.0002) and spontaneous preterm birth (odds ratio 6.89, P < 0.0032)."},{"Node1":"Dinoprostone","Edge_Type":"chemical_to_mechanism","Node2":"prostaglandin E receptor 3","Weight":1,"Paper_List":"23805813","Original_Text":"PMID:23805813; Original text:The models revealed a significant relation between a specific polymorphism of prostaglandin E receptor 3 (a gene associated with inflammatory response) and both periodontal treatment failure (odds ratio 11.09, P <0.0002) and spontaneous preterm birth (odds ratio 6.89, P < 0.0032)."},{"Node1":"Premature Birth","Edge_Type":"disease_to_mechanism","Node2":"prostaglandin E receptor 3","Weight":1,"Paper_List":"23805813","Original_Text":"PMID:23805813; Original text:The models revealed a significant relation between a specific polymorphism of prostaglandin E receptor 3 (a gene associated with inflammatory response) and both periodontal treatment failure (odds ratio 11.09, P <0.0002) and spontaneous preterm birth (odds ratio 6.89, P < 0.0032)."},{"Node1":"Ligaments, Articular","Edge_Type":"anatomy","Node2":"Membranes","Weight":1,"Paper_List":"20932158","Original_Text":"PMID:20932158; Original text:guided tissue regeneration treatment of intrabony defects with the collagen membrane from bovine pericardium and adjunct implantation of the new bovine bone biomaterial may result in significant clinical improvements that can be maintained over a period of 3 years, and regeneration of cementum and periodontal ligament, but without bone formation."},{"Node1":"Ligaments, Articular","Edge_Type":"anatomy","Node2":"Periodontium","Weight":1,"Paper_List":"20932158","Original_Text":"PMID:20932158; Original text:guided tissue regeneration treatment of intrabony defects with the collagen membrane from bovine pericardium and adjunct implantation of the new bovine bone biomaterial may result in significant clinical improvements that can be maintained over a period of 3 years, and regeneration of cementum and periodontal ligament, but without bone formation."},{"Node1":"Dental Cementum","Edge_Type":"anatomy","Node2":"Ligaments, Articular","Weight":1,"Paper_List":"20932158","Original_Text":"PMID:20932158; Original text:guided tissue regeneration treatment of intrabony defects with the collagen membrane from bovine pericardium and adjunct implantation of the new bovine bone biomaterial may result in significant clinical improvements that can be maintained over a period of 3 years, and regeneration of cementum and periodontal ligament, but without bone formation."},{"Node1":"Ligaments, Articular","Edge_Type":"anatomy","Node2":"Pericardium","Weight":1,"Paper_List":"20932158","Original_Text":"PMID:20932158; Original text:guided tissue regeneration treatment of intrabony defects with the collagen membrane from bovine pericardium and adjunct implantation of the new bovine bone biomaterial may result in significant clinical improvements that can be maintained over a period of 3 years, and regeneration of cementum and periodontal ligament, but without bone formation."},{"Node1":"Membranes","Edge_Type":"anatomy","Node2":"Periodontium","Weight":2,"Paper_List":"20932158|8832474","Original_Text":"PMID:20932158; Original text:guided tissue regeneration treatment of intrabony defects with the collagen membrane from bovine pericardium and adjunct implantation of the new bovine bone biomaterial may result in significant clinical improvements that can be maintained over a period of 3 years, and regeneration of cementum and periodontal ligament, but without bone formation.|PMID:8832474; Original text:The results of this study indicate that clinically and statistically significant improvements in vertical probing depth, clinical attachment levels, and Hvertical probing depth occurred after treatment of Class II furcations and 2- to 3-wall intrabony defects with the bioabsorbable periodontal membrane."},{"Node1":"Dental Cementum","Edge_Type":"anatomy","Node2":"Membranes","Weight":1,"Paper_List":"20932158","Original_Text":"PMID:20932158; Original text:guided tissue regeneration treatment of intrabony defects with the collagen membrane from bovine pericardium and adjunct implantation of the new bovine bone biomaterial may result in significant clinical improvements that can be maintained over a period of 3 years, and regeneration of cementum and periodontal ligament, but without bone formation."},{"Node1":"Membranes","Edge_Type":"anatomy","Node2":"Pericardium","Weight":1,"Paper_List":"20932158","Original_Text":"PMID:20932158; Original text:guided tissue regeneration treatment of intrabony defects with the collagen membrane from bovine pericardium and adjunct implantation of the new bovine bone biomaterial may result in significant clinical improvements that can be maintained over a period of 3 years, and regeneration of cementum and periodontal ligament, but without bone formation."},{"Node1":"Dental Cementum","Edge_Type":"anatomy","Node2":"Periodontium","Weight":1,"Paper_List":"20932158","Original_Text":"PMID:20932158; Original text:guided tissue regeneration treatment of intrabony defects with the collagen membrane from bovine pericardium and adjunct implantation of the new bovine bone biomaterial may result in significant clinical improvements that can be maintained over a period of 3 years, and regeneration of cementum and periodontal ligament, but without bone formation."},{"Node1":"Pericardium","Edge_Type":"anatomy","Node2":"Periodontium","Weight":1,"Paper_List":"20932158","Original_Text":"PMID:20932158; Original text:guided tissue regeneration treatment of intrabony defects with the collagen membrane from bovine pericardium and adjunct implantation of the new bovine bone biomaterial may result in significant clinical improvements that can be maintained over a period of 3 years, and regeneration of cementum and periodontal ligament, but without bone formation."},{"Node1":"Dental Cementum","Edge_Type":"anatomy","Node2":"Pericardium","Weight":1,"Paper_List":"20932158","Original_Text":"PMID:20932158; Original text:guided tissue regeneration treatment of intrabony defects with the collagen membrane from bovine pericardium and adjunct implantation of the new bovine bone biomaterial may result in significant clinical improvements that can be maintained over a period of 3 years, and regeneration of cementum and periodontal ligament, but without bone formation."},{"Node1":"collagen","Edge_Type":"mechanism_to_anatomy","Node2":"Ligaments, Articular","Weight":1,"Paper_List":"20932158","Original_Text":"PMID:20932158; Original text:guided tissue regeneration treatment of intrabony defects with the collagen membrane from bovine pericardium and adjunct implantation of the new bovine bone biomaterial may result in significant clinical improvements that can be maintained over a period of 3 years, and regeneration of cementum and periodontal ligament, but without bone formation."},{"Node1":"collagen","Edge_Type":"mechanism_to_anatomy","Node2":"Periodontium","Weight":1,"Paper_List":"20932158","Original_Text":"PMID:20932158; Original text:guided tissue regeneration treatment of intrabony defects with the collagen membrane from bovine pericardium and adjunct implantation of the new bovine bone biomaterial may result in significant clinical improvements that can be maintained over a period of 3 years, and regeneration of cementum and periodontal ligament, but without bone formation."},{"Node1":"collagen","Edge_Type":"mechanism_to_anatomy","Node2":"Dental Cementum","Weight":2,"Paper_List":"20932158|11990442","Original_Text":"PMID:20932158; Original text:guided tissue regeneration treatment of intrabony defects with the collagen membrane from bovine pericardium and adjunct implantation of the new bovine bone biomaterial may result in significant clinical improvements that can be maintained over a period of 3 years, and regeneration of cementum and periodontal ligament, but without bone formation.|PMID:11990442; Original text:Histometrically, significant amounts of new connective tissue attachment (i.e., cementum with inserting collagen fibers) were observed in both groups (guided tissue regeneration: 2.29 mm; an enamel matrix protein derivative: 1.81 mm)."},{"Node1":"collagen","Edge_Type":"mechanism_to_anatomy","Node2":"Pericardium","Weight":1,"Paper_List":"20932158","Original_Text":"PMID:20932158; Original text:guided tissue regeneration treatment of intrabony defects with the collagen membrane from bovine pericardium and adjunct implantation of the new bovine bone biomaterial may result in significant clinical improvements that can be maintained over a period of 3 years, and regeneration of cementum and periodontal ligament, but without bone formation."},{"Node1":"Extracellular Matrix","Edge_Type":"anatomy","Node2":"Gingiva","Weight":2,"Paper_List":"18315429|18315429","Original_Text":"PMID:18315429; Original text:From baseline to 6 months, the gingival crevicular fluid extracellular matrix metalloproteinase inducer levels were reduced significantly in the subantimicrobial dose doxycycline group (P <0.025).|PMID:18315429; Original text:The gingival crevicular fluid extracellular matrix metalloproteinase inducer level in the subantimicrobial dose doxycycline group was significantly lower than that of the placebo group at 3 and 6 months (P <0.05)."},{"Node1":"Extracellular Matrix","Edge_Type":"anatomy","Node2":"Gingival Crevicular Fluid","Weight":2,"Paper_List":"18315429|18315429","Original_Text":"PMID:18315429; Original text:From baseline to 6 months, the gingival crevicular fluid extracellular matrix metalloproteinase inducer levels were reduced significantly in the subantimicrobial dose doxycycline group (P <0.025).|PMID:18315429; Original text:The gingival crevicular fluid extracellular matrix metalloproteinase inducer level in the subantimicrobial dose doxycycline group was significantly lower than that of the placebo group at 3 and 6 months (P <0.05)."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_anatomy","Node2":"Extracellular Matrix","Weight":2,"Paper_List":"18315429|18315429","Original_Text":"PMID:18315429; Original text:From baseline to 6 months, the gingival crevicular fluid extracellular matrix metalloproteinase inducer levels were reduced significantly in the subantimicrobial dose doxycycline group (P <0.025).|PMID:18315429; Original text:The gingival crevicular fluid extracellular matrix metalloproteinase inducer level in the subantimicrobial dose doxycycline group was significantly lower than that of the placebo group at 3 and 6 months (P <0.05)."},{"Node1":"Glucose","Edge_Type":"chemical","Node2":"Triglycerides","Weight":2,"Paper_List":"25129881|34197339","Original_Text":"PMID:25129881; Original text:Both groups displayed significant improvements, however, using clinical attachment gain and reductions in HDL, LDL and Total Cholesterol, Triglycerides, Glucose and Uric acid, from baseline to 1 year, as criteria for treatment success, H performed significantly better than SRP.|PMID:34197339; Original text:Both groups showed significant clinical and laboratory improvements during the study from baseline to 1 year with reductions in total cholesterol (total cholesterol), triglycerides, glucose, glycated hemoglobin (glycated hemoglobin), uric acid and C-reactive protein (uric acid and C-reactive protein)."},{"Node1":"Triglycerides","Edge_Type":"chemical","Node2":"Uric Acid","Weight":2,"Paper_List":"25129881|34197339","Original_Text":"PMID:25129881; Original text:Both groups displayed significant improvements, however, using clinical attachment gain and reductions in HDL, LDL and Total Cholesterol, Triglycerides, Glucose and Uric acid, from baseline to 1 year, as criteria for treatment success, H performed significantly better than SRP.|PMID:34197339; Original text:Both groups showed significant clinical and laboratory improvements during the study from baseline to 1 year with reductions in total cholesterol (total cholesterol), triglycerides, glucose, glycated hemoglobin (glycated hemoglobin), uric acid and C-reactive protein (uric acid and C-reactive protein)."},{"Node1":"Cholesterol","Edge_Type":"chemical","Node2":"Triglycerides","Weight":3,"Paper_List":"25129881|24111886|34197339","Original_Text":"PMID:25129881; Original text:Both groups displayed significant improvements, however, using clinical attachment gain and reductions in HDL, LDL and Total Cholesterol, Triglycerides, Glucose and Uric acid, from baseline to 1 year, as criteria for treatment success, H performed significantly better than SRP.|PMID:24111886; Original text:Importantly, periodontitis patients with co-morbidity benefitted most from periodontal therapy; significant significant weighted mean difference were observed for levels of hsCRP (-0.71 mg/l, 95% CI: -1.05; -0.36), IL-6 (-0.87 ng/l, 95% CI: -0.97; -0.78), triglycerides (-0.24 mmol/l, 95% CI: -0.26; -0.22), total cholesterol (-0.15 mmol/l, 95% CI: -0.29; -0.01), HDL-C (0.05 mmol/l, 95% CI: 0.03; 0.06) and HbA1c (-0.43%, 95% CI: -0.60; -0.25).|PMID:34197339; Original text:Both groups showed significant clinical and laboratory improvements during the study from baseline to 1 year with reductions in total cholesterol (total cholesterol), triglycerides, glucose, glycated hemoglobin (glycated hemoglobin), uric acid and C-reactive protein (uric acid and C-reactive protein)."},{"Node1":"Glucose","Edge_Type":"chemical","Node2":"Uric Acid","Weight":2,"Paper_List":"25129881|34197339","Original_Text":"PMID:25129881; Original text:Both groups displayed significant improvements, however, using clinical attachment gain and reductions in HDL, LDL and Total Cholesterol, Triglycerides, Glucose and Uric acid, from baseline to 1 year, as criteria for treatment success, H performed significantly better than SRP.|PMID:34197339; Original text:Both groups showed significant clinical and laboratory improvements during the study from baseline to 1 year with reductions in total cholesterol (total cholesterol), triglycerides, glucose, glycated hemoglobin (glycated hemoglobin), uric acid and C-reactive protein (uric acid and C-reactive protein)."},{"Node1":"Cholesterol","Edge_Type":"chemical","Node2":"Glucose","Weight":2,"Paper_List":"25129881|34197339","Original_Text":"PMID:25129881; Original text:Both groups displayed significant improvements, however, using clinical attachment gain and reductions in HDL, LDL and Total Cholesterol, Triglycerides, Glucose and Uric acid, from baseline to 1 year, as criteria for treatment success, H performed significantly better than SRP.|PMID:34197339; Original text:Both groups showed significant clinical and laboratory improvements during the study from baseline to 1 year with reductions in total cholesterol (total cholesterol), triglycerides, glucose, glycated hemoglobin (glycated hemoglobin), uric acid and C-reactive protein (uric acid and C-reactive protein)."},{"Node1":"Cholesterol","Edge_Type":"chemical","Node2":"Uric Acid","Weight":2,"Paper_List":"25129881|34197339","Original_Text":"PMID:25129881; Original text:Both groups displayed significant improvements, however, using clinical attachment gain and reductions in HDL, LDL and Total Cholesterol, Triglycerides, Glucose and Uric acid, from baseline to 1 year, as criteria for treatment success, H performed significantly better than SRP.|PMID:34197339; Original text:Both groups showed significant clinical and laboratory improvements during the study from baseline to 1 year with reductions in total cholesterol (total cholesterol), triglycerides, glucose, glycated hemoglobin (glycated hemoglobin), uric acid and C-reactive protein (uric acid and C-reactive protein)."},{"Node1":"Bacteroides Sp","Edge_Type":"bacteria","Node2":"Fusobacterium Species","Weight":1,"Paper_List":"1825332","Original_Text":"PMID:1825332; Original text:In the supragingival scaling period, significant reduction in percentages of spirochetes and motile rods and significant increase of the percentage of coccoid cells were observed only at T sites."},{"Node1":"Dexamethasone","Edge_Type":"chemical_to_disease","Node2":"Pain","Weight":3,"Paper_List":"33483197|17076604|8151248","Original_Text":"PMID:33483197; Original text:Patients who received dexamethasone reported a greater reduction in pain at 12 h compared with the placebo group (p = 0.029).|PMID:17076604; Original text:The level of pain was lower in the dexamethasone group than in the placebo only at the 3-hour period (P = 0.001).|PMID:8151248; Original text:Patients with no radiographic periapical lesions had significantly more pain than patients with periapical lesions at 8-, 24-, 48-, and 72-h posttreatment regardless of whether they received placebo or dexamethasone."},{"Node1":"RAB27A, member RAS oncogene family S homeolog","Edge_Type":"mechanism","Node2":"pseudouridine 5'-phosphatase","Weight":1,"Paper_List":"16688105","Original_Text":"PMID:16688105; Original text:No statistical significant differences between Gs1 and Gs2 were observed."},{"Node1":"Cimetidine","Edge_Type":"chemical_to_anatomy","Node2":"Neutrophils","Weight":2,"Paper_List":"15948697|15948697","Original_Text":"PMID:15948697; Original text:In the first study, the mean number of phagocytosing neutrophils was statistically significantly increased (P = 0.016) in the cimetidine group (31.1 cells/subject) versus the placebo group (13.7 cells/subject) at day 28.|PMID:15948697; Original text:In addition, a statistically significant increase (P = 0.036) in bacterial killing was observed in the cimetidine rinse group; in the cimetidine group, 63.4% of bacteria in the neutrophils were killed compared to 46.2% in the placebo group."},{"Node1":"Lactic Acid","Edge_Type":"chemical_to_mechanism","Node2":"lactate dehydrogenase","Weight":2,"Paper_List":"15857076|25646170","Original_Text":"PMID:15857076; Original text:Gingival crevicular fluid lactate dehydrogenase activity was significantly elevated in all sites of the the test tooth and CT, as compared to the AT, where lactate dehydrogenase activity remained at the baseline level throughout the study.|PMID:25646170; Original text:ICG application does not seem to cause tissue damage as evident by the lactate dehydrogenase levels."},{"Node1":"Lactic Acid","Edge_Type":"chemical_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"15857076","Original_Text":"PMID:15857076; Original text:Gingival crevicular fluid lactate dehydrogenase activity was significantly elevated in all sites of the the test tooth and CT, as compared to the AT, where lactate dehydrogenase activity remained at the baseline level throughout the study."},{"Node1":"Lactic Acid","Edge_Type":"chemical_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"15857076","Original_Text":"PMID:15857076; Original text:Gingival crevicular fluid lactate dehydrogenase activity was significantly elevated in all sites of the the test tooth and CT, as compared to the AT, where lactate dehydrogenase activity remained at the baseline level throughout the study."},{"Node1":"lactate dehydrogenase","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"15857076","Original_Text":"PMID:15857076; Original text:Gingival crevicular fluid lactate dehydrogenase activity was significantly elevated in all sites of the the test tooth and CT, as compared to the AT, where lactate dehydrogenase activity remained at the baseline level throughout the study."},{"Node1":"lactate dehydrogenase","Edge_Type":"mechanism_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"15857076","Original_Text":"PMID:15857076; Original text:Gingival crevicular fluid lactate dehydrogenase activity was significantly elevated in all sites of the the test tooth and CT, as compared to the AT, where lactate dehydrogenase activity remained at the baseline level throughout the study."},{"Node1":"Dental Cementum","Edge_Type":"anatomy","Node2":"Tissues","Weight":1,"Paper_List":"15101598","Original_Text":"PMID:15101598; Original text:Data on peri-implant marginal bone levels and on soft tissue parameters were collected 4 years after implant placement and analyzed to determine whether there was a significant difference with respect to the method of retention (cemented versus screw-retained)."},{"Node1":"allograft inflammatory factor 1","Edge_Type":"mechanism","Node2":"interleukin 10","Weight":1,"Paper_List":"31327083","Original_Text":"PMID:31327083; Original text:20% doxycycline group exhibited a significant increase in the levels of anti-inflammatory interleukin (anti-inflammatory interleukin)-10 and a reduction in anti-inflammatory interleukin-8, IFN-y, anti-inflammatory interleukin-6, and anti-inflammatory interleukin-17"},{"Node1":"Doxycycline","Edge_Type":"chemical_to_mechanism","Node2":"interleukin 10","Weight":1,"Paper_List":"31327083","Original_Text":"PMID:31327083; Original text:20% doxycycline group exhibited a significant increase in the levels of anti-inflammatory interleukin (anti-inflammatory interleukin)-10 and a reduction in anti-inflammatory interleukin-8, IFN-y, anti-inflammatory interleukin-6, and anti-inflammatory interleukin-17"},{"Node1":"Doxycycline","Edge_Type":"chemical_to_mechanism","Node2":"allograft inflammatory factor 1","Weight":1,"Paper_List":"31327083","Original_Text":"PMID:31327083; Original text:20% doxycycline group exhibited a significant increase in the levels of anti-inflammatory interleukin (anti-inflammatory interleukin)-10 and a reduction in anti-inflammatory interleukin-8, IFN-y, anti-inflammatory interleukin-6, and anti-inflammatory interleukin-17"},{"Node1":"interleukin 8-like 1","Edge_Type":"mechanism","Node2":"mir-8 stem loop","Weight":1,"Paper_List":"32867199","Original_Text":"PMID:32867199; Original text:Accordingly, the levels of pro-inflammatory cytokines/chemokines interleukin (IL)-8 and IL-17 were markedly lower, while the level of anti-inflammatory IL-10 was significantly higher in the salivary samples of the patients supplemented with omega-3 Omega-3 polyunsaturated fatty acids at three months in comparison to the patients treated with root planning alone."},{"Node1":"interleukin 10 S homeolog","Edge_Type":"mechanism","Node2":"mir-8 stem loop","Weight":1,"Paper_List":"32867199","Original_Text":"PMID:32867199; Original text:Accordingly, the levels of pro-inflammatory cytokines/chemokines interleukin (IL)-8 and IL-17 were markedly lower, while the level of anti-inflammatory IL-10 was significantly higher in the salivary samples of the patients supplemented with omega-3 Omega-3 polyunsaturated fatty acids at three months in comparison to the patients treated with root planning alone."},{"Node1":"interleukin 17A","Edge_Type":"mechanism","Node2":"mir-8 stem loop","Weight":1,"Paper_List":"32867199","Original_Text":"PMID:32867199; Original text:Accordingly, the levels of pro-inflammatory cytokines/chemokines interleukin (IL)-8 and IL-17 were markedly lower, while the level of anti-inflammatory IL-10 was significantly higher in the salivary samples of the patients supplemented with omega-3 Omega-3 polyunsaturated fatty acids at three months in comparison to the patients treated with root planning alone."},{"Node1":"interleukin 10 S homeolog","Edge_Type":"mechanism","Node2":"interleukin 8-like 1","Weight":1,"Paper_List":"32867199","Original_Text":"PMID:32867199; Original text:Accordingly, the levels of pro-inflammatory cytokines/chemokines interleukin (IL)-8 and IL-17 were markedly lower, while the level of anti-inflammatory IL-10 was significantly higher in the salivary samples of the patients supplemented with omega-3 Omega-3 polyunsaturated fatty acids at three months in comparison to the patients treated with root planning alone."},{"Node1":"interleukin 17A","Edge_Type":"mechanism","Node2":"interleukin 8-like 1","Weight":1,"Paper_List":"32867199","Original_Text":"PMID:32867199; Original text:Accordingly, the levels of pro-inflammatory cytokines/chemokines interleukin (IL)-8 and IL-17 were markedly lower, while the level of anti-inflammatory IL-10 was significantly higher in the salivary samples of the patients supplemented with omega-3 Omega-3 polyunsaturated fatty acids at three months in comparison to the patients treated with root planning alone."},{"Node1":"interleukin 10 S homeolog","Edge_Type":"mechanism","Node2":"interleukin 17A","Weight":1,"Paper_List":"32867199","Original_Text":"PMID:32867199; Original text:Accordingly, the levels of pro-inflammatory cytokines/chemokines interleukin (IL)-8 and IL-17 were markedly lower, while the level of anti-inflammatory IL-10 was significantly higher in the salivary samples of the patients supplemented with omega-3 Omega-3 polyunsaturated fatty acids at three months in comparison to the patients treated with root planning alone."},{"Node1":"Polyunsaturated Alkamides","Edge_Type":"chemical_to_mechanism","Node2":"mir-8 stem loop","Weight":1,"Paper_List":"32867199","Original_Text":"PMID:32867199; Original text:Accordingly, the levels of pro-inflammatory cytokines/chemokines interleukin (IL)-8 and IL-17 were markedly lower, while the level of anti-inflammatory IL-10 was significantly higher in the salivary samples of the patients supplemented with omega-3 Omega-3 polyunsaturated fatty acids at three months in comparison to the patients treated with root planning alone."},{"Node1":"Polyunsaturated Alkamides","Edge_Type":"chemical_to_mechanism","Node2":"interleukin 8-like 1","Weight":1,"Paper_List":"32867199","Original_Text":"PMID:32867199; Original text:Accordingly, the levels of pro-inflammatory cytokines/chemokines interleukin (IL)-8 and IL-17 were markedly lower, while the level of anti-inflammatory IL-10 was significantly higher in the salivary samples of the patients supplemented with omega-3 Omega-3 polyunsaturated fatty acids at three months in comparison to the patients treated with root planning alone."},{"Node1":"Polyunsaturated Alkamides","Edge_Type":"chemical_to_mechanism","Node2":"interleukin 10 S homeolog","Weight":1,"Paper_List":"32867199","Original_Text":"PMID:32867199; Original text:Accordingly, the levels of pro-inflammatory cytokines/chemokines interleukin (IL)-8 and IL-17 were markedly lower, while the level of anti-inflammatory IL-10 was significantly higher in the salivary samples of the patients supplemented with omega-3 Omega-3 polyunsaturated fatty acids at three months in comparison to the patients treated with root planning alone."},{"Node1":"Polyunsaturated Alkamides","Edge_Type":"chemical_to_mechanism","Node2":"interleukin 17A","Weight":1,"Paper_List":"32867199","Original_Text":"PMID:32867199; Original text:Accordingly, the levels of pro-inflammatory cytokines/chemokines interleukin (IL)-8 and IL-17 were markedly lower, while the level of anti-inflammatory IL-10 was significantly higher in the salivary samples of the patients supplemented with omega-3 Omega-3 polyunsaturated fatty acids at three months in comparison to the patients treated with root planning alone."},{"Node1":"Polyunsaturated Alkamides","Edge_Type":"chemical_to_anatomy","Node2":"Salivary Glands","Weight":1,"Paper_List":"32867199","Original_Text":"PMID:32867199; Original text:Accordingly, the levels of pro-inflammatory cytokines/chemokines interleukin (IL)-8 and IL-17 were markedly lower, while the level of anti-inflammatory IL-10 was significantly higher in the salivary samples of the patients supplemented with omega-3 Omega-3 polyunsaturated fatty acids at three months in comparison to the patients treated with root planning alone."},{"Node1":"mir-8 stem loop","Edge_Type":"mechanism_to_anatomy","Node2":"Salivary Glands","Weight":1,"Paper_List":"32867199","Original_Text":"PMID:32867199; Original text:Accordingly, the levels of pro-inflammatory cytokines/chemokines interleukin (IL)-8 and IL-17 were markedly lower, while the level of anti-inflammatory IL-10 was significantly higher in the salivary samples of the patients supplemented with omega-3 Omega-3 polyunsaturated fatty acids at three months in comparison to the patients treated with root planning alone."},{"Node1":"interleukin 8-like 1","Edge_Type":"mechanism_to_anatomy","Node2":"Salivary Glands","Weight":1,"Paper_List":"32867199","Original_Text":"PMID:32867199; Original text:Accordingly, the levels of pro-inflammatory cytokines/chemokines interleukin (IL)-8 and IL-17 were markedly lower, while the level of anti-inflammatory IL-10 was significantly higher in the salivary samples of the patients supplemented with omega-3 Omega-3 polyunsaturated fatty acids at three months in comparison to the patients treated with root planning alone."},{"Node1":"interleukin 10 S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Salivary Glands","Weight":1,"Paper_List":"32867199","Original_Text":"PMID:32867199; Original text:Accordingly, the levels of pro-inflammatory cytokines/chemokines interleukin (IL)-8 and IL-17 were markedly lower, while the level of anti-inflammatory IL-10 was significantly higher in the salivary samples of the patients supplemented with omega-3 Omega-3 polyunsaturated fatty acids at three months in comparison to the patients treated with root planning alone."},{"Node1":"interleukin 17A","Edge_Type":"mechanism_to_anatomy","Node2":"Salivary Glands","Weight":1,"Paper_List":"32867199","Original_Text":"PMID:32867199; Original text:Accordingly, the levels of pro-inflammatory cytokines/chemokines interleukin (IL)-8 and IL-17 were markedly lower, while the level of anti-inflammatory IL-10 was significantly higher in the salivary samples of the patients supplemented with omega-3 Omega-3 polyunsaturated fatty acids at three months in comparison to the patients treated with root planning alone."},{"Node1":"Etoricoxib","Edge_Type":"chemical_to_disease","Node2":"Pain","Weight":1,"Paper_List":"21235334","Original_Text":"PMID:21235334; Original text:Pain intensity levels in the etoricoxib group were lower than in the placebo group at the 2-, 3-,"},{"Node1":"Celecoxib","Edge_Type":"chemical","Node2":"Etoricoxib","Weight":1,"Paper_List":"21235334","Original_Text":"PMID:21235334; Original text:There was no statistically significant difference between celecoxib and etoricoxib."},{"Node1":"Porphyromonas Gingivalis (Organism)","Edge_Type":"bacteria_to_antibody","Node2":"Anti-","Weight":1,"Paper_List":"8550186","Original_Text":"PMID:8550186; Original text:A comparative study of the number of P. gingivalis bacteria identified by conventional culture and immunofluorescence with monoclonal antibody 61BG 1.3 showed a very significant correlation between the two methods (Spearman r = 0.85, P < 0.001)."},{"Node1":"Porphyromonas Gingivalis (Organism)","Edge_Type":"bacteria_to_disease","Node2":"Periodontitis","Weight":2,"Paper_List":"8550186|29589156","Original_Text":"PMID:8550186; Original text:The number of P. gingivalis bacteria was then monitored, and significantly less recolonization of the sites with the most severe periodontitis was found in the monoclonal antibody-treated patients than in the control patients (P < 0.01).|PMID:29589156; Original text:At all time-points, levels of inflammatory markers in GCF were higher in arthritis-severe chronic periodontitis than in severe chronic periodontitis patients."},{"Node1":"Actinobacillus Actinomycetemcomitans","Edge_Type":"bacteria_to_anatomy","Node2":"Periodontal Ligament","Weight":1,"Paper_List":"18834241","Original_Text":"PMID:18834241; Original text:In full-term and preterm women, periodontal therapy significantly reduced (P <0.01) counts of all target species except for A. actinomycetemcomitans."},{"Node1":"Amoxicillin","Edge_Type":"chemical","Node2":"calcium lactate","Weight":1,"Paper_List":"11966932","Original_Text":"PMID:11966932; Original text:P. intermedia counts were always lower in active groups compared to PP and reached significance for AM and amoxycillin and calcium lactate tablets at 1 month and AM and PM at 3 months."},{"Node1":"calcium ","Edge_Type":"nutrient_to_chemical","Node2":"calcium lactate","Weight":1,"Paper_List":"11966932","Original_Text":"PMID:11966932; Original text:P. intermedia counts were always lower in active groups compared to PP and reached significance for AM and amoxycillin and calcium lactate tablets at 1 month and AM and PM at 3 months."},{"Node1":"calcium ","Edge_Type":"nutrient_to_chemical","Node2":"Amoxicillin","Weight":1,"Paper_List":"11966932","Original_Text":"PMID:11966932; Original text:P. intermedia counts were always lower in active groups compared to PP and reached significance for AM and amoxycillin and calcium lactate tablets at 1 month and AM and PM at 3 months."},{"Node1":"Metronidazole","Edge_Type":"chemical_to_disease","Node2":"Periodontal Diseases","Weight":1,"Paper_List":"11966932","Original_Text":"PMID:11966932; Original text:The significant differences among treatment groups and the overall trend in the data, in line with other studies, support the considerable adjunctive benefits to root planing of amoxycillin and metronidazole combined in the treatment of advanced chronic periodontal disease."},{"Node1":"Amoxicillin","Edge_Type":"chemical_to_disease","Node2":"Periodontal Diseases","Weight":1,"Paper_List":"11966932","Original_Text":"PMID:11966932; Original text:The significant differences among treatment groups and the overall trend in the data, in line with other studies, support the considerable adjunctive benefits to root planing of amoxycillin and metronidazole combined in the treatment of advanced chronic periodontal disease."},{"Node1":"Halitosis","Edge_Type":"disease","Node2":"Hemorrhage","Weight":1,"Paper_List":"25101909","Original_Text":"PMID:25101909; Original text:No statistically significant group × time interactions were found for plaque index, gingival index, pocket depth, bleeding on probing, and halitosis, which means three independent groups change like each other by time."},{"Node1":"Pain","Edge_Type":"disease_to_anatomy","Node2":"Tooth","Weight":2,"Paper_List":"29398090|11128919","Original_Text":"PMID:29398090; Original text:The linear regression analysis demonstrated that group variable had the most significant effect on postoperative pain at day 1 (P < .001) among the other variables (group, age, gender, tooth number, preoperative pain levels, and VAS scores of pain on percussion).|PMID:11128919; Original text:Smokers were found to have a statistically significantly higher incidence of severe symptoms in root hypersensitivity, tooth pain, and swelling compared to non-smokers (n = 21)."},{"Node1":"Diabetes Mellitus, Type 2","Edge_Type":"disease","Node2":"Periodontal Attachment Loss","Weight":1,"Paper_List":"20507373","Original_Text":"PMID:20507373; Original text:Site-level PPD at baseline was a significant effect modifier of associations between poorly-controlled type-2 diabetes mellitus and site-level clinical attachment loss and PPD progression [adjusted odds ratios ([adjusted odds ratios) according to poorly-controlled type-2 diabetes mellitus among PPD at baseline=3, 5 and 7 mm, respectively: clinical attachment loss progression=1.93, 2.64, and 3.62, PPD progression=1.98, 2.76, and 3.84; p<0.05 for all]."},{"Node1":"Arthropathy, progressive pseudorheumatoid, of childhood","Edge_Type":"disease","Node2":"Periodontal Attachment Loss","Weight":1,"Paper_List":"20507373","Original_Text":"PMID:20507373; Original text:Site-level PPD at baseline was a significant effect modifier of associations between poorly-controlled type-2 diabetes mellitus and site-level clinical attachment loss and PPD progression [adjusted odds ratios ([adjusted odds ratios) according to poorly-controlled type-2 diabetes mellitus among PPD at baseline=3, 5 and 7 mm, respectively: clinical attachment loss progression=1.93, 2.64, and 3.62, PPD progression=1.98, 2.76, and 3.84; p<0.05 for all]."},{"Node1":"Arthropathy, progressive pseudorheumatoid, of childhood","Edge_Type":"disease","Node2":"Diabetes Mellitus, Type 2","Weight":1,"Paper_List":"20507373","Original_Text":"PMID:20507373; Original text:Site-level PPD at baseline was a significant effect modifier of associations between poorly-controlled type-2 diabetes mellitus and site-level clinical attachment loss and PPD progression [adjusted odds ratios ([adjusted odds ratios) according to poorly-controlled type-2 diabetes mellitus among PPD at baseline=3, 5 and 7 mm, respectively: clinical attachment loss progression=1.93, 2.64, and 3.62, PPD progression=1.98, 2.76, and 3.84; p<0.05 for all]."},{"Node1":"Streptococcus Mutans","Edge_Type":"bacteria_to_disease","Node2":"Hemorrhage","Weight":1,"Paper_List":"30991136","Original_Text":"PMID:30991136; Original text:S. striata in the short term, improve plaque index, pocket depth and bleeding on probing but the number of Streptococcus mutans changed significantly in the long term and is more potent in comparison to Irsha mouthwash."},{"Node1":"Minocycline","Edge_Type":"chemical","Node2":"Tetracycline","Weight":1,"Paper_List":"23320860","Original_Text":"PMID:23320860; Original text:Subgingival application of tetracycline fibres, sustained released doxycycline and minocycline demonstrated a significant benefit in pocket depth reduction (a weighted mean difference between 0.5 and 0.7 mm)."},{"Node1":"Doxycycline","Edge_Type":"chemical","Node2":"Tetracycline","Weight":1,"Paper_List":"23320860","Original_Text":"PMID:23320860; Original text:Subgingival application of tetracycline fibres, sustained released doxycycline and minocycline demonstrated a significant benefit in pocket depth reduction (a weighted mean difference between 0.5 and 0.7 mm)."},{"Node1":"Doxycycline","Edge_Type":"chemical","Node2":"Minocycline","Weight":1,"Paper_List":"23320860","Original_Text":"PMID:23320860; Original text:Subgingival application of tetracycline fibres, sustained released doxycycline and minocycline demonstrated a significant benefit in pocket depth reduction (a weighted mean difference between 0.5 and 0.7 mm)."},{"Node1":"Sodium Hypochlorite","Edge_Type":"chemical","Node2":"chlorhexidine gluconate","Weight":1,"Paper_List":"21238793","Original_Text":"PMID:21238793; Original text:Both 2.5% sodium hypochlorite- and 0.12% chlorhexidine digluconate-based protocols were significantly effective in reducing the bacterial levels and number of taxa."},{"Node1":"Erectile Dysfunction","Edge_Type":"disease","Node2":"Periodontitis","Weight":4,"Paper_List":"26749274|33319469|33319469|27829669","Original_Text":"PMID:26749274; Original text:Based on random effects meta-analysis, a significant association between chronic periodontitis and erectile dysfunction was identified (OR = 3.07, 95% CI: 1.87-5.05, p < 0.001).|PMID:33319469; Original text:Out of nine studies, eight found a significant association between erectile dysfunction (erectile dysfunction) and periodontitis.|PMID:33319469; Original text:The results of this systematic review revealed a significant association between periodontitis and erectile dysfunction, although the responsible mechanisms remain unclear.|PMID:27829669; Original text:In conclusion, our meta-analysis suggested that there was a significant association between chronic periodontitis and the risk of erectile dysfunction."},{"Node1":"Body Fluids","Edge_Type":"anatomy","Node2":"Gingiva","Weight":2,"Paper_List":"25814780|25814780","Original_Text":"PMID:25814780; Original text:gingival crevicular fluid, salivary and gingival OPG profiles were significantly higher in control subjects compared to chronic periodontitis patients at baseline (P < 0.001).|PMID:25814780; Original text:Within chronic periodontitis group, OPG levels in gingival crevicular fluid, saliva, and gingival samples showed a significant increase at 3 and 6 months after open flap debridement (P < 0.001) compared to baseline."},{"Node1":"Body Fluids","Edge_Type":"anatomy","Node2":"Gingival Crevicular Fluid","Weight":3,"Paper_List":"25814780|25814780|1593412","Original_Text":"PMID:25814780; Original text:gingival crevicular fluid, salivary and gingival OPG profiles were significantly higher in control subjects compared to chronic periodontitis patients at baseline (P < 0.001).|PMID:25814780; Original text:Within chronic periodontitis group, OPG levels in gingival crevicular fluid, saliva, and gingival samples showed a significant increase at 3 and 6 months after open flap debridement (P < 0.001) compared to baseline.|PMID:1593412; Original text:Significant differences (P less than 0.001) with the oral irrigator were found for the following parameters: microscopy, pocket depth, crevicular fluid, and plaque index."},{"Node1":"Body Fluids","Edge_Type":"anatomy","Node2":"Salivary Glands","Weight":1,"Paper_List":"25814780","Original_Text":"PMID:25814780; Original text:gingival crevicular fluid, salivary and gingival OPG profiles were significantly higher in control subjects compared to chronic periodontitis patients at baseline (P < 0.001)."},{"Node1":"Pain, Postoperative","Edge_Type":"disease_to_anatomy","Node2":"Tooth","Weight":1,"Paper_List":"29398090","Original_Text":"PMID:29398090; Original text:The linear regression analysis demonstrated that group variable had the most significant effect on postoperative pain at day 1 (P < .001) among the other variables (group, age, gender, tooth number, preoperative pain levels, and VAS scores of pain on percussion)."},{"Node1":"Pancreatitis, Chronic","Edge_Type":"disease_to_anatomy","Node2":"Tooth","Weight":1,"Paper_List":"28645686","Original_Text":"PMID:28645686; Original text:A significant relationship was observed with atherothrombotic cardiovascular disease in 10 out of 10 studies addressing the degree of oral hygiene, in 14 of 17 that included loss of teeth, in 6 of 12 that analysed caries and in 11 of 15 that included chronic apical periodontitis."},{"Node1":"Pericardial Effusion","Edge_Type":"disease_to_anatomy","Node2":"Dental Pulp Cavity","Weight":1,"Paper_List":"20478447","Original_Text":"PMID:20478447; Original text:With regard to tooth-related factors, the following categories were significantly associated with higher healed rates: cases without preoperative pain or signs, cases with good density of root canal filling, and cases with absence or size < or = 5 mm of periapical lesion."},{"Node1":"Chronic Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"tumor necrosis factor receptor superfamily member 11b S homeolog","Weight":1,"Paper_List":"25814780","Original_Text":"PMID:25814780; Original text:Within chronic periodontitis group, OPG levels in gingival crevicular fluid, saliva, and gingival samples showed a significant increase at 3 and 6 months after open flap debridement (P < 0.001) compared to baseline."},{"Node1":"tumor necrosis factor receptor superfamily member 11b S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"25814780","Original_Text":"PMID:25814780; Original text:Within chronic periodontitis group, OPG levels in gingival crevicular fluid, saliva, and gingival samples showed a significant increase at 3 and 6 months after open flap debridement (P < 0.001) compared to baseline."},{"Node1":"tumor necrosis factor receptor superfamily member 11b S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"25814780","Original_Text":"PMID:25814780; Original text:Within chronic periodontitis group, OPG levels in gingival crevicular fluid, saliva, and gingival samples showed a significant increase at 3 and 6 months after open flap debridement (P < 0.001) compared to baseline."},{"Node1":"tumor necrosis factor receptor superfamily member 11b S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Body Fluids","Weight":1,"Paper_List":"25814780","Original_Text":"PMID:25814780; Original text:Within chronic periodontitis group, OPG levels in gingival crevicular fluid, saliva, and gingival samples showed a significant increase at 3 and 6 months after open flap debridement (P < 0.001) compared to baseline."},{"Node1":"Chlorhexidine","Edge_Type":"chemical_to_disease","Node2":"Gingivitis","Weight":3,"Paper_List":"15811057|1440118|10225548","Original_Text":"PMID:15811057; Original text:Although there was a significant treatment impact (mechanical debridement) in all groups, both Chlorhexidine solutions further decreased both plaque and gingivitis indices (p<0.001 and p<0.05, respectively), when compared with placebo.|PMID:1440118; Original text:Compared with placebo, swabbing with chlorhexidine resulted in consistent, and, in part, significant improvements in plaque, gingivitis, and periodontal pocket depth.|PMID:10225548; Original text:Sanguinarine-containing toothpaste and oral rinse significantly inhibited the redevelopment of gingivitis through the 12 weeks following the chlorhexidine phase compared to the control toothpaste and rinse."},{"Node1":"Alcohols","Edge_Type":"chemical","Node2":"Cetylpyridinium","Weight":1,"Paper_List":"15811057","Original_Text":"PMID:15811057; Original text:The subjective ratings were slightly in favour of the new Chlorhexidine-CHX 0.05%+ cetyl pyridinium chloride formulation when compared with the other Chlorhexidine-alcohol formulation, especially for taste of the product (p<0.05), but less impressive for the staining of teeth and tongue."},{"Node1":"Alcohols","Edge_Type":"chemical","Node2":"Chlorhexidine","Weight":1,"Paper_List":"15811057","Original_Text":"PMID:15811057; Original text:The subjective ratings were slightly in favour of the new Chlorhexidine-CHX 0.05%+ cetyl pyridinium chloride formulation when compared with the other Chlorhexidine-alcohol formulation, especially for taste of the product (p<0.05), but less impressive for the staining of teeth and tongue."},{"Node1":"Cetylpyridinium","Edge_Type":"chemical_to_anatomy","Node2":"Tooth","Weight":1,"Paper_List":"15811057","Original_Text":"PMID:15811057; Original text:The subjective ratings were slightly in favour of the new Chlorhexidine-CHX 0.05%+ cetyl pyridinium chloride formulation when compared with the other Chlorhexidine-alcohol formulation, especially for taste of the product (p<0.05), but less impressive for the staining of teeth and tongue."},{"Node1":"Alcohols","Edge_Type":"chemical_to_anatomy","Node2":"Tooth","Weight":1,"Paper_List":"15811057","Original_Text":"PMID:15811057; Original text:The subjective ratings were slightly in favour of the new Chlorhexidine-CHX 0.05%+ cetyl pyridinium chloride formulation when compared with the other Chlorhexidine-alcohol formulation, especially for taste of the product (p<0.05), but less impressive for the staining of teeth and tongue."},{"Node1":"Chlorhexidine","Edge_Type":"chemical_to_anatomy","Node2":"Tooth","Weight":1,"Paper_List":"15811057","Original_Text":"PMID:15811057; Original text:The subjective ratings were slightly in favour of the new Chlorhexidine-CHX 0.05%+ cetyl pyridinium chloride formulation when compared with the other Chlorhexidine-alcohol formulation, especially for taste of the product (p<0.05), but less impressive for the staining of teeth and tongue."},{"Node1":"Diabetic Retinopathy","Edge_Type":"disease","Node2":"Periodontitis","Weight":1,"Paper_List":"33490007","Original_Text":"PMID:33490007; Original text:Among the included studies, a significant relationship between the severity of periodontitis (CAL > 5 mm) and the severity of diabetic retinopathy (p < 0.05) was reported by four studies."},{"Node1":"Pericardial Effusion","Edge_Type":"disease_to_anatomy","Node2":"Gingiva","Weight":2,"Paper_List":"25963290|16640635","Original_Text":"PMID:25963290; Original text:Both the groups exhibited a significant reduction in pocket depth, clinical attachment level, gingival marginal position, and size of periapical lesion at 12-month period.|PMID:16640635; Original text:Both groups showed highly significant (P < 0.001) reductions in periodontal the periodontal pocket depth, clinical attachment level and size of periapical lesion at 12 months whilst gingival margin position was unaltered."},{"Node1":"hemoglobin, alpha embryonic 1.3","Edge_Type":"mechanism","Node2":"methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2 like","Weight":1,"Paper_List":"26039911","Original_Text":"PMID:26039911; Original text:There were no differences in TNF-α, interleukin-8, interleukin-17A and HbA1c levels in either group (p > 0.05), between the two periods."},{"Node1":"interleukin 17F","Edge_Type":"mechanism","Node2":"methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2 like","Weight":1,"Paper_List":"26039911","Original_Text":"PMID:26039911; Original text:There were no differences in TNF-α, interleukin-8, interleukin-17A and HbA1c levels in either group (p > 0.05), between the two periods."},{"Node1":"hemoglobin, alpha embryonic 1.3","Edge_Type":"mechanism","Node2":"interleukin 17F","Weight":1,"Paper_List":"26039911","Original_Text":"PMID:26039911; Original text:There were no differences in TNF-α, interleukin-8, interleukin-17A and HbA1c levels in either group (p > 0.05), between the two periods."},{"Node1":"interleukin 6 L homeolog","Edge_Type":"mechanism","Node2":"mast cell protease 1","Weight":1,"Paper_List":"26039911","Original_Text":"PMID:26039911; Original text:However, MCP-1 levels were significantly reduced in both the ST (p = 0.034) and the IT (p = 0.016) groups, whereas the serum interleukin-6 levels were significantly reduced only in the IT group (p = 0.001)."},{"Node1":"Amoxicillin","Edge_Type":"chemical","Node2":"Spiramycin","Weight":1,"Paper_List":"12787214","Original_Text":"PMID:12787214; Original text:This analysis showed a statistically significant additional benefit for spiramycin (pocket depth change) and amoxicillin/metronidazole (CAL change) in deep pockets."},{"Node1":"Metronidazole","Edge_Type":"chemical","Node2":"Spiramycin","Weight":1,"Paper_List":"12787214","Original_Text":"PMID:12787214; Original text:This analysis showed a statistically significant additional benefit for spiramycin (pocket depth change) and amoxicillin/metronidazole (CAL change) in deep pockets."},{"Node1":"Aggregatibacter Actinomycetemcomitans","Edge_Type":"bacteria","Node2":"Prevotella Intermedia","Weight":3,"Paper_List":"32865464|29327449|26313005","Original_Text":"PMID:32865464; Original text: mm after 12 months of follow-up.|PMID:29327449; Original text:Evaluation using clinical parameters showed better results in low-level laser therapy group.|PMID:26313005; Original text:The mere presence of Pg, even in low amount, was significantly associated with severe periodontitis, while the amount of Aggregatibacter actinomycetemcomitans, Treponema denticola, and Prevotella intermedia had to reach the critical thresholds to be significantly associated with disease."},{"Node1":"Endothelium, Vascular","Edge_Type":"anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"26547514","Original_Text":"PMID:26547514; Original text:Similarly, vascular endothelial growth factor concentration in gingival crevicular fluid was significantly higher in the ankaferd blood stopper/autogenous cortical bone graft group at postoperative weeks 2 and 4 compared to the autogenous cortical bone graft group (p < 0.01)."},{"Node1":"Cortical Bone","Edge_Type":"anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"26547514","Original_Text":"PMID:26547514; Original text:Similarly, vascular endothelial growth factor concentration in gingival crevicular fluid was significantly higher in the ankaferd blood stopper/autogenous cortical bone graft group at postoperative weeks 2 and 4 compared to the autogenous cortical bone graft group (p < 0.01)."},{"Node1":"Cortical Bone","Edge_Type":"anatomy","Node2":"Endothelium, Vascular","Weight":1,"Paper_List":"26547514","Original_Text":"PMID:26547514; Original text:Similarly, vascular endothelial growth factor concentration in gingival crevicular fluid was significantly higher in the ankaferd blood stopper/autogenous cortical bone graft group at postoperative weeks 2 and 4 compared to the autogenous cortical bone graft group (p < 0.01)."},{"Node1":"Endothelium, Vascular","Edge_Type":"anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"26547514","Original_Text":"PMID:26547514; Original text:Similarly, vascular endothelial growth factor concentration in gingival crevicular fluid was significantly higher in the ankaferd blood stopper/autogenous cortical bone graft group at postoperative weeks 2 and 4 compared to the autogenous cortical bone graft group (p < 0.01)."},{"Node1":"vascular endothelial growth factor precursor","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"26547514","Original_Text":"PMID:26547514; Original text:Similarly, vascular endothelial growth factor concentration in gingival crevicular fluid was significantly higher in the ankaferd blood stopper/autogenous cortical bone graft group at postoperative weeks 2 and 4 compared to the autogenous cortical bone graft group (p < 0.01)."},{"Node1":"vascular endothelial growth factor precursor","Edge_Type":"mechanism_to_anatomy","Node2":"Cortical Bone","Weight":1,"Paper_List":"26547514","Original_Text":"PMID:26547514; Original text:Similarly, vascular endothelial growth factor concentration in gingival crevicular fluid was significantly higher in the ankaferd blood stopper/autogenous cortical bone graft group at postoperative weeks 2 and 4 compared to the autogenous cortical bone graft group (p < 0.01)."},{"Node1":"vascular endothelial growth factor precursor","Edge_Type":"mechanism_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"26547514","Original_Text":"PMID:26547514; Original text:Similarly, vascular endothelial growth factor concentration in gingival crevicular fluid was significantly higher in the ankaferd blood stopper/autogenous cortical bone graft group at postoperative weeks 2 and 4 compared to the autogenous cortical bone graft group (p < 0.01)."},{"Node1":"myeloid-specific peroxidase","Edge_Type":"mechanism","Node2":"selectin P L homeolog","Weight":1,"Paper_List":"24495202","Original_Text":"PMID:24495202; Original text:Univariate analyses demonstrated significantly higher plasma levels of E-selectin (64.5 ± 30.9 vs 43.8 ± 22.2; P = 0.026) and myeloperoxidase (MPO) (103 ± 114.5 vs 49.1 ± 35.6; P = 0.032) in severe periodontitis than controls."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"selectin P L homeolog","Weight":2,"Paper_List":"24495202|24495202","Original_Text":"PMID:24495202; Original text:Univariate analyses demonstrated significantly higher plasma levels of E-selectin (64.5 ± 30.9 vs 43.8 ± 22.2; P = 0.026) and myeloperoxidase (MPO) (103 ± 114.5 vs 49.1 ± 35.6; P = 0.032) in severe periodontitis than controls.|PMID:24495202; Original text:In addition, significantly higher levels of E-selectin, MPO and ICAM-1 were found in periodontitis patients after adjustment by age and waist circumference."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"myeloid-specific peroxidase","Weight":1,"Paper_List":"24495202","Original_Text":"PMID:24495202; Original text:Univariate analyses demonstrated significantly higher plasma levels of E-selectin (64.5 ± 30.9 vs 43.8 ± 22.2; P = 0.026) and myeloperoxidase (MPO) (103 ± 114.5 vs 49.1 ± 35.6; P = 0.032) in severe periodontitis than controls."},{"Node1":"intercellular adhesion molecule-1","Edge_Type":"mechanism","Node2":"selectin P L homeolog","Weight":1,"Paper_List":"24495202","Original_Text":"PMID:24495202; Original text:In addition, significantly higher levels of E-selectin, MPO and ICAM-1 were found in periodontitis patients after adjustment by age and waist circumference."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"intercellular adhesion molecule-1","Weight":1,"Paper_List":"24495202","Original_Text":"PMID:24495202; Original text:In addition, significantly higher levels of E-selectin, MPO and ICAM-1 were found in periodontitis patients after adjustment by age and waist circumference."},{"Node1":"endothelin receptor type B","Edge_Type":"mechanism","Node2":"fibrinogen gamma chain","Weight":1,"Paper_List":"24111886","Original_Text":"PMID:24111886; Original text:Meta-analyses demonstrated significant weighted mean difference (significant weighted mean difference) for hsCRP (-0.50 mg/l, 95% CI:-0.78; -0.22), IL-6 (-0.48 ng/l, 95% CI: -0.90; -0.06), TNF-α (-0.75 pg/ml, 95% CI: -1.34; -0.17), fibrinogen (-0.47 g/l, 95% CI: -0.76; -0.17), total cholesterol (-0.11 mmol/l, 95% CI: -0.21; -0.01) and HDL-C (0.04 mmol/l, 95% CI: 0.03; 0.06) favouring periodontal intervention."},{"Node1":"endothelin receptor type B","Edge_Type":"mechanism","Node2":"interleukin 6 cytokine family signal transducer","Weight":2,"Paper_List":"24111886|24111886","Original_Text":"PMID:24111886; Original text:Meta-analyses demonstrated significant weighted mean difference (significant weighted mean difference) for hsCRP (-0.50 mg/l, 95% CI:-0.78; -0.22), IL-6 (-0.48 ng/l, 95% CI: -0.90; -0.06), TNF-α (-0.75 pg/ml, 95% CI: -1.34; -0.17), fibrinogen (-0.47 g/l, 95% CI: -0.76; -0.17), total cholesterol (-0.11 mmol/l, 95% CI: -0.21; -0.01) and HDL-C (0.04 mmol/l, 95% CI: 0.03; 0.06) favouring periodontal intervention.|PMID:24111886; Original text:Importantly, periodontitis patients with co-morbidity benefitted most from periodontal therapy; significant significant weighted mean difference were observed for levels of hsCRP (-0.71 mg/l, 95% CI: -1.05; -0.36), IL-6 (-0.87 ng/l, 95% CI: -0.97; -0.78), triglycerides (-0.24 mmol/l, 95% CI: -0.26; -0.22), total cholesterol (-0.15 mmol/l, 95% CI: -0.29; -0.01), HDL-C (0.05 mmol/l, 95% CI: 0.03; 0.06) and HbA1c (-0.43%, 95% CI: -0.60; -0.25)."},{"Node1":"fibrinogen gamma chain","Edge_Type":"mechanism","Node2":"interleukin 6 cytokine family signal transducer","Weight":3,"Paper_List":"24111886|16283108|19405832","Original_Text":"PMID:24111886; Original text:Meta-analyses demonstrated significant weighted mean difference (significant weighted mean difference) for hsCRP (-0.50 mg/l, 95% CI:-0.78; -0.22), IL-6 (-0.48 ng/l, 95% CI: -0.90; -0.06), TNF-α (-0.75 pg/ml, 95% CI: -1.34; -0.17), fibrinogen (-0.47 g/l, 95% CI: -0.76; -0.17), total cholesterol (-0.11 mmol/l, 95% CI: -0.21; -0.01) and HDL-C (0.04 mmol/l, 95% CI: 0.03; 0.06) favouring periodontal intervention.|PMID:16283108; Original text:TNF-alpha levels were significantly raised only after 1 day of therapy (P<0.01) whereas IL-6 (P<0.01), CRP (P<0.001) and Fibrinogen (P<0.001) concentrations peaked 24 hrs after and returned to baseline values within one month following therapy.|PMID:19405832; Original text:Periodontal treatment significantly reduced the blood levels of fibrinogen, CRP, and IL-6 in the test group."},{"Node1":"fibrinogen gamma chain","Edge_Type":"mechanism","Node2":"tumor necrosis factor receptor superfamily, member a","Weight":1,"Paper_List":"24111886","Original_Text":"PMID:24111886; Original text:Meta-analyses demonstrated significant weighted mean difference (significant weighted mean difference) for hsCRP (-0.50 mg/l, 95% CI:-0.78; -0.22), IL-6 (-0.48 ng/l, 95% CI: -0.90; -0.06), TNF-α (-0.75 pg/ml, 95% CI: -1.34; -0.17), fibrinogen (-0.47 g/l, 95% CI: -0.76; -0.17), total cholesterol (-0.11 mmol/l, 95% CI: -0.21; -0.01) and HDL-C (0.04 mmol/l, 95% CI: 0.03; 0.06) favouring periodontal intervention."},{"Node1":"Cholesterol","Edge_Type":"chemical_to_mechanism","Node2":"endothelin receptor type B","Weight":2,"Paper_List":"24111886|24111886","Original_Text":"PMID:24111886; Original text:Meta-analyses demonstrated significant weighted mean difference (significant weighted mean difference) for hsCRP (-0.50 mg/l, 95% CI:-0.78; -0.22), IL-6 (-0.48 ng/l, 95% CI: -0.90; -0.06), TNF-α (-0.75 pg/ml, 95% CI: -1.34; -0.17), fibrinogen (-0.47 g/l, 95% CI: -0.76; -0.17), total cholesterol (-0.11 mmol/l, 95% CI: -0.21; -0.01) and HDL-C (0.04 mmol/l, 95% CI: 0.03; 0.06) favouring periodontal intervention.|PMID:24111886; Original text:Importantly, periodontitis patients with co-morbidity benefitted most from periodontal therapy; significant significant weighted mean difference were observed for levels of hsCRP (-0.71 mg/l, 95% CI: -1.05; -0.36), IL-6 (-0.87 ng/l, 95% CI: -0.97; -0.78), triglycerides (-0.24 mmol/l, 95% CI: -0.26; -0.22), total cholesterol (-0.15 mmol/l, 95% CI: -0.29; -0.01), HDL-C (0.05 mmol/l, 95% CI: 0.03; 0.06) and HbA1c (-0.43%, 95% CI: -0.60; -0.25)."},{"Node1":"Cholesterol","Edge_Type":"chemical_to_mechanism","Node2":"fibrinogen gamma chain","Weight":1,"Paper_List":"24111886","Original_Text":"PMID:24111886; Original text:Meta-analyses demonstrated significant weighted mean difference (significant weighted mean difference) for hsCRP (-0.50 mg/l, 95% CI:-0.78; -0.22), IL-6 (-0.48 ng/l, 95% CI: -0.90; -0.06), TNF-α (-0.75 pg/ml, 95% CI: -1.34; -0.17), fibrinogen (-0.47 g/l, 95% CI: -0.76; -0.17), total cholesterol (-0.11 mmol/l, 95% CI: -0.21; -0.01) and HDL-C (0.04 mmol/l, 95% CI: 0.03; 0.06) favouring periodontal intervention."},{"Node1":"Cholesterol","Edge_Type":"chemical_to_mechanism","Node2":"interleukin 6 cytokine family signal transducer","Weight":2,"Paper_List":"24111886|24111886","Original_Text":"PMID:24111886; Original text:Meta-analyses demonstrated significant weighted mean difference (significant weighted mean difference) for hsCRP (-0.50 mg/l, 95% CI:-0.78; -0.22), IL-6 (-0.48 ng/l, 95% CI: -0.90; -0.06), TNF-α (-0.75 pg/ml, 95% CI: -1.34; -0.17), fibrinogen (-0.47 g/l, 95% CI: -0.76; -0.17), total cholesterol (-0.11 mmol/l, 95% CI: -0.21; -0.01) and HDL-C (0.04 mmol/l, 95% CI: 0.03; 0.06) favouring periodontal intervention.|PMID:24111886; Original text:Importantly, periodontitis patients with co-morbidity benefitted most from periodontal therapy; significant significant weighted mean difference were observed for levels of hsCRP (-0.71 mg/l, 95% CI: -1.05; -0.36), IL-6 (-0.87 ng/l, 95% CI: -0.97; -0.78), triglycerides (-0.24 mmol/l, 95% CI: -0.26; -0.22), total cholesterol (-0.15 mmol/l, 95% CI: -0.29; -0.01), HDL-C (0.05 mmol/l, 95% CI: 0.03; 0.06) and HbA1c (-0.43%, 95% CI: -0.60; -0.25)."},{"Node1":"Cholesterol","Edge_Type":"chemical_to_mechanism","Node2":"tumor necrosis factor receptor superfamily, member a","Weight":1,"Paper_List":"24111886","Original_Text":"PMID:24111886; Original text:Meta-analyses demonstrated significant weighted mean difference (significant weighted mean difference) for hsCRP (-0.50 mg/l, 95% CI:-0.78; -0.22), IL-6 (-0.48 ng/l, 95% CI: -0.90; -0.06), TNF-α (-0.75 pg/ml, 95% CI: -1.34; -0.17), fibrinogen (-0.47 g/l, 95% CI: -0.76; -0.17), total cholesterol (-0.11 mmol/l, 95% CI: -0.21; -0.01) and HDL-C (0.04 mmol/l, 95% CI: 0.03; 0.06) favouring periodontal intervention."},{"Node1":"Triglycerides","Edge_Type":"chemical_to_mechanism","Node2":"endothelin receptor type B","Weight":1,"Paper_List":"24111886","Original_Text":"PMID:24111886; Original text:Importantly, periodontitis patients with co-morbidity benefitted most from periodontal therapy; significant significant weighted mean difference were observed for levels of hsCRP (-0.71 mg/l, 95% CI: -1.05; -0.36), IL-6 (-0.87 ng/l, 95% CI: -0.97; -0.78), triglycerides (-0.24 mmol/l, 95% CI: -0.26; -0.22), total cholesterol (-0.15 mmol/l, 95% CI: -0.29; -0.01), HDL-C (0.05 mmol/l, 95% CI: 0.03; 0.06) and HbA1c (-0.43%, 95% CI: -0.60; -0.25)."},{"Node1":"Triglycerides","Edge_Type":"chemical_to_mechanism","Node2":"interleukin 6 cytokine family signal transducer","Weight":1,"Paper_List":"24111886","Original_Text":"PMID:24111886; Original text:Importantly, periodontitis patients with co-morbidity benefitted most from periodontal therapy; significant significant weighted mean difference were observed for levels of hsCRP (-0.71 mg/l, 95% CI: -1.05; -0.36), IL-6 (-0.87 ng/l, 95% CI: -0.97; -0.78), triglycerides (-0.24 mmol/l, 95% CI: -0.26; -0.22), total cholesterol (-0.15 mmol/l, 95% CI: -0.29; -0.01), HDL-C (0.05 mmol/l, 95% CI: 0.03; 0.06) and HbA1c (-0.43%, 95% CI: -0.60; -0.25)."},{"Node1":"Periodontal Abscess","Edge_Type":"disease_to_anatomy","Node2":"Blood Platelets","Weight":1,"Paper_List":"29023611","Original_Text":"PMID:29023611; Original text:Use of autologous platelet-rich fibrin significantly enhances the clinical and radiographic outcomes of open flap debridement in the treatment of periodontal intraosseous defects in patients affected by localized aggressive periodontitis."},{"Node1":"Hemoglobin","Edge_Type":"mechanism","Node2":"tumor necrosis factor S homeolog","Weight":1,"Paper_List":"24331774","Original_Text":"PMID:24331774; Original text:Generalized linear model revealed that changes of serum adiponectin and tumor necrosis factor-α and change of BOP correlated significantly with the reduction of Glycated hemoglobin at 6 months after periodontal treatments."},{"Node1":"Hemoglobin","Edge_Type":"mechanism","Node2":"adiponectin, C1Q and collagen domain containing S homeolog","Weight":1,"Paper_List":"24331774","Original_Text":"PMID:24331774; Original text:Generalized linear model revealed that changes of serum adiponectin and tumor necrosis factor-α and change of BOP correlated significantly with the reduction of Glycated hemoglobin at 6 months after periodontal treatments."},{"Node1":"Neoplasms","Edge_Type":"disease_to_mechanism","Node2":"Hemoglobin","Weight":1,"Paper_List":"24331774","Original_Text":"PMID:24331774; Original text:Generalized linear model revealed that changes of serum adiponectin and tumor necrosis factor-α and change of BOP correlated significantly with the reduction of Glycated hemoglobin at 6 months after periodontal treatments."},{"Node1":"Necrosis","Edge_Type":"disease_to_mechanism","Node2":"Hemoglobin","Weight":1,"Paper_List":"24331774","Original_Text":"PMID:24331774; Original text:Generalized linear model revealed that changes of serum adiponectin and tumor necrosis factor-α and change of BOP correlated significantly with the reduction of Glycated hemoglobin at 6 months after periodontal treatments."},{"Node1":"Glycine","Edge_Type":"chemical_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"25727403","Original_Text":"PMID:25727403; Original text:Significant improvement in plaque and gingival index scores were noted in glycine powder air-polishing and ultrasonic group."},{"Node1":"Periodontal Abscess","Edge_Type":"disease_to_anatomy","Node2":"Platelet-Rich Fibrin","Weight":1,"Paper_List":"29023611","Original_Text":"PMID:29023611; Original text:Use of autologous platelet-rich fibrin significantly enhances the clinical and radiographic outcomes of open flap debridement in the treatment of periodontal intraosseous defects in patients affected by localized aggressive periodontitis."},{"Node1":"Periodontal Diseases","Edge_Type":"disease_to_mechanism","Node2":"provisional ortholog of C-reactive protein L homeolog","Weight":1,"Paper_List":"24303954","Original_Text":"PMID:24303954; Original text:With the exception of GCF C-reactive protein, all biomarkers were significantly higher in the periodontal disease progression group compared to stable patients."},{"Node1":"Hemorrhage","Edge_Type":"disease","Node2":"Periodontitis","Weight":3,"Paper_List":"12789964|22779217|31923289","Original_Text":"PMID:12789964; Original text:Similarly, significant improvements in clinical attachment level and percent bleeding on probing were observed among advanced periodontitis patients treated with SRP plus minocycline microspheres relative to controls.|PMID:22779217; Original text:The adjunctive use over three months of 1.7% hydrogen peroxide gel, locally administered using prescription customized trays in the treatment of subjects with moderate to advanced periodontitis, demonstrated statistically significant clinical improvements in pocket depths and bleeding when compared with root planing alone.|PMID:31923289; Original text:Based on the results of meta-analyses, in implants with a rough surface, even under the regular regular supportive post-implant treatment, the periodontitis group showed a lower implant survival rate (Risk ratio: 0.96, 95% confidence interval [CI]: 0.94 to 0.98, P < .001) and more radiologic marginal bone loss (mean difference: 0.34 mm, 95% CI: 0.20 to 0.48, P < .001), pocket depth (mean difference: 0.47 mm, 95% CI: 0.19 to 0.74, P < .001), and bleeding on probing (mean difference: 0.08 mm, 95% CI: 0.04 to 0.11, P < .001) than the non-periodontitis group."},{"Node1":"Minocycline","Edge_Type":"chemical_to_disease","Node2":"Periodontitis","Weight":2,"Paper_List":"12789964|18384391","Original_Text":"PMID:12789964; Original text:Similarly, significant improvements in clinical attachment level and percent bleeding on probing were observed among advanced periodontitis patients treated with SRP plus minocycline microspheres relative to controls.|PMID:18384391; Original text:Applications of local minocycline as an adjunct to surgery in adults with moderate to severe, chronic periodontitis were associated with statistically significant greater reductions in probing depth than surgery alone."},{"Node1":"Beta-glucuronidase","Edge_Type":"mechanism","Node2":"hexosaminidase B (beta polypeptide) L homeolog","Weight":1,"Paper_List":"17458082","Original_Text":"PMID:17458082; Original text:Although the assessment of the activity of such enzymes as beta-glucuronidase, HEX, HEX A and HEX B in the saliva of aggressive periodontitis patients allows detection of periodontal inflammation, it cannot be used to determine the risk of its development and therefore has no practical significance."},{"Node1":"hematopoietically expressed homeobox S homeolog","Edge_Type":"mechanism","Node2":"hexosaminidase B (beta polypeptide) L homeolog","Weight":1,"Paper_List":"17458082","Original_Text":"PMID:17458082; Original text:Although the assessment of the activity of such enzymes as beta-glucuronidase, HEX, HEX A and HEX B in the saliva of aggressive periodontitis patients allows detection of periodontal inflammation, it cannot be used to determine the risk of its development and therefore has no practical significance."},{"Node1":"hexosaminidase B (beta polypeptide) L homeolog","Edge_Type":"mechanism","Node2":"hexosaminidase subunit beta","Weight":1,"Paper_List":"17458082","Original_Text":"PMID:17458082; Original text:Although the assessment of the activity of such enzymes as beta-glucuronidase, HEX, HEX A and HEX B in the saliva of aggressive periodontitis patients allows detection of periodontal inflammation, it cannot be used to determine the risk of its development and therefore has no practical significance."},{"Node1":"Beta-glucuronidase","Edge_Type":"mechanism","Node2":"hematopoietically expressed homeobox S homeolog","Weight":1,"Paper_List":"17458082","Original_Text":"PMID:17458082; Original text:Although the assessment of the activity of such enzymes as beta-glucuronidase, HEX, HEX A and HEX B in the saliva of aggressive periodontitis patients allows detection of periodontal inflammation, it cannot be used to determine the risk of its development and therefore has no practical significance."},{"Node1":"Beta-glucuronidase","Edge_Type":"mechanism","Node2":"hexosaminidase subunit beta","Weight":1,"Paper_List":"17458082","Original_Text":"PMID:17458082; Original text:Although the assessment of the activity of such enzymes as beta-glucuronidase, HEX, HEX A and HEX B in the saliva of aggressive periodontitis patients allows detection of periodontal inflammation, it cannot be used to determine the risk of its development and therefore has no practical significance."},{"Node1":"hematopoietically expressed homeobox S homeolog","Edge_Type":"mechanism","Node2":"hexosaminidase subunit beta","Weight":1,"Paper_List":"17458082","Original_Text":"PMID:17458082; Original text:Although the assessment of the activity of such enzymes as beta-glucuronidase, HEX, HEX A and HEX B in the saliva of aggressive periodontitis patients allows detection of periodontal inflammation, it cannot be used to determine the risk of its development and therefore has no practical significance."},{"Node1":"Inflammation","Edge_Type":"disease_to_mechanism","Node2":"hexosaminidase B (beta polypeptide) L homeolog","Weight":1,"Paper_List":"17458082","Original_Text":"PMID:17458082; Original text:Although the assessment of the activity of such enzymes as beta-glucuronidase, HEX, HEX A and HEX B in the saliva of aggressive periodontitis patients allows detection of periodontal inflammation, it cannot be used to determine the risk of its development and therefore has no practical significance."},{"Node1":"Inflammation","Edge_Type":"disease_to_mechanism","Node2":"Beta-glucuronidase","Weight":1,"Paper_List":"17458082","Original_Text":"PMID:17458082; Original text:Although the assessment of the activity of such enzymes as beta-glucuronidase, HEX, HEX A and HEX B in the saliva of aggressive periodontitis patients allows detection of periodontal inflammation, it cannot be used to determine the risk of its development and therefore has no practical significance."},{"Node1":"Inflammation","Edge_Type":"disease_to_mechanism","Node2":"hematopoietically expressed homeobox S homeolog","Weight":1,"Paper_List":"17458082","Original_Text":"PMID:17458082; Original text:Although the assessment of the activity of such enzymes as beta-glucuronidase, HEX, HEX A and HEX B in the saliva of aggressive periodontitis patients allows detection of periodontal inflammation, it cannot be used to determine the risk of its development and therefore has no practical significance."},{"Node1":"Inflammation","Edge_Type":"disease_to_mechanism","Node2":"hexosaminidase subunit beta","Weight":1,"Paper_List":"17458082","Original_Text":"PMID:17458082; Original text:Although the assessment of the activity of such enzymes as beta-glucuronidase, HEX, HEX A and HEX B in the saliva of aggressive periodontitis patients allows detection of periodontal inflammation, it cannot be used to determine the risk of its development and therefore has no practical significance."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"hexosaminidase B (beta polypeptide) L homeolog","Weight":1,"Paper_List":"17458082","Original_Text":"PMID:17458082; Original text:Although the assessment of the activity of such enzymes as beta-glucuronidase, HEX, HEX A and HEX B in the saliva of aggressive periodontitis patients allows detection of periodontal inflammation, it cannot be used to determine the risk of its development and therefore has no practical significance."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"Beta-glucuronidase","Weight":1,"Paper_List":"17458082","Original_Text":"PMID:17458082; Original text:Although the assessment of the activity of such enzymes as beta-glucuronidase, HEX, HEX A and HEX B in the saliva of aggressive periodontitis patients allows detection of periodontal inflammation, it cannot be used to determine the risk of its development and therefore has no practical significance."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"hematopoietically expressed homeobox S homeolog","Weight":1,"Paper_List":"17458082","Original_Text":"PMID:17458082; Original text:Although the assessment of the activity of such enzymes as beta-glucuronidase, HEX, HEX A and HEX B in the saliva of aggressive periodontitis patients allows detection of periodontal inflammation, it cannot be used to determine the risk of its development and therefore has no practical significance."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"hexosaminidase subunit beta","Weight":1,"Paper_List":"17458082","Original_Text":"PMID:17458082; Original text:Although the assessment of the activity of such enzymes as beta-glucuronidase, HEX, HEX A and HEX B in the saliva of aggressive periodontitis patients allows detection of periodontal inflammation, it cannot be used to determine the risk of its development and therefore has no practical significance."},{"Node1":"Periodontitis","Edge_Type":"disease","Node2":"Tooth Loss","Weight":3,"Paper_List":"16968387|16968387|25261053","Original_Text":"PMID:16968387; Original text:Moreover, significantly increased peri-implant marginal bone loss was observed in patients with periodontitis-associated tooth loss after 5 years, mean difference 0.5 mm (95% CI 0.06-0.94).|PMID:16968387; Original text:However, significantly increased incidence of peri-implantitis and significantly increased peri-implant marginal bone loss were revealed in individuals with periodontitis-associated tooth loss.|PMID:25261053; Original text:Policy makers need to be aware of a predictable increasing burden of severe periodontitis due to the growing world population associated with an increasing life expectancy and a significant decrease in the prevalence of total tooth loss throughout the world from 1990 to 2010."},{"Node1":"Aggregatibacter Actinomycetemcomitans","Edge_Type":"bacteria","Node2":"Tannerella Forsythensis","Weight":1,"Paper_List":"29327449","Original_Text":"PMID:29327449; Original text:Evaluation using clinical parameters showed better results in low-level laser therapy group."},{"Node1":"chemokine (C-C motif) ligand 5 S homeolog","Edge_Type":"mechanism","Node2":"interleukin 6 cytokine family signal transducer","Weight":1,"Paper_List":"23788609","Original_Text":"PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05)."},{"Node1":"granulocyte-macrophage colony-stimulating factor","Edge_Type":"mechanism","Node2":"interleukin 6 cytokine family signal transducer","Weight":2,"Paper_List":"23788609|22126282","Original_Text":"PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05).|PMID:22126282; Original text:Significant reductions in crevicular fluid GM-CSF, IL-1β and the ratio IL-1β/IL-10 and increases in crevicular fluid IL-6 were detected after therapy."},{"Node1":"C-X-C motif chemokine ligand 10","Edge_Type":"mechanism","Node2":"interleukin 6 cytokine family signal transducer","Weight":1,"Paper_List":"23788609","Original_Text":"PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05)."},{"Node1":"chemokine (C-C motif) ligand 5 S homeolog","Edge_Type":"mechanism","Node2":"interleukin 10","Weight":1,"Paper_List":"23788609","Original_Text":"PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05)."},{"Node1":"granulocyte-macrophage colony-stimulating factor","Edge_Type":"mechanism","Node2":"interleukin 10","Weight":1,"Paper_List":"23788609","Original_Text":"PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05)."},{"Node1":"C-X-C motif chemokine ligand 10","Edge_Type":"mechanism","Node2":"interleukin 10","Weight":1,"Paper_List":"23788609","Original_Text":"PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05)."},{"Node1":"chemokine (C-C motif) ligand 5 S homeolog","Edge_Type":"mechanism","Node2":"interleukin 12B","Weight":1,"Paper_List":"23788609","Original_Text":"PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05)."},{"Node1":"chemokine (C-C motif) ligand 5 S homeolog","Edge_Type":"mechanism","Node2":"mast cell protease 1","Weight":1,"Paper_List":"23788609","Original_Text":"PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05)."},{"Node1":"chemokine (C-C motif) ligand 5 S homeolog","Edge_Type":"mechanism","Node2":"granulocyte-macrophage colony-stimulating factor","Weight":1,"Paper_List":"23788609","Original_Text":"PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05)."},{"Node1":"chemokine (C-C motif) ligand 5 S homeolog","Edge_Type":"mechanism","Node2":"zinc finger protein 667","Weight":1,"Paper_List":"23788609","Original_Text":"PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05)."},{"Node1":"C-X-C motif chemokine ligand 10","Edge_Type":"mechanism","Node2":"chemokine (C-C motif) ligand 5 S homeolog","Weight":1,"Paper_List":"23788609","Original_Text":"PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05)."},{"Node1":"granulocyte-macrophage colony-stimulating factor","Edge_Type":"mechanism","Node2":"interleukin 12B","Weight":1,"Paper_List":"23788609","Original_Text":"PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05)."},{"Node1":"C-X-C motif chemokine ligand 10","Edge_Type":"mechanism","Node2":"interleukin 12B","Weight":1,"Paper_List":"23788609","Original_Text":"PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05)."},{"Node1":"granulocyte-macrophage colony-stimulating factor","Edge_Type":"mechanism","Node2":"mast cell protease 1","Weight":1,"Paper_List":"23788609","Original_Text":"PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05)."},{"Node1":"C-X-C motif chemokine ligand 10","Edge_Type":"mechanism","Node2":"mast cell protease 1","Weight":1,"Paper_List":"23788609","Original_Text":"PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05)."},{"Node1":"granulocyte-macrophage colony-stimulating factor","Edge_Type":"mechanism","Node2":"zinc finger protein 667","Weight":1,"Paper_List":"23788609","Original_Text":"PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05)."},{"Node1":"C-X-C motif chemokine ligand 10","Edge_Type":"mechanism","Node2":"granulocyte-macrophage colony-stimulating factor","Weight":1,"Paper_List":"23788609","Original_Text":"PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05)."},{"Node1":"C-X-C motif chemokine ligand 10","Edge_Type":"mechanism","Node2":"zinc finger protein 667","Weight":1,"Paper_List":"23788609","Original_Text":"PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05)."},{"Node1":"Porphyromonas Gingivalis (Organism)","Edge_Type":"bacteria_to_mechanism","Node2":"interleukin 6 cytokine family signal transducer","Weight":1,"Paper_List":"23788609","Original_Text":"PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05)."},{"Node1":"Porphyromonas Gingivalis (Organism)","Edge_Type":"bacteria_to_mechanism","Node2":"interleukin 10","Weight":1,"Paper_List":"23788609","Original_Text":"PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05)."},{"Node1":"Porphyromonas Gingivalis (Organism)","Edge_Type":"bacteria_to_mechanism","Node2":"chemokine (C-C motif) ligand 5 S homeolog","Weight":1,"Paper_List":"23788609","Original_Text":"PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05)."},{"Node1":"Porphyromonas Gingivalis (Organism)","Edge_Type":"bacteria_to_mechanism","Node2":"interleukin 12B","Weight":1,"Paper_List":"23788609","Original_Text":"PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05)."},{"Node1":"Porphyromonas Gingivalis (Organism)","Edge_Type":"bacteria_to_mechanism","Node2":"mast cell protease 1","Weight":1,"Paper_List":"23788609","Original_Text":"PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05)."},{"Node1":"Porphyromonas Gingivalis (Organism)","Edge_Type":"bacteria_to_mechanism","Node2":"granulocyte-macrophage colony-stimulating factor","Weight":1,"Paper_List":"23788609","Original_Text":"PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05)."},{"Node1":"Porphyromonas Gingivalis (Organism)","Edge_Type":"bacteria_to_mechanism","Node2":"zinc finger protein 667","Weight":1,"Paper_List":"23788609","Original_Text":"PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05)."},{"Node1":"Porphyromonas Gingivalis (Organism)","Edge_Type":"bacteria_to_mechanism","Node2":"C-X-C motif chemokine ligand 10","Weight":1,"Paper_List":"23788609","Original_Text":"PMID:23788609; Original text:Additionally, P. gingivalis LPS induction of eotaxin, IFNγ, IL10, IL12p40, IL1β, IL6, IP10, MCP1, MIP1α, GM-CSF, and TNFα was significantly decreased (p < .05)."},{"Node1":"Valacyclovir","Edge_Type":"chemical_to_disease","Node2":"Pain","Weight":1,"Paper_List":"34363831","Original_Text":"PMID:34363831; Original text:At the baseline examination, all 10 valacyclovir and 9 placebo patients exhibited moderate to severe pain and 18 patients needed pain medication."},{"Node1":"interleukin 1 beta","Edge_Type":"mechanism","Node2":"tachykinin 2","Weight":1,"Paper_List":"31833004","Original_Text":"PMID:31833004; Original text:Laser irradiation inhibited the elevation of interleukin-1β, prostaglandin E2 and substance P levels during the first month (P < 0.05)."},{"Node1":"Dinoprostone","Edge_Type":"chemical_to_mechanism","Node2":"interleukin 1 beta","Weight":1,"Paper_List":"31833004","Original_Text":"PMID:31833004; Original text:Laser irradiation inhibited the elevation of interleukin-1β, prostaglandin E2 and substance P levels during the first month (P < 0.05)."},{"Node1":"Dinoprostone","Edge_Type":"chemical_to_mechanism","Node2":"tachykinin 2","Weight":1,"Paper_List":"31833004","Original_Text":"PMID:31833004; Original text:Laser irradiation inhibited the elevation of interleukin-1β, prostaglandin E2 and substance P levels during the first month (P < 0.05)."},{"Node1":"Gingiva","Edge_Type":"anatomy","Node2":"Tooth Cervix","Weight":1,"Paper_List":"23167912","Original_Text":"PMID:23167912; Original text:The mean probing depth (PD), clinical attachment level (clinical attachment level) and gingival recession, cementoenamel junction to base of the defect (the defect), defect depth (DD) and cementoenamel junction to alveolar crest (alveolar crest), at baseline to 6 months post-operatively in both the groups were statistically significant."},{"Node1":"Hemorrhage","Edge_Type":"disease","Node2":"Suppuration","Weight":1,"Paper_List":"28902426","Original_Text":"PMID:28902426; Original text:Clinical examinations at 3 years after treatment revealed (i) improved peri-implant soft tissue health with a mean reduction in probing depth of 2.7 mm and a reduction in bleeding/suppuration on probing of 40% and (ii) stable peri-implant marginal bone levels (mean bone loss during follow-up: 0.04 mm)."},{"Node1":"Periodontal Cyst","Edge_Type":"disease_to_anatomy","Node2":"Allografts","Weight":2,"Paper_List":"18454658|19053917","Original_Text":"PMID:18454658; Original text:Treatment with a combination of platelet-rich plasma and a demineralized freeze-dried bone allograft led to a significantly greater clinical improvement in intrabony periodontal defects compared to a demineralized freeze-dried bone allograft with saline.|PMID:19053917; Original text:Both treatments were shown to be safe and effective therapy for periodontal defects; however, the addition of derivative to demineralized freeze-dried bone allograft provided no statistically significant improvement to the soft and hard tissue parameters measured."},{"Node1":"Periodontal Cyst","Edge_Type":"disease_to_anatomy","Node2":"Alveolar Process","Weight":1,"Paper_List":"29211309","Original_Text":"PMID:29211309; Original text:Thirteen of the experimentally induced periodontitis (81%) and 2 of the acute/chronified periodontal defect (29%) studies presented significantly better results in terms of alveolar bone level/amount in favor of statins."},{"Node1":"Porphyromonas Gingivalis (Organism)","Edge_Type":"bacteria_to_chemical","Node2":"Clarithromycin","Weight":1,"Paper_List":"28671507","Original_Text":"PMID:28671507; Original text:However, the clarithromycin group presented lower means of probing depth for pockets ≥7 mm at 6 months (4.0 ± 1.7 mm) compared with the placebo group (4.7 ± 1.3 mm)"},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"toll like receptor 4","Weight":1,"Paper_List":"18341600","Original_Text":"PMID:18341600; Original text:Ultrasonic instrumentation in patients with moderate to advanced periodontitis increases circulating levels of LPS after 5 min."},{"Node1":"AMY-101","Edge_Type":"chemical_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"34618684","Original_Text":"PMID:34618684; Original text:ResultsA once-weekly intragingival injection of AMY-101 for 3 weeks was safe and well tolerated in all participants and resulted in significant (P < 0.001) reductions in clinical indices measuring gingival inflammation (a modified gingival index and BOP)."},{"Node1":"matrix metallopeptidase 8","Edge_Type":"mechanism","Node2":"matrix metallopeptidase 9 gene 1 S homeolog","Weight":1,"Paper_List":"34618684","Original_Text":"PMID:34618684; Original text:AMY-101 significantly (P < 0.05) reduced MMP-8 and MMP-9 levels, indicators of inflammatory tissue destruction."},{"Node1":"AMY-101","Edge_Type":"chemical_to_mechanism","Node2":"matrix metallopeptidase 9 gene 1 S homeolog","Weight":1,"Paper_List":"34618684","Original_Text":"PMID:34618684; Original text:AMY-101 significantly (P < 0.05) reduced MMP-8 and MMP-9 levels, indicators of inflammatory tissue destruction."},{"Node1":"AMY-101","Edge_Type":"chemical_to_mechanism","Node2":"matrix metallopeptidase 8","Weight":1,"Paper_List":"34618684","Original_Text":"PMID:34618684; Original text:AMY-101 significantly (P < 0.05) reduced MMP-8 and MMP-9 levels, indicators of inflammatory tissue destruction."},{"Node1":"interleukin 6 cytokine family signal transducer","Edge_Type":"mechanism","Node2":"tumor necrosis factor S homeolog","Weight":1,"Paper_List":"16283108","Original_Text":"PMID:16283108; Original text:TNF-alpha levels were significantly raised only after 1 day of therapy (P<0.01) whereas IL-6 (P<0.01), CRP (P<0.001) and Fibrinogen (P<0.001) concentrations peaked 24 hrs after and returned to baseline values within one month following therapy."},{"Node1":"fibrinogen gamma chain","Edge_Type":"mechanism","Node2":"tumor necrosis factor S homeolog","Weight":1,"Paper_List":"16283108","Original_Text":"PMID:16283108; Original text:TNF-alpha levels were significantly raised only after 1 day of therapy (P<0.01) whereas IL-6 (P<0.01), CRP (P<0.001) and Fibrinogen (P<0.001) concentrations peaked 24 hrs after and returned to baseline values within one month following therapy."},{"Node1":"deoxypyridinoline","Edge_Type":"chemical","Node2":"pyridinoline","Weight":1,"Paper_List":"16160575","Original_Text":"PMID:16160575; Original text:In both univariate and multivariate analysis, osteocalcin, pyridinoline, and deoxypyridinoline were not significant predictive factors of oral implant failure."},{"Node1":"pyridinoline","Edge_Type":"chemical_to_mechanism","Node2":"polyamine modulated factor 1","Weight":1,"Paper_List":"16160575","Original_Text":"PMID:16160575; Original text:In both univariate and multivariate analysis, osteocalcin, pyridinoline, and deoxypyridinoline were not significant predictive factors of oral implant failure."},{"Node1":"deoxypyridinoline","Edge_Type":"chemical_to_mechanism","Node2":"polyamine modulated factor 1","Weight":1,"Paper_List":"16160575","Original_Text":"PMID:16160575; Original text:In both univariate and multivariate analysis, osteocalcin, pyridinoline, and deoxypyridinoline were not significant predictive factors of oral implant failure."},{"Node1":"interleukin 33","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"27363844","Original_Text":"PMID:27363844; Original text:The gingival crevicular fluid IL-33 concentration was significantly lower in the CP group than in the H and G groups (p < 0.001)."},{"Node1":"interleukin 33","Edge_Type":"mechanism_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"27363844","Original_Text":"PMID:27363844; Original text:The gingival crevicular fluid IL-33 concentration was significantly lower in the CP group than in the H and G groups (p < 0.001)."},{"Node1":"Spirochaetes","Edge_Type":"bacteria_to_chemical","Node2":"Methylene Blue","Weight":1,"Paper_List":"7852614","Original_Text":"PMID:7852614; Original text:The reductions in spirochaetes were significant for subgingival debridement and methylene blue by slow-release."},{"Node1":"carbazochrome","Edge_Type":"chemical_to_disease","Node2":"Inflammation","Weight":1,"Paper_List":"30845920","Original_Text":"PMID:30845920; Original text:Within the study, carbazochrome showed a significant reduction in gingival inflammation compared with a placebo."},{"Node1":"carbazochrome","Edge_Type":"chemical_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"30845920","Original_Text":"PMID:30845920; Original text:Within the study, carbazochrome showed a significant reduction in gingival inflammation compared with a placebo."},{"Node1":"hydroxide ion","Edge_Type":"chemical_to_disease","Node2":"Chronic Periodontitis","Weight":2,"Paper_List":"32708032|32708032","Original_Text":"PMID:32708032; Original text:Compared with the healthy controls, the circulating 25(OH)D levels were significantly lower in chronic periodontitis patients (pooled Mean difference = -6.80, 95% CI: -10.59 to -3.02).|PMID:32708032; Original text:Compared with healthy controls, 25(OH)D serum levels are significantly lower in chronic periodontitis patients, with an overall Recommendation Taxonomy A recommendation."},{"Node1":"high","Edge_Type":"mechanism","Node2":"sensitivity to RADLV","Weight":1,"Paper_List":"33940667","Original_Text":"PMID:33940667; Original text:In addition, (1) their blood high sensitivity C-reactive protein levels ranged from 0.94 to 12.6 mg/L with a mean of 3.41 mg/L, which is considered high risk for cardiovascular disease (cardiovascular disease) in spite of their statin therapy, and (2) the data demonstrated a positive correlation between severe periodontitis and elevated blood high sensitivity C-reactive protein levels (P< 0.05), consistent with systemic inflammation."},{"Node1":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","Edge_Type":"mechanism","Node2":"high","Weight":1,"Paper_List":"33940667","Original_Text":"PMID:33940667; Original text:In addition, (1) their blood high sensitivity C-reactive protein levels ranged from 0.94 to 12.6 mg/L with a mean of 3.41 mg/L, which is considered high risk for cardiovascular disease (cardiovascular disease) in spite of their statin therapy, and (2) the data demonstrated a positive correlation between severe periodontitis and elevated blood high sensitivity C-reactive protein levels (P< 0.05), consistent with systemic inflammation."},{"Node1":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","Edge_Type":"mechanism","Node2":"sensitivity to RADLV","Weight":1,"Paper_List":"33940667","Original_Text":"PMID:33940667; Original text:In addition, (1) their blood high sensitivity C-reactive protein levels ranged from 0.94 to 12.6 mg/L with a mean of 3.41 mg/L, which is considered high risk for cardiovascular disease (cardiovascular disease) in spite of their statin therapy, and (2) the data demonstrated a positive correlation between severe periodontitis and elevated blood high sensitivity C-reactive protein levels (P< 0.05), consistent with systemic inflammation."},{"Node1":"Cardiovascular Diseases","Edge_Type":"disease_to_mechanism","Node2":"high","Weight":1,"Paper_List":"33940667","Original_Text":"PMID:33940667; Original text:In addition, (1) their blood high sensitivity C-reactive protein levels ranged from 0.94 to 12.6 mg/L with a mean of 3.41 mg/L, which is considered high risk for cardiovascular disease (cardiovascular disease) in spite of their statin therapy, and (2) the data demonstrated a positive correlation between severe periodontitis and elevated blood high sensitivity C-reactive protein levels (P< 0.05), consistent with systemic inflammation."},{"Node1":"Cardiovascular Diseases","Edge_Type":"disease_to_mechanism","Node2":"sensitivity to RADLV","Weight":1,"Paper_List":"33940667","Original_Text":"PMID:33940667; Original text:In addition, (1) their blood high sensitivity C-reactive protein levels ranged from 0.94 to 12.6 mg/L with a mean of 3.41 mg/L, which is considered high risk for cardiovascular disease (cardiovascular disease) in spite of their statin therapy, and (2) the data demonstrated a positive correlation between severe periodontitis and elevated blood high sensitivity C-reactive protein levels (P< 0.05), consistent with systemic inflammation."},{"Node1":"Cardiovascular Diseases","Edge_Type":"disease_to_mechanism","Node2":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","Weight":1,"Paper_List":"33940667","Original_Text":"PMID:33940667; Original text:In addition, (1) their blood high sensitivity C-reactive protein levels ranged from 0.94 to 12.6 mg/L with a mean of 3.41 mg/L, which is considered high risk for cardiovascular disease (cardiovascular disease) in spite of their statin therapy, and (2) the data demonstrated a positive correlation between severe periodontitis and elevated blood high sensitivity C-reactive protein levels (P< 0.05), consistent with systemic inflammation."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"high","Weight":1,"Paper_List":"33940667","Original_Text":"PMID:33940667; Original text:In addition, (1) their blood high sensitivity C-reactive protein levels ranged from 0.94 to 12.6 mg/L with a mean of 3.41 mg/L, which is considered high risk for cardiovascular disease (cardiovascular disease) in spite of their statin therapy, and (2) the data demonstrated a positive correlation between severe periodontitis and elevated blood high sensitivity C-reactive protein levels (P< 0.05), consistent with systemic inflammation."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"sensitivity to RADLV","Weight":1,"Paper_List":"33940667","Original_Text":"PMID:33940667; Original text:In addition, (1) their blood high sensitivity C-reactive protein levels ranged from 0.94 to 12.6 mg/L with a mean of 3.41 mg/L, which is considered high risk for cardiovascular disease (cardiovascular disease) in spite of their statin therapy, and (2) the data demonstrated a positive correlation between severe periodontitis and elevated blood high sensitivity C-reactive protein levels (P< 0.05), consistent with systemic inflammation."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","Weight":2,"Paper_List":"33940667|29211309","Original_Text":"PMID:33940667; Original text:In addition, (1) their blood high sensitivity C-reactive protein levels ranged from 0.94 to 12.6 mg/L with a mean of 3.41 mg/L, which is considered high risk for cardiovascular disease (cardiovascular disease) in spite of their statin therapy, and (2) the data demonstrated a positive correlation between severe periodontitis and elevated blood high sensitivity C-reactive protein levels (P< 0.05), consistent with systemic inflammation.|PMID:29211309; Original text:Thirteen of the experimentally induced periodontitis (81%) and 2 of the acute/chronified periodontal defect (29%) studies presented significantly better results in terms of alveolar bone level/amount in favor of statins."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_mechanism","Node2":"collagenase","Weight":4,"Paper_List":"11168739|11168739|18672990|18672990","Original_Text":"PMID:11168739; Original text:Previous clinical studies have shown that doxycycline administered orally, at doses below those needed for antimicrobial efficacy, to human subjects with adult periodontitis resulted in significantly reduced collagenase activity in gingival crevicular fluid (gingival crevicular fluid) and in extracts of inflamed gingival tissues.|PMID:11168739; Original text:From baseline to week 12 (part I), treatment with specially formulated subantimicrobial dose doxycycline capsules (20 mg) 2x daily (1 x every 12 h) for up to 12 weeks was shown to significantly reduce gingival crevicular fluid collagenase activity and to improve periodontal attachment, effects not seen in patients treated with placebo.|PMID:18672990; Original text:Collagenase activity was significantly reduced by a 2-year subantimicrobial-dose doxycycline treatment relative to placebo based on intent-to-treat (P=0.01).|PMID:18672990; Original text:ICTP showed a similar pattern of change during a 2-year subantimicrobial-dose doxycycline treatment, and the gingival crevicular fluid collagenase activity and ICTP were positively correlated at all time periods (P<0.001)."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"collagenase","Weight":1,"Paper_List":"11168739","Original_Text":"PMID:11168739; Original text:Previous clinical studies have shown that doxycycline administered orally, at doses below those needed for antimicrobial efficacy, to human subjects with adult periodontitis resulted in significantly reduced collagenase activity in gingival crevicular fluid (gingival crevicular fluid) and in extracts of inflamed gingival tissues."},{"Node1":"Periodontal Cyst","Edge_Type":"disease_to_anatomy","Node2":"Bacterial Outer Membrane","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"collagenase","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":4,"Paper_List":"11168739|11168739|18672990|2177499","Original_Text":"PMID:11168739; Original text:Previous clinical studies have shown that doxycycline administered orally, at doses below those needed for antimicrobial efficacy, to human subjects with adult periodontitis resulted in significantly reduced collagenase activity in gingival crevicular fluid (gingival crevicular fluid) and in extracts of inflamed gingival tissues.|PMID:11168739; Original text:From baseline to week 12 (part I), treatment with specially formulated subantimicrobial dose doxycycline capsules (20 mg) 2x daily (1 x every 12 h) for up to 12 weeks was shown to significantly reduce gingival crevicular fluid collagenase activity and to improve periodontal attachment, effects not seen in patients treated with placebo.|PMID:18672990; Original text:ICTP showed a similar pattern of change during a 2-year subantimicrobial-dose doxycycline treatment, and the gingival crevicular fluid collagenase activity and ICTP were positively correlated at all time periods (P<0.001).|PMID:2177499; Original text:Collagenase activity in the crevicular fluid of periodontal pockets of an additional group of subjects was also significantly reduced, as was the severity of inflammation at the same gingival sites."},{"Node1":"collagenase","Edge_Type":"mechanism_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":4,"Paper_List":"11168739|11168739|18672990|2177499","Original_Text":"PMID:11168739; Original text:Previous clinical studies have shown that doxycycline administered orally, at doses below those needed for antimicrobial efficacy, to human subjects with adult periodontitis resulted in significantly reduced collagenase activity in gingival crevicular fluid (gingival crevicular fluid) and in extracts of inflamed gingival tissues.|PMID:11168739; Original text:From baseline to week 12 (part I), treatment with specially formulated subantimicrobial dose doxycycline capsules (20 mg) 2x daily (1 x every 12 h) for up to 12 weeks was shown to significantly reduce gingival crevicular fluid collagenase activity and to improve periodontal attachment, effects not seen in patients treated with placebo.|PMID:18672990; Original text:ICTP showed a similar pattern of change during a 2-year subantimicrobial-dose doxycycline treatment, and the gingival crevicular fluid collagenase activity and ICTP were positively correlated at all time periods (P<0.001).|PMID:2177499; Original text:Collagenase activity in the crevicular fluid of periodontal pockets of an additional group of subjects was also significantly reduced, as was the severity of inflammation at the same gingival sites."},{"Node1":"Periodontal Cyst","Edge_Type":"disease_to_anatomy","Node2":"Blood Platelets","Weight":4,"Paper_List":"18454658|15948682|30624092|20681813","Original_Text":"PMID:18454658; Original text:Treatment with a combination of platelet-rich plasma and a demineralized freeze-dried bone allograft led to a significantly greater clinical improvement in intrabony periodontal defects compared to a demineralized freeze-dried bone allograft with saline.|PMID:15948682; Original text:Treatment with a combination of platelet-rich plasma and HA compared to HA with saline led to a significantly more favorable clinical improvement in intrabony periodontal defects.|PMID:30624092; Original text:leukocyte-platelet-rich fibrin combined with open flap debridement significantly increases growth factors levels and thus, it enhances the periodontal healing on chronic periodontitis patients.|PMID:20681813; Original text:Periosteal coverage of periodontal defects is not associated with a significant increase in platelet-derived growth factor-BB levels."},{"Node1":"Chlorhexidine","Edge_Type":"chemical","Node2":"Hydrogen Peroxide","Weight":2,"Paper_List":"3479456|3479456","Original_Text":"PMID:3479456; Original text:The results revealed that repeated professional irrigation of unscaled periodontal pockets with chlorhexidine or hydrogen peroxide resulted in a temporarily reduced frequency of bleeding sites, but not in any clinically significant changes in probing assessments.|PMID:3479456; Original text:Hence, the study failed to demonstrate that professionally performed periodic subgingival irrigation with chlorhexidine or hydrogen peroxide, used alone or in combination with thorough mechanical debridement, has a significant therapeutic effect."},{"Node1":"Hydrogen Peroxide","Edge_Type":"chemical_to_disease","Node2":"Hemorrhage","Weight":2,"Paper_List":"3479456|22779217","Original_Text":"PMID:3479456; Original text:The results revealed that repeated professional irrigation of unscaled periodontal pockets with chlorhexidine or hydrogen peroxide resulted in a temporarily reduced frequency of bleeding sites, but not in any clinically significant changes in probing assessments.|PMID:22779217; Original text:The adjunctive use over three months of 1.7% hydrogen peroxide gel, locally administered using prescription customized trays in the treatment of subjects with moderate to advanced periodontitis, demonstrated statistically significant clinical improvements in pocket depths and bleeding when compared with root planing alone."},{"Node1":"Aggregatibacter Actinomycetemcomitans","Edge_Type":"bacteria_to_disease","Node2":"Periodontitis","Weight":2,"Paper_List":"28631250|26313005","Original_Text":"PMID:28631250; Original text:An effective mouthwash was developed for treatment of periodontitis and suppression of the indicator bacterium Aggregatibacter actinomycetemcomitans which is an obvious pathogen of periodontal disease.|PMID:26313005; Original text:The mere presence of Pg, even in low amount, was significantly associated with severe periodontitis, while the amount of Aggregatibacter actinomycetemcomitans, Treponema denticola, and Prevotella intermedia had to reach the critical thresholds to be significantly associated with disease."},{"Node1":"Aggregatibacter Actinomycetemcomitans","Edge_Type":"bacteria_to_disease","Node2":"Periodontal Diseases","Weight":1,"Paper_List":"28631250","Original_Text":"PMID:28631250; Original text:An effective mouthwash was developed for treatment of periodontitis and suppression of the indicator bacterium Aggregatibacter actinomycetemcomitans which is an obvious pathogen of periodontal disease."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"interleukin 18","Weight":2,"Paper_List":"24129807|24129807","Original_Text":"PMID:24129807; Original text:Our meta-analysis results indicated that the C variant of IL-18 -607A>C polymorphism was associated with increased periodontitis risk (C allele vs. A allele: Crude odds ratio = 1.86, 95 % 95 % confidence intervals: 1.30-2.65, P = 0.001; AC+CC vs. AA: Crude odds ratio = 2.64, 95 % 95 % confidence intervals: 1.34-5.21, P = 0.005).|PMID:24129807; Original text:There was also a significant association between the C variant of IL-18 -137G>C polymorphism and an increased periodontitis risk (C allele vs. G allele:"},{"Node1":"Overweight","Edge_Type":"disease","Node2":"Periodontitis","Weight":1,"Paper_List":"21348914","Original_Text":"PMID:21348914; Original text:Meta-analyses indicated statistically significant associations between periodontitis and body mass index (periodontitis and body mass index) category obese OR 1.81(1.42, 2.30), overweight OR 1.27(1.06, 1.51) and obese and overweight combined OR 2.13(1.40, 3.26)."},{"Node1":"Chlorhexidine","Edge_Type":"chemical_to_disease","Node2":"Inflammation","Weight":1,"Paper_List":"18294229","Original_Text":"PMID:18294229; Original text:ultrasonic mechanical instrumentation either with or without additional chlorhexidine use determined a significant reduction of supragingival plaque and gingival inflammation as well as a significant reduction of subgingival bacterial pathogens."},{"Node1":"Arcuate Nucleus of Hypothalamus","Edge_Type":"anatomy","Node2":"Jaw","Weight":1,"Paper_List":"15212351","Original_Text":"PMID:15212351; Original text:Non-smokers, defects in the mandibular arch, defects with deeper probing depths, or defects with greater attachment loss had statistically significant changes in one or more of the clinical parameters evaluated."},{"Node1":"Jaw","Edge_Type":"anatomy","Node2":"Mandible","Weight":1,"Paper_List":"15212351","Original_Text":"PMID:15212351; Original text:Non-smokers, defects in the mandibular arch, defects with deeper probing depths, or defects with greater attachment loss had statistically significant changes in one or more of the clinical parameters evaluated."},{"Node1":"Arcuate Nucleus of Hypothalamus","Edge_Type":"anatomy","Node2":"Mandible","Weight":1,"Paper_List":"15212351","Original_Text":"PMID:15212351; Original text:Non-smokers, defects in the mandibular arch, defects with deeper probing depths, or defects with greater attachment loss had statistically significant changes in one or more of the clinical parameters evaluated."},{"Node1":"Campylobacter Rectus","Edge_Type":"bacteria","Node2":"Treponema Denticola (Organism)","Weight":1,"Paper_List":"23088524","Original_Text":"PMID:23088524; Original text:Six months after root planing, the counts of Treponema denticola were significantly reduced in both groups (both P = 0.043), as were those of Campylobacter rectus in the test group only (P = 0.028)."},{"Node1":"Epithelial Attachment","Edge_Type":"anatomy","Node2":"Epithelium","Weight":1,"Paper_List":"22782041","Original_Text":"PMID:22782041; Original text:Clinical crown lengths did not change significantly in the treatment sites; therefore, improvements in probing depth can be attributed to improved clinical attachment levels (long junctional epithelium)."},{"Node1":"Calcium Sulfate","Edge_Type":"chemical_to_anatomy","Node2":"Membranes","Weight":1,"Paper_List":"18771362","Original_Text":"PMID:18771362; Original text:1.0 mm in the a bioabsorbable membrane group and 4.2 +/- 1.2 mm in the calcium sulfate group."},{"Node1":"Lysine","Edge_Type":"chemical","Node2":"Xanthine","Weight":1,"Paper_List":"20450373","Original_Text":"PMID:20450373; Original text:Statistical analysis indicates that CT significantly decreased the levels of inosine, lysine, putrescine, and xanthine at the gingivitis sites as early as week 1."},{"Node1":"Lysine","Edge_Type":"chemical","Node2":"Putrescine","Weight":1,"Paper_List":"20450373","Original_Text":"PMID:20450373; Original text:Statistical analysis indicates that CT significantly decreased the levels of inosine, lysine, putrescine, and xanthine at the gingivitis sites as early as week 1."},{"Node1":"Inosine","Edge_Type":"chemical","Node2":"Lysine","Weight":1,"Paper_List":"20450373","Original_Text":"PMID:20450373; Original text:Statistical analysis indicates that CT significantly decreased the levels of inosine, lysine, putrescine, and xanthine at the gingivitis sites as early as week 1."},{"Node1":"Putrescine","Edge_Type":"chemical","Node2":"Xanthine","Weight":1,"Paper_List":"20450373","Original_Text":"PMID:20450373; Original text:Statistical analysis indicates that CT significantly decreased the levels of inosine, lysine, putrescine, and xanthine at the gingivitis sites as early as week 1."},{"Node1":"Inosine","Edge_Type":"chemical","Node2":"Xanthine","Weight":1,"Paper_List":"20450373","Original_Text":"PMID:20450373; Original text:Statistical analysis indicates that CT significantly decreased the levels of inosine, lysine, putrescine, and xanthine at the gingivitis sites as early as week 1."},{"Node1":"Inosine","Edge_Type":"chemical","Node2":"Putrescine","Weight":1,"Paper_List":"20450373","Original_Text":"PMID:20450373; Original text:Statistical analysis indicates that CT significantly decreased the levels of inosine, lysine, putrescine, and xanthine at the gingivitis sites as early as week 1."},{"Node1":"Lysine","Edge_Type":"chemical_to_disease","Node2":"Gingivitis","Weight":1,"Paper_List":"20450373","Original_Text":"PMID:20450373; Original text:Statistical analysis indicates that CT significantly decreased the levels of inosine, lysine, putrescine, and xanthine at the gingivitis sites as early as week 1."},{"Node1":"Xanthine","Edge_Type":"chemical_to_disease","Node2":"Gingivitis","Weight":1,"Paper_List":"20450373","Original_Text":"PMID:20450373; Original text:Statistical analysis indicates that CT significantly decreased the levels of inosine, lysine, putrescine, and xanthine at the gingivitis sites as early as week 1."},{"Node1":"Putrescine","Edge_Type":"chemical_to_disease","Node2":"Gingivitis","Weight":1,"Paper_List":"20450373","Original_Text":"PMID:20450373; Original text:Statistical analysis indicates that CT significantly decreased the levels of inosine, lysine, putrescine, and xanthine at the gingivitis sites as early as week 1."},{"Node1":"Inosine","Edge_Type":"chemical_to_disease","Node2":"Gingivitis","Weight":1,"Paper_List":"20450373","Original_Text":"PMID:20450373; Original text:Statistical analysis indicates that CT significantly decreased the levels of inosine, lysine, putrescine, and xanthine at the gingivitis sites as early as week 1."},{"Node1":"Periodontal Cyst","Edge_Type":"disease_to_anatomy","Node2":"Bone and Bones","Weight":1,"Paper_List":"24844029","Original_Text":"PMID:24844029; Original text:Within the limits of the present study, one can conclude that MPM coverage of periodontal defects is associated with a significant initial increase in gingival crevicular fluid levels of bone morphogenetic protein-2, a factor that could improve the clinical outcomes of guided tissue regenerative surgery."},{"Node1":"polylevolactic acid","Edge_Type":"chemical_to_anatomy","Node2":"Tissues","Weight":1,"Paper_List":"8433249","Original_Text":"PMID:8433249; Original text:No statistically significant differences were found in soft tissue recession between groups or in the osseous defect measurement between polylactic acid and FPD."},{"Node1":"JIL-1 kinase","Edge_Type":"mechanism","Node2":"collectin subfamily member 11","Weight":1,"Paper_List":"27027257","Original_Text":"PMID:27027257; Original text:GCF levels of IL-1β, IL-6, IFN-γ and MCP-1/CCL2 were significantly higher in subjects diagnosed with chronic periodontitis than periodontally healthy subjects."},{"Node1":"collectin subfamily member 11","Edge_Type":"mechanism","Node2":"interleukin 6 cytokine family signal transducer","Weight":1,"Paper_List":"27027257","Original_Text":"PMID:27027257; Original text:GCF levels of IL-1β, IL-6, IFN-γ and MCP-1/CCL2 were significantly higher in subjects diagnosed with chronic periodontitis than periodontally healthy subjects."},{"Node1":"collectin subfamily member 11","Edge_Type":"mechanism","Node2":"mast cell protease 1","Weight":1,"Paper_List":"27027257","Original_Text":"PMID:27027257; Original text:GCF levels of IL-1β, IL-6, IFN-γ and MCP-1/CCL2 were significantly higher in subjects diagnosed with chronic periodontitis than periodontally healthy subjects."},{"Node1":"Chronic Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"collectin subfamily member 11","Weight":1,"Paper_List":"27027257","Original_Text":"PMID:27027257; Original text:GCF levels of IL-1β, IL-6, IFN-γ and MCP-1/CCL2 were significantly higher in subjects diagnosed with chronic periodontitis than periodontally healthy subjects."},{"Node1":"Chronic Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"JIL-1 kinase","Weight":1,"Paper_List":"27027257","Original_Text":"PMID:27027257; Original text:GCF levels of IL-1β, IL-6, IFN-γ and MCP-1/CCL2 were significantly higher in subjects diagnosed with chronic periodontitis than periodontally healthy subjects."},{"Node1":"Chronic Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"interleukin 6 cytokine family signal transducer","Weight":1,"Paper_List":"27027257","Original_Text":"PMID:27027257; Original text:GCF levels of IL-1β, IL-6, IFN-γ and MCP-1/CCL2 were significantly higher in subjects diagnosed with chronic periodontitis than periodontally healthy subjects."},{"Node1":"Chronic Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"mast cell protease 1","Weight":1,"Paper_List":"27027257","Original_Text":"PMID:27027257; Original text:GCF levels of IL-1β, IL-6, IFN-γ and MCP-1/CCL2 were significantly higher in subjects diagnosed with chronic periodontitis than periodontally healthy subjects."},{"Node1":"JIL-1 kinase","Edge_Type":"mechanism","Node2":"interleukin 17A","Weight":2,"Paper_List":"27027257|24509697","Original_Text":"PMID:27027257; Original text:A significant decrease in GCF levels of IL-1β and IL-17 was observed after non-surgical periodontal treatment, whereas a significant increase was observed for IL-4.|PMID:24509697; Original text:After completion of the therapy with probiotic tablets, 18 (75%) of the patients of Group 1 have manifested a significant decrease in levels of studied pro-inflammatory cytokines (TNF-α, IL-1β and IL-17)."},{"Node1":"JIL-1 kinase","Edge_Type":"mechanism","Node2":"interleukin 4","Weight":1,"Paper_List":"27027257","Original_Text":"PMID:27027257; Original text:A significant decrease in GCF levels of IL-1β and IL-17 was observed after non-surgical periodontal treatment, whereas a significant increase was observed for IL-4."},{"Node1":"interleukin 17A","Edge_Type":"mechanism","Node2":"interleukin 4","Weight":1,"Paper_List":"27027257","Original_Text":"PMID:27027257; Original text:A significant decrease in GCF levels of IL-1β and IL-17 was observed after non-surgical periodontal treatment, whereas a significant increase was observed for IL-4."},{"Node1":"Inflammation","Edge_Type":"disease","Node2":"Obesity","Weight":1,"Paper_List":"33904994","Original_Text":"PMID:33904994; Original text:However, meta-analysis showed that among individuals with periodontitis, significantly higher levels of gingival inflammation are observed in those with obesity (n of individuals=240) when compared to those who were not obese (n of individuals=574)"},{"Node1":"Periodontal Cyst","Edge_Type":"disease_to_anatomy","Node2":"Gingiva","Weight":3,"Paper_List":"7767709|22835005|24844029","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells.|PMID:22835005; Original text:Although periodontal therapy during pregnancy successfully reduced periodontal inflammation and gingival crevicular fluid cytokine levels, it did not have a significant impact on serum biomarkers.|PMID:24844029; Original text:Within the limits of the present study, one can conclude that MPM coverage of periodontal defects is associated with a significant initial increase in gingival crevicular fluid levels of bone morphogenetic protein-2, a factor that could improve the clinical outcomes of guided tissue regenerative surgery."},{"Node1":"Porphyromonas Gingivalis (Organism)","Edge_Type":"bacteria","Node2":"Streptococcus Mutans","Weight":1,"Paper_List":"30207437","Original_Text":"PMID:30207437; Original text:Among the microrganisms evaluated Porphyromonas gengivalis (OR [95% CI] 2.93"},{"Node1":"Aggregatibacter Actinomycetemcomitans","Edge_Type":"bacteria","Node2":"Streptococcus Mutans","Weight":1,"Paper_List":"30207437","Original_Text":"PMID:30207437; Original text:Among the microrganisms evaluated Porphyromonas gengivalis (OR [95% CI] 2.93"},{"Node1":"Vitamin E","Edge_Type":"nutrient_to_chemical","Node2":"Vitamin D","Weight":1,"Paper_List":"31960448","Original_Text":"PMID:31960448; Original text:Although statistically significant differences were observed in favor to vitamin D supplementation, the magnitude of effect size tended to be modest with limited clinical relevance and the long-term efficacy and safety warrant further investigation."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_anatomy","Node2":"Stem Cells","Weight":1,"Paper_List":"17668979","Original_Text":"PMID:17668979; Original text:Although there was a significant increase (P <0.001) in the total total colony forming units recovered from the 4 microg/ml doxycycline plates at 24 months for SDD versus placebo, the percentage that was clinically resistant to doxycycline (minimal inhibitory concentration [MIC] > or = 16 microg/ml) decreased over the 24-month period in both groups and did not differ between the treatment groups (SDD: 79% to 76%; placebo: 83% to 70%; P = 0.2)."},{"Node1":"Chronic Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"superoxide dismutase 2","Weight":1,"Paper_List":"23688096","Original_Text":"PMID:23688096; Original text:SOD activity in both serum (P <0.05) and saliva (P <0.001) was lower in patients with chronic periodontitis compared with controls."},{"Node1":"Azithromycin","Edge_Type":"chemical_to_anatomy","Node2":"Tooth","Weight":3,"Paper_List":"18631245|27223128|27223128","Original_Text":"PMID:18631245; Original text:Subjects administering azithromycin showed a higher percentage of teeth with attachment gain >or=1 mm (81.34 versus 63.63, p=0.037), whereas the controls had higher percentage of teeth with attachment loss >or=1 mm (11.57 versus 2.24, p=0.015).|PMID:27223128; Original text:Significant predictors of a reduction in mean pocket depth were: use of azithromycin, non-molar teeth, generalized disease and baseline pocket depth.|PMID:27223128; Original text:It may be concluded that dental plaque, tooth type, disease extent, baseline pocket depth, and use of azithromycin were significant predictors of the clinical response to treatment for aggressive periodontitis in young individuals."},{"Node1":"Healthcare-Associated Pneumonia","Edge_Type":"disease","Node2":"Periodontitis","Weight":1,"Paper_List":"32051966","Original_Text":"PMID:32051966; Original text:There was a significant association between periodontitis and nosocomial pneumonia in the meta-analysis (odds ratio 2.55, 95% 95% confidence interval 1.68 to 3.86)."},{"Node1":"tumor necrosis factor S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Erythrocytes","Weight":1,"Paper_List":"19335072","Original_Text":"PMID:19335072; Original text:Patients receiving periodontal treatment showed a significant decrease in the mean DAS28, erythrocyte sedimentation rate (P <0.001), and serum TNF-alpha (P <0.05)."},{"Node1":"JIL-1 kinase","Edge_Type":"mechanism","Node2":"granulocyte-macrophage colony-stimulating factor","Weight":1,"Paper_List":"22126282","Original_Text":"PMID:22126282; Original text:Significant reductions in crevicular fluid GM-CSF, IL-1β and the ratio IL-1β/IL-10 and increases in crevicular fluid IL-6 were detected after therapy."},{"Node1":"granulocyte-macrophage colony-stimulating factor","Edge_Type":"mechanism","Node2":"interleukin 10 S homeolog","Weight":1,"Paper_List":"22126282","Original_Text":"PMID:22126282; Original text:Significant reductions in crevicular fluid GM-CSF, IL-1β and the ratio IL-1β/IL-10 and increases in crevicular fluid IL-6 were detected after therapy."},{"Node1":"granulocyte-macrophage colony-stimulating factor","Edge_Type":"mechanism_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"22126282","Original_Text":"PMID:22126282; Original text:Significant reductions in crevicular fluid GM-CSF, IL-1β and the ratio IL-1β/IL-10 and increases in crevicular fluid IL-6 were detected after therapy."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"leptin S homeolog","Weight":1,"Paper_List":"25811944","Original_Text":"PMID:25811944; Original text:The highest leptin mRNA and protein expression was observed in the control group and was significantly (P ≤0.05) different from the chronic periodontitis and chronic periodontitis+type 2 diabetes mellitus groups."},{"Node1":"Leptin level","Edge_Type":"mechanism","Node2":"nicotinamide phosphoribosyltransferase pseudogene 1","Weight":1,"Paper_List":"25811944","Original_Text":"PMID:25811944; Original text:Gingival tissues from patients with chronic periodontitis and type 2 diabetes mellitus had a significant increase in visfatin and a decrease in leptin gene and protein expression (P <0.05) compared with both controls and patients with chronic periodontitis."},{"Node1":"Chronic Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"nicotinamide phosphoribosyltransferase pseudogene 1","Weight":1,"Paper_List":"25811944","Original_Text":"PMID:25811944; Original text:Gingival tissues from patients with chronic periodontitis and type 2 diabetes mellitus had a significant increase in visfatin and a decrease in leptin gene and protein expression (P <0.05) compared with both controls and patients with chronic periodontitis."},{"Node1":"Chronic Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"Leptin level","Weight":1,"Paper_List":"25811944","Original_Text":"PMID:25811944; Original text:Gingival tissues from patients with chronic periodontitis and type 2 diabetes mellitus had a significant increase in visfatin and a decrease in leptin gene and protein expression (P <0.05) compared with both controls and patients with chronic periodontitis."},{"Node1":"Diabetes Mellitus, Type 2","Edge_Type":"disease_to_mechanism","Node2":"nicotinamide phosphoribosyltransferase pseudogene 1","Weight":1,"Paper_List":"25811944","Original_Text":"PMID:25811944; Original text:Gingival tissues from patients with chronic periodontitis and type 2 diabetes mellitus had a significant increase in visfatin and a decrease in leptin gene and protein expression (P <0.05) compared with both controls and patients with chronic periodontitis."},{"Node1":"Diabetes Mellitus, Type 2","Edge_Type":"disease_to_mechanism","Node2":"Leptin level","Weight":1,"Paper_List":"25811944","Original_Text":"PMID:25811944; Original text:Gingival tissues from patients with chronic periodontitis and type 2 diabetes mellitus had a significant increase in visfatin and a decrease in leptin gene and protein expression (P <0.05) compared with both controls and patients with chronic periodontitis."},{"Node1":"Periodontal Cyst","Edge_Type":"disease_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":2,"Paper_List":"22835005|24844029","Original_Text":"PMID:22835005; Original text:Although periodontal therapy during pregnancy successfully reduced periodontal inflammation and gingival crevicular fluid cytokine levels, it did not have a significant impact on serum biomarkers.|PMID:24844029; Original text:Within the limits of the present study, one can conclude that MPM coverage of periodontal defects is associated with a significant initial increase in gingival crevicular fluid levels of bone morphogenetic protein-2, a factor that could improve the clinical outcomes of guided tissue regenerative surgery."},{"Node1":"nicotinamide phosphoribosyltransferase pseudogene 1","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"25811944","Original_Text":"PMID:25811944; Original text:Gingival tissues from patients with chronic periodontitis and type 2 diabetes mellitus had a significant increase in visfatin and a decrease in leptin gene and protein expression (P <0.05) compared with both controls and patients with chronic periodontitis."},{"Node1":"Leptin level","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"25811944","Original_Text":"PMID:25811944; Original text:Gingival tissues from patients with chronic periodontitis and type 2 diabetes mellitus had a significant increase in visfatin and a decrease in leptin gene and protein expression (P <0.05) compared with both controls and patients with chronic periodontitis."},{"Node1":"Coronary Disease","Edge_Type":"disease","Node2":"Periodontal Cyst","Weight":1,"Paper_List":"23146639","Original_Text":"PMID:23146639; Original text:No statistically significant association emerged between the CD14 C(-260)T and the CD14 C(-159)T polymorphism, endodontic or periodontal disease, and coronary heart disease."},{"Node1":"NADH:ubiquinone oxidoreductase subunit A2 L homeolog","Edge_Type":"mechanism","Node2":"polyphemus","Weight":1,"Paper_List":"23146639","Original_Text":"PMID:23146639; Original text:No statistically significant association emerged between the CD14 C(-260)T and the CD14 C(-159)T polymorphism, endodontic or periodontal disease, and coronary heart disease."},{"Node1":"Periodontal Cyst","Edge_Type":"disease_to_mechanism","Node2":"NADH:ubiquinone oxidoreductase subunit A2 L homeolog","Weight":1,"Paper_List":"23146639","Original_Text":"PMID:23146639; Original text:No statistically significant association emerged between the CD14 C(-260)T and the CD14 C(-159)T polymorphism, endodontic or periodontal disease, and coronary heart disease."},{"Node1":"Periodontal Cyst","Edge_Type":"disease_to_mechanism","Node2":"polyphemus","Weight":1,"Paper_List":"23146639","Original_Text":"PMID:23146639; Original text:No statistically significant association emerged between the CD14 C(-260)T and the CD14 C(-159)T polymorphism, endodontic or periodontal disease, and coronary heart disease."},{"Node1":"Coronary Disease","Edge_Type":"disease_to_mechanism","Node2":"NADH:ubiquinone oxidoreductase subunit A2 L homeolog","Weight":1,"Paper_List":"23146639","Original_Text":"PMID:23146639; Original text:No statistically significant association emerged between the CD14 C(-260)T and the CD14 C(-159)T polymorphism, endodontic or periodontal disease, and coronary heart disease."},{"Node1":"Coronary Disease","Edge_Type":"disease_to_mechanism","Node2":"polyphemus","Weight":1,"Paper_List":"23146639","Original_Text":"PMID:23146639; Original text:No statistically significant association emerged between the CD14 C(-260)T and the CD14 C(-159)T polymorphism, endodontic or periodontal disease, and coronary heart disease."},{"Node1":"Cardiovascular Diseases","Edge_Type":"disease","Node2":"Stroke","Weight":2,"Paper_List":"11216961|18052701","Original_Text":"PMID:11216961; Original text:In Cox proportional hazards regression analysis adjusted for age and treatment assignment, physicians who reported periodontal disease at baseline had slightly elevated, but statistically nonsignificant, relative risks (statistically nonsignificant, relative risks) of nonfatal myocardial infarction, (statistically nonsignificant, relative risks, 1.12; 95% confidence interval [CI], 0.92 to 1.36), nonfatal stroke (statistically nonsignificant, relative risks, 1.10; CI, 0.88 to 1.37) and cardiovascular death (statistically nonsignificant, relative risks, 1.20; CI, 0.97 to 1.49).|PMID:18052701; Original text:This group was not associated with cardiovascular disease events or with stroke but was associated with a significant increase in mean early atherogenesis (0.03 mm; 95% CI: 0.02 to 0.04)."},{"Node1":"Cardiovascular Diseases","Edge_Type":"disease","Node2":"Myocardial Infarction","Weight":1,"Paper_List":"11216961","Original_Text":"PMID:11216961; Original text:In Cox proportional hazards regression analysis adjusted for age and treatment assignment, physicians who reported periodontal disease at baseline had slightly elevated, but statistically nonsignificant, relative risks (statistically nonsignificant, relative risks) of nonfatal myocardial infarction, (statistically nonsignificant, relative risks, 1.12; 95% confidence interval [CI], 0.92 to 1.36), nonfatal stroke (statistically nonsignificant, relative risks, 1.10; CI, 0.88 to 1.37) and cardiovascular death (statistically nonsignificant, relative risks, 1.20; CI, 0.97 to 1.49)."},{"Node1":"Periodontal Diseases","Edge_Type":"disease","Node2":"Stroke","Weight":1,"Paper_List":"11216961","Original_Text":"PMID:11216961; Original text:In Cox proportional hazards regression analysis adjusted for age and treatment assignment, physicians who reported periodontal disease at baseline had slightly elevated, but statistically nonsignificant, relative risks (statistically nonsignificant, relative risks) of nonfatal myocardial infarction, (statistically nonsignificant, relative risks, 1.12; 95% confidence interval [CI], 0.92 to 1.36), nonfatal stroke (statistically nonsignificant, relative risks, 1.10; CI, 0.88 to 1.37) and cardiovascular death (statistically nonsignificant, relative risks, 1.20; CI, 0.97 to 1.49)."},{"Node1":"Myocardial Infarction","Edge_Type":"disease","Node2":"Periodontal Diseases","Weight":1,"Paper_List":"11216961","Original_Text":"PMID:11216961; Original text:In Cox proportional hazards regression analysis adjusted for age and treatment assignment, physicians who reported periodontal disease at baseline had slightly elevated, but statistically nonsignificant, relative risks (statistically nonsignificant, relative risks) of nonfatal myocardial infarction, (statistically nonsignificant, relative risks, 1.12; 95% confidence interval [CI], 0.92 to 1.36), nonfatal stroke (statistically nonsignificant, relative risks, 1.10; CI, 0.88 to 1.37) and cardiovascular death (statistically nonsignificant, relative risks, 1.20; CI, 0.97 to 1.49)."},{"Node1":"Myocardial Infarction","Edge_Type":"disease","Node2":"Stroke","Weight":1,"Paper_List":"11216961","Original_Text":"PMID:11216961; Original text:In Cox proportional hazards regression analysis adjusted for age and treatment assignment, physicians who reported periodontal disease at baseline had slightly elevated, but statistically nonsignificant, relative risks (statistically nonsignificant, relative risks) of nonfatal myocardial infarction, (statistically nonsignificant, relative risks, 1.12; 95% confidence interval [CI], 0.92 to 1.36), nonfatal stroke (statistically nonsignificant, relative risks, 1.10; CI, 0.88 to 1.37) and cardiovascular death (statistically nonsignificant, relative risks, 1.20; CI, 0.97 to 1.49)."},{"Node1":"Periodontal Cyst","Edge_Type":"disease_to_anatomy","Node2":"Gonadotrophs","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"Periodontal Cyst","Edge_Type":"disease_to_anatomy","Node2":"Leukocytes","Weight":1,"Paper_List":"30624092","Original_Text":"PMID:30624092; Original text:leukocyte-platelet-rich fibrin combined with open flap debridement significantly increases growth factors levels and thus, it enhances the periodontal healing on chronic periodontitis patients."},{"Node1":"Periodontal Cyst","Edge_Type":"disease_to_anatomy","Node2":"Membranes","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"Periodontal Cyst","Edge_Type":"disease_to_anatomy","Node2":"Plasma","Weight":2,"Paper_List":"18454658|15948682","Original_Text":"PMID:18454658; Original text:Treatment with a combination of platelet-rich plasma and a demineralized freeze-dried bone allograft led to a significantly greater clinical improvement in intrabony periodontal defects compared to a demineralized freeze-dried bone allograft with saline.|PMID:15948682; Original text:Treatment with a combination of platelet-rich plasma and HA compared to HA with saline led to a significantly more favorable clinical improvement in intrabony periodontal defects."},{"Node1":"Bone and Bones","Edge_Type":"anatomy","Node2":"Mandible","Weight":1,"Paper_List":"22177808","Original_Text":"PMID:22177808; Original text:Grafting of osseous defects distal to mandibular second molars with an anorganic xenograft plus a membrane predictably resulted in a significant reduction in the probing pocket depth, clinical attachment level gain, and bone fill, which suggests that grafting the extraction sites with an anorganic xenograft plus a membrane could prevent periodontal disease in the future."},{"Node1":"Heterografts","Edge_Type":"anatomy","Node2":"Membranes","Weight":1,"Paper_List":"22177808","Original_Text":"PMID:22177808; Original text:Grafting of osseous defects distal to mandibular second molars with an anorganic xenograft plus a membrane predictably resulted in a significant reduction in the probing pocket depth, clinical attachment level gain, and bone fill, which suggests that grafting the extraction sites with an anorganic xenograft plus a membrane could prevent periodontal disease in the future."},{"Node1":"Heterografts","Edge_Type":"anatomy","Node2":"Mandible","Weight":1,"Paper_List":"22177808","Original_Text":"PMID:22177808; Original text:Grafting of osseous defects distal to mandibular second molars with an anorganic xenograft plus a membrane predictably resulted in a significant reduction in the probing pocket depth, clinical attachment level gain, and bone fill, which suggests that grafting the extraction sites with an anorganic xenograft plus a membrane could prevent periodontal disease in the future."},{"Node1":"Mandible","Edge_Type":"anatomy","Node2":"Membranes","Weight":1,"Paper_List":"22177808","Original_Text":"PMID:22177808; Original text:Grafting of osseous defects distal to mandibular second molars with an anorganic xenograft plus a membrane predictably resulted in a significant reduction in the probing pocket depth, clinical attachment level gain, and bone fill, which suggests that grafting the extraction sites with an anorganic xenograft plus a membrane could prevent periodontal disease in the future."},{"Node1":"Periodontal Cyst","Edge_Type":"disease_to_anatomy","Node2":"Platelet-Rich Fibrin","Weight":1,"Paper_List":"30624092","Original_Text":"PMID:30624092; Original text:leukocyte-platelet-rich fibrin combined with open flap debridement significantly increases growth factors levels and thus, it enhances the periodontal healing on chronic periodontitis patients."},{"Node1":"Periodontal Cyst","Edge_Type":"disease_to_anatomy","Node2":"Platelet-Rich Plasma","Weight":2,"Paper_List":"18454658|15948682","Original_Text":"PMID:18454658; Original text:Treatment with a combination of platelet-rich plasma and a demineralized freeze-dried bone allograft led to a significantly greater clinical improvement in intrabony periodontal defects compared to a demineralized freeze-dried bone allograft with saline.|PMID:15948682; Original text:Treatment with a combination of platelet-rich plasma and HA compared to HA with saline led to a significantly more favorable clinical improvement in intrabony periodontal defects."},{"Node1":"Periodontal Cyst","Edge_Type":"disease_to_anatomy","Node2":"Tissues","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"Periodontal Diseases","Edge_Type":"disease_to_anatomy","Node2":"Bone and Bones","Weight":1,"Paper_List":"22177808","Original_Text":"PMID:22177808; Original text:Grafting of osseous defects distal to mandibular second molars with an anorganic xenograft plus a membrane predictably resulted in a significant reduction in the probing pocket depth, clinical attachment level gain, and bone fill, which suggests that grafting the extraction sites with an anorganic xenograft plus a membrane could prevent periodontal disease in the future."},{"Node1":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","Edge_Type":"chemical_to_disease","Node2":"Periodontal Cyst","Weight":1,"Paper_List":"29211309","Original_Text":"PMID:29211309; Original text:Thirteen of the experimentally induced periodontitis (81%) and 2 of the acute/chronified periodontal defect (29%) studies presented significantly better results in terms of alveolar bone level/amount in favor of statins."},{"Node1":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","Edge_Type":"chemical_to_disease","Node2":"Periodontitis","Weight":1,"Paper_List":"29211309","Original_Text":"PMID:29211309; Original text:Thirteen of the experimentally induced periodontitis (81%) and 2 of the acute/chronified periodontal defect (29%) studies presented significantly better results in terms of alveolar bone level/amount in favor of statins."},{"Node1":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","Edge_Type":"chemical_to_mechanism","Node2":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","Weight":1,"Paper_List":"29211309","Original_Text":"PMID:29211309; Original text:Thirteen of the experimentally induced periodontitis (81%) and 2 of the acute/chronified periodontal defect (29%) studies presented significantly better results in terms of alveolar bone level/amount in favor of statins."},{"Node1":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","Edge_Type":"chemical_to_anatomy","Node2":"Alveolar Process","Weight":1,"Paper_List":"29211309","Original_Text":"PMID:29211309; Original text:Thirteen of the experimentally induced periodontitis (81%) and 2 of the acute/chronified periodontal defect (29%) studies presented significantly better results in terms of alveolar bone level/amount in favor of statins."},{"Node1":"Periodontal Cyst","Edge_Type":"disease_to_mechanism","Node2":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","Weight":1,"Paper_List":"29211309","Original_Text":"PMID:29211309; Original text:Thirteen of the experimentally induced periodontitis (81%) and 2 of the acute/chronified periodontal defect (29%) studies presented significantly better results in terms of alveolar bone level/amount in favor of statins."},{"Node1":"Periodontal Diseases","Edge_Type":"disease_to_anatomy","Node2":"Brachial Artery","Weight":1,"Paper_List":"24386401","Original_Text":"PMID:24386401; Original text:In contrast to previous studies, high levels of periodontal disease were significantly associated with high the brachial artery values."},{"Node1":"Periodontal Diseases","Edge_Type":"disease_to_anatomy","Node2":"Extracellular Matrix","Weight":1,"Paper_List":"25166440","Original_Text":"PMID:25166440; Original text:Matrix metalloproteinases (Matrix metalloproteinases) and cytokines play a role of extracellular matrix degradation and remodelling, and are significantly involved in the course of periodontal disease."},{"Node1":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","Edge_Type":"mechanism_to_anatomy","Node2":"Alveolar Process","Weight":1,"Paper_List":"29211309","Original_Text":"PMID:29211309; Original text:Thirteen of the experimentally induced periodontitis (81%) and 2 of the acute/chronified periodontal defect (29%) studies presented significantly better results in terms of alveolar bone level/amount in favor of statins."},{"Node1":"Atorvastatin","Edge_Type":"chemical_to_disease","Node2":"Periodontitis","Weight":1,"Paper_List":"29211309","Original_Text":"PMID:29211309; Original text:Meta-analysis based on 14 experimentally induced periodontitis trials confirmed a significant benefit of local and systemic statin use (P < .001) in terms of alveolar bone level/amount; meta-regression revealed that statin type exhibited a significant effect (P = .014) in favor of atorvastatin."},{"Node1":"Atorvastatin","Edge_Type":"chemical_to_mechanism","Node2":"stathmin 3","Weight":1,"Paper_List":"29211309","Original_Text":"PMID:29211309; Original text:Meta-analysis based on 14 experimentally induced periodontitis trials confirmed a significant benefit of local and systemic statin use (P < .001) in terms of alveolar bone level/amount; meta-regression revealed that statin type exhibited a significant effect (P = .014) in favor of atorvastatin."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"stathmin 3","Weight":1,"Paper_List":"29211309","Original_Text":"PMID:29211309; Original text:Meta-analysis based on 14 experimentally induced periodontitis trials confirmed a significant benefit of local and systemic statin use (P < .001) in terms of alveolar bone level/amount; meta-regression revealed that statin type exhibited a significant effect (P = .014) in favor of atorvastatin."},{"Node1":"stathmin 3","Edge_Type":"mechanism_to_anatomy","Node2":"Alveolar Process","Weight":1,"Paper_List":"29211309","Original_Text":"PMID:29211309; Original text:Meta-analysis based on 14 experimentally induced periodontitis trials confirmed a significant benefit of local and systemic statin use (P < .001) in terms of alveolar bone level/amount; meta-regression revealed that statin type exhibited a significant effect (P = .014) in favor of atorvastatin."},{"Node1":"Proanthocyanidins","Edge_Type":"chemical","Node2":"secnidazole","Weight":1,"Paper_List":"28337876","Original_Text":"PMID:28337876; Original text:In conclusion, the adjunctive use of proanthocyanidins or secnidazole in combination with scaling and root planing in adults with periodontitis is effective in reducing the pathogenic flora and achieves significantly better clinical results to a certain degree."},{"Node1":"Proanthocyanidins","Edge_Type":"chemical_to_disease","Node2":"Periodontitis","Weight":1,"Paper_List":"28337876","Original_Text":"PMID:28337876; Original text:In conclusion, the adjunctive use of proanthocyanidins or secnidazole in combination with scaling and root planing in adults with periodontitis is effective in reducing the pathogenic flora and achieves significantly better clinical results to a certain degree."},{"Node1":"secnidazole","Edge_Type":"chemical_to_disease","Node2":"Periodontitis","Weight":1,"Paper_List":"28337876","Original_Text":"PMID:28337876; Original text:In conclusion, the adjunctive use of proanthocyanidins or secnidazole in combination with scaling and root planing in adults with periodontitis is effective in reducing the pathogenic flora and achieves significantly better clinical results to a certain degree."},{"Node1":"Periodontitis","Edge_Type":"disease","Node2":"Pre-Eclampsia","Weight":2,"Paper_List":"32266957|32266957","Original_Text":"PMID:32266957; Original text:Periodontitis is an independent risk factor for preeclampsia (preeclampsia), and periodontal treatment could play a significant role in the prevention of this pregnancy complication.|PMID:32266957; Original text:A significant relationship between periodontitis and the risk for developing preeclampsia was demonstrated in 5 cohort trials, which was not confirmed by only 1 study."},{"Node1":"Periodontitis","Edge_Type":"disease","Node2":"Polycystic Ovary Syndrome","Weight":1,"Paper_List":"28598285","Original_Text":"PMID:28598285; Original text:Both the test and control group showed significant consistent improvement in metabolic parameters at 3- and 6-month follow-up, which was further comparable to group A. root planing together with medical treatment results in a greater reduction of systemic inflammatory burden compared with medical treatment alone in management of women with polycystic ovary syndrome and chronic periodontitis."},{"Node1":"Arthritis","Edge_Type":"disease","Node2":"Periodontitis","Weight":2,"Paper_List":"29589156|29589156","Original_Text":"PMID:29589156; Original text:At all time-points, levels of inflammatory markers in GCF were higher in arthritis-severe chronic periodontitis than in severe chronic periodontitis patients.|PMID:29589156; Original text:In addition, disease activity markers of arthritis (DAS28, CRP, ESR) and specific antibodies (specific antibodies) were monitored in the arthritis-severe chronic periodontitis group."},{"Node1":"Tannerella Forsythia","Edge_Type":"bacteria_to_disease","Node2":"Arthritis","Weight":1,"Paper_List":"29589156","Original_Text":"PMID:29589156; Original text:At all time-points, levels of inflammatory markers in GCF were higher in arthritis-severe chronic periodontitis than in severe chronic periodontitis patients."},{"Node1":"Tannerella Forsythia","Edge_Type":"bacteria_to_disease","Node2":"Periodontitis","Weight":1,"Paper_List":"29589156","Original_Text":"PMID:29589156; Original text:At all time-points, levels of inflammatory markers in GCF were higher in arthritis-severe chronic periodontitis than in severe chronic periodontitis patients."},{"Node1":"Porphyromonas Gingivalis (Organism)","Edge_Type":"bacteria_to_disease","Node2":"Arthritis","Weight":1,"Paper_List":"29589156","Original_Text":"PMID:29589156; Original text:At all time-points, levels of inflammatory markers in GCF were higher in arthritis-severe chronic periodontitis than in severe chronic periodontitis patients."},{"Node1":"Treponema Denticola (Organism)","Edge_Type":"bacteria_to_disease","Node2":"Arthritis","Weight":1,"Paper_List":"29589156","Original_Text":"PMID:29589156; Original text:At all time-points, levels of inflammatory markers in GCF were higher in arthritis-severe chronic periodontitis than in severe chronic periodontitis patients."},{"Node1":"Treponema Denticola (Organism)","Edge_Type":"bacteria_to_disease","Node2":"Periodontitis","Weight":3,"Paper_List":"29589156|26313005|26313005","Original_Text":"PMID:29589156; Original text:At all time-points, levels of inflammatory markers in GCF were higher in arthritis-severe chronic periodontitis than in severe chronic periodontitis patients.|PMID:26313005; Original text:The mere presence of Pg, even in low amount, was significantly associated with severe periodontitis, while the amount of Aggregatibacter actinomycetemcomitans, Treponema denticola, and Prevotella intermedia had to reach the critical thresholds to be significantly associated with disease.|PMID:26313005; Original text:Compared to individuals with low levels of both Treponema denticola and Prevotella intermedia, high colonization by either Treponema denticola or Prevotella intermedia alone significantly increased the odds of having severe periodontitis by 2.5 (95%CI 1.7-3.5) folds."},{"Node1":"Arthritis","Edge_Type":"disease_to_mechanism","Node2":"proline rich 4","Weight":1,"Paper_List":"29589156","Original_Text":"PMID:29589156; Original text:In addition, disease activity markers of arthritis (DAS28, CRP, ESR) and specific antibodies (specific antibodies) were monitored in the arthritis-severe chronic periodontitis group."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"proline rich 4","Weight":1,"Paper_List":"29589156","Original_Text":"PMID:29589156; Original text:In addition, disease activity markers of arthritis (DAS28, CRP, ESR) and specific antibodies (specific antibodies) were monitored in the arthritis-severe chronic periodontitis group."},{"Node1":"Epithelium","Edge_Type":"anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"27435493","Original_Text":"PMID:27435493; Original text:Postsurgery, a higher number of inflammatory cells and stronger expression of proinflammatory cytokines were observed in the epithelium and connective tissue of conventional osseous resective surgery gingival samples compared with fibre retention osseous resective surgery gingival samples (p < 0.001)."},{"Node1":"Epithelium","Edge_Type":"anatomy","Node2":"Tissues","Weight":1,"Paper_List":"27435493","Original_Text":"PMID:27435493; Original text:Postsurgery, a higher number of inflammatory cells and stronger expression of proinflammatory cytokines were observed in the epithelium and connective tissue of conventional osseous resective surgery gingival samples compared with fibre retention osseous resective surgery gingival samples (p < 0.001)."},{"Node1":"Connective Tissue","Edge_Type":"anatomy","Node2":"Epithelium","Weight":1,"Paper_List":"27435493","Original_Text":"PMID:27435493; Original text:Postsurgery, a higher number of inflammatory cells and stronger expression of proinflammatory cytokines were observed in the epithelium and connective tissue of conventional osseous resective surgery gingival samples compared with fibre retention osseous resective surgery gingival samples (p < 0.001)."},{"Node1":"Amoxicillin-Potassium Clavulanate Combination","Edge_Type":"chemical_to_disease","Node2":"Pain","Weight":1,"Paper_List":"8398438","Original_Text":"PMID:8398438; Original text:Symptoms improved in all patients following the start of treatment, however those receiving co-amoxiclav recorded a significantly greater decrease in pain during the second (P = 0.026) and third days (P = 0.025)."},{"Node1":"Lycopene","Edge_Type":"chemical_to_anatomy","Node2":"Periodontium","Weight":1,"Paper_List":"30633595","Original_Text":"PMID:30633595; Original text:In conclusion, locally delivered Lycopene solid lipid microparticles along with root planing could have a protective effect over periodontal tissues and it has the ability to decrease oxidative damage of proteins in diseased periodontium."},{"Node1":"Metronidazole","Edge_Type":"chemical_to_mechanism","Node2":"alpha-2-macroglobulin S homeolog","Weight":1,"Paper_List":"19088952","Original_Text":"PMID:19088952; Original text:Alpha2-macroglobulin was significantly reduced for scaling and root planing and metronidazole after 3 and 6 months (P< .001)."},{"Node1":"COX1","Edge_Type":"mechanism","Node2":"COX2","Weight":2,"Paper_List":"12593597|12593597","Original_Text":"PMID:12593597; Original text:In the non-selective COX-1/COX-2 inhibitor group, the gingival tissue prostaglandinE2 levels exhibited a significant decrease (P < 0.05).|PMID:12593597; Original text:Both the (COX)-2 inhibitor and non-selective COX-1/COX-2 inhibitor groups showed a significant decrease (P<0.05) in prostaglandinF2alpha level, while the placebo group showed a significant increase (P<0.05)."},{"Node1":"Dinoprostone","Edge_Type":"chemical_to_mechanism","Node2":"COX1","Weight":1,"Paper_List":"12593597","Original_Text":"PMID:12593597; Original text:In the non-selective COX-1/COX-2 inhibitor group, the gingival tissue prostaglandinE2 levels exhibited a significant decrease (P < 0.05)."},{"Node1":"Dinoprostone","Edge_Type":"chemical_to_mechanism","Node2":"COX2","Weight":1,"Paper_List":"12593597","Original_Text":"PMID:12593597; Original text:In the non-selective COX-1/COX-2 inhibitor group, the gingival tissue prostaglandinE2 levels exhibited a significant decrease (P < 0.05)."},{"Node1":"COX1","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"12593597","Original_Text":"PMID:12593597; Original text:In the non-selective COX-1/COX-2 inhibitor group, the gingival tissue prostaglandinE2 levels exhibited a significant decrease (P < 0.05)."},{"Node1":"COX2","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"12593597","Original_Text":"PMID:12593597; Original text:In the non-selective COX-1/COX-2 inhibitor group, the gingival tissue prostaglandinE2 levels exhibited a significant decrease (P < 0.05)."},{"Node1":"Dinoprost","Edge_Type":"chemical_to_mechanism","Node2":"COX1","Weight":1,"Paper_List":"12593597","Original_Text":"PMID:12593597; Original text:Both the (COX)-2 inhibitor and non-selective COX-1/COX-2 inhibitor groups showed a significant decrease (P<0.05) in prostaglandinF2alpha level, while the placebo group showed a significant increase (P<0.05)."},{"Node1":"Dinoprost","Edge_Type":"chemical_to_mechanism","Node2":"COX2","Weight":1,"Paper_List":"12593597","Original_Text":"PMID:12593597; Original text:Both the (COX)-2 inhibitor and non-selective COX-1/COX-2 inhibitor groups showed a significant decrease (P<0.05) in prostaglandinF2alpha level, while the placebo group showed a significant increase (P<0.05)."},{"Node1":"Aggregatibacter Actinomycetemcomitans","Edge_Type":"bacteria_to_chemical","Node2":"Moxifloxacin","Weight":1,"Paper_List":"26538521","Original_Text":"PMID:26538521; Original text:The significance of the treatment option (moxifloxacin or root planing + placebo) on the dependent variables (probing depth [PD] and clinical attachment level [CAL]), considering the interaction with the baseline detection of A. actinomycetemcomitans, was estimated."},{"Node1":"Triglycerides","Edge_Type":"chemical_to_anatomy","Node2":"Erythrocytes","Weight":1,"Paper_List":"25041550","Original_Text":"PMID:25041550; Original text:After 2 months of periodontal treatment there was a significant reduction of erythrocyte sedimentation rate (erythrocyte sedimentation rate) and triglycerides (p = 0.002, p = 0.004, respectively) in the test group."},{"Node1":"Aggressive Periodontitis","Edge_Type":"disease","Node2":"Hereditary pancreatitis","Weight":1,"Paper_List":"28013438","Original_Text":"PMID:28013438; Original text:The 3-year survival rate for chronic periodontitis and HP patients was 100 % while in aggressive periodontitis subjects, the respective value was 97.98 %; this difference being statistically significant."},{"Node1":"Chronic Periodontitis","Edge_Type":"disease","Node2":"Hereditary pancreatitis","Weight":1,"Paper_List":"28013438","Original_Text":"PMID:28013438; Original text:The 3-year survival rate for chronic periodontitis and HP patients was 100 % while in aggressive periodontitis subjects, the respective value was 97.98 %; this difference being statistically significant."},{"Node1":"Nuclear factor 7","Edge_Type":"mechanism","Node2":"tumor necrosis factor receptor superfamily member 11b S homeolog","Weight":1,"Paper_List":"23826645","Original_Text":"PMID:23826645; Original text:nuclear factor-κB ligand and osteoprotegerin concentrations were increased in the open-flap group at 3 months (P <0.05)."},{"Node1":"Periodontal Diseases","Edge_Type":"disease_to_anatomy","Node2":"Gingiva","Weight":2,"Paper_List":"24415114|26252751","Original_Text":"PMID:24415114; Original text:p = 0.17), and SLEDAI (5.9 ± 4.2 vs. 6.3 ± 4.3, p = 0.73) as well as Periodontal disease parameters [bleeding gingival index (40.8 ± 31.0 vs. 40.7 ± 36.2 %, p = 0.89), depth (1.7 ± 1.8 vs. 1.5 ± |PMID:26252751; Original text:In all groups, a significant reduction was observed in the percentage of periodontal diseased sites, gingival index, plaque index, and clinical attachment level gain at 90 days, demonstrating effectiveness of the treatment, independently of the adjuvant."},{"Node1":"Lunate Bone","Edge_Type":"anatomy","Node2":"Membranes","Weight":1,"Paper_List":"26233970","Original_Text":"PMID:26233970; Original text:Placement of a vascularized a vascularized marginal periosteal barrier membrane as a barrier membrane, using a semilunar incision, demonstrated a significant improvement in both clinical and histological outcomes of class II furcation defects in lower molars."},{"Node1":"Allografts","Edge_Type":"anatomy","Node2":"Bone and Bones","Weight":2,"Paper_List":"25972081|15068108","Original_Text":"PMID:25972081; Original text:However, the PRP/demineralized freeze-dried bone allograft group exhibited statistically significantly greater changes compared with the demineralized freeze-dried bone allograft/saline group in PD (4.15 ± 0.84 vs 3.60 ± 0.51 mm), CAL (3.73 ± 0.74 vs 2.61 ± 0.68 mm), REC (0.47 ± 0.56 vs 1.00 ± 0.61 mm), bone fill (3.50 ± 0.67 vs 2.49 ± 0.64 mm) and defect resolution (3.73 ± 0.63 vs 2.75 ± 0.57 mm).|PMID:15068108; Original text:Therefore, the purpose of this clinical trial was to determine whether the addition of bone graft (i.e., demineralized freeze-dried bone allograft [DFDBA]) significantly affects the outcome of collagen membrane guided tissue regeneration-based root coverage procedures."},{"Node1":"Periodontal Diseases","Edge_Type":"disease","Node2":"Spondylarthritis","Weight":1,"Paper_List":"20126902","Original_Text":"PMID:20126902; Original text:Statistically significant differences for periodontal disease after 3 (p=0.0055) and after 6 months (p=0.0066) were obtained in Group 1 (arthritis+periodontal disease+TR+) and 2(arthritis+periodontal disease+TR-); significant reduction in the % of BOP after 6 months (p=0.0128) and significant reduction in the % of Pl after 3 (p=0.0128) and 6 months (p=0.0002) in Group 1."},{"Node1":"Copper","Edge_Type":"chemical_to_disease","Node2":"Abscess","Weight":1,"Paper_List":"15592552","Original_Text":"PMID:15592552; Original text:There were no differences in the proportions of restorations lost between restoration types, although partial caries removal:a black copper cement restorations did have significantly more abscess/sinus formation over the 24-month study period."},{"Node1":"Flurbiprofen","Edge_Type":"chemical","Node2":"Ketorolac","Weight":2,"Paper_List":"7623251|7623251","Original_Text":"PMID:7623251; Original text:A significant loss in bone height was observed during the study period in the placebo group (-0.63 +/- 0.11; P < 0.001), but not in the flurbiprofen (-0.10 +/- 0.12; P = 0.40) or ketorolac rinse (+0.20 +/- 0.11 mm; P = 0.07) groups.|PMID:7623251; Original text:Nested ANOVA revealed that ketorolac and flurbiprofen groups had less bone loss (P < 0.01) and reduced gingival crevicular fluid PGE2 levels (P < 0.03) compared to placebo."},{"Node1":"Flurbiprofen","Edge_Type":"chemical_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"7623251","Original_Text":"PMID:7623251; Original text:Nested ANOVA revealed that ketorolac and flurbiprofen groups had less bone loss (P < 0.01) and reduced gingival crevicular fluid PGE2 levels (P < 0.03) compared to placebo."},{"Node1":"Flurbiprofen","Edge_Type":"chemical_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"7623251","Original_Text":"PMID:7623251; Original text:Nested ANOVA revealed that ketorolac and flurbiprofen groups had less bone loss (P < 0.01) and reduced gingival crevicular fluid PGE2 levels (P < 0.03) compared to placebo."},{"Node1":"Ketorolac","Edge_Type":"chemical_to_anatomy","Node2":"Gingiva","Weight":2,"Paper_List":"7623251|9706855","Original_Text":"PMID:7623251; Original text:Nested ANOVA revealed that ketorolac and flurbiprofen groups had less bone loss (P < 0.01) and reduced gingival crevicular fluid PGE2 levels (P < 0.03) compared to placebo.|PMID:9706855; Original text:A statistically significant increase in gingival crevicular fluid prostaglandin E2 levels was noted at days 28 and 42 in the placebo group (P < 0.01), but not in the ketorolac group (P > 0.05), when compared to baseline, however."},{"Node1":"Ketorolac","Edge_Type":"chemical_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":2,"Paper_List":"7623251|9706855","Original_Text":"PMID:7623251; Original text:Nested ANOVA revealed that ketorolac and flurbiprofen groups had less bone loss (P < 0.01) and reduced gingival crevicular fluid PGE2 levels (P < 0.03) compared to placebo.|PMID:9706855; Original text:A statistically significant increase in gingival crevicular fluid prostaglandin E2 levels was noted at days 28 and 42 in the placebo group (P < 0.01), but not in the ketorolac group (P > 0.05), when compared to baseline, however."},{"Node1":"Diabetes, Gestational","Edge_Type":"disease","Node2":"Periodontitis","Weight":1,"Paper_List":"26334246","Original_Text":"PMID:26334246; Original text:There was a significant association between periodontitis and periodontitis and gestational diabetes mellitus in the meta-analyses of four cross-sectional studies (odds ratio 1.67, 95% 95% confidence interval 1.20 to 2.32) and two case-control studies (odds ratio 2.66, 95% 95% confidence interval 1.52 to 4.65)."},{"Node1":"Sodium Hypochlorite","Edge_Type":"chemical_to_disease","Node2":"Pain","Weight":1,"Paper_List":"21187618","Original_Text":"PMID:21187618; Original text:There was significant difference in the pain level between the two groups only at 6 th hour postoperatively (P<0.05) and the pain was more in sodium hypochlorite group."},{"Node1":"Celecoxib","Edge_Type":"chemical_to_disease","Node2":"Pain","Weight":1,"Paper_List":"17076604","Original_Text":"PMID:17076604; Original text:Pain perception was statistically significantly lower in the celecoxib group than in the placebo group during the first 4 hours using the visual analog scale (P = 0.01) and at 1, 2, 3, 4, 6, and 7 hours using the 101-point numerical rate scale (P = 0.03)."},{"Node1":"Celecoxib","Edge_Type":"chemical","Node2":"Dexamethasone","Weight":1,"Paper_List":"17076604","Original_Text":"PMID:17076604; Original text:There was no statistically significant difference between the celecoxib and dexamethasone groups."},{"Node1":"Vitamin D","Edge_Type":"chemical_to_disease","Node2":"Periodontitis","Weight":1,"Paper_List":"30957605","Original_Text":"PMID:30957605; Original text:Pooled analyses suggested that vitamin D receptor rs2228570 variant was significantly associated with the susceptibility to periodontitis under dominant genetic model in the overall population (p = .03, OR = 0.82, 95%CI: 0.69-0.98,"},{"Node1":"Vitamin D","Edge_Type":"chemical_to_mechanism","Node2":"vitamin D receptor a","Weight":1,"Paper_List":"30957605","Original_Text":"PMID:30957605; Original text:Pooled analyses suggested that vitamin D receptor rs2228570 variant was significantly associated with the susceptibility to periodontitis under dominant genetic model in the overall population (p = .03, OR = 0.82, 95%CI: 0.69-0.98,"},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"vitamin D receptor a","Weight":1,"Paper_List":"30957605","Original_Text":"PMID:30957605; Original text:Pooled analyses suggested that vitamin D receptor rs2228570 variant was significantly associated with the susceptibility to periodontitis under dominant genetic model in the overall population (p = .03, OR = 0.82, 95%CI: 0.69-0.98,"},{"Node1":"Dinoprostone","Edge_Type":"chemical_to_mechanism","Node2":"interleukin 1 receptor antagonist","Weight":1,"Paper_List":"11966926","Original_Text":"PMID:11966926; Original text:Unlike controls, systemic analysis of cytokines showed a statistically significant reduction from baseline for IL-1beta at 6 weeks and PGE2 at 6 and 12 weeks (p<0.05) within test group."},{"Node1":"Enterococcus Faecalis (Organism)","Edge_Type":"bacteria_to_chemical","Node2":"Metronidazole","Weight":1,"Paper_List":"23754205","Original_Text":"PMID:23754205; Original text:Metronidazole gel (3% w/v) was more effective than metronidazole solution (0.5% w/v) against E. faecalis."},{"Node1":"Amoxicillin","Edge_Type":"chemical","Node2":"Erythromycin","Weight":1,"Paper_List":"26654350","Original_Text":"PMID:26654350; Original text:Amoxicillin plus metronidazole did not significantly affect the resistance pattern of the The viridans group streptococci to penicillin or erythromycin."},{"Node1":"Erythromycin","Edge_Type":"chemical","Node2":"Metronidazole","Weight":1,"Paper_List":"26654350","Original_Text":"PMID:26654350; Original text:Amoxicillin plus metronidazole did not significantly affect the resistance pattern of the The viridans group streptococci to penicillin or erythromycin."},{"Node1":"Erythromycin","Edge_Type":"chemical","Node2":"Penicillins","Weight":1,"Paper_List":"26654350","Original_Text":"PMID:26654350; Original text:Amoxicillin plus metronidazole did not significantly affect the resistance pattern of the The viridans group streptococci to penicillin or erythromycin."},{"Node1":"Amoxicillin","Edge_Type":"chemical","Node2":"Penicillins","Weight":1,"Paper_List":"26654350","Original_Text":"PMID:26654350; Original text:Amoxicillin plus metronidazole did not significantly affect the resistance pattern of the The viridans group streptococci to penicillin or erythromycin."},{"Node1":"Metronidazole","Edge_Type":"chemical","Node2":"Penicillins","Weight":1,"Paper_List":"26654350","Original_Text":"PMID:26654350; Original text:Amoxicillin plus metronidazole did not significantly affect the resistance pattern of the The viridans group streptococci to penicillin or erythromycin."},{"Node1":"Viridans Group Streptococci","Edge_Type":"bacteria_to_chemical","Node2":"Erythromycin","Weight":1,"Paper_List":"26654350","Original_Text":"PMID:26654350; Original text:Amoxicillin plus metronidazole did not significantly affect the resistance pattern of the The viridans group streptococci to penicillin or erythromycin."},{"Node1":"Viridans Group Streptococci","Edge_Type":"bacteria_to_chemical","Node2":"Amoxicillin","Weight":1,"Paper_List":"26654350","Original_Text":"PMID:26654350; Original text:Amoxicillin plus metronidazole did not significantly affect the resistance pattern of the The viridans group streptococci to penicillin or erythromycin."},{"Node1":"Viridans Group Streptococci","Edge_Type":"bacteria_to_chemical","Node2":"Metronidazole","Weight":1,"Paper_List":"26654350","Original_Text":"PMID:26654350; Original text:Amoxicillin plus metronidazole did not significantly affect the resistance pattern of the The viridans group streptococci to penicillin or erythromycin."},{"Node1":"Viridans Group Streptococci","Edge_Type":"bacteria_to_chemical","Node2":"Penicillins","Weight":1,"Paper_List":"26654350","Original_Text":"PMID:26654350; Original text:Amoxicillin plus metronidazole did not significantly affect the resistance pattern of the The viridans group streptococci to penicillin or erythromycin."},{"Node1":"Chronic Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"interleukin 1 beta L homeolog","Weight":1,"Paper_List":"24655616","Original_Text":"PMID:24655616; Original text:Individuals with type 2 diabetes mellitus (type 2 diabetes mellitus) and chronic periodontitis have significantly higher levels of interleukin-1 beta compared with systemically healthy individuals with chronic periodontitis."},{"Node1":"Diabetes Mellitus, Type 2","Edge_Type":"disease_to_mechanism","Node2":"interleukin 1 beta L homeolog","Weight":1,"Paper_List":"24655616","Original_Text":"PMID:24655616; Original text:Individuals with type 2 diabetes mellitus (type 2 diabetes mellitus) and chronic periodontitis have significantly higher levels of interleukin-1 beta compared with systemically healthy individuals with chronic periodontitis."},{"Node1":"Cytomegalovirus Retinitis","Edge_Type":"disease","Node2":"Periodontitis","Weight":3,"Paper_List":"26666412|26666412|32167179","Original_Text":"PMID:26666412; Original text:The pooled result showed that human cytomegalovirus also has a significant association with chronic periodontitis (odds ratios = 3.59, 95% 95% confidence intervals = 1.41-9.16, P = 0.007).|PMID:26666412; Original text:The findings of this meta-analysis suggest that two members of the herpesvirus family, Epstein-Barr virus and human cytomegalovirus, are significantly associated with chronic periodontitis.|PMID:32167179; Original text:Forest plot of combined studies revealed significant increased odds for periodontitis when subgingival Human cytomegalovirus was detected (OR 5.31; 95% CI 3.15-8.97)."},{"Node1":"Epstein-Barr Virus Infections","Edge_Type":"disease","Node2":"Periodontitis","Weight":1,"Paper_List":"26666412","Original_Text":"PMID:26666412; Original text:The findings of this meta-analysis suggest that two members of the herpesvirus family, Epstein-Barr virus and human cytomegalovirus, are significantly associated with chronic periodontitis."},{"Node1":"Cytomegalovirus Retinitis","Edge_Type":"disease","Node2":"Epstein-Barr Virus Infections","Weight":1,"Paper_List":"26666412","Original_Text":"PMID:26666412; Original text:The findings of this meta-analysis suggest that two members of the herpesvirus family, Epstein-Barr virus and human cytomegalovirus, are significantly associated with chronic periodontitis."},{"Node1":"Spirochetes","Edge_Type":"bacteria","Node2":"Streptococci Sp.","Weight":1,"Paper_List":"1332988","Original_Text":"PMID:1332988; Original text:Proportions of black pigmented anaerobes including Prevotella intermedia, and the number of spirochetes were significantly reduced after both treatments with a concomitant increase in the proportions of streptococci."},{"Node1":"Prevotella Intermedia","Edge_Type":"bacteria","Node2":"Streptococci Sp.","Weight":1,"Paper_List":"1332988","Original_Text":"PMID:1332988; Original text:Proportions of black pigmented anaerobes including Prevotella intermedia, and the number of spirochetes were significantly reduced after both treatments with a concomitant increase in the proportions of streptococci."},{"Node1":"Prevotella Intermedia","Edge_Type":"bacteria","Node2":"Spirochetes","Weight":1,"Paper_List":"1332988","Original_Text":"PMID:1332988; Original text:Proportions of black pigmented anaerobes including Prevotella intermedia, and the number of spirochetes were significantly reduced after both treatments with a concomitant increase in the proportions of streptococci."},{"Node1":"Actinobacillus Actinomycetemcomitans","Edge_Type":"bacteria_to_chemical","Node2":"Metronidazole","Weight":1,"Paper_List":"1332988","Original_Text":"PMID:1332988; Original text:While scaling resulted in a statistically significant increase in the proportion of A. actinomycetemcomitans, this was avoided after metronidazole treatment.(ABSTRACT TRUNCATED AT 250 WORDS)"},{"Node1":"Melatonin","Edge_Type":"chemical_to_disease","Node2":"Alveolar Bone Loss","Weight":1,"Paper_List":"33673616","Original_Text":"PMID:33673616; Original text:Neither radiography nor μCT revealed any significant effects of melatonin on alveolar bone loss."},{"Node1":"Melatonin","Edge_Type":"chemical_to_anatomy","Node2":"Alveolar Process","Weight":1,"Paper_List":"33673616","Original_Text":"PMID:33673616; Original text:Neither radiography nor μCT revealed any significant effects of melatonin on alveolar bone loss."},{"Node1":"calcitonin related polypeptide beta","Edge_Type":"mechanism","Node2":"matrix metallopeptidase 8","Weight":2,"Paper_List":"24331986|24331986","Original_Text":"PMID:24331986; Original text:All of the measured parameters were significantly reduced in group L (P < .05), whereas the level of pain on percussion, calcitonin gene-related peptide, and matrix metalloproteinase-8 were significantly reduced in group C (P < .05).|PMID:24331986; Original text:The 1440-nm Nd:YAG laser had significantly better effect on the relief of pain on percussion and the reduction of substance P, calcitonin gene-related peptide, and matrix metalloproteinase-8 levels."},{"Node1":"Pain","Edge_Type":"disease_to_mechanism","Node2":"calcitonin related polypeptide beta","Weight":2,"Paper_List":"24331986|24331986","Original_Text":"PMID:24331986; Original text:All of the measured parameters were significantly reduced in group L (P < .05), whereas the level of pain on percussion, calcitonin gene-related peptide, and matrix metalloproteinase-8 were significantly reduced in group C (P < .05).|PMID:24331986; Original text:The 1440-nm Nd:YAG laser had significantly better effect on the relief of pain on percussion and the reduction of substance P, calcitonin gene-related peptide, and matrix metalloproteinase-8 levels."},{"Node1":"Pain","Edge_Type":"disease_to_mechanism","Node2":"matrix metallopeptidase 8","Weight":2,"Paper_List":"24331986|24331986","Original_Text":"PMID:24331986; Original text:All of the measured parameters were significantly reduced in group L (P < .05), whereas the level of pain on percussion, calcitonin gene-related peptide, and matrix metalloproteinase-8 were significantly reduced in group C (P < .05).|PMID:24331986; Original text:The 1440-nm Nd:YAG laser had significantly better effect on the relief of pain on percussion and the reduction of substance P, calcitonin gene-related peptide, and matrix metalloproteinase-8 levels."},{"Node1":"calcitonin related polypeptide beta","Edge_Type":"mechanism","Node2":"tachykinin precursor 1 S homeolog","Weight":1,"Paper_List":"24331986","Original_Text":"PMID:24331986; Original text:The 1440-nm Nd:YAG laser had significantly better effect on the relief of pain on percussion and the reduction of substance P, calcitonin gene-related peptide, and matrix metalloproteinase-8 levels."},{"Node1":"matrix metallopeptidase 8","Edge_Type":"mechanism","Node2":"tachykinin precursor 1 S homeolog","Weight":1,"Paper_List":"24331986","Original_Text":"PMID:24331986; Original text:The 1440-nm Nd:YAG laser had significantly better effect on the relief of pain on percussion and the reduction of substance P, calcitonin gene-related peptide, and matrix metalloproteinase-8 levels."},{"Node1":"Pain","Edge_Type":"disease_to_mechanism","Node2":"tachykinin precursor 1 S homeolog","Weight":1,"Paper_List":"24331986","Original_Text":"PMID:24331986; Original text:The 1440-nm Nd:YAG laser had significantly better effect on the relief of pain on percussion and the reduction of substance P, calcitonin gene-related peptide, and matrix metalloproteinase-8 levels."},{"Node1":"Amoxicillin","Edge_Type":"chemical_to_disease","Node2":"Periodontitis","Weight":4,"Paper_List":"20447259|17618330|26034931|21062335","Original_Text":"PMID:20447259; Original text:Subjects with generalized aggressive periodontitis significantly benefit from the adjunctive use of metronidazole and amoxicillin.|PMID:17618330; Original text:The significant differences between treatment and placebo groups are in line with other studies and support the considerable adjunctive benefits of the combination of amoxicillin and metronidazole in the treatment of chronic periodontitis.|PMID:26034931; Original text:Systemic administration of moxifloxacin as an adjunct to non-surgical treatment significantly improves clinical outcomes and provides comparable clinical improvement with less adverse events to that of combination of amoxicillin and metronidazole in the treatment of generalized aggressive periodontitis.|PMID:21062335; Original text:Previously, we showed that systemic metronidazole and amoxicillin significantly improved the outcomes of non-surgical debridement in generalized aggressive periodontitis patients."},{"Node1":"Diabetes Mellitus, Type 1","Edge_Type":"disease","Node2":"Periodontal Cyst","Weight":1,"Paper_List":"16623181","Original_Text":"PMID:16623181; Original text:We conclude that a full-mouth disinfection approach significantly improves periodontal status and metabolic control in type 1 diabetes patients with periodontitis."},{"Node1":"Diabetes Mellitus, Type 1","Edge_Type":"disease","Node2":"Periodontitis","Weight":1,"Paper_List":"16623181","Original_Text":"PMID:16623181; Original text:We conclude that a full-mouth disinfection approach significantly improves periodontal status and metabolic control in type 1 diabetes patients with periodontitis."},{"Node1":"Actinobacillus Actinomycetemcomitans","Edge_Type":"bacteria_to_disease","Node2":"Mycetoma","Weight":1,"Paper_List":"10551154","Original_Text":"PMID:10551154; Original text:In patients harboring A. actinomycetemcomitans intraorally, the IgG4 antibody reactivity against the 110-kDa protein of A. actinomycetemcomitans was associated with significantly increased survival rates of teeth and of sites not exhibiting 2 mm or more of probing attachment loss."},{"Node1":"Actinobacillus Actinomycetemcomitans","Edge_Type":"bacteria_to_antibody","Node2":"Anti-immunoglobulin heavy chain (S107 family)","Weight":1,"Paper_List":"10551154","Original_Text":"PMID:10551154; Original text:In patients harboring A. actinomycetemcomitans intraorally, the IgG4 antibody reactivity against the 110-kDa protein of A. actinomycetemcomitans was associated with significantly increased survival rates of teeth and of sites not exhibiting 2 mm or more of probing attachment loss."},{"Node1":"Actinobacillus Actinomycetemcomitans","Edge_Type":"bacteria_to_anatomy","Node2":"Tooth","Weight":1,"Paper_List":"10551154","Original_Text":"PMID:10551154; Original text:In patients harboring A. actinomycetemcomitans intraorally, the IgG4 antibody reactivity against the 110-kDa protein of A. actinomycetemcomitans was associated with significantly increased survival rates of teeth and of sites not exhibiting 2 mm or more of probing attachment loss."},{"Node1":"Mycetoma","Edge_Type":"disease_to_antibody","Node2":"Anti-immunoglobulin heavy chain (S107 family)","Weight":1,"Paper_List":"10551154","Original_Text":"PMID:10551154; Original text:In patients harboring A. actinomycetemcomitans intraorally, the IgG4 antibody reactivity against the 110-kDa protein of A. actinomycetemcomitans was associated with significantly increased survival rates of teeth and of sites not exhibiting 2 mm or more of probing attachment loss."},{"Node1":"Periodontal Diseases","Edge_Type":"disease_to_anatomy","Node2":"Heterografts","Weight":1,"Paper_List":"22177808","Original_Text":"PMID:22177808; Original text:Grafting of osseous defects distal to mandibular second molars with an anorganic xenograft plus a membrane predictably resulted in a significant reduction in the probing pocket depth, clinical attachment level gain, and bone fill, which suggests that grafting the extraction sites with an anorganic xenograft plus a membrane could prevent periodontal disease in the future."},{"Node1":"Anti-immunoglobulin heavy chain (S107 family)","Edge_Type":"antibody_to_anatomy","Node2":"Tooth","Weight":1,"Paper_List":"10551154","Original_Text":"PMID:10551154; Original text:In patients harboring A. actinomycetemcomitans intraorally, the IgG4 antibody reactivity against the 110-kDa protein of A. actinomycetemcomitans was associated with significantly increased survival rates of teeth and of sites not exhibiting 2 mm or more of probing attachment loss."},{"Node1":"Porphyromonas Gingivalis (Organism)","Edge_Type":"bacteria_to_disease","Node2":"Porphyrias","Weight":1,"Paper_List":"24555751","Original_Text":"PMID:24555751; Original text:An inferior frequency detection of Porphyromonas gingivalis was observed in the photodynamic therapy protocol at 3 and 6 months and in the root planing protocol at 6 months from baseline (P <0.05)."},{"Node1":"interferon gamma","Edge_Type":"mechanism","Node2":"interleukin 1 beta","Weight":1,"Paper_List":"24555751","Original_Text":"PMID:24555751; Original text:Intergroup analyses showed reduced anti-inflammatory interleukin-10 and increased interferon-γ and anti-inflammatory interleukin-1β levels in the 2) photosensitizer protocol when compared with the other therapies during follow-ups (P <0.05)."},{"Node1":"interferon gamma","Edge_Type":"mechanism","Node2":"interleukin 10 S homeolog","Weight":1,"Paper_List":"24555751","Original_Text":"PMID:24555751; Original text:Intergroup analyses showed reduced anti-inflammatory interleukin-10 and increased interferon-γ and anti-inflammatory interleukin-1β levels in the 2) photosensitizer protocol when compared with the other therapies during follow-ups (P <0.05)."},{"Node1":"Mutans Streptococcus","Edge_Type":"bacteria_to_anatomy","Node2":"Salivary Glands","Weight":2,"Paper_List":"8436631|16032940","Original_Text":"PMID:8436631; Original text:13 patients with > 5 new DFS% during the 3rd 4-year period (years 9-12) differed significantly from 14 patients with < or = 5 new DFS% in salivary mutans streptococcus counts (p < 0.01), plaque scores (p < 0.001) and new DFS% during the 2nd 4-year period (years 5-8) (p < 0.001).|PMID:16032940; Original text:Salivary count of Mutans Streptococci and Lactobacilli had significant decrease 3.37 (+/- 0.71) to 2.27 (+/- 0.80) and 3.22 (+/- 0.85) to 2.32 (+/- 0.87) respectively (P = 0.000)."},{"Node1":"Actinobacillus Actinomycetemcomitans","Edge_Type":"bacteria_to_anatomy","Node2":"Lunate Bone","Weight":2,"Paper_List":"17618330|17618330","Original_Text":"PMID:17618330; Original text:Parallel to the clinical changes, treatment significantly reduced the number of Actinobacillus actinomycetemcomitans (Actinobacillus actinomycetemcomitans), Porphyromonas gingivalis (Pg), and P. intermedia (P. intermedia) compared with baseline in the T group (P=0.003, 0.021 and 0.0001, respectively).|PMID:17618330; Original text:After therapy, there was a significant difference between the T and P groups in the number of patients negative for Actinobacillus actinomycetemcomitans, Pg, and P. intermedia (Pv = 0.033)."},{"Node1":"Porphyromonas Gingivalis (Organism)","Edge_Type":"bacteria_to_anatomy","Node2":"Lunate Bone","Weight":1,"Paper_List":"17618330","Original_Text":"PMID:17618330; Original text:Parallel to the clinical changes, treatment significantly reduced the number of Actinobacillus actinomycetemcomitans (Actinobacillus actinomycetemcomitans), Porphyromonas gingivalis (Pg), and P. intermedia (P. intermedia) compared with baseline in the T group (P=0.003, 0.021 and 0.0001, respectively)."},{"Node1":"Chlorhexidine","Edge_Type":"chemical","Node2":"Metronidazole","Weight":1,"Paper_List":"26273264","Original_Text":"PMID:26273264; Original text:In the T group, significant increases in the The minimum inhibitory concentrations of chlorhexidine (p < 0.05) and amoxicillin (p < 0.01) were detected during the first 3 months; however, the MIC of metronidazole decreased at 12 months (p < 0.05)."},{"Node1":"Amoxicillin","Edge_Type":"chemical","Node2":"Chlorhexidine","Weight":1,"Paper_List":"26273264","Original_Text":"PMID:26273264; Original text:In the T group, significant increases in the The minimum inhibitory concentrations of chlorhexidine (p < 0.05) and amoxicillin (p < 0.01) were detected during the first 3 months; however, the MIC of metronidazole decreased at 12 months (p < 0.05)."},{"Node1":"Streptococci Sp.","Edge_Type":"bacteria_to_chemical","Node2":"Metronidazole","Weight":1,"Paper_List":"26273264","Original_Text":"PMID:26273264; Original text:In the T group, significant increases in the The minimum inhibitory concentrations of chlorhexidine (p < 0.05) and amoxicillin (p < 0.01) were detected during the first 3 months; however, the MIC of metronidazole decreased at 12 months (p < 0.05)."},{"Node1":"Streptococci Sp.","Edge_Type":"bacteria_to_chemical","Node2":"Amoxicillin","Weight":1,"Paper_List":"26273264","Original_Text":"PMID:26273264; Original text:In the T group, significant increases in the The minimum inhibitory concentrations of chlorhexidine (p < 0.05) and amoxicillin (p < 0.01) were detected during the first 3 months; however, the MIC of metronidazole decreased at 12 months (p < 0.05)."},{"Node1":"Streptococci Sp.","Edge_Type":"bacteria_to_chemical","Node2":"Chlorhexidine","Weight":1,"Paper_List":"26273264","Original_Text":"PMID:26273264; Original text:In the T group, significant increases in the The minimum inhibitory concentrations of chlorhexidine (p < 0.05) and amoxicillin (p < 0.01) were detected during the first 3 months; however, the MIC of metronidazole decreased at 12 months (p < 0.05)."},{"Node1":"Alendronate","Edge_Type":"chemical_to_anatomy","Node2":"Alveolar Process","Weight":1,"Paper_List":"11288794","Original_Text":"PMID:11288794; Original text:Alveolar bone border-the cemento-enamel-junction distance increased in the placebo, but decreased in the Alendronate group (P = 0.0003)."},{"Node1":"matrix metallopeptidase 1","Edge_Type":"mechanism","Node2":"tissue inhibitor of metalloproteinase-1 L homeolog","Weight":3,"Paper_List":"23161345|23161345|25741580","Original_Text":"PMID:23161345; Original text:MMP-1, metalloproteinase-8, and TIMP-1 showed significant differences between groups after treatment compared to baseline (p < 0.05).|PMID:23161345; Original text:The total amount of IL-1β, interleukin-6, MMP-1, metalloproteinase-8, and TIMP-1 decreased (p < 0.05) and interleukin-8 increased after treatment in both diode laser and control groups (p < 0.05).|PMID:25741580; Original text:Decreased Gingival crevicular fluid metalloproteinase-8 levels and increased TIMP-1 levels were found to be significant up to day 180 (P <0.05)."},{"Node1":"matrix metallopeptidase 1","Edge_Type":"mechanism","Node2":"matrix metallopeptidase 8 L homeolog","Weight":2,"Paper_List":"23161345|23161345","Original_Text":"PMID:23161345; Original text:MMP-1, metalloproteinase-8, and TIMP-1 showed significant differences between groups after treatment compared to baseline (p < 0.05).|PMID:23161345; Original text:The total amount of IL-1β, interleukin-6, MMP-1, metalloproteinase-8, and TIMP-1 decreased (p < 0.05) and interleukin-8 increased after treatment in both diode laser and control groups (p < 0.05)."},{"Node1":"matrix metallopeptidase 8 L homeolog","Edge_Type":"mechanism","Node2":"tissue inhibitor of metalloproteinase-1 L homeolog","Weight":2,"Paper_List":"23161345|23161345","Original_Text":"PMID:23161345; Original text:MMP-1, metalloproteinase-8, and TIMP-1 showed significant differences between groups after treatment compared to baseline (p < 0.05).|PMID:23161345; Original text:The total amount of IL-1β, interleukin-6, MMP-1, metalloproteinase-8, and TIMP-1 decreased (p < 0.05) and interleukin-8 increased after treatment in both diode laser and control groups (p < 0.05)."},{"Node1":"JIL-1 kinase","Edge_Type":"mechanism","Node2":"tissue inhibitor of metalloproteinase-1 L homeolog","Weight":1,"Paper_List":"23161345","Original_Text":"PMID:23161345; Original text:The total amount of IL-1β, interleukin-6, MMP-1, metalloproteinase-8, and TIMP-1 decreased (p < 0.05) and interleukin-8 increased after treatment in both diode laser and control groups (p < 0.05)."},{"Node1":"JIL-1 kinase","Edge_Type":"mechanism","Node2":"interleukin 6 L homeolog","Weight":1,"Paper_List":"23161345","Original_Text":"PMID:23161345; Original text:The total amount of IL-1β, interleukin-6, MMP-1, metalloproteinase-8, and TIMP-1 decreased (p < 0.05) and interleukin-8 increased after treatment in both diode laser and control groups (p < 0.05)."},{"Node1":"interleukin 6 L homeolog","Edge_Type":"mechanism","Node2":"matrix metallopeptidase 8 L homeolog","Weight":1,"Paper_List":"23161345","Original_Text":"PMID:23161345; Original text:The total amount of IL-1β, interleukin-6, MMP-1, metalloproteinase-8, and TIMP-1 decreased (p < 0.05) and interleukin-8 increased after treatment in both diode laser and control groups (p < 0.05)."},{"Node1":"interleukin 6 L homeolog","Edge_Type":"mechanism","Node2":"matrix metallopeptidase 1","Weight":1,"Paper_List":"23161345","Original_Text":"PMID:23161345; Original text:The total amount of IL-1β, interleukin-6, MMP-1, metalloproteinase-8, and TIMP-1 decreased (p < 0.05) and interleukin-8 increased after treatment in both diode laser and control groups (p < 0.05)."},{"Node1":"JIL-1 kinase","Edge_Type":"mechanism","Node2":"methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2 like","Weight":1,"Paper_List":"23161345","Original_Text":"PMID:23161345; Original text:The total amount of IL-1β, interleukin-6, MMP-1, metalloproteinase-8, and TIMP-1 decreased (p < 0.05) and interleukin-8 increased after treatment in both diode laser and control groups (p < 0.05)."},{"Node1":"matrix metallopeptidase 8 L homeolog","Edge_Type":"mechanism","Node2":"methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2 like","Weight":1,"Paper_List":"23161345","Original_Text":"PMID:23161345; Original text:The total amount of IL-1β, interleukin-6, MMP-1, metalloproteinase-8, and TIMP-1 decreased (p < 0.05) and interleukin-8 increased after treatment in both diode laser and control groups (p < 0.05)."},{"Node1":"matrix metallopeptidase 1","Edge_Type":"mechanism","Node2":"methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2 like","Weight":1,"Paper_List":"23161345","Original_Text":"PMID:23161345; Original text:The total amount of IL-1β, interleukin-6, MMP-1, metalloproteinase-8, and TIMP-1 decreased (p < 0.05) and interleukin-8 increased after treatment in both diode laser and control groups (p < 0.05)."},{"Node1":"JIL-1 kinase","Edge_Type":"mechanism","Node2":"matrix metallopeptidase 8 L homeolog","Weight":1,"Paper_List":"23161345","Original_Text":"PMID:23161345; Original text:The total amount of IL-1β, interleukin-6, MMP-1, metalloproteinase-8, and TIMP-1 decreased (p < 0.05) and interleukin-8 increased after treatment in both diode laser and control groups (p < 0.05)."},{"Node1":"JIL-1 kinase","Edge_Type":"mechanism","Node2":"matrix metallopeptidase 1","Weight":1,"Paper_List":"23161345","Original_Text":"PMID:23161345; Original text:The total amount of IL-1β, interleukin-6, MMP-1, metalloproteinase-8, and TIMP-1 decreased (p < 0.05) and interleukin-8 increased after treatment in both diode laser and control groups (p < 0.05)."},{"Node1":"TNF superfamily member 11","Edge_Type":"mechanism","Node2":"tumor necrosis factor receptor superfamily member 11b S homeolog","Weight":1,"Paper_List":"29099236","Original_Text":"PMID:29099236; Original text:Bone thickness correlated negatively with nuclear factor kappa-B ligand/RANKL)/osteoprotegerin ratio between T1 and treatment ( P < .05)."},{"Node1":"Obesity","Edge_Type":"disease_to_mechanism","Node2":"transcription factor AP-2 alpha","Weight":1,"Paper_List":"26385382","Original_Text":"PMID:26385382; Original text:The means of obesity measures decreased significantly more in the obese group (body mass index 2.53 ± 0.96, waist-to-hip ratio (WHR) 4.88 ± 1.58 %, low-density lipoprotein 35.85 ± 21.74 mgdL(-1)) than in the normal weight group (body mass index 0.78 ± 0.72, WHR 2.00 ±"},{"Node1":"component of oligomeric golgi complex 1","Edge_Type":"mechanism","Node2":"matrix metallopeptidase 8 S homeolog","Weight":1,"Paper_List":"26385382","Original_Text":"PMID:26385382; Original text:Anthropometric measures and the amounts of serum and gingival crevicular fluid biomarkers had weak positive correlations (0.242 ≤ r ≤ 0.340), and low-density lipoprotein in serum correlated with MMP-8 (r = 0.332) and IL-1β (r = 0.342) in the obese group."},{"Node1":"matrix metallopeptidase 8 S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"26385382","Original_Text":"PMID:26385382; Original text:Anthropometric measures and the amounts of serum and gingival crevicular fluid biomarkers had weak positive correlations (0.242 ≤ r ≤ 0.340), and low-density lipoprotein in serum correlated with MMP-8 (r = 0.332) and IL-1β (r = 0.342) in the obese group."},{"Node1":"matrix metallopeptidase 8 S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"26385382","Original_Text":"PMID:26385382; Original text:Anthropometric measures and the amounts of serum and gingival crevicular fluid biomarkers had weak positive correlations (0.242 ≤ r ≤ 0.340), and low-density lipoprotein in serum correlated with MMP-8 (r = 0.332) and IL-1β (r = 0.342) in the obese group."},{"Node1":"component of oligomeric golgi complex 1","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"26385382","Original_Text":"PMID:26385382; Original text:Anthropometric measures and the amounts of serum and gingival crevicular fluid biomarkers had weak positive correlations (0.242 ≤ r ≤ 0.340), and low-density lipoprotein in serum correlated with MMP-8 (r = 0.332) and IL-1β (r = 0.342) in the obese group."},{"Node1":"component of oligomeric golgi complex 1","Edge_Type":"mechanism_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"26385382","Original_Text":"PMID:26385382; Original text:Anthropometric measures and the amounts of serum and gingival crevicular fluid biomarkers had weak positive correlations (0.242 ≤ r ≤ 0.340), and low-density lipoprotein in serum correlated with MMP-8 (r = 0.332) and IL-1β (r = 0.342) in the obese group."},{"Node1":"provisional ortholog of C-reactive protein L homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"21631509","Original_Text":"PMID:21631509; Original text:In the treatment group, the reduction in [C-reactive protein was significantly, linearly and directly correlated with the reduction in the plaque index, the gingival index and the percentage of sites with pocket depth ≥ 7 mm (Pearson correlation coefficient = 0.746, 0.425 and 0.621, respectively)."},{"Node1":"Gingiva","Edge_Type":"anatomy","Node2":"Neutrophils","Weight":1,"Paper_List":"33028054","Original_Text":"PMID:33028054; Original text:Whole-mouth (the plaque index, gingival index, BOP, PD, clinical attachment level and PD) parameters, bacterial level in subgingival plaque and number of oral neutrophils decreased statistically significantly after treatment compared to baseline in both groups (p < 0.01)."},{"Node1":"Simvastatin","Edge_Type":"chemical_to_mechanism","Node2":"interleukin 8-like 2","Weight":1,"Paper_List":"28601733","Original_Text":"PMID:28601733; Original text:Both the groups showed significant reduction in all the clinical parameters scores and IL-6 and IL-8 levels after non-surgical periodontal therapy (root planing for group I/root planing+1.2% 1.2% simvastatin gel for group II) in contrast to baseline values."},{"Node1":"Simvastatin","Edge_Type":"chemical_to_mechanism","Node2":"interleukin 6 cytokine family signal transducer","Weight":1,"Paper_List":"28601733","Original_Text":"PMID:28601733; Original text:Both the groups showed significant reduction in all the clinical parameters scores and IL-6 and IL-8 levels after non-surgical periodontal therapy (root planing for group I/root planing+1.2% 1.2% simvastatin gel for group II) in contrast to baseline values."},{"Node1":"B-Lymphocytes","Edge_Type":"anatomy","Node2":"Memory B Cells","Weight":1,"Paper_List":"29447240","Original_Text":"PMID:29447240; Original text:A significantly higher percentage of CD27+ memory B cells was observed in patients with severe periodontitis."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"CD27 molecule","Weight":1,"Paper_List":"29447240","Original_Text":"PMID:29447240; Original text:A significantly higher percentage of CD27+ memory B cells was observed in patients with severe periodontitis."},{"Node1":"Periodontal Diseases","Edge_Type":"disease_to_anatomy","Node2":"Mandible","Weight":1,"Paper_List":"22177808","Original_Text":"PMID:22177808; Original text:Grafting of osseous defects distal to mandibular second molars with an anorganic xenograft plus a membrane predictably resulted in a significant reduction in the probing pocket depth, clinical attachment level gain, and bone fill, which suggests that grafting the extraction sites with an anorganic xenograft plus a membrane could prevent periodontal disease in the future."},{"Node1":"Periodontal Diseases","Edge_Type":"disease_to_anatomy","Node2":"Membranes","Weight":1,"Paper_List":"22177808","Original_Text":"PMID:22177808; Original text:Grafting of osseous defects distal to mandibular second molars with an anorganic xenograft plus a membrane predictably resulted in a significant reduction in the probing pocket depth, clinical attachment level gain, and bone fill, which suggests that grafting the extraction sites with an anorganic xenograft plus a membrane could prevent periodontal disease in the future."},{"Node1":"CD27 molecule","Edge_Type":"mechanism_to_anatomy","Node2":"Memory B Cells","Weight":1,"Paper_List":"29447240","Original_Text":"PMID:29447240; Original text:A significantly higher percentage of CD27+ memory B cells was observed in patients with severe periodontitis."},{"Node1":"CD27 molecule","Edge_Type":"mechanism_to_anatomy","Node2":"B-Lymphocytes","Weight":2,"Paper_List":"29447240|29447240","Original_Text":"PMID:29447240; Original text:A significantly higher percentage of CD27+ memory B cells was observed in patients with severe periodontitis.|PMID:29447240; Original text:Among these CD27+ B cells, the proportion of the switched memory subset was significantly higher."},{"Node1":"B-Lymphocytes","Edge_Type":"anatomy","Node2":"T-Lymphocyte Subsets","Weight":1,"Paper_List":"29447240","Original_Text":"PMID:29447240; Original text:The RANKL expression increased in every B cell subset from the severe periodontitis patients and was significantly greater in activated B cells than in the subjects without periodontitis."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"TNF superfamily member 11 S homeolog","Weight":1,"Paper_List":"29447240","Original_Text":"PMID:29447240; Original text:The RANKL expression increased in every B cell subset from the severe periodontitis patients and was significantly greater in activated B cells than in the subjects without periodontitis."},{"Node1":"Periodontal Diseases","Edge_Type":"disease_to_anatomy","Node2":"Myocardium","Weight":1,"Paper_List":"11216961","Original_Text":"PMID:11216961; Original text:In Cox proportional hazards regression analysis adjusted for age and treatment assignment, physicians who reported periodontal disease at baseline had slightly elevated, but statistically nonsignificant, relative risks (statistically nonsignificant, relative risks) of nonfatal myocardial infarction, (statistically nonsignificant, relative risks, 1.12; 95% confidence interval [CI], 0.92 to 1.36), nonfatal stroke (statistically nonsignificant, relative risks, 1.10; CI, 0.88 to 1.37) and cardiovascular death (statistically nonsignificant, relative risks, 1.20; CI, 0.97 to 1.49)."},{"Node1":"TNF superfamily member 11 S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"T-Lymphocyte Subsets","Weight":1,"Paper_List":"29447240","Original_Text":"PMID:29447240; Original text:The RANKL expression increased in every B cell subset from the severe periodontitis patients and was significantly greater in activated B cells than in the subjects without periodontitis."},{"Node1":"TNF superfamily member 11 S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"B-Lymphocytes","Weight":1,"Paper_List":"29447240","Original_Text":"PMID:29447240; Original text:The RANKL expression increased in every B cell subset from the severe periodontitis patients and was significantly greater in activated B cells than in the subjects without periodontitis."},{"Node1":"B-Lymphocytes","Edge_Type":"anatomy","Node2":"Cells","Weight":1,"Paper_List":"29447240","Original_Text":"PMID:29447240; Original text:Among these CD27+ B cells, the proportion of the switched memory subset was significantly higher."},{"Node1":"CD27 molecule","Edge_Type":"mechanism_to_anatomy","Node2":"Cells","Weight":1,"Paper_List":"29447240","Original_Text":"PMID:29447240; Original text:Among these CD27+ B cells, the proportion of the switched memory subset was significantly higher."},{"Node1":"Periodontal Pocket","Edge_Type":"disease_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"7752836","Original_Text":"PMID:7752836; Original text:However, significant improvements in the modified gingival index, bleeding on probing and peptidase activity derived from periodontopathic bacteria were observed only at experimental sites."},{"Node1":"Lactobacillus Sp.","Edge_Type":"bacteria_to_disease","Node2":"Hemorrhage","Weight":1,"Paper_List":"30834725","Original_Text":"PMID:30834725; Original text:Regarding bleeding after pocket probing, the full-mouth with lactobacillus groups also showed more reduction than the placebo group (P< 0.01)."},{"Node1":"natriuretic peptide B","Edge_Type":"mechanism","Node2":"provisional ortholog of C-reactive protein L homeolog","Weight":1,"Paper_List":"32350903","Original_Text":"PMID:32350903; Original text:The serum levels of N-terminal pro-B type natriuretic peptide (N-terminal pro-B type natriuretic peptide) as a cardiac stress biomarker, C-reactive protein and interleukin-6 decreased numerically without reaching statistical significance."},{"Node1":"interleukin 6 L homeolog","Edge_Type":"mechanism","Node2":"natriuretic peptide B","Weight":1,"Paper_List":"32350903","Original_Text":"PMID:32350903; Original text:The serum levels of N-terminal pro-B type natriuretic peptide (N-terminal pro-B type natriuretic peptide) as a cardiac stress biomarker, C-reactive protein and interleukin-6 decreased numerically without reaching statistical significance."},{"Node1":"interleukin 6 L homeolog","Edge_Type":"mechanism","Node2":"provisional ortholog of C-reactive protein L homeolog","Weight":1,"Paper_List":"32350903","Original_Text":"PMID:32350903; Original text:The serum levels of N-terminal pro-B type natriuretic peptide (N-terminal pro-B type natriuretic peptide) as a cardiac stress biomarker, C-reactive protein and interleukin-6 decreased numerically without reaching statistical significance."},{"Node1":"Diabetes Complications","Edge_Type":"disease","Node2":"Periodontitis","Weight":1,"Paper_List":"32350903","Original_Text":"PMID:32350903; Original text:Periodontitis significantly increases the risk of diabetic complications."},{"Node1":"Leukocytes","Edge_Type":"anatomy","Node2":"Platelet-Rich Fibrin","Weight":3,"Paper_List":"30624092|30624092|30624092","Original_Text":"PMID:30624092; Original text:PD reduction and clinical attachment level gain were significantly higher in the open flap debridement + leukocyte-platelet-rich fibrin sites than in open flap debridement sites.|PMID:30624092; Original text:leukocyte-platelet-rich fibrin combined with open flap debridement significantly increases growth factors levels and thus, it enhances the periodontal healing on chronic periodontitis patients.|PMID:30624092; Original text:open flap debridement + leukocyte-platelet-rich fibrin group showed significantly increased bone morphogenetic protein-2 and insulin-like growth factor-1 at 2 weeks compared with baseline."},{"Node1":"Blood Platelets","Edge_Type":"anatomy","Node2":"Leukocytes","Weight":3,"Paper_List":"30624092|30624092|30624092","Original_Text":"PMID:30624092; Original text:PD reduction and clinical attachment level gain were significantly higher in the open flap debridement + leukocyte-platelet-rich fibrin sites than in open flap debridement sites.|PMID:30624092; Original text:leukocyte-platelet-rich fibrin combined with open flap debridement significantly increases growth factors levels and thus, it enhances the periodontal healing on chronic periodontitis patients.|PMID:30624092; Original text:open flap debridement + leukocyte-platelet-rich fibrin group showed significantly increased bone morphogenetic protein-2 and insulin-like growth factor-1 at 2 weeks compared with baseline."},{"Node1":"silk fibroin light chain","Edge_Type":"mechanism_to_anatomy","Node2":"Leukocytes","Weight":3,"Paper_List":"30624092|30624092|30624092","Original_Text":"PMID:30624092; Original text:PD reduction and clinical attachment level gain were significantly higher in the open flap debridement + leukocyte-platelet-rich fibrin sites than in open flap debridement sites.|PMID:30624092; Original text:leukocyte-platelet-rich fibrin combined with open flap debridement significantly increases growth factors levels and thus, it enhances the periodontal healing on chronic periodontitis patients.|PMID:30624092; Original text:open flap debridement + leukocyte-platelet-rich fibrin group showed significantly increased bone morphogenetic protein-2 and insulin-like growth factor-1 at 2 weeks compared with baseline."},{"Node1":"Periodontal Cyst","Edge_Type":"disease_to_mechanism","Node2":"silk fibroin light chain","Weight":1,"Paper_List":"30624092","Original_Text":"PMID:30624092; Original text:leukocyte-platelet-rich fibrin combined with open flap debridement significantly increases growth factors levels and thus, it enhances the periodontal healing on chronic periodontitis patients."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"silk fibroin light chain","Weight":1,"Paper_List":"30624092","Original_Text":"PMID:30624092; Original text:leukocyte-platelet-rich fibrin combined with open flap debridement significantly increases growth factors levels and thus, it enhances the periodontal healing on chronic periodontitis patients."},{"Node1":"Periodontitis","Edge_Type":"disease_to_anatomy","Node2":"Alveolar Process","Weight":2,"Paper_List":"29211309|29211309","Original_Text":"PMID:29211309; Original text:Thirteen of the experimentally induced periodontitis (81%) and 2 of the acute/chronified periodontal defect (29%) studies presented significantly better results in terms of alveolar bone level/amount in favor of statins.|PMID:29211309; Original text:Meta-analysis based on 14 experimentally induced periodontitis trials confirmed a significant benefit of local and systemic statin use (P < .001) in terms of alveolar bone level/amount; meta-regression revealed that statin type exhibited a significant effect (P = .014) in favor of atorvastatin."},{"Node1":"Periodontitis","Edge_Type":"disease_to_anatomy","Node2":"Bacterial Outer Membrane","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"Periodontitis","Edge_Type":"disease_to_anatomy","Node2":"Blood Platelets","Weight":2,"Paper_List":"29023611|30624092","Original_Text":"PMID:29023611; Original text:Use of autologous platelet-rich fibrin significantly enhances the clinical and radiographic outcomes of open flap debridement in the treatment of periodontal intraosseous defects in patients affected by localized aggressive periodontitis.|PMID:30624092; Original text:leukocyte-platelet-rich fibrin combined with open flap debridement significantly increases growth factors levels and thus, it enhances the periodontal healing on chronic periodontitis patients."},{"Node1":"Bone morphogenetic protein 2","Edge_Type":"mechanism","Node2":"silk fibroin light chain","Weight":1,"Paper_List":"30624092","Original_Text":"PMID:30624092; Original text:open flap debridement + leukocyte-platelet-rich fibrin group showed significantly increased bone morphogenetic protein-2 and insulin-like growth factor-1 at 2 weeks compared with baseline."},{"Node1":"insulin like growth factor 1","Edge_Type":"mechanism","Node2":"silk fibroin light chain","Weight":1,"Paper_List":"30624092","Original_Text":"PMID:30624092; Original text:open flap debridement + leukocyte-platelet-rich fibrin group showed significantly increased bone morphogenetic protein-2 and insulin-like growth factor-1 at 2 weeks compared with baseline."},{"Node1":"Bone morphogenetic protein 2","Edge_Type":"mechanism","Node2":"insulin like growth factor 1","Weight":1,"Paper_List":"30624092","Original_Text":"PMID:30624092; Original text:open flap debridement + leukocyte-platelet-rich fibrin group showed significantly increased bone morphogenetic protein-2 and insulin-like growth factor-1 at 2 weeks compared with baseline."},{"Node1":"Bone morphogenetic protein 2","Edge_Type":"mechanism_to_anatomy","Node2":"Platelet-Rich Fibrin","Weight":1,"Paper_List":"30624092","Original_Text":"PMID:30624092; Original text:open flap debridement + leukocyte-platelet-rich fibrin group showed significantly increased bone morphogenetic protein-2 and insulin-like growth factor-1 at 2 weeks compared with baseline."},{"Node1":"Bone morphogenetic protein 2","Edge_Type":"mechanism_to_anatomy","Node2":"Blood Platelets","Weight":1,"Paper_List":"30624092","Original_Text":"PMID:30624092; Original text:open flap debridement + leukocyte-platelet-rich fibrin group showed significantly increased bone morphogenetic protein-2 and insulin-like growth factor-1 at 2 weeks compared with baseline."},{"Node1":"Bone morphogenetic protein 2","Edge_Type":"mechanism_to_anatomy","Node2":"Leukocytes","Weight":1,"Paper_List":"30624092","Original_Text":"PMID:30624092; Original text:open flap debridement + leukocyte-platelet-rich fibrin group showed significantly increased bone morphogenetic protein-2 and insulin-like growth factor-1 at 2 weeks compared with baseline."},{"Node1":"insulin like growth factor 1","Edge_Type":"mechanism_to_anatomy","Node2":"Platelet-Rich Fibrin","Weight":1,"Paper_List":"30624092","Original_Text":"PMID:30624092; Original text:open flap debridement + leukocyte-platelet-rich fibrin group showed significantly increased bone morphogenetic protein-2 and insulin-like growth factor-1 at 2 weeks compared with baseline."},{"Node1":"insulin like growth factor 1","Edge_Type":"mechanism_to_anatomy","Node2":"Blood Platelets","Weight":1,"Paper_List":"30624092","Original_Text":"PMID:30624092; Original text:open flap debridement + leukocyte-platelet-rich fibrin group showed significantly increased bone morphogenetic protein-2 and insulin-like growth factor-1 at 2 weeks compared with baseline."},{"Node1":"insulin like growth factor 1","Edge_Type":"mechanism_to_anatomy","Node2":"Leukocytes","Weight":1,"Paper_List":"30624092","Original_Text":"PMID:30624092; Original text:open flap debridement + leukocyte-platelet-rich fibrin group showed significantly increased bone morphogenetic protein-2 and insulin-like growth factor-1 at 2 weeks compared with baseline."},{"Node1":"Lactobacillus Reuteri","Edge_Type":"bacteria_to_disease","Node2":"Chronic Periodontitis","Weight":1,"Paper_List":"24509697","Original_Text":"PMID:24509697; Original text:Results obtained in this study indicate that application of oral treatment with tablets containing probiotic strain of L. reuteri induces in most patients with chronic periodontitis a significant reduction of pro-inflammatory cytokine response and improvement of clinical parameters (sulcus bleeding index, periodontal probing depth, clinical attachment level)."},{"Node1":"Lactobacillus Reuteri","Edge_Type":"bacteria_to_disease","Node2":"Hemorrhage","Weight":1,"Paper_List":"24509697","Original_Text":"PMID:24509697; Original text:Results obtained in this study indicate that application of oral treatment with tablets containing probiotic strain of L. reuteri induces in most patients with chronic periodontitis a significant reduction of pro-inflammatory cytokine response and improvement of clinical parameters (sulcus bleeding index, periodontal probing depth, clinical attachment level)."},{"Node1":"Lactobacillus Reuteri","Edge_Type":"bacteria_to_anatomy","Node2":"Periodontal Ligament","Weight":1,"Paper_List":"24509697","Original_Text":"PMID:24509697; Original text:Results obtained in this study indicate that application of oral treatment with tablets containing probiotic strain of L. reuteri induces in most patients with chronic periodontitis a significant reduction of pro-inflammatory cytokine response and improvement of clinical parameters (sulcus bleeding index, periodontal probing depth, clinical attachment level)."},{"Node1":"Melatonin","Edge_Type":"chemical_to_disease","Node2":"Periodontitis","Weight":2,"Paper_List":"33063408|33063408","Original_Text":"PMID:33063408; Original text:The meta-analysis revealed a significant reduction (p < .0001) in salivary melatonin levels in chronic periodontitis (3.26 ± 3.44 pg/ml) compared with healthy controls (5.27 ± 5.39 pg/ml), with a mean difference of 2.65 ± 7.84 and a confidence interval of 1.94-3.36.|PMID:33063408; Original text:The significantly lower salivary melatonin levels in periodontitis must be inferred with caution given the low quality of the included studies."},{"Node1":"Melatonin","Edge_Type":"chemical_to_anatomy","Node2":"Salivary Glands","Weight":2,"Paper_List":"33063408|33063408","Original_Text":"PMID:33063408; Original text:The meta-analysis revealed a significant reduction (p < .0001) in salivary melatonin levels in chronic periodontitis (3.26 ± 3.44 pg/ml) compared with healthy controls (5.27 ± 5.39 pg/ml), with a mean difference of 2.65 ± 7.84 and a confidence interval of 1.94-3.36.|PMID:33063408; Original text:The significantly lower salivary melatonin levels in periodontitis must be inferred with caution given the low quality of the included studies."},{"Node1":"Periodontitis","Edge_Type":"disease_to_anatomy","Node2":"B-Lymphocytes","Weight":2,"Paper_List":"29447240|29447240","Original_Text":"PMID:29447240; Original text:A significantly higher percentage of CD27+ memory B cells was observed in patients with severe periodontitis.|PMID:29447240; Original text:The RANKL expression increased in every B cell subset from the severe periodontitis patients and was significantly greater in activated B cells than in the subjects without periodontitis."},{"Node1":"matrix metallopeptidase 1","Edge_Type":"mechanism","Node2":"saliva","Weight":1,"Paper_List":"29504999","Original_Text":"PMID:29504999; Original text:Our meta-analysis showed that salivary the salivary matrix metalloproteinase-8 levels were significantly higher in periodontitis patients compared with healthy controls overall."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"saliva","Weight":1,"Paper_List":"29504999","Original_Text":"PMID:29504999; Original text:Our meta-analysis showed that salivary the salivary matrix metalloproteinase-8 levels were significantly higher in periodontitis patients compared with healthy controls overall."},{"Node1":"matrix metallopeptidase 1","Edge_Type":"mechanism_to_anatomy","Node2":"Salivary Glands","Weight":2,"Paper_List":"29504999|20572767","Original_Text":"PMID:29504999; Original text:Our meta-analysis showed that salivary the salivary matrix metalloproteinase-8 levels were significantly higher in periodontitis patients compared with healthy controls overall.|PMID:20572767; Original text:Salivary nuclear factor-kappa B ligand and metalloproteinase-8 levels showed significant reductions in the ω-3 group in response to treatment at 3 and 6 months and compared to the control group at 6 months (P <0.01)."},{"Node1":"Periodontal Diseases","Edge_Type":"disease","Node2":"Sleep Apnea, Obstructive","Weight":1,"Paper_List":"25801281","Original_Text":"PMID:25801281; Original text:Meta-analysis of four studies revealed a statistically significant association between periodontal disease and obstructive sleep apnea (pooled odds ratio = 1.65, 95 % confidence interval (CI) = 1.11, 2.46, P = 0.01)."},{"Node1":"provisional ortholog of C-reactive protein L homeolog","Edge_Type":"mechanism","Node2":"serum amyloid A 3","Weight":1,"Paper_List":"23660738","Original_Text":"PMID:23660738; Original text:A significant overall decrease was observed from baseline to month 6 for C-reactive protein, serum amyloid"},{"Node1":"b2-microglobulin","Edge_Type":"mechanism","Node2":"calcitonin related polypeptide alpha","Weight":2,"Paper_List":"23660738|22181685","Original_Text":"PMID:23660738; Original text:A, fibrinogen, procalcitonin, and α-2 macroglobulin.|PMID:22181685; Original text:The levels of five acute-phase proteins (α-2 macroglobulin, haptoglobin, serum amyloid P, procalcitonin, and tissue plasminogen activator) were significantly higher at 6 months than at baseline."},{"Node1":"b2-microglobulin","Edge_Type":"mechanism","Node2":"fibrinogen gamma chain","Weight":1,"Paper_List":"23660738","Original_Text":"PMID:23660738; Original text:A, fibrinogen, procalcitonin, and α-2 macroglobulin."},{"Node1":"calcitonin related polypeptide alpha","Edge_Type":"mechanism","Node2":"fibrinogen gamma chain","Weight":1,"Paper_List":"23660738","Original_Text":"PMID:23660738; Original text:A, fibrinogen, procalcitonin, and α-2 macroglobulin."},{"Node1":"Hypertension","Edge_Type":"disease_to_mechanism","Node2":"tld-related-2","Weight":1,"Paper_List":"23711357","Original_Text":"PMID:23711357; Original text:A significant increase was observed in the expression of TLR-2 in the placentas of patients with hypertensive disorders (p = 0.04)."},{"Node1":"Periodontitis","Edge_Type":"disease_to_anatomy","Node2":"Brachial Artery","Weight":1,"Paper_List":"24386401","Original_Text":"PMID:24386401; Original text:Consistently, the brachial artery values increased significantly across categories of the percentage of sites with Clinical attachment loss ≥ 6 mm (p(trend)=0.01) and the periodontitis case definition (p(trend)=0.006)."},{"Node1":"tld-related-2","Edge_Type":"mechanism_to_anatomy","Node2":"Placenta","Weight":1,"Paper_List":"23711357","Original_Text":"PMID:23711357; Original text:A significant increase was observed in the expression of TLR-2 in the placentas of patients with hypertensive disorders (p = 0.04)."},{"Node1":"Periodontitis","Edge_Type":"disease_to_anatomy","Node2":"Endothelium, Vascular","Weight":1,"Paper_List":"30077530","Original_Text":"PMID:30077530; Original text:Intensive Periodontitis treatment (Intensive PD treatment) can significantly improve endothelial function and metabolic control, although the mechanisms remain unclear."},{"Node1":"Periodontitis","Edge_Type":"disease_to_anatomy","Node2":"Gingiva","Weight":8,"Paper_List":"29488617|34246253|7767709|34618684|11168739|33904994|16441729|16441729","Original_Text":"PMID:29488617; Original text:The expression levels of TLR4 in the gingival tissues and on mast cells in patients with advanced chronic periodontitis were significantly higher, compared with those in patients with mild chronic periodontitis (P<0.05).|PMID:34246253; Original text:As the primary results, the change of PD was not statistically significant and in the secondary results changes of plaque index, gingival index, attachment loss and BOP were also not statistically significant in rheumatoid arthritis patients with periodontitis compared to non-rheumatoid arthritis periodontitis patients.|PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells.|PMID:34618684; Original text:ConclusionAMY-101 treatment resulted in a significant and sustainable reduction in gingival inflammation without adverse events and, we believe, merits further investigation for the treatment of periodontitis and other oral or peri-implant inflammatory conditions.|PMID:11168739; Original text:Previous clinical studies have shown that doxycycline administered orally, at doses below those needed for antimicrobial efficacy, to human subjects with adult periodontitis resulted in significantly reduced collagenase activity in gingival crevicular fluid (gingival crevicular fluid) and in extracts of inflamed gingival tissues.|PMID:33904994; Original text:However, meta-analysis showed that among individuals with periodontitis, significantly higher levels of gingival inflammation are observed in those with obesity (n of individuals=240) when compared to those who were not obese (n of individuals=574)|PMID:16441729; Original text:In addition, gingival crevicular fluid volume was significantly higher in aggressive periodontitis group compared with either LR or HR groups at each observation interval (p<0.001).|PMID:16441729; Original text:These results suggest that susceptibility to gingival inflammation in response to de novo plaque accumulation may be related to susceptibility to periodontitis."},{"Node1":"Plateletcrit","Edge_Type":"mechanism","Node2":"silk fibroin light chain","Weight":1,"Paper_List":"33842996","Original_Text":"PMID:33842996; Original text:open flap debridement+AA/platelet-rich fibrin and open flap debridement+platelet-rich fibrin demonstrated significant intragroup CAL gain and pocket depth reduction at 3 and 6 months (p < 0.001)."},{"Node1":"Gingiva","Edge_Type":"anatomy","Node2":"Platelet-Rich Fibrin","Weight":2,"Paper_List":"33842996|33842996","Original_Text":"PMID:33842996; Original text:open flap debridement+AA/platelet-rich fibrin demonstrated significant gingival recession depth reduction of 0.90 ± 0.50 mm and 0.80 ± 0.71 mm at 3 and 6 months, while open flap debridement+platelet-rich fibrin showed gingival recession depth reduction of 0.10 ± 0.77 mm at 3 months, with an gingival recession depth-increase of 0.20 ± 0.82 mm at 6 months (p < 0.05).|PMID:33842996; Original text:open flap debridement+AA/platelet-rich fibrin and open flap debridement+platelet-rich fibrin demonstrated significant radiographic linear defect depth reduction (2.29 ± 0.61 mm and 1.63 ± 0.46 mm; p < 0.05) and gingival recession depthBD-increase (14.61 ± 5.39% and 12.58 ± 5.03%; p > 0.05)."},{"Node1":"Chlorhexidine","Edge_Type":"chemical_to_anatomy","Node2":"Alveolar Process","Weight":1,"Paper_List":"10711616","Original_Text":"PMID:10711616; Original text:These data indicate that the a biodegradable chlorhexidine-gelatin chip chip, when used as an adjunct to scaling and root planing, significantly reduces loss of alveolar bone."},{"Node1":"Inflammation","Edge_Type":"disease","Node2":"Periodontal Cyst","Weight":1,"Paper_List":"22835005","Original_Text":"PMID:22835005; Original text:Although periodontal therapy during pregnancy successfully reduced periodontal inflammation and gingival crevicular fluid cytokine levels, it did not have a significant impact on serum biomarkers."},{"Node1":"Periodontitis","Edge_Type":"disease_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":2,"Paper_List":"11168739|16441729","Original_Text":"PMID:11168739; Original text:Previous clinical studies have shown that doxycycline administered orally, at doses below those needed for antimicrobial efficacy, to human subjects with adult periodontitis resulted in significantly reduced collagenase activity in gingival crevicular fluid (gingival crevicular fluid) and in extracts of inflamed gingival tissues.|PMID:16441729; Original text:In addition, gingival crevicular fluid volume was significantly higher in aggressive periodontitis group compared with either LR or HR groups at each observation interval (p<0.001)."},{"Node1":"Periodontitis","Edge_Type":"disease_to_anatomy","Node2":"Gonadotrophs","Weight":1,"Paper_List":"7767709","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells."},{"Node1":"methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2 like","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"22835005","Original_Text":"PMID:22835005; Original text:Periodontal therapy significantly reduced the levels of interleukin-1β and interleukin-8 in gingival crevicular fluid (p < 0.001)."},{"Node1":"methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2 like","Edge_Type":"mechanism_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"22835005","Original_Text":"PMID:22835005; Original text:Periodontal therapy significantly reduced the levels of interleukin-1β and interleukin-8 in gingival crevicular fluid (p < 0.001)."},{"Node1":"Inflammation","Edge_Type":"disease","Node2":"Stroke","Weight":1,"Paper_List":"26405803","Original_Text":"PMID:26405803; Original text:There were significant differences between the patients with stroke and subjects without in pack-years of smoking (p = 0.01), prevalence of gingival inflammation (gingival inflammation) (p = 0.03), and dental calculus (p = 0.017)."},{"Node1":"Dental Calculus","Edge_Type":"disease","Node2":"Inflammation","Weight":1,"Paper_List":"26405803","Original_Text":"PMID:26405803; Original text:There were significant differences between the patients with stroke and subjects without in pack-years of smoking (p = 0.01), prevalence of gingival inflammation (gingival inflammation) (p = 0.03), and dental calculus (p = 0.017)."},{"Node1":"Dental Calculus","Edge_Type":"disease","Node2":"Stroke","Weight":1,"Paper_List":"26405803","Original_Text":"PMID:26405803; Original text:There were significant differences between the patients with stroke and subjects without in pack-years of smoking (p = 0.01), prevalence of gingival inflammation (gingival inflammation) (p = 0.03), and dental calculus (p = 0.017)."},{"Node1":"Periodontitis","Edge_Type":"disease_to_anatomy","Node2":"Leukocytes","Weight":2,"Paper_List":"30624092|18190553","Original_Text":"PMID:30624092; Original text:leukocyte-platelet-rich fibrin combined with open flap debridement significantly increases growth factors levels and thus, it enhances the periodontal healing on chronic periodontitis patients.|PMID:18190553; Original text:Patients with aggressive periodontitis showed a positive association with particular human leukocyte antigens-A9 [odds ratio=2.59 (95% confidence interval 1.36-4.83), p=0.004] and particular human leukocyte antigens-B15 [1.90 (1.15-3.16), p=0.01] as well as a negative association with particular human leukocyte antigens-A2 [0.72 (0.56-0.94), p=0.01] and -B5"},{"Node1":"Periodontitis","Edge_Type":"disease_to_anatomy","Node2":"Mast Cells","Weight":1,"Paper_List":"29488617","Original_Text":"PMID:29488617; Original text:The expression levels of TLR4 in the gingival tissues and on mast cells in patients with advanced chronic periodontitis were significantly higher, compared with those in patients with mild chronic periodontitis (P<0.05)."},{"Node1":"8-Hydroxy-2'-Deoxyguanosine","Edge_Type":"chemical","Node2":"Lycopene","Weight":1,"Paper_List":"22536592","Original_Text":"PMID:22536592; Original text:However, there was no statistically significant difference in the clinical parameters when lycopene-treated sites in smokers and nonsmokers were compared, except for the reduction in the 8-hydroxydeoxyguanosine levels."},{"Node1":"Hemorrhage","Edge_Type":"disease","Node2":"Pain","Weight":1,"Paper_List":"26805006","Original_Text":"PMID:26805006; Original text:Patients' report of bleeding gums and pain in the gums while chewing showed statistically significant reduction in the test group at 2 weeks and 1 month (p<0.05)."},{"Node1":"hydroxide ion","Edge_Type":"chemical_to_mechanism","Node2":"vasoactive intestinal peptide","Weight":1,"Paper_List":"29948282","Original_Text":"PMID:29948282; Original text:Intragroup analyses revealed that in the Ca(OH)2 group, the post-treatment vasoactive intestinal peptide level was found to be significantly higher than the pre-treatment vasoactive intestinal peptide level."},{"Node1":"Titanium","Edge_Type":"chemical","Node2":"zirconium oxide","Weight":1,"Paper_List":"21365044","Original_Text":"PMID:21365044; Original text:No statistically significant differences were found between probing depths or DNA copy numbers of A actinomycetemcomitans, P gingivalis, and total bacteria both for both titanium alloys and zirconium oxide surfaces and the biops specimens obtained from their buccal gingival."},{"Node1":"Gingiva","Edge_Type":"anatomy","Node2":"Integumentary System","Weight":1,"Paper_List":"21365044","Original_Text":"PMID:21365044; Original text:No statistically significant differences were found between probing depths or DNA copy numbers of A actinomycetemcomitans, P gingivalis, and total bacteria both for both titanium alloys and zirconium oxide surfaces and the biops specimens obtained from their buccal gingival."},{"Node1":"Actinomycetes (Organism)","Edge_Type":"bacteria_to_chemical","Node2":"Titanium","Weight":1,"Paper_List":"21365044","Original_Text":"PMID:21365044; Original text:No statistically significant differences were found between probing depths or DNA copy numbers of A actinomycetemcomitans, P gingivalis, and total bacteria both for both titanium alloys and zirconium oxide surfaces and the biops specimens obtained from their buccal gingival."},{"Node1":"Actinomycetes (Organism)","Edge_Type":"bacteria_to_chemical","Node2":"zirconium oxide","Weight":1,"Paper_List":"21365044","Original_Text":"PMID:21365044; Original text:No statistically significant differences were found between probing depths or DNA copy numbers of A actinomycetemcomitans, P gingivalis, and total bacteria both for both titanium alloys and zirconium oxide surfaces and the biops specimens obtained from their buccal gingival."},{"Node1":"Actinomycetes (Organism)","Edge_Type":"bacteria_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"21365044","Original_Text":"PMID:21365044; Original text:No statistically significant differences were found between probing depths or DNA copy numbers of A actinomycetemcomitans, P gingivalis, and total bacteria both for both titanium alloys and zirconium oxide surfaces and the biops specimens obtained from their buccal gingival."},{"Node1":"Actinomycetes (Organism)","Edge_Type":"bacteria_to_anatomy","Node2":"Integumentary System","Weight":1,"Paper_List":"21365044","Original_Text":"PMID:21365044; Original text:No statistically significant differences were found between probing depths or DNA copy numbers of A actinomycetemcomitans, P gingivalis, and total bacteria both for both titanium alloys and zirconium oxide surfaces and the biops specimens obtained from their buccal gingival."},{"Node1":"Titanium","Edge_Type":"chemical_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"21365044","Original_Text":"PMID:21365044; Original text:No statistically significant differences were found between probing depths or DNA copy numbers of A actinomycetemcomitans, P gingivalis, and total bacteria both for both titanium alloys and zirconium oxide surfaces and the biops specimens obtained from their buccal gingival."},{"Node1":"Titanium","Edge_Type":"chemical_to_anatomy","Node2":"Integumentary System","Weight":1,"Paper_List":"21365044","Original_Text":"PMID:21365044; Original text:No statistically significant differences were found between probing depths or DNA copy numbers of A actinomycetemcomitans, P gingivalis, and total bacteria both for both titanium alloys and zirconium oxide surfaces and the biops specimens obtained from their buccal gingival."},{"Node1":"zirconium oxide","Edge_Type":"chemical_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"21365044","Original_Text":"PMID:21365044; Original text:No statistically significant differences were found between probing depths or DNA copy numbers of A actinomycetemcomitans, P gingivalis, and total bacteria both for both titanium alloys and zirconium oxide surfaces and the biops specimens obtained from their buccal gingival."},{"Node1":"zirconium oxide","Edge_Type":"chemical_to_anatomy","Node2":"Integumentary System","Weight":1,"Paper_List":"21365044","Original_Text":"PMID:21365044; Original text:No statistically significant differences were found between probing depths or DNA copy numbers of A actinomycetemcomitans, P gingivalis, and total bacteria both for both titanium alloys and zirconium oxide surfaces and the biops specimens obtained from their buccal gingival."},{"Node1":"Cholesterol","Edge_Type":"chemical","Node2":"Doxycycline","Weight":3,"Paper_List":"21357860|21357860|23649042","Original_Text":"PMID:21357860; Original text:However, in women more than five years postmenopausal, subantimicrobial-dose-doxycycline elevated the level of high-density lipoprotein (high-density lipoprotein) cholesterol (difference in means [milligrams per deciliter], 5.99; P = .01).|PMID:21357860; Original text:A two-year subantimicrobial-dose-doxycycline regimen in postmenopausal women significantly reduced the serum inflammatory biomarkers SDD treatment reduced median high-sensitivity C-reactive protein and serum matrix metalloproteinase-9 and, among women more than five years postmenopausal, increased the high-density lipoprotein cholesterol level. subantimicrobial-dose-doxycycline significantly reduced the systemic inflammatory biomarkers SDD treatment reduced median high-sensitivity C-reactive protein and serum matrix metalloproteinase-9.|PMID:23649042; Original text:Subantimicrobial-dose doxycycline subjects demonstrated a significant increase in serum-mediated cholesterol efflux from macrophages at both time points compared to baseline (p < 0.04 for each)."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_mechanism","Node2":"high density lipoprotein (HDL) level 4","Weight":1,"Paper_List":"21357860","Original_Text":"PMID:21357860; Original text:However, in women more than five years postmenopausal, subantimicrobial-dose-doxycycline elevated the level of high-density lipoprotein (high-density lipoprotein) cholesterol (difference in means [milligrams per deciliter], 5.99; P = .01)."},{"Node1":"Cholesterol","Edge_Type":"chemical_to_mechanism","Node2":"high density lipoprotein (HDL) level 4","Weight":1,"Paper_List":"21357860","Original_Text":"PMID:21357860; Original text:However, in women more than five years postmenopausal, subantimicrobial-dose-doxycycline elevated the level of high-density lipoprotein (high-density lipoprotein) cholesterol (difference in means [milligrams per deciliter], 5.99; P = .01)."},{"Node1":"High density lipoprotein cholesterol level QTL 6","Edge_Type":"mechanism","Node2":"matrix metallopeptidase 1","Weight":1,"Paper_List":"21357860","Original_Text":"PMID:21357860; Original text:A two-year subantimicrobial-dose-doxycycline regimen in postmenopausal women significantly reduced the serum inflammatory biomarkers SDD treatment reduced median high-sensitivity C-reactive protein and serum matrix metalloproteinase-9 and, among women more than five years postmenopausal, increased the high-density lipoprotein cholesterol level. subantimicrobial-dose-doxycycline significantly reduced the systemic inflammatory biomarkers SDD treatment reduced median high-sensitivity C-reactive protein and serum matrix metalloproteinase-9."},{"Node1":"High density lipoprotein cholesterol level QTL 6","Edge_Type":"mechanism","Node2":"nejire","Weight":1,"Paper_List":"21357860","Original_Text":"PMID:21357860; Original text:A two-year subantimicrobial-dose-doxycycline regimen in postmenopausal women significantly reduced the serum inflammatory biomarkers SDD treatment reduced median high-sensitivity C-reactive protein and serum matrix metalloproteinase-9 and, among women more than five years postmenopausal, increased the high-density lipoprotein cholesterol level. subantimicrobial-dose-doxycycline significantly reduced the systemic inflammatory biomarkers SDD treatment reduced median high-sensitivity C-reactive protein and serum matrix metalloproteinase-9."},{"Node1":"matrix metallopeptidase 1","Edge_Type":"mechanism","Node2":"nejire","Weight":1,"Paper_List":"21357860","Original_Text":"PMID:21357860; Original text:A two-year subantimicrobial-dose-doxycycline regimen in postmenopausal women significantly reduced the serum inflammatory biomarkers SDD treatment reduced median high-sensitivity C-reactive protein and serum matrix metalloproteinase-9 and, among women more than five years postmenopausal, increased the high-density lipoprotein cholesterol level. subantimicrobial-dose-doxycycline significantly reduced the systemic inflammatory biomarkers SDD treatment reduced median high-sensitivity C-reactive protein and serum matrix metalloproteinase-9."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_mechanism","Node2":"High density lipoprotein cholesterol level QTL 6","Weight":1,"Paper_List":"21357860","Original_Text":"PMID:21357860; Original text:A two-year subantimicrobial-dose-doxycycline regimen in postmenopausal women significantly reduced the serum inflammatory biomarkers SDD treatment reduced median high-sensitivity C-reactive protein and serum matrix metalloproteinase-9 and, among women more than five years postmenopausal, increased the high-density lipoprotein cholesterol level. subantimicrobial-dose-doxycycline significantly reduced the systemic inflammatory biomarkers SDD treatment reduced median high-sensitivity C-reactive protein and serum matrix metalloproteinase-9."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_mechanism","Node2":"matrix metallopeptidase 1","Weight":2,"Paper_List":"21357860|15088884","Original_Text":"PMID:21357860; Original text:A two-year subantimicrobial-dose-doxycycline regimen in postmenopausal women significantly reduced the serum inflammatory biomarkers SDD treatment reduced median high-sensitivity C-reactive protein and serum matrix metalloproteinase-9 and, among women more than five years postmenopausal, increased the high-density lipoprotein cholesterol level. subantimicrobial-dose-doxycycline significantly reduced the systemic inflammatory biomarkers SDD treatment reduced median high-sensitivity C-reactive protein and serum matrix metalloproteinase-9.|PMID:15088884; Original text:Consistent with previous studies on animal models of chronic destructive disease (e.g., rheumatoid arthritis), the subantimicrobial dose doxycycline and NSAID ) low-dose flurbiprofen therapy synergistically suppressed MMP and other neutral proteinases in the gingiva of chronic periodontitis patients."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_mechanism","Node2":"nejire","Weight":1,"Paper_List":"21357860","Original_Text":"PMID:21357860; Original text:A two-year subantimicrobial-dose-doxycycline regimen in postmenopausal women significantly reduced the serum inflammatory biomarkers SDD treatment reduced median high-sensitivity C-reactive protein and serum matrix metalloproteinase-9 and, among women more than five years postmenopausal, increased the high-density lipoprotein cholesterol level. subantimicrobial-dose-doxycycline significantly reduced the systemic inflammatory biomarkers SDD treatment reduced median high-sensitivity C-reactive protein and serum matrix metalloproteinase-9."},{"Node1":"Cholesterol","Edge_Type":"chemical_to_mechanism","Node2":"matrix metallopeptidase 1","Weight":1,"Paper_List":"21357860","Original_Text":"PMID:21357860; Original text:A two-year subantimicrobial-dose-doxycycline regimen in postmenopausal women significantly reduced the serum inflammatory biomarkers SDD treatment reduced median high-sensitivity C-reactive protein and serum matrix metalloproteinase-9 and, among women more than five years postmenopausal, increased the high-density lipoprotein cholesterol level. subantimicrobial-dose-doxycycline significantly reduced the systemic inflammatory biomarkers SDD treatment reduced median high-sensitivity C-reactive protein and serum matrix metalloproteinase-9."},{"Node1":"Cholesterol","Edge_Type":"chemical_to_mechanism","Node2":"nejire","Weight":1,"Paper_List":"21357860","Original_Text":"PMID:21357860; Original text:A two-year subantimicrobial-dose-doxycycline regimen in postmenopausal women significantly reduced the serum inflammatory biomarkers SDD treatment reduced median high-sensitivity C-reactive protein and serum matrix metalloproteinase-9 and, among women more than five years postmenopausal, increased the high-density lipoprotein cholesterol level. subantimicrobial-dose-doxycycline significantly reduced the systemic inflammatory biomarkers SDD treatment reduced median high-sensitivity C-reactive protein and serum matrix metalloproteinase-9."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_disease","Node2":"Coronary Artery Disease","Weight":1,"Paper_List":"21357860","Original_Text":"PMID:21357860; Original text:More research is needed to determine whether subantimicrobial-dose-doxycycline has a role in managing the care of patients at risk of developing coronary artery disease."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_anatomy","Node2":"Coronary Vessels","Weight":1,"Paper_List":"21357860","Original_Text":"PMID:21357860; Original text:More research is needed to determine whether subantimicrobial-dose-doxycycline has a role in managing the care of patients at risk of developing coronary artery disease."},{"Node1":"Periodontitis","Edge_Type":"disease_to_anatomy","Node2":"Maxilla","Weight":1,"Paper_List":"11195135","Original_Text":"PMID:11195135; Original text:There was no difference in probing depth reduction, probing attachment gain or bone fill between the two treatment modalities for treating maxillary class II buccal furca invasion of rapidly progressive periodontitis."},{"Node1":"Periodontitis","Edge_Type":"disease_to_anatomy","Node2":"Membranes","Weight":2,"Paper_List":"7767709|28583874","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells.|PMID:28583874; Original text:Moreover, preliminary clinical trials on patients proved therapeutic efficacy of the nanofiber membrane by eliciting a significant (p<0.05) decrease in clinical markers of periodontitis."},{"Node1":"Periodontitis","Edge_Type":"disease_to_anatomy","Node2":"Memory B Cells","Weight":1,"Paper_List":"29447240","Original_Text":"PMID:29447240; Original text:A significantly higher percentage of CD27+ memory B cells was observed in patients with severe periodontitis."},{"Node1":"globin 1","Edge_Type":"mechanism","Node2":"nejire","Weight":1,"Paper_List":"24965218","Original_Text":"PMID:24965218; Original text:Participants who demonstrated ≥ 50% reduction in pocket depth showed significant reductions of glycosylated haemoglobin and high-sensitivity C-reactive protein levels (p = 0.004 and p = 0.012)."},{"Node1":"Ischemic Stroke","Edge_Type":"disease","Node2":"Periodontitis","Weight":1,"Paper_List":"27300352","Original_Text":"PMID:27300352; Original text:These meta-analyses showed statistically significant association between periodontitis and ischemic stroke in both cohort pooled relative risks at 2.52 (1.77-3.58), and case-control studies pooled relative risks at 3.04 (1.10-8.43)."},{"Node1":"Ciprofloxacin","Edge_Type":"chemical","Node2":"Ibuprofen","Weight":2,"Paper_List":"32034789|32034789","Original_Text":"PMID:32034789; Original text:The percentage reduction from root canal treatment to the final samples and from chemo-mechanical procedures to the final samples was significantly greater in the Ca(OH)2 + Ciprofloxacin than the pure Ca(OH)2 and Ca(OH)2 + Ibuprofen groups (P < 0.05).|PMID:32034789; Original text:In the Ca(OH)2  + Ciprofloxacin group, there were significantly fewer positive cases (8/15) than the pure Ca(OH)2 (13/15) and Ca(OH)2  + Ibuprofen (13/15) groups (P < 0.05)."},{"Node1":"Ibuprofen","Edge_Type":"chemical","Node2":"hydroxide ion","Weight":2,"Paper_List":"32034789|32034789","Original_Text":"PMID:32034789; Original text:The percentage reduction from root canal treatment to the final samples and from chemo-mechanical procedures to the final samples was significantly greater in the Ca(OH)2 + Ciprofloxacin than the pure Ca(OH)2 and Ca(OH)2 + Ibuprofen groups (P < 0.05).|PMID:32034789; Original text:In the Ca(OH)2  + Ciprofloxacin group, there were significantly fewer positive cases (8/15) than the pure Ca(OH)2 (13/15) and Ca(OH)2  + Ibuprofen (13/15) groups (P < 0.05)."},{"Node1":"Ciprofloxacin","Edge_Type":"chemical","Node2":"hydroxide ion","Weight":2,"Paper_List":"32034789|32034789","Original_Text":"PMID:32034789; Original text:The percentage reduction from root canal treatment to the final samples and from chemo-mechanical procedures to the final samples was significantly greater in the Ca(OH)2 + Ciprofloxacin than the pure Ca(OH)2 and Ca(OH)2 + Ibuprofen groups (P < 0.05).|PMID:32034789; Original text:In the Ca(OH)2  + Ciprofloxacin group, there were significantly fewer positive cases (8/15) than the pure Ca(OH)2 (13/15) and Ca(OH)2  + Ibuprofen (13/15) groups (P < 0.05)."},{"Node1":"Ibuprofen","Edge_Type":"chemical_to_anatomy","Node2":"Dental Pulp Cavity","Weight":1,"Paper_List":"32034789","Original_Text":"PMID:32034789; Original text:The percentage reduction from root canal treatment to the final samples and from chemo-mechanical procedures to the final samples was significantly greater in the Ca(OH)2 + Ciprofloxacin than the pure Ca(OH)2 and Ca(OH)2 + Ibuprofen groups (P < 0.05)."},{"Node1":"Ciprofloxacin","Edge_Type":"chemical_to_anatomy","Node2":"Dental Pulp Cavity","Weight":1,"Paper_List":"32034789","Original_Text":"PMID:32034789; Original text:The percentage reduction from root canal treatment to the final samples and from chemo-mechanical procedures to the final samples was significantly greater in the Ca(OH)2 + Ciprofloxacin than the pure Ca(OH)2 and Ca(OH)2 + Ibuprofen groups (P < 0.05)."},{"Node1":"hydroxide ion","Edge_Type":"chemical_to_anatomy","Node2":"Dental Pulp Cavity","Weight":1,"Paper_List":"32034789","Original_Text":"PMID:32034789; Original text:The percentage reduction from root canal treatment to the final samples and from chemo-mechanical procedures to the final samples was significantly greater in the Ca(OH)2 + Ciprofloxacin than the pure Ca(OH)2 and Ca(OH)2 + Ibuprofen groups (P < 0.05)."},{"Node1":"Lactobacillus Sp.","Edge_Type":"bacteria","Node2":"Mutans Streptococcus","Weight":1,"Paper_List":"16032940","Original_Text":"PMID:16032940; Original text:Salivary count of Mutans Streptococci and Lactobacilli had significant decrease 3.37 (+/- 0.71) to 2.27 (+/- 0.80) and 3.22 (+/- 0.85) to 2.32 (+/- 0.87) respectively (P = 0.000)."},{"Node1":"Lactobacillus Sp.","Edge_Type":"bacteria_to_anatomy","Node2":"Salivary Glands","Weight":1,"Paper_List":"16032940","Original_Text":"PMID:16032940; Original text:Salivary count of Mutans Streptococci and Lactobacilli had significant decrease 3.37 (+/- 0.71) to 2.27 (+/- 0.80) and 3.22 (+/- 0.85) to 2.32 (+/- 0.87) respectively (P = 0.000)."},{"Node1":"Bacteria","Edge_Type":"bacteria","Node2":"Mutans Streptococcus","Weight":1,"Paper_List":"16032940","Original_Text":"PMID:16032940; Original text:It was concluded that tongue scraping twice daily for 7 days had significant effect on Mutans streptococci and Lb bacteria and also decreased oral malodour"},{"Node1":"Pain","Edge_Type":"disease","Node2":"Toothache","Weight":1,"Paper_List":"9776027","Original_Text":"PMID:9776027; Original text:Adverse effects were minor and transient toothache, including pain, tenderness, aching, throbbing, soreness, discomfort, or sensitivity was the only adverse effect that was higher in the chlorhexidine group as compared to placebo (P = 0.042)."},{"Node1":"Chlorhexidine","Edge_Type":"chemical_to_disease","Node2":"Toothache","Weight":1,"Paper_List":"9776027","Original_Text":"PMID:9776027; Original text:Adverse effects were minor and transient toothache, including pain, tenderness, aching, throbbing, soreness, discomfort, or sensitivity was the only adverse effect that was higher in the chlorhexidine group as compared to placebo (P = 0.042)."},{"Node1":"Chlorhexidine","Edge_Type":"chemical_to_disease","Node2":"Pain","Weight":1,"Paper_List":"9776027","Original_Text":"PMID:9776027; Original text:Adverse effects were minor and transient toothache, including pain, tenderness, aching, throbbing, soreness, discomfort, or sensitivity was the only adverse effect that was higher in the chlorhexidine group as compared to placebo (P = 0.042)."},{"Node1":"elastase 2","Edge_Type":"mechanism","Node2":"interleukin 1 beta S homeolog","Weight":1,"Paper_List":"16584354","Original_Text":"PMID:16584354; Original text:For total protein, interleukin-1beta, and elastase, no statistically significant differences were noted for subjects with or without antibiotic therapy at any time point."},{"Node1":"GLYcosylation related","Edge_Type":"mechanism","Node2":"interleukin 6 L homeolog","Weight":1,"Paper_List":"21804283","Original_Text":"PMID:21804283; Original text:After 3 months, the serum levels of hsCRP, TNF-α, interleukin-6, fasting plasma glucose (plasma glucose), glycosylated hemoglobin (glycosylated hemoglobin), fasting insulin (insulin) and HOMA-adiponectin, insulin resistance index decreased, and adiponectin was significantly increased in type 2 diabetes mellitus-T group compared to those in the type 2 diabetes mellitus-NT group (p<0.05 or p<0.01)."},{"Node1":"GLYcosylation related","Edge_Type":"mechanism","Node2":"provisional ortholog of insulin L homeolog","Weight":1,"Paper_List":"21804283","Original_Text":"PMID:21804283; Original text:After 3 months, the serum levels of hsCRP, TNF-α, interleukin-6, fasting plasma glucose (plasma glucose), glycosylated hemoglobin (glycosylated hemoglobin), fasting insulin (insulin) and HOMA-adiponectin, insulin resistance index decreased, and adiponectin was significantly increased in type 2 diabetes mellitus-T group compared to those in the type 2 diabetes mellitus-NT group (p<0.05 or p<0.01)."},{"Node1":"GLYcosylation related","Edge_Type":"mechanism","Node2":"endothelin receptor type B","Weight":1,"Paper_List":"21804283","Original_Text":"PMID:21804283; Original text:After 3 months, the serum levels of hsCRP, TNF-α, interleukin-6, fasting plasma glucose (plasma glucose), glycosylated hemoglobin (glycosylated hemoglobin), fasting insulin (insulin) and HOMA-adiponectin, insulin resistance index decreased, and adiponectin was significantly increased in type 2 diabetes mellitus-T group compared to those in the type 2 diabetes mellitus-NT group (p<0.05 or p<0.01)."},{"Node1":"GLYcosylation related","Edge_Type":"mechanism","Node2":"adiponectin, C1Q and collagen domain containing S homeolog","Weight":1,"Paper_List":"21804283","Original_Text":"PMID:21804283; Original text:After 3 months, the serum levels of hsCRP, TNF-α, interleukin-6, fasting plasma glucose (plasma glucose), glycosylated hemoglobin (glycosylated hemoglobin), fasting insulin (insulin) and HOMA-adiponectin, insulin resistance index decreased, and adiponectin was significantly increased in type 2 diabetes mellitus-T group compared to those in the type 2 diabetes mellitus-NT group (p<0.05 or p<0.01)."},{"Node1":"interleukin 6 L homeolog","Edge_Type":"mechanism","Node2":"provisional ortholog of insulin L homeolog","Weight":1,"Paper_List":"21804283","Original_Text":"PMID:21804283; Original text:After 3 months, the serum levels of hsCRP, TNF-α, interleukin-6, fasting plasma glucose (plasma glucose), glycosylated hemoglobin (glycosylated hemoglobin), fasting insulin (insulin) and HOMA-adiponectin, insulin resistance index decreased, and adiponectin was significantly increased in type 2 diabetes mellitus-T group compared to those in the type 2 diabetes mellitus-NT group (p<0.05 or p<0.01)."},{"Node1":"endothelin receptor type B","Edge_Type":"mechanism","Node2":"interleukin 6 L homeolog","Weight":1,"Paper_List":"21804283","Original_Text":"PMID:21804283; Original text:After 3 months, the serum levels of hsCRP, TNF-α, interleukin-6, fasting plasma glucose (plasma glucose), glycosylated hemoglobin (glycosylated hemoglobin), fasting insulin (insulin) and HOMA-adiponectin, insulin resistance index decreased, and adiponectin was significantly increased in type 2 diabetes mellitus-T group compared to those in the type 2 diabetes mellitus-NT group (p<0.05 or p<0.01)."},{"Node1":"adiponectin, C1Q and collagen domain containing S homeolog","Edge_Type":"mechanism","Node2":"interleukin 6 L homeolog","Weight":1,"Paper_List":"21804283","Original_Text":"PMID:21804283; Original text:After 3 months, the serum levels of hsCRP, TNF-α, interleukin-6, fasting plasma glucose (plasma glucose), glycosylated hemoglobin (glycosylated hemoglobin), fasting insulin (insulin) and HOMA-adiponectin, insulin resistance index decreased, and adiponectin was significantly increased in type 2 diabetes mellitus-T group compared to those in the type 2 diabetes mellitus-NT group (p<0.05 or p<0.01)."},{"Node1":"endothelin receptor type B","Edge_Type":"mechanism","Node2":"provisional ortholog of insulin L homeolog","Weight":1,"Paper_List":"21804283","Original_Text":"PMID:21804283; Original text:After 3 months, the serum levels of hsCRP, TNF-α, interleukin-6, fasting plasma glucose (plasma glucose), glycosylated hemoglobin (glycosylated hemoglobin), fasting insulin (insulin) and HOMA-adiponectin, insulin resistance index decreased, and adiponectin was significantly increased in type 2 diabetes mellitus-T group compared to those in the type 2 diabetes mellitus-NT group (p<0.05 or p<0.01)."},{"Node1":"adiponectin, C1Q and collagen domain containing S homeolog","Edge_Type":"mechanism","Node2":"provisional ortholog of insulin L homeolog","Weight":1,"Paper_List":"21804283","Original_Text":"PMID:21804283; Original text:After 3 months, the serum levels of hsCRP, TNF-α, interleukin-6, fasting plasma glucose (plasma glucose), glycosylated hemoglobin (glycosylated hemoglobin), fasting insulin (insulin) and HOMA-adiponectin, insulin resistance index decreased, and adiponectin was significantly increased in type 2 diabetes mellitus-T group compared to those in the type 2 diabetes mellitus-NT group (p<0.05 or p<0.01)."},{"Node1":"adiponectin, C1Q and collagen domain containing S homeolog","Edge_Type":"mechanism","Node2":"endothelin receptor type B","Weight":1,"Paper_List":"21804283","Original_Text":"PMID:21804283; Original text:After 3 months, the serum levels of hsCRP, TNF-α, interleukin-6, fasting plasma glucose (plasma glucose), glycosylated hemoglobin (glycosylated hemoglobin), fasting insulin (insulin) and HOMA-adiponectin, insulin resistance index decreased, and adiponectin was significantly increased in type 2 diabetes mellitus-T group compared to those in the type 2 diabetes mellitus-NT group (p<0.05 or p<0.01)."},{"Node1":"Glucose","Edge_Type":"chemical_to_disease","Node2":"Diabetes Mellitus, Type 2","Weight":1,"Paper_List":"21804283","Original_Text":"PMID:21804283; Original text:After 3 months, the serum levels of hsCRP, TNF-α, interleukin-6, fasting plasma glucose (plasma glucose), glycosylated hemoglobin (glycosylated hemoglobin), fasting insulin (insulin) and HOMA-adiponectin, insulin resistance index decreased, and adiponectin was significantly increased in type 2 diabetes mellitus-T group compared to those in the type 2 diabetes mellitus-NT group (p<0.05 or p<0.01)."},{"Node1":"Glucose","Edge_Type":"chemical_to_mechanism","Node2":"interleukin 6 L homeolog","Weight":1,"Paper_List":"21804283","Original_Text":"PMID:21804283; Original text:After 3 months, the serum levels of hsCRP, TNF-α, interleukin-6, fasting plasma glucose (plasma glucose), glycosylated hemoglobin (glycosylated hemoglobin), fasting insulin (insulin) and HOMA-adiponectin, insulin resistance index decreased, and adiponectin was significantly increased in type 2 diabetes mellitus-T group compared to those in the type 2 diabetes mellitus-NT group (p<0.05 or p<0.01)."},{"Node1":"Glucose","Edge_Type":"chemical_to_mechanism","Node2":"endothelin receptor type B","Weight":1,"Paper_List":"21804283","Original_Text":"PMID:21804283; Original text:After 3 months, the serum levels of hsCRP, TNF-α, interleukin-6, fasting plasma glucose (plasma glucose), glycosylated hemoglobin (glycosylated hemoglobin), fasting insulin (insulin) and HOMA-adiponectin, insulin resistance index decreased, and adiponectin was significantly increased in type 2 diabetes mellitus-T group compared to those in the type 2 diabetes mellitus-NT group (p<0.05 or p<0.01)."},{"Node1":"Glucose","Edge_Type":"chemical_to_mechanism","Node2":"adiponectin, C1Q and collagen domain containing S homeolog","Weight":3,"Paper_List":"21804283|20889139|20889139","Original_Text":"PMID:21804283; Original text:After 3 months, the serum levels of hsCRP, TNF-α, interleukin-6, fasting plasma glucose (plasma glucose), glycosylated hemoglobin (glycosylated hemoglobin), fasting insulin (insulin) and HOMA-adiponectin, insulin resistance index decreased, and adiponectin was significantly increased in type 2 diabetes mellitus-T group compared to those in the type 2 diabetes mellitus-NT group (p<0.05 or p<0.01).|PMID:20889139; Original text:The serum adiponectin levels at baseline had decreased tendency with significant difference between each two groups, while CRP, TNF-α, and IL-6 levels had increased tendency with significant difference between each two groups among NC, impaired glucose tolerance, DM1 and DM2 groups (all P<0.01).|PMID:20889139; Original text:At 3 months after periodontal intervention, the serum adiponectin levels were increased than those without periodontal intervention (all P<0.01), while CRP, IL-6 and TNF-α significantly decreased (all P<0.05) in both impaired glucose tolerance and DM1 groups."},{"Node1":"Diabetes Mellitus, Type 2","Edge_Type":"disease_to_mechanism","Node2":"GLYcosylation related","Weight":1,"Paper_List":"21804283","Original_Text":"PMID:21804283; Original text:After 3 months, the serum levels of hsCRP, TNF-α, interleukin-6, fasting plasma glucose (plasma glucose), glycosylated hemoglobin (glycosylated hemoglobin), fasting insulin (insulin) and HOMA-adiponectin, insulin resistance index decreased, and adiponectin was significantly increased in type 2 diabetes mellitus-T group compared to those in the type 2 diabetes mellitus-NT group (p<0.05 or p<0.01)."},{"Node1":"Diabetes Mellitus, Type 2","Edge_Type":"disease_to_mechanism","Node2":"interleukin 6 L homeolog","Weight":1,"Paper_List":"21804283","Original_Text":"PMID:21804283; Original text:After 3 months, the serum levels of hsCRP, TNF-α, interleukin-6, fasting plasma glucose (plasma glucose), glycosylated hemoglobin (glycosylated hemoglobin), fasting insulin (insulin) and HOMA-adiponectin, insulin resistance index decreased, and adiponectin was significantly increased in type 2 diabetes mellitus-T group compared to those in the type 2 diabetes mellitus-NT group (p<0.05 or p<0.01)."},{"Node1":"Diabetes Mellitus, Type 2","Edge_Type":"disease_to_mechanism","Node2":"provisional ortholog of insulin L homeolog","Weight":1,"Paper_List":"21804283","Original_Text":"PMID:21804283; Original text:After 3 months, the serum levels of hsCRP, TNF-α, interleukin-6, fasting plasma glucose (plasma glucose), glycosylated hemoglobin (glycosylated hemoglobin), fasting insulin (insulin) and HOMA-adiponectin, insulin resistance index decreased, and adiponectin was significantly increased in type 2 diabetes mellitus-T group compared to those in the type 2 diabetes mellitus-NT group (p<0.05 or p<0.01)."},{"Node1":"Diabetes Mellitus, Type 2","Edge_Type":"disease_to_mechanism","Node2":"endothelin receptor type B","Weight":1,"Paper_List":"21804283","Original_Text":"PMID:21804283; Original text:After 3 months, the serum levels of hsCRP, TNF-α, interleukin-6, fasting plasma glucose (plasma glucose), glycosylated hemoglobin (glycosylated hemoglobin), fasting insulin (insulin) and HOMA-adiponectin, insulin resistance index decreased, and adiponectin was significantly increased in type 2 diabetes mellitus-T group compared to those in the type 2 diabetes mellitus-NT group (p<0.05 or p<0.01)."},{"Node1":"Diabetes Mellitus, Type 2","Edge_Type":"disease_to_mechanism","Node2":"adiponectin, C1Q and collagen domain containing S homeolog","Weight":1,"Paper_List":"21804283","Original_Text":"PMID:21804283; Original text:After 3 months, the serum levels of hsCRP, TNF-α, interleukin-6, fasting plasma glucose (plasma glucose), glycosylated hemoglobin (glycosylated hemoglobin), fasting insulin (insulin) and HOMA-adiponectin, insulin resistance index decreased, and adiponectin was significantly increased in type 2 diabetes mellitus-T group compared to those in the type 2 diabetes mellitus-NT group (p<0.05 or p<0.01)."},{"Node1":"Rosuvastatin Calcium","Edge_Type":"chemical_to_disease","Node2":"Hemorrhage","Weight":1,"Paper_List":"28855141","Original_Text":"PMID:28855141; Original text:Local but not systemic statin application as an adjunct to non-surgical treatment yielded significantly larger probing pocket depth (pocket depth), radiographic defect depth (RDD), and bleeding index reduction, and larger clinical attachment level gain, and less residual pocket depth and RDD (p≤0.016); rosuvastatin appeared as the most efficacious."},{"Node1":"Rosuvastatin Calcium","Edge_Type":"chemical_to_mechanism","Node2":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","Weight":1,"Paper_List":"28855141","Original_Text":"PMID:28855141; Original text:Local but not systemic statin application as an adjunct to non-surgical treatment yielded significantly larger probing pocket depth (pocket depth), radiographic defect depth (RDD), and bleeding index reduction, and larger clinical attachment level gain, and less residual pocket depth and RDD (p≤0.016); rosuvastatin appeared as the most efficacious."},{"Node1":"Hemorrhage","Edge_Type":"disease_to_mechanism","Node2":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","Weight":1,"Paper_List":"28855141","Original_Text":"PMID:28855141; Original text:Local but not systemic statin application as an adjunct to non-surgical treatment yielded significantly larger probing pocket depth (pocket depth), radiographic defect depth (RDD), and bleeding index reduction, and larger clinical attachment level gain, and less residual pocket depth and RDD (p≤0.016); rosuvastatin appeared as the most efficacious."},{"Node1":"docosahexaenoic acid ","Edge_Type":"nutrient_to_chemical","Node2":"Docosahexaenoic Acids","Weight":2,"Paper_List":"24970858|24970858","Original_Text":"PMID:24970858; Original text:docosahexaenoic acid supplementation decreased mean pocket depth (-0.29 ± 0.13; p = .03) and gingival index (-0.26 ± 0.13; p = .04).|PMID:24970858; Original text:Significant adjusted differences were found between docosahexaenoic acid and control for both gingival crevicular fluid high-sensitivity C-reactive protein (-5.3 ng/mL, standard error [SE] = 2.4, p = .03) and IL-1β (-20.1 pg/mL, SE = 8.2, p = .02) but not IL-6 (0.02 pg/mL, SE = 0.71, p = .98) or systemic high-sensitivity C-reactive protein (-1.19 mg/L, SE = 0.90, p = .20)."},{"Node1":"docosahexaenoic acid ","Edge_Type":"nutrient_to_anatomy","Node2":"Gingiva","Weight":2,"Paper_List":"24970858|24970858","Original_Text":"PMID:24970858; Original text:docosahexaenoic acid supplementation decreased mean pocket depth (-0.29 ± 0.13; p = .03) and gingival index (-0.26 ± 0.13; p = .04).|PMID:24970858; Original text:Significant adjusted differences were found between docosahexaenoic acid and control for both gingival crevicular fluid high-sensitivity C-reactive protein (-5.3 ng/mL, standard error [SE] = 2.4, p = .03) and IL-1β (-20.1 pg/mL, SE = 8.2, p = .02) but not IL-6 (0.02 pg/mL, SE = 0.71, p = .98) or systemic high-sensitivity C-reactive protein (-1.19 mg/L, SE = 0.90, p = .20)."},{"Node1":"Docosahexaenoic Acids","Edge_Type":"chemical_to_anatomy","Node2":"Gingiva","Weight":2,"Paper_List":"24970858|24970858","Original_Text":"PMID:24970858; Original text:docosahexaenoic acid supplementation decreased mean pocket depth (-0.29 ± 0.13; p = .03) and gingival index (-0.26 ± 0.13; p = .04).|PMID:24970858; Original text:Significant adjusted differences were found between docosahexaenoic acid and control for both gingival crevicular fluid high-sensitivity C-reactive protein (-5.3 ng/mL, standard error [SE] = 2.4, p = .03) and IL-1β (-20.1 pg/mL, SE = 8.2, p = .02) but not IL-6 (0.02 pg/mL, SE = 0.71, p = .98) or systemic high-sensitivity C-reactive protein (-1.19 mg/L, SE = 0.90, p = .20)."},{"Node1":"JIL-1 kinase","Edge_Type":"mechanism","Node2":"high","Weight":1,"Paper_List":"24970858","Original_Text":"PMID:24970858; Original text:Significant adjusted differences were found between docosahexaenoic acid and control for both gingival crevicular fluid high-sensitivity C-reactive protein (-5.3 ng/mL, standard error [SE] = 2.4, p = .03) and IL-1β (-20.1 pg/mL, SE = 8.2, p = .02) but not IL-6 (0.02 pg/mL, SE = 0.71, p = .98) or systemic high-sensitivity C-reactive protein (-1.19 mg/L, SE = 0.90, p = .20)."},{"Node1":"high","Edge_Type":"mechanism","Node2":"interleukin 6 cytokine family signal transducer","Weight":1,"Paper_List":"24970858","Original_Text":"PMID:24970858; Original text:Significant adjusted differences were found between docosahexaenoic acid and control for both gingival crevicular fluid high-sensitivity C-reactive protein (-5.3 ng/mL, standard error [SE] = 2.4, p = .03) and IL-1β (-20.1 pg/mL, SE = 8.2, p = .02) but not IL-6 (0.02 pg/mL, SE = 0.71, p = .98) or systemic high-sensitivity C-reactive protein (-1.19 mg/L, SE = 0.90, p = .20)."},{"Node1":"docosahexaenoic acid ","Edge_Type":"nutrient_to_mechanism","Node2":"high","Weight":1,"Paper_List":"24970858","Original_Text":"PMID:24970858; Original text:Significant adjusted differences were found between docosahexaenoic acid and control for both gingival crevicular fluid high-sensitivity C-reactive protein (-5.3 ng/mL, standard error [SE] = 2.4, p = .03) and IL-1β (-20.1 pg/mL, SE = 8.2, p = .02) but not IL-6 (0.02 pg/mL, SE = 0.71, p = .98) or systemic high-sensitivity C-reactive protein (-1.19 mg/L, SE = 0.90, p = .20)."},{"Node1":"docosahexaenoic acid ","Edge_Type":"nutrient_to_mechanism","Node2":"JIL-1 kinase","Weight":1,"Paper_List":"24970858","Original_Text":"PMID:24970858; Original text:Significant adjusted differences were found between docosahexaenoic acid and control for both gingival crevicular fluid high-sensitivity C-reactive protein (-5.3 ng/mL, standard error [SE] = 2.4, p = .03) and IL-1β (-20.1 pg/mL, SE = 8.2, p = .02) but not IL-6 (0.02 pg/mL, SE = 0.71, p = .98) or systemic high-sensitivity C-reactive protein (-1.19 mg/L, SE = 0.90, p = .20)."},{"Node1":"docosahexaenoic acid ","Edge_Type":"nutrient_to_mechanism","Node2":"interleukin 6 cytokine family signal transducer","Weight":1,"Paper_List":"24970858","Original_Text":"PMID:24970858; Original text:Significant adjusted differences were found between docosahexaenoic acid and control for both gingival crevicular fluid high-sensitivity C-reactive protein (-5.3 ng/mL, standard error [SE] = 2.4, p = .03) and IL-1β (-20.1 pg/mL, SE = 8.2, p = .02) but not IL-6 (0.02 pg/mL, SE = 0.71, p = .98) or systemic high-sensitivity C-reactive protein (-1.19 mg/L, SE = 0.90, p = .20)."},{"Node1":"docosahexaenoic acid ","Edge_Type":"nutrient_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"24970858","Original_Text":"PMID:24970858; Original text:Significant adjusted differences were found between docosahexaenoic acid and control for both gingival crevicular fluid high-sensitivity C-reactive protein (-5.3 ng/mL, standard error [SE] = 2.4, p = .03) and IL-1β (-20.1 pg/mL, SE = 8.2, p = .02) but not IL-6 (0.02 pg/mL, SE = 0.71, p = .98) or systemic high-sensitivity C-reactive protein (-1.19 mg/L, SE = 0.90, p = .20)."},{"Node1":"Docosahexaenoic Acids","Edge_Type":"chemical_to_mechanism","Node2":"high","Weight":1,"Paper_List":"24970858","Original_Text":"PMID:24970858; Original text:Significant adjusted differences were found between docosahexaenoic acid and control for both gingival crevicular fluid high-sensitivity C-reactive protein (-5.3 ng/mL, standard error [SE] = 2.4, p = .03) and IL-1β (-20.1 pg/mL, SE = 8.2, p = .02) but not IL-6 (0.02 pg/mL, SE = 0.71, p = .98) or systemic high-sensitivity C-reactive protein (-1.19 mg/L, SE = 0.90, p = .20)."},{"Node1":"Docosahexaenoic Acids","Edge_Type":"chemical_to_mechanism","Node2":"JIL-1 kinase","Weight":1,"Paper_List":"24970858","Original_Text":"PMID:24970858; Original text:Significant adjusted differences were found between docosahexaenoic acid and control for both gingival crevicular fluid high-sensitivity C-reactive protein (-5.3 ng/mL, standard error [SE] = 2.4, p = .03) and IL-1β (-20.1 pg/mL, SE = 8.2, p = .02) but not IL-6 (0.02 pg/mL, SE = 0.71, p = .98) or systemic high-sensitivity C-reactive protein (-1.19 mg/L, SE = 0.90, p = .20)."},{"Node1":"Docosahexaenoic Acids","Edge_Type":"chemical_to_mechanism","Node2":"interleukin 6 cytokine family signal transducer","Weight":1,"Paper_List":"24970858","Original_Text":"PMID:24970858; Original text:Significant adjusted differences were found between docosahexaenoic acid and control for both gingival crevicular fluid high-sensitivity C-reactive protein (-5.3 ng/mL, standard error [SE] = 2.4, p = .03) and IL-1β (-20.1 pg/mL, SE = 8.2, p = .02) but not IL-6 (0.02 pg/mL, SE = 0.71, p = .98) or systemic high-sensitivity C-reactive protein (-1.19 mg/L, SE = 0.90, p = .20)."},{"Node1":"Docosahexaenoic Acids","Edge_Type":"chemical_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"24970858","Original_Text":"PMID:24970858; Original text:Significant adjusted differences were found between docosahexaenoic acid and control for both gingival crevicular fluid high-sensitivity C-reactive protein (-5.3 ng/mL, standard error [SE] = 2.4, p = .03) and IL-1β (-20.1 pg/mL, SE = 8.2, p = .02) but not IL-6 (0.02 pg/mL, SE = 0.71, p = .98) or systemic high-sensitivity C-reactive protein (-1.19 mg/L, SE = 0.90, p = .20)."},{"Node1":"high","Edge_Type":"mechanism_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"24970858","Original_Text":"PMID:24970858; Original text:Significant adjusted differences were found between docosahexaenoic acid and control for both gingival crevicular fluid high-sensitivity C-reactive protein (-5.3 ng/mL, standard error [SE] = 2.4, p = .03) and IL-1β (-20.1 pg/mL, SE = 8.2, p = .02) but not IL-6 (0.02 pg/mL, SE = 0.71, p = .98) or systemic high-sensitivity C-reactive protein (-1.19 mg/L, SE = 0.90, p = .20)."},{"Node1":"Aspirin","Edge_Type":"chemical","Node2":"Docosahexaenoic Acids","Weight":1,"Paper_List":"24970858","Original_Text":"PMID:24970858; Original text:In this randomized controlled trial, aspirin-triggered docosahexaenoic acid supplementation significantly improved periodontal outcomes in people with periodontitis, indicating its potential therapeutic efficacy (clinicaltrials.gov NCT01976806)."},{"Node1":"Docosahexaenoic Acids","Edge_Type":"chemical_to_disease","Node2":"Periodontal Cyst","Weight":1,"Paper_List":"24970858","Original_Text":"PMID:24970858; Original text:In this randomized controlled trial, aspirin-triggered docosahexaenoic acid supplementation significantly improved periodontal outcomes in people with periodontitis, indicating its potential therapeutic efficacy (clinicaltrials.gov NCT01976806)."},{"Node1":"Docosahexaenoic Acids","Edge_Type":"chemical_to_disease","Node2":"Periodontitis","Weight":1,"Paper_List":"24970858","Original_Text":"PMID:24970858; Original text:In this randomized controlled trial, aspirin-triggered docosahexaenoic acid supplementation significantly improved periodontal outcomes in people with periodontitis, indicating its potential therapeutic efficacy (clinicaltrials.gov NCT01976806)."},{"Node1":"Aspirin","Edge_Type":"chemical_to_disease","Node2":"Periodontal Cyst","Weight":1,"Paper_List":"24970858","Original_Text":"PMID:24970858; Original text:In this randomized controlled trial, aspirin-triggered docosahexaenoic acid supplementation significantly improved periodontal outcomes in people with periodontitis, indicating its potential therapeutic efficacy (clinicaltrials.gov NCT01976806)."},{"Node1":"Aspirin","Edge_Type":"chemical_to_disease","Node2":"Periodontitis","Weight":1,"Paper_List":"24970858","Original_Text":"PMID:24970858; Original text:In this randomized controlled trial, aspirin-triggered docosahexaenoic acid supplementation significantly improved periodontal outcomes in people with periodontitis, indicating its potential therapeutic efficacy (clinicaltrials.gov NCT01976806)."},{"Node1":"Atherosclerosis","Edge_Type":"disease","Node2":"Cardiovascular Diseases","Weight":1,"Paper_List":"18052701","Original_Text":"PMID:18052701; Original text:This group was not associated with cardiovascular disease events or with stroke but was associated with a significant increase in mean early atherogenesis (0.03 mm; 95% CI: 0.02 to 0.04)."},{"Node1":"Atherosclerosis","Edge_Type":"disease","Node2":"Stroke","Weight":1,"Paper_List":"18052701","Original_Text":"PMID:18052701; Original text:This group was not associated with cardiovascular disease events or with stroke but was associated with a significant increase in mean early atherogenesis (0.03 mm; 95% CI: 0.02 to 0.04)."},{"Node1":"Edema","Edge_Type":"disease","Node2":"Pain","Weight":2,"Paper_List":"30374832|22524327","Original_Text":"PMID:30374832; Original text:The majority of patients reported some discomfort, pain, and edema with mild intensity without any significant differences between treatment modalities.|PMID:22524327; Original text:Statistically significant differences were seen for tissue edema (P = 0.041), pain medication consumption (P <0.001), and Pain scale assessment (P <0.001) favoring test sites."},{"Node1":"Colon","Edge_Type":"anatomy","Node2":"Stem Cells","Weight":1,"Paper_List":"23855840","Original_Text":"PMID:23855840; Original text:Also, colony-forming units in group A were significantly reduced compared with group B, P <0.05 (independent t-test)."},{"Node1":"Eikenella Corrodens (Organism)","Edge_Type":"bacteria","Node2":"Treponema Denticola (Organism)","Weight":1,"Paper_List":"10842858","Original_Text":"PMID:10842858; Original text:Significantly increased levels of Treponema denticola but, in contrast, lower levels of Eikenella corrodens were found in nonbleeding sites of HIV-infected patients compared with controls."},{"Node1":"Eikenella Corrodens (Organism)","Edge_Type":"bacteria_to_disease","Node2":"HIV Infections","Weight":1,"Paper_List":"10842858","Original_Text":"PMID:10842858; Original text:Significantly increased levels of Treponema denticola but, in contrast, lower levels of Eikenella corrodens were found in nonbleeding sites of HIV-infected patients compared with controls."},{"Node1":"Treponema Denticola (Organism)","Edge_Type":"bacteria_to_disease","Node2":"HIV Infections","Weight":1,"Paper_List":"10842858","Original_Text":"PMID:10842858; Original text:Significantly increased levels of Treponema denticola but, in contrast, lower levels of Eikenella corrodens were found in nonbleeding sites of HIV-infected patients compared with controls."},{"Node1":"Metronidazole","Edge_Type":"chemical","Node2":"Moxifloxacin","Weight":1,"Paper_List":"26034931","Original_Text":"PMID:26034931; Original text:Systemic administration of moxifloxacin as an adjunct to non-surgical treatment significantly improves clinical outcomes and provides comparable clinical improvement with less adverse events to that of combination of amoxicillin and metronidazole in the treatment of generalized aggressive periodontitis."},{"Node1":"Amoxicillin","Edge_Type":"chemical","Node2":"Moxifloxacin","Weight":1,"Paper_List":"26034931","Original_Text":"PMID:26034931; Original text:Systemic administration of moxifloxacin as an adjunct to non-surgical treatment significantly improves clinical outcomes and provides comparable clinical improvement with less adverse events to that of combination of amoxicillin and metronidazole in the treatment of generalized aggressive periodontitis."},{"Node1":"Moxifloxacin","Edge_Type":"chemical_to_disease","Node2":"Periodontitis","Weight":1,"Paper_List":"26034931","Original_Text":"PMID:26034931; Original text:Systemic administration of moxifloxacin as an adjunct to non-surgical treatment significantly improves clinical outcomes and provides comparable clinical improvement with less adverse events to that of combination of amoxicillin and metronidazole in the treatment of generalized aggressive periodontitis."},{"Node1":"Doxycycline","Edge_Type":"chemical","Node2":"Flurbiprofen","Weight":1,"Paper_List":"15088884","Original_Text":"PMID:15088884; Original text:Consistent with previous studies on animal models of chronic destructive disease (e.g., rheumatoid arthritis), the subantimicrobial dose doxycycline and NSAID ) low-dose flurbiprofen therapy synergistically suppressed MMP and other neutral proteinases in the gingiva of chronic periodontitis patients."},{"Node1":"Flurbiprofen","Edge_Type":"chemical_to_disease","Node2":"Periodontitis","Weight":1,"Paper_List":"15088884","Original_Text":"PMID:15088884; Original text:Consistent with previous studies on animal models of chronic destructive disease (e.g., rheumatoid arthritis), the subantimicrobial dose doxycycline and NSAID ) low-dose flurbiprofen therapy synergistically suppressed MMP and other neutral proteinases in the gingiva of chronic periodontitis patients."},{"Node1":"Flurbiprofen","Edge_Type":"chemical_to_disease","Node2":"Arthritis, Rheumatoid","Weight":1,"Paper_List":"15088884","Original_Text":"PMID:15088884; Original text:Consistent with previous studies on animal models of chronic destructive disease (e.g., rheumatoid arthritis), the subantimicrobial dose doxycycline and NSAID ) low-dose flurbiprofen therapy synergistically suppressed MMP and other neutral proteinases in the gingiva of chronic periodontitis patients."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_disease","Node2":"Arthritis, Rheumatoid","Weight":1,"Paper_List":"15088884","Original_Text":"PMID:15088884; Original text:Consistent with previous studies on animal models of chronic destructive disease (e.g., rheumatoid arthritis), the subantimicrobial dose doxycycline and NSAID ) low-dose flurbiprofen therapy synergistically suppressed MMP and other neutral proteinases in the gingiva of chronic periodontitis patients."},{"Node1":"Flurbiprofen","Edge_Type":"chemical_to_mechanism","Node2":"matrix metallopeptidase 1","Weight":2,"Paper_List":"15088884|15088884","Original_Text":"PMID:15088884; Original text:Consistent with previous studies on animal models of chronic destructive disease (e.g., rheumatoid arthritis), the subantimicrobial dose doxycycline and NSAID ) low-dose flurbiprofen therapy synergistically suppressed MMP and other neutral proteinases in the gingiva of chronic periodontitis patients.|PMID:15088884; Original text:A mechanism, suggested by earlier animal studies, involves the NSAID, in the ) low-dose flurbiprofen regimen, increasing the uptake of the tetracycline-based MMP inhibitor in the inflammatory lesion, thus synergistically enhancing the efficacy of this medication."},{"Node1":"Arthritis, Rheumatoid","Edge_Type":"disease_to_mechanism","Node2":"matrix metallopeptidase 1","Weight":1,"Paper_List":"15088884","Original_Text":"PMID:15088884; Original text:Consistent with previous studies on animal models of chronic destructive disease (e.g., rheumatoid arthritis), the subantimicrobial dose doxycycline and NSAID ) low-dose flurbiprofen therapy synergistically suppressed MMP and other neutral proteinases in the gingiva of chronic periodontitis patients."},{"Node1":"Flurbiprofen","Edge_Type":"chemical","Node2":"Tetracycline","Weight":1,"Paper_List":"15088884","Original_Text":"PMID:15088884; Original text:A mechanism, suggested by earlier animal studies, involves the NSAID, in the ) low-dose flurbiprofen regimen, increasing the uptake of the tetracycline-based MMP inhibitor in the inflammatory lesion, thus synergistically enhancing the efficacy of this medication."},{"Node1":"Tetracycline","Edge_Type":"chemical_to_disease","Node2":"Inflammatory Bowel Diseases","Weight":1,"Paper_List":"15088884","Original_Text":"PMID:15088884; Original text:A mechanism, suggested by earlier animal studies, involves the NSAID, in the ) low-dose flurbiprofen regimen, increasing the uptake of the tetracycline-based MMP inhibitor in the inflammatory lesion, thus synergistically enhancing the efficacy of this medication."},{"Node1":"Flurbiprofen","Edge_Type":"chemical_to_disease","Node2":"Inflammatory Bowel Diseases","Weight":1,"Paper_List":"15088884","Original_Text":"PMID:15088884; Original text:A mechanism, suggested by earlier animal studies, involves the NSAID, in the ) low-dose flurbiprofen regimen, increasing the uptake of the tetracycline-based MMP inhibitor in the inflammatory lesion, thus synergistically enhancing the efficacy of this medication."},{"Node1":"Tetracycline","Edge_Type":"chemical_to_mechanism","Node2":"matrix metallopeptidase 1","Weight":1,"Paper_List":"15088884","Original_Text":"PMID:15088884; Original text:A mechanism, suggested by earlier animal studies, involves the NSAID, in the ) low-dose flurbiprofen regimen, increasing the uptake of the tetracycline-based MMP inhibitor in the inflammatory lesion, thus synergistically enhancing the efficacy of this medication."},{"Node1":"Inflammatory Bowel Diseases","Edge_Type":"disease_to_mechanism","Node2":"matrix metallopeptidase 1","Weight":1,"Paper_List":"15088884","Original_Text":"PMID:15088884; Original text:A mechanism, suggested by earlier animal studies, involves the NSAID, in the ) low-dose flurbiprofen regimen, increasing the uptake of the tetracycline-based MMP inhibitor in the inflammatory lesion, thus synergistically enhancing the efficacy of this medication."},{"Node1":"Pain","Edge_Type":"disease","Node2":"Periapical Diseases","Weight":1,"Paper_List":"8151248","Original_Text":"PMID:8151248; Original text:Patients with no radiographic periapical lesions had significantly more pain than patients with periapical lesions at 8-, 24-, 48-, and 72-h posttreatment regardless of whether they received placebo or dexamethasone."},{"Node1":"Dexamethasone","Edge_Type":"chemical_to_disease","Node2":"Periapical Diseases","Weight":1,"Paper_List":"8151248","Original_Text":"PMID:8151248; Original text:Patients with no radiographic periapical lesions had significantly more pain than patients with periapical lesions at 8-, 24-, 48-, and 72-h posttreatment regardless of whether they received placebo or dexamethasone."},{"Node1":"Actinobacillus Actinomycetemcomitans","Edge_Type":"bacteria_to_chemical","Node2":"Minocycline","Weight":1,"Paper_List":"8396177","Original_Text":"PMID:8396177; Original text:Subgingival minocycline ointment resulted in statistically significantly greater reduction of P. gingivalis at weeks 2, 4, 6, and 12; P. intermedia at weeks 2, 4, 6, and 12; and A. actinomycetemcomitans at weeks 6 and 12."},{"Node1":"Porphyromonas Gingivalis (Organism)","Edge_Type":"bacteria_to_chemical","Node2":"Minocycline","Weight":1,"Paper_List":"8396177","Original_Text":"PMID:8396177; Original text:Subgingival minocycline ointment resulted in statistically significantly greater reduction of P. gingivalis at weeks 2, 4, 6, and 12; P. intermedia at weeks 2, 4, 6, and 12; and A. actinomycetemcomitans at weeks 6 and 12."},{"Node1":"Prevotella Intermedia","Edge_Type":"bacteria_to_chemical","Node2":"Minocycline","Weight":1,"Paper_List":"8396177","Original_Text":"PMID:8396177; Original text:Subgingival minocycline ointment resulted in statistically significantly greater reduction of P. gingivalis at weeks 2, 4, 6, and 12; P. intermedia at weeks 2, 4, 6, and 12; and A. actinomycetemcomitans at weeks 6 and 12."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"interleukin 17A","Weight":2,"Paper_List":"31231967|31231967","Original_Text":"PMID:31231967; Original text:Our case-control study revealed a significant association between IL-17 A-197G transition and chronic periodontitis.|PMID:31231967; Original text:The overall meta-analysis revealed significant associations between the IL-17 A-197G polymorphism and chronic periodontitis risk in homozygote co-dominant and recessive models."},{"Node1":"Cardiomegaly","Edge_Type":"disease","Node2":"Pain, Postoperative","Weight":1,"Paper_List":"29033088","Original_Text":"PMID:29033088; Original text:The results of the meta-analysis showed that postoperative pain is higher in the endodontic treatment with foraminal enlargement, with a statistically significant difference in the first, second, fourth, sixth, and seventh days."},{"Node1":"Capnocytophaga Ochracea","Edge_Type":"bacteria","Node2":"Treponema Denticola (Organism)","Weight":1,"Paper_List":"22445846","Original_Text":"PMID:22445846; Original text:When subjects were analysed as a single group, significant reductions after supragingival scaling were observed for Actinomyces gerencseriae, Capnocytophaga ochracea, and Treponema denticola."},{"Node1":"Actinomyces Gerencseriae","Edge_Type":"bacteria","Node2":"Treponema Denticola (Organism)","Weight":1,"Paper_List":"22445846","Original_Text":"PMID:22445846; Original text:When subjects were analysed as a single group, significant reductions after supragingival scaling were observed for Actinomyces gerencseriae, Capnocytophaga ochracea, and Treponema denticola."},{"Node1":"Actinomyces Gerencseriae","Edge_Type":"bacteria","Node2":"Capnocytophaga Ochracea","Weight":1,"Paper_List":"22445846","Original_Text":"PMID:22445846; Original text:When subjects were analysed as a single group, significant reductions after supragingival scaling were observed for Actinomyces gerencseriae, Capnocytophaga ochracea, and Treponema denticola."},{"Node1":"Prevotella Intermedia","Edge_Type":"bacteria_to_disease","Node2":"Periodontitis","Weight":2,"Paper_List":"26313005|26313005","Original_Text":"PMID:26313005; Original text:The mere presence of Pg, even in low amount, was significantly associated with severe periodontitis, while the amount of Aggregatibacter actinomycetemcomitans, Treponema denticola, and Prevotella intermedia had to reach the critical thresholds to be significantly associated with disease.|PMID:26313005; Original text:Compared to individuals with low levels of both Treponema denticola and Prevotella intermedia, high colonization by either Treponema denticola or Prevotella intermedia alone significantly increased the odds of having severe periodontitis by 2.5 (95%CI 1.7-3.5) folds."},{"Node1":"fibrinogen gamma chain","Edge_Type":"mechanism","Node2":"proline rich 4","Weight":1,"Paper_List":"19405832","Original_Text":"PMID:19405832; Original text:Periodontal treatment significantly reduced the blood levels of fibrinogen, CRP, and IL-6 in the test group."},{"Node1":"Periodontitis","Edge_Type":"disease","Node2":"Psoriasis","Weight":1,"Paper_List":"27862342","Original_Text":"PMID:27862342; Original text:Patients with periodontitis have a significantly elevated risk of psoriasis."},{"Node1":"Chlorhexidine","Edge_Type":"chemical","Node2":"Curcumin","Weight":1,"Paper_List":"32690830","Original_Text":"PMID:32690830; Original text:The experimental group (2% curcumin gel) showed statistically significant improvements in periodontal [i.e., sulcus bleeding index (periodontal [i.e., sulcus bleeding index), probing pocket depth (pocket depth), and relative attachment level (relative attachment level)] and microbiologic parameters in the form of colony-forming units (colony-forming units) in comparison with control group (0.2% chlorhexidine gel)."},{"Node1":"Curcumin","Edge_Type":"chemical_to_disease","Node2":"Hemorrhage","Weight":1,"Paper_List":"32690830","Original_Text":"PMID:32690830; Original text:The experimental group (2% curcumin gel) showed statistically significant improvements in periodontal [i.e., sulcus bleeding index (periodontal [i.e., sulcus bleeding index), probing pocket depth (pocket depth), and relative attachment level (relative attachment level)] and microbiologic parameters in the form of colony-forming units (colony-forming units) in comparison with control group (0.2% chlorhexidine gel)."},{"Node1":"Curcumin","Edge_Type":"chemical_to_anatomy","Node2":"Stem Cells","Weight":1,"Paper_List":"32690830","Original_Text":"PMID:32690830; Original text:The experimental group (2% curcumin gel) showed statistically significant improvements in periodontal [i.e., sulcus bleeding index (periodontal [i.e., sulcus bleeding index), probing pocket depth (pocket depth), and relative attachment level (relative attachment level)] and microbiologic parameters in the form of colony-forming units (colony-forming units) in comparison with control group (0.2% chlorhexidine gel)."},{"Node1":"Chlorhexidine","Edge_Type":"chemical_to_anatomy","Node2":"Stem Cells","Weight":1,"Paper_List":"32690830","Original_Text":"PMID:32690830; Original text:The experimental group (2% curcumin gel) showed statistically significant improvements in periodontal [i.e., sulcus bleeding index (periodontal [i.e., sulcus bleeding index), probing pocket depth (pocket depth), and relative attachment level (relative attachment level)] and microbiologic parameters in the form of colony-forming units (colony-forming units) in comparison with control group (0.2% chlorhexidine gel)."},{"Node1":"Periodontitis","Edge_Type":"disease_to_anatomy","Node2":"Myocardium","Weight":1,"Paper_List":"14643271","Original_Text":"PMID:14643271; Original text:The odds ratio of having acute myocardial infarction and periodontitis varied between 9.2:1 to 14.1:1 with the greatest odds ratio if bone loss exceeded 4mm at >/=50"},{"Node1":"Amoxicillin","Edge_Type":"chemical","Node2":"Cefixime","Weight":3,"Paper_List":"27498443|27498443|27498443","Original_Text":"PMID:27498443; Original text:The improvement in the control group of patients on the day 7 was 19% in BOP and 28% in gingival index; this improvement was statistically highly significant after the addition of amoxicillin plus metronodazole (71% in BOP and 77% in gingival index) or cefixime (62% in BOP and 82% in gingival index).|PMID:27498443; Original text:Compared to the combination of amoxicillin and metronidazole, cefixim was statistically significantly more effective for gingival index (p < 0.05), while for the other three clinical parameters their effects were equal.|PMID:27498443; Original text:The conjunction of amoxicillin plus metronidazole or cefixime to the causal treatment of patients with chronic periodontitis led to statistically significant improvement in efficacy in relation to gingival index and BOP parameters, while cefixime was statistically significantly more efficient than the combination of amoxicillin and metronidazole for gingival index."},{"Node1":"Cefixime","Edge_Type":"chemical","Node2":"Metronidazole","Weight":3,"Paper_List":"27498443|27498443|27498443","Original_Text":"PMID:27498443; Original text:The improvement in the control group of patients on the day 7 was 19% in BOP and 28% in gingival index; this improvement was statistically highly significant after the addition of amoxicillin plus metronodazole (71% in BOP and 77% in gingival index) or cefixime (62% in BOP and 82% in gingival index).|PMID:27498443; Original text:Compared to the combination of amoxicillin and metronidazole, cefixim was statistically significantly more effective for gingival index (p < 0.05), while for the other three clinical parameters their effects were equal.|PMID:27498443; Original text:The conjunction of amoxicillin plus metronidazole or cefixime to the causal treatment of patients with chronic periodontitis led to statistically significant improvement in efficacy in relation to gingival index and BOP parameters, while cefixime was statistically significantly more efficient than the combination of amoxicillin and metronidazole for gingival index."},{"Node1":"Cefixime","Edge_Type":"chemical_to_anatomy","Node2":"Gingiva","Weight":3,"Paper_List":"27498443|27498443|27498443","Original_Text":"PMID:27498443; Original text:The improvement in the control group of patients on the day 7 was 19% in BOP and 28% in gingival index; this improvement was statistically highly significant after the addition of amoxicillin plus metronodazole (71% in BOP and 77% in gingival index) or cefixime (62% in BOP and 82% in gingival index).|PMID:27498443; Original text:Compared to the combination of amoxicillin and metronidazole, cefixim was statistically significantly more effective for gingival index (p < 0.05), while for the other three clinical parameters their effects were equal.|PMID:27498443; Original text:The conjunction of amoxicillin plus metronidazole or cefixime to the causal treatment of patients with chronic periodontitis led to statistically significant improvement in efficacy in relation to gingival index and BOP parameters, while cefixime was statistically significantly more efficient than the combination of amoxicillin and metronidazole for gingival index."},{"Node1":"Amoxicillin","Edge_Type":"chemical_to_anatomy","Node2":"Gingiva","Weight":3,"Paper_List":"27498443|27498443|27498443","Original_Text":"PMID:27498443; Original text:The improvement in the control group of patients on the day 7 was 19% in BOP and 28% in gingival index; this improvement was statistically highly significant after the addition of amoxicillin plus metronodazole (71% in BOP and 77% in gingival index) or cefixime (62% in BOP and 82% in gingival index).|PMID:27498443; Original text:Compared to the combination of amoxicillin and metronidazole, cefixim was statistically significantly more effective for gingival index (p < 0.05), while for the other three clinical parameters their effects were equal.|PMID:27498443; Original text:The conjunction of amoxicillin plus metronidazole or cefixime to the causal treatment of patients with chronic periodontitis led to statistically significant improvement in efficacy in relation to gingival index and BOP parameters, while cefixime was statistically significantly more efficient than the combination of amoxicillin and metronidazole for gingival index."},{"Node1":"Cefixime","Edge_Type":"chemical_to_disease","Node2":"Chronic Periodontitis","Weight":1,"Paper_List":"27498443","Original_Text":"PMID:27498443; Original text:The conjunction of amoxicillin plus metronidazole or cefixime to the causal treatment of patients with chronic periodontitis led to statistically significant improvement in efficacy in relation to gingival index and BOP parameters, while cefixime was statistically significantly more efficient than the combination of amoxicillin and metronidazole for gingival index."},{"Node1":"Amoxicillin","Edge_Type":"chemical_to_disease","Node2":"Chronic Periodontitis","Weight":1,"Paper_List":"27498443","Original_Text":"PMID:27498443; Original text:The conjunction of amoxicillin plus metronidazole or cefixime to the causal treatment of patients with chronic periodontitis led to statistically significant improvement in efficacy in relation to gingival index and BOP parameters, while cefixime was statistically significantly more efficient than the combination of amoxicillin and metronidazole for gingival index."},{"Node1":"Metronidazole","Edge_Type":"chemical_to_disease","Node2":"Chronic Periodontitis","Weight":1,"Paper_List":"27498443","Original_Text":"PMID:27498443; Original text:The conjunction of amoxicillin plus metronidazole or cefixime to the causal treatment of patients with chronic periodontitis led to statistically significant improvement in efficacy in relation to gingival index and BOP parameters, while cefixime was statistically significantly more efficient than the combination of amoxicillin and metronidazole for gingival index."},{"Node1":"matrix metallopeptidase 1","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"25741580","Original_Text":"PMID:25741580; Original text:Decreased Gingival crevicular fluid metalloproteinase-8 levels and increased TIMP-1 levels were found to be significant up to day 180 (P <0.05)."},{"Node1":"matrix metallopeptidase 1","Edge_Type":"mechanism_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"25741580","Original_Text":"PMID:25741580; Original text:Decreased Gingival crevicular fluid metalloproteinase-8 levels and increased TIMP-1 levels were found to be significant up to day 180 (P <0.05)."},{"Node1":"tissue inhibitor of metalloproteinase-1 L homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"25741580","Original_Text":"PMID:25741580; Original text:Decreased Gingival crevicular fluid metalloproteinase-8 levels and increased TIMP-1 levels were found to be significant up to day 180 (P <0.05)."},{"Node1":"tissue inhibitor of metalloproteinase-1 L homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"25741580","Original_Text":"PMID:25741580; Original text:Decreased Gingival crevicular fluid metalloproteinase-8 levels and increased TIMP-1 levels were found to be significant up to day 180 (P <0.05)."},{"Node1":"Bone Diseases, Metabolic","Edge_Type":"disease","Node2":"Bone Resorption","Weight":1,"Paper_List":"20348487","Original_Text":"PMID:20348487; Original text:We previously demonstrated that subantimicrobial-dose-doxycycline (SDD) treatment of post-menopausal osteopenic women significantly reduced periodontal disease progression, and biomarkers of collagen destruction and bone resorption locally in periodontal pockets, in a double-blind placebo-controlled clinical trial."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_disease","Node2":"Bone Resorption","Weight":1,"Paper_List":"20348487","Original_Text":"PMID:20348487; Original text:We previously demonstrated that subantimicrobial-dose-doxycycline (SDD) treatment of post-menopausal osteopenic women significantly reduced periodontal disease progression, and biomarkers of collagen destruction and bone resorption locally in periodontal pockets, in a double-blind placebo-controlled clinical trial."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_disease","Node2":"Bone Diseases, Metabolic","Weight":1,"Paper_List":"20348487","Original_Text":"PMID:20348487; Original text:We previously demonstrated that subantimicrobial-dose-doxycycline (SDD) treatment of post-menopausal osteopenic women significantly reduced periodontal disease progression, and biomarkers of collagen destruction and bone resorption locally in periodontal pockets, in a double-blind placebo-controlled clinical trial."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_mechanism","Node2":"collagen","Weight":1,"Paper_List":"20348487","Original_Text":"PMID:20348487; Original text:We previously demonstrated that subantimicrobial-dose-doxycycline (SDD) treatment of post-menopausal osteopenic women significantly reduced periodontal disease progression, and biomarkers of collagen destruction and bone resorption locally in periodontal pockets, in a double-blind placebo-controlled clinical trial."},{"Node1":"Bone Resorption","Edge_Type":"disease_to_mechanism","Node2":"collagen","Weight":1,"Paper_List":"20348487","Original_Text":"PMID:20348487; Original text:We previously demonstrated that subantimicrobial-dose-doxycycline (SDD) treatment of post-menopausal osteopenic women significantly reduced periodontal disease progression, and biomarkers of collagen destruction and bone resorption locally in periodontal pockets, in a double-blind placebo-controlled clinical trial."},{"Node1":"Bone Diseases, Metabolic","Edge_Type":"disease_to_mechanism","Node2":"collagen","Weight":1,"Paper_List":"20348487","Original_Text":"PMID:20348487; Original text:We previously demonstrated that subantimicrobial-dose-doxycycline (SDD) treatment of post-menopausal osteopenic women significantly reduced periodontal disease progression, and biomarkers of collagen destruction and bone resorption locally in periodontal pockets, in a double-blind placebo-controlled clinical trial."},{"Node1":"Periodontitis","Edge_Type":"disease_to_anatomy","Node2":"Plasma","Weight":1,"Paper_List":"20569170","Original_Text":"PMID:20569170; Original text:chronic periodontitis is significantly associated with lower levels of plasma total antioxidant capacity."},{"Node1":"Periodontitis","Edge_Type":"disease_to_anatomy","Node2":"Platelet-Rich Fibrin","Weight":2,"Paper_List":"29023611|30624092","Original_Text":"PMID:29023611; Original text:Use of autologous platelet-rich fibrin significantly enhances the clinical and radiographic outcomes of open flap debridement in the treatment of periodontal intraosseous defects in patients affected by localized aggressive periodontitis.|PMID:30624092; Original text:leukocyte-platelet-rich fibrin combined with open flap debridement significantly increases growth factors levels and thus, it enhances the periodontal healing on chronic periodontitis patients."},{"Node1":"Periodontitis","Edge_Type":"disease_to_anatomy","Node2":"Prostate","Weight":1,"Paper_List":"33029095","Original_Text":"PMID:33029095; Original text:With statistical significance, participants with periodontitis might have enhanced risks of esophageal cancer (HR = 1.79, 95% CI: 1.15-2.79), prostate cancer (HR = 1.20, 95% CI: 1.09-1.31), hematological malignancy (HR = 1.19, 95% CI: 1.09-1.29), and melanoma of skin (HR = 1.21, 95% CI: 1.03-1.42), compared with those without periodontitis."},{"Node1":"Dentin Sensitivity","Edge_Type":"disease","Node2":"Pain","Weight":1,"Paper_List":"23252480","Original_Text":"PMID:23252480; Original text:ORS was associated with patient perception of greater surgical hardship (p = 0.0264), higher 1-week pain experience (p = 0.0001) and greater dental hypersensitivity (p = 0.0002)."},{"Node1":"Periodontitis","Edge_Type":"disease_to_anatomy","Node2":"Salivary Glands","Weight":3,"Paper_List":"33063408|33063408|29504999","Original_Text":"PMID:33063408; Original text:The meta-analysis revealed a significant reduction (p < .0001) in salivary melatonin levels in chronic periodontitis (3.26 ± 3.44 pg/ml) compared with healthy controls (5.27 ± 5.39 pg/ml), with a mean difference of 2.65 ± 7.84 and a confidence interval of 1.94-3.36.|PMID:33063408; Original text:The significantly lower salivary melatonin levels in periodontitis must be inferred with caution given the low quality of the included studies.|PMID:29504999; Original text:Our meta-analysis showed that salivary the salivary matrix metalloproteinase-8 levels were significantly higher in periodontitis patients compared with healthy controls overall."},{"Node1":"Periodontitis","Edge_Type":"disease","Node2":"Preterm Premature Rupture of the Membranes","Weight":1,"Paper_List":"21375427","Original_Text":"PMID:21375427; Original text:After adjustment for two sets of potential confounders (four pre-term birth risk factors and four social characteristics), for periodontitis status and for inter-examiner variability, tooth decay was not significantly associated with either pre-term birth or spontaneous pre-term birth/PPROM (aOR = 1.10 [0.91-1.32] and aOR = 1.14 [0.91-1.42], respectively)."},{"Node1":"Periodontitis","Edge_Type":"disease_to_anatomy","Node2":"Skin","Weight":1,"Paper_List":"33029095","Original_Text":"PMID:33029095; Original text:With statistical significance, participants with periodontitis might have enhanced risks of esophageal cancer (HR = 1.79, 95% CI: 1.15-2.79), prostate cancer (HR = 1.20, 95% CI: 1.09-1.31), hematological malignancy (HR = 1.19, 95% CI: 1.09-1.29), and melanoma of skin (HR = 1.21, 95% CI: 1.03-1.42), compared with those without periodontitis."},{"Node1":"Gingiva","Edge_Type":"anatomy","Node2":"Mucous Membrane","Weight":1,"Paper_List":"22540356","Original_Text":"PMID:22540356; Original text:Plaque index and Gingival index values were also found significantly higher for implants without keratinized mucosa (P < 0.05)."},{"Node1":"Glycine","Edge_Type":"chemical_to_anatomy","Node2":"Integumentary System","Weight":1,"Paper_List":"17539712","Original_Text":"PMID:17539712; Original text:Glycine powder air polishing (Glycine powder air polishing) has been shown to be significantly more effective in reducing the subgingival cultivable microflora in shallow periodontal pockets compared to curets and is safe when applied directly to root surfaces."},{"Node1":"Dinoprostone","Edge_Type":"chemical","Node2":"Ketorolac","Weight":1,"Paper_List":"9706855","Original_Text":"PMID:9706855; Original text:A statistically significant increase in gingival crevicular fluid prostaglandin E2 levels was noted at days 28 and 42 in the placebo group (P < 0.01), but not in the ketorolac group (P > 0.05), when compared to baseline, however."},{"Node1":"Pain","Edge_Type":"disease_to_mechanism","Node2":"collagen","Weight":1,"Paper_List":"19678861","Original_Text":"PMID:19678861; Original text:The a new collagen matrix group had a significantly lower patient morbidity (pain and medication intake) as well as reduced surgery time."},{"Node1":"interleukin 6 L homeolog","Edge_Type":"mechanism","Node2":"tumor necrosis factor S homeolog","Weight":1,"Paper_List":"20932155","Original_Text":"PMID:20932155; Original text:Decrease in interleukin-6 in the adjunctive subantimicrobial-dose doxycycline group was significantly higher compared to the placebo group at 6 and 9 months in deep pockets (P <0.05), whereas tumor necrosis factor-α was significantly reduced in moderately deep pockets (P <0.05)."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_disease","Node2":"Neoplasms","Weight":1,"Paper_List":"20932155","Original_Text":"PMID:20932155; Original text:Decrease in interleukin-6 in the adjunctive subantimicrobial-dose doxycycline group was significantly higher compared to the placebo group at 6 and 9 months in deep pockets (P <0.05), whereas tumor necrosis factor-α was significantly reduced in moderately deep pockets (P <0.05)."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_disease","Node2":"Necrosis","Weight":1,"Paper_List":"20932155","Original_Text":"PMID:20932155; Original text:Decrease in interleukin-6 in the adjunctive subantimicrobial-dose doxycycline group was significantly higher compared to the placebo group at 6 and 9 months in deep pockets (P <0.05), whereas tumor necrosis factor-α was significantly reduced in moderately deep pockets (P <0.05)."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_mechanism","Node2":"tumor necrosis factor S homeolog","Weight":1,"Paper_List":"20932155","Original_Text":"PMID:20932155; Original text:Decrease in interleukin-6 in the adjunctive subantimicrobial-dose doxycycline group was significantly higher compared to the placebo group at 6 and 9 months in deep pockets (P <0.05), whereas tumor necrosis factor-α was significantly reduced in moderately deep pockets (P <0.05)."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_mechanism","Node2":"interleukin 6 L homeolog","Weight":1,"Paper_List":"20932155","Original_Text":"PMID:20932155; Original text:Decrease in interleukin-6 in the adjunctive subantimicrobial-dose doxycycline group was significantly higher compared to the placebo group at 6 and 9 months in deep pockets (P <0.05), whereas tumor necrosis factor-α was significantly reduced in moderately deep pockets (P <0.05)."},{"Node1":"Neoplasms","Edge_Type":"disease_to_mechanism","Node2":"interleukin 6 L homeolog","Weight":1,"Paper_List":"20932155","Original_Text":"PMID:20932155; Original text:Decrease in interleukin-6 in the adjunctive subantimicrobial-dose doxycycline group was significantly higher compared to the placebo group at 6 and 9 months in deep pockets (P <0.05), whereas tumor necrosis factor-α was significantly reduced in moderately deep pockets (P <0.05)."},{"Node1":"Necrosis","Edge_Type":"disease_to_mechanism","Node2":"interleukin 6 L homeolog","Weight":1,"Paper_List":"20932155","Original_Text":"PMID:20932155; Original text:Decrease in interleukin-6 in the adjunctive subantimicrobial-dose doxycycline group was significantly higher compared to the placebo group at 6 and 9 months in deep pockets (P <0.05), whereas tumor necrosis factor-α was significantly reduced in moderately deep pockets (P <0.05)."},{"Node1":"GDP-D-glucose phosphorylase 1","Edge_Type":"mechanism","Node2":"interleukin 10 S homeolog","Weight":1,"Paper_List":"20932155","Original_Text":"PMID:20932155; Original text:adjunctive subantimicrobial-dose doxycycline resulted in a stable interleukin-4 and interleukin-10 response while reducing the monocyte chemoattractant protein 1 levels at 3 months (P <0.05)."},{"Node1":"GDP-D-glucose phosphorylase 1","Edge_Type":"mechanism","Node2":"interleukin 4","Weight":1,"Paper_List":"20932155","Original_Text":"PMID:20932155; Original text:adjunctive subantimicrobial-dose doxycycline resulted in a stable interleukin-4 and interleukin-10 response while reducing the monocyte chemoattractant protein 1 levels at 3 months (P <0.05)."},{"Node1":"interleukin 10 S homeolog","Edge_Type":"mechanism","Node2":"interleukin 4","Weight":1,"Paper_List":"20932155","Original_Text":"PMID:20932155; Original text:adjunctive subantimicrobial-dose doxycycline resulted in a stable interleukin-4 and interleukin-10 response while reducing the monocyte chemoattractant protein 1 levels at 3 months (P <0.05)."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_mechanism","Node2":"GDP-D-glucose phosphorylase 1","Weight":1,"Paper_List":"20932155","Original_Text":"PMID:20932155; Original text:adjunctive subantimicrobial-dose doxycycline resulted in a stable interleukin-4 and interleukin-10 response while reducing the monocyte chemoattractant protein 1 levels at 3 months (P <0.05)."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_mechanism","Node2":"interleukin 10 S homeolog","Weight":1,"Paper_List":"20932155","Original_Text":"PMID:20932155; Original text:adjunctive subantimicrobial-dose doxycycline resulted in a stable interleukin-4 and interleukin-10 response while reducing the monocyte chemoattractant protein 1 levels at 3 months (P <0.05)."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_mechanism","Node2":"interleukin 4","Weight":1,"Paper_List":"20932155","Original_Text":"PMID:20932155; Original text:adjunctive subantimicrobial-dose doxycycline resulted in a stable interleukin-4 and interleukin-10 response while reducing the monocyte chemoattractant protein 1 levels at 3 months (P <0.05)."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_anatomy","Node2":"Monocytes","Weight":1,"Paper_List":"20932155","Original_Text":"PMID:20932155; Original text:adjunctive subantimicrobial-dose doxycycline resulted in a stable interleukin-4 and interleukin-10 response while reducing the monocyte chemoattractant protein 1 levels at 3 months (P <0.05)."},{"Node1":"GDP-D-glucose phosphorylase 1","Edge_Type":"mechanism_to_anatomy","Node2":"Monocytes","Weight":1,"Paper_List":"20932155","Original_Text":"PMID:20932155; Original text:adjunctive subantimicrobial-dose doxycycline resulted in a stable interleukin-4 and interleukin-10 response while reducing the monocyte chemoattractant protein 1 levels at 3 months (P <0.05)."},{"Node1":"interleukin 10 S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Monocytes","Weight":1,"Paper_List":"20932155","Original_Text":"PMID:20932155; Original text:adjunctive subantimicrobial-dose doxycycline resulted in a stable interleukin-4 and interleukin-10 response while reducing the monocyte chemoattractant protein 1 levels at 3 months (P <0.05)."},{"Node1":"interleukin 4","Edge_Type":"mechanism_to_anatomy","Node2":"Monocytes","Weight":1,"Paper_List":"20932155","Original_Text":"PMID:20932155; Original text:adjunctive subantimicrobial-dose doxycycline resulted in a stable interleukin-4 and interleukin-10 response while reducing the monocyte chemoattractant protein 1 levels at 3 months (P <0.05)."},{"Node1":"Citric Acid","Edge_Type":"chemical","Node2":"Edetic Acid","Weight":1,"Paper_List":"14971255","Original_Text":"PMID:14971255; Original text:Evidence to date suggests that the use of citric acid, tetracycline, or ethylenediaminetetraacetic acid to modify the root surface provides no benefit of clinical significance to regeneration in patients with chronic periodontitis."},{"Node1":"Edetic Acid","Edge_Type":"chemical","Node2":"Tetracycline","Weight":1,"Paper_List":"14971255","Original_Text":"PMID:14971255; Original text:Evidence to date suggests that the use of citric acid, tetracycline, or ethylenediaminetetraacetic acid to modify the root surface provides no benefit of clinical significance to regeneration in patients with chronic periodontitis."},{"Node1":"Citric Acid","Edge_Type":"chemical","Node2":"Tetracycline","Weight":1,"Paper_List":"14971255","Original_Text":"PMID:14971255; Original text:Evidence to date suggests that the use of citric acid, tetracycline, or ethylenediaminetetraacetic acid to modify the root surface provides no benefit of clinical significance to regeneration in patients with chronic periodontitis."},{"Node1":"Edetic Acid","Edge_Type":"chemical_to_disease","Node2":"Chronic Periodontitis","Weight":1,"Paper_List":"14971255","Original_Text":"PMID:14971255; Original text:Evidence to date suggests that the use of citric acid, tetracycline, or ethylenediaminetetraacetic acid to modify the root surface provides no benefit of clinical significance to regeneration in patients with chronic periodontitis."},{"Node1":"Citric Acid","Edge_Type":"chemical_to_disease","Node2":"Chronic Periodontitis","Weight":1,"Paper_List":"14971255","Original_Text":"PMID:14971255; Original text:Evidence to date suggests that the use of citric acid, tetracycline, or ethylenediaminetetraacetic acid to modify the root surface provides no benefit of clinical significance to regeneration in patients with chronic periodontitis."},{"Node1":"Periodontal Cyst","Edge_Type":"disease_to_mechanism","Node2":"platelet derived growth factor subunit B","Weight":1,"Paper_List":"20681813","Original_Text":"PMID:20681813; Original text:Periosteal coverage of periodontal defects is not associated with a significant increase in platelet-derived growth factor-BB levels."},{"Node1":"platelet derived growth factor subunit B","Edge_Type":"mechanism_to_anatomy","Node2":"Blood Platelets","Weight":1,"Paper_List":"20681813","Original_Text":"PMID:20681813; Original text:Periosteal coverage of periodontal defects is not associated with a significant increase in platelet-derived growth factor-BB levels."},{"Node1":"Lidocaine","Edge_Type":"chemical","Node2":"Sodium Bicarbonate","Weight":1,"Paper_List":"24139250","Original_Text":"PMID:24139250; Original text:The addition of a sodium bicarbonate buffer to 2% lidocaine with 1:100,000 epinephrine did not result in significantly decreased pain of infiltrations or significantly decreased pain of the incision and drainage procedure when compared with 2% lidocaine with 1:100,000 epinephrine in symptomatic patients with a diagnosis of pulpal necrosis and associated acute swelling."},{"Node1":"Epinephrine","Edge_Type":"chemical","Node2":"Lidocaine","Weight":1,"Paper_List":"24139250","Original_Text":"PMID:24139250; Original text:The addition of a sodium bicarbonate buffer to 2% lidocaine with 1:100,000 epinephrine did not result in significantly decreased pain of infiltrations or significantly decreased pain of the incision and drainage procedure when compared with 2% lidocaine with 1:100,000 epinephrine in symptomatic patients with a diagnosis of pulpal necrosis and associated acute swelling."},{"Node1":"Epinephrine","Edge_Type":"chemical","Node2":"Sodium Bicarbonate","Weight":1,"Paper_List":"24139250","Original_Text":"PMID:24139250; Original text:The addition of a sodium bicarbonate buffer to 2% lidocaine with 1:100,000 epinephrine did not result in significantly decreased pain of infiltrations or significantly decreased pain of the incision and drainage procedure when compared with 2% lidocaine with 1:100,000 epinephrine in symptomatic patients with a diagnosis of pulpal necrosis and associated acute swelling."},{"Node1":"Dental Pulp Necrosis","Edge_Type":"disease","Node2":"Pain","Weight":1,"Paper_List":"24139250","Original_Text":"PMID:24139250; Original text:The addition of a sodium bicarbonate buffer to 2% lidocaine with 1:100,000 epinephrine did not result in significantly decreased pain of infiltrations or significantly decreased pain of the incision and drainage procedure when compared with 2% lidocaine with 1:100,000 epinephrine in symptomatic patients with a diagnosis of pulpal necrosis and associated acute swelling."},{"Node1":"Lidocaine","Edge_Type":"chemical_to_disease","Node2":"Dental Pulp Necrosis","Weight":1,"Paper_List":"24139250","Original_Text":"PMID:24139250; Original text:The addition of a sodium bicarbonate buffer to 2% lidocaine with 1:100,000 epinephrine did not result in significantly decreased pain of infiltrations or significantly decreased pain of the incision and drainage procedure when compared with 2% lidocaine with 1:100,000 epinephrine in symptomatic patients with a diagnosis of pulpal necrosis and associated acute swelling."},{"Node1":"Sodium Bicarbonate","Edge_Type":"chemical_to_disease","Node2":"Pain","Weight":1,"Paper_List":"24139250","Original_Text":"PMID:24139250; Original text:The addition of a sodium bicarbonate buffer to 2% lidocaine with 1:100,000 epinephrine did not result in significantly decreased pain of infiltrations or significantly decreased pain of the incision and drainage procedure when compared with 2% lidocaine with 1:100,000 epinephrine in symptomatic patients with a diagnosis of pulpal necrosis and associated acute swelling."},{"Node1":"Sodium Bicarbonate","Edge_Type":"chemical_to_disease","Node2":"Dental Pulp Necrosis","Weight":1,"Paper_List":"24139250","Original_Text":"PMID:24139250; Original text:The addition of a sodium bicarbonate buffer to 2% lidocaine with 1:100,000 epinephrine did not result in significantly decreased pain of infiltrations or significantly decreased pain of the incision and drainage procedure when compared with 2% lidocaine with 1:100,000 epinephrine in symptomatic patients with a diagnosis of pulpal necrosis and associated acute swelling."},{"Node1":"Epinephrine","Edge_Type":"chemical_to_disease","Node2":"Pain","Weight":1,"Paper_List":"24139250","Original_Text":"PMID:24139250; Original text:The addition of a sodium bicarbonate buffer to 2% lidocaine with 1:100,000 epinephrine did not result in significantly decreased pain of infiltrations or significantly decreased pain of the incision and drainage procedure when compared with 2% lidocaine with 1:100,000 epinephrine in symptomatic patients with a diagnosis of pulpal necrosis and associated acute swelling."},{"Node1":"Epinephrine","Edge_Type":"chemical_to_disease","Node2":"Dental Pulp Necrosis","Weight":1,"Paper_List":"24139250","Original_Text":"PMID:24139250; Original text:The addition of a sodium bicarbonate buffer to 2% lidocaine with 1:100,000 epinephrine did not result in significantly decreased pain of infiltrations or significantly decreased pain of the incision and drainage procedure when compared with 2% lidocaine with 1:100,000 epinephrine in symptomatic patients with a diagnosis of pulpal necrosis and associated acute swelling."},{"Node1":"Edetic Acid","Edge_Type":"chemical_to_anatomy","Node2":"Dental Pulp Cavity","Weight":1,"Paper_List":"25771141","Original_Text":"PMID:25771141; Original text:After a root canal rinse with EDTA (EDTA), intracanal medication (s4), and before root canal obturation (root canal obturation), endotoxin levels reduced without differences between groups (P < .05)."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_mechanism","Node2":"laminin subunit gamma 2","Weight":3,"Paper_List":"15562917|15562917|15562917","Original_Text":"PMID:15562917; Original text:In the Low-dose doxycycline group, gingival crevicular fluid Laminin-5 gamma2 chain fragment levels were significantly reduced at 3 months (P < 0.0125) and then slightly increased during the rest of the study period.|PMID:15562917; Original text:gingival crevicular fluid Laminin-5 gamma2 chain fragment levels in Low-dose doxycycline group were significantly lower than those of the placebo group during the study period (P < 0.05).|PMID:15562917; Original text:The present data indicate that Low-dose doxycycline therapy in combination with root planing therapy can reduce gingival crevicular fluid Laminin-5 gamma2 chain fragment levels and improve clinical periodontal parameters in patients with chronic periodontitis."},{"Node1":"laminin subunit gamma 2","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":3,"Paper_List":"15562917|15562917|15562917","Original_Text":"PMID:15562917; Original text:In the Low-dose doxycycline group, gingival crevicular fluid Laminin-5 gamma2 chain fragment levels were significantly reduced at 3 months (P < 0.0125) and then slightly increased during the rest of the study period.|PMID:15562917; Original text:gingival crevicular fluid Laminin-5 gamma2 chain fragment levels in Low-dose doxycycline group were significantly lower than those of the placebo group during the study period (P < 0.05).|PMID:15562917; Original text:The present data indicate that Low-dose doxycycline therapy in combination with root planing therapy can reduce gingival crevicular fluid Laminin-5 gamma2 chain fragment levels and improve clinical periodontal parameters in patients with chronic periodontitis."},{"Node1":"laminin subunit gamma 2","Edge_Type":"mechanism_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":3,"Paper_List":"15562917|15562917|15562917","Original_Text":"PMID:15562917; Original text:In the Low-dose doxycycline group, gingival crevicular fluid Laminin-5 gamma2 chain fragment levels were significantly reduced at 3 months (P < 0.0125) and then slightly increased during the rest of the study period.|PMID:15562917; Original text:gingival crevicular fluid Laminin-5 gamma2 chain fragment levels in Low-dose doxycycline group were significantly lower than those of the placebo group during the study period (P < 0.05).|PMID:15562917; Original text:The present data indicate that Low-dose doxycycline therapy in combination with root planing therapy can reduce gingival crevicular fluid Laminin-5 gamma2 chain fragment levels and improve clinical periodontal parameters in patients with chronic periodontitis."},{"Node1":"Chronic Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"laminin subunit gamma 2","Weight":1,"Paper_List":"15562917","Original_Text":"PMID:15562917; Original text:The present data indicate that Low-dose doxycycline therapy in combination with root planing therapy can reduce gingival crevicular fluid Laminin-5 gamma2 chain fragment levels and improve clinical periodontal parameters in patients with chronic periodontitis."},{"Node1":"alpha-Esterase-9","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"15562917","Original_Text":"PMID:15562917; Original text:In the placebo group, gingival crevicular fluid 45 and 70 kDa Laminin-5 gamma2 chain fragments tended to decrease at 3 months compared to baseline, but did not reach significance; these levels continued to increase throughout the remainder of the study period."},{"Node1":"alpha-Esterase-9","Edge_Type":"mechanism_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"15562917","Original_Text":"PMID:15562917; Original text:In the placebo group, gingival crevicular fluid 45 and 70 kDa Laminin-5 gamma2 chain fragments tended to decrease at 3 months compared to baseline, but did not reach significance; these levels continued to increase throughout the remainder of the study period."},{"Node1":"Malondialdehyde","Edge_Type":"chemical","Node2":"Superoxides","Weight":2,"Paper_List":"20415915|20415915","Original_Text":"PMID:20415915; Original text:The levels of total oxidative status and superoxide dismutase values were significantly higher in the chronic periodontitis group than in the control group (p < 0.05), but only Malondialdehyde in GCF.|PMID:20415915; Original text:Post-periodontal therapy, serum, saliva and GCF total oxidative status and superoxide dismutase levels significantly decreased compared to basal levels (p < 0.05), but only Malondialdehyde in GCF."},{"Node1":"Malondialdehyde","Edge_Type":"chemical_to_disease","Node2":"Periodontitis","Weight":1,"Paper_List":"20415915","Original_Text":"PMID:20415915; Original text:The levels of total oxidative status and superoxide dismutase values were significantly higher in the chronic periodontitis group than in the control group (p < 0.05), but only Malondialdehyde in GCF."},{"Node1":"Superoxides","Edge_Type":"chemical_to_disease","Node2":"Periodontitis","Weight":2,"Paper_List":"20415915|25511061","Original_Text":"PMID:20415915; Original text:The levels of total oxidative status and superoxide dismutase values were significantly higher in the chronic periodontitis group than in the control group (p < 0.05), but only Malondialdehyde in GCF.|PMID:25511061; Original text:The post-treatment levels of the superoxide dismutase were statistically higher than the pre-treatment levels in periodontitis and gingivitis group."},{"Node1":"Malondialdehyde","Edge_Type":"chemical_to_mechanism","Node2":"superoxide dismutase","Weight":2,"Paper_List":"20415915|20415915","Original_Text":"PMID:20415915; Original text:The levels of total oxidative status and superoxide dismutase values were significantly higher in the chronic periodontitis group than in the control group (p < 0.05), but only Malondialdehyde in GCF.|PMID:20415915; Original text:Post-periodontal therapy, serum, saliva and GCF total oxidative status and superoxide dismutase levels significantly decreased compared to basal levels (p < 0.05), but only Malondialdehyde in GCF."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"superoxide dismutase","Weight":2,"Paper_List":"20415915|25511061","Original_Text":"PMID:20415915; Original text:The levels of total oxidative status and superoxide dismutase values were significantly higher in the chronic periodontitis group than in the control group (p < 0.05), but only Malondialdehyde in GCF.|PMID:25511061; Original text:The post-treatment levels of the superoxide dismutase were statistically higher than the pre-treatment levels in periodontitis and gingivitis group."},{"Node1":"Malondialdehyde","Edge_Type":"chemical_to_anatomy","Node2":"Serum","Weight":1,"Paper_List":"20415915","Original_Text":"PMID:20415915; Original text:Post-periodontal therapy, serum, saliva and GCF total oxidative status and superoxide dismutase levels significantly decreased compared to basal levels (p < 0.05), but only Malondialdehyde in GCF."},{"Node1":"Superoxides","Edge_Type":"chemical_to_anatomy","Node2":"Serum","Weight":1,"Paper_List":"20415915","Original_Text":"PMID:20415915; Original text:Post-periodontal therapy, serum, saliva and GCF total oxidative status and superoxide dismutase levels significantly decreased compared to basal levels (p < 0.05), but only Malondialdehyde in GCF."},{"Node1":"superoxide dismutase","Edge_Type":"mechanism_to_anatomy","Node2":"Serum","Weight":1,"Paper_List":"20415915","Original_Text":"PMID:20415915; Original text:Post-periodontal therapy, serum, saliva and GCF total oxidative status and superoxide dismutase levels significantly decreased compared to basal levels (p < 0.05), but only Malondialdehyde in GCF."},{"Node1":"Inflammation","Edge_Type":"disease","Node2":"Pain","Weight":1,"Paper_List":"26525126","Original_Text":"PMID:26525126; Original text:Overall, debridement discomfort was associated with not receiving LA, noncompliance with the pain control regimen allocated, longer treatment duration, greater gingival inflammation and a higher percentage sites with probing pocket depths≥5 mm (p<0.05)."},{"Node1":"Periodontitis","Edge_Type":"disease_to_anatomy","Node2":"Th2 Cells","Weight":1,"Paper_List":"32745291","Original_Text":"PMID:32745291; Original text:Within limitations of this study, a haplotype of CTLA4 concerning Th2 cell regulation, may be associated with periodontitis in Chinese nonsmokers followed."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"chromosome 17 open reading frame 99","Weight":1,"Paper_List":"25029213","Original_Text":"PMID:25029213; Original text:However, subgroup analysis showed that the interleukin-4 -590 T allele (odds ratio [OR] = 1.2, 95% confidence interval [CI] = 1.02 to 1.42, P = 0.03) and TT genotype (OR = 1.68, 95% CI = 1.05 to 2.67, P = 0.03) were associated with periodontitis in whites."},{"Node1":"Superoxides","Edge_Type":"chemical_to_disease","Node2":"Gingivitis","Weight":1,"Paper_List":"25511061","Original_Text":"PMID:25511061; Original text:The post-treatment levels of the superoxide dismutase were statistically higher than the pre-treatment levels in periodontitis and gingivitis group."},{"Node1":"Gingivitis","Edge_Type":"disease_to_mechanism","Node2":"superoxide dismutase","Weight":1,"Paper_List":"25511061","Original_Text":"PMID:25511061; Original text:The post-treatment levels of the superoxide dismutase were statistically higher than the pre-treatment levels in periodontitis and gingivitis group."},{"Node1":"interleukin 6 L homeolog","Edge_Type":"mechanism","Node2":"tumor necrosis factor receptor superfamily, member a","Weight":1,"Paper_List":"29111391","Original_Text":"PMID:29111391; Original text:Inter-group comparison showed significant difference for TNF-α (p=0.024) and interleukin-6 (p=0.044) levels for antimicrobial photodynamic therapy group at 12 week follow-up."},{"Node1":"collagen","Edge_Type":"mechanism_to_anatomy","Node2":"Allografts","Weight":1,"Paper_List":"15068108","Original_Text":"PMID:15068108; Original text:Therefore, the purpose of this clinical trial was to determine whether the addition of bone graft (i.e., demineralized freeze-dried bone allograft [DFDBA]) significantly affects the outcome of collagen membrane guided tissue regeneration-based root coverage procedures."},{"Node1":"Durapatite","Edge_Type":"chemical_to_anatomy","Node2":"Allografts","Weight":1,"Paper_List":"19055225","Original_Text":"PMID:19055225; Original text:In conclusion, no adverse healing events were noted with the use of allograft in site preservation procedures, and sites treated with the combination of allograft plus resorbable hydroxyapatite showed significantly greater ridge thickness preservation at six months when compared to sites treated with allograft alone (6.8 +/- 1.26 and 5.53 +/- 1.06 respectively)."},{"Node1":"Allografts","Edge_Type":"anatomy","Node2":"Autografts","Weight":1,"Paper_List":"19055225","Original_Text":"PMID:19055225; Original text:Because no statistically significant differences between the groups were observed, it was concluded that the allograft can be used as a substitute for the autograft."},{"Node1":"argininosuccinate synthase 1","Edge_Type":"mechanism","Node2":"immunoglobulin heavy chain (S107 family)","Weight":1,"Paper_List":"33641208","Original_Text":"PMID:33641208; Original text:The patients with a moderate to high rheumatoid arthritis disease activity showed significantly higher levels of probing depth (probing depth), clinical attachment level, anti-cyclic citrullinated peptide IgG, and anti-agalactosyl IgG titer and greater mean percentages of severe periodontitis than those with a low rheumatoid arthritis disease activity (p < .05 for all)."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"argininosuccinate synthase 1","Weight":1,"Paper_List":"33641208","Original_Text":"PMID:33641208; Original text:The patients with a moderate to high rheumatoid arthritis disease activity showed significantly higher levels of probing depth (probing depth), clinical attachment level, anti-cyclic citrullinated peptide IgG, and anti-agalactosyl IgG titer and greater mean percentages of severe periodontitis than those with a low rheumatoid arthritis disease activity (p < .05 for all)."},{"Node1":"Arthritis, Rheumatoid","Edge_Type":"disease_to_mechanism","Node2":"argininosuccinate synthase 1","Weight":1,"Paper_List":"33641208","Original_Text":"PMID:33641208; Original text:The patients with a moderate to high rheumatoid arthritis disease activity showed significantly higher levels of probing depth (probing depth), clinical attachment level, anti-cyclic citrullinated peptide IgG, and anti-agalactosyl IgG titer and greater mean percentages of severe periodontitis than those with a low rheumatoid arthritis disease activity (p < .05 for all)."},{"Node1":"Coronary Disease","Edge_Type":"disease","Node2":"Periodontitis","Weight":1,"Paper_List":"12787204","Original_Text":"PMID:12787204; Original text:Percentage-wise, 50% of the cohort studies (4/8), 75% of the case-control studies (3/4) and 50% of the cross-sectional studies (2/4) reported a significant association between clinical measures of periodontitis and coronary heart disease (excess risk ranged from 0 to 3.3-fold)."},{"Node1":"Allografts","Edge_Type":"anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"23593633","Original_Text":"PMID:23593633; Original text:The results of this study demonstrate that acellular dermal matrix allograft with a a coronally positioned flap is an effective procedure for the treatment of multiple gingival recessions."},{"Node1":"Acellular Dermis","Edge_Type":"anatomy","Node2":"Allografts","Weight":1,"Paper_List":"23593633","Original_Text":"PMID:23593633; Original text:The results of this study demonstrate that acellular dermal matrix allograft with a a coronally positioned flap is an effective procedure for the treatment of multiple gingival recessions."},{"Node1":"Periodontitis","Edge_Type":"disease_to_anatomy","Node2":"Tissues","Weight":2,"Paper_List":"7767709|31831777","Original_Text":"PMID:7767709; Original text:These results indicate that periodontal hygienic treatment was not sufficient to alter significantly the number of IgG- and IgM-secreting cells present in gingival tissue of adult periodontitis patients, but it promoted a reduction of IgG anti-Fusobacterium nucleatum outer membrane secreting cells.|PMID:31831777; Original text:Expression of WNT3, WNT3A and WNT5A in apical periodontitis tissues was significantly higher than in control tissues, and inversely correlated with the expression of SERPINB1, COL1A1 and TIMP1 (P < 0.05)."},{"Node1":"Periodontitis","Edge_Type":"disease_to_anatomy","Node2":"T-Lymphocyte Subsets","Weight":1,"Paper_List":"29447240","Original_Text":"PMID:29447240; Original text:The RANKL expression increased in every B cell subset from the severe periodontitis patients and was significantly greater in activated B cells than in the subjects without periodontitis."},{"Node1":"Periapical Periodontitis","Edge_Type":"disease","Node2":"Periodontitis","Weight":1,"Paper_List":"30209331","Original_Text":"PMID:30209331; Original text:SNP VAMP8 showed significant association (periodontitis[Replication]: P = 0.008 OR = 1.09, 95% CI = [1.02-1.16]; periodontitis [Discovery + Replication]: P = 0.0002, OR = 1.11, 95% CI = [1.05-1.17])."},{"Node1":"benzo(d,e)estra-1,3,5(10)-triene-3,17 beta-diol 17-acetate","Edge_Type":"chemical","Node2":"tricalcium phosphate","Weight":1,"Paper_List":"16836164","Original_Text":"PMID:16836164; Original text:A significant gain in clinical attachment level was observed 3 months postsurgery for sites treated with 0.3 mg/mL rhPDGF-BB + a biocompatible, osteoconductive, synthetic scaffold beta-tricalcium phosphate versus a biocompatible, osteoconductive, synthetic scaffold beta-tricalcium phosphate + buffer (active control), with this trend continuing at 6 months postsurgery."},{"Node1":"Bone and Bones","Edge_Type":"anatomy","Node2":"Tooth","Weight":1,"Paper_List":"12702111","Original_Text":"PMID:12702111; Original text:When the tooth in the cleft was compared to the contra-lateral tooth, differences were only found for both the approximal probing depths, attachment loss and bone loss, which were significantly higher for the tooth in the cleft."},{"Node1":"HIV Infections","Edge_Type":"disease","Node2":"Periodontal Diseases","Weight":1,"Paper_List":"8366414","Original_Text":"PMID:8366414; Original text:However, a significant difference in the change of periodontal disease index (periodontal disease index) was observed between the HIV-infected and control groups (P = 0.005)."},{"Node1":"Chlorhexidine","Edge_Type":"chemical","Node2":"sanguinarine","Weight":1,"Paper_List":"10225548","Original_Text":"PMID:10225548; Original text:Sanguinarine-containing toothpaste and oral rinse significantly inhibited the redevelopment of gingivitis through the 12 weeks following the chlorhexidine phase compared to the control toothpaste and rinse."},{"Node1":"sanguinarine","Edge_Type":"chemical_to_disease","Node2":"Gingivitis","Weight":1,"Paper_List":"10225548","Original_Text":"PMID:10225548; Original text:Sanguinarine-containing toothpaste and oral rinse significantly inhibited the redevelopment of gingivitis through the 12 weeks following the chlorhexidine phase compared to the control toothpaste and rinse."},{"Node1":"Nuclear factor 7","Edge_Type":"mechanism","Node2":"matrix metallopeptidase 1","Weight":1,"Paper_List":"20572767","Original_Text":"PMID:20572767; Original text:Salivary nuclear factor-kappa B ligand and metalloproteinase-8 levels showed significant reductions in the ω-3 group in response to treatment at 3 and 6 months and compared to the control group at 6 months (P <0.01)."},{"Node1":"Nuclear factor 7","Edge_Type":"mechanism_to_anatomy","Node2":"Salivary Glands","Weight":1,"Paper_List":"20572767","Original_Text":"PMID:20572767; Original text:Salivary nuclear factor-kappa B ligand and metalloproteinase-8 levels showed significant reductions in the ω-3 group in response to treatment at 3 and 6 months and compared to the control group at 6 months (P <0.01)."},{"Node1":"Indocyanine Green","Edge_Type":"chemical_to_disease","Node2":"Diabetes Mellitus, Type 2","Weight":2,"Paper_List":"34087466|34087466","Original_Text":"PMID:34087466; Original text:A statistically significant reduction for BOP was noted for indocyanine-green mediated antimicrobial photodynamic therapy group for non-diabetic subjects at 3 months follow up only, while a significant reduction was seen at both 3 months and 6 months among well-controlled and poorly-controlled type-2 diabetes mellitus subjects (p<0.05).|PMID:34087466; Original text:For PD and interdental clinical attachment loss, a significant improvement was seen for indocyanine-green mediated antimicrobial photodynamic therapy group among non-diabetic and well-controlled type-2 diabetes mellitus subjects at both 3- and 6-months follow up, while a significant reduction was seen at only 3 months among poorly-controlled type-2 diabetes mellitus subjects."},{"Node1":"Diabetes Mellitus, Type 2","Edge_Type":"disease","Node2":"Periodontitis","Weight":2,"Paper_List":"34087466|28559203","Original_Text":"PMID:34087466; Original text:indocyanine-green mediated antimicrobial photodynamic therapy significantly improved clinical and antimicrobial parameters in well-controlled and poorly-controlled type-2 diabetes mellitus having stage III and grade C periodontitis.|PMID:28559203; Original text:Considering the effects of adjunctive antimicrobial photodynamic therapy as compared to root planing on clinical signs of chronic periodontitis in type 2 diabetes mellitus and smokers, no difference could be observed for all evaluated parameters (PD: Z=-0.81, P=0.41; CAL: Z=-0.19, P=0.84) except IL-1β (Z=4.57, P<0.001)."},{"Node1":"Bone and Bones","Edge_Type":"anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"24844029","Original_Text":"PMID:24844029; Original text:Within the limits of the present study, one can conclude that MPM coverage of periodontal defects is associated with a significant initial increase in gingival crevicular fluid levels of bone morphogenetic protein-2, a factor that could improve the clinical outcomes of guided tissue regenerative surgery."},{"Node1":"Periodontal Cyst","Edge_Type":"disease_to_mechanism","Node2":"Bone morphogenetic protein 2","Weight":1,"Paper_List":"24844029","Original_Text":"PMID:24844029; Original text:Within the limits of the present study, one can conclude that MPM coverage of periodontal defects is associated with a significant initial increase in gingival crevicular fluid levels of bone morphogenetic protein-2, a factor that could improve the clinical outcomes of guided tissue regenerative surgery."},{"Node1":"Periodontitis","Edge_Type":"disease_to_anatomy","Node2":"Tongue","Weight":1,"Paper_List":"19192047","Original_Text":"PMID:19192047; Original text:A regression equation which included six variables had been established by using logistic regression analysis, indicating that the habit of tongue thrusting, lip sucking, periodontitis, smoking, outcome of recent medication, depression were the principal risk factors, among which tongue thrusting was the most significant."},{"Node1":"Bone morphogenetic protein 2","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"24844029","Original_Text":"PMID:24844029; Original text:Within the limits of the present study, one can conclude that MPM coverage of periodontal defects is associated with a significant initial increase in gingival crevicular fluid levels of bone morphogenetic protein-2, a factor that could improve the clinical outcomes of guided tissue regenerative surgery."},{"Node1":"Bone morphogenetic protein 2","Edge_Type":"mechanism_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"24844029","Original_Text":"PMID:24844029; Original text:Within the limits of the present study, one can conclude that MPM coverage of periodontal defects is associated with a significant initial increase in gingival crevicular fluid levels of bone morphogenetic protein-2, a factor that could improve the clinical outcomes of guided tissue regenerative surgery."},{"Node1":"Bone morphogenetic protein 2","Edge_Type":"mechanism_to_anatomy","Node2":"Bone and Bones","Weight":1,"Paper_List":"24844029","Original_Text":"PMID:24844029; Original text:Within the limits of the present study, one can conclude that MPM coverage of periodontal defects is associated with a significant initial increase in gingival crevicular fluid levels of bone morphogenetic protein-2, a factor that could improve the clinical outcomes of guided tissue regenerative surgery."},{"Node1":"Citric Acid","Edge_Type":"chemical","Node2":"Sodium Hypochlorite","Weight":1,"Paper_List":"3550035","Original_Text":"PMID:3550035; Original text:This study investigated the hypothesis that antiformin-citric acid chemical curettage combined with scaling and root planing (SRP/AF) would significantly reduce pathogenic bacteria of the periodontal pocket when compared to scaling and root planing alone (SRP)."},{"Node1":"Metronidazole","Edge_Type":"chemical","Node2":"Tetracycline","Weight":1,"Paper_List":"14971252","Original_Text":"PMID:14971252; Original text:When examining the effects of individual or combinations of antibiotics, it was found that there were statistically significant improvements in mean attachment level change for tetracycline, metronidazole, and an effect of borderline statistical significance for the combination of amoxicillin plus metronidazole."},{"Node1":"Amoxicillin","Edge_Type":"chemical","Node2":"Tetracycline","Weight":1,"Paper_List":"14971252","Original_Text":"PMID:14971252; Original text:When examining the effects of individual or combinations of antibiotics, it was found that there were statistically significant improvements in mean attachment level change for tetracycline, metronidazole, and an effect of borderline statistical significance for the combination of amoxicillin plus metronidazole."},{"Node1":"Capnocytophaga Sputigena","Edge_Type":"bacteria","Node2":"Lactobacillus Acidophilus","Weight":1,"Paper_List":"18261121","Original_Text":"PMID:18261121; Original text:Tannerella forsythia (P<0.05), Capnocytophaga sputigena (P<0.05), Actinomyces israelii (P<0.05) and Lactobacillus acidophilus (P<0.05) were found at higher levels at tooth surfaces."},{"Node1":"Lactobacillus Acidophilus","Edge_Type":"bacteria","Node2":"Tannerella Forsythia","Weight":1,"Paper_List":"18261121","Original_Text":"PMID:18261121; Original text:Tannerella forsythia (P<0.05), Capnocytophaga sputigena (P<0.05), Actinomyces israelii (P<0.05) and Lactobacillus acidophilus (P<0.05) were found at higher levels at tooth surfaces."},{"Node1":"Actinomyces Israelii","Edge_Type":"bacteria","Node2":"Lactobacillus Acidophilus","Weight":1,"Paper_List":"18261121","Original_Text":"PMID:18261121; Original text:Tannerella forsythia (P<0.05), Capnocytophaga sputigena (P<0.05), Actinomyces israelii (P<0.05) and Lactobacillus acidophilus (P<0.05) were found at higher levels at tooth surfaces."},{"Node1":"Capnocytophaga Sputigena","Edge_Type":"bacteria","Node2":"Tannerella Forsythia","Weight":1,"Paper_List":"18261121","Original_Text":"PMID:18261121; Original text:Tannerella forsythia (P<0.05), Capnocytophaga sputigena (P<0.05), Actinomyces israelii (P<0.05) and Lactobacillus acidophilus (P<0.05) were found at higher levels at tooth surfaces."},{"Node1":"Actinomyces Israelii","Edge_Type":"bacteria","Node2":"Capnocytophaga Sputigena","Weight":1,"Paper_List":"18261121","Original_Text":"PMID:18261121; Original text:Tannerella forsythia (P<0.05), Capnocytophaga sputigena (P<0.05), Actinomyces israelii (P<0.05) and Lactobacillus acidophilus (P<0.05) were found at higher levels at tooth surfaces."},{"Node1":"Actinomyces Israelii","Edge_Type":"bacteria","Node2":"Tannerella Forsythia","Weight":1,"Paper_List":"18261121","Original_Text":"PMID:18261121; Original text:Tannerella forsythia (P<0.05), Capnocytophaga sputigena (P<0.05), Actinomyces israelii (P<0.05) and Lactobacillus acidophilus (P<0.05) were found at higher levels at tooth surfaces."},{"Node1":"Lactobacillus Acidophilus","Edge_Type":"bacteria_to_anatomy","Node2":"Integumentary System","Weight":1,"Paper_List":"18261121","Original_Text":"PMID:18261121; Original text:Tannerella forsythia (P<0.05), Capnocytophaga sputigena (P<0.05), Actinomyces israelii (P<0.05) and Lactobacillus acidophilus (P<0.05) were found at higher levels at tooth surfaces."},{"Node1":"Capnocytophaga Sputigena","Edge_Type":"bacteria_to_anatomy","Node2":"Integumentary System","Weight":1,"Paper_List":"18261121","Original_Text":"PMID:18261121; Original text:Tannerella forsythia (P<0.05), Capnocytophaga sputigena (P<0.05), Actinomyces israelii (P<0.05) and Lactobacillus acidophilus (P<0.05) were found at higher levels at tooth surfaces."},{"Node1":"Tannerella Forsythia","Edge_Type":"bacteria_to_anatomy","Node2":"Integumentary System","Weight":1,"Paper_List":"18261121","Original_Text":"PMID:18261121; Original text:Tannerella forsythia (P<0.05), Capnocytophaga sputigena (P<0.05), Actinomyces israelii (P<0.05) and Lactobacillus acidophilus (P<0.05) were found at higher levels at tooth surfaces."},{"Node1":"Actinomyces Israelii","Edge_Type":"bacteria_to_anatomy","Node2":"Integumentary System","Weight":1,"Paper_List":"18261121","Original_Text":"PMID:18261121; Original text:Tannerella forsythia (P<0.05), Capnocytophaga sputigena (P<0.05), Actinomyces israelii (P<0.05) and Lactobacillus acidophilus (P<0.05) were found at higher levels at tooth surfaces."},{"Node1":"Atorvastatin","Edge_Type":"chemical","Node2":"Rosuvastatin Calcium","Weight":2,"Paper_List":"26878748|26878748","Original_Text":"PMID:26878748; Original text:Improvements in these parameters were significantly greater with Rosuvastatin ATV gel local drug delivery than atorvastatin or placebo gels at 6 and 9 months.|PMID:26878748; Original text:ATV gel local drug delivery of 1.2% Rosuvastatin results in significantly greater clinico-radiographic improvement than 1.2% atorvastatin or placebo gels as adjunct to mechanical periodontal therapy."},{"Node1":"Hemorrhage","Edge_Type":"disease_to_mechanism","Node2":"stathmin 3","Weight":1,"Paper_List":"26878748","Original_Text":"PMID:26878748; Original text:Mean sulcus bleeding index and PD reductions, CAL gain, and IBD depth reduction with statin drugs were significantly greater than with placebo gel ATV gel local drug delivery."},{"Node1":"interleukin 1 beta L homeolog","Edge_Type":"mechanism","Node2":"interleukin 6 L homeolog","Weight":1,"Paper_List":"8884648","Original_Text":"PMID:8884648; Original text:Considerable variation was present in the levels detected for both inflammatory cytokines tested, however, concentration of interleukin-1 beta was significantly lower in the GCF of sonic group patients (P = 0.05), while concentration of interleukin-6 was significantly reduced in both groups (P < or = 0.05) (t tests)."},{"Node1":"Glucose Intolerance","Edge_Type":"disease","Node2":"Myotonic Dystrophy","Weight":2,"Paper_List":"20889139|20889139","Original_Text":"PMID:20889139; Original text:The serum adiponectin levels at baseline had decreased tendency with significant difference between each two groups, while CRP, TNF-α, and IL-6 levels had increased tendency with significant difference between each two groups among NC, impaired glucose tolerance, DM1 and DM2 groups (all P<0.01).|PMID:20889139; Original text:At 3 months after periodontal intervention, the serum adiponectin levels were increased than those without periodontal intervention (all P<0.01), while CRP, IL-6 and TNF-α significantly decreased (all P<0.05) in both impaired glucose tolerance and DM1 groups."},{"Node1":"adiponectin, C1Q and collagen domain containing S homeolog","Edge_Type":"mechanism","Node2":"proline rich 4","Weight":2,"Paper_List":"20889139|20889139","Original_Text":"PMID:20889139; Original text:The serum adiponectin levels at baseline had decreased tendency with significant difference between each two groups, while CRP, TNF-α, and IL-6 levels had increased tendency with significant difference between each two groups among NC, impaired glucose tolerance, DM1 and DM2 groups (all P<0.01).|PMID:20889139; Original text:At 3 months after periodontal intervention, the serum adiponectin levels were increased than those without periodontal intervention (all P<0.01), while CRP, IL-6 and TNF-α significantly decreased (all P<0.05) in both impaired glucose tolerance and DM1 groups."},{"Node1":"adiponectin, C1Q and collagen domain containing S homeolog","Edge_Type":"mechanism","Node2":"interleukin 6 cytokine family signal transducer","Weight":2,"Paper_List":"20889139|20889139","Original_Text":"PMID:20889139; Original text:The serum adiponectin levels at baseline had decreased tendency with significant difference between each two groups, while CRP, TNF-α, and IL-6 levels had increased tendency with significant difference between each two groups among NC, impaired glucose tolerance, DM1 and DM2 groups (all P<0.01).|PMID:20889139; Original text:At 3 months after periodontal intervention, the serum adiponectin levels were increased than those without periodontal intervention (all P<0.01), while CRP, IL-6 and TNF-α significantly decreased (all P<0.05) in both impaired glucose tolerance and DM1 groups."},{"Node1":"Glucose","Edge_Type":"chemical_to_disease","Node2":"Glucose Intolerance","Weight":2,"Paper_List":"20889139|20889139","Original_Text":"PMID:20889139; Original text:The serum adiponectin levels at baseline had decreased tendency with significant difference between each two groups, while CRP, TNF-α, and IL-6 levels had increased tendency with significant difference between each two groups among NC, impaired glucose tolerance, DM1 and DM2 groups (all P<0.01).|PMID:20889139; Original text:At 3 months after periodontal intervention, the serum adiponectin levels were increased than those without periodontal intervention (all P<0.01), while CRP, IL-6 and TNF-α significantly decreased (all P<0.05) in both impaired glucose tolerance and DM1 groups."},{"Node1":"Glucose","Edge_Type":"chemical_to_disease","Node2":"Myotonic Dystrophy","Weight":2,"Paper_List":"20889139|20889139","Original_Text":"PMID:20889139; Original text:The serum adiponectin levels at baseline had decreased tendency with significant difference between each two groups, while CRP, TNF-α, and IL-6 levels had increased tendency with significant difference between each two groups among NC, impaired glucose tolerance, DM1 and DM2 groups (all P<0.01).|PMID:20889139; Original text:At 3 months after periodontal intervention, the serum adiponectin levels were increased than those without periodontal intervention (all P<0.01), while CRP, IL-6 and TNF-α significantly decreased (all P<0.05) in both impaired glucose tolerance and DM1 groups."},{"Node1":"Glucose","Edge_Type":"chemical_to_mechanism","Node2":"proline rich 4","Weight":2,"Paper_List":"20889139|20889139","Original_Text":"PMID:20889139; Original text:The serum adiponectin levels at baseline had decreased tendency with significant difference between each two groups, while CRP, TNF-α, and IL-6 levels had increased tendency with significant difference between each two groups among NC, impaired glucose tolerance, DM1 and DM2 groups (all P<0.01).|PMID:20889139; Original text:At 3 months after periodontal intervention, the serum adiponectin levels were increased than those without periodontal intervention (all P<0.01), while CRP, IL-6 and TNF-α significantly decreased (all P<0.05) in both impaired glucose tolerance and DM1 groups."},{"Node1":"Glucose","Edge_Type":"chemical_to_mechanism","Node2":"interleukin 6 cytokine family signal transducer","Weight":2,"Paper_List":"20889139|20889139","Original_Text":"PMID:20889139; Original text:The serum adiponectin levels at baseline had decreased tendency with significant difference between each two groups, while CRP, TNF-α, and IL-6 levels had increased tendency with significant difference between each two groups among NC, impaired glucose tolerance, DM1 and DM2 groups (all P<0.01).|PMID:20889139; Original text:At 3 months after periodontal intervention, the serum adiponectin levels were increased than those without periodontal intervention (all P<0.01), while CRP, IL-6 and TNF-α significantly decreased (all P<0.05) in both impaired glucose tolerance and DM1 groups."},{"Node1":"Glucose Intolerance","Edge_Type":"disease_to_mechanism","Node2":"proline rich 4","Weight":2,"Paper_List":"20889139|20889139","Original_Text":"PMID:20889139; Original text:The serum adiponectin levels at baseline had decreased tendency with significant difference between each two groups, while CRP, TNF-α, and IL-6 levels had increased tendency with significant difference between each two groups among NC, impaired glucose tolerance, DM1 and DM2 groups (all P<0.01).|PMID:20889139; Original text:At 3 months after periodontal intervention, the serum adiponectin levels were increased than those without periodontal intervention (all P<0.01), while CRP, IL-6 and TNF-α significantly decreased (all P<0.05) in both impaired glucose tolerance and DM1 groups."},{"Node1":"Glucose Intolerance","Edge_Type":"disease_to_mechanism","Node2":"interleukin 6 cytokine family signal transducer","Weight":2,"Paper_List":"20889139|20889139","Original_Text":"PMID:20889139; Original text:The serum adiponectin levels at baseline had decreased tendency with significant difference between each two groups, while CRP, TNF-α, and IL-6 levels had increased tendency with significant difference between each two groups among NC, impaired glucose tolerance, DM1 and DM2 groups (all P<0.01).|PMID:20889139; Original text:At 3 months after periodontal intervention, the serum adiponectin levels were increased than those without periodontal intervention (all P<0.01), while CRP, IL-6 and TNF-α significantly decreased (all P<0.05) in both impaired glucose tolerance and DM1 groups."},{"Node1":"Glucose Intolerance","Edge_Type":"disease_to_mechanism","Node2":"adiponectin, C1Q and collagen domain containing S homeolog","Weight":2,"Paper_List":"20889139|20889139","Original_Text":"PMID:20889139; Original text:The serum adiponectin levels at baseline had decreased tendency with significant difference between each two groups, while CRP, TNF-α, and IL-6 levels had increased tendency with significant difference between each two groups among NC, impaired glucose tolerance, DM1 and DM2 groups (all P<0.01).|PMID:20889139; Original text:At 3 months after periodontal intervention, the serum adiponectin levels were increased than those without periodontal intervention (all P<0.01), while CRP, IL-6 and TNF-α significantly decreased (all P<0.05) in both impaired glucose tolerance and DM1 groups."},{"Node1":"Myotonic Dystrophy","Edge_Type":"disease_to_mechanism","Node2":"proline rich 4","Weight":2,"Paper_List":"20889139|20889139","Original_Text":"PMID:20889139; Original text:The serum adiponectin levels at baseline had decreased tendency with significant difference between each two groups, while CRP, TNF-α, and IL-6 levels had increased tendency with significant difference between each two groups among NC, impaired glucose tolerance, DM1 and DM2 groups (all P<0.01).|PMID:20889139; Original text:At 3 months after periodontal intervention, the serum adiponectin levels were increased than those without periodontal intervention (all P<0.01), while CRP, IL-6 and TNF-α significantly decreased (all P<0.05) in both impaired glucose tolerance and DM1 groups."},{"Node1":"Myotonic Dystrophy","Edge_Type":"disease_to_mechanism","Node2":"interleukin 6 cytokine family signal transducer","Weight":2,"Paper_List":"20889139|20889139","Original_Text":"PMID:20889139; Original text:The serum adiponectin levels at baseline had decreased tendency with significant difference between each two groups, while CRP, TNF-α, and IL-6 levels had increased tendency with significant difference between each two groups among NC, impaired glucose tolerance, DM1 and DM2 groups (all P<0.01).|PMID:20889139; Original text:At 3 months after periodontal intervention, the serum adiponectin levels were increased than those without periodontal intervention (all P<0.01), while CRP, IL-6 and TNF-α significantly decreased (all P<0.05) in both impaired glucose tolerance and DM1 groups."},{"Node1":"Myotonic Dystrophy","Edge_Type":"disease_to_mechanism","Node2":"adiponectin, C1Q and collagen domain containing S homeolog","Weight":2,"Paper_List":"20889139|20889139","Original_Text":"PMID:20889139; Original text:The serum adiponectin levels at baseline had decreased tendency with significant difference between each two groups, while CRP, TNF-α, and IL-6 levels had increased tendency with significant difference between each two groups among NC, impaired glucose tolerance, DM1 and DM2 groups (all P<0.01).|PMID:20889139; Original text:At 3 months after periodontal intervention, the serum adiponectin levels were increased than those without periodontal intervention (all P<0.01), while CRP, IL-6 and TNF-α significantly decreased (all P<0.05) in both impaired glucose tolerance and DM1 groups."},{"Node1":"H. Pylori","Edge_Type":"bacteria_to_anatomy","Node2":"Periodontal Ligament","Weight":1,"Paper_List":"26852297","Original_Text":"PMID:26852297; Original text:In addition, periodontal therapy also had benefits on long-term gastric H. pylori eradication."},{"Node1":"Platelet Aggregation, Spontaneous","Edge_Type":"disease_to_mechanism","Node2":"collagen","Weight":1,"Paper_List":"29972709","Original_Text":"PMID:29972709; Original text:Moreover, platelet turnover, measured by platelet RNA content and platelet aggregation in response to collagen, differed significantly between patients that were treated and those who were untreated."},{"Node1":"Periodontitis","Edge_Type":"disease_to_anatomy","Node2":"Tooth","Weight":2,"Paper_List":"21375427|27223128","Original_Text":"PMID:21375427; Original text:After adjustment for two sets of potential confounders (four pre-term birth risk factors and four social characteristics), for periodontitis status and for inter-examiner variability, tooth decay was not significantly associated with either pre-term birth or spontaneous pre-term birth/PPROM (aOR = 1.10 [0.91-1.32] and aOR = 1.14 [0.91-1.42], respectively).|PMID:27223128; Original text:It may be concluded that dental plaque, tooth type, disease extent, baseline pocket depth, and use of azithromycin were significant predictors of the clinical response to treatment for aggressive periodontitis in young individuals."},{"Node1":"collagen","Edge_Type":"mechanism_to_anatomy","Node2":"Blood Platelets","Weight":1,"Paper_List":"29972709","Original_Text":"PMID:29972709; Original text:Moreover, platelet turnover, measured by platelet RNA content and platelet aggregation in response to collagen, differed significantly between patients that were treated and those who were untreated."},{"Node1":"Azithromycin","Edge_Type":"chemical_to_disease","Node2":"Hemorrhage","Weight":1,"Paper_List":"27223128","Original_Text":"PMID:27223128; Original text:Azithromycin, plaque, and baseline pocket depth were significant predictors of bleeding on probing."},{"Node1":"Amoxicillin","Edge_Type":"chemical","Node2":"Cephalexin","Weight":1,"Paper_List":"19678579","Original_Text":"PMID:19678579; Original text:Empirical, peroral use of amoxicillin or cefalexin after surgical treatment in early phase of development of dentoalveolar abscess significantly reduced the time of clinical symptoms duration in the acute odontogenic infections in comparison to surgical treatment only."},{"Node1":"Odontogenic Cysts","Edge_Type":"disease","Node2":"Periapical Abscess","Weight":1,"Paper_List":"19678579","Original_Text":"PMID:19678579; Original text:Empirical, peroral use of amoxicillin or cefalexin after surgical treatment in early phase of development of dentoalveolar abscess significantly reduced the time of clinical symptoms duration in the acute odontogenic infections in comparison to surgical treatment only."},{"Node1":"Amoxicillin","Edge_Type":"chemical_to_disease","Node2":"Odontogenic Cysts","Weight":1,"Paper_List":"19678579","Original_Text":"PMID:19678579; Original text:Empirical, peroral use of amoxicillin or cefalexin after surgical treatment in early phase of development of dentoalveolar abscess significantly reduced the time of clinical symptoms duration in the acute odontogenic infections in comparison to surgical treatment only."},{"Node1":"Amoxicillin","Edge_Type":"chemical_to_disease","Node2":"Periapical Abscess","Weight":1,"Paper_List":"19678579","Original_Text":"PMID:19678579; Original text:Empirical, peroral use of amoxicillin or cefalexin after surgical treatment in early phase of development of dentoalveolar abscess significantly reduced the time of clinical symptoms duration in the acute odontogenic infections in comparison to surgical treatment only."},{"Node1":"Cephalexin","Edge_Type":"chemical_to_disease","Node2":"Odontogenic Cysts","Weight":1,"Paper_List":"19678579","Original_Text":"PMID:19678579; Original text:Empirical, peroral use of amoxicillin or cefalexin after surgical treatment in early phase of development of dentoalveolar abscess significantly reduced the time of clinical symptoms duration in the acute odontogenic infections in comparison to surgical treatment only."},{"Node1":"Cephalexin","Edge_Type":"chemical_to_disease","Node2":"Periapical Abscess","Weight":1,"Paper_List":"19678579","Original_Text":"PMID:19678579; Original text:Empirical, peroral use of amoxicillin or cefalexin after surgical treatment in early phase of development of dentoalveolar abscess significantly reduced the time of clinical symptoms duration in the acute odontogenic infections in comparison to surgical treatment only."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"CD59 molecule (CD59 blood group)","Weight":1,"Paper_List":"18190553","Original_Text":"PMID:18190553; Original text:Patients with aggressive periodontitis showed a positive association with particular human leukocyte antigens-A9 [odds ratio=2.59 (95% confidence interval 1.36-4.83), p=0.004] and particular human leukocyte antigens-B15 [1.90 (1.15-3.16), p=0.01] as well as a negative association with particular human leukocyte antigens-A2 [0.72 (0.56-0.94), p=0.01] and -B5"},{"Node1":"CD59 molecule (CD59 blood group)","Edge_Type":"mechanism_to_anatomy","Node2":"Leukocytes","Weight":1,"Paper_List":"18190553","Original_Text":"PMID:18190553; Original text:Patients with aggressive periodontitis showed a positive association with particular human leukocyte antigens-A9 [odds ratio=2.59 (95% confidence interval 1.36-4.83), p=0.004] and particular human leukocyte antigens-B15 [1.90 (1.15-3.16), p=0.01] as well as a negative association with particular human leukocyte antigens-A2 [0.72 (0.56-0.94), p=0.01] and -B5"},{"Node1":"Hydrogen Peroxide","Edge_Type":"chemical_to_disease","Node2":"Periodontitis","Weight":1,"Paper_List":"22779217","Original_Text":"PMID:22779217; Original text:The adjunctive use over three months of 1.7% hydrogen peroxide gel, locally administered using prescription customized trays in the treatment of subjects with moderate to advanced periodontitis, demonstrated statistically significant clinical improvements in pocket depths and bleeding when compared with root planing alone."},{"Node1":"Gingiva","Edge_Type":"anatomy","Node2":"Tongue","Weight":1,"Paper_List":"22126407","Original_Text":"PMID:22126407; Original text:Linear regression analysis demonstrated the following significant associations: (i) oral malodour from H(2)S and thickness of the tongue coating, (ii) oral malodour from CH(3)SH and periodontal pocket depth of 5 mm or more and the presence of gingival bleeding and (iii) oral malodour from (CH(3))(2)S and systemic disease, medications and thickness of the tongue coating."},{"Node1":"Platelet Aggregation, Spontaneous","Edge_Type":"disease_to_anatomy","Node2":"Blood Platelets","Weight":1,"Paper_List":"29972709","Original_Text":"PMID:29972709; Original text:Moreover, platelet turnover, measured by platelet RNA content and platelet aggregation in response to collagen, differed significantly between patients that were treated and those who were untreated."},{"Node1":"Chlorhexidine","Edge_Type":"chemical","Node2":"Tetracycline","Weight":2,"Paper_List":"9797051|9797051","Original_Text":"PMID:9797051; Original text:BoP was significantly reduced in tetracycline HCl50 compared to tetracycline HCl10, chlorhexidine and sterile saline sites from week 8 post-irrigation.|PMID:9797051; Original text:CALs remained unaltered from pre-irrigation for tetracycline HCl10, chlorhexidine and sterile saline sites over the 12-week observation interval, whereas tetracycline HCl50 sites consistently improved to significantly differ from all other groups at week 10 and 12 post-irrigation."},{"Node1":"Fusobacterium Sp.","Edge_Type":"bacteria","Node2":"S. Aureus","Weight":1,"Paper_List":"21417591","Original_Text":"PMID:21417591; Original text:Porphyromonas gingivalis counts were higher in cases with progressive peri-implantitis (P <0.001)."},{"Node1":"P. Aeruginosa","Edge_Type":"bacteria","Node2":"S. Aureus","Weight":1,"Paper_List":"21417591","Original_Text":"PMID:21417591; Original text:Porphyromonas gingivalis counts were higher in cases with progressive peri-implantitis (P <0.001)."},{"Node1":"Fusobacterium Sp.","Edge_Type":"bacteria","Node2":"P. Aeruginosa","Weight":1,"Paper_List":"21417591","Original_Text":"PMID:21417591; Original text:Porphyromonas gingivalis counts were higher in cases with progressive peri-implantitis (P <0.001)."},{"Node1":"S. Aureus","Edge_Type":"bacteria_to_disease","Node2":"Peri-Implantitis","Weight":1,"Paper_List":"21417591","Original_Text":"PMID:21417591; Original text:Porphyromonas gingivalis counts were higher in cases with progressive peri-implantitis (P <0.001)."},{"Node1":"Fusobacterium Sp.","Edge_Type":"bacteria_to_disease","Node2":"Peri-Implantitis","Weight":1,"Paper_List":"21417591","Original_Text":"PMID:21417591; Original text:Porphyromonas gingivalis counts were higher in cases with progressive peri-implantitis (P <0.001)."},{"Node1":"P. Aeruginosa","Edge_Type":"bacteria_to_disease","Node2":"Peri-Implantitis","Weight":1,"Paper_List":"21417591","Original_Text":"PMID:21417591; Original text:Porphyromonas gingivalis counts were higher in cases with progressive peri-implantitis (P <0.001)."},{"Node1":"Sodium Hypochlorite","Edge_Type":"chemical_to_disease","Node2":"Periodontitis","Weight":1,"Paper_List":"33687555","Original_Text":"PMID:33687555; Original text:In patients with untreated periodontitis, treatment of deep pockets by means of minimally invasive nonsurgical therapy in conjunction with a buffered sodium hypochlorite gel may represent a valuable approach to additionally improve the clinical outcomes obtained with minimally invasive nonsurgical therapy alone."},{"Node1":"Metabolic Syndrome","Edge_Type":"disease","Node2":"Periodontitis","Weight":1,"Paper_List":"29846383","Original_Text":"PMID:29846383; Original text:metabolic syndrome and periodontitis were associated with an odds ratio of 1.38 (95%CI 1.26-1.51; I2 = 92.7%; p < 0.001)."},{"Node1":"Durapatite","Edge_Type":"chemical_to_disease","Node2":"Bone Cysts","Weight":1,"Paper_List":"15086616","Original_Text":"PMID:15086616; Original text:The results of the present study indicate that both collagen/chondroitin sulphate biomaterial and a bovine-derived hydroxyapatite xenograft grafting biomaterials have determined a clinically and statistically significant improvement in terms of clinical attachment level gain, pocket probing depth reduction and radiographic the defect gain when used for the treatment of deep intra-osseous defects."},{"Node1":"Durapatite","Edge_Type":"chemical_to_anatomy","Node2":"Heterografts","Weight":1,"Paper_List":"15086616","Original_Text":"PMID:15086616; Original text:The results of the present study indicate that both collagen/chondroitin sulphate biomaterial and a bovine-derived hydroxyapatite xenograft grafting biomaterials have determined a clinically and statistically significant improvement in terms of clinical attachment level gain, pocket probing depth reduction and radiographic the defect gain when used for the treatment of deep intra-osseous defects."},{"Node1":"Bone Cysts","Edge_Type":"disease_to_mechanism","Node2":"collagen","Weight":1,"Paper_List":"15086616","Original_Text":"PMID:15086616; Original text:The results of the present study indicate that both collagen/chondroitin sulphate biomaterial and a bovine-derived hydroxyapatite xenograft grafting biomaterials have determined a clinically and statistically significant improvement in terms of clinical attachment level gain, pocket probing depth reduction and radiographic the defect gain when used for the treatment of deep intra-osseous defects."},{"Node1":"Preterm Premature Rupture of the Membranes","Edge_Type":"disease_to_anatomy","Node2":"Tooth","Weight":2,"Paper_List":"21375427|21375427","Original_Text":"PMID:21375427; Original text:Crude associations between presence of tooth decay and pre-term birth or spontaneous pre-term birth/PPROM were significant (OR = 1.21|PMID:21375427; Original text:After adjustment for two sets of potential confounders (four pre-term birth risk factors and four social characteristics), for periodontitis status and for inter-examiner variability, tooth decay was not significantly associated with either pre-term birth or spontaneous pre-term birth/PPROM (aOR = 1.10 [0.91-1.32] and aOR = 1.14 [0.91-1.42], respectively)."},{"Node1":"collagen","Edge_Type":"mechanism_to_anatomy","Node2":"Heterografts","Weight":1,"Paper_List":"15086616","Original_Text":"PMID:15086616; Original text:The results of the present study indicate that both collagen/chondroitin sulphate biomaterial and a bovine-derived hydroxyapatite xenograft grafting biomaterials have determined a clinically and statistically significant improvement in terms of clinical attachment level gain, pocket probing depth reduction and radiographic the defect gain when used for the treatment of deep intra-osseous defects."},{"Node1":"fentiazac","Edge_Type":"chemical_to_disease","Node2":"Pain","Weight":1,"Paper_List":"3886139","Original_Text":"PMID:3886139; Original text:A statistically significant difference favoring fentiazac was seen in the patients' assessments of induced pain (while eating) but not in the investigator's assessment of induced pain (percussion)."},{"Node1":"High density lipoprotein cholesterol level QTL 6","Edge_Type":"mechanism","Node2":"T-cell receptor gamma locus L homeolog","Weight":1,"Paper_List":"26434651","Original_Text":"PMID:26434651; Original text:Two and 6 months after treatment, TRG levels were significantly lower in group 2 than in group 1 (P < 0.05), and the levels of high-density lipoprotein cholesterol were significantly higher (P < 0.05)."},{"Node1":"Cholesterol","Edge_Type":"chemical_to_mechanism","Node2":"T-cell receptor gamma locus L homeolog","Weight":1,"Paper_List":"26434651","Original_Text":"PMID:26434651; Original text:Two and 6 months after treatment, TRG levels were significantly lower in group 2 than in group 1 (P < 0.05), and the levels of high-density lipoprotein cholesterol were significantly higher (P < 0.05)."},{"Node1":"Simvastatin","Edge_Type":"chemical_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"20151799","Original_Text":"PMID:20151799; Original text:There was a greater decrease in gingival index and depth and more clinical attachment level gain with significant intrabony defect fill at sites treated with root planing plus locally delivered Simvastatin in patients with chronic periodontitis."},{"Node1":"Metformin","Edge_Type":"chemical_to_disease","Node2":"Chronic Periodontitis","Weight":1,"Paper_List":"25787121","Original_Text":"PMID:25787121; Original text:One percent Metformin was found to significantly improve clinical and radiographic parameters in intrabony defects in patients with chronic periodontitis."},{"Node1":"Durapatite","Edge_Type":"chemical_to_disease","Node2":"Periodontal Cyst","Weight":1,"Paper_List":"18315420","Original_Text":"PMID:18315420; Original text:Treatment of intrabony periodontal defects with a novel nanocrystalline hydroxyapatite paste significantly improved clinical outcomes compared to open flap debridement."},{"Node1":"Diabetes Mellitus, Type 2","Edge_Type":"disease_to_mechanism","Node2":"JIL-1 kinase","Weight":1,"Paper_List":"28559203","Original_Text":"PMID:28559203; Original text:Considering the effects of adjunctive antimicrobial photodynamic therapy as compared to root planing on clinical signs of chronic periodontitis in type 2 diabetes mellitus and smokers, no difference could be observed for all evaluated parameters (PD: Z=-0.81, P=0.41; CAL: Z=-0.19, P=0.84) except IL-1β (Z=4.57, P<0.001)."},{"Node1":"ibuprofen arginine","Edge_Type":"chemical_to_disease","Node2":"Pain","Weight":1,"Paper_List":"16634956","Original_Text":"PMID:16634956; Original text:The median maximum pain was 28 (inter-quartile range 10-50) following placebo and 10 (4-31) following ibuprofen arginine (p=0.065)."},{"Node1":"glycogen phosphorylase, muscle associated","Edge_Type":"mechanism","Node2":"pink","Weight":1,"Paper_List":"9848540","Original_Text":"PMID:9848540; Original text:The M+A group showed a significant reduction of sites with high levels of Pg (P = 0.001) at 2 months compared with baseline values, and there was a significant reduction of sites with Pg and Pi in the M+A group compared with the placebo group."},{"Node1":"glycogen phosphorylase, muscle associated","Edge_Type":"mechanism","Node2":"serpin family A member 1","Weight":1,"Paper_List":"9848540","Original_Text":"PMID:9848540; Original text:The M+A group showed a significant reduction of sites with high levels of Pg (P = 0.001) at 2 months compared with baseline values, and there was a significant reduction of sites with Pg and Pi in the M+A group compared with the placebo group."},{"Node1":"pink","Edge_Type":"mechanism","Node2":"serpin family A member 1","Weight":1,"Paper_List":"9848540","Original_Text":"PMID:9848540; Original text:The M+A group showed a significant reduction of sites with high levels of Pg (P = 0.001) at 2 months compared with baseline values, and there was a significant reduction of sites with Pg and Pi in the M+A group compared with the placebo group."},{"Node1":"Pain","Edge_Type":"disease","Node2":"Pericardial Effusion","Weight":1,"Paper_List":"20478447","Original_Text":"PMID:20478447; Original text:With regard to tooth-related factors, the following categories were significantly associated with higher healed rates: cases without preoperative pain or signs, cases with good density of root canal filling, and cases with absence or size < or = 5 mm of periapical lesion."},{"Node1":"Prostatic Neoplasms","Edge_Type":"disease_to_anatomy","Node2":"Prostate","Weight":1,"Paper_List":"33029095","Original_Text":"PMID:33029095; Original text:With statistical significance, participants with periodontitis might have enhanced risks of esophageal cancer (HR = 1.79, 95% CI: 1.15-2.79), prostate cancer (HR = 1.20, 95% CI: 1.09-1.31), hematological malignancy (HR = 1.19, 95% CI: 1.09-1.29), and melanoma of skin (HR = 1.21, 95% CI: 1.03-1.42), compared with those without periodontitis."},{"Node1":"Prostatic Neoplasms","Edge_Type":"disease_to_anatomy","Node2":"Skin","Weight":1,"Paper_List":"33029095","Original_Text":"PMID:33029095; Original text:With statistical significance, participants with periodontitis might have enhanced risks of esophageal cancer (HR = 1.79, 95% CI: 1.15-2.79), prostate cancer (HR = 1.20, 95% CI: 1.09-1.31), hematological malignancy (HR = 1.19, 95% CI: 1.09-1.29), and melanoma of skin (HR = 1.21, 95% CI: 1.03-1.42), compared with those without periodontitis."},{"Node1":"Peroxides","Edge_Type":"chemical_to_disease","Node2":"Hemorrhage","Weight":1,"Paper_List":"24660272","Original_Text":"PMID:24660272; Original text:After two weeks of peroxide gel use prior to root planing, mean i.e., pocket probing depth for the test group significantly decreased from baseline by 0.21 mm and mean bleeding index significantly dropped by 0.14; clinical parameters for the control group were unchanged."},{"Node1":"Hemoglobin","Edge_Type":"mechanism","Node2":"provisional ortholog of C-reactive protein L homeolog","Weight":1,"Paper_List":"34197339","Original_Text":"PMID:34197339; Original text:Both groups showed significant clinical and laboratory improvements during the study from baseline to 1 year with reductions in total cholesterol (total cholesterol), triglycerides, glucose, glycated hemoglobin (glycated hemoglobin), uric acid and C-reactive protein (uric acid and C-reactive protein)."},{"Node1":"Triglycerides","Edge_Type":"chemical_to_mechanism","Node2":"Hemoglobin","Weight":1,"Paper_List":"34197339","Original_Text":"PMID:34197339; Original text:Both groups showed significant clinical and laboratory improvements during the study from baseline to 1 year with reductions in total cholesterol (total cholesterol), triglycerides, glucose, glycated hemoglobin (glycated hemoglobin), uric acid and C-reactive protein (uric acid and C-reactive protein)."},{"Node1":"Triglycerides","Edge_Type":"chemical_to_mechanism","Node2":"provisional ortholog of C-reactive protein L homeolog","Weight":1,"Paper_List":"34197339","Original_Text":"PMID:34197339; Original text:Both groups showed significant clinical and laboratory improvements during the study from baseline to 1 year with reductions in total cholesterol (total cholesterol), triglycerides, glucose, glycated hemoglobin (glycated hemoglobin), uric acid and C-reactive protein (uric acid and C-reactive protein)."},{"Node1":"Uric Acid","Edge_Type":"chemical_to_mechanism","Node2":"Hemoglobin","Weight":1,"Paper_List":"34197339","Original_Text":"PMID:34197339; Original text:Both groups showed significant clinical and laboratory improvements during the study from baseline to 1 year with reductions in total cholesterol (total cholesterol), triglycerides, glucose, glycated hemoglobin (glycated hemoglobin), uric acid and C-reactive protein (uric acid and C-reactive protein)."},{"Node1":"Uric Acid","Edge_Type":"chemical_to_mechanism","Node2":"provisional ortholog of C-reactive protein L homeolog","Weight":1,"Paper_List":"34197339","Original_Text":"PMID:34197339; Original text:Both groups showed significant clinical and laboratory improvements during the study from baseline to 1 year with reductions in total cholesterol (total cholesterol), triglycerides, glucose, glycated hemoglobin (glycated hemoglobin), uric acid and C-reactive protein (uric acid and C-reactive protein)."},{"Node1":"Cholesterol","Edge_Type":"chemical_to_mechanism","Node2":"Hemoglobin","Weight":1,"Paper_List":"34197339","Original_Text":"PMID:34197339; Original text:Both groups showed significant clinical and laboratory improvements during the study from baseline to 1 year with reductions in total cholesterol (total cholesterol), triglycerides, glucose, glycated hemoglobin (glycated hemoglobin), uric acid and C-reactive protein (uric acid and C-reactive protein)."},{"Node1":"Doxycycline","Edge_Type":"chemical_to_anatomy","Node2":"Macrophages","Weight":1,"Paper_List":"23649042","Original_Text":"PMID:23649042; Original text:Subantimicrobial-dose doxycycline subjects demonstrated a significant increase in serum-mediated cholesterol efflux from macrophages at both time points compared to baseline (p < 0.04 for each)."},{"Node1":"Cholesterol","Edge_Type":"chemical_to_anatomy","Node2":"Macrophages","Weight":1,"Paper_List":"23649042","Original_Text":"PMID:23649042; Original text:Subantimicrobial-dose doxycycline subjects demonstrated a significant increase in serum-mediated cholesterol efflux from macrophages at both time points compared to baseline (p < 0.04 for each)."},{"Node1":"Campylobacter Rectus","Edge_Type":"bacteria","Node2":"Fusobacterium Necrophorum","Weight":1,"Paper_List":"21303403","Original_Text":"PMID:21303403; Original text:Sites that showed attachment loss and probing depth increase harboured higher levels of Dialister pneumosintes, Campylobacter rectus, Fusobacterium necrophorum, Prevotella tannerea and Peptostreptococcus anaerobius than sites that improved after both therapies (p<0.05)."},{"Node1":"Campylobacter Rectus","Edge_Type":"bacteria","Node2":"Prevotella Tannerae (Organism)","Weight":1,"Paper_List":"21303403","Original_Text":"PMID:21303403; Original text:Sites that showed attachment loss and probing depth increase harboured higher levels of Dialister pneumosintes, Campylobacter rectus, Fusobacterium necrophorum, Prevotella tannerea and Peptostreptococcus anaerobius than sites that improved after both therapies (p<0.05)."},{"Node1":"Campylobacter Rectus","Edge_Type":"bacteria","Node2":"Dialister Pneumosintes (Organism)","Weight":1,"Paper_List":"21303403","Original_Text":"PMID:21303403; Original text:Sites that showed attachment loss and probing depth increase harboured higher levels of Dialister pneumosintes, Campylobacter rectus, Fusobacterium necrophorum, Prevotella tannerea and Peptostreptococcus anaerobius than sites that improved after both therapies (p<0.05)."},{"Node1":"Campylobacter Rectus","Edge_Type":"bacteria","Node2":"Peptostreptococcus Anaerobius (Living Organism)","Weight":1,"Paper_List":"21303403","Original_Text":"PMID:21303403; Original text:Sites that showed attachment loss and probing depth increase harboured higher levels of Dialister pneumosintes, Campylobacter rectus, Fusobacterium necrophorum, Prevotella tannerea and Peptostreptococcus anaerobius than sites that improved after both therapies (p<0.05)."},{"Node1":"Fusobacterium Necrophorum","Edge_Type":"bacteria","Node2":"Prevotella Tannerae (Organism)","Weight":1,"Paper_List":"21303403","Original_Text":"PMID:21303403; Original text:Sites that showed attachment loss and probing depth increase harboured higher levels of Dialister pneumosintes, Campylobacter rectus, Fusobacterium necrophorum, Prevotella tannerea and Peptostreptococcus anaerobius than sites that improved after both therapies (p<0.05)."},{"Node1":"Dialister Pneumosintes (Organism)","Edge_Type":"bacteria","Node2":"Fusobacterium Necrophorum","Weight":1,"Paper_List":"21303403","Original_Text":"PMID:21303403; Original text:Sites that showed attachment loss and probing depth increase harboured higher levels of Dialister pneumosintes, Campylobacter rectus, Fusobacterium necrophorum, Prevotella tannerea and Peptostreptococcus anaerobius than sites that improved after both therapies (p<0.05)."},{"Node1":"Fusobacterium Necrophorum","Edge_Type":"bacteria","Node2":"Peptostreptococcus Anaerobius (Living Organism)","Weight":1,"Paper_List":"21303403","Original_Text":"PMID:21303403; Original text:Sites that showed attachment loss and probing depth increase harboured higher levels of Dialister pneumosintes, Campylobacter rectus, Fusobacterium necrophorum, Prevotella tannerea and Peptostreptococcus anaerobius than sites that improved after both therapies (p<0.05)."},{"Node1":"Dialister Pneumosintes (Organism)","Edge_Type":"bacteria","Node2":"Prevotella Tannerae (Organism)","Weight":1,"Paper_List":"21303403","Original_Text":"PMID:21303403; Original text:Sites that showed attachment loss and probing depth increase harboured higher levels of Dialister pneumosintes, Campylobacter rectus, Fusobacterium necrophorum, Prevotella tannerea and Peptostreptococcus anaerobius than sites that improved after both therapies (p<0.05)."},{"Node1":"Peptostreptococcus Anaerobius (Living Organism)","Edge_Type":"bacteria","Node2":"Prevotella Tannerae (Organism)","Weight":1,"Paper_List":"21303403","Original_Text":"PMID:21303403; Original text:Sites that showed attachment loss and probing depth increase harboured higher levels of Dialister pneumosintes, Campylobacter rectus, Fusobacterium necrophorum, Prevotella tannerea and Peptostreptococcus anaerobius than sites that improved after both therapies (p<0.05)."},{"Node1":"Dialister Pneumosintes (Organism)","Edge_Type":"bacteria","Node2":"Peptostreptococcus Anaerobius (Living Organism)","Weight":1,"Paper_List":"21303403","Original_Text":"PMID:21303403; Original text:Sites that showed attachment loss and probing depth increase harboured higher levels of Dialister pneumosintes, Campylobacter rectus, Fusobacterium necrophorum, Prevotella tannerea and Peptostreptococcus anaerobius than sites that improved after both therapies (p<0.05)."},{"Node1":"Aggregatibacter Actinomycetemcomitans","Edge_Type":"bacteria_to_chemical","Node2":"Metronidazole","Weight":1,"Paper_List":"22288485","Original_Text":"PMID:22288485; Original text:Amoxicillin/metronidazole used as an adjunct to the full-mouth ultrasonic debridement protocol added clinical and microbiologic benefits to GAgP treatment (P <0.05)."},{"Node1":"Aggregatibacter Actinomycetemcomitans","Edge_Type":"bacteria_to_chemical","Node2":"Amoxicillin","Weight":1,"Paper_List":"22288485","Original_Text":"PMID:22288485; Original text:Amoxicillin/metronidazole used as an adjunct to the full-mouth ultrasonic debridement protocol added clinical and microbiologic benefits to GAgP treatment (P <0.05)."},{"Node1":"Tannerella Forsythia","Edge_Type":"bacteria_to_chemical","Node2":"Metronidazole","Weight":1,"Paper_List":"22288485","Original_Text":"PMID:22288485; Original text:full-mouth ultrasonic debridement+amoxicillin/metronidazole groups presented an additional pocket probing depth reduction in initially deep pocket probing depths at the 3-month follow-up (3.99 ± 1.16 mm and 3.09 ± 0.78 mm for full-mouth ultrasonic debridement+amoxicillin/metronidazole and full-mouth ultrasonic debridement, respectively; P <0.05), a lower number of residual pockets at the 3- and 6-month follow-ups, and a statistical reduction in amounts of Aggregatibacter actinomycetemcomitans (P <0.05)."},{"Node1":"interferon gamma","Edge_Type":"mechanism","Node2":"interleukin 4","Weight":1,"Paper_List":"22329861","Original_Text":"PMID:22329861; Original text:Clinical parameters and local levels of interferon-γ, interleukin (interleukin)-17, interleukin-23 and interleukin-4 were assessed at baseline, 3 and 6 months post-therapies."},{"Node1":"Interleukin-17","Edge_Type":"mechanism","Node2":"interferon gamma","Weight":1,"Paper_List":"22329861","Original_Text":"PMID:22329861; Original text:Clinical parameters and local levels of interferon-γ, interleukin (interleukin)-17, interleukin-23 and interleukin-4 were assessed at baseline, 3 and 6 months post-therapies."},{"Node1":"interferon gamma","Edge_Type":"mechanism","Node2":"interleukin 8-like 1","Weight":1,"Paper_List":"22329861","Original_Text":"PMID:22329861; Original text:Clinical parameters and local levels of interferon-γ, interleukin (interleukin)-17, interleukin-23 and interleukin-4 were assessed at baseline, 3 and 6 months post-therapies."},{"Node1":"interferon gamma","Edge_Type":"mechanism","Node2":"interleukin 37","Weight":1,"Paper_List":"22329861","Original_Text":"PMID:22329861; Original text:Clinical parameters and local levels of interferon-γ, interleukin (interleukin)-17, interleukin-23 and interleukin-4 were assessed at baseline, 3 and 6 months post-therapies."},{"Node1":"Interleukin-17","Edge_Type":"mechanism","Node2":"interleukin 4","Weight":1,"Paper_List":"22329861","Original_Text":"PMID:22329861; Original text:Clinical parameters and local levels of interferon-γ, interleukin (interleukin)-17, interleukin-23 and interleukin-4 were assessed at baseline, 3 and 6 months post-therapies."},{"Node1":"interleukin 4","Edge_Type":"mechanism","Node2":"interleukin 8-like 1","Weight":1,"Paper_List":"22329861","Original_Text":"PMID:22329861; Original text:Clinical parameters and local levels of interferon-γ, interleukin (interleukin)-17, interleukin-23 and interleukin-4 were assessed at baseline, 3 and 6 months post-therapies."},{"Node1":"interleukin 37","Edge_Type":"mechanism","Node2":"interleukin 4","Weight":1,"Paper_List":"22329861","Original_Text":"PMID:22329861; Original text:Clinical parameters and local levels of interferon-γ, interleukin (interleukin)-17, interleukin-23 and interleukin-4 were assessed at baseline, 3 and 6 months post-therapies."},{"Node1":"Interleukin-17","Edge_Type":"mechanism","Node2":"interleukin 8-like 1","Weight":1,"Paper_List":"22329861","Original_Text":"PMID:22329861; Original text:Clinical parameters and local levels of interferon-γ, interleukin (interleukin)-17, interleukin-23 and interleukin-4 were assessed at baseline, 3 and 6 months post-therapies."},{"Node1":"Interleukin-17","Edge_Type":"mechanism","Node2":"interleukin 37","Weight":1,"Paper_List":"22329861","Original_Text":"PMID:22329861; Original text:Clinical parameters and local levels of interferon-γ, interleukin (interleukin)-17, interleukin-23 and interleukin-4 were assessed at baseline, 3 and 6 months post-therapies."},{"Node1":"interleukin 37","Edge_Type":"mechanism","Node2":"interleukin 8-like 1","Weight":1,"Paper_List":"22329861","Original_Text":"PMID:22329861; Original text:Clinical parameters and local levels of interferon-γ, interleukin (interleukin)-17, interleukin-23 and interleukin-4 were assessed at baseline, 3 and 6 months post-therapies."},{"Node1":"Integumentary System","Edge_Type":"anatomy","Node2":"Membranes","Weight":1,"Paper_List":"7823272","Original_Text":"PMID:7823272; Original text:During the first month of membrane implantation, no statistically significant differences between test and control surfaces were noted with respect to inflammation of the marginal gingiva."},{"Node1":"Sleep Initiation and Maintenance Disorders","Edge_Type":"disease_to_anatomy","Node2":"Salivary Glands","Weight":1,"Paper_List":"30298556","Original_Text":"PMID:30298556; Original text: months of therapy, whereas the measurements of pocket depth reduction (PD reduction), bleeding on probing (BOP %), and the changes in salivary TNF-α levels and Athens insomnia scale (insomnia scale) scores represented the secondary endpoints."},{"Node1":"Stroke","Edge_Type":"disease_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"26405803","Original_Text":"PMID:26405803; Original text:There were significant differences between the patients with stroke and subjects without in pack-years of smoking (p = 0.01), prevalence of gingival inflammation (gingival inflammation) (p = 0.03), and dental calculus (p = 0.017)."},{"Node1":"Lidocaine","Edge_Type":"chemical","Node2":"Prilocaine","Weight":1,"Paper_List":"12828139","Original_Text":"PMID:12828139; Original text:In 2 previous multicenter studies evaluating the efficacy of a novel anesthetic gel (lidocaine 25 mg/g plus prilocaine 25 mg/g), there was a rather small, although statistically significant, overall difference between the active and placebo gels."},{"Node1":"Diabetes Mellitus","Edge_Type":"disease_to_mechanism","Node2":"GLYcosylation related","Weight":1,"Paper_List":"24934646","Original_Text":"PMID:24934646; Original text:Participants were assessed at baseline and 3 month follow up for glycosylated hemoglobin (significantly lower glycosylated hemoglobin), fasting plasma glucose (plasma glucose), body mass index (Bmotivational interviewing), periodontal status, knowledge, attitude and practice of oral health and diabetes mellitus."},{"Node1":"Stroke","Edge_Type":"disease_to_anatomy","Node2":"Myocardium","Weight":1,"Paper_List":"11216961","Original_Text":"PMID:11216961; Original text:In Cox proportional hazards regression analysis adjusted for age and treatment assignment, physicians who reported periodontal disease at baseline had slightly elevated, but statistically nonsignificant, relative risks (statistically nonsignificant, relative risks) of nonfatal myocardial infarction, (statistically nonsignificant, relative risks, 1.12; 95% confidence interval [CI], 0.92 to 1.36), nonfatal stroke (statistically nonsignificant, relative risks, 1.10; CI, 0.88 to 1.37) and cardiovascular death (statistically nonsignificant, relative risks, 1.20; CI, 0.97 to 1.49)."},{"Node1":"Inflammation","Edge_Type":"disease_to_mechanism","Node2":"collagenase","Weight":1,"Paper_List":"2177499","Original_Text":"PMID:2177499; Original text:Collagenase activity in the crevicular fluid of periodontal pockets of an additional group of subjects was also significantly reduced, as was the severity of inflammation at the same gingival sites."},{"Node1":"UCON 50-HB-5100","Edge_Type":"chemical","Node2":"hydroxyethylene","Weight":1,"Paper_List":"23003342","Original_Text":"PMID:23003342; Original text:In vitro release studies showed controlled drug release which was influenced significantly by the properties and concentration of F-127 and Hydroxy Ethyl Cellulose."},{"Node1":"Gingival Crevicular Fluid","Edge_Type":"anatomy","Node2":"Tooth","Weight":1,"Paper_List":"21121958","Original_Text":"PMID:21121958; Original text:periimplant sulcular fluidthe osmotic pressure positively correlated with the clinical parameters of implants (P<0.01 for Silness-Löe plaque index, Löe-Silness gingival index and Bthe osmotic pressure; P<0.05 for pocket depth and attachment level), and gingival crevicular fluidthe osmotic pressure positively correlated with the clinical parameters of teeth (P<0.01 for pocket depth; P<0.05 for Silness-Löe plaque index, Löe-Silness gingival index, Bthe osmotic pressure and attachment level)."},{"Node1":"interleukin 1 beta","Edge_Type":"mechanism","Node2":"matrix metallopeptidase 8 S homeolog","Weight":1,"Paper_List":"21480939","Original_Text":"PMID:21480939; Original text:interleukin-1β and MMP-8 levels decreased significantly from baseline (p<0.04) in the root planing group only."},{"Node1":"matrix metallopeptidase 8 S homeolog","Edge_Type":"mechanism","Node2":"tumor necrosis factor receptor superfamily member 11b S homeolog","Weight":1,"Paper_List":"21480939","Original_Text":"PMID:21480939; Original text:OPG, MMP-8, and macrophage inflammatory protein-1α were significantly reduced in responders compared with non-responders (p=0.04, 0.01, 0.05, respectively)."},{"Node1":"C-C motif chemokine ligand 3 like 3","Edge_Type":"mechanism","Node2":"matrix metallopeptidase 8 S homeolog","Weight":1,"Paper_List":"21480939","Original_Text":"PMID:21480939; Original text:OPG, MMP-8, and macrophage inflammatory protein-1α were significantly reduced in responders compared with non-responders (p=0.04, 0.01, 0.05, respectively)."},{"Node1":"C-C motif chemokine ligand 3 like 3","Edge_Type":"mechanism","Node2":"tumor necrosis factor receptor superfamily member 11b S homeolog","Weight":1,"Paper_List":"21480939","Original_Text":"PMID:21480939; Original text:OPG, MMP-8, and macrophage inflammatory protein-1α were significantly reduced in responders compared with non-responders (p=0.04, 0.01, 0.05, respectively)."},{"Node1":"matrix metallopeptidase 8 S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Macrophages","Weight":1,"Paper_List":"21480939","Original_Text":"PMID:21480939; Original text:OPG, MMP-8, and macrophage inflammatory protein-1α were significantly reduced in responders compared with non-responders (p=0.04, 0.01, 0.05, respectively)."},{"Node1":"tumor necrosis factor receptor superfamily member 11b S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Macrophages","Weight":1,"Paper_List":"21480939","Original_Text":"PMID:21480939; Original text:OPG, MMP-8, and macrophage inflammatory protein-1α were significantly reduced in responders compared with non-responders (p=0.04, 0.01, 0.05, respectively)."},{"Node1":"Mandible","Edge_Type":"anatomy","Node2":"Maxilla","Weight":1,"Paper_List":"12026923","Original_Text":"PMID:12026923; Original text:There were significantly more painful flare-ups in mandibular teeth than in maxillary (p < 0.05)."},{"Node1":"Gingival Recession","Edge_Type":"disease_to_mechanism","Node2":"amelogenin X-linked","Weight":1,"Paper_List":"11846197","Original_Text":"PMID:11846197; Original text:The 1-year results indicated that: 1) all treatment modalities resulted in clinically significant improvements in clinical attachment levels (clinical attachment levels) and reduction in probing depth (probing depth); 2) a statistically significant treatment effect was demonstrated comparing the enamel matrix proteins test, the membrane control, and the flap control groups in terms of clinical attachment levels gains; 3) both the enamel matrix proteins test and the membrane control groups showed significant clinical attachment levels gains compared to the flap control group; 4) a statistically significantly greater amount of clinical attachment levels gain was demonstrated in guided tissue regeneration-treated compared to enamel matrix proteins-treated patients; 5) deeper residual probing depths but smaller increases in gingival recession were demonstrated following enamel matrix proteins therapy; and 6) smoking habits reduced the clinical outcomes of both regenerative procedures."},{"Node1":"amelogenin X-linked","Edge_Type":"mechanism_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"11846197","Original_Text":"PMID:11846197; Original text:The 1-year results indicated that: 1) all treatment modalities resulted in clinically significant improvements in clinical attachment levels (clinical attachment levels) and reduction in probing depth (probing depth); 2) a statistically significant treatment effect was demonstrated comparing the enamel matrix proteins test, the membrane control, and the flap control groups in terms of clinical attachment levels gains; 3) both the enamel matrix proteins test and the membrane control groups showed significant clinical attachment levels gains compared to the flap control group; 4) a statistically significantly greater amount of clinical attachment levels gain was demonstrated in guided tissue regeneration-treated compared to enamel matrix proteins-treated patients; 5) deeper residual probing depths but smaller increases in gingival recession were demonstrated following enamel matrix proteins therapy; and 6) smoking habits reduced the clinical outcomes of both regenerative procedures."},{"Node1":"Cardiovascular Diseases","Edge_Type":"disease","Node2":"Chronic Periodontitis","Weight":1,"Paper_List":"25123257","Original_Text":"PMID:25123257; Original text:There was insufficient evidence to determine the effect of root planing and community care in reducing the risk of cardiovascular disease recurrence in patients with chronic periodontitis (risk ratio (risk ratio) 0.72; 95% confidence interval (95% confidence interval) 0.23 to 2.22; very low quality evidence)."},{"Node1":"Chlorhexidine","Edge_Type":"chemical","Node2":"Minocycline","Weight":1,"Paper_List":"18454662","Original_Text":"PMID:18454662; Original text:The use of minocycline resulted in significant improvements in probing depths compared to chlorhexidine at days 30, 90, and 180 (P = 0.5, P = 0.01, and P = 0.04, respectively)."},{"Node1":"Suppuration","Edge_Type":"disease_to_anatomy","Node2":"Heterografts","Weight":2,"Paper_List":"22548359|22548359","Original_Text":"PMID:22548359; Original text:At 12 months, significant better results were obtained in the bovine-derived xenograft group for bone levels (p < 0.001), BOP (p = 0.004), PI (p = 0.003) and suppuration (p < 0.01).|PMID:22548359; Original text:When adjusting for number of implants treated per subject, a successful treatment outcome probing depth ≤ 5.0 mm, no pus, no bone loss and BOP at 1/4 or less sites the likelihood of defect fill was higher in the bovine-derived xenograft group (LR: 3.2, 95% CI: 1.0-10.6, p < 0.05)."},{"Node1":"amelogenin X-linked","Edge_Type":"mechanism","Node2":"collagen","Weight":1,"Paper_List":"11990442","Original_Text":"PMID:11990442; Original text:Histometrically, significant amounts of new connective tissue attachment (i.e., cementum with inserting collagen fibers) were observed in both groups (guided tissue regeneration: 2.29 mm; an enamel matrix protein derivative: 1.81 mm)."},{"Node1":"Connective Tissue","Edge_Type":"anatomy","Node2":"Dental Cementum","Weight":1,"Paper_List":"11990442","Original_Text":"PMID:11990442; Original text:Histometrically, significant amounts of new connective tissue attachment (i.e., cementum with inserting collagen fibers) were observed in both groups (guided tissue regeneration: 2.29 mm; an enamel matrix protein derivative: 1.81 mm)."},{"Node1":"amelogenin X-linked","Edge_Type":"mechanism_to_anatomy","Node2":"Dental Cementum","Weight":1,"Paper_List":"11990442","Original_Text":"PMID:11990442; Original text:Histometrically, significant amounts of new connective tissue attachment (i.e., cementum with inserting collagen fibers) were observed in both groups (guided tissue regeneration: 2.29 mm; an enamel matrix protein derivative: 1.81 mm)."},{"Node1":"amelogenin X-linked","Edge_Type":"mechanism_to_anatomy","Node2":"Connective Tissue","Weight":1,"Paper_List":"11990442","Original_Text":"PMID:11990442; Original text:Histometrically, significant amounts of new connective tissue attachment (i.e., cementum with inserting collagen fibers) were observed in both groups (guided tissue regeneration: 2.29 mm; an enamel matrix protein derivative: 1.81 mm)."},{"Node1":"collagen","Edge_Type":"mechanism_to_anatomy","Node2":"Connective Tissue","Weight":1,"Paper_List":"11990442","Original_Text":"PMID:11990442; Original text:Histometrically, significant amounts of new connective tissue attachment (i.e., cementum with inserting collagen fibers) were observed in both groups (guided tissue regeneration: 2.29 mm; an enamel matrix protein derivative: 1.81 mm)."},{"Node1":"Suppuration","Edge_Type":"disease_to_anatomy","Node2":"Tissues","Weight":1,"Paper_List":"28902426","Original_Text":"PMID:28902426; Original text:Clinical examinations at 3 years after treatment revealed (i) improved peri-implant soft tissue health with a mean reduction in probing depth of 2.7 mm and a reduction in bleeding/suppuration on probing of 40% and (ii) stable peri-implant marginal bone levels (mean bone loss during follow-up: 0.04 mm)."},{"Node1":"Alendronate","Edge_Type":"chemical_to_disease","Node2":"Chronic Periodontitis","Weight":1,"Paper_List":"22264208","Original_Text":"PMID:22264208; Original text:In patients with type 2 type 2 diabetes and chronic periodontitis, local delivery of 1% Alendronate into periodontal pockets resulted in a significant increase in the PD reduction, CAL gain, and improved bone fill compared to placebo gel as an adjunct to root planing."},{"Node1":"Interleukin-17","Edge_Type":"mechanism","Node2":"colony stimulating factor 1b (macrophage)","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"colony stimulating factor 1b (macrophage)","Edge_Type":"mechanism","Node2":"colony stimulating factor 3 S homeolog","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"Granulocyte percentage","Edge_Type":"mechanism","Node2":"colony stimulating factor 1b (macrophage)","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"C-C motif chemokine ligand 3 like 3","Edge_Type":"mechanism","Node2":"colony stimulating factor 1b (macrophage)","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"colony stimulating factor 1b (macrophage)","Edge_Type":"mechanism","Node2":"fibroblast growth factor 2","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"Interleukin-17","Edge_Type":"mechanism","Node2":"colony stimulating factor 3 S homeolog","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"Granulocyte percentage","Edge_Type":"mechanism","Node2":"Interleukin-17","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"C-C motif chemokine ligand 3 like 3","Edge_Type":"mechanism","Node2":"Interleukin-17","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"Interleukin-17","Edge_Type":"mechanism","Node2":"fibroblast growth factor 2","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"Granulocyte percentage","Edge_Type":"mechanism","Node2":"colony stimulating factor 3 S homeolog","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"C-C motif chemokine ligand 3 like 3","Edge_Type":"mechanism","Node2":"colony stimulating factor 3 S homeolog","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"colony stimulating factor 3 S homeolog","Edge_Type":"mechanism","Node2":"fibroblast growth factor 2","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"C-C motif chemokine ligand 3 like 3","Edge_Type":"mechanism","Node2":"Granulocyte percentage","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"Granulocyte percentage","Edge_Type":"mechanism","Node2":"fibroblast growth factor 2","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"C-C motif chemokine ligand 3 like 3","Edge_Type":"mechanism","Node2":"fibroblast growth factor 2","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"Fibroblasts","Edge_Type":"anatomy","Node2":"Granulocyte-Macrophage Progenitor Cells","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"Fibroblasts","Edge_Type":"anatomy","Node2":"Granulocytes","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"Fibroblasts","Edge_Type":"anatomy","Node2":"Macrophages","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"colony stimulating factor 1b (macrophage)","Edge_Type":"mechanism_to_anatomy","Node2":"Granulocyte-Macrophage Progenitor Cells","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"colony stimulating factor 1b (macrophage)","Edge_Type":"mechanism_to_anatomy","Node2":"Granulocytes","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"colony stimulating factor 1b (macrophage)","Edge_Type":"mechanism_to_anatomy","Node2":"Macrophages","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"colony stimulating factor 1b (macrophage)","Edge_Type":"mechanism_to_anatomy","Node2":"Fibroblasts","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"Interleukin-17","Edge_Type":"mechanism_to_anatomy","Node2":"Granulocyte-Macrophage Progenitor Cells","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"Interleukin-17","Edge_Type":"mechanism_to_anatomy","Node2":"Granulocytes","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"Interleukin-17","Edge_Type":"mechanism_to_anatomy","Node2":"Macrophages","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"Interleukin-17","Edge_Type":"mechanism_to_anatomy","Node2":"Fibroblasts","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"colony stimulating factor 3 S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Granulocyte-Macrophage Progenitor Cells","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"colony stimulating factor 3 S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Macrophages","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"colony stimulating factor 3 S homeolog","Edge_Type":"mechanism_to_anatomy","Node2":"Fibroblasts","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"Granulocyte percentage","Edge_Type":"mechanism_to_anatomy","Node2":"Granulocyte-Macrophage Progenitor Cells","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"Granulocyte percentage","Edge_Type":"mechanism_to_anatomy","Node2":"Granulocytes","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"Granulocyte percentage","Edge_Type":"mechanism_to_anatomy","Node2":"Macrophages","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"Granulocyte percentage","Edge_Type":"mechanism_to_anatomy","Node2":"Fibroblasts","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"C-C motif chemokine ligand 3 like 3","Edge_Type":"mechanism_to_anatomy","Node2":"Granulocyte-Macrophage Progenitor Cells","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"C-C motif chemokine ligand 3 like 3","Edge_Type":"mechanism_to_anatomy","Node2":"Granulocytes","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"C-C motif chemokine ligand 3 like 3","Edge_Type":"mechanism_to_anatomy","Node2":"Fibroblasts","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"fibroblast growth factor 2","Edge_Type":"mechanism_to_anatomy","Node2":"Granulocyte-Macrophage Progenitor Cells","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"fibroblast growth factor 2","Edge_Type":"mechanism_to_anatomy","Node2":"Granulocytes","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"fibroblast growth factor 2","Edge_Type":"mechanism_to_anatomy","Node2":"Macrophages","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"fibroblast growth factor 2","Edge_Type":"mechanism_to_anatomy","Node2":"Fibroblasts","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:Treatment with photodynamic therapy, DSL, or root planing led to significant changes in several cytokines and acute-phase proteins: Compared with baseline, levels of interleukin-17, basic fibroblast growth factor, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and macrophage inflammatory protein 1-α were lower 14 days and 2 months after treatment."},{"Node1":"haptoglobin-related protein","Edge_Type":"mechanism","Node2":"plasminogen activator, tissue L homeolog","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:The levels of five acute-phase proteins (α-2 macroglobulin, haptoglobin, serum amyloid P, procalcitonin, and tissue plasminogen activator) were significantly higher at 6 months than at baseline."},{"Node1":"haptoglobin-related protein","Edge_Type":"mechanism","Node2":"serum amyloid A 3","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:The levels of five acute-phase proteins (α-2 macroglobulin, haptoglobin, serum amyloid P, procalcitonin, and tissue plasminogen activator) were significantly higher at 6 months than at baseline."},{"Node1":"calcitonin related polypeptide alpha","Edge_Type":"mechanism","Node2":"haptoglobin-related protein","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:The levels of five acute-phase proteins (α-2 macroglobulin, haptoglobin, serum amyloid P, procalcitonin, and tissue plasminogen activator) were significantly higher at 6 months than at baseline."},{"Node1":"b2-microglobulin","Edge_Type":"mechanism","Node2":"haptoglobin-related protein","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:The levels of five acute-phase proteins (α-2 macroglobulin, haptoglobin, serum amyloid P, procalcitonin, and tissue plasminogen activator) were significantly higher at 6 months than at baseline."},{"Node1":"plasminogen activator, tissue L homeolog","Edge_Type":"mechanism","Node2":"serum amyloid A 3","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:The levels of five acute-phase proteins (α-2 macroglobulin, haptoglobin, serum amyloid P, procalcitonin, and tissue plasminogen activator) were significantly higher at 6 months than at baseline."},{"Node1":"calcitonin related polypeptide alpha","Edge_Type":"mechanism","Node2":"plasminogen activator, tissue L homeolog","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:The levels of five acute-phase proteins (α-2 macroglobulin, haptoglobin, serum amyloid P, procalcitonin, and tissue plasminogen activator) were significantly higher at 6 months than at baseline."},{"Node1":"b2-microglobulin","Edge_Type":"mechanism","Node2":"plasminogen activator, tissue L homeolog","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:The levels of five acute-phase proteins (α-2 macroglobulin, haptoglobin, serum amyloid P, procalcitonin, and tissue plasminogen activator) were significantly higher at 6 months than at baseline."},{"Node1":"calcitonin related polypeptide alpha","Edge_Type":"mechanism","Node2":"serum amyloid A 3","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:The levels of five acute-phase proteins (α-2 macroglobulin, haptoglobin, serum amyloid P, procalcitonin, and tissue plasminogen activator) were significantly higher at 6 months than at baseline."},{"Node1":"b2-microglobulin","Edge_Type":"mechanism","Node2":"serum amyloid A 3","Weight":1,"Paper_List":"22181685","Original_Text":"PMID:22181685; Original text:The levels of five acute-phase proteins (α-2 macroglobulin, haptoglobin, serum amyloid P, procalcitonin, and tissue plasminogen activator) were significantly higher at 6 months than at baseline."},{"Node1":"Ibuprofen","Edge_Type":"chemical_to_mechanism","Node2":"leukocyte immunoglobulin like receptor B2","Weight":1,"Paper_List":"8997678","Original_Text":"PMID:8997678; Original text:Ibuprofen had no detectable effect on tissue levels of iLTB4."},{"Node1":"Aggregatibacter Actinomycetemcomitans","Edge_Type":"bacteria_to_mechanism","Node2":"TNF superfamily member 11","Weight":1,"Paper_List":"28667678","Original_Text":"PMID:28667678; Original text:nuclear factor-kappaB ligand was significantly decreased at week 13 in the root planing + photodynamic therapy group compared with the root planing group."},{"Node1":"Tooth Loss","Edge_Type":"disease_to_anatomy","Node2":"Tooth","Weight":2,"Paper_List":"33512339|31025366","Original_Text":"PMID:33512339; Original text:Overall meta-analysis demonstrated that non-compliant patients in supportive periodontal therapy have a 26% increased risk of tooth loss when compared with compliant patients (OR = 1.26; 95% CI = 1.06 to 1.51, Heterogeneity: I2 = 0%, p = 0.008).|PMID:31025366; Original text:Older patients (n = 8 studies; OR: 1.05, 95% CI: 1.03-1.08/year), non-compliant ones (n = 11; 1.51, 1.06-2.16), diabetics (n = 7; 1.80, 1.26-2.57), those with IL-1-polymorphism (n = 3; 1.80; 1.29-2.52) and smokers (n = 15; 1.98, 1.58-2.48) had a significantly higher risk of tooth loss."},{"Node1":"Aggressive Periodontitis","Edge_Type":"disease","Node2":"Coronary Artery Disease","Weight":2,"Paper_List":"25466412|25466412","Original_Text":"PMID:25466412; Original text:In-depth genotyping of 46 published coronary artery disease risk loci of genome-wide significance in the worldwide largest case-control sample of the severe early-onset phenotype aggressive periodontitis (the severe early-onset phenotype aggressive periodontitis) with the Illumina Immunochip (600 German the severe early-onset phenotype aggressive periodontitis cases, 1448 controls) and the Affymetrix 500K array set (283 German the severe early-onset phenotype aggressive periodontitis cases and 972 controls) highlighted ANRIL as the major risk gene and revealed further associations with the severe early-onset phenotype aggressive periodontitis for the gene PLASMINOGEN (PLG; rs4252120: P=5.9×10(-5); odds ratio, 1.27; 95% confidence interval, 1.3-1.4 [adjusted for smoking and sex]; 818 cases; 5309 controls).|PMID:25466412; Original text:Subsequent combined analyses of several genome-wide data sets of coronary artery disease and the severe early-onset phenotype aggressive periodontitis suggested TGFBRAP1 to be associated with the severe early-onset phenotype aggressive periodontitis (rs2679895: P=0.0016; odds ratio, 1.27 [95% confidence interval, 1.1-1.5]; 703 cases; 2.143 controls) and coronary artery disease (P=0.0003; odds ratio, 0.84 [95% confidence interval, 0.8-0.9]; n=4117 cases; 5824 controls)."},{"Node1":"Aggressive Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"CDKN2B antisense RNA 1","Weight":1,"Paper_List":"25466412","Original_Text":"PMID:25466412; Original text:In-depth genotyping of 46 published coronary artery disease risk loci of genome-wide significance in the worldwide largest case-control sample of the severe early-onset phenotype aggressive periodontitis (the severe early-onset phenotype aggressive periodontitis) with the Illumina Immunochip (600 German the severe early-onset phenotype aggressive periodontitis cases, 1448 controls) and the Affymetrix 500K array set (283 German the severe early-onset phenotype aggressive periodontitis cases and 972 controls) highlighted ANRIL as the major risk gene and revealed further associations with the severe early-onset phenotype aggressive periodontitis for the gene PLASMINOGEN (PLG; rs4252120: P=5.9×10(-5); odds ratio, 1.27; 95% confidence interval, 1.3-1.4 [adjusted for smoking and sex]; 818 cases; 5309 controls)."},{"Node1":"Coronary Artery Disease","Edge_Type":"disease_to_mechanism","Node2":"CDKN2B antisense RNA 1","Weight":1,"Paper_List":"25466412","Original_Text":"PMID:25466412; Original text:In-depth genotyping of 46 published coronary artery disease risk loci of genome-wide significance in the worldwide largest case-control sample of the severe early-onset phenotype aggressive periodontitis (the severe early-onset phenotype aggressive periodontitis) with the Illumina Immunochip (600 German the severe early-onset phenotype aggressive periodontitis cases, 1448 controls) and the Affymetrix 500K array set (283 German the severe early-onset phenotype aggressive periodontitis cases and 972 controls) highlighted ANRIL as the major risk gene and revealed further associations with the severe early-onset phenotype aggressive periodontitis for the gene PLASMINOGEN (PLG; rs4252120: P=5.9×10(-5); odds ratio, 1.27; 95% confidence interval, 1.3-1.4 [adjusted for smoking and sex]; 818 cases; 5309 controls)."},{"Node1":"Ulcer","Edge_Type":"disease_to_anatomy","Node2":"Tooth","Weight":1,"Paper_List":"19076988","Original_Text":"PMID:19076988; Original text:Periodontal indices, the number of oral ulcers and the daily frequency of tooth brushing were related to the severity scores of Behçet's disease (p < 0.001)."},{"Node1":"CDKN2B antisense RNA 1","Edge_Type":"mechanism_to_anatomy","Node2":"Coronary Vessels","Weight":1,"Paper_List":"25466412","Original_Text":"PMID:25466412; Original text:In-depth genotyping of 46 published coronary artery disease risk loci of genome-wide significance in the worldwide largest case-control sample of the severe early-onset phenotype aggressive periodontitis (the severe early-onset phenotype aggressive periodontitis) with the Illumina Immunochip (600 German the severe early-onset phenotype aggressive periodontitis cases, 1448 controls) and the Affymetrix 500K array set (283 German the severe early-onset phenotype aggressive periodontitis cases and 972 controls) highlighted ANRIL as the major risk gene and revealed further associations with the severe early-onset phenotype aggressive periodontitis for the gene PLASMINOGEN (PLG; rs4252120: P=5.9×10(-5); odds ratio, 1.27; 95% confidence interval, 1.3-1.4 [adjusted for smoking and sex]; 818 cases; 5309 controls)."},{"Node1":"Aggressive Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"transforming growth factor beta receptor associated protein 1","Weight":1,"Paper_List":"25466412","Original_Text":"PMID:25466412; Original text:Subsequent combined analyses of several genome-wide data sets of coronary artery disease and the severe early-onset phenotype aggressive periodontitis suggested TGFBRAP1 to be associated with the severe early-onset phenotype aggressive periodontitis (rs2679895: P=0.0016; odds ratio, 1.27 [95% confidence interval, 1.1-1.5]; 703 cases; 2.143 controls) and coronary artery disease (P=0.0003; odds ratio, 0.84 [95% confidence interval, 0.8-0.9]; n=4117 cases; 5824 controls)."},{"Node1":"Coronary Artery Disease","Edge_Type":"disease_to_mechanism","Node2":"transforming growth factor beta receptor associated protein 1","Weight":1,"Paper_List":"25466412","Original_Text":"PMID:25466412; Original text:Subsequent combined analyses of several genome-wide data sets of coronary artery disease and the severe early-onset phenotype aggressive periodontitis suggested TGFBRAP1 to be associated with the severe early-onset phenotype aggressive periodontitis (rs2679895: P=0.0016; odds ratio, 1.27 [95% confidence interval, 1.1-1.5]; 703 cases; 2.143 controls) and coronary artery disease (P=0.0003; odds ratio, 0.84 [95% confidence interval, 0.8-0.9]; n=4117 cases; 5824 controls)."},{"Node1":"transforming growth factor beta receptor associated protein 1","Edge_Type":"mechanism_to_anatomy","Node2":"Coronary Vessels","Weight":1,"Paper_List":"25466412","Original_Text":"PMID:25466412; Original text:Subsequent combined analyses of several genome-wide data sets of coronary artery disease and the severe early-onset phenotype aggressive periodontitis suggested TGFBRAP1 to be associated with the severe early-onset phenotype aggressive periodontitis (rs2679895: P=0.0016; odds ratio, 1.27 [95% confidence interval, 1.1-1.5]; 703 cases; 2.143 controls) and coronary artery disease (P=0.0003; odds ratio, 0.84 [95% confidence interval, 0.8-0.9]; n=4117 cases; 5824 controls)."},{"Node1":"Aggregatibacter Actinomycetemcomitans","Edge_Type":"bacteria_to_chemical","Node2":"Azithromycin","Weight":1,"Paper_List":"25044531","Original_Text":"PMID:25044531; Original text:The systemic azithromycin group showed statistically significant reduction in mean depth (2.91 ± 0.88 mm) as compared to placebo (1.51 ± 0.98 mm)"},{"Node1":"Lactic Acid","Edge_Type":"chemical_to_disease","Node2":"Inflammation","Weight":1,"Paper_List":"10743863","Original_Text":"PMID:10743863; Original text:Npolylactic acid membranes treated sites showed less signs of post-surgical inflammation during the 1st 4 weeks of healing than did polylactic acid membranes treated sites (p<0.05)."},{"Node1":"Lactic Acid","Edge_Type":"chemical_to_anatomy","Node2":"Membranes","Weight":2,"Paper_List":"10743863|10743863","Original_Text":"PMID:10743863; Original text:Npolylactic acid membranes treated sites showed less signs of post-surgical inflammation during the 1st 4 weeks of healing than did polylactic acid membranes treated sites (p<0.05).|PMID:10743863; Original text:All improvements were statistically significant (p<0.01) but there was no difference between polylactic acid membranes and Npolylactic acid membranes treatments for any of the efficacy variables."},{"Node1":"Lactic Acid","Edge_Type":"chemical","Node2":"polylevolactic acid","Weight":1,"Paper_List":"10743863","Original_Text":"PMID:10743863; Original text:All improvements were statistically significant (p<0.01) but there was no difference between polylactic acid membranes and Npolylactic acid membranes treatments for any of the efficacy variables."},{"Node1":"polylevolactic acid","Edge_Type":"chemical_to_anatomy","Node2":"Membranes","Weight":3,"Paper_List":"10743863|10743863|10743863","Original_Text":"PMID:10743863; Original text:All improvements were statistically significant (p<0.01) but there was no difference between polylactic acid membranes and Npolylactic acid membranes treatments for any of the efficacy variables.|PMID:10743863; Original text:The results of this study indicated that there was no clinically significant difference in treatment outcomes following GTR treatment of intrabony defects with citric acid ester softened polylactic acid membranes as compared to non-resorbable expanded polytetrafluoroethylene barriers.|PMID:10743863; Original text:Thus, no clinically significant difference in treatment outcomes was observed following GTR treatment of intrabony defects with citric acid ester softened polylactic acid membranes or non-resorbable expanded polytetrafluoroethylene barriers."},{"Node1":"Citric Acid","Edge_Type":"chemical","Node2":"polylevolactic acid","Weight":2,"Paper_List":"10743863|10743863","Original_Text":"PMID:10743863; Original text:The results of this study indicated that there was no clinically significant difference in treatment outcomes following GTR treatment of intrabony defects with citric acid ester softened polylactic acid membranes as compared to non-resorbable expanded polytetrafluoroethylene barriers.|PMID:10743863; Original text:Thus, no clinically significant difference in treatment outcomes was observed following GTR treatment of intrabony defects with citric acid ester softened polylactic acid membranes or non-resorbable expanded polytetrafluoroethylene barriers."},{"Node1":"Citric Acid","Edge_Type":"chemical","Node2":"polytetrafluoroethylene-silicone","Weight":2,"Paper_List":"10743863|10743863","Original_Text":"PMID:10743863; Original text:The results of this study indicated that there was no clinically significant difference in treatment outcomes following GTR treatment of intrabony defects with citric acid ester softened polylactic acid membranes as compared to non-resorbable expanded polytetrafluoroethylene barriers.|PMID:10743863; Original text:Thus, no clinically significant difference in treatment outcomes was observed following GTR treatment of intrabony defects with citric acid ester softened polylactic acid membranes or non-resorbable expanded polytetrafluoroethylene barriers."},{"Node1":"Citric Acid","Edge_Type":"chemical_to_anatomy","Node2":"Membranes","Weight":2,"Paper_List":"10743863|10743863","Original_Text":"PMID:10743863; Original text:The results of this study indicated that there was no clinically significant difference in treatment outcomes following GTR treatment of intrabony defects with citric acid ester softened polylactic acid membranes as compared to non-resorbable expanded polytetrafluoroethylene barriers.|PMID:10743863; Original text:Thus, no clinically significant difference in treatment outcomes was observed following GTR treatment of intrabony defects with citric acid ester softened polylactic acid membranes or non-resorbable expanded polytetrafluoroethylene barriers."},{"Node1":"Hemorrhage","Edge_Type":"disease","Node2":"Infarction","Weight":1,"Paper_List":"14643271","Original_Text":"PMID:14643271; Original text:mm (2.7% for non-acute myocardial infarction and 12.1% for acute myocardial infarction group, 95% CI: -2.8 to 0.01, P<0.05) but no difference in the extent of gingival bleeding was found between groups."},{"Node1":"Gingiva","Edge_Type":"anatomy","Node2":"Myocardium","Weight":1,"Paper_List":"14643271","Original_Text":"PMID:14643271; Original text:mm (2.7% for non-acute myocardial infarction and 12.1% for acute myocardial infarction group, 95% CI: -2.8 to 0.01, P<0.05) but no difference in the extent of gingival bleeding was found between groups."},{"Node1":"Voice Disorders","Edge_Type":"disease_to_anatomy","Node2":"Molar","Weight":1,"Paper_List":"8340625","Original_Text":"PMID:8340625; Original text:There were no statistically significant differences between methods in relation to pain, facial swelling, sensory loss, infection, or periodontal pocket depth distal to the second molar, although 2% of third molars removed by chisel had lingual sensory disturbance at 7 days, as compared with 8% where burs had been used."},{"Node1":"Voice Disorders","Edge_Type":"disease_to_anatomy","Node2":"Molar, Third","Weight":1,"Paper_List":"8340625","Original_Text":"PMID:8340625; Original text:There were no statistically significant differences between methods in relation to pain, facial swelling, sensory loss, infection, or periodontal pocket depth distal to the second molar, although 2% of third molars removed by chisel had lingual sensory disturbance at 7 days, as compared with 8% where burs had been used."},{"Node1":"Voice Disorders","Edge_Type":"disease_to_anatomy","Node2":"Sensilla","Weight":1,"Paper_List":"8340625","Original_Text":"PMID:8340625; Original text:There were no statistically significant differences between methods in relation to pain, facial swelling, sensory loss, infection, or periodontal pocket depth distal to the second molar, although 2% of third molars removed by chisel had lingual sensory disturbance at 7 days, as compared with 8% where burs had been used."},{"Node1":"Infarction","Edge_Type":"disease","Node2":"Periodontitis","Weight":1,"Paper_List":"14643271","Original_Text":"PMID:14643271; Original text:The odds ratio of having acute myocardial infarction and periodontitis varied between 9.2:1 to 14.1:1 with the greatest odds ratio if bone loss exceeded 4mm at >/=50"},{"Node1":"Wounds and Injuries","Edge_Type":"disease_to_anatomy","Node2":"Gingiva","Weight":1,"Paper_List":"25639826","Original_Text":"PMID:25639826; Original text:Flossing cannot be recommended other than for sites of gingival and periodontal health, where inter-dental brushes (inter-dental brushes) will not pass through the interproximal area without trauma."},{"Node1":"Chronic Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"saliva","Weight":1,"Paper_List":"28177133","Original_Text":"PMID:28177133; Original text:The results demonstrated that dietary supplementation with low-dose omega-3 omega-3 polyunsaturated fatty acids improves salivary TNF-α without any significant impact on clinical parameters in patients with chronic periodontitis, suggesting that the systemic benefits of dietary omega-3 omega-3 polyunsaturated fatty acids may not be translated to periodontal health."},{"Node1":"superoxide dismutase 2","Edge_Type":"mechanism_to_anatomy","Node2":"Salivary Glands","Weight":1,"Paper_List":"28177133","Original_Text":"PMID:28177133; Original text:Salivary SOD levels increased significantly at 3 and 6 mo in the test group and at 6 mo in placebo groups compared to baseline with no statistically significant differences between the groups."},{"Node1":"Periodontitis","Edge_Type":"disease_to_mechanism","Node2":"collagenase 3-like","Weight":1,"Paper_List":"10872948","Original_Text":"PMID:10872948; Original text:After treatment there were substantial reductions of A fluorogenic matrix metalloproteinase substrate assay in gingivitis (approximately 51%; P <0.01) and severe periodontitis (approximately 45%; P <0.001), but not in stable periodontitis (13%; P >0.2)."},{"Node1":"Gingivitis","Edge_Type":"disease_to_mechanism","Node2":"collagenase 3-like","Weight":1,"Paper_List":"10872948","Original_Text":"PMID:10872948; Original text:After treatment there were substantial reductions of A fluorogenic matrix metalloproteinase substrate assay in gingivitis (approximately 51%; P <0.01) and severe periodontitis (approximately 45%; P <0.001), but not in stable periodontitis (13%; P >0.2)."},{"Node1":"collagenase 3-like","Edge_Type":"mechanism_to_anatomy","Node2":"Gingival Crevicular Fluid","Weight":1,"Paper_List":"10872948","Original_Text":"PMID:10872948; Original text:A fluorogenic matrix metalloproteinase substrate assay measurements were also positively associated with crevicular fluid flow at baseline, but after treatment there was a approximately 67% decrease (P <0.01) in the highest crevicular fluid flow class."},{"Node1":"Calcium Hydroxide","Edge_Type":"chemical","Node2":"Chlorhexidine","Weight":2,"Paper_List":"30144986|30144986","Original_Text":"PMID:30144986; Original text:chemomechanical preparation to intracanal medication reduction was 97% in the antibiotic group and 39% in the calcium hydroxide/chlorhexidine group; only the former reached statistical significance (P < .01).|PMID:30144986; Original text:Interappointment medication with a triple antibiotic solution at the concentration of 1 mg/mL significantly improved root canal disinfection, and its effects were at least comparable with the calcium hydroxide/chlorhexidine paste."},{"Node1":"Calcium Hydroxide","Edge_Type":"chemical_to_anatomy","Node2":"Dental Pulp Cavity","Weight":1,"Paper_List":"30144986","Original_Text":"PMID:30144986; Original text:Interappointment medication with a triple antibiotic solution at the concentration of 1 mg/mL significantly improved root canal disinfection, and its effects were at least comparable with the calcium hydroxide/chlorhexidine paste."},{"Node1":"Chlorhexidine","Edge_Type":"chemical_to_anatomy","Node2":"Dental Pulp Cavity","Weight":1,"Paper_List":"30144986","Original_Text":"PMID:30144986; Original text:Interappointment medication with a triple antibiotic solution at the concentration of 1 mg/mL significantly improved root canal disinfection, and its effects were at least comparable with the calcium hydroxide/chlorhexidine paste."},{"Node1":"heat shock protein family B (small) member 3","Edge_Type":"mechanism","Node2":"interleukin 1 beta","Weight":1,"Paper_List":"25604769","Original_Text":"PMID:25604769; Original text:Furthermore, the treatment protocol showed a significant reduction in levels of protein-3 and interleukin 1β at 3 and 6 mo compared to the placebo group."},{"Node1":"interleukin 1 receptor antagonist","Edge_Type":"mechanism","Node2":"vascular endothelial growth factor precursor","Weight":1,"Paper_List":"18496484","Original_Text":"PMID:18496484; Original text:IL-1beta, vascular endothelial growth factor and PGE(2) levels were significantly lower in test compared to control group."},{"Node1":"Prostaglandins E","Edge_Type":"chemical_to_mechanism","Node2":"interleukin 1 receptor antagonist","Weight":1,"Paper_List":"18496484","Original_Text":"PMID:18496484; Original text:IL-1beta, vascular endothelial growth factor and PGE(2) levels were significantly lower in test compared to control group."},{"Node1":"Prostaglandins E","Edge_Type":"chemical_to_mechanism","Node2":"vascular endothelial growth factor precursor","Weight":1,"Paper_List":"18496484","Original_Text":"PMID:18496484; Original text:IL-1beta, vascular endothelial growth factor and PGE(2) levels were significantly lower in test compared to control group."},{"Node1":"Prostaglandins E","Edge_Type":"chemical_to_anatomy","Node2":"Endothelium, Vascular","Weight":1,"Paper_List":"18496484","Original_Text":"PMID:18496484; Original text:IL-1beta, vascular endothelial growth factor and PGE(2) levels were significantly lower in test compared to control group."},{"Node1":"interleukin 1 receptor antagonist","Edge_Type":"mechanism_to_anatomy","Node2":"Endothelium, Vascular","Weight":1,"Paper_List":"18496484","Original_Text":"PMID:18496484; Original text:IL-1beta, vascular endothelial growth factor and PGE(2) levels were significantly lower in test compared to control group."},{"Node1":"Hemorrhage","Edge_Type":"disease","Node2":"Mucositis","Weight":1,"Paper_List":"29352461","Original_Text":"PMID:29352461; Original text:The probiotic L. reuteri, together with mechanical therapy, produced an additional improvement over treatment with mechanical therapy alone, both in the general clinical parameters of patients with mucositis (bleeding on probing) and at the level of implants with mucositis (probing pocket depth) or peri-implantitis (bleeding on probing and probing pocket depth)."},{"Node1":"Mucositis","Edge_Type":"disease","Node2":"Peri-Implantitis","Weight":1,"Paper_List":"29352461","Original_Text":"PMID:29352461; Original text:The probiotic L. reuteri, together with mechanical therapy, produced an additional improvement over treatment with mechanical therapy alone, both in the general clinical parameters of patients with mucositis (bleeding on probing) and at the level of implants with mucositis (probing pocket depth) or peri-implantitis (bleeding on probing and probing pocket depth)."},{"Node1":"Hemorrhage","Edge_Type":"disease","Node2":"Peri-Implantitis","Weight":1,"Paper_List":"29352461","Original_Text":"PMID:29352461; Original text:The probiotic L. reuteri, together with mechanical therapy, produced an additional improvement over treatment with mechanical therapy alone, both in the general clinical parameters of patients with mucositis (bleeding on probing) and at the level of implants with mucositis (probing pocket depth) or peri-implantitis (bleeding on probing and probing pocket depth)."}]